id	sid	tid	token	lemma	pos
fnp-3805	1	1	neuromuscular	neuromuscular	ADJ
fnp-3805	1	2	disease	disease	NOUN
fnp-3805	1	3	:	:	PUNCT
fnp-3805	1	4	2022	2022	NUM
fnp-3805	1	5	update	update	NOUN
fnp-3805	1	6	feel	feel	VERB
fnp-3805	1	7	free	free	ADJ
fnp-3805	1	8	to	to	PART
fnp-3805	1	9	add	add	VERB
fnp-3805	1	10	comments	comment	NOUN
fnp-3805	1	11	by	by	ADP
fnp-3805	1	12	clicking	click	VERB
fnp-3805	1	13	these	these	DET
fnp-3805	1	14	icons	icon	NOUN
fnp-3805	1	15	on	on	ADP
fnp-3805	1	16	the	the	DET
fnp-3805	1	17	sidebar	sidebar	NOUN
fnp-3805	1	18	free	free	ADJ
fnp-3805	1	19	neuropathology	neuropathology	NOUN
fnp-3805	1	20	3:5	3:5	NUM
fnp-3805	1	21	(	(	PUNCT
fnp-3805	1	22	2022	2022	NUM
fnp-3805	1	23	)	)	PUNCT
fnp-3805	1	24	review	review	VERB
fnp-3805	1	25	neuromuscular	neuromuscular	ADJ
fnp-3805	1	26	disease	disease	NOUN
fnp-3805	1	27	:	:	PUNCT
fnp-3805	1	28	2022	2022	NUM
fnp-3805	1	29	update	update	NOUN
fnp-3805	1	30	marta	marta	PROPN
fnp-3805	1	31	margeta1	margeta1	PROPN
fnp-3805	1	32	1	1	NUM
fnp-3805	1	33	department	department	NOUN
fnp-3805	1	34	of	of	ADP
fnp-3805	1	35	pathology	pathology	PROPN
fnp-3805	1	36	,	,	PUNCT
fnp-3805	1	37	university	university	PROPN
fnp-3805	1	38	of	of	ADP
fnp-3805	1	39	california	california	PROPN
fnp-3805	1	40	,	,	PUNCT
fnp-3805	1	41	san	san	PROPN
fnp-3805	1	42	francisco	francisco	PROPN
fnp-3805	1	43	,	,	PUNCT
fnp-3805	1	44	ca	ca	PROPN
fnp-3805	1	45	,	,	PUNCT
fnp-3805	1	46	usa	usa	PROPN
fnp-3805	1	47	address	address	NOUN
fnp-3805	1	48	for	for	ADP
fnp-3805	1	49	correspondence	correspondence	NOUN
fnp-3805	1	50	:	:	PUNCT
fnp-3805	1	51	marta	marta	PROPN
fnp-3805	1	52	margeta	margeta	PROPN
fnp-3805	1	53	·	·	PUNCT
fnp-3805	1	54	ucsf	ucsf	PROPN
fnp-3805	1	55	pathology	pathology	PROPN
fnp-3805	1	56	,	,	PUNCT
fnp-3805	1	57	box	box	PROPN
fnp-3805	1	58	0511	0511	NUM
fnp-3805	1	59	·	·	PUNCT
fnp-3805	2	1	513	513	NUM
fnp-3805	2	2	parnassus	parnassus	PROPN
fnp-3805	2	3	ave	ave	PROPN
fnp-3805	2	4	.	.	PROPN
fnp-3805	2	5	,	,	PUNCT
fnp-3805	2	6	hsw-514	hsw-514	NOUN
fnp-3805	2	7	·	·	PUNCT
fnp-3805	2	8	san	san	PROPN
fnp-3805	2	9	francisco	francisco	PROPN
fnp-3805	2	10	,	,	PUNCT
fnp-3805	2	11	ca	ca	PROPN
fnp-3805	2	12	94143	94143	NUM
fnp-3805	2	13	·	·	PUNCT
fnp-3805	3	1	usa	usa	PROPN
fnp-3805	3	2	marta.margeta@ucsf.edu	marta.margeta@ucsf.edu	PROPN
fnp-3805	3	3	submitted	submit	VERB
fnp-3805	3	4	:	:	PUNCT
fnp-3805	3	5	16	16	NUM
fnp-3805	3	6	february	february	PROPN
fnp-3805	3	7	2022	2022	NUM
fnp-3805	3	8	accepted	accept	VERB
fnp-3805	3	9	:	:	PUNCT
fnp-3805	3	10	02	02	NUM
fnp-3805	3	11	march	march	NOUN
fnp-3805	3	12	2022	2022	NUM
fnp-3805	3	13	copyedited	copyedit	VERB
fnp-3805	3	14	by	by	ADP
fnp-3805	3	15	:	:	PUNCT
fnp-3805	3	16	henry	henry	PROPN
fnp-3805	3	17	robbert	robbert	PROPN
fnp-3805	3	18	published	publish	VERB
fnp-3805	3	19	:	:	PUNCT
fnp-3805	3	20	04	04	NUM
fnp-3805	3	21	march	march	NOUN
fnp-3805	3	22	2022	2022	NUM
fnp-3805	3	23	https://doi.org/10.17879/freeneuropathology-2022-3805	https://doi.org/10.17879/freeneuropathology-2022-3805	PROPN
fnp-3805	3	24	keywords	keyword	VERB
fnp-3805	3	25	:	:	PUNCT
fnp-3805	3	26	covid-19	covid-19	PROPN
fnp-3805	3	27	,	,	PUNCT
fnp-3805	3	28	guillain	guillain	NOUN
fnp-3805	3	29	-	-	PUNCT
fnp-3805	3	30	barré	barré	PROPN
fnp-3805	3	31	syndrome	syndrome	NOUN
fnp-3805	3	32	,	,	PUNCT
fnp-3805	3	33	mlip	mlip	NOUN
fnp-3805	3	34	,	,	PUNCT
fnp-3805	3	35	vwa1	vwa1	NOUN
fnp-3805	3	36	,	,	PUNCT
fnp-3805	3	37	optic	optic	ADJ
fnp-3805	3	38	neuropathy	neuropathy	ADJ
fnp-3805	3	39	,	,	PUNCT
fnp-3805	3	40	autophagy	autophagy	ADJ
fnp-3805	3	41	,	,	PUNCT
fnp-3805	3	42	peripheral	peripheral	ADJ
fnp-3805	3	43	neuropathy	neuropathy	ADJ
fnp-3805	3	44	,	,	PUNCT
fnp-3805	3	45	systemic	systemic	ADJ
fnp-3805	3	46	sclerosis	sclerosis	NOUN
fnp-3805	3	47	,	,	PUNCT
fnp-3805	3	48	microvessels	microvessel	NOUN
fnp-3805	3	49	,	,	PUNCT
fnp-3805	3	50	idiopathic	idiopathic	ADJ
fnp-3805	3	51	inflammatory	inflammatory	ADJ
fnp-3805	3	52	myopathy	myopathy	ADJ
fnp-3805	3	53	,	,	PUNCT
fnp-3805	3	54	gene	gene	NOUN
fnp-3805	3	55	expression	expression	NOUN
fnp-3805	3	56	profiling	profiling	NOUN
fnp-3805	3	57	,	,	PUNCT
fnp-3805	3	58	pompe	pompe	PROPN
fnp-3805	3	59	disease	disease	NOUN
fnp-3805	3	60	abstract	abstract	NOUN
fnp-3805	4	1	this	this	DET
fnp-3805	4	2	review	review	NOUN
fnp-3805	4	3	highlights	highlight	VERB
fnp-3805	4	4	ten	ten	NUM
fnp-3805	4	5	important	important	ADJ
fnp-3805	4	6	advances	advance	NOUN
fnp-3805	4	7	in	in	ADP
fnp-3805	4	8	the	the	DET
fnp-3805	4	9	neuromuscular	neuromuscular	ADJ
fnp-3805	4	10	disease	disease	NOUN
fnp-3805	4	11	field	field	NOUN
fnp-3805	4	12	that	that	PRON
fnp-3805	4	13	were	be	AUX
fnp-3805	4	14	reported	report	VERB
fnp-3805	4	15	in	in	ADP
fnp-3805	4	16	2021	2021	NUM
fnp-3805	4	17	.	.	PUNCT
fnp-3805	5	1	as	as	ADP
fnp-3805	5	2	with	with	ADP
fnp-3805	5	3	prior	prior	ADJ
fnp-3805	5	4	updates	update	NOUN
fnp-3805	5	5	in	in	ADP
fnp-3805	5	6	this	this	DET
fnp-3805	5	7	article	article	NOUN
fnp-3805	5	8	series	series	NOUN
fnp-3805	5	9	,	,	PUNCT
fnp-3805	5	10	the	the	DET
fnp-3805	5	11	overarching	overarching	ADJ
fnp-3805	5	12	topics	topic	NOUN
fnp-3805	5	13	include	include	VERB
fnp-3805	5	14	(	(	PUNCT
fnp-3805	5	15	i	i	NOUN
fnp-3805	5	16	)	)	PUNCT
fnp-3805	5	17	advances	advance	NOUN
fnp-3805	5	18	in	in	ADP
fnp-3805	5	19	understanding	understanding	NOUN
fnp-3805	5	20	of	of	ADP
fnp-3805	5	21	fundamental	fundamental	ADJ
fnp-3805	5	22	neuromuscular	neuromuscular	ADJ
fnp-3805	5	23	biology	biology	NOUN
fnp-3805	5	24	;	;	PUNCT
fnp-3805	5	25	(	(	PUNCT
fnp-3805	5	26	ii	ii	NOUN
fnp-3805	5	27	)	)	PUNCT
fnp-3805	5	28	new	new	ADJ
fnp-3805	5	29	/	/	SYM
fnp-3805	5	30	emerging	emerge	VERB
fnp-3805	5	31	diseases	disease	NOUN
fnp-3805	5	32	;	;	PUNCT
fnp-3805	5	33	(	(	PUNCT
fnp-3805	5	34	iii	iii	X
fnp-3805	5	35	)	)	PUNCT
fnp-3805	5	36	advances	advance	NOUN
fnp-3805	5	37	in	in	ADP
fnp-3805	5	38	understanding	understanding	NOUN
fnp-3805	5	39	of	of	ADP
fnp-3805	5	40	disease	disease	NOUN
fnp-3805	5	41	etiology	etiology	NOUN
fnp-3805	5	42	and	and	CCONJ
fnp-3805	5	43	pathogenesis	pathogenesis	NOUN
fnp-3805	5	44	;	;	PUNCT
fnp-3805	5	45	(	(	PUNCT
fnp-3805	5	46	iii	iii	X
fnp-3805	5	47	)	)	PUNCT
fnp-3805	5	48	diagnostic	diagnostic	ADJ
fnp-3805	5	49	advances	advance	NOUN
fnp-3805	5	50	;	;	PUNCT
fnp-3805	5	51	and	and	CCONJ
fnp-3805	5	52	(	(	PUNCT
fnp-3805	5	53	iv	iv	X
fnp-3805	5	54	)	)	PUNCT
fnp-3805	5	55	therapeutic	therapeutic	ADJ
fnp-3805	5	56	advances	advance	NOUN
fnp-3805	5	57	.	.	PUNCT
fnp-3805	6	1	within	within	ADP
fnp-3805	6	2	this	this	DET
fnp-3805	6	3	general	general	ADJ
fnp-3805	6	4	framework	framework	NOUN
fnp-3805	6	5	,	,	PUNCT
fnp-3805	6	6	the	the	DET
fnp-3805	6	7	individual	individual	ADJ
fnp-3805	6	8	disease	disease	NOUN
fnp-3805	6	9	entities	entity	NOUN
fnp-3805	6	10	that	that	PRON
fnp-3805	6	11	are	be	AUX
fnp-3805	6	12	discussed	discuss	VERB
fnp-3805	6	13	in	in	ADP
fnp-3805	6	14	more	more	ADJ
fnp-3805	6	15	detail	detail	NOUN
fnp-3805	6	16	include	include	VERB
fnp-3805	6	17	neuromuscular	neuromuscular	ADJ
fnp-3805	6	18	complications	complication	NOUN
fnp-3805	6	19	of	of	ADP
fnp-3805	6	20	covid-19	covid-19	PROPN
fnp-3805	6	21	(	(	PUNCT
fnp-3805	6	22	another	another	DET
fnp-3805	6	23	look	look	NOUN
fnp-3805	6	24	at	at	ADP
fnp-3805	6	25	the	the	DET
fnp-3805	6	26	topic	topic	NOUN
fnp-3805	6	27	first	first	ADV
fnp-3805	6	28	covered	cover	VERB
fnp-3805	6	29	in	in	ADP
fnp-3805	6	30	the	the	DET
fnp-3805	6	31	2021	2021	NUM
fnp-3805	6	32	review	review	NOUN
fnp-3805	6	33	)	)	PUNCT
fnp-3805	6	34	,	,	PUNCT
fnp-3805	6	35	autosomal	autosomal	ADJ
fnp-3805	6	36	recessive	recessive	ADJ
fnp-3805	6	37	myopathy	myopathy	NOUN
fnp-3805	6	38	caused	cause	VERB
fnp-3805	6	39	by	by	ADP
fnp-3805	6	40	mlip	mlip	ADJ
fnp-3805	6	41	mutations	mutation	NOUN
fnp-3805	6	42	,	,	PUNCT
fnp-3805	6	43	autosomal	autosomal	ADJ
fnp-3805	6	44	recessive	recessive	ADJ
fnp-3805	6	45	neuromuscular	neuromuscular	ADJ
fnp-3805	6	46	disease	disease	NOUN
fnp-3805	6	47	caused	cause	VERB
fnp-3805	6	48	by	by	ADP
fnp-3805	6	49	vwa1	vwa1	NOUN
fnp-3805	6	50	mutations	mutation	NOUN
fnp-3805	6	51	,	,	PUNCT
fnp-3805	6	52	leber	leber	PROPN
fnp-3805	6	53	’s	’s	PART
fnp-3805	6	54	hereditary	hereditary	ADJ
fnp-3805	6	55	optic	optic	NOUN
fnp-3805	6	56	neuropathy	neuropathy	ADJ
fnp-3805	6	57	,	,	PUNCT
fnp-3805	6	58	myopathies	myopathy	NOUN
fnp-3805	6	59	with	with	ADP
fnp-3805	6	60	autophagic	autophagic	ADJ
fnp-3805	6	61	defects	defect	NOUN
fnp-3805	6	62	,	,	PUNCT
fnp-3805	6	63	trna	trna	NOUN
fnp-3805	6	64	synthetase	synthetase	NOUN
fnp-3805	6	65	-	-	PUNCT
fnp-3805	6	66	associated	associate	VERB
fnp-3805	6	67	charcot	charcot	PROPN
fnp-3805	6	68	-	-	PUNCT
fnp-3805	6	69	marie	marie	PROPN
fnp-3805	6	70	-	-	PUNCT
fnp-3805	6	71	tooth	tooth	NOUN
fnp-3805	6	72	disease	disease	NOUN
fnp-3805	6	73	,	,	PUNCT
fnp-3805	6	74	systemic	systemic	ADJ
fnp-3805	6	75	sclerosis	sclerosis	NOUN
fnp-3805	6	76	-	-	PUNCT
fnp-3805	6	77	associated	associate	VERB
fnp-3805	6	78	myopathy	myopathy	ADJ
fnp-3805	6	79	,	,	PUNCT
fnp-3805	6	80	humoral	humoral	ADJ
fnp-3805	6	81	immune	immune	ADJ
fnp-3805	6	82	endoneurial	endoneurial	NOUN
fnp-3805	6	83	microvasculopathy	microvasculopathy	ADJ
fnp-3805	6	84	,	,	PUNCT
fnp-3805	6	85	and	and	CCONJ
fnp-3805	6	86	late	late	ADJ
fnp-3805	6	87	-	-	PUNCT
fnp-3805	6	88	onset	onset	NOUN
fnp-3805	6	89	pompe	pompe	PROPN
fnp-3805	6	90	disease	disease	NOUN
fnp-3805	6	91	.	.	PUNCT
fnp-3805	7	1	in	in	ADP
fnp-3805	7	2	addition	addition	NOUN
fnp-3805	7	3	,	,	PUNCT
fnp-3805	7	4	the	the	DET
fnp-3805	7	5	review	review	NOUN
fnp-3805	7	6	highlights	highlight	VERB
fnp-3805	7	7	a	a	DET
fnp-3805	7	8	few	few	ADJ
fnp-3805	7	9	other	other	ADJ
fnp-3805	7	10	advances	advance	NOUN
fnp-3805	7	11	(	(	PUNCT
fnp-3805	7	12	including	include	VERB
fnp-3805	7	13	new	new	ADJ
fnp-3805	7	14	insights	insight	NOUN
fnp-3805	7	15	into	into	ADP
fnp-3805	7	16	mechanisms	mechanism	NOUN
fnp-3805	7	17	of	of	ADP
fnp-3805	7	18	muscle	muscle	NOUN
fnp-3805	7	19	and	and	CCONJ
fnp-3805	7	20	nerve	nerve	NOUN
fnp-3805	7	21	regeneration	regeneration	NOUN
fnp-3805	7	22	and	and	CCONJ
fnp-3805	7	23	the	the	DET
fnp-3805	7	24	use	use	NOUN
fnp-3805	7	25	of	of	ADP
fnp-3805	7	26	gene	gene	NOUN
fnp-3805	7	27	expression	expression	NOUN
fnp-3805	7	28	profiling	profiling	NOUN
fnp-3805	7	29	to	to	PART
fnp-3805	7	30	better	well	ADV
fnp-3805	7	31	characterize	characterize	VERB
fnp-3805	7	32	different	different	ADJ
fnp-3805	7	33	subtypes	subtype	NOUN
fnp-3805	7	34	of	of	ADP
fnp-3805	7	35	immune	immune	NOUN
fnp-3805	7	36	-	-	PUNCT
fnp-3805	7	37	mediated	mediate	VERB
fnp-3805	7	38	myopathies	myopathy	NOUN
fnp-3805	7	39	)	)	PUNCT
fnp-3805	7	40	that	that	PRON
fnp-3805	7	41	will	will	AUX
fnp-3805	7	42	be	be	AUX
fnp-3805	7	43	of	of	ADP
fnp-3805	7	44	significant	significant	ADJ
fnp-3805	7	45	interest	interest	NOUN
fnp-3805	7	46	for	for	ADP
fnp-3805	7	47	clinicians	clinician	NOUN
fnp-3805	7	48	and	and	CCONJ
fnp-3805	7	49	researchers	researcher	NOUN
fnp-3805	7	50	who	who	PRON
fnp-3805	7	51	specialize	specialize	VERB
fnp-3805	7	52	in	in	ADP
fnp-3805	7	53	neuromuscular	neuromuscular	ADJ
fnp-3805	7	54	disease	disease	NOUN
fnp-3805	7	55	.	.	PUNCT
fnp-3805	8	1	abbreviations	abbreviation	NOUN
fnp-3805	8	2	ars	ar	VERB
fnp-3805	8	3	aminoacyl	aminoacyl	PROPN
fnp-3805	8	4	-	-	PUNCT
fnp-3805	8	5	trna	trna	NOUN
fnp-3805	8	6	synthetase	synthetase	NOUN
fnp-3805	8	7	,	,	PUNCT
fnp-3805	8	8	ass	ass	NOUN
fnp-3805	8	9	anti	anti	ADJ
fnp-3805	8	10	-	-	ADJ
fnp-3805	8	11	synthetase	synthetase	ADJ
fnp-3805	8	12	syndrome	syndrome	NOUN
fnp-3805	8	13	,	,	PUNCT
fnp-3805	8	14	assm	assm	NOUN
fnp-3805	8	15	anti	anti	ADJ
fnp-3805	8	16	-	-	ADJ
fnp-3805	8	17	synthetase	synthetase	ADJ
fnp-3805	8	18	syndrome	syndrome	NOUN
fnp-3805	8	19	-	-	PUNCT
fnp-3805	8	20	associated	associate	VERB
fnp-3805	8	21	myositis	myositis	NOUN
fnp-3805	8	22	,	,	PUNCT
fnp-3805	8	23	avm	avm	PROPN
fnp-3805	8	24	autophagic	autophagic	PROPN
fnp-3805	8	25	vacuolar	vacuolar	ADJ
fnp-3805	8	26	myopathy	myopathy	ADJ
fnp-3805	8	27	,	,	PUNCT
fnp-3805	8	28	casa	casa	PROPN
fnp-3805	8	29	chaperone	chaperone	NOUN
fnp-3805	8	30	-	-	PUNCT
fnp-3805	8	31	assisted	assist	VERB
fnp-3805	8	32	selective	selective	ADJ
fnp-3805	8	33	autophagy	autophagy	NOUN
fnp-3805	8	34	,	,	PUNCT
fnp-3805	8	35	covid-19	covid-19	PROPN
fnp-3805	8	36	coronavirus	coronavirus	NOUN
fnp-3805	8	37	disease	disease	NOUN
fnp-3805	8	38	2019	2019	NUM
fnp-3805	8	39	,	,	PUNCT
fnp-3805	8	40	ck	ck	PROPN
fnp-3805	8	41	creatine	creatine	PROPN
fnp-3805	8	42	kinase	kinase	PROPN
fnp-3805	8	43	,	,	PUNCT
fnp-3805	8	44	cmt	cmt	PROPN
fnp-3805	8	45	charcot	charcot	PROPN
fnp-3805	8	46	-	-	PUNCT
fnp-3805	8	47	marie	marie	PROPN
fnp-3805	8	48	-	-	PUNCT
fnp-3805	8	49	tooth	tooth	NOUN
fnp-3805	8	50	disease	disease	NOUN
fnp-3805	8	51	,	,	PUNCT
fnp-3805	8	52	dm	dm	PROPN
fnp-3805	8	53	dermatomyositis	dermatomyositis	PROPN
fnp-3805	8	54	,	,	PUNCT
fnp-3805	8	55	ert	ert	VERB
fnp-3805	8	56	enzyme	enzyme	NOUN
fnp-3805	8	57	replacement	replacement	NOUN
fnp-3805	8	58	therapy	therapy	NOUN
fnp-3805	8	59	,	,	PUNCT
fnp-3805	8	60	gaa	gaa	PROPN
fnp-3805	8	61	acid	acid	PROPN
fnp-3805	8	62	α	α	PROPN
fnp-3805	8	63	-	-	PUNCT
fnp-3805	8	64	glucosidase	glucosidase	ADJ
fnp-3805	8	65	,	,	PUNCT
fnp-3805	8	66	gbs	gbs	PROPN
fnp-3805	8	67	guillain	guillain	PROPN
fnp-3805	8	68	-	-	PUNCT
fnp-3805	8	69	barré	barré	PROPN
fnp-3805	8	70	syndrome	syndrome	NOUN
fnp-3805	8	71	,	,	PUNCT
fnp-3805	8	72	hiem	hiem	NOUN
fnp-3805	8	73	humoral	humoral	ADJ
fnp-3805	8	74	immune	immune	ADJ
fnp-3805	8	75	endoneurial	endoneurial	ADJ
fnp-3805	8	76	microvasculopathy	microvasculopathy	ADJ
fnp-3805	8	77	,	,	PUNCT
fnp-3805	8	78	hmgcr	hmgcr	NOUN
fnp-3805	8	79	3	3	NUM
fnp-3805	8	80	-	-	PUNCT
fnp-3805	8	81	hydroxy-3	hydroxy-3	NUM
fnp-3805	8	82	-	-	PUNCT
fnp-3805	8	83	methylglutaryl	methylglutaryl	ADJ
fnp-3805	8	84	-	-	PUNCT
fnp-3805	8	85	coa	coa	NOUN
fnp-3805	8	86	reductase	reductase	NOUN
fnp-3805	8	87	,	,	PUNCT
fnp-3805	8	88	iim	iim	ADJ
fnp-3805	8	89	idiopathic	idiopathic	ADJ
fnp-3805	8	90	inflammatory	inflammatory	ADJ
fnp-3805	8	91	myopathy	myopathy	ADJ
fnp-3805	8	92	,	,	PUNCT
fnp-3805	8	93	imnm	imnm	PROPN
fnp-3805	8	94	immune	immune	NOUN
fnp-3805	8	95	-	-	PUNCT
fnp-3805	8	96	mediated	mediate	VERB
fnp-3805	8	97	necrotizing	necrotizing	NOUN
fnp-3805	8	98	myopathy	myopathy	ADJ
fnp-3805	8	99	,	,	PUNCT
fnp-3805	8	100	isr	isr	NOUN
fnp-3805	8	101	integrated	integrate	VERB
fnp-3805	8	102	stress	stress	NOUN
fnp-3805	8	103	response	response	NOUN
fnp-3805	8	104	,	,	PUNCT
fnp-3805	8	105	lhon	lhon	PROPN
fnp-3805	8	106	leber	leber	PROPN
fnp-3805	8	107	’s	’s	PART
fnp-3805	8	108	hereditary	hereditary	ADJ
fnp-3805	8	109	optic	optic	NOUN
fnp-3805	8	110	neuropathy	neuropathy	ADJ
fnp-3805	8	111	,	,	PUNCT
fnp-3805	8	112	lopd	lopd	NOUN
fnp-3805	8	113	late	late	ADJ
fnp-3805	8	114	-	-	PUNCT
fnp-3805	8	115	onset	onset	NOUN
fnp-3805	8	116	pompe	pompe	PROPN
fnp-3805	8	117	disease	disease	NOUN
fnp-3805	8	118	,	,	PUNCT
fnp-3805	8	119	m6p	m6p	NOUN
fnp-3805	8	120	mannose-6	mannose-6	NOUN
fnp-3805	8	121	-	-	NOUN
fnp-3805	8	122	phosphate	phosphate	NOUN
fnp-3805	8	123	,	,	PUNCT
fnp-3805	8	124	mct1	mct1	PROPN
fnp-3805	8	125	monocarboxylate	monocarboxylate	ADJ
fnp-3805	8	126	transporter	transporter	NOUN
fnp-3805	8	127	1	1	NUM
fnp-3805	8	128	,	,	PUNCT
fnp-3805	8	129	mlip	mlip	ADV
fnp-3805	8	130	muscular	muscular	ADJ
fnp-3805	8	131	a	a	DET
fnp-3805	8	132	-	-	PUNCT
fnp-3805	8	133	type	type	NOUN
fnp-3805	8	134	lamin	lamin	NOUN
fnp-3805	8	135	-	-	PUNCT
fnp-3805	8	136	interacting	interact	VERB
fnp-3805	8	137	protein	protein	NOUN
fnp-3805	8	138	,	,	PUNCT
fnp-3805	8	139	mmcp	mmcp	PROPN
fnp-3805	8	140	minimal	minimal	ADJ
fnp-3805	8	141	myositis	myositis	PROPN
fnp-3805	8	142	with	with	ADP
fnp-3805	8	143	capillary	capillary	ADJ
fnp-3805	8	144	pathology	pathology	NOUN
fnp-3805	8	145	,	,	PUNCT
fnp-3805	8	146	msa	msa	PROPN
fnp-3805	8	147	myositis	myositis	PROPN
fnp-3805	8	148	specific	specific	ADJ
fnp-3805	8	149	antibody	antibody	NOUN
fnp-3805	8	150	,	,	PUNCT
fnp-3805	8	151	msp	msp	PROPN
fnp-3805	8	152	multiple	multiple	ADJ
fnp-3805	8	153	system	system	NOUN
fnp-3805	8	154	proteinopathy	proteinopathy	ADJ
fnp-3805	8	155	,	,	PUNCT
fnp-3805	8	156	musc	musc	PROPN
fnp-3805	8	157	muscle	muscle	NOUN
fnp-3805	8	158	stem	stem	NOUN
fnp-3805	8	159	cells	cell	NOUN
fnp-3805	8	160	,	,	PUNCT
fnp-3805	8	161	mxa	mxa	NOUN
fnp-3805	8	162	myxovirus	myxovirus	NOUN
fnp-3805	8	163	(	(	PUNCT
fnp-3805	8	164	influenza	influenza	NOUN
fnp-3805	8	165	virus	virus	NOUN
fnp-3805	8	166	)	)	PUNCT
fnp-3805	8	167	resistance	resistance	NOUN
fnp-3805	8	168	1	1	NUM
fnp-3805	8	169	,	,	PUNCT
fnp-3805	8	170	interferon	interferon	ADJ
fnp-3805	8	171	-	-	PUNCT
fnp-3805	8	172	inducible	inducible	ADJ
fnp-3805	8	173	protein	protein	NOUN
fnp-3805	8	174	p78	p78	NOUN
fnp-3805	8	175	,	,	PUNCT
fnp-3805	8	176	nampta	nampta	NOUN
fnp-3805	8	177	nicotinamide	nicotinamide	NOUN
fnp-3805	8	178	phosphoribosyl	phosphoribosyl	NOUN
fnp-3805	8	179	transferase	transferase	NOUN
fnp-3805	8	180	a	a	NOUN
fnp-3805	8	181	,	,	PUNCT
fnp-3805	8	182	nmd	nmd	PROPN
fnp-3805	8	183	neuromuscular	neuromuscular	ADJ
fnp-3805	8	184	disease	disease	NOUN
fnp-3805	8	185	,	,	PUNCT
fnp-3805	8	186	sibm	sibm	PROPN
fnp-3805	8	187	sporadic	sporadic	ADJ
fnp-3805	8	188	inclusion	inclusion	NOUN
fnp-3805	8	189	body	body	NOUN
fnp-3805	8	190	myositis	myositis	NOUN
fnp-3805	8	191	,	,	PUNCT
fnp-3805	8	192	ssc	ssc	X
fnp-3805	8	193	systemic	systemic	ADJ
fnp-3805	8	194	sclerosis	sclerosis	NOUN
fnp-3805	8	195	,	,	PUNCT
fnp-3805	8	196	vwa1	vwa1	PROPN
fnp-3805	8	197	von	von	PROPN
fnp-3805	8	198	willebrand	willebrand	PROPN
fnp-3805	8	199	factor	factor	NOUN
fnp-3805	8	200	a	a	DET
fnp-3805	8	201	containing	contain	VERB
fnp-3805	8	202	1	1	NUM
fnp-3805	8	203	protein	protein	NOUN
fnp-3805	8	204	.	.	PUNCT
fnp-3805	8	205	  	  	SPACE
fnp-3805	9	1	in	in	ADP
fnp-3805	9	2	this	this	DET
fnp-3805	9	3	annual	annual	ADJ
fnp-3805	9	4	update	update	NOUN
fnp-3805	9	5	,	,	PUNCT
fnp-3805	9	6	i	i	PRON
fnp-3805	9	7	will	will	AUX
fnp-3805	9	8	briefly	briefly	ADV
fnp-3805	9	9	describe	describe	VERB
fnp-3805	9	10	ten	ten	NUM
fnp-3805	9	11	neuromuscular	neuromuscular	ADJ
fnp-3805	9	12	field	field	NOUN
fnp-3805	9	13	advances	advance	NOUN
fnp-3805	9	14	from	from	ADP
fnp-3805	9	15	last	last	ADJ
fnp-3805	9	16	year	year	NOUN
fnp-3805	9	17	that	that	PRON
fnp-3805	9	18	i	i	PRON
fnp-3805	9	19	consider	consider	VERB
fnp-3805	9	20	to	to	PART
fnp-3805	9	21	be	be	AUX
fnp-3805	9	22	most	most	ADV
fnp-3805	9	23	important	important	ADJ
fnp-3805	9	24	and/or	and/or	CCONJ
fnp-3805	9	25	interesting	interesting	ADJ
fnp-3805	9	26	;	;	PUNCT
fnp-3805	9	27	as	as	ADP
fnp-3805	9	28	in	in	ADP
fnp-3805	9	29	the	the	DET
fnp-3805	9	30	earlier	early	ADJ
fnp-3805	9	31	updates	update	NOUN
fnp-3805	9	32	(	(	PUNCT
fnp-3805	9	33	margeta	margeta	NOUN
fnp-3805	9	34	,	,	PUNCT
fnp-3805	9	35	2020b	2020b	NUM
fnp-3805	9	36	,	,	PUNCT
fnp-3805	9	37	2021	2021	NUM
fnp-3805	9	38	)	)	PUNCT
fnp-3805	9	39	,	,	PUNCT
fnp-3805	9	40	these	these	DET
fnp-3805	9	41	advances	advance	NOUN
fnp-3805	9	42	will	will	AUX
fnp-3805	9	43	be	be	AUX
fnp-3805	9	44	grouped	group	VERB
fnp-3805	9	45	into	into	ADP
fnp-3805	9	46	different	different	ADJ
fnp-3805	9	47	“	"	PUNCT
fnp-3805	9	48	discovery	discovery	NOUN
fnp-3805	9	49	clusters	cluster	NOUN
fnp-3805	9	50	”	"	PUNCT
fnp-3805	9	51	and	and	CCONJ
fnp-3805	9	52	listed	list	VERB
fnp-3805	9	53	in	in	ADP
fnp-3805	9	54	no	no	DET
fnp-3805	9	55	particular	particular	ADJ
fnp-3805	9	56	order	order	NOUN
fnp-3805	9	57	.	.	PUNCT
fnp-3805	10	1	advances	advance	NOUN
fnp-3805	10	2	in	in	ADP
fnp-3805	10	3	fundamental	fundamental	ADJ
fnp-3805	10	4	neuromuscular	neuromuscular	ADJ
fnp-3805	10	5	biology	biology	NOUN
fnp-3805	10	6	with	with	ADP
fnp-3805	10	7	implications	implication	NOUN
fnp-3805	10	8	for	for	ADP
fnp-3805	10	9	neuromuscular	neuromuscular	ADJ
fnp-3805	10	10	disease	disease	NOUN
fnp-3805	10	11	1	1	NUM
fnp-3805	10	12	.	.	PUNCT
fnp-3805	10	13	revisiting	revisit	VERB
fnp-3805	10	14	the	the	DET
fnp-3805	10	15	role	role	NOUN
fnp-3805	10	16	of	of	ADP
fnp-3805	10	17	macrophages	macrophage	NOUN
fnp-3805	10	18	in	in	ADP
fnp-3805	10	19	nerve	nerve	NOUN
fnp-3805	10	20	and	and	CCONJ
fnp-3805	10	21	muscle	muscle	NOUN
fnp-3805	10	22	regeneration	regeneration	NOUN
fnp-3805	10	23	in	in	ADP
fnp-3805	10	24	the	the	DET
fnp-3805	10	25	last	last	ADJ
fnp-3805	10	26	year	year	NOUN
fnp-3805	10	27	’s	’s	PART
fnp-3805	10	28	review	review	NOUN
fnp-3805	10	29	(	(	PUNCT
fnp-3805	10	30	margeta	margeta	NOUN
fnp-3805	10	31	,	,	PUNCT
fnp-3805	10	32	2021	2021	NUM
fnp-3805	10	33	)	)	PUNCT
fnp-3805	10	34	,	,	PUNCT
fnp-3805	10	35	i	i	PRON
fnp-3805	10	36	highlighted	highlight	VERB
fnp-3805	10	37	the	the	DET
fnp-3805	10	38	2020	2020	NUM
fnp-3805	10	39	discovery	discovery	NOUN
fnp-3805	10	40	of	of	ADP
fnp-3805	10	41	a	a	DET
fnp-3805	10	42	crosstalk	crosstalk	NOUN
fnp-3805	10	43	between	between	ADP
fnp-3805	10	44	macrophages	macrophage	NOUN
fnp-3805	10	45	and	and	CCONJ
fnp-3805	10	46	satellite	satellite	NOUN
fnp-3805	10	47	cells	cell	NOUN
fnp-3805	10	48	in	in	ADP
fnp-3805	10	49	skeletal	skeletal	ADJ
fnp-3805	10	50	muscle	muscle	NOUN
fnp-3805	10	51	repair	repair	NOUN
fnp-3805	10	52	.	.	PUNCT
fnp-3805	11	1	excitingly	excitingly	ADV
fnp-3805	11	2	,	,	PUNCT
fnp-3805	11	3	two	two	NUM
fnp-3805	11	4	studies	study	NOUN
fnp-3805	11	5	published	publish	VERB
fnp-3805	11	6	in	in	ADP
fnp-3805	11	7	2021	2021	NUM
fnp-3805	11	8	extended	extend	VERB
fnp-3805	11	9	that	that	DET
fnp-3805	11	10	work	work	NOUN
fnp-3805	11	11	by	by	ADP
fnp-3805	11	12	further	far	ADV
fnp-3805	11	13	dissecting	dissect	VERB
fnp-3805	11	14	the	the	DET
fnp-3805	11	15	molecular	molecular	ADJ
fnp-3805	11	16	mechanisms	mechanism	NOUN
fnp-3805	11	17	by	by	ADP
fnp-3805	11	18	which	which	PRON
fnp-3805	11	19	macrophages	macrophage	NOUN
fnp-3805	11	20	promote	promote	VERB
fnp-3805	11	21	regeneration	regeneration	NOUN
fnp-3805	11	22	not	not	PART
fnp-3805	11	23	only	only	ADV
fnp-3805	11	24	in	in	ADP
fnp-3805	11	25	skeletal	skeletal	ADJ
fnp-3805	11	26	muscle	muscle	NOUN
fnp-3805	11	27	(	(	PUNCT
fnp-3805	11	28	ratnayake	ratnayake	NOUN
fnp-3805	11	29	et	et	PROPN
fnp-3805	11	30	al	al	PROPN
fnp-3805	11	31	.	.	PROPN
fnp-3805	11	32	,	,	PUNCT
fnp-3805	11	33	2021	2021	NUM
fnp-3805	11	34	)	)	PUNCT
fnp-3805	11	35	but	but	CCONJ
fnp-3805	11	36	also	also	ADV
fnp-3805	11	37	in	in	ADP
fnp-3805	11	38	peripheral	peripheral	ADJ
fnp-3805	11	39	nerves	nerve	NOUN
fnp-3805	11	40	(	(	PUNCT
fnp-3805	11	41	jha	jha	PROPN
fnp-3805	11	42	et	et	PROPN
fnp-3805	11	43	al	al	PROPN
fnp-3805	11	44	.	.	PROPN
fnp-3805	11	45	,	,	PUNCT
fnp-3805	11	46	2021	2021	NUM
fnp-3805	11	47	)	)	PUNCT
fnp-3805	11	48	.	.	PUNCT
fnp-3805	12	1	together	together	ADV
fnp-3805	12	2	with	with	ADP
fnp-3805	12	3	other	other	ADJ
fnp-3805	12	4	recent	recent	ADJ
fnp-3805	12	5	work	work	NOUN
fnp-3805	12	6	in	in	ADP
fnp-3805	12	7	the	the	DET
fnp-3805	12	8	field	field	NOUN
fnp-3805	12	9	of	of	ADP
fnp-3805	12	10	regenerative	regenerative	ADJ
fnp-3805	12	11	medicine	medicine	NOUN
fnp-3805	12	12	,	,	PUNCT
fnp-3805	12	13	these	these	DET
fnp-3805	12	14	two	two	NUM
fnp-3805	12	15	studies	study	NOUN
fnp-3805	12	16	provide	provide	VERB
fnp-3805	12	17	evidence	evidence	NOUN
fnp-3805	12	18	that	that	SCONJ
fnp-3805	12	19	macrophages	macrophage	NOUN
fnp-3805	12	20	–	–	PUNCT
fnp-3805	12	21	which	which	PRON
fnp-3805	12	22	are	be	AUX
fnp-3805	12	23	readily	readily	ADV
fnp-3805	12	24	detectable	detectable	ADJ
fnp-3805	12	25	within	within	ADP
fnp-3805	12	26	necrotic	necrotic	ADJ
fnp-3805	12	27	muscle	muscle	NOUN
fnp-3805	12	28	fibers	fiber	NOUN
fnp-3805	12	29	(	(	PUNCT
fnp-3805	12	30	fig	fig	NOUN
fnp-3805	12	31	.	.	PUNCT
fnp-3805	13	1	1a	1a	PROPN
fnp-3805	13	2	-	-	PUNCT
fnp-3805	13	3	b	b	NOUN
fnp-3805	13	4	)	)	PUNCT
fnp-3805	13	5	and	and	CCONJ
fnp-3805	13	6	adjacent	adjacent	ADJ
fnp-3805	13	7	to	to	ADP
fnp-3805	13	8	degenerating	degenerate	VERB
fnp-3805	13	9	peripheral	peripheral	ADJ
fnp-3805	13	10	nerve	nerve	NOUN
fnp-3805	13	11	axons	axon	NOUN
fnp-3805	13	12	(	(	PUNCT
fnp-3805	13	13	fig	fig	NOUN
fnp-3805	13	14	.	.	PUNCT
fnp-3805	14	1	1c	1c	NOUN
fnp-3805	14	2	-	-	PUNCT
fnp-3805	14	3	d	d	NOUN
fnp-3805	14	4	)	)	PUNCT
fnp-3805	14	5	–	–	PUNCT
fnp-3805	14	6	play	play	VERB
fnp-3805	14	7	a	a	DET
fnp-3805	14	8	major	major	ADJ
fnp-3805	14	9	role	role	NOUN
fnp-3805	14	10	in	in	ADP
fnp-3805	14	11	the	the	DET
fnp-3805	14	12	pns	pns	PROPN
fnp-3805	14	13	repair	repair	NOUN
fnp-3805	14	14	,	,	PUNCT
fnp-3805	14	15	extending	extend	VERB
fnp-3805	14	16	well	well	ADV
fnp-3805	14	17	beyond	beyond	ADP
fnp-3805	14	18	the	the	DET
fnp-3805	14	19	long	long	ADV
fnp-3805	14	20	-	-	PUNCT
fnp-3805	14	21	recognized	recognize	VERB
fnp-3805	14	22	phagocytic	phagocytic	ADJ
fnp-3805	14	23	clearance	clearance	NOUN
fnp-3805	14	24	of	of	ADP
fnp-3805	14	25	necrotic	necrotic	ADJ
fnp-3805	14	26	cellular	cellular	ADJ
fnp-3805	14	27	debris	debris	NOUN
fnp-3805	14	28	at	at	ADP
fnp-3805	14	29	injury	injury	NOUN
fnp-3805	14	30	sites	site	NOUN
fnp-3805	14	31	.	.	PUNCT
fnp-3805	15	1	figure	figure	NOUN
fnp-3805	15	2	1	1	NUM
fnp-3805	15	3	.	.	PUNCT
fnp-3805	15	4	macrophages	macrophage	NOUN
fnp-3805	15	5	home	home	ADV
fnp-3805	15	6	on	on	ADP
fnp-3805	15	7	degenerating	degenerate	VERB
fnp-3805	15	8	muscle	muscle	NOUN
fnp-3805	15	9	and	and	CCONJ
fnp-3805	15	10	nerve	nerve	NOUN
fnp-3805	15	11	fibers	fiber	NOUN
fnp-3805	15	12	.	.	PUNCT
fnp-3805	16	1	a	a	DET
fnp-3805	16	2	representative	representative	ADJ
fnp-3805	16	3	field	field	NOUN
fnp-3805	16	4	from	from	ADP
fnp-3805	16	5	an	an	DET
fnp-3805	16	6	h&e	h&e	PROPN
fnp-3805	16	7	-	-	PUNCT
fnp-3805	16	8	stained	stain	VERB
fnp-3805	16	9	muscle	muscle	NOUN
fnp-3805	16	10	section	section	NOUN
fnp-3805	16	11	(	(	PUNCT
fnp-3805	16	12	a	a	X
fnp-3805	16	13	)	)	PUNCT
fnp-3805	16	14	shows	show	VERB
fnp-3805	16	15	muscle	muscle	NOUN
fnp-3805	16	16	fibers	fiber	NOUN
fnp-3805	16	17	in	in	ADP
fnp-3805	16	18	varying	vary	VERB
fnp-3805	16	19	stages	stage	NOUN
fnp-3805	16	20	of	of	ADP
fnp-3805	16	21	necrosis	necrosis	NOUN
fnp-3805	16	22	and	and	CCONJ
fnp-3805	16	23	repair	repair	NOUN
fnp-3805	16	24	,	,	PUNCT
fnp-3805	16	25	starting	start	VERB
fnp-3805	16	26	with	with	ADP
fnp-3805	16	27	early	early	ADJ
fnp-3805	16	28	coagulative	coagulative	NOUN
fnp-3805	16	29	necrosis	necrosis	NOUN
fnp-3805	16	30	,	,	PUNCT
fnp-3805	16	31	progressing	progress	VERB
fnp-3805	16	32	through	through	ADP
fnp-3805	16	33	myophagocytosis	myophagocytosis	NOUN
fnp-3805	16	34	,	,	PUNCT
fnp-3805	16	35	and	and	CCONJ
fnp-3805	16	36	ending	end	VERB
fnp-3805	16	37	with	with	ADP
fnp-3805	16	38	regeneration	regeneration	NOUN
fnp-3805	16	39	mediated	mediate	VERB
fnp-3805	16	40	by	by	ADP
fnp-3805	16	41	macrophage	macrophage	ADJ
fnp-3805	16	42	-	-	PUNCT
fnp-3805	16	43	activated	activate	VERB
fnp-3805	16	44	satellite	satellite	NOUN
fnp-3805	16	45	cells	cell	NOUN
fnp-3805	16	46	;	;	PUNCT
fnp-3805	16	47	in	in	ADP
fnp-3805	16	48	this	this	DET
fnp-3805	16	49	case	case	NOUN
fnp-3805	16	50	,	,	PUNCT
fnp-3805	16	51	the	the	DET
fnp-3805	16	52	fiber	fiber	NOUN
fnp-3805	16	53	injury	injury	NOUN
fnp-3805	16	54	was	be	AUX
fnp-3805	16	55	immune	immune	NOUN
fnp-3805	16	56	-	-	PUNCT
fnp-3805	16	57	mediated	mediate	VERB
fnp-3805	16	58	,	,	PUNCT
fnp-3805	16	59	but	but	CCONJ
fnp-3805	16	60	similar	similar	ADJ
fnp-3805	16	61	changes	change	NOUN
fnp-3805	16	62	are	be	AUX
fnp-3805	16	63	seen	see	VERB
fnp-3805	16	64	in	in	ADP
fnp-3805	16	65	all	all	DET
fnp-3805	16	66	necrotizing	necrotize	VERB
fnp-3805	16	67	myopathies	myopathy	NOUN
fnp-3805	16	68	regardless	regardless	ADV
fnp-3805	16	69	of	of	ADP
fnp-3805	16	70	the	the	DET
fnp-3805	16	71	underlying	underlie	VERB
fnp-3805	16	72	etiology	etiology	NOUN
fnp-3805	16	73	.	.	PUNCT
fnp-3805	17	1	the	the	DET
fnp-3805	17	2	cd68	cd68	PROPN
fnp-3805	17	3	stain	stain	NOUN
fnp-3805	17	4	of	of	ADP
fnp-3805	17	5	the	the	DET
fnp-3805	17	6	same	same	ADJ
fnp-3805	17	7	area	area	NOUN
fnp-3805	17	8	(	(	PUNCT
fnp-3805	17	9	b	b	NOUN
fnp-3805	17	10	)	)	PUNCT
fnp-3805	17	11	highlights	highlight	NOUN
fnp-3805	17	12	macrophages	macrophage	NOUN
fnp-3805	17	13	within	within	ADP
fnp-3805	17	14	necrotic	necrotic	ADJ
fnp-3805	17	15	muscle	muscle	NOUN
fnp-3805	17	16	fiber	fiber	NOUN
fnp-3805	17	17	segments	segment	NOUN
fnp-3805	17	18	(	(	PUNCT
fnp-3805	17	19	myophagocytosis	myophagocytosis	NOUN
fnp-3805	17	20	)	)	PUNCT
fnp-3805	17	21	.	.	PUNCT
fnp-3805	18	1	a	a	DET
fnp-3805	18	2	representative	representative	ADJ
fnp-3805	18	3	field	field	NOUN
fnp-3805	18	4	from	from	ADP
fnp-3805	18	5	an	an	DET
fnp-3805	18	6	h&e	h&e	NOUN
fnp-3805	18	7	-	-	PUNCT
fnp-3805	18	8	stained	stain	VERB
fnp-3805	18	9	peripheral	peripheral	ADJ
fnp-3805	18	10	nerve	nerve	NOUN
fnp-3805	18	11	section	section	NOUN
fnp-3805	18	12	(	(	PUNCT
fnp-3805	18	13	c	c	NOUN
fnp-3805	18	14	)	)	PUNCT
fnp-3805	18	15	shows	show	VERB
fnp-3805	18	16	a	a	DET
fnp-3805	18	17	marked	mark	VERB
fnp-3805	18	18	loss	loss	NOUN
fnp-3805	18	19	of	of	ADP
fnp-3805	18	20	large	large	ADJ
fnp-3805	18	21	myelinated	myelinated	ADJ
fnp-3805	18	22	axons	axon	NOUN
fnp-3805	18	23	and	and	CCONJ
fnp-3805	18	24	abundant	abundant	ADJ
fnp-3805	18	25	digestion	digestion	NOUN
fnp-3805	18	26	chambers	chamber	NOUN
fnp-3805	18	27	(	(	PUNCT
fnp-3805	18	28	fragments	fragment	NOUN
fnp-3805	18	29	of	of	ADP
fnp-3805	18	30	degenerating	degenerate	VERB
fnp-3805	18	31	axons	axon	NOUN
fnp-3805	18	32	)	)	PUNCT
fnp-3805	18	33	in	in	ADP
fnp-3805	18	34	a	a	DET
fnp-3805	18	35	case	case	NOUN
fnp-3805	18	36	of	of	ADP
fnp-3805	18	37	acute	acute	ADJ
fnp-3805	18	38	axonal	axonal	ADJ
fnp-3805	18	39	neuropathy	neuropathy	ADJ
fnp-3805	18	40	.	.	PUNCT
fnp-3805	19	1	the	the	DET
fnp-3805	19	2	cd68	cd68	PROPN
fnp-3805	19	3	stain	stain	NOUN
fnp-3805	19	4	of	of	ADP
fnp-3805	19	5	the	the	DET
fnp-3805	19	6	same	same	ADJ
fnp-3805	19	7	microscopic	microscopic	ADJ
fnp-3805	19	8	field	field	NOUN
fnp-3805	19	9	(	(	PUNCT
fnp-3805	19	10	d	d	X
fnp-3805	19	11	)	)	PUNCT
fnp-3805	19	12	highlights	highlight	NOUN
fnp-3805	19	13	endoneurial	endoneurial	ADJ
fnp-3805	19	14	macrophages	macrophage	NOUN
fnp-3805	19	15	associated	associate	VERB
fnp-3805	19	16	with	with	ADP
fnp-3805	19	17	degenerating	degenerate	VERB
fnp-3805	19	18	axon	axon	NOUN
fnp-3805	19	19	fragments	fragment	NOUN
fnp-3805	19	20	.	.	PUNCT
fnp-3805	20	1	the	the	DET
fnp-3805	20	2	stains	stain	NOUN
fnp-3805	20	3	were	be	AUX
fnp-3805	20	4	performed	perform	VERB
fnp-3805	20	5	on	on	ADP
fnp-3805	20	6	formalin	formalin	NOUN
fnp-3805	20	7	-	-	PUNCT
fnp-3805	20	8	fixed	fix	VERB
fnp-3805	20	9	,	,	PUNCT
fnp-3805	20	10	paraffin	paraffin	NOUN
fnp-3805	20	11	-	-	PUNCT
fnp-3805	20	12	embedded	embed	VERB
fnp-3805	20	13	tissue	tissue	NOUN
fnp-3805	20	14	;	;	PUNCT
fnp-3805	20	15	scale	scale	NOUN
fnp-3805	20	16	bar	bar	NOUN
fnp-3805	20	17	,	,	PUNCT
fnp-3805	20	18	50	50	NUM
fnp-3805	20	19	 	 	SPACE
fnp-3805	20	20	μm	μm	NOUN
fnp-3805	20	21	.	.	PUNCT
fnp-3805	21	1	ratnayake	ratnayake	NOUN
fnp-3805	21	2	and	and	CCONJ
fnp-3805	21	3	colleagues	colleague	NOUN
fnp-3805	21	4	used	use	VERB
fnp-3805	21	5	sophisticated	sophisticated	ADJ
fnp-3805	21	6	genetic	genetic	ADJ
fnp-3805	21	7	and	and	CCONJ
fnp-3805	21	8	pharmacologic	pharmacologic	ADJ
fnp-3805	21	9	approaches	approach	NOUN
fnp-3805	21	10	to	to	PART
fnp-3805	21	11	delineate	delineate	VERB
fnp-3805	21	12	the	the	DET
fnp-3805	21	13	macrophage	macrophage	ADJ
fnp-3805	21	14	-	-	PUNCT
fnp-3805	21	15	stem	stem	NOUN
fnp-3805	21	16	cell	cell	NOUN
fnp-3805	21	17	interactions	interaction	NOUN
fnp-3805	21	18	that	that	PRON
fnp-3805	21	19	are	be	AUX
fnp-3805	21	20	required	require	VERB
fnp-3805	21	21	for	for	ADP
fnp-3805	21	22	muscle	muscle	NOUN
fnp-3805	21	23	wound	wound	NOUN
fnp-3805	21	24	repair	repair	NOUN
fnp-3805	21	25	in	in	ADP
fnp-3805	21	26	both	both	CCONJ
fnp-3805	21	27	zebrafish	zebrafish	ADJ
fnp-3805	21	28	and	and	CCONJ
fnp-3805	21	29	mice	mouse	NOUN
fnp-3805	21	30	(	(	PUNCT
fnp-3805	21	31	ratnayake	ratnayake	VERB
fnp-3805	21	32	et	et	PROPN
fnp-3805	21	33	al	al	PROPN
fnp-3805	21	34	.	.	PROPN
fnp-3805	21	35	,	,	PUNCT
fnp-3805	21	36	2021	2021	NUM
fnp-3805	21	37	)	)	PUNCT
fnp-3805	21	38	.	.	PUNCT
fnp-3805	22	1	using	use	VERB
fnp-3805	22	2	the	the	DET
fnp-3805	22	3	zebrafish	zebrafish	ADJ
fnp-3805	22	4	laser	laser	NOUN
fnp-3805	22	5	-	-	PUNCT
fnp-3805	22	6	ablation	ablation	NOUN
fnp-3805	22	7	injury	injury	NOUN
fnp-3805	22	8	model	model	NOUN
fnp-3805	22	9	,	,	PUNCT
fnp-3805	22	10	they	they	PRON
fnp-3805	22	11	showed	show	VERB
fnp-3805	22	12	that	that	SCONJ
fnp-3805	22	13	a	a	DET
fnp-3805	22	14	subset	subset	NOUN
fnp-3805	22	15	of	of	ADP
fnp-3805	22	16	tissue	tissue	NOUN
fnp-3805	22	17	-	-	PUNCT
fnp-3805	22	18	resident	resident	NOUN
fnp-3805	22	19	macrophages	macrophage	NOUN
fnp-3805	22	20	that	that	PRON
fnp-3805	22	21	are	be	AUX
fnp-3805	22	22	recruited	recruit	VERB
fnp-3805	22	23	to	to	ADP
fnp-3805	22	24	the	the	DET
fnp-3805	22	25	wound	wound	NOUN
fnp-3805	22	26	following	follow	VERB
fnp-3805	22	27	injury	injury	NOUN
fnp-3805	22	28	remained	remain	VERB
fnp-3805	22	29	at	at	ADP
fnp-3805	22	30	the	the	DET
fnp-3805	22	31	injury	injury	NOUN
fnp-3805	22	32	site	site	NOUN
fnp-3805	22	33	,	,	PUNCT
fnp-3805	22	34	creating	create	VERB
fnp-3805	22	35	a	a	DET
fnp-3805	22	36	“	"	PUNCT
fnp-3805	22	37	dwelling	dwelling	ADJ
fnp-3805	22	38	”	"	PUNCT
fnp-3805	22	39	macrophage	macrophage	ADJ
fnp-3805	22	40	population	population	NOUN
fnp-3805	22	41	that	that	PRON
fnp-3805	22	42	had	have	VERB
fnp-3805	22	43	spherical	spherical	ADJ
fnp-3805	22	44	morphology	morphology	NOUN
fnp-3805	22	45	(	(	PUNCT
fnp-3805	22	46	in	in	ADP
fnp-3805	22	47	contrast	contrast	NOUN
fnp-3805	22	48	to	to	PART
fnp-3805	22	49	transient	transient	VERB
fnp-3805	22	50	macrophages	macrophage	NOUN
fnp-3805	22	51	,	,	PUNCT
fnp-3805	22	52	which	which	PRON
fnp-3805	22	53	had	have	VERB
fnp-3805	22	54	a	a	DET
fnp-3805	22	55	stellate	stellate	ADJ
fnp-3805	22	56	appearance	appearance	NOUN
fnp-3805	22	57	)	)	PUNCT
fnp-3805	22	58	;	;	PUNCT
fnp-3805	22	59	these	these	DET
fnp-3805	22	60	dwelling	dwelling	ADJ
fnp-3805	22	61	macrophages	macrophage	NOUN
fnp-3805	22	62	formed	form	VERB
fnp-3805	22	63	intimate	intimate	ADJ
fnp-3805	22	64	connections	connection	NOUN
fnp-3805	22	65	with	with	ADP
fnp-3805	22	66	muscle	muscle	NOUN
fnp-3805	22	67	stem	stem	NOUN
fnp-3805	22	68	cells	cell	NOUN
fnp-3805	22	69	(	(	PUNCT
fnp-3805	22	70	musc	musc	NOUN
fnp-3805	22	71	)	)	PUNCT
fnp-3805	22	72	that	that	PRON
fnp-3805	22	73	were	be	AUX
fnp-3805	22	74	reminiscent	reminiscent	ADJ
fnp-3805	22	75	of	of	ADP
fnp-3805	22	76	dendritic	dendritic	ADJ
fnp-3805	22	77	cell	cell	NOUN
fnp-3805	22	78	-	-	PUNCT
fnp-3805	22	79	t	t	NOUN
fnp-3805	22	80	cell	cell	NOUN
fnp-3805	22	81	immunological	immunological	ADJ
fnp-3805	22	82	synapses	synapsis	NOUN
fnp-3805	22	83	,	,	PUNCT
fnp-3805	22	84	forming	form	VERB
fnp-3805	22	85	a	a	DET
fnp-3805	22	86	transient	transient	ADJ
fnp-3805	22	87	pro	pro	ADJ
fnp-3805	22	88	-	-	ADJ
fnp-3805	22	89	proliferative	proliferative	ADJ
fnp-3805	22	90	stem	stem	NOUN
fnp-3805	22	91	cell	cell	NOUN
fnp-3805	22	92	niche	niche	NOUN
fnp-3805	22	93	that	that	PRON
fnp-3805	22	94	persisted	persist	VERB
fnp-3805	22	95	until	until	ADP
fnp-3805	22	96	musc	musc	NOUN
fnp-3805	22	97	underwent	underwent	NOUN
fnp-3805	22	98	cell	cell	NOUN
fnp-3805	22	99	division	division	NOUN
fnp-3805	22	100	.	.	PUNCT
fnp-3805	23	1	based	base	VERB
fnp-3805	23	2	on	on	ADP
fnp-3805	23	3	their	their	PRON
fnp-3805	23	4	gene	gene	NOUN
fnp-3805	23	5	expression	expression	NOUN
fnp-3805	23	6	profiles	profile	NOUN
fnp-3805	23	7	,	,	PUNCT
fnp-3805	23	8	dwelling	dwell	VERB
fnp-3805	23	9	macrophages	macrophage	NOUN
fnp-3805	23	10	were	be	AUX
fnp-3805	23	11	shown	show	VERB
fnp-3805	23	12	to	to	PART
fnp-3805	23	13	be	be	AUX
fnp-3805	23	14	a	a	DET
fnp-3805	23	15	heterogenous	heterogenous	ADJ
fnp-3805	23	16	cell	cell	NOUN
fnp-3805	23	17	population	population	NOUN
fnp-3805	23	18	;	;	PUNCT
fnp-3805	23	19	however	however	ADV
fnp-3805	23	20	,	,	PUNCT
fnp-3805	23	21	the	the	DET
fnp-3805	23	22	authors	author	NOUN
fnp-3805	23	23	identified	identify	VERB
fnp-3805	23	24	a	a	DET
fnp-3805	23	25	single	single	ADJ
fnp-3805	23	26	“	"	PUNCT
fnp-3805	23	27	mature	mature	ADJ
fnp-3805	23	28	”	"	PUNCT
fnp-3805	23	29	subpopulation	subpopulation	NOUN
fnp-3805	23	30	(	(	PUNCT
fnp-3805	23	31	defined	define	VERB
fnp-3805	23	32	by	by	ADP
fnp-3805	23	33	expression	expression	NOUN
fnp-3805	23	34	of	of	ADP
fnp-3805	23	35	markers	marker	NOUN
fnp-3805	23	36	associated	associate	VERB
fnp-3805	23	37	with	with	ADP
fnp-3805	23	38	the	the	DET
fnp-3805	23	39	anti	anti	ADJ
fnp-3805	23	40	-	-	ADJ
fnp-3805	23	41	inflammatory	inflammatory	ADJ
fnp-3805	23	42	macrophage	macrophage	ADJ
fnp-3805	23	43	phenotype	phenotype	NOUN
fnp-3805	23	44	,	,	PUNCT
fnp-3805	23	45	such	such	ADJ
fnp-3805	23	46	as	as	ADP
fnp-3805	23	47	arginase	arginase	NOUN
fnp-3805	23	48	2	2	NUM
fnp-3805	23	49	and	and	CCONJ
fnp-3805	23	50	matrix	matrix	NOUN
fnp-3805	23	51	metalloproteinase-9	metalloproteinase-9	NUM
fnp-3805	23	52	)	)	PUNCT
fnp-3805	23	53	that	that	PRON
fnp-3805	23	54	mediated	mediate	VERB
fnp-3805	23	55	muscle	muscle	NOUN
fnp-3805	23	56	repair	repair	NOUN
fnp-3805	23	57	by	by	ADP
fnp-3805	23	58	stimulating	stimulate	VERB
fnp-3805	23	59	musc	musc	NOUN
fnp-3805	23	60	proliferation	proliferation	NOUN
fnp-3805	23	61	.	.	PUNCT
fnp-3805	24	1	to	to	PART
fnp-3805	24	2	promote	promote	VERB
fnp-3805	24	3	musc	musc	NOUN
fnp-3805	24	4	mitogenesis	mitogenesis	NOUN
fnp-3805	24	5	,	,	PUNCT
fnp-3805	24	6	these	these	DET
fnp-3805	24	7	mature	mature	ADJ
fnp-3805	24	8	dwelling	dwelling	ADJ
fnp-3805	24	9	macrophages	macrophage	NOUN
fnp-3805	24	10	(	(	PUNCT
fnp-3805	24	11	which	which	PRON
fnp-3805	24	12	constitute	constitute	VERB
fnp-3805	24	13	~70	~70	NOUN
fnp-3805	24	14	%	%	NOUN
fnp-3805	24	15	of	of	ADP
fnp-3805	24	16	all	all	DET
fnp-3805	24	17	dwelling	dwelling	ADJ
fnp-3805	24	18	macrophages	macrophage	NOUN
fnp-3805	24	19	)	)	PUNCT
fnp-3805	24	20	secreted	secrete	VERB
fnp-3805	24	21	nicotinamide	nicotinamide	NOUN
fnp-3805	24	22	phosphoribosyl	phosphoribosyl	NOUN
fnp-3805	24	23	transferase	transferase	NOUN
fnp-3805	24	24	a	a	DET
fnp-3805	24	25	(	(	PUNCT
fnp-3805	24	26	nampta	nampta	NOUN
fnp-3805	24	27	)	)	PUNCT
fnp-3805	24	28	,	,	PUNCT
fnp-3805	24	29	which	which	PRON
fnp-3805	24	30	bound	bind	VERB
fnp-3805	24	31	to	to	ADP
fnp-3805	24	32	the	the	DET
fnp-3805	24	33	chemokine	chemokine	ADJ
fnp-3805	24	34	receptor	receptor	NOUN
fnp-3805	24	35	ccr5	ccr5	NOUN
fnp-3805	24	36	expressed	express	VERB
fnp-3805	24	37	by	by	ADP
fnp-3805	24	38	musc	musc	NOUN
fnp-3805	24	39	;	;	PUNCT
fnp-3805	24	40	interestingly	interestingly	ADV
fnp-3805	24	41	,	,	PUNCT
fnp-3805	24	42	this	this	DET
fnp-3805	24	43	mitogenic	mitogenic	ADJ
fnp-3805	24	44	effect	effect	NOUN
fnp-3805	24	45	of	of	ADP
fnp-3805	24	46	nampta	nampta	NOUN
fnp-3805	24	47	was	be	AUX
fnp-3805	24	48	independent	independent	ADJ
fnp-3805	24	49	of	of	ADP
fnp-3805	24	50	its	its	PRON
fnp-3805	24	51	enzymatic	enzymatic	ADJ
fnp-3805	24	52	activity	activity	NOUN
fnp-3805	24	53	.	.	PUNCT
fnp-3805	25	1	the	the	DET
fnp-3805	25	2	zebrafish	zebrafish	ADJ
fnp-3805	25	3	findings	finding	NOUN
fnp-3805	25	4	were	be	AUX
fnp-3805	25	5	replicated	replicate	VERB
fnp-3805	25	6	in	in	ADP
fnp-3805	25	7	mice	mouse	NOUN
fnp-3805	25	8	using	use	VERB
fnp-3805	25	9	the	the	DET
fnp-3805	25	10	volumetric	volumetric	ADJ
fnp-3805	25	11	muscle	muscle	NOUN
fnp-3805	25	12	loss	loss	NOUN
fnp-3805	25	13	model	model	NOUN
fnp-3805	25	14	,	,	PUNCT
fnp-3805	25	15	which	which	PRON
fnp-3805	25	16	simulates	simulate	VERB
fnp-3805	25	17	irrecoverable	irrecoverable	ADJ
fnp-3805	25	18	muscle	muscle	NOUN
fnp-3805	25	19	injury	injury	NOUN
fnp-3805	25	20	that	that	PRON
fnp-3805	25	21	occurs	occur	VERB
fnp-3805	25	22	following	follow	VERB
fnp-3805	25	23	trauma	trauma	NOUN
fnp-3805	25	24	,	,	PUNCT
fnp-3805	25	25	tumor	tumor	NOUN
fnp-3805	25	26	excision	excision	NOUN
fnp-3805	25	27	,	,	PUNCT
fnp-3805	25	28	or	or	CCONJ
fnp-3805	25	29	infarction	infarction	NOUN
fnp-3805	25	30	(	(	PUNCT
fnp-3805	25	31	quarta	quarta	PROPN
fnp-3805	25	32	et	et	PROPN
fnp-3805	25	33	al	al	PROPN
fnp-3805	25	34	.	.	PROPN
fnp-3805	25	35	,	,	PUNCT
fnp-3805	25	36	2017	2017	NUM
fnp-3805	25	37	;	;	PUNCT
fnp-3805	25	38	sicari	sicari	PROPN
fnp-3805	25	39	et	et	PROPN
fnp-3805	25	40	al	al	PROPN
fnp-3805	25	41	.	.	PROPN
fnp-3805	25	42	,	,	PUNCT
fnp-3805	25	43	2012	2012	NUM
fnp-3805	25	44	):	):	PUNCT
fnp-3805	25	45	delivery	delivery	NOUN
fnp-3805	25	46	of	of	ADP
fnp-3805	25	47	human	human	ADJ
fnp-3805	25	48	recombinant	recombinant	ADJ
fnp-3805	25	49	nampt	nampt	NOUN
fnp-3805	25	50	(	(	PUNCT
fnp-3805	25	51	the	the	DET
fnp-3805	25	52	human	human	ADJ
fnp-3805	25	53	analogue	analogue	NOUN
fnp-3805	25	54	of	of	ADP
fnp-3805	25	55	zebrafish	zebrafish	PROPN
fnp-3805	25	56	nampta	nampta	NOUN
fnp-3805	25	57	)	)	PUNCT
fnp-3805	25	58	into	into	ADP
fnp-3805	25	59	the	the	DET
fnp-3805	25	60	excisional	excisional	ADJ
fnp-3805	25	61	muscle	muscle	NOUN
fnp-3805	25	62	defect	defect	NOUN
fnp-3805	25	63	using	use	VERB
fnp-3805	25	64	a	a	DET
fnp-3805	25	65	fibrin	fibrin	ADJ
fnp-3805	25	66	hydrogel	hydrogel	NOUN
fnp-3805	25	67	led	lead	VERB
fnp-3805	25	68	to	to	ADP
fnp-3805	25	69	a	a	DET
fnp-3805	25	70	complete	complete	ADJ
fnp-3805	25	71	restoration	restoration	NOUN
fnp-3805	25	72	of	of	ADP
fnp-3805	25	73	muscle	muscle	NOUN
fnp-3805	25	74	architecture	architecture	NOUN
fnp-3805	25	75	,	,	PUNCT
fnp-3805	25	76	with	with	ADP
fnp-3805	25	77	an	an	DET
fnp-3805	25	78	increase	increase	NOUN
fnp-3805	25	79	in	in	ADP
fnp-3805	25	80	the	the	DET
fnp-3805	25	81	number	number	NOUN
fnp-3805	25	82	of	of	ADP
fnp-3805	25	83	proliferating	proliferate	VERB
fnp-3805	25	84	satellite	satellite	NOUN
fnp-3805	25	85	cells	cell	NOUN
fnp-3805	25	86	and	and	CCONJ
fnp-3805	25	87	centrally	centrally	ADV
fnp-3805	25	88	nucleated	nucleated	ADJ
fnp-3805	25	89	,	,	PUNCT
fnp-3805	25	90	regenerating	regenerate	VERB
fnp-3805	25	91	muscle	muscle	NOUN
fnp-3805	25	92	fibers	fiber	NOUN
fnp-3805	25	93	relative	relative	ADJ
fnp-3805	25	94	to	to	ADP
fnp-3805	25	95	the	the	DET
fnp-3805	25	96	control	control	NOUN
fnp-3805	25	97	condition	condition	NOUN
fnp-3805	25	98	(	(	PUNCT
fnp-3805	25	99	fibrin	fibrin	NOUN
fnp-3805	25	100	hydrogel	hydrogel	NOUN
fnp-3805	25	101	without	without	ADP
fnp-3805	25	102	nampt	nampt	ADJ
fnp-3805	25	103	)	)	PUNCT
fnp-3805	25	104	.	.	PUNCT
fnp-3805	26	1	while	while	SCONJ
fnp-3805	26	2	these	these	DET
fnp-3805	26	3	results	result	NOUN
fnp-3805	26	4	are	be	AUX
fnp-3805	26	5	very	very	ADV
fnp-3805	26	6	promising	promising	ADJ
fnp-3805	26	7	from	from	ADP
fnp-3805	26	8	the	the	DET
fnp-3805	26	9	tissue	tissue	NOUN
fnp-3805	26	10	engineering	engineering	NOUN
fnp-3805	26	11	standpoint	standpoint	NOUN
fnp-3805	26	12	,	,	PUNCT
fnp-3805	26	13	it	it	PRON
fnp-3805	26	14	remains	remain	VERB
fnp-3805	26	15	to	to	PART
fnp-3805	26	16	be	be	AUX
fnp-3805	26	17	seen	see	VERB
fnp-3805	26	18	whether	whether	SCONJ
fnp-3805	26	19	a	a	DET
fnp-3805	26	20	similar	similar	ADJ
fnp-3805	26	21	approach	approach	NOUN
fnp-3805	26	22	can	can	AUX
fnp-3805	26	23	be	be	AUX
fnp-3805	26	24	used	use	VERB
fnp-3805	26	25	to	to	PART
fnp-3805	26	26	promote	promote	VERB
fnp-3805	26	27	muscle	muscle	NOUN
fnp-3805	26	28	fiber	fiber	NOUN
fnp-3805	26	29	regeneration	regeneration	NOUN
fnp-3805	26	30	in	in	ADP
fnp-3805	26	31	muscle	muscle	NOUN
fnp-3805	26	32	dystrophies	dystrophy	NOUN
fnp-3805	26	33	and	and	CCONJ
fnp-3805	26	34	other	other	ADJ
fnp-3805	26	35	muscle	muscle	NOUN
fnp-3805	26	36	diseases	disease	NOUN
fnp-3805	26	37	that	that	PRON
fnp-3805	26	38	show	show	VERB
fnp-3805	26	39	a	a	DET
fnp-3805	26	40	significant	significant	ADJ
fnp-3805	26	41	loss	loss	NOUN
fnp-3805	26	42	of	of	ADP
fnp-3805	26	43	muscle	muscle	NOUN
fnp-3805	26	44	volume	volume	NOUN
fnp-3805	26	45	.	.	PUNCT
fnp-3805	27	1	the	the	DET
fnp-3805	27	2	study	study	NOUN
fnp-3805	27	3	by	by	ADP
fnp-3805	27	4	jha	jha	PROPN
fnp-3805	27	5	and	and	CCONJ
fnp-3805	27	6	colleagues	colleague	NOUN
fnp-3805	27	7	(	(	PUNCT
fnp-3805	27	8	jha	jha	PROPN
fnp-3805	27	9	et	et	PROPN
fnp-3805	27	10	al	al	PROPN
fnp-3805	27	11	.	.	PROPN
fnp-3805	27	12	,	,	PUNCT
fnp-3805	27	13	2021	2021	NUM
fnp-3805	27	14	)	)	PUNCT
fnp-3805	27	15	focused	focus	VERB
fnp-3805	27	16	on	on	ADP
fnp-3805	27	17	the	the	DET
fnp-3805	27	18	role	role	NOUN
fnp-3805	27	19	of	of	ADP
fnp-3805	27	20	macrophage	macrophage	ADJ
fnp-3805	27	21	metabolism	metabolism	NOUN
fnp-3805	27	22	in	in	ADP
fnp-3805	27	23	the	the	DET
fnp-3805	27	24	peripheral	peripheral	ADJ
fnp-3805	27	25	nerve	nerve	NOUN
fnp-3805	27	26	repair	repair	NOUN
fnp-3805	27	27	following	follow	VERB
fnp-3805	27	28	mechanical	mechanical	ADJ
fnp-3805	27	29	injury	injury	NOUN
fnp-3805	27	30	,	,	PUNCT
fnp-3805	27	31	and	and	CCONJ
fnp-3805	27	32	their	their	PRON
fnp-3805	27	33	nerve	nerve	NOUN
fnp-3805	27	34	regeneration	regeneration	NOUN
fnp-3805	27	35	findings	finding	NOUN
fnp-3805	27	36	in	in	ADP
fnp-3805	27	37	many	many	ADJ
fnp-3805	27	38	ways	way	NOUN
fnp-3805	27	39	echo	echo	VERB
fnp-3805	27	40	the	the	DET
fnp-3805	27	41	muscle	muscle	NOUN
fnp-3805	27	42	regeneration	regeneration	NOUN
fnp-3805	27	43	findings	finding	NOUN
fnp-3805	27	44	made	make	VERB
fnp-3805	27	45	by	by	ADP
fnp-3805	27	46	ratnayake	ratnayake	NOUN
fnp-3805	27	47	et	et	PROPN
fnp-3805	27	48	al	al	PROPN
fnp-3805	27	49	.	.	PUNCT
fnp-3805	28	1	using	use	VERB
fnp-3805	28	2	the	the	DET
fnp-3805	28	3	murine	murine	ADJ
fnp-3805	28	4	sciatic	sciatic	ADJ
fnp-3805	28	5	nerve	nerve	NOUN
fnp-3805	28	6	crush	crush	NOUN
fnp-3805	28	7	model	model	NOUN
fnp-3805	28	8	of	of	ADP
fnp-3805	28	9	wallerian	wallerian	ADJ
fnp-3805	28	10	degeneration	degeneration	NOUN
fnp-3805	28	11	,	,	PUNCT
fnp-3805	28	12	jha	jha	PROPN
fnp-3805	28	13	et	et	PROPN
fnp-3805	28	14	al	al	PROPN
fnp-3805	28	15	.	.	PROPN
fnp-3805	28	16	showed	show	VERB
fnp-3805	28	17	that	that	SCONJ
fnp-3805	28	18	the	the	DET
fnp-3805	28	19	activity	activity	NOUN
fnp-3805	28	20	of	of	ADP
fnp-3805	28	21	monocarboxylate	monocarboxylate	ADJ
fnp-3805	28	22	transporter	transporter	NOUN
fnp-3805	28	23	1	1	NUM
fnp-3805	28	24	(	(	PUNCT
fnp-3805	28	25	mct1	mct1	PROPN
fnp-3805	28	26	,	,	PUNCT
fnp-3805	28	27	encoded	encode	VERB
fnp-3805	28	28	by	by	ADP
fnp-3805	28	29	slc16a1	slc16a1	VERB
fnp-3805	28	30	gene	gene	NOUN
fnp-3805	28	31	)	)	PUNCT
fnp-3805	28	32	in	in	ADP
fnp-3805	28	33	macrophages	macrophage	NOUN
fnp-3805	28	34	,	,	PUNCT
fnp-3805	28	35	but	but	CCONJ
fnp-3805	28	36	not	not	PART
fnp-3805	28	37	in	in	ADP
fnp-3805	28	38	dorsal	dorsal	NOUN
fnp-3805	28	39	root	root	NOUN
fnp-3805	28	40	ganglion	ganglion	NOUN
fnp-3805	28	41	neurons	neuron	NOUN
fnp-3805	28	42	,	,	PUNCT
fnp-3805	28	43	schwann	schwann	PROPN
fnp-3805	28	44	cells	cell	NOUN
fnp-3805	28	45	,	,	PUNCT
fnp-3805	28	46	or	or	CCONJ
fnp-3805	28	47	perineurial	perineurial	ADJ
fnp-3805	28	48	cells	cell	NOUN
fnp-3805	28	49	,	,	PUNCT
fnp-3805	28	50	plays	play	VERB
fnp-3805	28	51	a	a	DET
fnp-3805	28	52	key	key	ADJ
fnp-3805	28	53	role	role	NOUN
fnp-3805	28	54	in	in	ADP
fnp-3805	28	55	axon	axon	NOUN
fnp-3805	28	56	regeneration	regeneration	NOUN
fnp-3805	28	57	.	.	PUNCT
fnp-3805	29	1	selective	selective	ADJ
fnp-3805	29	2	deletion	deletion	NOUN
fnp-3805	29	3	of	of	ADP
fnp-3805	29	4	mct1	mct1	PROPN
fnp-3805	29	5	from	from	ADP
fnp-3805	29	6	macrophages	macrophage	NOUN
fnp-3805	29	7	did	do	AUX
fnp-3805	29	8	not	not	PART
fnp-3805	29	9	affect	affect	VERB
fnp-3805	29	10	macrophage	macrophage	ADJ
fnp-3805	29	11	recruitment	recruitment	NOUN
fnp-3805	29	12	to	to	ADP
fnp-3805	29	13	the	the	DET
fnp-3805	29	14	portion	portion	NOUN
fnp-3805	29	15	of	of	ADP
fnp-3805	29	16	the	the	DET
fnp-3805	29	17	nerve	nerve	NOUN
fnp-3805	29	18	distal	distal	NOUN
fnp-3805	29	19	to	to	ADP
fnp-3805	29	20	the	the	DET
fnp-3805	29	21	site	site	NOUN
fnp-3805	29	22	of	of	ADP
fnp-3805	29	23	injury	injury	NOUN
fnp-3805	29	24	;	;	PUNCT
fnp-3805	29	25	instead	instead	ADV
fnp-3805	29	26	,	,	PUNCT
fnp-3805	29	27	it	it	PRON
fnp-3805	29	28	impaired	impair	VERB
fnp-3805	29	29	the	the	DET
fnp-3805	29	30	ability	ability	NOUN
fnp-3805	29	31	of	of	ADP
fnp-3805	29	32	recruited	recruit	VERB
fnp-3805	29	33	macrophages	macrophage	NOUN
fnp-3805	29	34	to	to	PART
fnp-3805	29	35	phagocytose	phagocytose	VERB
fnp-3805	29	36	axon	axon	NOUN
fnp-3805	29	37	and	and	CCONJ
fnp-3805	29	38	myelin	myelin	NOUN
fnp-3805	29	39	debris	debris	NOUN
fnp-3805	29	40	.	.	PUNCT
fnp-3805	30	1	in	in	ADP
fnp-3805	30	2	addition	addition	NOUN
fnp-3805	30	3	,	,	PUNCT
fnp-3805	30	4	mct1	mct1	PROPN
fnp-3805	30	5	deletion	deletion	NOUN
fnp-3805	30	6	led	lead	VERB
fnp-3805	30	7	to	to	ADP
fnp-3805	30	8	a	a	DET
fnp-3805	30	9	decrease	decrease	NOUN
fnp-3805	30	10	in	in	ADP
fnp-3805	30	11	the	the	DET
fnp-3805	30	12	expression	expression	NOUN
fnp-3805	30	13	of	of	ADP
fnp-3805	30	14	macrophage	macrophage	ADJ
fnp-3805	30	15	transcription	transcription	NOUN
fnp-3805	30	16	factor	factor	NOUN
fnp-3805	30	17	atf3	atf3	NOUN
fnp-3805	30	18	,	,	PUNCT
fnp-3805	30	19	thereby	thereby	ADV
fnp-3805	30	20	attenuating	attenuate	VERB
fnp-3805	30	21	macrophage	macrophage	ADJ
fnp-3805	30	22	reprogramming	reprogramming	NOUN
fnp-3805	30	23	into	into	ADP
fnp-3805	30	24	a	a	DET
fnp-3805	30	25	pro	pro	ADJ
fnp-3805	30	26	-	-	ADJ
fnp-3805	30	27	regenerative	regenerative	ADJ
fnp-3805	30	28	,	,	PUNCT
fnp-3805	30	29	anti	anti	ADJ
fnp-3805	30	30	-	-	ADJ
fnp-3805	30	31	inflammatory	inflammatory	ADJ
fnp-3805	30	32	phenotype	phenotype	NOUN
fnp-3805	30	33	characterized	characterize	VERB
fnp-3805	30	34	by	by	ADP
fnp-3805	30	35	high	high	ADJ
fnp-3805	30	36	expression	expression	NOUN
fnp-3805	30	37	of	of	ADP
fnp-3805	30	38	arginase	arginase	NOUN
fnp-3805	30	39	1	1	NUM
fnp-3805	30	40	and	and	CCONJ
fnp-3805	30	41	chitinase	chitinase	NOUN
fnp-3805	30	42	-	-	PUNCT
fnp-3805	30	43	like	like	ADJ
fnp-3805	30	44	3	3	NUM
fnp-3805	30	45	.	.	PUNCT
fnp-3805	30	46	excitingly	excitingly	ADV
fnp-3805	30	47	,	,	PUNCT
fnp-3805	30	48	the	the	DET
fnp-3805	30	49	authors	author	NOUN
fnp-3805	30	50	also	also	ADV
fnp-3805	30	51	showed	show	VERB
fnp-3805	30	52	that	that	SCONJ
fnp-3805	30	53	i.v	i.v	PROPN
fnp-3805	30	54	.	.	PUNCT
fnp-3805	30	55	treatment	treatment	NOUN
fnp-3805	30	56	with	with	ADP
fnp-3805	30	57	bone	bone	NOUN
fnp-3805	30	58	marrow	marrow	NOUN
fnp-3805	30	59	-	-	PUNCT
fnp-3805	30	60	derived	derive	VERB
fnp-3805	30	61	wt	wt	NOUN
fnp-3805	30	62	macrophages	macrophage	NOUN
fnp-3805	30	63	fully	fully	ADV
fnp-3805	30	64	restored	restore	VERB
fnp-3805	30	65	peripheral	peripheral	ADJ
fnp-3805	30	66	nerve	nerve	NOUN
fnp-3805	30	67	regeneration	regeneration	NOUN
fnp-3805	30	68	in	in	ADP
fnp-3805	30	69	mice	mouse	NOUN
fnp-3805	30	70	with	with	ADP
fnp-3805	30	71	macrophage	macrophage	ADJ
fnp-3805	30	72	-	-	PUNCT
fnp-3805	30	73	selective	selective	ADJ
fnp-3805	30	74	mct1	mct1	NOUN
fnp-3805	30	75	deletion	deletion	NOUN
fnp-3805	30	76	,	,	PUNCT
fnp-3805	30	77	while	while	SCONJ
fnp-3805	30	78	macrophage	macrophage	ADJ
fnp-3805	30	79	-	-	PUNCT
fnp-3805	30	80	specific	specific	ADJ
fnp-3805	30	81	mct1	mct1	NOUN
fnp-3805	30	82	upregulation	upregulation	NOUN
fnp-3805	30	83	led	lead	VERB
fnp-3805	30	84	to	to	ADP
fnp-3805	30	85	improved	improve	VERB
fnp-3805	30	86	nerve	nerve	NOUN
fnp-3805	30	87	regeneration	regeneration	NOUN
fnp-3805	30	88	.	.	PUNCT
fnp-3805	31	1	taken	take	VERB
fnp-3805	31	2	together	together	ADV
fnp-3805	31	3	,	,	PUNCT
fnp-3805	31	4	these	these	DET
fnp-3805	31	5	findings	finding	NOUN
fnp-3805	31	6	suggest	suggest	VERB
fnp-3805	31	7	that	that	SCONJ
fnp-3805	31	8	adoptive	adoptive	ADJ
fnp-3805	31	9	transfer	transfer	NOUN
fnp-3805	31	10	of	of	ADP
fnp-3805	31	11	patient	patient	NOUN
fnp-3805	31	12	-	-	PUNCT
fnp-3805	31	13	derived	derive	VERB
fnp-3805	31	14	macrophages	macrophage	NOUN
fnp-3805	31	15	engineered	engineer	VERB
fnp-3805	31	16	to	to	PART
fnp-3805	31	17	upregulate	upregulate	VERB
fnp-3805	31	18	their	their	PRON
fnp-3805	31	19	mct1	mct1	NOUN
fnp-3805	31	20	activity	activity	NOUN
fnp-3805	31	21	could	could	AUX
fnp-3805	31	22	be	be	AUX
fnp-3805	31	23	used	use	VERB
fnp-3805	31	24	to	to	PART
fnp-3805	31	25	treat	treat	VERB
fnp-3805	31	26	severe	severe	ADJ
fnp-3805	31	27	peripheral	peripheral	ADJ
fnp-3805	31	28	nerve	nerve	NOUN
fnp-3805	31	29	injuries	injury	NOUN
fnp-3805	31	30	.	.	PUNCT
fnp-3805	32	1	however	however	ADV
fnp-3805	32	2	,	,	PUNCT
fnp-3805	32	3	this	this	DET
fnp-3805	32	4	study	study	NOUN
fnp-3805	32	5	has	have	VERB
fnp-3805	32	6	one	one	NUM
fnp-3805	32	7	very	very	ADV
fnp-3805	32	8	significant	significant	ADJ
fnp-3805	32	9	caveat	caveat	NOUN
fnp-3805	32	10	:	:	PUNCT
fnp-3805	32	11	while	while	SCONJ
fnp-3805	32	12	both	both	CCONJ
fnp-3805	32	13	anti	anti	ADJ
fnp-3805	32	14	-	-	ADJ
fnp-3805	32	15	regenerative	regenerative	ADJ
fnp-3805	32	16	and	and	CCONJ
fnp-3805	32	17	pro	pro	ADJ
fnp-3805	32	18	-	-	ADJ
fnp-3805	32	19	regenerative	regenerative	ADJ
fnp-3805	32	20	effects	effect	NOUN
fnp-3805	32	21	of	of	ADP
fnp-3805	32	22	various	various	ADJ
fnp-3805	32	23	experimental	experimental	ADJ
fnp-3805	32	24	manipulations	manipulation	NOUN
fnp-3805	32	25	could	could	AUX
fnp-3805	32	26	be	be	AUX
fnp-3805	32	27	demonstrated	demonstrate	VERB
fnp-3805	32	28	on	on	ADP
fnp-3805	32	29	the	the	DET
fnp-3805	32	30	tissue	tissue	NOUN
fnp-3805	32	31	level	level	NOUN
fnp-3805	32	32	(	(	PUNCT
fnp-3805	32	33	by	by	ADP
fnp-3805	32	34	quantifying	quantify	VERB
fnp-3805	32	35	regenerating	regenerate	VERB
fnp-3805	32	36	axon	axon	NOUN
fnp-3805	32	37	clusters	cluster	NOUN
fnp-3805	32	38	,	,	PUNCT
fnp-3805	32	39	relative	relative	ADJ
fnp-3805	32	40	thickness	thickness	NOUN
fnp-3805	32	41	of	of	ADP
fnp-3805	32	42	axon	axon	NOUN
fnp-3805	32	43	myelin	myelin	NOUN
fnp-3805	32	44	sheaths	sheath	NOUN
fnp-3805	32	45	,	,	PUNCT
fnp-3805	32	46	and	and	CCONJ
fnp-3805	32	47	the	the	DET
fnp-3805	32	48	number	number	NOUN
fnp-3805	32	49	and	and	CCONJ
fnp-3805	32	50	distribution	distribution	NOUN
fnp-3805	32	51	of	of	ADP
fnp-3805	32	52	neuromuscular	neuromuscular	ADJ
fnp-3805	32	53	junctions	junction	NOUN
fnp-3805	32	54	in	in	ADP
fnp-3805	32	55	the	the	DET
fnp-3805	32	56	gastrocnemius	gastrocnemius	NOUN
fnp-3805	32	57	muscle	muscle	NOUN
fnp-3805	32	58	)	)	PUNCT
fnp-3805	32	59	,	,	PUNCT
fnp-3805	32	60	they	they	PRON
fnp-3805	32	61	were	be	AUX
fnp-3805	32	62	not	not	PART
fnp-3805	32	63	accompanied	accompany	VERB
fnp-3805	32	64	by	by	ADP
fnp-3805	32	65	parallel	parallel	ADJ
fnp-3805	32	66	measures	measure	NOUN
fnp-3805	32	67	of	of	ADP
fnp-3805	32	68	behavioral	behavioral	ADJ
fnp-3805	32	69	recovery	recovery	NOUN
fnp-3805	32	70	.	.	PUNCT
fnp-3805	33	1	one	one	NUM
fnp-3805	33	2	possible	possible	ADJ
fnp-3805	33	3	explanation	explanation	NOUN
fnp-3805	33	4	for	for	ADP
fnp-3805	33	5	this	this	DET
fnp-3805	33	6	discrepancy	discrepancy	NOUN
fnp-3805	33	7	is	be	AUX
fnp-3805	33	8	that	that	SCONJ
fnp-3805	33	9	behavioral	behavioral	ADJ
fnp-3805	33	10	recovery	recovery	NOUN
fnp-3805	33	11	actually	actually	ADV
fnp-3805	33	12	preceded	precede	VERB
fnp-3805	33	13	tissue	tissue	NOUN
fnp-3805	33	14	recovery	recovery	NOUN
fnp-3805	33	15	in	in	ADP
fnp-3805	33	16	this	this	DET
fnp-3805	33	17	mouse	mouse	NOUN
fnp-3805	33	18	model	model	NOUN
fnp-3805	33	19	,	,	PUNCT
fnp-3805	33	20	suggesting	suggest	VERB
fnp-3805	33	21	that	that	SCONJ
fnp-3805	33	22	alternate	alternate	ADJ
fnp-3805	33	23	recovery	recovery	NOUN
fnp-3805	33	24	/	/	SYM
fnp-3805	33	25	behavioral	behavioral	ADJ
fnp-3805	33	26	compensation	compensation	NOUN
fnp-3805	33	27	pathways	pathway	NOUN
fnp-3805	33	28	are	be	AUX
fnp-3805	33	29	important	important	ADJ
fnp-3805	33	30	,	,	PUNCT
fnp-3805	33	31	at	at	ADP
fnp-3805	33	32	least	least	ADJ
fnp-3805	33	33	in	in	ADP
fnp-3805	33	34	rodents	rodent	NOUN
fnp-3805	33	35	;	;	PUNCT
fnp-3805	33	36	nonetheless	nonetheless	ADV
fnp-3805	33	37	,	,	PUNCT
fnp-3805	33	38	this	this	DET
fnp-3805	33	39	animal	animal	NOUN
fnp-3805	33	40	model	model	NOUN
fnp-3805	33	41	discrepancy	discrepancy	NOUN
fnp-3805	33	42	needs	need	VERB
fnp-3805	33	43	to	to	PART
fnp-3805	33	44	be	be	AUX
fnp-3805	33	45	resolved	resolve	VERB
fnp-3805	33	46	before	before	ADP
fnp-3805	33	47	exploring	explore	VERB
fnp-3805	33	48	the	the	DET
fnp-3805	33	49	efficacy	efficacy	NOUN
fnp-3805	33	50	of	of	ADP
fnp-3805	33	51	macrophage	macrophage	NOUN
fnp-3805	33	52	-	-	PUNCT
fnp-3805	33	53	based	base	VERB
fnp-3805	33	54	therapies	therapy	NOUN
fnp-3805	33	55	for	for	ADP
fnp-3805	33	56	human	human	ADJ
fnp-3805	33	57	axonal	axonal	ADJ
fnp-3805	33	58	neuropathies	neuropathy	NOUN
fnp-3805	33	59	.	.	PUNCT
fnp-3805	34	1	newly	newly	ADV
fnp-3805	34	2	defined	define	VERB
fnp-3805	34	3	/	/	SYM
fnp-3805	34	4	emerging	emerge	VERB
fnp-3805	34	5	neuromuscular	neuromuscular	ADJ
fnp-3805	34	6	diseases	disease	NOUN
fnp-3805	34	7	2	2	NUM
fnp-3805	34	8	.	.	X
fnp-3805	34	9	neuromuscular	neuromuscular	ADJ
fnp-3805	34	10	complications	complication	NOUN
fnp-3805	34	11	of	of	ADP
fnp-3805	34	12	covid-19	covid-19	PROPN
fnp-3805	34	13	:	:	PUNCT
fnp-3805	34	14	what	what	PRON
fnp-3805	34	15	have	have	AUX
fnp-3805	34	16	we	we	PRON
fnp-3805	34	17	learned	learn	VERB
fnp-3805	34	18	after	after	ADP
fnp-3805	34	19	one	one	NUM
fnp-3805	34	20	more	more	ADJ
fnp-3805	34	21	year	year	NOUN
fnp-3805	34	22	of	of	ADP
fnp-3805	34	23	the	the	DET
fnp-3805	34	24	pandemic	pandemic	NOUN
fnp-3805	34	25	?	?	PUNCT
fnp-3805	35	1	covid-19	covid-19	PROPN
fnp-3805	35	2	,	,	PUNCT
fnp-3805	35	3	the	the	DET
fnp-3805	35	4	novel	novel	ADJ
fnp-3805	35	5	infectious	infectious	ADJ
fnp-3805	35	6	disease	disease	NOUN
fnp-3805	35	7	caused	cause	VERB
fnp-3805	35	8	by	by	ADP
fnp-3805	35	9	sars	sar	NOUN
fnp-3805	35	10	-	-	PUNCT
fnp-3805	35	11	cov-2	cov-2	NOUN
fnp-3805	35	12	,	,	PUNCT
fnp-3805	35	13	primarily	primarily	ADV
fnp-3805	35	14	targets	target	VERB
fnp-3805	35	15	the	the	DET
fnp-3805	35	16	respiratory	respiratory	ADJ
fnp-3805	35	17	system	system	NOUN
fnp-3805	35	18	but	but	CCONJ
fnp-3805	35	19	can	can	AUX
fnp-3805	35	20	also	also	ADV
fnp-3805	35	21	affect	affect	VERB
fnp-3805	35	22	many	many	ADJ
fnp-3805	35	23	other	other	ADJ
fnp-3805	35	24	tissues	tissue	NOUN
fnp-3805	35	25	and	and	CCONJ
fnp-3805	35	26	organs	organ	NOUN
fnp-3805	35	27	,	,	PUNCT
fnp-3805	35	28	including	include	VERB
fnp-3805	35	29	the	the	DET
fnp-3805	35	30	pns	pns	NOUN
fnp-3805	35	31	.	.	PUNCT
fnp-3805	36	1	in	in	ADP
fnp-3805	36	2	the	the	DET
fnp-3805	36	3	last	last	ADJ
fnp-3805	36	4	year	year	NOUN
fnp-3805	36	5	’s	’s	PART
fnp-3805	36	6	review	review	NOUN
fnp-3805	36	7	(	(	PUNCT
fnp-3805	36	8	margeta	margeta	NOUN
fnp-3805	36	9	,	,	PUNCT
fnp-3805	36	10	2021	2021	NUM
fnp-3805	36	11	)	)	PUNCT
fnp-3805	36	12	,	,	PUNCT
fnp-3805	36	13	i	i	PRON
fnp-3805	36	14	summarized	summarize	VERB
fnp-3805	36	15	what	what	PRON
fnp-3805	36	16	was	be	AUX
fnp-3805	36	17	known	know	VERB
fnp-3805	36	18	about	about	ADP
fnp-3805	36	19	the	the	DET
fnp-3805	36	20	neuromuscular	neuromuscular	ADJ
fnp-3805	36	21	complications	complication	NOUN
fnp-3805	36	22	of	of	ADP
fnp-3805	36	23	covid-19	covid-19	PROPN
fnp-3805	36	24	at	at	ADP
fnp-3805	36	25	the	the	DET
fnp-3805	36	26	end	end	NOUN
fnp-3805	36	27	of	of	ADP
fnp-3805	36	28	2020	2020	NUM
fnp-3805	36	29	;	;	PUNCT
fnp-3805	36	30	given	give	VERB
fnp-3805	36	31	the	the	DET
fnp-3805	36	32	preliminary	preliminary	ADJ
fnp-3805	36	33	nature	nature	NOUN
fnp-3805	36	34	of	of	ADP
fnp-3805	36	35	those	those	DET
fnp-3805	36	36	investigations	investigation	NOUN
fnp-3805	36	37	,	,	PUNCT
fnp-3805	36	38	i	i	PRON
fnp-3805	36	39	decided	decide	VERB
fnp-3805	36	40	to	to	PART
fnp-3805	36	41	revisit	revisit	VERB
fnp-3805	36	42	this	this	DET
fnp-3805	36	43	topic	topic	NOUN
fnp-3805	36	44	in	in	ADP
fnp-3805	36	45	the	the	DET
fnp-3805	36	46	current	current	ADJ
fnp-3805	36	47	review	review	NOUN
fnp-3805	36	48	,	,	PUNCT
fnp-3805	36	49	providing	provide	VERB
fnp-3805	36	50	an	an	DET
fnp-3805	36	51	update	update	NOUN
fnp-3805	36	52	on	on	ADP
fnp-3805	36	53	what	what	PRON
fnp-3805	36	54	has	have	AUX
fnp-3805	36	55	been	be	AUX
fnp-3805	36	56	learned	learn	VERB
fnp-3805	36	57	since	since	SCONJ
fnp-3805	36	58	then	then	ADV
fnp-3805	36	59	.	.	PUNCT
fnp-3805	37	1	one	one	NUM
fnp-3805	37	2	area	area	NOUN
fnp-3805	37	3	of	of	ADP
fnp-3805	37	4	intense	intense	ADJ
fnp-3805	37	5	interest	interest	NOUN
fnp-3805	37	6	within	within	ADP
fnp-3805	37	7	the	the	DET
fnp-3805	37	8	neuromuscular	neuromuscular	ADJ
fnp-3805	37	9	field	field	NOUN
fnp-3805	37	10	has	have	AUX
fnp-3805	37	11	been	be	AUX
fnp-3805	37	12	the	the	DET
fnp-3805	37	13	possible	possible	ADJ
fnp-3805	37	14	link	link	NOUN
fnp-3805	37	15	between	between	ADP
fnp-3805	37	16	covid-19	covid-19	PROPN
fnp-3805	37	17	and	and	CCONJ
fnp-3805	37	18	guillain	guillain	NOUN
fnp-3805	37	19	-	-	PUNCT
fnp-3805	37	20	barré	barré	PROPN
fnp-3805	37	21	syndrome	syndrome	PROPN
fnp-3805	37	22	(	(	PUNCT
fnp-3805	37	23	gbs	gbs	PROPN
fnp-3805	37	24	)	)	PUNCT
fnp-3805	37	25	,	,	PUNCT
fnp-3805	37	26	an	an	DET
fnp-3805	37	27	acute	acute	ADJ
fnp-3805	37	28	immune	immune	NOUN
fnp-3805	37	29	-	-	PUNCT
fnp-3805	37	30	mediated	mediate	VERB
fnp-3805	37	31	polyneuropathy	polyneuropathy	NOUN
fnp-3805	37	32	characterized	characterize	VERB
fnp-3805	37	33	by	by	ADP
fnp-3805	37	34	ascending	ascend	VERB
fnp-3805	37	35	weakness	weakness	NOUN
fnp-3805	37	36	,	,	PUNCT
fnp-3805	37	37	mild	mild	ADJ
fnp-3805	37	38	-	-	PUNCT
fnp-3805	37	39	moderate	moderate	ADJ
fnp-3805	37	40	sensory	sensory	ADJ
fnp-3805	37	41	abnormalities	abnormality	NOUN
fnp-3805	37	42	,	,	PUNCT
fnp-3805	37	43	and	and	CCONJ
fnp-3805	37	44	pain	pain	NOUN
fnp-3805	37	45	.	.	PUNCT
fnp-3805	38	1	most	most	ADJ
fnp-3805	38	2	gbs	gbs	PROPN
fnp-3805	38	3	cases	case	NOUN
fnp-3805	38	4	are	be	AUX
fnp-3805	38	5	triggered	trigger	VERB
fnp-3805	38	6	by	by	ADP
fnp-3805	38	7	a	a	DET
fnp-3805	38	8	bacterial	bacterial	ADJ
fnp-3805	38	9	or	or	CCONJ
fnp-3805	38	10	viral	viral	ADJ
fnp-3805	38	11	infection	infection	NOUN
fnp-3805	38	12	that	that	PRON
fnp-3805	38	13	precedes	precede	VERB
fnp-3805	38	14	neurologic	neurologic	ADJ
fnp-3805	38	15	symptoms	symptom	NOUN
fnp-3805	38	16	by	by	ADP
fnp-3805	38	17	1	1	NUM
fnp-3805	38	18	-	-	SYM
fnp-3805	38	19	3	3	NUM
fnp-3805	38	20	weeks	week	NOUN
fnp-3805	38	21	;	;	PUNCT
fnp-3805	38	22	the	the	DET
fnp-3805	38	23	strongest	strong	ADJ
fnp-3805	38	24	association	association	NOUN
fnp-3805	38	25	is	be	AUX
fnp-3805	38	26	seen	see	VERB
fnp-3805	38	27	with	with	ADP
fnp-3805	38	28	campylobacter	campylobacter	NOUN
fnp-3805	38	29	jejuni	jejuni	PROPN
fnp-3805	38	30	bacterium	bacterium	NOUN
fnp-3805	38	31	(	(	PUNCT
fnp-3805	38	32	~100	~100	PROPN
fnp-3805	38	33	gbs	gbs	PROPN
fnp-3805	38	34	cases	case	NOUN
fnp-3805	38	35	/	/	SYM
fnp-3805	38	36	100	100	NUM
fnp-3805	38	37	000	000	NUM
fnp-3805	38	38	c.	c.	PROPN
fnp-3805	38	39	jejuni	jejuni	PROPN
fnp-3805	38	40	infections	infection	NOUN
fnp-3805	38	41	)	)	PUNCT
fnp-3805	38	42	and	and	CCONJ
fnp-3805	38	43	with	with	ADP
fnp-3805	38	44	zika	zika	X
fnp-3805	38	45	virus	virus	NOUN
fnp-3805	38	46	(	(	PUNCT
fnp-3805	38	47	~50	~50	NUM
fnp-3805	38	48	gbs	gbs	PROPN
fnp-3805	38	49	cases	case	NOUN
fnp-3805	38	50	/	/	SYM
fnp-3805	38	51	100	100	NUM
fnp-3805	38	52	000	000	NUM
fnp-3805	38	53	zika	zika	NOUN
fnp-3805	38	54	virus	virus	NOUN
fnp-3805	38	55	infections	infection	NOUN
fnp-3805	38	56	)	)	PUNCT
fnp-3805	38	57	.	.	PUNCT
fnp-3805	39	1	while	while	SCONJ
fnp-3805	39	2	small	small	ADJ
fnp-3805	39	3	early	early	ADJ
fnp-3805	39	4	studies	study	NOUN
fnp-3805	39	5	from	from	ADP
fnp-3805	39	6	italy	italy	PROPN
fnp-3805	39	7	and	and	CCONJ
fnp-3805	39	8	spain	spain	PROPN
fnp-3805	39	9	suggested	suggest	VERB
fnp-3805	39	10	that	that	SCONJ
fnp-3805	39	11	gbs	gbs	PROPN
fnp-3805	39	12	could	could	AUX
fnp-3805	39	13	also	also	ADV
fnp-3805	39	14	be	be	AUX
fnp-3805	39	15	triggered	trigger	VERB
fnp-3805	39	16	by	by	ADP
fnp-3805	39	17	a	a	DET
fnp-3805	39	18	preceding	precede	VERB
fnp-3805	39	19	sars	sar	NOUN
fnp-3805	39	20	-	-	PUNCT
fnp-3805	39	21	cov-2	cov-2	NOUN
fnp-3805	39	22	infection	infection	NOUN
fnp-3805	39	23	(	(	PUNCT
fnp-3805	39	24	filosto	filosto	NOUN
fnp-3805	39	25	et	et	PROPN
fnp-3805	39	26	al	al	PROPN
fnp-3805	39	27	.	.	PROPN
fnp-3805	39	28	,	,	PUNCT
fnp-3805	39	29	2021	2021	NUM
fnp-3805	39	30	;	;	PUNCT
fnp-3805	39	31	fragiel	fragiel	PROPN
fnp-3805	39	32	et	et	PROPN
fnp-3805	39	33	al	al	PROPN
fnp-3805	39	34	.	.	PROPN
fnp-3805	39	35	,	,	PUNCT
fnp-3805	39	36	2021	2021	NUM
fnp-3805	39	37	)	)	PUNCT
fnp-3805	39	38	,	,	PUNCT
fnp-3805	39	39	no	no	DET
fnp-3805	39	40	such	such	ADJ
fnp-3805	39	41	link	link	NOUN
fnp-3805	39	42	was	be	AUX
fnp-3805	39	43	found	find	VERB
fnp-3805	39	44	in	in	ADP
fnp-3805	39	45	a	a	DET
fnp-3805	39	46	more	more	ADV
fnp-3805	39	47	comprehensive	comprehensive	ADJ
fnp-3805	39	48	epidemiologic	epidemiologic	ADJ
fnp-3805	39	49	study	study	NOUN
fnp-3805	39	50	performed	perform	VERB
fnp-3805	39	51	in	in	ADP
fnp-3805	39	52	the	the	DET
fnp-3805	39	53	uk	uk	PROPN
fnp-3805	39	54	(	(	PUNCT
fnp-3805	39	55	keddie	keddie	PROPN
fnp-3805	39	56	et	et	PROPN
fnp-3805	39	57	al	al	PROPN
fnp-3805	39	58	.	.	PROPN
fnp-3805	39	59	,	,	PUNCT
fnp-3805	39	60	2021	2021	NUM
fnp-3805	39	61	)	)	PUNCT
fnp-3805	40	1	[	[	X
fnp-3805	40	2	for	for	ADP
fnp-3805	40	3	a	a	DET
fnp-3805	40	4	more	more	ADV
fnp-3805	40	5	detailed	detailed	ADJ
fnp-3805	40	6	discussion	discussion	NOUN
fnp-3805	40	7	of	of	ADP
fnp-3805	40	8	the	the	DET
fnp-3805	40	9	2020	2020	NUM
fnp-3805	40	10	data	datum	NOUN
fnp-3805	40	11	,	,	PUNCT
fnp-3805	40	12	see	see	VERB
fnp-3805	40	13	the	the	DET
fnp-3805	40	14	last	last	ADJ
fnp-3805	40	15	year	year	NOUN
fnp-3805	40	16	’s	’s	PART
fnp-3805	40	17	review	review	NOUN
fnp-3805	40	18	(	(	PUNCT
fnp-3805	40	19	margeta	margeta	NOUN
fnp-3805	40	20	,	,	PUNCT
fnp-3805	40	21	2021	2021	NUM
fnp-3805	40	22	)	)	PUNCT
fnp-3805	40	23	]	]	PUNCT
fnp-3805	40	24	.	.	PUNCT
fnp-3805	41	1	discrepancies	discrepancy	NOUN
fnp-3805	41	2	between	between	ADP
fnp-3805	41	3	these	these	DET
fnp-3805	41	4	initial	initial	ADJ
fnp-3805	41	5	studies	study	NOUN
fnp-3805	41	6	prompted	prompt	VERB
fnp-3805	41	7	animated	animated	ADJ
fnp-3805	41	8	discussion	discussion	NOUN
fnp-3805	41	9	among	among	ADP
fnp-3805	41	10	the	the	DET
fnp-3805	41	11	gbs	gbs	PROPN
fnp-3805	41	12	experts	expert	NOUN
fnp-3805	41	13	,	,	PUNCT
fnp-3805	41	14	but	but	CCONJ
fnp-3805	41	15	also	also	ADV
fnp-3805	41	16	led	lead	VERB
fnp-3805	41	17	to	to	ADP
fnp-3805	41	18	additional	additional	ADJ
fnp-3805	41	19	investigations	investigation	NOUN
fnp-3805	41	20	undertaken	undertake	VERB
fnp-3805	41	21	by	by	ADP
fnp-3805	41	22	several	several	ADJ
fnp-3805	41	23	different	different	ADJ
fnp-3805	41	24	groups	group	NOUN
fnp-3805	41	25	;	;	PUNCT
fnp-3805	41	26	taken	take	VERB
fnp-3805	41	27	as	as	ADP
fnp-3805	41	28	a	a	DET
fnp-3805	41	29	whole	whole	NOUN
fnp-3805	41	30	,	,	PUNCT
fnp-3805	41	31	this	this	DET
fnp-3805	41	32	new	new	ADJ
fnp-3805	41	33	evidence	evidence	NOUN
fnp-3805	41	34	provides	provide	VERB
fnp-3805	41	35	further	further	ADJ
fnp-3805	41	36	support	support	NOUN
fnp-3805	41	37	for	for	ADP
fnp-3805	41	38	a	a	DET
fnp-3805	41	39	lack	lack	NOUN
fnp-3805	41	40	of	of	ADP
fnp-3805	41	41	a	a	DET
fnp-3805	41	42	strong	strong	ADJ
fnp-3805	41	43	link	link	NOUN
fnp-3805	41	44	between	between	ADP
fnp-3805	41	45	covid-19	covid-19	PROPN
fnp-3805	41	46	and	and	CCONJ
fnp-3805	41	47	gbs	gbs	PROPN
fnp-3805	41	48	.	.	PUNCT
fnp-3805	42	1	for	for	ADP
fnp-3805	42	2	example	example	NOUN
fnp-3805	42	3	,	,	PUNCT
fnp-3805	42	4	the	the	DET
fnp-3805	42	5	data	datum	NOUN
fnp-3805	42	6	originally	originally	ADV
fnp-3805	42	7	reported	report	VERB
fnp-3805	42	8	by	by	ADP
fnp-3805	42	9	keddie	keddie	PROPN
fnp-3805	42	10	at	at	ADP
fnp-3805	42	11	al	al	PROPN
fnp-3805	42	12	.	.	PROPN
fnp-3805	42	13	reflected	reflect	VERB
fnp-3805	42	14	the	the	DET
fnp-3805	42	15	first	first	ADJ
fnp-3805	42	16	uk	uk	PROPN
fnp-3805	42	17	covid-19	covid-19	PROPN
fnp-3805	42	18	surge	surge	NOUN
fnp-3805	42	19	(	(	PUNCT
fnp-3805	42	20	in	in	ADP
fnp-3805	42	21	march	march	PROPN
fnp-3805	42	22	and	and	CCONJ
fnp-3805	42	23	april	april	PROPN
fnp-3805	42	24	2020	2020	NUM
fnp-3805	42	25	)	)	PUNCT
fnp-3805	42	26	;	;	PUNCT
fnp-3805	42	27	extension	extension	NOUN
fnp-3805	42	28	of	of	ADP
fnp-3805	42	29	the	the	DET
fnp-3805	42	30	same	same	ADJ
fnp-3805	42	31	study	study	NOUN
fnp-3805	42	32	until	until	ADP
fnp-3805	42	33	the	the	DET
fnp-3805	42	34	end	end	NOUN
fnp-3805	42	35	of	of	ADP
fnp-3805	42	36	2020	2020	NUM
fnp-3805	42	37	showed	show	VERB
fnp-3805	42	38	essentially	essentially	ADV
fnp-3805	42	39	the	the	DET
fnp-3805	42	40	same	same	ADJ
fnp-3805	42	41	findings	finding	NOUN
fnp-3805	42	42	,	,	PUNCT
fnp-3805	42	43	with	with	ADP
fnp-3805	42	44	a	a	DET
fnp-3805	42	45	large	large	ADJ
fnp-3805	42	46	increase	increase	NOUN
fnp-3805	42	47	in	in	ADP
fnp-3805	42	48	the	the	DET
fnp-3805	42	49	number	number	NOUN
fnp-3805	42	50	of	of	ADP
fnp-3805	42	51	covid-19	covid-19	PROPN
fnp-3805	42	52	cases	case	NOUN
fnp-3805	42	53	in	in	ADP
fnp-3805	42	54	the	the	DET
fnp-3805	42	55	fall	fall	NOUN
fnp-3805	42	56	of	of	ADP
fnp-3805	42	57	2020	2020	NUM
fnp-3805	42	58	that	that	PRON
fnp-3805	42	59	was	be	AUX
fnp-3805	42	60	accompanied	accompany	VERB
fnp-3805	42	61	by	by	ADP
fnp-3805	42	62	a	a	DET
fnp-3805	42	63	decrease	decrease	NOUN
fnp-3805	42	64	,	,	PUNCT
fnp-3805	42	65	rather	rather	ADV
fnp-3805	42	66	than	than	ADP
fnp-3805	42	67	an	an	DET
fnp-3805	42	68	increase	increase	NOUN
fnp-3805	42	69	,	,	PUNCT
fnp-3805	42	70	in	in	ADP
fnp-3805	42	71	the	the	DET
fnp-3805	42	72	number	number	NOUN
fnp-3805	42	73	of	of	ADP
fnp-3805	42	74	gbs	gbs	PROPN
fnp-3805	42	75	cases	case	NOUN
fnp-3805	42	76	during	during	ADP
fnp-3805	42	77	the	the	DET
fnp-3805	42	78	same	same	ADJ
fnp-3805	42	79	time	time	NOUN
fnp-3805	42	80	period	period	NOUN
fnp-3805	42	81	[	[	X
fnp-3805	42	82	(	(	PUNCT
fnp-3805	42	83	lunn	lunn	PROPN
fnp-3805	42	84	et	et	PROPN
fnp-3805	42	85	al	al	PROPN
fnp-3805	42	86	.	.	PROPN
fnp-3805	42	87	,	,	PUNCT
fnp-3805	42	88	2021	2021	NUM
fnp-3805	42	89	)	)	PUNCT
fnp-3805	42	90	and	and	CCONJ
fnp-3805	42	91	fig	fig	NOUN
fnp-3805	42	92	.	.	PUNCT
fnp-3805	43	1	2	2	NUM
fnp-3805	43	2	]	]	PUNCT
fnp-3805	43	3	.	.	PUNCT
fnp-3805	44	1	moreover	moreover	ADV
fnp-3805	44	2	,	,	PUNCT
fnp-3805	44	3	as	as	SCONJ
fnp-3805	44	4	reported	report	VERB
fnp-3805	44	5	by	by	ADP
fnp-3805	44	6	the	the	DET
fnp-3805	44	7	same	same	ADJ
fnp-3805	44	8	group	group	NOUN
fnp-3805	44	9	of	of	ADP
fnp-3805	44	10	investigators	investigator	NOUN
fnp-3805	44	11	in	in	ADP
fnp-3805	44	12	a	a	DET
fnp-3805	44	13	very	very	ADV
fnp-3805	44	14	recently	recently	ADV
fnp-3805	44	15	published	publish	VERB
fnp-3805	44	16	medrχiv	medrχiv	NOUN
fnp-3805	44	17	preprint	preprint	NOUN
fnp-3805	44	18	(	(	PUNCT
fnp-3805	44	19	keh	keh	INTJ
fnp-3805	44	20	et	et	PROPN
fnp-3805	44	21	al	al	PROPN
fnp-3805	44	22	.	.	PROPN
fnp-3805	44	23	,	,	PUNCT
fnp-3805	44	24	2022	2022	NUM
fnp-3805	44	25	)	)	PUNCT
fnp-3805	44	26	,	,	PUNCT
fnp-3805	44	27	this	this	DET
fnp-3805	44	28	disassociation	disassociation	NOUN
fnp-3805	44	29	between	between	ADP
fnp-3805	44	30	covid-19	covid-19	PROPN
fnp-3805	44	31	and	and	CCONJ
fnp-3805	44	32	gbs	gbs	PROPN
fnp-3805	44	33	numbers	number	NOUN
fnp-3805	44	34	has	have	AUX
fnp-3805	44	35	persisted	persist	VERB
fnp-3805	44	36	into	into	ADP
fnp-3805	44	37	2021	2021	NUM
fnp-3805	44	38	,	,	PUNCT
fnp-3805	44	39	with	with	ADP
fnp-3805	44	40	a	a	DET
fnp-3805	44	41	clear	clear	ADJ
fnp-3805	44	42	uptick	uptick	NOUN
fnp-3805	44	43	in	in	ADP
fnp-3805	44	44	gbs	gbs	PROPN
fnp-3805	44	45	cases	case	NOUN
fnp-3805	44	46	observed	observe	VERB
fnp-3805	44	47	in	in	ADP
fnp-3805	44	48	march	march	PROPN
fnp-3805	44	49	and	and	CCONJ
fnp-3805	44	50	april	april	PROPN
fnp-3805	44	51	of	of	ADP
fnp-3805	44	52	2021	2021	NUM
fnp-3805	44	53	(	(	PUNCT
fnp-3805	44	54	secondary	secondary	ADJ
fnp-3805	44	55	to	to	ADP
fnp-3805	44	56	covid-19	covid-19	PROPN
fnp-3805	44	57	vaccination	vaccination	NOUN
fnp-3805	44	58	;	;	PUNCT
fnp-3805	44	59	further	far	ADV
fnp-3805	44	60	discussed	discuss	VERB
fnp-3805	44	61	below	below	ADV
fnp-3805	44	62	)	)	PUNCT
fnp-3805	44	63	,	,	PUNCT
fnp-3805	44	64	but	but	CCONJ
fnp-3805	44	65	no	no	DET
fnp-3805	44	66	similar	similar	ADJ
fnp-3805	44	67	increase	increase	NOUN
fnp-3805	44	68	was	be	AUX
fnp-3805	44	69	seen	see	VERB
fnp-3805	44	70	in	in	ADP
fnp-3805	44	71	august	august	PROPN
fnp-3805	44	72	and	and	CCONJ
fnp-3805	44	73	september	september	PROPN
fnp-3805	44	74	of	of	ADP
fnp-3805	44	75	2021	2021	NUM
fnp-3805	44	76	,	,	PUNCT
fnp-3805	44	77	during	during	ADP
fnp-3805	44	78	the	the	DET
fnp-3805	44	79	delta	delta	NOUN
fnp-3805	44	80	variant	variant	NOUN
fnp-3805	44	81	-	-	PUNCT
fnp-3805	44	82	associated	associate	VERB
fnp-3805	44	83	covid-19	covid-19	PROPN
fnp-3805	44	84	surge	surge	NOUN
fnp-3805	44	85	.	.	PUNCT
fnp-3805	45	1	(	(	PUNCT
fnp-3805	45	2	no	no	DET
fnp-3805	45	3	data	data	NOUN
fnp-3805	45	4	is	be	AUX
fnp-3805	45	5	yet	yet	ADV
fnp-3805	45	6	available	available	ADJ
fnp-3805	45	7	for	for	ADP
fnp-3805	45	8	the	the	DET
fnp-3805	45	9	most	most	ADV
fnp-3805	45	10	recent	recent	ADJ
fnp-3805	45	11	covid-19	covid-19	PROPN
fnp-3805	45	12	surge	surge	NOUN
fnp-3805	45	13	caused	cause	VERB
fnp-3805	45	14	by	by	ADP
fnp-3805	45	15	the	the	DET
fnp-3805	45	16	omicron	omicron	PROPN
fnp-3805	45	17	variant	variant	NOUN
fnp-3805	45	18	of	of	ADP
fnp-3805	45	19	sars	sar	NOUN
fnp-3805	45	20	-	-	PUNCT
fnp-3805	45	21	cov-2	cov-2	NOUN
fnp-3805	45	22	.	.	PUNCT
fnp-3805	45	23	)	)	PUNCT
fnp-3805	46	1	a	a	DET
fnp-3805	46	2	similar	similar	ADJ
fnp-3805	46	3	lack	lack	NOUN
fnp-3805	46	4	of	of	ADP
fnp-3805	46	5	association	association	NOUN
fnp-3805	46	6	between	between	ADP
fnp-3805	46	7	covid-19	covid-19	PROPN
fnp-3805	46	8	and	and	CCONJ
fnp-3805	46	9	gbs	gbs	PROPN
fnp-3805	46	10	was	be	AUX
fnp-3805	46	11	observed	observe	VERB
fnp-3805	46	12	by	by	ADP
fnp-3805	46	13	a	a	DET
fnp-3805	46	14	team	team	NOUN
fnp-3805	46	15	of	of	ADP
fnp-3805	46	16	investigators	investigator	NOUN
fnp-3805	46	17	in	in	ADP
fnp-3805	46	18	singapore	singapore	PROPN
fnp-3805	46	19	(	(	PUNCT
fnp-3805	46	20	umapathi	umapathi	INTJ
fnp-3805	46	21	et	et	PROPN
fnp-3805	46	22	al	al	PROPN
fnp-3805	46	23	.	.	PROPN
fnp-3805	46	24	,	,	PUNCT
fnp-3805	46	25	2021	2021	NUM
fnp-3805	46	26	)	)	PUNCT
fnp-3805	46	27	.	.	PUNCT
fnp-3805	47	1	in	in	ADP
fnp-3805	47	2	contrast	contrast	NOUN
fnp-3805	47	3	,	,	PUNCT
fnp-3805	47	4	a	a	DET
fnp-3805	47	5	weak	weak	ADJ
fnp-3805	47	6	association	association	NOUN
fnp-3805	47	7	between	between	ADP
fnp-3805	47	8	sars	sar	NOUN
fnp-3805	47	9	-	-	PUNCT
fnp-3805	47	10	cov-2	cov-2	PART
fnp-3805	47	11	infection	infection	NOUN
fnp-3805	47	12	and	and	CCONJ
fnp-3805	47	13	gbs	gbs	PROPN
fnp-3805	47	14	(	(	PUNCT
fnp-3805	47	15	1.5	1.5	NUM
fnp-3805	47	16	excess	excess	ADJ
fnp-3805	47	17	gbs	gbs	NOUN
fnp-3805	47	18	cases	case	NOUN
fnp-3805	47	19	per	per	ADP
fnp-3805	47	20	100	100	NUM
fnp-3805	47	21	000	000	NUM
fnp-3805	47	22	sars	sar	NOUN
fnp-3805	47	23	-	-	PUNCT
fnp-3805	47	24	cov-2	cov-2	NOUN
fnp-3805	47	25	-	-	ADJ
fnp-3805	47	26	positive	positive	ADJ
fnp-3805	47	27	tests	test	NOUN
fnp-3805	47	28	)	)	PUNCT
fnp-3805	47	29	was	be	AUX
fnp-3805	47	30	reported	report	VERB
fnp-3805	47	31	by	by	ADP
fnp-3805	47	32	a	a	DET
fnp-3805	47	33	different	different	ADJ
fnp-3805	47	34	group	group	NOUN
fnp-3805	47	35	of	of	ADP
fnp-3805	47	36	uk	uk	PROPN
fnp-3805	47	37	investigators	investigator	NOUN
fnp-3805	47	38	(	(	PUNCT
fnp-3805	47	39	patone	patone	NOUN
fnp-3805	47	40	et	et	NOUN
fnp-3805	47	41	al	al	PROPN
fnp-3805	47	42	.	.	PROPN
fnp-3805	47	43	,	,	PUNCT
fnp-3805	47	44	2021	2021	NUM
fnp-3805	47	45	)	)	PUNCT
fnp-3805	47	46	;	;	PUNCT
fnp-3805	47	47	however	however	ADV
fnp-3805	47	48	,	,	PUNCT
fnp-3805	47	49	that	that	DET
fnp-3805	47	50	study	study	NOUN
fnp-3805	47	51	was	be	AUX
fnp-3805	47	52	based	base	VERB
fnp-3805	47	53	on	on	ADP
fnp-3805	47	54	the	the	DET
fnp-3805	47	55	hospital	hospital	NOUN
fnp-3805	47	56	coding	code	VERB
fnp-3805	47	57	data	datum	NOUN
fnp-3805	47	58	,	,	PUNCT
fnp-3805	47	59	which	which	PRON
fnp-3805	47	60	are	be	AUX
fnp-3805	47	61	not	not	PART
fnp-3805	47	62	always	always	ADV
fnp-3805	47	63	entirely	entirely	ADV
fnp-3805	47	64	accurate	accurate	ADJ
fnp-3805	47	65	,	,	PUNCT
fnp-3805	47	66	and	and	CCONJ
fnp-3805	47	67	included	include	VERB
fnp-3805	47	68	gbs	gbs	PROPN
fnp-3805	47	69	cases	case	NOUN
fnp-3805	47	70	that	that	PRON
fnp-3805	47	71	were	be	AUX
fnp-3805	47	72	diagnosed	diagnose	VERB
fnp-3805	47	73	on	on	ADP
fnp-3805	47	74	the	the	DET
fnp-3805	47	75	same	same	ADJ
fnp-3805	47	76	day	day	NOUN
fnp-3805	47	77	as	as	ADP
fnp-3805	47	78	covid-19	covid-19	PROPN
fnp-3805	47	79	(	(	PUNCT
fnp-3805	47	80	suggesting	suggest	VERB
fnp-3805	47	81	a	a	DET
fnp-3805	47	82	coincidental	coincidental	ADJ
fnp-3805	47	83	rather	rather	ADV
fnp-3805	47	84	than	than	ADP
fnp-3805	47	85	causative	causative	ADJ
fnp-3805	47	86	relationship	relationship	NOUN
fnp-3805	47	87	)	)	PUNCT
fnp-3805	47	88	.	.	PUNCT
fnp-3805	48	1	finally	finally	ADV
fnp-3805	48	2	,	,	PUNCT
fnp-3805	48	3	no	no	DET
fnp-3805	48	4	excess	excess	ADJ
fnp-3805	48	5	gbs	gbs	NOUN
fnp-3805	48	6	cases	case	NOUN
fnp-3805	48	7	were	be	AUX
fnp-3805	48	8	observed	observe	VERB
fnp-3805	48	9	by	by	ADP
fnp-3805	48	10	researchers	researcher	NOUN
fnp-3805	48	11	of	of	ADP
fnp-3805	48	12	the	the	DET
fnp-3805	48	13	international	international	PROPN
fnp-3805	48	14	gbs	gbs	PROPN
fnp-3805	48	15	outcome	outcome	NOUN
fnp-3805	48	16	study	study	NOUN
fnp-3805	48	17	consortium	consortium	NOUN
fnp-3805	48	18	,	,	PUNCT
fnp-3805	48	19	which	which	PRON
fnp-3805	48	20	includes	include	VERB
fnp-3805	48	21	gbs	gbs	PROPN
fnp-3805	48	22	experts	expert	NOUN
fnp-3805	48	23	from	from	ADP
fnp-3805	48	24	china	china	PROPN
fnp-3805	48	25	and	and	CCONJ
fnp-3805	48	26	japan	japan	PROPN
fnp-3805	48	27	in	in	ADP
fnp-3805	48	28	addition	addition	NOUN
fnp-3805	48	29	to	to	ADP
fnp-3805	48	30	several	several	ADJ
fnp-3805	48	31	european	european	ADJ
fnp-3805	48	32	countries	country	NOUN
fnp-3805	48	33	.	.	PUNCT
fnp-3805	49	1	while	while	SCONJ
fnp-3805	49	2	this	this	DET
fnp-3805	49	3	study	study	NOUN
fnp-3805	49	4	was	be	AUX
fnp-3805	49	5	not	not	PART
fnp-3805	49	6	designed	design	VERB
fnp-3805	49	7	for	for	ADP
fnp-3805	49	8	systematic	systematic	ADJ
fnp-3805	49	9	gbs	gbs	PROPN
fnp-3805	49	10	surveillance	surveillance	NOUN
fnp-3805	49	11	,	,	PUNCT
fnp-3805	49	12	a	a	DET
fnp-3805	49	13	significant	significant	ADJ
fnp-3805	49	14	increase	increase	NOUN
fnp-3805	49	15	in	in	ADP
fnp-3805	49	16	the	the	DET
fnp-3805	49	17	gbs	gbs	PROPN
fnp-3805	49	18	case	case	NOUN
fnp-3805	49	19	incidence	incidence	NOUN
fnp-3805	49	20	should	should	AUX
fnp-3805	49	21	have	have	AUX
fnp-3805	49	22	led	lead	VERB
fnp-3805	49	23	to	to	ADP
fnp-3805	49	24	an	an	DET
fnp-3805	49	25	observable	observable	ADJ
fnp-3805	49	26	increase	increase	NOUN
fnp-3805	49	27	in	in	ADP
fnp-3805	49	28	the	the	DET
fnp-3805	49	29	study	study	NOUN
fnp-3805	49	30	inclusion	inclusion	NOUN
fnp-3805	49	31	rate	rate	NOUN
fnp-3805	49	32	;	;	PUNCT
fnp-3805	49	33	instead	instead	ADV
fnp-3805	49	34	,	,	PUNCT
fnp-3805	49	35	the	the	DET
fnp-3805	49	36	inclusion	inclusion	NOUN
fnp-3805	49	37	rate	rate	NOUN
fnp-3805	49	38	in	in	ADP
fnp-3805	49	39	the	the	DET
fnp-3805	49	40	first	first	ADJ
fnp-3805	49	41	5	5	NUM
fnp-3805	49	42	months	month	NOUN
fnp-3805	49	43	of	of	ADP
fnp-3805	49	44	2020	2020	NUM
fnp-3805	49	45	was	be	AUX
fnp-3805	49	46	comparable	comparable	ADJ
fnp-3805	49	47	to	to	ADP
fnp-3805	49	48	inclusion	inclusion	NOUN
fnp-3805	49	49	rates	rate	NOUN
fnp-3805	49	50	in	in	ADP
fnp-3805	49	51	2017	2017	NUM
fnp-3805	49	52	,	,	PUNCT
fnp-3805	49	53	2018	2018	NUM
fnp-3805	49	54	and	and	CCONJ
fnp-3805	49	55	2019	2019	NUM
fnp-3805	49	56	(	(	PUNCT
fnp-3805	49	57	luijten	luijten	VERB
fnp-3805	49	58	et	et	PROPN
fnp-3805	49	59	al	al	PROPN
fnp-3805	49	60	.	.	PROPN
fnp-3805	49	61	,	,	PUNCT
fnp-3805	49	62	2021	2021	NUM
fnp-3805	49	63	)	)	PUNCT
fnp-3805	49	64	.	.	PUNCT
fnp-3805	50	1	taken	take	VERB
fnp-3805	50	2	together	together	ADV
fnp-3805	50	3	,	,	PUNCT
fnp-3805	50	4	the	the	DET
fnp-3805	50	5	preponderance	preponderance	NOUN
fnp-3805	50	6	of	of	ADP
fnp-3805	50	7	data	datum	NOUN
fnp-3805	50	8	available	available	ADJ
fnp-3805	50	9	to	to	ADP
fnp-3805	50	10	date	date	NOUN
fnp-3805	50	11	suggests	suggest	VERB
fnp-3805	50	12	that	that	SCONJ
fnp-3805	50	13	a	a	DET
fnp-3805	50	14	preceding	precede	VERB
fnp-3805	50	15	sars	sar	NOUN
fnp-3805	50	16	-	-	PUNCT
fnp-3805	50	17	cov-2	cov-2	PART
fnp-3805	50	18	infection	infection	NOUN
fnp-3805	50	19	is	be	AUX
fnp-3805	50	20	not	not	PART
fnp-3805	50	21	a	a	DET
fnp-3805	50	22	major	major	ADJ
fnp-3805	50	23	risk	risk	NOUN
fnp-3805	50	24	factor	factor	NOUN
fnp-3805	50	25	for	for	ADP
fnp-3805	50	26	development	development	NOUN
fnp-3805	50	27	of	of	ADP
fnp-3805	50	28	gbs	gbs	PROPN
fnp-3805	50	29	;	;	PUNCT
fnp-3805	50	30	however	however	ADV
fnp-3805	50	31	,	,	PUNCT
fnp-3805	50	32	it	it	PRON
fnp-3805	50	33	remains	remain	VERB
fnp-3805	50	34	possible	possible	ADJ
fnp-3805	50	35	that	that	SCONJ
fnp-3805	50	36	rare	rare	ADJ
fnp-3805	50	37	gbs	gbs	PROPN
fnp-3805	50	38	cases	case	NOUN
fnp-3805	50	39	could	could	AUX
fnp-3805	50	40	be	be	AUX
fnp-3805	50	41	triggered	trigger	VERB
fnp-3805	50	42	by	by	ADP
fnp-3805	50	43	infection	infection	NOUN
fnp-3805	50	44	with	with	ADP
fnp-3805	50	45	this	this	DET
fnp-3805	50	46	virus	virus	NOUN
fnp-3805	50	47	.	.	PUNCT
fnp-3805	51	1	figure	figure	NOUN
fnp-3805	51	2	2	2	NUM
fnp-3805	51	3	.	.	PUNCT
fnp-3805	51	4	daily	daily	PROPN
fnp-3805	51	5	uk	uk	PROPN
fnp-3805	51	6	infections	infection	NOUN
fnp-3805	51	7	with	with	ADP
fnp-3805	51	8	covid-19	covid-19	PROPN
fnp-3805	51	9	by	by	ADP
fnp-3805	51	10	pcr	pcr	PROPN
fnp-3805	51	11	(	(	PUNCT
fnp-3805	51	12	blue	blue	ADJ
fnp-3805	51	13	bars	bar	NOUN
fnp-3805	51	14	)	)	PUNCT
fnp-3805	51	15	and	and	CCONJ
fnp-3805	51	16	monthly	monthly	ADJ
fnp-3805	51	17	cases	case	NOUN
fnp-3805	51	18	of	of	ADP
fnp-3805	51	19	gbs	gbs	PROPN
fnp-3805	51	20	.	.	PROPN
fnp-3805	51	21	2020	2020	NUM
fnp-3805	51	22	 	 	SPACE
fnp-3805	51	23	=	=	NOUN
fnp-3805	51	24	 	 	SPACE
fnp-3805	51	25	red	red	ADJ
fnp-3805	51	26	dotted	dotted	ADJ
fnp-3805	51	27	line	line	NOUN
fnp-3805	51	28	,	,	PUNCT
fnp-3805	51	29	2019	2019	NUM
fnp-3805	51	30	 	 	SPACE
fnp-3805	51	31	=	=	NOUN
fnp-3805	51	32	 	 	SPACE
fnp-3805	51	33	green	green	ADJ
fnp-3805	51	34	dashed	dash	VERB
fnp-3805	51	35	line	line	NOUN
fnp-3805	51	36	,	,	PUNCT
fnp-3805	51	37	secondary	secondary	ADJ
fnp-3805	51	38	y	y	NOUN
fnp-3805	51	39	-	-	PUNCT
fnp-3805	51	40	axis	axis	NOUN
fnp-3805	51	41	.	.	PUNCT
fnp-3805	52	1	the	the	DET
fnp-3805	52	2	graphs	graph	NOUN
fnp-3805	52	3	demonstrate	demonstrate	VERB
fnp-3805	52	4	no	no	DET
fnp-3805	52	5	visible	visible	ADJ
fnp-3805	52	6	increase	increase	NOUN
fnp-3805	52	7	in	in	ADP
fnp-3805	52	8	gbs	gbs	PROPN
fnp-3805	52	9	in	in	ADP
fnp-3805	52	10	the	the	DET
fnp-3805	52	11	last	last	ADJ
fnp-3805	52	12	quarter	quarter	NOUN
fnp-3805	52	13	of	of	ADP
fnp-3805	52	14	2020	2020	NUM
fnp-3805	52	15	with	with	ADP
fnp-3805	52	16	a	a	DET
fnp-3805	52	17	rise	rise	NOUN
fnp-3805	52	18	in	in	ADP
fnp-3805	52	19	case	case	NOUN
fnp-3805	52	20	numbers	number	NOUN
fnp-3805	52	21	between	between	ADP
fnp-3805	52	22	30	30	NUM
fnp-3805	52	23	%	%	NOUN
fnp-3805	52	24	and	and	CCONJ
fnp-3805	52	25	1000	1000	NUM
fnp-3805	52	26	%	%	NOUN
fnp-3805	52	27	more	more	ADJ
fnp-3805	52	28	than	than	ADP
fnp-3805	52	29	in	in	ADP
fnp-3805	52	30	march	march	PROPN
fnp-3805	52	31	/	/	SYM
fnp-3805	52	32	april	april	PROPN
fnp-3805	52	33	.	.	PUNCT
fnp-3805	53	1	note	note	VERB
fnp-3805	53	2	significant	significant	ADJ
fnp-3805	53	3	alterations	alteration	NOUN
fnp-3805	53	4	in	in	ADP
fnp-3805	53	5	testing	testing	NOUN
fnp-3805	53	6	occurred	occur	VERB
fnp-3805	53	7	in	in	ADP
fnp-3805	53	8	the	the	DET
fnp-3805	53	9	uk	uk	PROPN
fnp-3805	53	10	in	in	ADP
fnp-3805	53	11	april	april	PROPN
fnp-3805	53	12	2020	2020	NUM
fnp-3805	53	13	resulting	result	VERB
fnp-3805	53	14	in	in	ADP
fnp-3805	53	15	the	the	DET
fnp-3805	53	16	subsequent	subsequent	ADJ
fnp-3805	53	17	enhanced	enhanced	ADJ
fnp-3805	53	18	detection	detection	NOUN
fnp-3805	53	19	of	of	ADP
fnp-3805	53	20	most	most	ADJ
fnp-3805	53	21	symptomatic	symptomatic	ADJ
fnp-3805	53	22	cases	case	NOUN
fnp-3805	53	23	.	.	PUNCT
fnp-3805	54	1	hospital	hospital	NOUN
fnp-3805	54	2	admissions	admission	NOUN
fnp-3805	54	3	were	be	AUX
fnp-3805	54	4	30	30	NUM
fnp-3805	54	5	%	%	NOUN
fnp-3805	54	6	higher	high	ADJ
fnp-3805	54	7	on	on	ADP
fnp-3805	54	8	1	1	NUM
fnp-3805	54	9	january	january	NOUN
fnp-3805	54	10	2021	2021	NUM
fnp-3805	54	11	than	than	ADP
fnp-3805	54	12	in	in	ADP
fnp-3805	54	13	april	april	PROPN
fnp-3805	54	14	2020	2020	NUM
fnp-3805	54	15	.	.	PUNCT
fnp-3805	55	1	sources	source	NOUN
fnp-3805	55	2	:	:	PUNCT
fnp-3805	55	3	covid	covid	PROPN
fnp-3805	55	4	cases	case	NOUN
fnp-3805	55	5	(	(	PUNCT
fnp-3805	55	6	left	leave	VERB
fnp-3805	55	7	axis	axis	NOUN
fnp-3805	55	8	,	,	PUNCT
fnp-3805	55	9	blue	blue	ADJ
fnp-3805	55	10	bars	bar	NOUN
fnp-3805	55	11	)	)	PUNCT
fnp-3805	55	12	https://coronavirus.data.gov.uk/details/cases	https://coronavirus.data.gov.uk/details/cases	PROPN
fnp-3805	55	13	;	;	PUNCT
fnp-3805	55	14	nhse	nhse	PROPN
fnp-3805	55	15	national	national	PROPN
fnp-3805	55	16	immunoglobulin	immunoglobulin	PROPN
fnp-3805	55	17	database	database	PROPN
fnp-3805	55	18	courtesy	courtesy	PROPN
fnp-3805	55	19	mdsas	mdsa	NOUN
fnp-3805	55	20	,	,	PUNCT
fnp-3805	55	21	manchester	manchester	PROPN
fnp-3805	55	22	,	,	PUNCT
fnp-3805	55	23	uk	uk	PROPN
fnp-3805	55	24	.	.	PUNCT
fnp-3805	56	1	[	[	X
fnp-3805	56	2	with	with	ADP
fnp-3805	56	3	publisher	publisher	NOUN
fnp-3805	56	4	’s	’s	PART
fnp-3805	56	5	permission	permission	NOUN
fnp-3805	56	6	,	,	PUNCT
fnp-3805	56	7	this	this	DET
fnp-3805	56	8	figure	figure	NOUN
fnp-3805	56	9	and	and	CCONJ
fnp-3805	56	10	its	its	PRON
fnp-3805	56	11	legend	legend	NOUN
fnp-3805	56	12	are	be	AUX
fnp-3805	56	13	reproduced	reproduce	VERB
fnp-3805	56	14	from	from	ADP
fnp-3805	56	15	(	(	PUNCT
fnp-3805	56	16	lunn	lunn	PROPN
fnp-3805	56	17	et	et	PROPN
fnp-3805	56	18	al	al	PROPN
fnp-3805	56	19	.	.	PROPN
fnp-3805	56	20	,	,	PUNCT
fnp-3805	56	21	2021	2021	NUM
fnp-3805	56	22	)	)	PUNCT
fnp-3805	56	23	.	.	PUNCT
fnp-3805	56	24	]	]	PUNCT
fnp-3805	57	1	in	in	ADP
fnp-3805	57	2	contrast	contrast	NOUN
fnp-3805	57	3	to	to	ADP
fnp-3805	57	4	a	a	DET
fnp-3805	57	5	lack	lack	NOUN
fnp-3805	57	6	of	of	ADP
fnp-3805	57	7	definite	definite	ADJ
fnp-3805	57	8	association	association	NOUN
fnp-3805	57	9	between	between	ADP
fnp-3805	57	10	gbs	gbs	PROPN
fnp-3805	57	11	and	and	CCONJ
fnp-3805	57	12	covid-19	covid-19	PROPN
fnp-3805	57	13	,	,	PUNCT
fnp-3805	57	14	there	there	PRON
fnp-3805	57	15	is	be	VERB
fnp-3805	57	16	a	a	DET
fnp-3805	57	17	clear	clear	ADJ
fnp-3805	57	18	link	link	NOUN
fnp-3805	57	19	between	between	ADP
fnp-3805	57	20	gbs	gbs	PROPN
fnp-3805	57	21	and	and	CCONJ
fnp-3805	57	22	the	the	DET
fnp-3805	57	23	first	first	ADJ
fnp-3805	57	24	dose	dose	NOUN
fnp-3805	57	25	of	of	ADP
fnp-3805	57	26	the	the	DET
fnp-3805	57	27	chadox1	chadox1	NOUN
fnp-3805	58	1	ncov-19	ncov-19	PROPN
fnp-3805	58	2	(	(	PUNCT
fnp-3805	58	3	astrazeneca	astrazeneca	PROPN
fnp-3805	58	4	)	)	PUNCT
fnp-3805	58	5	adenoviral	adenoviral	NOUN
fnp-3805	58	6	covid-19	covid-19	PROPN
fnp-3805	58	7	vaccine	vaccine	NOUN
fnp-3805	58	8	,	,	PUNCT
fnp-3805	58	9	with	with	ADP
fnp-3805	58	10	an	an	DET
fnp-3805	58	11	excess	excess	ADJ
fnp-3805	58	12	risk	risk	NOUN
fnp-3805	58	13	of	of	ADP
fnp-3805	58	14	~0.4	~0.4	NOUN
fnp-3805	58	15	-	-	SYM
fnp-3805	58	16	0.6	0.6	NUM
fnp-3805	58	17	gbs	gbs	PROPN
fnp-3805	58	18	cases	case	NOUN
fnp-3805	58	19	for	for	ADP
fnp-3805	58	20	each	each	DET
fnp-3805	58	21	100	100	NUM
fnp-3805	58	22	000	000	NUM
fnp-3805	58	23	administered	administer	VERB
fnp-3805	58	24	vaccine	vaccine	NOUN
fnp-3805	58	25	doses	dose	NOUN
fnp-3805	58	26	(	(	PUNCT
fnp-3805	58	27	keh	keh	INTJ
fnp-3805	58	28	et	et	PROPN
fnp-3805	58	29	al	al	PROPN
fnp-3805	58	30	.	.	PROPN
fnp-3805	58	31	,	,	PUNCT
fnp-3805	58	32	2022	2022	NUM
fnp-3805	58	33	;	;	PUNCT
fnp-3805	58	34	patone	patone	NOUN
fnp-3805	58	35	et	et	NOUN
fnp-3805	58	36	al	al	PROPN
fnp-3805	58	37	.	.	PROPN
fnp-3805	58	38	,	,	PUNCT
fnp-3805	58	39	2021	2021	NUM
fnp-3805	58	40	)	)	PUNCT
fnp-3805	58	41	.	.	PUNCT
fnp-3805	59	1	interestingly	interestingly	ADV
fnp-3805	59	2	,	,	PUNCT
fnp-3805	59	3	a	a	DET
fnp-3805	59	4	similar	similar	ADJ
fnp-3805	59	5	excess	excess	ADJ
fnp-3805	59	6	gbs	gbs	NOUN
fnp-3805	59	7	risk	risk	NOUN
fnp-3805	59	8	was	be	AUX
fnp-3805	59	9	seen	see	VERB
fnp-3805	59	10	in	in	ADP
fnp-3805	59	11	the	the	DET
fnp-3805	59	12	us	we	PRON
fnp-3805	59	13	during	during	ADP
fnp-3805	59	14	the	the	DET
fnp-3805	59	15	1976	1976	NUM
fnp-3805	59	16	-	-	SYM
fnp-3805	59	17	77	77	NUM
fnp-3805	59	18	flu	flu	NOUN
fnp-3805	59	19	vaccination	vaccination	NOUN
fnp-3805	59	20	campaign	campaign	NOUN
fnp-3805	59	21	,	,	PUNCT
fnp-3805	59	22	with	with	ADP
fnp-3805	59	23	0.5	0.5	NUM
fnp-3805	59	24	-	-	SYM
fnp-3805	59	25	0.6	0.6	NUM
fnp-3805	59	26	gbs	gbs	PROPN
fnp-3805	59	27	cases	case	NOUN
fnp-3805	59	28	observed	observe	VERB
fnp-3805	59	29	for	for	ADP
fnp-3805	59	30	each	each	DET
fnp-3805	59	31	100	100	NUM
fnp-3805	59	32	000	000	NUM
fnp-3805	59	33	doses	dose	NOUN
fnp-3805	59	34	of	of	ADP
fnp-3805	59	35	the	the	DET
fnp-3805	59	36	“	"	PUNCT
fnp-3805	59	37	swine	swine	ADJ
fnp-3805	59	38	flu	flu	NOUN
fnp-3805	59	39	”	"	PUNCT
fnp-3805	59	40	vaccine	vaccine	NOUN
fnp-3805	59	41	given	give	VERB
fnp-3805	59	42	that	that	DET
fnp-3805	59	43	year	year	NOUN
fnp-3805	59	44	;	;	PUNCT
fnp-3805	59	45	the	the	DET
fnp-3805	59	46	risk	risk	NOUN
fnp-3805	59	47	attributable	attributable	ADJ
fnp-3805	59	48	to	to	ADP
fnp-3805	59	49	later	later	ADV
fnp-3805	59	50	influenza	influenza	NOUN
fnp-3805	59	51	vaccines	vaccine	NOUN
fnp-3805	59	52	has	have	AUX
fnp-3805	59	53	been	be	AUX
fnp-3805	59	54	significantly	significantly	ADV
fnp-3805	59	55	lower	low	ADJ
fnp-3805	59	56	(	(	PUNCT
fnp-3805	59	57	~0.1	~0.1	NOUN
fnp-3805	59	58	gbs	gbs	NOUN
fnp-3805	59	59	cases	case	NOUN
fnp-3805	59	60	for	for	ADP
fnp-3805	59	61	each	each	DET
fnp-3805	59	62	100	100	NUM
fnp-3805	59	63	000	000	NUM
fnp-3805	59	64	vaccines	vaccine	NOUN
fnp-3805	59	65	)	)	PUNCT
fnp-3805	59	66	,	,	PUNCT
fnp-3805	59	67	and	and	CCONJ
fnp-3805	59	68	no	no	DET
fnp-3805	59	69	increase	increase	NOUN
fnp-3805	59	70	in	in	ADP
fnp-3805	59	71	the	the	DET
fnp-3805	59	72	gbs	gbs	PROPN
fnp-3805	59	73	risk	risk	NOUN
fnp-3805	59	74	has	have	AUX
fnp-3805	59	75	been	be	AUX
fnp-3805	59	76	observed	observe	VERB
fnp-3805	59	77	with	with	ADP
fnp-3805	59	78	the	the	DET
fnp-3805	59	79	mrna	mrna	NOUN
fnp-3805	59	80	-	-	PUNCT
fnp-3805	59	81	based	base	VERB
fnp-3805	59	82	covid	covid	PROPN
fnp-3805	59	83	vaccines	vaccine	NOUN
fnp-3805	59	84	,	,	PUNCT
fnp-3805	59	85	bnt162b2	bnt162b2	PROPN
fnp-3805	59	86	/	/	SYM
fnp-3805	59	87	tozinameran	tozinameran	NOUN
fnp-3805	59	88	(	(	PUNCT
fnp-3805	59	89	pfizer	pfizer	NOUN
fnp-3805	59	90	)	)	PUNCT
fnp-3805	59	91	and	and	CCONJ
fnp-3805	59	92	mrna-1273	mrna-1273	ADJ
fnp-3805	59	93	(	(	PUNCT
fnp-3805	59	94	moderna	moderna	PROPN
fnp-3805	59	95	)	)	PUNCT
fnp-3805	59	96	.	.	PUNCT
fnp-3805	60	1	given	give	VERB
fnp-3805	60	2	that	that	SCONJ
fnp-3805	60	3	all	all	DET
fnp-3805	60	4	these	these	DET
fnp-3805	60	5	covid-19	covid-19	PROPN
fnp-3805	60	6	vaccines	vaccine	NOUN
fnp-3805	60	7	target	target	VERB
fnp-3805	60	8	the	the	DET
fnp-3805	60	9	spike	spike	ADJ
fnp-3805	60	10	protein	protein	NOUN
fnp-3805	60	11	of	of	ADP
fnp-3805	60	12	sars	sar	NOUN
fnp-3805	60	13	-	-	PUNCT
fnp-3805	60	14	cov-2	cov-2	NOUN
fnp-3805	60	15	,	,	PUNCT
fnp-3805	60	16	the	the	DET
fnp-3805	60	17	differences	difference	NOUN
fnp-3805	60	18	among	among	ADP
fnp-3805	60	19	them	they	PRON
fnp-3805	60	20	suggest	suggest	VERB
fnp-3805	60	21	that	that	SCONJ
fnp-3805	60	22	the	the	DET
fnp-3805	60	23	excess	excess	ADJ
fnp-3805	60	24	gbs	gbs	NOUN
fnp-3805	60	25	risk	risk	NOUN
fnp-3805	60	26	is	be	AUX
fnp-3805	60	27	attributable	attributable	ADJ
fnp-3805	60	28	to	to	ADP
fnp-3805	60	29	the	the	DET
fnp-3805	60	30	adenoviral	adenoviral	ADJ
fnp-3805	60	31	vector	vector	NOUN
fnp-3805	60	32	rather	rather	ADV
fnp-3805	60	33	than	than	ADP
fnp-3805	60	34	the	the	DET
fnp-3805	60	35	sars	sar	NOUN
fnp-3805	60	36	-	-	PUNCT
fnp-3805	60	37	cov-2	cov-2	NOUN
fnp-3805	60	38	spike	spike	ADJ
fnp-3805	60	39	protein	protein	NOUN
fnp-3805	60	40	antigen	antigen	ADV
fnp-3805	60	41	;	;	PUNCT
fnp-3805	60	42	supporting	support	VERB
fnp-3805	60	43	this	this	DET
fnp-3805	60	44	hypothesis	hypothesis	NOUN
fnp-3805	60	45	,	,	PUNCT
fnp-3805	60	46	a	a	DET
fnp-3805	60	47	warning	warning	NOUN
fnp-3805	60	48	about	about	ADP
fnp-3805	60	49	a	a	DET
fnp-3805	60	50	link	link	NOUN
fnp-3805	60	51	between	between	ADP
fnp-3805	60	52	the	the	DET
fnp-3805	60	53	adenovirus	adenovirus	NOUN
fnp-3805	60	54	-	-	PUNCT
fnp-3805	60	55	based	base	VERB
fnp-3805	60	56	ad26.cov2.s	ad26.cov2.s	X
fnp-3805	60	57	(	(	PUNCT
fnp-3805	60	58	j&j	j&j	PROPN
fnp-3805	60	59	)	)	PUNCT
fnp-3805	60	60	covid-19	covid-19	PROPN
fnp-3805	60	61	vaccine	vaccine	NOUN
fnp-3805	60	62	and	and	CCONJ
fnp-3805	60	63	gbs	gbs	PROPN
fnp-3805	60	64	was	be	AUX
fnp-3805	60	65	announced	announce	VERB
fnp-3805	60	66	by	by	ADP
fnp-3805	60	67	the	the	DET
fnp-3805	60	68	us	us	PROPN
fnp-3805	60	69	food	food	NOUN
fnp-3805	60	70	and	and	CCONJ
fnp-3805	60	71	drug	drug	PROPN
fnp-3805	60	72	administration	administration	NOUN
fnp-3805	60	73	in	in	ADP
fnp-3805	60	74	july	july	PROPN
fnp-3805	60	75	2021	2021	NUM
fnp-3805	60	76	(	(	PUNCT
fnp-3805	60	77	https://fda.gov/news-events/press-announcements/coronavirus-covid-19-update-july-13-2021	https://fda.gov/news-events/press-announcements/coronavirus-covid-19-update-july-13-2021	PROPN
fnp-3805	60	78	)	)	PUNCT
fnp-3805	60	79	,	,	PUNCT
fnp-3805	60	80	although	although	SCONJ
fnp-3805	60	81	no	no	DET
fnp-3805	60	82	formal	formal	ADJ
fnp-3805	60	83	scientific	scientific	ADJ
fnp-3805	60	84	study	study	NOUN
fnp-3805	60	85	about	about	ADP
fnp-3805	60	86	this	this	DET
fnp-3805	60	87	association	association	NOUN
fnp-3805	60	88	has	have	AUX
fnp-3805	60	89	been	be	AUX
fnp-3805	60	90	published	publish	VERB
fnp-3805	60	91	to	to	ADP
fnp-3805	60	92	date	date	NOUN
fnp-3805	60	93	.	.	PUNCT
fnp-3805	61	1	what	what	PRON
fnp-3805	61	2	about	about	ADP
fnp-3805	61	3	covid-19	covid-19	PROPN
fnp-3805	61	4	-	-	PUNCT
fnp-3805	61	5	associated	associate	VERB
fnp-3805	61	6	myopathy	myopathy	ADJ
fnp-3805	61	7	?	?	PUNCT
fnp-3805	62	1	although	although	SCONJ
fnp-3805	62	2	initial	initial	ADJ
fnp-3805	62	3	studies	study	NOUN
fnp-3805	62	4	were	be	AUX
fnp-3805	62	5	extremely	extremely	ADV
fnp-3805	62	6	limited	limited	ADJ
fnp-3805	62	7	,	,	PUNCT
fnp-3805	62	8	they	they	PRON
fnp-3805	62	9	suggested	suggest	VERB
fnp-3805	62	10	that	that	SCONJ
fnp-3805	62	11	weakness	weakness	NOUN
fnp-3805	62	12	and	and	CCONJ
fnp-3805	62	13	high	high	ADJ
fnp-3805	62	14	creatine	creatine	NOUN
fnp-3805	62	15	kinase	kinase	PROPN
fnp-3805	62	16	(	(	PUNCT
fnp-3805	62	17	ck	ck	NOUN
fnp-3805	62	18	)	)	PUNCT
fnp-3805	62	19	levels	level	NOUN
fnp-3805	62	20	seen	see	VERB
fnp-3805	62	21	in	in	ADP
fnp-3805	62	22	a	a	DET
fnp-3805	62	23	significant	significant	ADJ
fnp-3805	62	24	subset	subset	NOUN
fnp-3805	62	25	of	of	ADP
fnp-3805	62	26	covid-19	covid-19	PROPN
fnp-3805	62	27	patients	patient	NOUN
fnp-3805	62	28	were	be	AUX
fnp-3805	62	29	immune	immune	NOUN
fnp-3805	62	30	-	-	PUNCT
fnp-3805	62	31	mediated	mediate	VERB
fnp-3805	62	32	rather	rather	ADV
fnp-3805	62	33	than	than	ADP
fnp-3805	62	34	due	due	ADJ
fnp-3805	62	35	to	to	ADP
fnp-3805	62	36	direct	direct	VERB
fnp-3805	62	37	viral	viral	ADJ
fnp-3805	62	38	infection	infection	NOUN
fnp-3805	62	39	of	of	ADP
fnp-3805	62	40	skeletal	skeletal	ADJ
fnp-3805	62	41	muscle	muscle	NOUN
fnp-3805	62	42	[	[	PUNCT
fnp-3805	62	43	reviewed	review	VERB
fnp-3805	62	44	in	in	ADP
fnp-3805	62	45	(	(	PUNCT
fnp-3805	62	46	margeta	margeta	NOUN
fnp-3805	62	47	,	,	PUNCT
fnp-3805	62	48	2021	2021	NUM
fnp-3805	62	49	)	)	PUNCT
fnp-3805	62	50	]	]	PUNCT
fnp-3805	62	51	.	.	PUNCT
fnp-3805	63	1	based	base	VERB
fnp-3805	63	2	on	on	ADP
fnp-3805	63	3	the	the	DET
fnp-3805	63	4	two	two	NUM
fnp-3805	63	5	large	large	ADJ
fnp-3805	63	6	autopsy	autopsy	ADJ
fnp-3805	63	7	case	case	NOUN
fnp-3805	63	8	-	-	PUNCT
fnp-3805	63	9	control	control	NOUN
fnp-3805	63	10	studies	study	NOUN
fnp-3805	63	11	published	publish	VERB
fnp-3805	63	12	since	since	SCONJ
fnp-3805	63	13	then	then	ADV
fnp-3805	63	14	(	(	PUNCT
fnp-3805	63	15	aschman	aschman	NOUN
fnp-3805	63	16	et	et	PROPN
fnp-3805	63	17	al	al	PROPN
fnp-3805	63	18	.	.	PROPN
fnp-3805	63	19	,	,	PUNCT
fnp-3805	63	20	2021	2021	NUM
fnp-3805	63	21	;	;	PUNCT
fnp-3805	63	22	suh	suh	PROPN
fnp-3805	63	23	et	et	PROPN
fnp-3805	63	24	al	al	PROPN
fnp-3805	63	25	.	.	PROPN
fnp-3805	63	26	,	,	PUNCT
fnp-3805	63	27	2021	2021	NUM
fnp-3805	63	28	)	)	PUNCT
fnp-3805	63	29	,	,	PUNCT
fnp-3805	63	30	this	this	DET
fnp-3805	63	31	initial	initial	ADJ
fnp-3805	63	32	impression	impression	NOUN
fnp-3805	63	33	was	be	AUX
fnp-3805	63	34	essentially	essentially	ADV
fnp-3805	63	35	correct	correct	ADJ
fnp-3805	63	36	.	.	PUNCT
fnp-3805	64	1	aschman	aschman	NOUN
fnp-3805	64	2	and	and	CCONJ
fnp-3805	64	3	colleagues	colleague	NOUN
fnp-3805	64	4	examined	examine	VERB
fnp-3805	64	5	deltoid	deltoid	NOUN
fnp-3805	64	6	and	and	CCONJ
fnp-3805	64	7	quadriceps	quadricep	NOUN
fnp-3805	64	8	muscles	muscle	NOUN
fnp-3805	64	9	from	from	ADP
fnp-3805	64	10	43	43	NUM
fnp-3805	64	11	patients	patient	NOUN
fnp-3805	64	12	with	with	ADP
fnp-3805	64	13	covid-19	covid-19	PROPN
fnp-3805	64	14	and	and	CCONJ
fnp-3805	64	15	compared	compare	VERB
fnp-3805	64	16	them	they	PRON
fnp-3805	64	17	to	to	ADP
fnp-3805	64	18	the	the	DET
fnp-3805	64	19	same	same	ADJ
fnp-3805	64	20	muscles	muscle	NOUN
fnp-3805	64	21	sampled	sample	VERB
fnp-3805	64	22	from	from	ADP
fnp-3805	64	23	11	11	NUM
fnp-3805	64	24	severely	severely	ADV
fnp-3805	64	25	ill	ill	ADJ
fnp-3805	64	26	patients	patient	NOUN
fnp-3805	64	27	negative	negative	ADJ
fnp-3805	64	28	for	for	ADP
fnp-3805	64	29	sars	sar	NOUN
fnp-3805	64	30	-	-	PUNCT
fnp-3805	64	31	cov-2	cov-2	NOUN
fnp-3805	64	32	.	.	PUNCT
fnp-3805	65	1	they	they	PRON
fnp-3805	65	2	found	find	VERB
fnp-3805	65	3	that	that	SCONJ
fnp-3805	65	4	~60	~60	ADV
fnp-3805	65	5	%	%	NOUN
fnp-3805	65	6	of	of	ADP
fnp-3805	65	7	patients	patient	NOUN
fnp-3805	65	8	who	who	PRON
fnp-3805	65	9	died	die	VERB
fnp-3805	65	10	with	with	ADP
fnp-3805	65	11	severe	severe	ADJ
fnp-3805	65	12	covid-19	covid-19	PROPN
fnp-3805	65	13	showed	show	VERB
fnp-3805	65	14	evidence	evidence	NOUN
fnp-3805	65	15	of	of	ADP
fnp-3805	65	16	immune	immune	NOUN
fnp-3805	65	17	-	-	PUNCT
fnp-3805	65	18	mediated	mediate	VERB
fnp-3805	65	19	muscle	muscle	NOUN
fnp-3805	65	20	pathology	pathology	NOUN
fnp-3805	65	21	including	include	VERB
fnp-3805	65	22	some	some	DET
fnp-3805	65	23	combination	combination	NOUN
fnp-3805	65	24	of	of	ADP
fnp-3805	65	25	mild	mild	ADJ
fnp-3805	65	26	-	-	PUNCT
fnp-3805	65	27	severe	severe	ADJ
fnp-3805	65	28	inflammation	inflammation	NOUN
fnp-3805	65	29	(	(	PUNCT
fnp-3805	65	30	mostly	mostly	ADV
fnp-3805	65	31	consisting	consist	VERB
fnp-3805	65	32	of	of	ADP
fnp-3805	65	33	cd8	cd8	PROPN
fnp-3805	65	34	+	+	PROPN
fnp-3805	65	35	t	t	PROPN
fnp-3805	65	36	cells	cell	NOUN
fnp-3805	65	37	and	and	CCONJ
fnp-3805	65	38	macrophages	macrophage	NOUN
fnp-3805	65	39	)	)	PUNCT
fnp-3805	65	40	,	,	PUNCT
fnp-3805	65	41	degenerating	degenerate	VERB
fnp-3805	65	42	muscle	muscle	NOUN
fnp-3805	65	43	fibers	fiber	NOUN
fnp-3805	65	44	,	,	PUNCT
fnp-3805	65	45	and	and	CCONJ
fnp-3805	65	46	mhc	mhc	PROPN
fnp-3805	65	47	-	-	PUNCT
fnp-3805	65	48	i	i	PROPN
fnp-3805	65	49	and	and	CCONJ
fnp-3805	65	50	mhc	mhc	PROPN
fnp-3805	65	51	-	-	PUNCT
fnp-3805	65	52	ii	ii	PROPN
fnp-3805	65	53	upregulation	upregulation	NOUN
fnp-3805	65	54	in	in	ADP
fnp-3805	65	55	muscle	muscle	NOUN
fnp-3805	65	56	fiber	fiber	NOUN
fnp-3805	65	57	sarcolemma	sarcolemma	PROPN
fnp-3805	65	58	(	(	PUNCT
fnp-3805	65	59	the	the	DET
fnp-3805	65	60	latter	latter	NOUN
fnp-3805	65	61	mostly	mostly	ADV
fnp-3805	65	62	seen	see	VERB
fnp-3805	65	63	in	in	ADP
fnp-3805	65	64	chronic	chronic	ADJ
fnp-3805	65	65	cases	case	NOUN
fnp-3805	65	66	)	)	PUNCT
fnp-3805	65	67	.	.	PUNCT
fnp-3805	66	1	three	three	NUM
fnp-3805	66	2	samples	sample	NOUN
fnp-3805	66	3	showed	show	VERB
fnp-3805	66	4	perifascicular	perifascicular	ADJ
fnp-3805	66	5	upregulation	upregulation	NOUN
fnp-3805	66	6	of	of	ADP
fnp-3805	66	7	mhc	mhc	PROPN
fnp-3805	66	8	-	-	PUNCT
fnp-3805	66	9	i	i	PROPN
fnp-3805	66	10	and	and	CCONJ
fnp-3805	66	11	mhc	mhc	PROPN
fnp-3805	66	12	-	-	PUNCT
fnp-3805	66	13	ii	ii	PROPN
fnp-3805	66	14	;	;	PUNCT
fnp-3805	66	15	however	however	ADV
fnp-3805	66	16	,	,	PUNCT
fnp-3805	66	17	no	no	DET
fnp-3805	66	18	sarcoplasmic	sarcoplasmic	ADJ
fnp-3805	66	19	upregulation	upregulation	NOUN
fnp-3805	66	20	of	of	ADP
fnp-3805	66	21	dermatomyositis	dermatomyositis	PROPN
fnp-3805	66	22	(	(	PUNCT
fnp-3805	66	23	dm	dm	NOUN
fnp-3805	66	24	)	)	PUNCT
fnp-3805	66	25	marker	marker	NOUN
fnp-3805	66	26	mxa	mxa	NOUN
fnp-3805	66	27	[	[	X
fnp-3805	66	28	myxovirus	myxovirus	NOUN
fnp-3805	66	29	(	(	PUNCT
fnp-3805	66	30	influenza	influenza	NOUN
fnp-3805	66	31	virus	virus	NOUN
fnp-3805	66	32	)	)	PUNCT
fnp-3805	66	33	resistance	resistance	NOUN
fnp-3805	66	34	1	1	NUM
fnp-3805	66	35	,	,	PUNCT
fnp-3805	66	36	interferon	interferon	ADJ
fnp-3805	66	37	-	-	PUNCT
fnp-3805	66	38	inducible	inducible	ADJ
fnp-3805	66	39	protein	protein	NOUN
fnp-3805	66	40	p78	p78	NOUN
fnp-3805	66	41	;	;	PUNCT
fnp-3805	66	42	also	also	ADV
fnp-3805	66	43	known	know	VERB
fnp-3805	66	44	as	as	ADP
fnp-3805	66	45	mx1	mx1	PROPN
fnp-3805	66	46	]	]	PUNCT
fnp-3805	66	47	was	be	AUX
fnp-3805	66	48	seen	see	VERB
fnp-3805	66	49	in	in	ADP
fnp-3805	66	50	any	any	PRON
fnp-3805	66	51	of	of	ADP
fnp-3805	66	52	the	the	DET
fnp-3805	66	53	specimens	specimen	NOUN
fnp-3805	66	54	.	.	PUNCT
fnp-3805	67	1	(	(	PUNCT
fnp-3805	67	2	interestingly	interestingly	ADV
fnp-3805	67	3	,	,	PUNCT
fnp-3805	67	4	some	some	DET
fnp-3805	67	5	covid-19	covid-19	PROPN
fnp-3805	67	6	samples	sample	NOUN
fnp-3805	67	7	showed	show	VERB
fnp-3805	67	8	increased	increase	VERB
fnp-3805	67	9	mxa	mxa	NOUN
fnp-3805	67	10	expression	expression	NOUN
fnp-3805	67	11	in	in	ADP
fnp-3805	67	12	the	the	DET
fnp-3805	67	13	endomysial	endomysial	ADJ
fnp-3805	67	14	capillaries	capillary	NOUN
fnp-3805	67	15	,	,	PUNCT
fnp-3805	67	16	possibly	possibly	ADV
fnp-3805	67	17	reflecting	reflect	VERB
fnp-3805	67	18	a	a	DET
fnp-3805	67	19	nonspecific	nonspecific	ADJ
fnp-3805	67	20	response	response	NOUN
fnp-3805	67	21	to	to	ADP
fnp-3805	67	22	systemic	systemic	ADJ
fnp-3805	67	23	viral	viral	ADJ
fnp-3805	67	24	infection	infection	NOUN
fnp-3805	67	25	.	.	PUNCT
fnp-3805	67	26	)	)	PUNCT
fnp-3805	68	1	in	in	ADP
fnp-3805	68	2	addition	addition	NOUN
fnp-3805	68	3	,	,	PUNCT
fnp-3805	68	4	a	a	DET
fnp-3805	68	5	few	few	ADJ
fnp-3805	68	6	covid-19	covid-19	PROPN
fnp-3805	68	7	samples	sample	NOUN
fnp-3805	68	8	showed	show	VERB
fnp-3805	68	9	evidence	evidence	NOUN
fnp-3805	68	10	of	of	ADP
fnp-3805	68	11	small	small	ADJ
fnp-3805	68	12	and	and	CCONJ
fnp-3805	68	13	medium	medium	ADJ
fnp-3805	68	14	-	-	PUNCT
fnp-3805	68	15	vessel	vessel	NOUN
fnp-3805	68	16	angiitis	angiitis	ADV
fnp-3805	68	17	.	.	PUNCT
fnp-3805	69	1	although	although	SCONJ
fnp-3805	69	2	sars	sar	NOUN
fnp-3805	69	3	-	-	PUNCT
fnp-3805	69	4	cov-2	cov-2	NOUN
fnp-3805	69	5	rna	rna	NOUN
fnp-3805	69	6	was	be	AUX
fnp-3805	69	7	detectable	detectable	ADJ
fnp-3805	69	8	by	by	ADP
fnp-3805	69	9	pcr	pcr	NOUN
fnp-3805	69	10	in	in	ADP
fnp-3805	69	11	some	some	DET
fnp-3805	69	12	muscle	muscle	NOUN
fnp-3805	69	13	homogenates	homogenate	NOUN
fnp-3805	69	14	,	,	PUNCT
fnp-3805	69	15	immunohistochemistry	immunohistochemistry	NOUN
fnp-3805	69	16	against	against	ADP
fnp-3805	69	17	sars	sar	NOUN
fnp-3805	69	18	-	-	PUNCT
fnp-3805	69	19	cov-2	cov-2	NOUN
fnp-3805	69	20	spike	spike	ADJ
fnp-3805	69	21	protein	protein	NOUN
fnp-3805	69	22	was	be	AUX
fnp-3805	69	23	negative	negative	ADJ
fnp-3805	69	24	in	in	ADP
fnp-3805	69	25	all	all	DET
fnp-3805	69	26	cases	case	NOUN
fnp-3805	69	27	and	and	CCONJ
fnp-3805	69	28	no	no	DET
fnp-3805	69	29	viral	viral	ADJ
fnp-3805	69	30	particles	particle	NOUN
fnp-3805	69	31	were	be	AUX
fnp-3805	69	32	demonstrated	demonstrate	VERB
fnp-3805	69	33	on	on	ADP
fnp-3805	69	34	electron	electron	NOUN
fnp-3805	69	35	microscopy	microscopy	NOUN
fnp-3805	69	36	(	(	PUNCT
fnp-3805	69	37	aschman	aschman	NOUN
fnp-3805	69	38	et	et	PROPN
fnp-3805	69	39	al	al	PROPN
fnp-3805	69	40	.	.	PROPN
fnp-3805	69	41	,	,	PUNCT
fnp-3805	69	42	2021	2021	NUM
fnp-3805	69	43	)	)	PUNCT
fnp-3805	69	44	.	.	PUNCT
fnp-3805	70	1	very	very	ADV
fnp-3805	70	2	similar	similar	ADJ
fnp-3805	70	3	findings	finding	NOUN
fnp-3805	70	4	were	be	AUX
fnp-3805	70	5	reported	report	VERB
fnp-3805	70	6	by	by	ADP
fnp-3805	70	7	suh	suh	PROPN
fnp-3805	70	8	et	et	PROPN
fnp-3805	70	9	al	al	PROPN
fnp-3805	70	10	.	.	PROPN
fnp-3805	70	11	,	,	PUNCT
fnp-3805	70	12	who	who	PRON
fnp-3805	70	13	studied	study	VERB
fnp-3805	70	14	psoas	psoas	ADJ
fnp-3805	70	15	muscles	muscle	NOUN
fnp-3805	70	16	from	from	ADP
fnp-3805	70	17	35	35	NUM
fnp-3805	70	18	patients	patient	NOUN
fnp-3805	70	19	who	who	PRON
fnp-3805	70	20	died	die	VERB
fnp-3805	70	21	following	follow	VERB
fnp-3805	70	22	covid-19	covid-19	PROPN
fnp-3805	70	23	infection	infection	NOUN
fnp-3805	70	24	and	and	CCONJ
fnp-3805	70	25	10	10	NUM
fnp-3805	70	26	severely	severely	ADV
fnp-3805	70	27	ill	ill	ADJ
fnp-3805	70	28	patients	patient	NOUN
fnp-3805	70	29	who	who	PRON
fnp-3805	70	30	were	be	AUX
fnp-3805	70	31	covid-19	covid-19	PROPN
fnp-3805	70	32	-	-	PUNCT
fnp-3805	70	33	negative	negative	ADJ
fnp-3805	70	34	.	.	PUNCT
fnp-3805	71	1	in	in	ADP
fnp-3805	71	2	addition	addition	NOUN
fnp-3805	71	3	to	to	ADP
fnp-3805	71	4	diffuse	diffuse	VERB
fnp-3805	71	5	type	type	NOUN
fnp-3805	71	6	2	2	NUM
fnp-3805	71	7	fiber	fiber	NOUN
fnp-3805	71	8	atrophy	atrophy	NOUN
fnp-3805	71	9	(	(	PUNCT
fnp-3805	71	10	which	which	PRON
fnp-3805	71	11	was	be	AUX
fnp-3805	71	12	present	present	ADJ
fnp-3805	71	13	in	in	ADP
fnp-3805	71	14	almost	almost	ADV
fnp-3805	71	15	all	all	PRON
fnp-3805	71	16	cases	case	NOUN
fnp-3805	71	17	and	and	CCONJ
fnp-3805	71	18	controls	control	NOUN
fnp-3805	71	19	)	)	PUNCT
fnp-3805	71	20	,	,	PUNCT
fnp-3805	71	21	these	these	DET
fnp-3805	71	22	authors	author	NOUN
fnp-3805	71	23	found	find	VERB
fnp-3805	71	24	evidence	evidence	NOUN
fnp-3805	71	25	of	of	ADP
fnp-3805	71	26	immune	immune	NOUN
fnp-3805	71	27	-	-	PUNCT
fnp-3805	71	28	mediated	mediate	VERB
fnp-3805	71	29	muscle	muscle	NOUN
fnp-3805	71	30	pathology	pathology	NOUN
fnp-3805	71	31	in	in	ADP
fnp-3805	71	32	~70	~70	NOUN
fnp-3805	71	33	%	%	NOUN
fnp-3805	71	34	of	of	ADP
fnp-3805	71	35	covid-19	covid-19	PROPN
fnp-3805	71	36	cases	case	NOUN
fnp-3805	71	37	,	,	PUNCT
fnp-3805	71	38	with	with	ADP
fnp-3805	71	39	necrotizing	necrotize	VERB
fnp-3805	71	40	myopathy	myopathy	NOUN
fnp-3805	71	41	in	in	ADP
fnp-3805	71	42	9	9	NUM
fnp-3805	71	43	patients	patient	NOUN
fnp-3805	71	44	,	,	PUNCT
fnp-3805	71	45	t	t	PROPN
fnp-3805	71	46	celland	celland	NOUN
fnp-3805	71	47	macrophage	macrophage	ADV
fnp-3805	71	48	-	-	PUNCT
fnp-3805	71	49	mediated	mediate	VERB
fnp-3805	71	50	myositis	myositis	NOUN
fnp-3805	71	51	in	in	ADP
fnp-3805	71	52	8	8	NUM
fnp-3805	71	53	patients	patient	NOUN
fnp-3805	71	54	,	,	PUNCT
fnp-3805	71	55	and	and	CCONJ
fnp-3805	71	56	isolated	isolate	VERB
fnp-3805	71	57	diffuse	diffuse	NOUN
fnp-3805	71	58	or	or	CCONJ
fnp-3805	71	59	multifocal	multifocal	ADJ
fnp-3805	71	60	mhc	mhc	PROPN
fnp-3805	71	61	-	-	PUNCT
fnp-3805	71	62	i	i	PRON
fnp-3805	71	63	upregulation	upregulation	NOUN
fnp-3805	71	64	in	in	ADP
fnp-3805	71	65	additional	additional	ADJ
fnp-3805	71	66	8	8	NUM
fnp-3805	71	67	patients	patient	NOUN
fnp-3805	71	68	.	.	PUNCT
fnp-3805	72	1	like	like	INTJ
fnp-3805	72	2	aschman	aschman	NOUN
fnp-3805	72	3	et	et	PROPN
fnp-3805	72	4	al	al	PROPN
fnp-3805	72	5	.	.	PROPN
fnp-3805	72	6	,	,	PUNCT
fnp-3805	72	7	suh	suh	PROPN
fnp-3805	72	8	et	et	PROPN
fnp-3805	72	9	al	al	PROPN
fnp-3805	72	10	.	.	PROPN
fnp-3805	72	11	observed	observe	VERB
fnp-3805	72	12	perifascicular	perifascicular	ADJ
fnp-3805	72	13	pattern	pattern	NOUN
fnp-3805	72	14	of	of	ADP
fnp-3805	72	15	mhc	mhc	PROPN
fnp-3805	72	16	-	-	PUNCT
fnp-3805	72	17	i	i	PRON
fnp-3805	72	18	upregulation	upregulation	NOUN
fnp-3805	72	19	without	without	ADP
fnp-3805	72	20	concurrent	concurrent	ADJ
fnp-3805	72	21	sarcolemmal	sarcolemmal	ADJ
fnp-3805	72	22	mxa	mxa	NOUN
fnp-3805	72	23	upregulation	upregulation	NOUN
fnp-3805	72	24	in	in	ADP
fnp-3805	72	25	one	one	NUM
fnp-3805	72	26	covid-19	covid-19	PROPN
fnp-3805	72	27	case	case	NOUN
fnp-3805	72	28	,	,	PUNCT
fnp-3805	72	29	while	while	SCONJ
fnp-3805	72	30	mxa	mxa	NOUN
fnp-3805	72	31	expression	expression	NOUN
fnp-3805	72	32	restricted	restrict	VERB
fnp-3805	72	33	to	to	ADP
fnp-3805	72	34	endomysial	endomysial	ADJ
fnp-3805	72	35	capillaries	capillary	NOUN
fnp-3805	72	36	was	be	AUX
fnp-3805	72	37	seen	see	VERB
fnp-3805	72	38	in	in	ADP
fnp-3805	72	39	8	8	NUM
fnp-3805	72	40	covid-19	covid-19	PROPN
fnp-3805	72	41	cases	case	NOUN
fnp-3805	72	42	.	.	PUNCT
fnp-3805	73	1	immunohistochemistry	immunohistochemistry	NOUN
fnp-3805	73	2	against	against	ADP
fnp-3805	73	3	sars	sar	NOUN
fnp-3805	73	4	-	-	PUNCT
fnp-3805	73	5	cov-2	cov-2	NOUN
fnp-3805	73	6	nucleocapsid	nucleocapsid	ADJ
fnp-3805	73	7	protein	protein	NOUN
fnp-3805	73	8	was	be	AUX
fnp-3805	73	9	negative	negative	ADJ
fnp-3805	73	10	in	in	ADP
fnp-3805	73	11	all	all	DET
fnp-3805	73	12	35	35	NUM
fnp-3805	73	13	covid-19	covid-19	PROPN
fnp-3805	73	14	cases	case	NOUN
fnp-3805	73	15	.	.	PUNCT
fnp-3805	74	1	in	in	ADP
fnp-3805	74	2	contrast	contrast	NOUN
fnp-3805	74	3	to	to	ADP
fnp-3805	74	4	the	the	DET
fnp-3805	74	5	findings	finding	NOUN
fnp-3805	74	6	in	in	ADP
fnp-3805	74	7	these	these	DET
fnp-3805	74	8	autopsy	autopsy	ADJ
fnp-3805	74	9	studies	study	NOUN
fnp-3805	74	10	,	,	PUNCT
fnp-3805	74	11	direct	direct	ADJ
fnp-3805	74	12	viral	viral	ADJ
fnp-3805	74	13	infection	infection	NOUN
fnp-3805	74	14	of	of	ADP
fnp-3805	74	15	muscle	muscle	NOUN
fnp-3805	74	16	fibers	fiber	NOUN
fnp-3805	74	17	was	be	AUX
fnp-3805	74	18	recently	recently	ADV
fnp-3805	74	19	documented	document	VERB
fnp-3805	74	20	by	by	ADP
fnp-3805	74	21	both	both	PRON
fnp-3805	74	22	immunohistochemistry	immunohistochemistry	NOUN
fnp-3805	74	23	and	and	CCONJ
fnp-3805	74	24	electron	electron	NOUN
fnp-3805	74	25	microscopy	microscopy	NOUN
fnp-3805	74	26	in	in	ADP
fnp-3805	74	27	muscle	muscle	NOUN
fnp-3805	74	28	biopsies	biopsy	NOUN
fnp-3805	74	29	from	from	ADP
fnp-3805	74	30	two	two	NUM
fnp-3805	74	31	of	of	ADP
fnp-3805	74	32	three	three	NUM
fnp-3805	74	33	covid-19	covid-19	PROPN
fnp-3805	74	34	patients	patient	NOUN
fnp-3805	74	35	with	with	ADP
fnp-3805	74	36	critical	critical	ADJ
fnp-3805	74	37	illness	illness	NOUN
fnp-3805	74	38	myopathy	myopathy	ADJ
fnp-3805	74	39	and	and	CCONJ
fnp-3805	74	40	persistent	persistent	ADJ
fnp-3805	74	41	sars	sar	NOUN
fnp-3805	74	42	-	-	PUNCT
fnp-3805	74	43	cov-2	cov-2	NOUN
fnp-3805	74	44	positivity	positivity	NOUN
fnp-3805	74	45	on	on	ADP
fnp-3805	74	46	pcr	pcr	NOUN
fnp-3805	74	47	testing	testing	NOUN
fnp-3805	74	48	(	(	PUNCT
fnp-3805	74	49	dodig	dodig	NOUN
fnp-3805	74	50	et	et	NOUN
fnp-3805	74	51	al	al	PROPN
fnp-3805	74	52	.	.	PROPN
fnp-3805	74	53	,	,	PUNCT
fnp-3805	74	54	2022	2022	NUM
fnp-3805	74	55	)	)	PUNCT
fnp-3805	74	56	.	.	PUNCT
fnp-3805	75	1	it	it	PRON
fnp-3805	75	2	is	be	AUX
fnp-3805	75	3	currently	currently	ADV
fnp-3805	75	4	unclear	unclear	ADJ
fnp-3805	75	5	what	what	PRON
fnp-3805	75	6	accounts	account	VERB
fnp-3805	75	7	for	for	ADP
fnp-3805	75	8	the	the	DET
fnp-3805	75	9	discrepancy	discrepancy	NOUN
fnp-3805	75	10	between	between	ADP
fnp-3805	75	11	these	these	DET
fnp-3805	75	12	three	three	NUM
fnp-3805	75	13	studies	study	NOUN
fnp-3805	75	14	;	;	PUNCT
fnp-3805	75	15	one	one	NUM
fnp-3805	75	16	possibility	possibility	NOUN
fnp-3805	75	17	is	be	AUX
fnp-3805	75	18	that	that	SCONJ
fnp-3805	75	19	the	the	DET
fnp-3805	75	20	difference	difference	NOUN
fnp-3805	75	21	reflects	reflect	VERB
fnp-3805	75	22	the	the	DET
fnp-3805	75	23	sample	sample	NOUN
fnp-3805	75	24	type	type	NOUN
fnp-3805	75	25	used	use	VERB
fnp-3805	75	26	(	(	PUNCT
fnp-3805	75	27	muscle	muscle	NOUN
fnp-3805	75	28	biopsy	biopsy	NOUN
fnp-3805	75	29	vs.	vs.	X
fnp-3805	75	30	autopsy	autopsy	ADJ
fnp-3805	75	31	)	)	PUNCT
fnp-3805	75	32	,	,	PUNCT
fnp-3805	75	33	although	although	SCONJ
fnp-3805	75	34	that	that	PRON
fnp-3805	75	35	does	do	AUX
fnp-3805	75	36	not	not	PART
fnp-3805	75	37	seem	seem	VERB
fnp-3805	75	38	likely	likely	ADV
fnp-3805	75	39	given	give	VERB
fnp-3805	75	40	(	(	PUNCT
fnp-3805	75	41	1	1	NUM
fnp-3805	75	42	)	)	PUNCT
fnp-3805	75	43	that	that	SCONJ
fnp-3805	75	44	sars	sar	NOUN
fnp-3805	75	45	-	-	PUNCT
fnp-3805	75	46	cov-2	cov-2	PART
fnp-3805	75	47	viral	viral	ADJ
fnp-3805	75	48	infection	infection	NOUN
fnp-3805	75	49	can	can	AUX
fnp-3805	75	50	be	be	AUX
fnp-3805	75	51	demonstrated	demonstrate	VERB
fnp-3805	75	52	by	by	ADP
fnp-3805	75	53	both	both	PRON
fnp-3805	75	54	immunohistochemistry	immunohistochemistry	NOUN
fnp-3805	75	55	and	and	CCONJ
fnp-3805	75	56	electron	electron	NOUN
fnp-3805	75	57	microscopy	microscopy	NOUN
fnp-3805	75	58	in	in	ADP
fnp-3805	75	59	the	the	DET
fnp-3805	75	60	lungs	lung	NOUN
fnp-3805	75	61	of	of	ADP
fnp-3805	75	62	autopsied	autopsie	VERB
fnp-3805	75	63	covid-19	covid-19	PROPN
fnp-3805	75	64	patients	patient	NOUN
fnp-3805	75	65	and	and	CCONJ
fnp-3805	75	66	(	(	PUNCT
fnp-3805	75	67	2	2	NUM
fnp-3805	75	68	)	)	PUNCT
fnp-3805	75	69	that	that	SCONJ
fnp-3805	75	70	no	no	DET
fnp-3805	75	71	sars	sar	NOUN
fnp-3805	75	72	-	-	PUNCT
fnp-3805	75	73	cov-2	cov-2	PART
fnp-3805	75	74	was	be	AUX
fnp-3805	75	75	definitively	definitively	ADV
fnp-3805	75	76	detected	detect	VERB
fnp-3805	75	77	in	in	ADP
fnp-3805	75	78	other	other	ADJ
fnp-3805	75	79	muscle	muscle	NOUN
fnp-3805	75	80	biopsies	biopsy	NOUN
fnp-3805	75	81	from	from	ADP
fnp-3805	75	82	covid-19	covid-19	PROPN
fnp-3805	75	83	patients	patient	NOUN
fnp-3805	75	84	reported	report	VERB
fnp-3805	75	85	to	to	ADP
fnp-3805	75	86	date	date	NOUN
fnp-3805	75	87	.	.	PUNCT
fnp-3805	76	1	more	more	ADV
fnp-3805	76	2	likely	likely	ADJ
fnp-3805	76	3	,	,	PUNCT
fnp-3805	76	4	this	this	DET
fnp-3805	76	5	difference	difference	NOUN
fnp-3805	76	6	can	can	AUX
fnp-3805	76	7	be	be	AUX
fnp-3805	76	8	attributed	attribute	VERB
fnp-3805	76	9	to	to	ADP
fnp-3805	76	10	the	the	DET
fnp-3805	76	11	effects	effect	NOUN
fnp-3805	76	12	of	of	ADP
fnp-3805	76	13	a	a	DET
fnp-3805	76	14	long	long	ADV
fnp-3805	76	15	-	-	PUNCT
fnp-3805	76	16	standing	stand	VERB
fnp-3805	76	17	and	and	CCONJ
fnp-3805	76	18	persistent	persistent	ADJ
fnp-3805	76	19	sars	sar	NOUN
fnp-3805	76	20	-	-	PUNCT
fnp-3805	76	21	cov-2	cov-2	PART
fnp-3805	76	22	infection	infection	NOUN
fnp-3805	76	23	,	,	PUNCT
fnp-3805	76	24	which	which	PRON
fnp-3805	76	25	was	be	AUX
fnp-3805	76	26	documented	document	VERB
fnp-3805	76	27	in	in	ADP
fnp-3805	76	28	the	the	DET
fnp-3805	76	29	patients	patient	NOUN
fnp-3805	76	30	described	describe	VERB
fnp-3805	76	31	by	by	ADP
fnp-3805	76	32	dodig	dodig	PROPN
fnp-3805	76	33	et	et	PROPN
fnp-3805	76	34	al	al	PROPN
fnp-3805	76	35	.	.	PUNCT
fnp-3805	77	1	but	but	CCONJ
fnp-3805	77	2	is	be	AUX
fnp-3805	77	3	not	not	PART
fnp-3805	77	4	a	a	DET
fnp-3805	77	5	common	common	ADJ
fnp-3805	77	6	feature	feature	NOUN
fnp-3805	77	7	of	of	ADP
fnp-3805	77	8	covid-19	covid-19	PROPN
fnp-3805	77	9	.	.	PUNCT
fnp-3805	78	1	importantly	importantly	ADV
fnp-3805	78	2	,	,	PUNCT
fnp-3805	78	3	and	and	CCONJ
fnp-3805	78	4	regardless	regardless	ADV
fnp-3805	78	5	of	of	ADP
fnp-3805	78	6	the	the	DET
fnp-3805	78	7	specific	specific	ADJ
fnp-3805	78	8	reason	reason	NOUN
fnp-3805	78	9	for	for	ADP
fnp-3805	78	10	the	the	DET
fnp-3805	78	11	rarity	rarity	NOUN
fnp-3805	78	12	of	of	ADP
fnp-3805	78	13	this	this	DET
fnp-3805	78	14	finding	finding	NOUN
fnp-3805	78	15	,	,	PUNCT
fnp-3805	78	16	the	the	DET
fnp-3805	78	17	study	study	NOUN
fnp-3805	78	18	by	by	ADP
fnp-3805	78	19	dodig	dodig	PROPN
fnp-3805	78	20	and	and	CCONJ
fnp-3805	78	21	coauthors	coauthor	NOUN
fnp-3805	78	22	demonstrates	demonstrate	VERB
fnp-3805	78	23	that	that	SCONJ
fnp-3805	78	24	direct	direct	ADJ
fnp-3805	78	25	sars	sar	NOUN
fnp-3805	78	26	-	-	PUNCT
fnp-3805	78	27	cov-2	cov-2	PART
fnp-3805	78	28	infection	infection	NOUN
fnp-3805	78	29	of	of	ADP
fnp-3805	78	30	skeletal	skeletal	ADJ
fnp-3805	78	31	muscle	muscle	NOUN
fnp-3805	78	32	can	can	AUX
fnp-3805	78	33	occur	occur	VERB
fnp-3805	78	34	,	,	PUNCT
fnp-3805	78	35	and	and	CCONJ
fnp-3805	78	36	raises	raise	VERB
fnp-3805	78	37	the	the	DET
fnp-3805	78	38	possibility	possibility	NOUN
fnp-3805	78	39	that	that	SCONJ
fnp-3805	78	40	such	such	ADJ
fnp-3805	78	41	infection	infection	NOUN
fnp-3805	78	42	is	be	AUX
fnp-3805	78	43	present	present	ADJ
fnp-3805	78	44	in	in	ADP
fnp-3805	78	45	the	the	DET
fnp-3805	78	46	early	early	ADJ
fnp-3805	78	47	stages	stage	NOUN
fnp-3805	78	48	of	of	ADP
fnp-3805	78	49	covid-19	covid-19	PROPN
fnp-3805	78	50	in	in	ADP
fnp-3805	78	51	many	many	ADJ
fnp-3805	78	52	patients	patient	NOUN
fnp-3805	78	53	,	,	PUNCT
fnp-3805	78	54	acting	act	VERB
fnp-3805	78	55	as	as	ADP
fnp-3805	78	56	a	a	DET
fnp-3805	78	57	trigger	trigger	NOUN
fnp-3805	78	58	for	for	ADP
fnp-3805	78	59	the	the	DET
fnp-3805	78	60	subsequent	subsequent	ADJ
fnp-3805	78	61	immune	immune	NOUN
fnp-3805	78	62	-	-	PUNCT
fnp-3805	78	63	mediated	mediate	VERB
fnp-3805	78	64	muscle	muscle	NOUN
fnp-3805	78	65	pathology	pathology	NOUN
fnp-3805	78	66	that	that	PRON
fnp-3805	78	67	develops	develop	VERB
fnp-3805	78	68	in	in	ADP
fnp-3805	78	69	some	some	DET
fnp-3805	78	70	instances	instance	NOUN
fnp-3805	78	71	.	.	PUNCT
fnp-3805	79	1	3	3	X
fnp-3805	79	2	.	.	X
fnp-3805	79	3	autosomal	autosomal	ADJ
fnp-3805	79	4	recessive	recessive	ADJ
fnp-3805	79	5	myopathy	myopathy	NOUN
fnp-3805	79	6	caused	cause	VERB
fnp-3805	79	7	by	by	ADP
fnp-3805	79	8	truncating	truncate	VERB
fnp-3805	79	9	mutations	mutation	NOUN
fnp-3805	79	10	of	of	ADP
fnp-3805	79	11	mlip	mlip	NOUN
fnp-3805	79	12	(	(	PUNCT
fnp-3805	79	13	muscular	muscular	ADJ
fnp-3805	79	14	a	a	DET
fnp-3805	79	15	-	-	PUNCT
fnp-3805	79	16	type	type	NOUN
fnp-3805	79	17	lamin	lamin	NOUN
fnp-3805	79	18	-	-	PUNCT
fnp-3805	79	19	interacting	interact	VERB
fnp-3805	79	20	protein	protein	NOUN
fnp-3805	79	21	)	)	PUNCT
fnp-3805	79	22	unexplained	unexplained	ADJ
fnp-3805	79	23	persistent	persistent	ADJ
fnp-3805	79	24	elevation	elevation	NOUN
fnp-3805	79	25	of	of	ADP
fnp-3805	79	26	serum	serum	PROPN
fnp-3805	79	27	ck	ck	PROPN
fnp-3805	79	28	levels	level	NOUN
fnp-3805	79	29	points	point	VERB
fnp-3805	79	30	to	to	ADP
fnp-3805	79	31	a	a	DET
fnp-3805	79	32	chronic	chronic	ADJ
fnp-3805	79	33	myopathic	myopathic	ADJ
fnp-3805	79	34	process	process	NOUN
fnp-3805	79	35	that	that	PRON
fnp-3805	79	36	is	be	AUX
fnp-3805	79	37	likely	likely	ADV
fnp-3805	79	38	genetic	genetic	ADJ
fnp-3805	79	39	in	in	ADP
fnp-3805	79	40	origin	origin	NOUN
fnp-3805	79	41	,	,	PUNCT
fnp-3805	79	42	but	but	CCONJ
fnp-3805	79	43	identifying	identify	VERB
fnp-3805	79	44	the	the	DET
fnp-3805	79	45	specific	specific	ADJ
fnp-3805	79	46	underlying	underlie	VERB
fnp-3805	79	47	etiology	etiology	NOUN
fnp-3805	79	48	can	can	AUX
fnp-3805	79	49	be	be	AUX
fnp-3805	79	50	challenging	challenge	VERB
fnp-3805	79	51	if	if	SCONJ
fnp-3805	79	52	no	no	DET
fnp-3805	79	53	other	other	ADJ
fnp-3805	79	54	symptoms	symptom	NOUN
fnp-3805	79	55	and	and	CCONJ
fnp-3805	79	56	signs	sign	NOUN
fnp-3805	79	57	are	be	AUX
fnp-3805	79	58	present	present	ADJ
fnp-3805	79	59	to	to	PART
fnp-3805	79	60	narrow	narrow	VERB
fnp-3805	79	61	the	the	DET
fnp-3805	79	62	differential	differential	ADJ
fnp-3805	79	63	diagnosis	diagnosis	NOUN
fnp-3805	79	64	.	.	PUNCT
fnp-3805	80	1	when	when	SCONJ
fnp-3805	80	2	chronic	chronic	ADJ
fnp-3805	80	3	hyperckemia	hyperckemia	NOUN
fnp-3805	80	4	is	be	AUX
fnp-3805	80	5	associated	associate	VERB
fnp-3805	80	6	with	with	ADP
fnp-3805	80	7	exercise	exercise	NOUN
fnp-3805	80	8	intolerance	intolerance	NOUN
fnp-3805	80	9	and	and	CCONJ
fnp-3805	80	10	exercise	exercise	NOUN
fnp-3805	80	11	-	-	PUNCT
fnp-3805	80	12	induced	induce	VERB
fnp-3805	80	13	rhabdomyolysis	rhabdomyolysis	NOUN
fnp-3805	80	14	,	,	PUNCT
fnp-3805	80	15	the	the	DET
fnp-3805	80	16	underlying	underlying	ADJ
fnp-3805	80	17	problem	problem	NOUN
fnp-3805	80	18	is	be	AUX
fnp-3805	80	19	usually	usually	ADV
fnp-3805	80	20	metabolic	metabolic	ADJ
fnp-3805	80	21	;	;	PUNCT
fnp-3805	80	22	if	if	SCONJ
fnp-3805	80	23	,	,	PUNCT
fnp-3805	80	24	on	on	ADP
fnp-3805	80	25	the	the	DET
fnp-3805	80	26	other	other	ADJ
fnp-3805	80	27	hand	hand	NOUN
fnp-3805	80	28	,	,	PUNCT
fnp-3805	80	29	chronic	chronic	ADJ
fnp-3805	80	30	ck	ck	PRON
fnp-3805	80	31	elevation	elevation	NOUN
fnp-3805	80	32	is	be	AUX
fnp-3805	80	33	accompanied	accompany	VERB
fnp-3805	80	34	by	by	ADP
fnp-3805	80	35	muscle	muscle	NOUN
fnp-3805	80	36	weakness	weakness	NOUN
fnp-3805	80	37	and	and	CCONJ
fnp-3805	80	38	wasting	wasting	NOUN
fnp-3805	80	39	,	,	PUNCT
fnp-3805	80	40	the	the	DET
fnp-3805	80	41	patient	patient	NOUN
fnp-3805	80	42	likely	likely	ADV
fnp-3805	80	43	has	have	VERB
fnp-3805	80	44	a	a	DET
fnp-3805	80	45	muscular	muscular	ADJ
fnp-3805	80	46	dystrophy	dystrophy	NOUN
fnp-3805	80	47	.	.	PUNCT
fnp-3805	81	1	two	two	NUM
fnp-3805	81	2	interesting	interesting	ADJ
fnp-3805	81	3	papers	paper	NOUN
fnp-3805	81	4	published	publish	VERB
fnp-3805	81	5	in	in	ADP
fnp-3805	81	6	2021	2021	NUM
fnp-3805	81	7	(	(	PUNCT
fnp-3805	81	8	lopes	lope	NOUN
fnp-3805	81	9	abath	abath	ADP
fnp-3805	81	10	neto	neto	PROPN
fnp-3805	81	11	et	et	PROPN
fnp-3805	81	12	al	al	PROPN
fnp-3805	81	13	.	.	PROPN
fnp-3805	81	14	,	,	PUNCT
fnp-3805	81	15	2021	2021	NUM
fnp-3805	81	16	;	;	PUNCT
fnp-3805	81	17	salzer	salzer	NOUN
fnp-3805	81	18	-	-	PUNCT
fnp-3805	81	19	sheelo	sheelo	NOUN
fnp-3805	81	20	et	et	PROPN
fnp-3805	81	21	al	al	PROPN
fnp-3805	81	22	.	.	PROPN
fnp-3805	81	23	,	,	PUNCT
fnp-3805	81	24	2021	2021	NUM
fnp-3805	81	25	)	)	PUNCT
fnp-3805	81	26	uncovered	uncover	VERB
fnp-3805	81	27	a	a	DET
fnp-3805	81	28	novel	novel	ADJ
fnp-3805	81	29	autosomal	autosomal	ADJ
fnp-3805	81	30	recessive	recessive	ADJ
fnp-3805	81	31	myopathy	myopathy	NOUN
fnp-3805	81	32	that	that	PRON
fnp-3805	81	33	is	be	AUX
fnp-3805	81	34	caused	cause	VERB
fnp-3805	81	35	by	by	ADP
fnp-3805	81	36	loss	loss	NOUN
fnp-3805	81	37	-	-	PUNCT
fnp-3805	81	38	of	of	ADP
fnp-3805	81	39	-	-	PUNCT
fnp-3805	81	40	function	function	NOUN
fnp-3805	81	41	mutations	mutation	NOUN
fnp-3805	81	42	in	in	ADP
fnp-3805	81	43	mlip	mlip	NOUN
fnp-3805	81	44	(	(	PUNCT
fnp-3805	81	45	muscular	muscular	ADJ
fnp-3805	81	46	a	a	DET
fnp-3805	81	47	-	-	PUNCT
fnp-3805	81	48	type	type	NOUN
fnp-3805	81	49	lamin	lamin	NOUN
fnp-3805	81	50	-	-	PUNCT
fnp-3805	81	51	interacting	interact	VERB
fnp-3805	81	52	protein	protein	NOUN
fnp-3805	81	53	;	;	PUNCT
fnp-3805	81	54	also	also	ADV
fnp-3805	81	55	known	know	VERB
fnp-3805	81	56	as	as	ADP
fnp-3805	81	57	muscular	muscular	ADJ
fnp-3805	81	58	lmna	lmna	NOUN
fnp-3805	81	59	-	-	PUNCT
fnp-3805	81	60	interacting	interact	VERB
fnp-3805	81	61	protein	protein	NOUN
fnp-3805	81	62	)	)	PUNCT
fnp-3805	81	63	and	and	CCONJ
fnp-3805	81	64	is	be	AUX
fnp-3805	81	65	clinically	clinically	ADV
fnp-3805	81	66	characterized	characterize	VERB
fnp-3805	81	67	by	by	ADP
fnp-3805	81	68	persistent	persistent	ADJ
fnp-3805	81	69	basal	basal	PROPN
fnp-3805	81	70	hyperckemia	hyperckemia	NOUN
fnp-3805	81	71	.	.	PUNCT
fnp-3805	82	1	among	among	ADP
fnp-3805	82	2	the	the	DET
fnp-3805	82	3	twelve	twelve	NUM
fnp-3805	82	4	affected	affect	VERB
fnp-3805	82	5	individuals	individual	NOUN
fnp-3805	82	6	identified	identify	VERB
fnp-3805	82	7	to	to	ADP
fnp-3805	82	8	date	date	NOUN
fnp-3805	82	9	,	,	PUNCT
fnp-3805	82	10	eight	eight	NUM
fnp-3805	82	11	developed	developed	ADJ
fnp-3805	82	12	symptoms	symptom	NOUN
fnp-3805	82	13	in	in	ADP
fnp-3805	82	14	childhood	childhood	NOUN
fnp-3805	82	15	(	(	PUNCT
fnp-3805	82	16	with	with	ADP
fnp-3805	82	17	symptom	symptom	NOUN
fnp-3805	82	18	onset	onset	NOUN
fnp-3805	82	19	between	between	ADP
fnp-3805	82	20	8	8	NUM
fnp-3805	82	21	months	month	NOUN
fnp-3805	82	22	and	and	CCONJ
fnp-3805	82	23	7	7	NUM
fnp-3805	82	24	years	year	NOUN
fnp-3805	82	25	of	of	ADP
fnp-3805	82	26	age	age	NOUN
fnp-3805	82	27	)	)	PUNCT
fnp-3805	82	28	;	;	PUNCT
fnp-3805	82	29	their	their	PRON
fnp-3805	82	30	clinical	clinical	ADJ
fnp-3805	82	31	findings	finding	NOUN
fnp-3805	82	32	included	include	VERB
fnp-3805	82	33	exertional	exertional	ADJ
fnp-3805	82	34	myalgia	myalgia	NOUN
fnp-3805	82	35	,	,	PUNCT
fnp-3805	82	36	episodes	episode	NOUN
fnp-3805	82	37	of	of	ADP
fnp-3805	82	38	rhabdomyolysis	rhabdomyolysis	NOUN
fnp-3805	82	39	(	(	PUNCT
fnp-3805	82	40	occasionally	occasionally	ADV
fnp-3805	82	41	exercise	exercise	NOUN
fnp-3805	82	42	-	-	PUNCT
fnp-3805	82	43	induced	induced	ADJ
fnp-3805	82	44	,	,	PUNCT
fnp-3805	82	45	but	but	CCONJ
fnp-3805	82	46	without	without	ADP
fnp-3805	82	47	clear	clear	ADJ
fnp-3805	82	48	trigger	trigger	NOUN
fnp-3805	82	49	in	in	ADP
fnp-3805	82	50	most	most	ADJ
fnp-3805	82	51	cases	case	NOUN
fnp-3805	82	52	)	)	PUNCT
fnp-3805	82	53	,	,	PUNCT
fnp-3805	82	54	and/or	and/or	CCONJ
fnp-3805	82	55	mild	mild	ADJ
fnp-3805	82	56	progressive	progressive	ADJ
fnp-3805	82	57	proximal	proximal	ADJ
fnp-3805	82	58	muscle	muscle	NOUN
fnp-3805	82	59	weakness	weakness	NOUN
fnp-3805	82	60	in	in	ADP
fnp-3805	82	61	addition	addition	NOUN
fnp-3805	82	62	to	to	ADP
fnp-3805	82	63	chronically	chronically	ADV
fnp-3805	82	64	elevated	elevate	VERB
fnp-3805	82	65	ck	ck	ADJ
fnp-3805	82	66	levels	level	NOUN
fnp-3805	82	67	.	.	PUNCT
fnp-3805	83	1	the	the	DET
fnp-3805	83	2	remaining	remain	VERB
fnp-3805	83	3	four	four	NUM
fnp-3805	83	4	individuals	individual	NOUN
fnp-3805	83	5	were	be	AUX
fnp-3805	83	6	identified	identify	VERB
fnp-3805	83	7	based	base	VERB
fnp-3805	83	8	on	on	ADP
fnp-3805	83	9	genetic	genetic	ADJ
fnp-3805	83	10	screening	screening	NOUN
fnp-3805	83	11	of	of	ADP
fnp-3805	83	12	the	the	DET
fnp-3805	83	13	subject	subject	ADJ
fnp-3805	83	14	cohort	cohort	NOUN
fnp-3805	83	15	enrolled	enrol	VERB
fnp-3805	83	16	in	in	ADP
fnp-3805	83	17	the	the	DET
fnp-3805	83	18	university	university	PROPN
fnp-3805	83	19	of	of	ADP
fnp-3805	83	20	maryland	maryland	PROPN
fnp-3805	83	21	study	study	NOUN
fnp-3805	83	22	of	of	ADP
fnp-3805	83	23	old	old	ADJ
fnp-3805	83	24	order	order	NOUN
fnp-3805	83	25	amish	amish	NOUN
fnp-3805	83	26	;	;	PUNCT
fnp-3805	83	27	based	base	VERB
fnp-3805	83	28	on	on	ADP
fnp-3805	83	29	the	the	DET
fnp-3805	83	30	evaluation	evaluation	NOUN
fnp-3805	83	31	of	of	ADP
fnp-3805	83	32	banked	banked	ADJ
fnp-3805	83	33	serum	serum	NOUN
fnp-3805	83	34	specimens	specimen	NOUN
fnp-3805	83	35	(	(	PUNCT
fnp-3805	83	36	available	available	ADJ
fnp-3805	83	37	for	for	ADP
fnp-3805	83	38	3	3	NUM
fnp-3805	83	39	of	of	ADP
fnp-3805	83	40	4	4	NUM
fnp-3805	83	41	individuals	individual	NOUN
fnp-3805	83	42	)	)	PUNCT
fnp-3805	83	43	,	,	PUNCT
fnp-3805	83	44	those	those	DET
fnp-3805	83	45	patients	patient	NOUN
fnp-3805	83	46	,	,	PUNCT
fnp-3805	83	47	who	who	PRON
fnp-3805	83	48	currently	currently	ADV
fnp-3805	83	49	range	range	VERB
fnp-3805	83	50	from	from	ADP
fnp-3805	83	51	24	24	NUM
fnp-3805	83	52	to	to	PART
fnp-3805	83	53	67	67	NUM
fnp-3805	83	54	years	year	NOUN
fnp-3805	83	55	in	in	ADP
fnp-3805	83	56	age	age	NOUN
fnp-3805	83	57	,	,	PUNCT
fnp-3805	83	58	also	also	ADV
fnp-3805	83	59	have	have	VERB
fnp-3805	83	60	chronic	chronic	ADJ
fnp-3805	83	61	hyperckemia	hyperckemia	NOUN
fnp-3805	83	62	,	,	PUNCT
fnp-3805	83	63	but	but	CCONJ
fnp-3805	83	64	no	no	DET
fnp-3805	83	65	other	other	ADJ
fnp-3805	83	66	known	know	VERB
fnp-3805	83	67	neuromuscular	neuromuscular	ADJ
fnp-3805	83	68	symptoms	symptom	NOUN
fnp-3805	83	69	.	.	PUNCT
fnp-3805	84	1	muscle	muscle	NOUN
fnp-3805	84	2	biopsies	biopsy	NOUN
fnp-3805	84	3	were	be	AUX
fnp-3805	84	4	performed	perform	VERB
fnp-3805	84	5	for	for	ADP
fnp-3805	84	6	7	7	NUM
fnp-3805	84	7	of	of	ADP
fnp-3805	84	8	8	8	NUM
fnp-3805	84	9	clinically	clinically	ADV
fnp-3805	84	10	affected	affect	VERB
fnp-3805	84	11	patients	patient	NOUN
fnp-3805	84	12	and	and	CCONJ
fnp-3805	84	13	showed	show	VERB
fnp-3805	84	14	a	a	DET
fnp-3805	84	15	wide	wide	ADJ
fnp-3805	84	16	spectrum	spectrum	NOUN
fnp-3805	84	17	of	of	ADP
fnp-3805	84	18	histopathologic	histopathologic	PROPN
fnp-3805	84	19	findings	finding	NOUN
fnp-3805	84	20	,	,	PUNCT
fnp-3805	84	21	ranging	range	VERB
fnp-3805	84	22	from	from	ADP
fnp-3805	84	23	mild	mild	ADJ
fnp-3805	84	24	nonspecific	nonspecific	ADJ
fnp-3805	84	25	features	feature	NOUN
fnp-3805	84	26	to	to	ADP
fnp-3805	84	27	necrotizing	necrotizing	NOUN
fnp-3805	84	28	and	and	CCONJ
fnp-3805	84	29	–	–	PUNCT
fnp-3805	84	30	less	less	ADV
fnp-3805	84	31	frequently	frequently	ADV
fnp-3805	84	32	–	–	PUNCT
fnp-3805	84	33	dystrophic	dystrophic	ADJ
fnp-3805	84	34	changes	change	NOUN
fnp-3805	84	35	.	.	PUNCT
fnp-3805	85	1	thus	thus	ADV
fnp-3805	85	2	,	,	PUNCT
fnp-3805	85	3	it	it	PRON
fnp-3805	85	4	is	be	AUX
fnp-3805	85	5	not	not	PART
fnp-3805	85	6	yet	yet	ADV
fnp-3805	85	7	entirely	entirely	ADV
fnp-3805	85	8	clear	clear	ADJ
fnp-3805	85	9	whether	whether	SCONJ
fnp-3805	85	10	to	to	PART
fnp-3805	85	11	classify	classify	VERB
fnp-3805	85	12	this	this	DET
fnp-3805	85	13	new	new	ADJ
fnp-3805	85	14	disease	disease	NOUN
fnp-3805	85	15	as	as	ADP
fnp-3805	85	16	a	a	DET
fnp-3805	85	17	metabolic	metabolic	NOUN
fnp-3805	85	18	myopathy	myopathy	NOUN
fnp-3805	85	19	or	or	CCONJ
fnp-3805	85	20	a	a	DET
fnp-3805	85	21	muscular	muscular	ADJ
fnp-3805	85	22	dystrophy	dystrophy	NOUN
fnp-3805	85	23	;	;	PUNCT
fnp-3805	85	24	while	while	SCONJ
fnp-3805	85	25	muscular	muscular	ADJ
fnp-3805	85	26	dystrophy	dystrophy	NOUN
fnp-3805	85	27	is	be	AUX
fnp-3805	85	28	more	more	ADV
fnp-3805	85	29	likely	likely	ADJ
fnp-3805	85	30	,	,	PUNCT
fnp-3805	85	31	the	the	DET
fnp-3805	85	32	final	final	ADJ
fnp-3805	85	33	classification	classification	NOUN
fnp-3805	85	34	will	will	AUX
fnp-3805	85	35	require	require	VERB
fnp-3805	85	36	careful	careful	ADJ
fnp-3805	85	37	clinical	clinical	ADJ
fnp-3805	85	38	follow	follow	NOUN
fnp-3805	85	39	-	-	PUNCT
fnp-3805	85	40	up	up	NOUN
fnp-3805	85	41	and	and	CCONJ
fnp-3805	85	42	repeat	repeat	VERB
fnp-3805	85	43	muscle	muscle	NOUN
fnp-3805	85	44	biopsies	biopsy	NOUN
fnp-3805	85	45	of	of	ADP
fnp-3805	85	46	the	the	DET
fnp-3805	85	47	known	know	VERB
fnp-3805	85	48	symptomatic	symptomatic	ADJ
fnp-3805	85	49	individuals	individual	NOUN
fnp-3805	85	50	(	(	PUNCT
fnp-3805	85	51	who	who	PRON
fnp-3805	85	52	currently	currently	ADV
fnp-3805	85	53	range	range	VERB
fnp-3805	85	54	from	from	ADP
fnp-3805	85	55	5	5	NUM
fnp-3805	85	56	-	-	SYM
fnp-3805	85	57	19	19	NUM
fnp-3805	85	58	years	year	NOUN
fnp-3805	85	59	of	of	ADP
fnp-3805	85	60	age	age	NOUN
fnp-3805	85	61	)	)	PUNCT
fnp-3805	85	62	,	,	PUNCT
fnp-3805	85	63	as	as	ADV
fnp-3805	85	64	well	well	ADV
fnp-3805	85	65	as	as	ADP
fnp-3805	85	66	identification	identification	NOUN
fnp-3805	85	67	of	of	ADP
fnp-3805	85	68	additional	additional	ADJ
fnp-3805	85	69	patients	patient	NOUN
fnp-3805	85	70	by	by	ADP
fnp-3805	85	71	genetic	genetic	ADJ
fnp-3805	85	72	testing	testing	NOUN
fnp-3805	85	73	of	of	ADP
fnp-3805	85	74	individuals	individual	NOUN
fnp-3805	85	75	with	with	ADP
fnp-3805	85	76	otherwise	otherwise	ADV
fnp-3805	85	77	unexplained	unexplained	ADJ
fnp-3805	85	78	chronic	chronic	ADJ
fnp-3805	85	79	hyperckemia	hyperckemia	NOUN
fnp-3805	85	80	.	.	PUNCT
fnp-3805	86	1	mlip	mlip	PROPN
fnp-3805	86	2	is	be	AUX
fnp-3805	86	3	a	a	DET
fnp-3805	86	4	ubiquitously	ubiquitously	ADV
fnp-3805	86	5	expressed	express	VERB
fnp-3805	86	6	,	,	PUNCT
fnp-3805	86	7	alternatively	alternatively	ADV
fnp-3805	86	8	spliced	splice	VERB
fnp-3805	86	9	protein	protein	NOUN
fnp-3805	86	10	(	(	PUNCT
fnp-3805	86	11	23	23	NUM
fnp-3805	86	12	-	-	SYM
fnp-3805	86	13	57	57	NUM
fnp-3805	86	14	kda	kda	NOUN
fnp-3805	86	15	)	)	PUNCT
fnp-3805	86	16	that	that	PRON
fnp-3805	86	17	directly	directly	ADV
fnp-3805	86	18	interacts	interact	VERB
fnp-3805	86	19	with	with	ADP
fnp-3805	86	20	lamins	lamin	NOUN
fnp-3805	86	21	a	a	PRON
fnp-3805	86	22	/	/	SYM
fnp-3805	86	23	c	c	NOUN
fnp-3805	86	24	(	(	PUNCT
fnp-3805	86	25	two	two	NUM
fnp-3805	86	26	intermediate	intermediate	ADJ
fnp-3805	86	27	filaments	filament	NOUN
fnp-3805	86	28	,	,	PUNCT
fnp-3805	86	29	both	both	PRON
fnp-3805	86	30	derived	derive	VERB
fnp-3805	86	31	from	from	ADP
fnp-3805	86	32	the	the	DET
fnp-3805	86	33	lmna	lmna	NOUN
fnp-3805	86	34	gene	gene	NOUN
fnp-3805	86	35	,	,	PUNCT
fnp-3805	86	36	that	that	PRON
fnp-3805	86	37	are	be	AUX
fnp-3805	86	38	the	the	DET
fnp-3805	86	39	main	main	ADJ
fnp-3805	86	40	constituents	constituent	NOUN
fnp-3805	86	41	of	of	ADP
fnp-3805	86	42	the	the	DET
fnp-3805	86	43	nuclear	nuclear	ADJ
fnp-3805	86	44	envelope	envelope	NOUN
fnp-3805	86	45	)	)	PUNCT
fnp-3805	86	46	;	;	PUNCT
fnp-3805	86	47	its	its	PRON
fnp-3805	86	48	expression	expression	NOUN
fnp-3805	86	49	is	be	AUX
fnp-3805	86	50	highest	high	ADJ
fnp-3805	86	51	in	in	ADP
fnp-3805	86	52	the	the	DET
fnp-3805	86	53	heart	heart	NOUN
fnp-3805	86	54	,	,	PUNCT
fnp-3805	86	55	skeletal	skeletal	ADJ
fnp-3805	86	56	muscle	muscle	NOUN
fnp-3805	86	57	,	,	PUNCT
fnp-3805	86	58	and	and	CCONJ
fnp-3805	86	59	brain	brain	NOUN
fnp-3805	86	60	,	,	PUNCT
fnp-3805	86	61	but	but	CCONJ
fnp-3805	86	62	its	its	PRON
fnp-3805	86	63	function	function	NOUN
fnp-3805	86	64	remains	remains	AUX
fnp-3805	86	65	poorly	poorly	ADV
fnp-3805	86	66	understood	understand	VERB
fnp-3805	86	67	(	(	PUNCT
fnp-3805	86	68	ahmady	ahmady	NOUN
fnp-3805	86	69	et	et	PROPN
fnp-3805	86	70	al	al	PROPN
fnp-3805	86	71	.	.	PROPN
fnp-3805	86	72	,	,	PUNCT
fnp-3805	86	73	2011	2011	NUM
fnp-3805	86	74	)	)	PUNCT
fnp-3805	86	75	.	.	PUNCT
fnp-3805	87	1	in	in	ADP
fnp-3805	87	2	a	a	DET
fnp-3805	87	3	murine	murine	ADJ
fnp-3805	87	4	model	model	NOUN
fnp-3805	87	5	,	,	PUNCT
fnp-3805	87	6	mlip	mlip	ADJ
fnp-3805	87	7	deletion	deletion	NOUN
fnp-3805	87	8	in	in	ADP
fnp-3805	87	9	the	the	DET
fnp-3805	87	10	heart	heart	NOUN
fnp-3805	87	11	led	lead	VERB
fnp-3805	87	12	to	to	ADP
fnp-3805	87	13	metabolic	metabolic	NOUN
fnp-3805	87	14	abnormalities	abnormality	NOUN
fnp-3805	87	15	,	,	PUNCT
fnp-3805	87	16	abnormal	abnormal	ADJ
fnp-3805	87	17	adaptation	adaptation	NOUN
fnp-3805	87	18	to	to	PART
fnp-3805	87	19	stress	stress	VERB
fnp-3805	87	20	,	,	PUNCT
fnp-3805	87	21	and	and	CCONJ
fnp-3805	87	22	accelerated	accelerate	VERB
fnp-3805	87	23	progression	progression	NOUN
fnp-3805	87	24	from	from	ADP
fnp-3805	87	25	compensated	compensated	ADJ
fnp-3805	87	26	cardiac	cardiac	ADJ
fnp-3805	87	27	hypertrophy	hypertrophy	NOUN
fnp-3805	87	28	to	to	PART
fnp-3805	87	29	decompensated	decompensate	VERB
fnp-3805	87	30	heart	heart	NOUN
fnp-3805	87	31	failure	failure	NOUN
fnp-3805	87	32	(	(	PUNCT
fnp-3805	87	33	cattin	cattin	NOUN
fnp-3805	87	34	et	et	PROPN
fnp-3805	87	35	al	al	PROPN
fnp-3805	87	36	.	.	PROPN
fnp-3805	87	37	,	,	PUNCT
fnp-3805	87	38	2015	2015	NUM
fnp-3805	87	39	;	;	PUNCT
fnp-3805	87	40	huang	huang	PROPN
fnp-3805	87	41	et	et	PROPN
fnp-3805	87	42	al	al	PROPN
fnp-3805	87	43	.	.	PROPN
fnp-3805	87	44	,	,	PUNCT
fnp-3805	87	45	2015	2015	NUM
fnp-3805	87	46	)	)	PUNCT
fnp-3805	87	47	.	.	PUNCT
fnp-3805	88	1	in	in	ADP
fnp-3805	88	2	contrast	contrast	NOUN
fnp-3805	88	3	,	,	PUNCT
fnp-3805	88	4	mlip	mlip	ADJ
fnp-3805	88	5	deletion	deletion	NOUN
fnp-3805	88	6	in	in	ADP
fnp-3805	88	7	murine	murine	ADJ
fnp-3805	88	8	skeletal	skeletal	ADJ
fnp-3805	88	9	muscle	muscle	NOUN
fnp-3805	88	10	led	lead	VERB
fnp-3805	88	11	to	to	ADP
fnp-3805	88	12	increased	increase	VERB
fnp-3805	88	13	central	central	ADJ
fnp-3805	88	14	nucleation	nucleation	NOUN
fnp-3805	88	15	but	but	CCONJ
fnp-3805	88	16	no	no	DET
fnp-3805	88	17	obvious	obvious	ADJ
fnp-3805	88	18	neuromuscular	neuromuscular	ADJ
fnp-3805	88	19	phenotype	phenotype	NOUN
fnp-3805	88	20	(	(	PUNCT
fnp-3805	88	21	liu	liu	PROPN
fnp-3805	88	22	et	et	PROPN
fnp-3805	88	23	al	al	PROPN
fnp-3805	88	24	.	.	PROPN
fnp-3805	88	25	,	,	PUNCT
fnp-3805	88	26	2020	2020	NUM
fnp-3805	88	27	)	)	PUNCT
fnp-3805	88	28	.	.	PUNCT
fnp-3805	89	1	in	in	ADP
fnp-3805	89	2	humans	human	NOUN
fnp-3805	89	3	,	,	PUNCT
fnp-3805	89	4	variants	variant	NOUN
fnp-3805	89	5	in	in	ADP
fnp-3805	89	6	the	the	DET
fnp-3805	89	7	mlip	mlip	ADJ
fnp-3805	89	8	genetic	genetic	ADJ
fnp-3805	89	9	locus	locus	NOUN
fnp-3805	89	10	[	[	X
fnp-3805	89	11	a	a	DET
fnp-3805	89	12	single	single	ADJ
fnp-3805	89	13	coding	code	VERB
fnp-3805	89	14	missense	missense	NOUN
fnp-3805	89	15	variant	variant	NOUN
fnp-3805	89	16	(	(	PUNCT
fnp-3805	89	17	nm_138569	nm_138569	PROPN
fnp-3805	89	18	,	,	PUNCT
fnp-3805	89	19	c.475g	c.475g	PROPN
fnp-3805	89	20	>	>	X
fnp-3805	89	21	a	a	PRON
fnp-3805	89	22	,	,	PUNCT
fnp-3805	89	23	p.val159ile	p.val159ile	ADJ
fnp-3805	89	24	)	)	PUNCT
fnp-3805	89	25	and	and	CCONJ
fnp-3805	89	26	several	several	ADJ
fnp-3805	89	27	noncoding	noncoding	ADJ
fnp-3805	89	28	variants	variant	NOUN
fnp-3805	89	29	]	]	PUNCT
fnp-3805	89	30	have	have	AUX
fnp-3805	89	31	been	be	AUX
fnp-3805	89	32	shown	show	VERB
fnp-3805	89	33	to	to	PART
fnp-3805	89	34	increase	increase	VERB
fnp-3805	89	35	the	the	DET
fnp-3805	89	36	risk	risk	NOUN
fnp-3805	89	37	of	of	ADP
fnp-3805	89	38	dilated	dilated	ADJ
fnp-3805	89	39	cardiomyopathy	cardiomyopathy	ADJ
fnp-3805	89	40	(	(	PUNCT
fnp-3805	89	41	esslinger	esslinger	NOUN
fnp-3805	89	42	et	et	PROPN
fnp-3805	89	43	al	al	PROPN
fnp-3805	89	44	.	.	PROPN
fnp-3805	89	45	,	,	PUNCT
fnp-3805	89	46	2017	2017	NUM
fnp-3805	89	47	)	)	PUNCT
fnp-3805	89	48	;	;	PUNCT
fnp-3805	89	49	however	however	ADV
fnp-3805	89	50	,	,	PUNCT
fnp-3805	89	51	prior	prior	ADV
fnp-3805	89	52	to	to	ADP
fnp-3805	89	53	studies	study	NOUN
fnp-3805	89	54	by	by	ADP
fnp-3805	89	55	lopes	lopes	PROPN
fnp-3805	89	56	abath	abath	ADP
fnp-3805	89	57	neto	neto	PROPN
fnp-3805	89	58	et	et	PROPN
fnp-3805	89	59	al	al	PROPN
fnp-3805	89	60	.	.	PROPN
fnp-3805	89	61	and	and	CCONJ
fnp-3805	89	62	salzer	salzer	NOUN
fnp-3805	89	63	-	-	PUNCT
fnp-3805	89	64	sheelo	sheelo	NOUN
fnp-3805	89	65	et	et	PROPN
fnp-3805	89	66	al	al	PROPN
fnp-3805	89	67	.	.	PROPN
fnp-3805	89	68	,	,	PUNCT
fnp-3805	89	69	it	it	PRON
fnp-3805	89	70	was	be	AUX
fnp-3805	89	71	not	not	PART
fnp-3805	89	72	known	know	VERB
fnp-3805	89	73	whether	whether	SCONJ
fnp-3805	89	74	mlip	mlip	ADJ
fnp-3805	89	75	mutations	mutation	NOUN
fnp-3805	89	76	can	can	AUX
fnp-3805	89	77	directly	directly	ADV
fnp-3805	89	78	cause	cause	VERB
fnp-3805	89	79	human	human	ADJ
fnp-3805	89	80	disease	disease	NOUN
fnp-3805	89	81	.	.	PUNCT
fnp-3805	90	1	twelve	twelve	NUM
fnp-3805	90	2	affected	affect	VERB
fnp-3805	90	3	individuals	individual	NOUN
fnp-3805	90	4	from	from	ADP
fnp-3805	90	5	8	8	NUM
fnp-3805	90	6	unrelated	unrelated	ADJ
fnp-3805	90	7	families	family	NOUN
fnp-3805	90	8	that	that	PRON
fnp-3805	90	9	are	be	AUX
fnp-3805	90	10	described	describe	VERB
fnp-3805	90	11	in	in	ADP
fnp-3805	90	12	these	these	DET
fnp-3805	90	13	two	two	NUM
fnp-3805	90	14	studies	study	NOUN
fnp-3805	90	15	all	all	PRON
fnp-3805	90	16	carry	carry	VERB
fnp-3805	90	17	either	either	CCONJ
fnp-3805	90	18	homozygous	homozygous	ADJ
fnp-3805	90	19	or	or	CCONJ
fnp-3805	90	20	heterozygous	heterozygous	ADJ
fnp-3805	90	21	biallelic	biallelic	ADJ
fnp-3805	90	22	truncating	truncate	VERB
fnp-3805	90	23	mutations	mutation	NOUN
fnp-3805	90	24	of	of	ADP
fnp-3805	90	25	mlip	mlip	ADJ
fnp-3805	90	26	gene	gene	NOUN
fnp-3805	90	27	,	,	PUNCT
fnp-3805	90	28	with	with	ADP
fnp-3805	90	29	mutation	mutation	NOUN
fnp-3805	90	30	hotspots	hotspot	NOUN
fnp-3805	90	31	in	in	ADP
fnp-3805	90	32	exons	exon	NOUN
fnp-3805	90	33	4	4	NUM
fnp-3805	90	34	and	and	CCONJ
fnp-3805	90	35	exons	exon	NOUN
fnp-3805	90	36	9	9	NUM
fnp-3805	90	37	;	;	PUNCT
fnp-3805	90	38	while	while	SCONJ
fnp-3805	90	39	the	the	DET
fnp-3805	90	40	molecular	molecular	ADJ
fnp-3805	90	41	consequences	consequence	NOUN
fnp-3805	90	42	of	of	ADP
fnp-3805	90	43	these	these	DET
fnp-3805	90	44	mutations	mutation	NOUN
fnp-3805	90	45	still	still	ADV
fnp-3805	90	46	need	need	VERB
fnp-3805	90	47	to	to	PART
fnp-3805	90	48	be	be	AUX
fnp-3805	90	49	fully	fully	ADV
fnp-3805	90	50	elucidated	elucidate	VERB
fnp-3805	90	51	,	,	PUNCT
fnp-3805	90	52	initial	initial	ADJ
fnp-3805	90	53	work	work	NOUN
fnp-3805	90	54	suggests	suggest	VERB
fnp-3805	90	55	that	that	SCONJ
fnp-3805	90	56	they	they	PRON
fnp-3805	90	57	lead	lead	VERB
fnp-3805	90	58	to	to	ADP
fnp-3805	90	59	nonsense	nonsense	NOUN
fnp-3805	90	60	-	-	PUNCT
fnp-3805	90	61	mediated	mediate	VERB
fnp-3805	90	62	mrna	mrna	NOUN
fnp-3805	90	63	decay	decay	NOUN
fnp-3805	90	64	and	and	CCONJ
fnp-3805	90	65	presumed	presume	VERB
fnp-3805	90	66	loss	loss	NOUN
fnp-3805	90	67	of	of	ADP
fnp-3805	90	68	protein	protein	NOUN
fnp-3805	90	69	expression	expression	NOUN
fnp-3805	90	70	[	[	X
fnp-3805	90	71	although	although	SCONJ
fnp-3805	90	72	the	the	DET
fnp-3805	90	73	latter	latter	NOUN
fnp-3805	90	74	is	be	AUX
fnp-3805	90	75	likely	likely	ADV
fnp-3805	90	76	specific	specific	ADJ
fnp-3805	90	77	for	for	ADP
fnp-3805	90	78	individual	individual	ADJ
fnp-3805	90	79	splice	splice	NOUN
fnp-3805	90	80	variants	variant	NOUN
fnp-3805	90	81	and	and	CCONJ
fnp-3805	90	82	has	have	AUX
fnp-3805	90	83	therefore	therefore	ADV
fnp-3805	90	84	been	be	AUX
fnp-3805	90	85	difficult	difficult	ADJ
fnp-3805	90	86	to	to	PART
fnp-3805	90	87	establish	establish	VERB
fnp-3805	90	88	(	(	PUNCT
fnp-3805	90	89	lopes	lope	NOUN
fnp-3805	90	90	abath	abath	ADP
fnp-3805	90	91	neto	neto	PROPN
fnp-3805	90	92	et	et	PROPN
fnp-3805	90	93	al	al	PROPN
fnp-3805	90	94	.	.	PROPN
fnp-3805	90	95	,	,	PUNCT
fnp-3805	90	96	2021	2021	NUM
fnp-3805	90	97	)	)	PUNCT
fnp-3805	90	98	]	]	PUNCT
fnp-3805	90	99	.	.	PUNCT
fnp-3805	91	1	interestingly	interestingly	ADV
fnp-3805	91	2	,	,	PUNCT
fnp-3805	91	3	1	1	NUM
fnp-3805	91	4	of	of	ADP
fnp-3805	91	5	8	8	NUM
fnp-3805	91	6	affected	affected	ADJ
fnp-3805	91	7	children	child	NOUN
fnp-3805	91	8	and	and	CCONJ
fnp-3805	91	9	all	all	DET
fnp-3805	91	10	4	4	NUM
fnp-3805	91	11	affected	affected	ADJ
fnp-3805	91	12	adults	adult	NOUN
fnp-3805	91	13	with	with	ADP
fnp-3805	91	14	biallelic	biallelic	ADJ
fnp-3805	91	15	mlip	mlip	ADJ
fnp-3805	91	16	mutations	mutation	NOUN
fnp-3805	91	17	showed	show	VERB
fnp-3805	91	18	evidence	evidence	NOUN
fnp-3805	91	19	of	of	ADP
fnp-3805	91	20	mild	mild	ADJ
fnp-3805	91	21	cardiac	cardiac	ADJ
fnp-3805	91	22	involvement	involvement	NOUN
fnp-3805	91	23	,	,	PUNCT
fnp-3805	91	24	raising	raise	VERB
fnp-3805	91	25	the	the	DET
fnp-3805	91	26	possibility	possibility	NOUN
fnp-3805	91	27	that	that	SCONJ
fnp-3805	91	28	mlip	mlip	ADJ
fnp-3805	91	29	deficiency	deficiency	NOUN
fnp-3805	91	30	causes	cause	VERB
fnp-3805	91	31	cardiac	cardiac	ADJ
fnp-3805	91	32	abnormalities	abnormality	NOUN
fnp-3805	91	33	in	in	ADP
fnp-3805	91	34	humans	human	NOUN
fnp-3805	91	35	as	as	ADV
fnp-3805	91	36	well	well	ADV
fnp-3805	91	37	as	as	ADP
fnp-3805	91	38	mice	mouse	NOUN
fnp-3805	91	39	;	;	PUNCT
fnp-3805	91	40	this	this	PRON
fnp-3805	91	41	is	be	AUX
fnp-3805	91	42	particularly	particularly	ADV
fnp-3805	91	43	intriguing	intriguing	ADJ
fnp-3805	91	44	given	give	VERB
fnp-3805	91	45	the	the	DET
fnp-3805	91	46	broad	broad	ADJ
fnp-3805	91	47	spectrum	spectrum	NOUN
fnp-3805	91	48	of	of	ADP
fnp-3805	91	49	human	human	ADJ
fnp-3805	91	50	disease	disease	NOUN
fnp-3805	91	51	associated	associate	VERB
fnp-3805	91	52	with	with	ADP
fnp-3805	91	53	lmna	lmna	PROPN
fnp-3805	91	54	mutations	mutation	NOUN
fnp-3805	91	55	,	,	PUNCT
fnp-3805	91	56	which	which	PRON
fnp-3805	91	57	includes	include	VERB
fnp-3805	91	58	cardiomyopathy	cardiomyopathy	ADJ
fnp-3805	91	59	in	in	ADP
fnp-3805	91	60	addition	addition	NOUN
fnp-3805	91	61	to	to	ADP
fnp-3805	91	62	muscular	muscular	ADJ
fnp-3805	91	63	dystrophy	dystrophy	NOUN
fnp-3805	91	64	,	,	PUNCT
fnp-3805	91	65	peripheral	peripheral	ADJ
fnp-3805	91	66	neuropathy	neuropathy	ADJ
fnp-3805	91	67	,	,	PUNCT
fnp-3805	91	68	lipodystrophy	lipodystrophy	NOUN
fnp-3805	91	69	,	,	PUNCT
fnp-3805	91	70	and	and	CCONJ
fnp-3805	91	71	premature	premature	ADJ
fnp-3805	91	72	aging	age	VERB
fnp-3805	91	73	(	(	PUNCT
fnp-3805	91	74	ho	ho	X
fnp-3805	91	75	and	and	CCONJ
fnp-3805	91	76	hegele	hegele	NOUN
fnp-3805	91	77	,	,	PUNCT
fnp-3805	91	78	2019	2019	NUM
fnp-3805	91	79	)	)	PUNCT
fnp-3805	91	80	.	.	PUNCT
fnp-3805	92	1	future	future	ADJ
fnp-3805	92	2	work	work	NOUN
fnp-3805	92	3	will	will	AUX
fnp-3805	92	4	be	be	AUX
fnp-3805	92	5	required	require	VERB
fnp-3805	92	6	to	to	PART
fnp-3805	92	7	fully	fully	ADV
fnp-3805	92	8	define	define	VERB
fnp-3805	92	9	the	the	DET
fnp-3805	92	10	nature	nature	NOUN
fnp-3805	92	11	and	and	CCONJ
fnp-3805	92	12	scope	scope	NOUN
fnp-3805	92	13	of	of	ADP
fnp-3805	92	14	skeletal	skeletal	ADJ
fnp-3805	92	15	and	and	CCONJ
fnp-3805	92	16	cardiac	cardiac	ADJ
fnp-3805	92	17	muscle	muscle	NOUN
fnp-3805	92	18	phenotypes	phenotype	NOUN
fnp-3805	92	19	caused	cause	VERB
fnp-3805	92	20	by	by	ADP
fnp-3805	92	21	mlip	mlip	ADJ
fnp-3805	92	22	deficiency	deficiency	NOUN
fnp-3805	92	23	and	and	CCONJ
fnp-3805	92	24	to	to	PART
fnp-3805	92	25	elucidate	elucidate	VERB
fnp-3805	92	26	whether	whether	SCONJ
fnp-3805	92	27	mlip	mlip	ADJ
fnp-3805	92	28	interaction	interaction	NOUN
fnp-3805	92	29	with	with	ADP
fnp-3805	92	30	lamins	lamin	NOUN
fnp-3805	92	31	a	a	DET
fnp-3805	92	32	/	/	SYM
fnp-3805	92	33	c	c	NOUN
fnp-3805	92	34	plays	play	VERB
fnp-3805	92	35	an	an	DET
fnp-3805	92	36	important	important	ADJ
fnp-3805	92	37	role	role	NOUN
fnp-3805	92	38	in	in	ADP
fnp-3805	92	39	the	the	DET
fnp-3805	92	40	pathogenesis	pathogenesis	NOUN
fnp-3805	92	41	of	of	ADP
fnp-3805	92	42	this	this	DET
fnp-3805	92	43	new	new	ADJ
fnp-3805	92	44	human	human	ADJ
fnp-3805	92	45	disease	disease	NOUN
fnp-3805	92	46	.	.	PUNCT
fnp-3805	93	1	4	4	X
fnp-3805	93	2	.	.	NOUN
fnp-3805	93	3	autosomal	autosomal	ADJ
fnp-3805	93	4	recessive	recessive	ADJ
fnp-3805	93	5	neuromuscular	neuromuscular	ADJ
fnp-3805	93	6	disease	disease	NOUN
fnp-3805	93	7	caused	cause	VERB
fnp-3805	93	8	by	by	ADP
fnp-3805	93	9	mutations	mutation	NOUN
fnp-3805	93	10	in	in	ADP
fnp-3805	93	11	vwa1	vwa1	NOUN
fnp-3805	93	12	(	(	PUNCT
fnp-3805	93	13	von	von	PROPN
fnp-3805	93	14	willebrand	willebrand	PROPN
fnp-3805	93	15	factor	factor	NOUN
fnp-3805	93	16	a	a	DET
fnp-3805	93	17	containing	contain	VERB
fnp-3805	93	18	1	1	NUM
fnp-3805	93	19	protein	protein	NOUN
fnp-3805	93	20	)	)	PUNCT
fnp-3805	93	21	in	in	ADP
fnp-3805	93	22	the	the	DET
fnp-3805	93	23	past	past	NOUN
fnp-3805	93	24	,	,	PUNCT
fnp-3805	93	25	a	a	DET
fnp-3805	93	26	disease	disease	NOUN
fnp-3805	93	27	was	be	AUX
fnp-3805	93	28	typically	typically	ADV
fnp-3805	93	29	defined	define	VERB
fnp-3805	93	30	based	base	VERB
fnp-3805	93	31	on	on	ADP
fnp-3805	93	32	its	its	PRON
fnp-3805	93	33	unique	unique	ADJ
fnp-3805	93	34	clinicopathologic	clinicopathologic	ADJ
fnp-3805	93	35	features	feature	NOUN
fnp-3805	93	36	,	,	PUNCT
fnp-3805	93	37	with	with	SCONJ
fnp-3805	93	38	the	the	DET
fnp-3805	93	39	underlying	underlie	VERB
fnp-3805	93	40	etiology	etiology	NOUN
fnp-3805	93	41	and	and	CCONJ
fnp-3805	93	42	pathogenesis	pathogenesis	NOUN
fnp-3805	93	43	established	establish	VERB
fnp-3805	93	44	later	later	ADV
fnp-3805	93	45	.	.	PUNCT
fnp-3805	94	1	in	in	ADP
fnp-3805	94	2	the	the	DET
fnp-3805	94	3	era	era	NOUN
fnp-3805	94	4	of	of	ADP
fnp-3805	94	5	comprehensive	comprehensive	ADJ
fnp-3805	94	6	genetic	genetic	ADJ
fnp-3805	94	7	testing	testing	NOUN
fnp-3805	94	8	,	,	PUNCT
fnp-3805	94	9	this	this	DET
fnp-3805	94	10	traditional	traditional	ADJ
fnp-3805	94	11	sequence	sequence	NOUN
fnp-3805	94	12	is	be	AUX
fnp-3805	94	13	being	be	AUX
fnp-3805	94	14	inverted	invert	VERB
fnp-3805	94	15	:	:	PUNCT
fnp-3805	94	16	new	new	ADJ
fnp-3805	94	17	genetic	genetic	ADJ
fnp-3805	94	18	diseases	disease	NOUN
fnp-3805	94	19	are	be	AUX
fnp-3805	94	20	identified	identify	VERB
fnp-3805	94	21	and	and	CCONJ
fnp-3805	94	22	defined	define	VERB
fnp-3805	94	23	based	base	VERB
fnp-3805	94	24	on	on	ADP
fnp-3805	94	25	their	their	PRON
fnp-3805	94	26	etiology	etiology	NOUN
fnp-3805	94	27	,	,	PUNCT
fnp-3805	94	28	and	and	CCONJ
fnp-3805	94	29	future	future	ADJ
fnp-3805	94	30	work	work	NOUN
fnp-3805	94	31	is	be	AUX
fnp-3805	94	32	required	require	VERB
fnp-3805	94	33	to	to	PART
fnp-3805	94	34	fully	fully	ADV
fnp-3805	94	35	define	define	VERB
fnp-3805	94	36	their	their	PRON
fnp-3805	94	37	clinicopathologic	clinicopathologic	ADJ
fnp-3805	94	38	features	feature	NOUN
fnp-3805	94	39	.	.	PUNCT
fnp-3805	95	1	as	as	ADP
fnp-3805	95	2	with	with	ADP
fnp-3805	95	3	the	the	DET
fnp-3805	95	4	mlip	mlip	ADV
fnp-3805	95	5	-	-	PUNCT
fnp-3805	95	6	associated	associate	VERB
fnp-3805	95	7	recessive	recessive	ADJ
fnp-3805	95	8	myopathy	myopathy	NOUN
fnp-3805	95	9	described	describe	VERB
fnp-3805	95	10	in	in	ADP
fnp-3805	95	11	discovery	discovery	NOUN
fnp-3805	95	12	#	#	SYM
fnp-3805	95	13	2	2	NUM
fnp-3805	95	14	,	,	PUNCT
fnp-3805	95	15	two	two	NUM
fnp-3805	95	16	different	different	ADJ
fnp-3805	95	17	research	research	NOUN
fnp-3805	95	18	groups	group	NOUN
fnp-3805	95	19	(	(	PUNCT
fnp-3805	95	20	deschauer	deschauer	NOUN
fnp-3805	95	21	et	et	PROPN
fnp-3805	95	22	al	al	PROPN
fnp-3805	95	23	.	.	PROPN
fnp-3805	95	24	,	,	PUNCT
fnp-3805	95	25	2021	2021	NUM
fnp-3805	95	26	;	;	PUNCT
fnp-3805	95	27	pagnamenta	pagnamenta	VERB
fnp-3805	95	28	et	et	PROPN
fnp-3805	95	29	al	al	PROPN
fnp-3805	95	30	.	.	PROPN
fnp-3805	95	31	,	,	PUNCT
fnp-3805	95	32	2021	2021	NUM
fnp-3805	95	33	)	)	PUNCT
fnp-3805	95	34	used	use	VERB
fnp-3805	95	35	a	a	DET
fnp-3805	95	36	genetic	genetic	ADJ
fnp-3805	95	37	approach	approach	NOUN
fnp-3805	95	38	to	to	PART
fnp-3805	95	39	identify	identify	VERB
fnp-3805	95	40	a	a	DET
fnp-3805	95	41	novel	novel	ADJ
fnp-3805	95	42	autosomal	autosomal	ADJ
fnp-3805	95	43	recessive	recessive	ADJ
fnp-3805	95	44	neuromyopathy	neuromyopathy	NOUN
fnp-3805	95	45	caused	cause	VERB
fnp-3805	95	46	by	by	ADP
fnp-3805	95	47	mutations	mutation	NOUN
fnp-3805	95	48	in	in	ADP
fnp-3805	95	49	vwa1	vwa1	NOUN
fnp-3805	95	50	(	(	PUNCT
fnp-3805	95	51	von	von	PROPN
fnp-3805	95	52	willebrand	willebrand	PROPN
fnp-3805	95	53	factor	factor	NOUN
fnp-3805	95	54	a	a	DET
fnp-3805	95	55	containing	contain	VERB
fnp-3805	95	56	1	1	NUM
fnp-3805	95	57	protein	protein	NOUN
fnp-3805	95	58	)	)	PUNCT
fnp-3805	95	59	,	,	PUNCT
fnp-3805	95	60	also	also	ADV
fnp-3805	95	61	known	know	VERB
fnp-3805	95	62	as	as	ADP
fnp-3805	95	63	warp	warp	NOUN
fnp-3805	95	64	(	(	PUNCT
fnp-3805	95	65	von	von	PROPN
fnp-3805	95	66	willebrand	willebrand	NOUN
fnp-3805	95	67	factor	factor	NOUN
fnp-3805	95	68	a	a	DET
fnp-3805	95	69	domain	domain	NOUN
fnp-3805	95	70	-	-	PUNCT
fnp-3805	95	71	related	relate	VERB
fnp-3805	95	72	protein	protein	NOUN
fnp-3805	95	73	)	)	PUNCT
fnp-3805	95	74	.	.	PUNCT
fnp-3805	96	1	deschauer	deschauer	PROPN
fnp-3805	96	2	et	et	PROPN
fnp-3805	96	3	al	al	PROPN
fnp-3805	96	4	.	.	PROPN
fnp-3805	96	5	started	start	VERB
fnp-3805	96	6	their	their	PRON
fnp-3805	96	7	study	study	NOUN
fnp-3805	96	8	in	in	ADP
fnp-3805	96	9	a	a	DET
fnp-3805	96	10	more	more	ADV
fnp-3805	96	11	“	"	PUNCT
fnp-3805	96	12	conventional	conventional	ADJ
fnp-3805	96	13	”	"	PUNCT
fnp-3805	96	14	manner	manner	NOUN
fnp-3805	96	15	,	,	PUNCT
fnp-3805	96	16	by	by	ADP
fnp-3805	96	17	performing	perform	VERB
fnp-3805	96	18	exome	exome	NOUN
fnp-3805	96	19	sequencing	sequencing	NOUN
fnp-3805	96	20	of	of	ADP
fnp-3805	96	21	10	10	NUM
fnp-3805	96	22	individuals	individual	NOUN
fnp-3805	96	23	with	with	ADP
fnp-3805	96	24	presumed	presume	VERB
fnp-3805	96	25	genetic	genetic	ADJ
fnp-3805	96	26	neuromuscular	neuromuscular	ADJ
fnp-3805	96	27	disease	disease	NOUN
fnp-3805	96	28	but	but	CCONJ
fnp-3805	96	29	without	without	ADP
fnp-3805	96	30	genetic	genetic	ADJ
fnp-3805	96	31	diagnosis	diagnosis	NOUN
fnp-3805	96	32	;	;	PUNCT
fnp-3805	96	33	2	2	NUM
fnp-3805	96	34	of	of	ADP
fnp-3805	96	35	these	these	DET
fnp-3805	96	36	10	10	NUM
fnp-3805	96	37	patients	patient	NOUN
fnp-3805	96	38	turned	turn	VERB
fnp-3805	96	39	out	out	ADP
fnp-3805	96	40	to	to	PART
fnp-3805	96	41	carry	carry	VERB
fnp-3805	96	42	biallelic	biallelic	ADJ
fnp-3805	96	43	truncating	truncate	VERB
fnp-3805	96	44	mutations	mutation	NOUN
fnp-3805	96	45	in	in	ADP
fnp-3805	96	46	vwa1	vwa1	NOUN
fnp-3805	96	47	,	,	PUNCT
fnp-3805	96	48	a	a	DET
fnp-3805	96	49	gene	gene	NOUN
fnp-3805	96	50	not	not	PART
fnp-3805	96	51	previously	previously	ADV
fnp-3805	96	52	associated	associate	VERB
fnp-3805	96	53	with	with	ADP
fnp-3805	96	54	human	human	ADJ
fnp-3805	96	55	disease	disease	NOUN
fnp-3805	96	56	but	but	CCONJ
fnp-3805	96	57	with	with	ADP
fnp-3805	96	58	high	high	ADJ
fnp-3805	96	59	expression	expression	NOUN
fnp-3805	96	60	in	in	ADP
fnp-3805	96	61	peripheral	peripheral	ADJ
fnp-3805	96	62	nerve	nerve	NOUN
fnp-3805	96	63	and	and	CCONJ
fnp-3805	96	64	skeletal	skeletal	ADJ
fnp-3805	96	65	muscle	muscle	NOUN
fnp-3805	96	66	tissues	tissue	NOUN
fnp-3805	96	67	.	.	PUNCT
fnp-3805	97	1	follow	follow	VERB
fnp-3805	97	2	-	-	PUNCT
fnp-3805	97	3	up	up	ADP
fnp-3805	97	4	analyses	analysis	NOUN
fnp-3805	97	5	of	of	ADP
fnp-3805	97	6	the	the	DET
fnp-3805	97	7	patients	patient	NOUN
fnp-3805	97	8	’	'	PUNCT
fnp-3805	97	9	families	family	NOUN
fnp-3805	97	10	and	and	CCONJ
fnp-3805	97	11	additional	additional	ADJ
fnp-3805	97	12	“	"	PUNCT
fnp-3805	97	13	unsolved	unsolved	ADJ
fnp-3805	97	14	”	"	PUNCT
fnp-3805	97	15	patient	patient	ADJ
fnp-3805	97	16	cohorts	cohort	NOUN
fnp-3805	97	17	identified	identify	VERB
fnp-3805	97	18	13	13	NUM
fnp-3805	97	19	additional	additional	ADJ
fnp-3805	97	20	individuals	individual	NOUN
fnp-3805	97	21	with	with	ADP
fnp-3805	97	22	biallelic	biallelic	ADJ
fnp-3805	97	23	vwa1	vwa1	NOUN
fnp-3805	97	24	mutations	mutation	NOUN
fnp-3805	97	25	;	;	PUNCT
fnp-3805	97	26	5	5	NUM
fnp-3805	97	27	of	of	ADP
fnp-3805	97	28	6	6	NUM
fnp-3805	97	29	identified	identify	VERB
fnp-3805	97	30	mutations	mutation	NOUN
fnp-3805	97	31	are	be	AUX
fnp-3805	97	32	predicted	predict	VERB
fnp-3805	97	33	to	to	PART
fnp-3805	97	34	result	result	VERB
fnp-3805	97	35	in	in	ADP
fnp-3805	97	36	protein	protein	NOUN
fnp-3805	97	37	truncation	truncation	NOUN
fnp-3805	97	38	,	,	PUNCT
fnp-3805	97	39	and	and	CCONJ
fnp-3805	97	40	all	all	DET
fnp-3805	97	41	6	6	NUM
fnp-3805	97	42	are	be	AUX
fnp-3805	97	43	predicted	predict	VERB
fnp-3805	97	44	to	to	PART
fnp-3805	97	45	result	result	VERB
fnp-3805	97	46	in	in	ADP
fnp-3805	97	47	a	a	DET
fnp-3805	97	48	loss	loss	NOUN
fnp-3805	97	49	of	of	ADP
fnp-3805	97	50	protein	protein	NOUN
fnp-3805	97	51	function	function	NOUN
fnp-3805	97	52	.	.	PUNCT
fnp-3805	98	1	pagnamanta	pagnamanta	PROPN
fnp-3805	98	2	et	et	PROPN
fnp-3805	98	3	al	al	PROPN
fnp-3805	98	4	.	.	PROPN
fnp-3805	98	5	used	use	VERB
fnp-3805	98	6	a	a	DET
fnp-3805	98	7	slightly	slightly	ADV
fnp-3805	98	8	different	different	ADJ
fnp-3805	98	9	approach	approach	NOUN
fnp-3805	98	10	:	:	PUNCT
fnp-3805	98	11	they	they	PRON
fnp-3805	98	12	identified	identify	VERB
fnp-3805	98	13	vwa1	vwa1	NOUN
fnp-3805	98	14	as	as	ADP
fnp-3805	98	15	a	a	DET
fnp-3805	98	16	potentially	potentially	ADV
fnp-3805	98	17	interesting	interesting	ADJ
fnp-3805	98	18	gene	gene	NOUN
fnp-3805	98	19	based	base	VERB
fnp-3805	98	20	on	on	ADP
fnp-3805	98	21	its	its	PRON
fnp-3805	98	22	high	high	ADJ
fnp-3805	98	23	expression	expression	NOUN
fnp-3805	98	24	in	in	ADP
fnp-3805	98	25	the	the	DET
fnp-3805	98	26	pns	pns	NOUN
fnp-3805	98	27	and	and	CCONJ
fnp-3805	98	28	searched	search	VERB
fnp-3805	98	29	the	the	DET
fnp-3805	98	30	data	datum	NOUN
fnp-3805	98	31	from	from	ADP
fnp-3805	98	32	the	the	DET
fnp-3805	98	33	100k	100k	NUM
fnp-3805	98	34	genome	genome	NOUN
fnp-3805	98	35	project	project	NOUN
fnp-3805	98	36	(	(	PUNCT
fnp-3805	98	37	turnbull	turnbull	PROPN
fnp-3805	98	38	et	et	PROPN
fnp-3805	98	39	al	al	PROPN
fnp-3805	98	40	.	.	PROPN
fnp-3805	98	41	,	,	PUNCT
fnp-3805	98	42	2018	2018	NUM
fnp-3805	98	43	)	)	PUNCT
fnp-3805	98	44	for	for	ADP
fnp-3805	98	45	individuals	individual	NOUN
fnp-3805	98	46	carrying	carry	VERB
fnp-3805	98	47	biallelic	biallelic	ADJ
fnp-3805	98	48	vwa1	vwa1	NOUN
fnp-3805	98	49	variants	variant	NOUN
fnp-3805	98	50	.	.	PUNCT
fnp-3805	99	1	this	this	DET
fnp-3805	99	2	analysis	analysis	NOUN
fnp-3805	99	3	ultimately	ultimately	ADV
fnp-3805	99	4	yielded	yield	VERB
fnp-3805	99	5	10	10	NUM
fnp-3805	99	6	unrelated	unrelated	ADJ
fnp-3805	99	7	patients	patient	NOUN
fnp-3805	99	8	that	that	PRON
fnp-3805	99	9	fit	fit	VERB
fnp-3805	99	10	the	the	DET
fnp-3805	99	11	inclusion	inclusion	NOUN
fnp-3805	99	12	criteria	criterion	NOUN
fnp-3805	99	13	,	,	PUNCT
fnp-3805	99	14	with	with	ADP
fnp-3805	99	15	7	7	NUM
fnp-3805	99	16	additional	additional	ADJ
fnp-3805	99	17	individuals	individual	NOUN
fnp-3805	99	18	identified	identify	VERB
fnp-3805	99	19	through	through	ADP
fnp-3805	99	20	follow	follow	NOUN
fnp-3805	99	21	-	-	PUNCT
fnp-3805	99	22	up	up	ADP
fnp-3805	99	23	studies	study	NOUN
fnp-3805	99	24	of	of	ADP
fnp-3805	99	25	other	other	ADJ
fnp-3805	99	26	patient	patient	ADJ
fnp-3805	99	27	cohorts	cohort	NOUN
fnp-3805	99	28	.	.	PUNCT
fnp-3805	100	1	interestingly	interestingly	ADV
fnp-3805	100	2	,	,	PUNCT
fnp-3805	100	3	15	15	NUM
fnp-3805	100	4	of	of	ADP
fnp-3805	100	5	these	these	DET
fnp-3805	100	6	17	17	NUM
fnp-3805	100	7	patients	patient	NOUN
fnp-3805	100	8	(	(	PUNCT
fnp-3805	100	9	from	from	ADP
fnp-3805	100	10	14	14	NUM
fnp-3805	100	11	of	of	ADP
fnp-3805	100	12	15	15	NUM
fnp-3805	100	13	separate	separate	ADJ
fnp-3805	100	14	families	family	NOUN
fnp-3805	100	15	)	)	PUNCT
fnp-3805	100	16	carry	carry	VERB
fnp-3805	100	17	the	the	DET
fnp-3805	100	18	same	same	ADJ
fnp-3805	100	19	truncating	truncate	VERB
fnp-3805	100	20	vwa1	vwa1	NOUN
fnp-3805	100	21	mutation	mutation	NOUN
fnp-3805	100	22	(	(	PUNCT
fnp-3805	100	23	10	10	NUM
fnp-3805	100	24	-	-	PUNCT
fnp-3805	100	25	bp	bp	NOUN
fnp-3805	100	26	insertion	insertion	NOUN
fnp-3805	100	27	,	,	PUNCT
fnp-3805	100	28	nm_022834	nm_022834	NOUN
fnp-3805	100	29	,	,	PUNCT
fnp-3805	100	30	c.62_71dup	c.62_71dup	NOUN
fnp-3805	100	31	;	;	PUNCT
fnp-3805	100	32	pgly25argfster74	pgly25argfster74	NOUN
fnp-3805	100	33	)	)	PUNCT
fnp-3805	100	34	in	in	ADP
fnp-3805	100	35	either	either	CCONJ
fnp-3805	100	36	homozygous	homozygous	ADJ
fnp-3805	100	37	or	or	CCONJ
fnp-3805	100	38	heterozygous	heterozygous	ADJ
fnp-3805	100	39	state	state	NOUN
fnp-3805	100	40	;	;	PUNCT
fnp-3805	100	41	this	this	DET
fnp-3805	100	42	mutation	mutation	NOUN
fnp-3805	100	43	was	be	AUX
fnp-3805	100	44	also	also	ADV
fnp-3805	100	45	identified	identify	VERB
fnp-3805	100	46	in	in	ADP
fnp-3805	100	47	3	3	NUM
fnp-3805	100	48	of	of	ADP
fnp-3805	100	49	6	6	NUM
fnp-3805	100	50	families	family	NOUN
fnp-3805	100	51	described	describe	VERB
fnp-3805	100	52	by	by	ADP
fnp-3805	100	53	deschauer	deschauer	NOUN
fnp-3805	100	54	et	et	PROPN
fnp-3805	100	55	al	al	PROPN
fnp-3805	100	56	.	.	PROPN
fnp-3805	100	57	,	,	PUNCT
fnp-3805	100	58	and	and	CCONJ
fnp-3805	100	59	is	be	AUX
fnp-3805	100	60	estimated	estimate	VERB
fnp-3805	100	61	by	by	ADP
fnp-3805	100	62	pagnamanta	pagnamanta	PROPN
fnp-3805	100	63	et	et	PROPN
fnp-3805	100	64	al	al	PROPN
fnp-3805	100	65	.	.	PUNCT
fnp-3805	101	1	to	to	PART
fnp-3805	101	2	have	have	AUX
fnp-3805	101	3	arisen	arise	VERB
fnp-3805	101	4	in	in	ADP
fnp-3805	101	5	europe	europe	PROPN
fnp-3805	101	6	~8000	~8000	NUM
fnp-3805	101	7	years	year	NOUN
fnp-3805	101	8	ago	ago	ADV
fnp-3805	101	9	.	.	PUNCT
fnp-3805	102	1	interestingly	interestingly	ADV
fnp-3805	102	2	,	,	PUNCT
fnp-3805	102	3	the	the	DET
fnp-3805	102	4	same	same	ADJ
fnp-3805	102	5	10	10	NUM
fnp-3805	102	6	-	-	PUNCT
fnp-3805	102	7	bp	bp	PROPN
fnp-3805	102	8	tandem	tandem	PROPN
fnp-3805	102	9	repeat	repeat	NOUN
fnp-3805	102	10	is	be	AUX
fnp-3805	102	11	deleted	delete	VERB
fnp-3805	102	12	(	(	PUNCT
fnp-3805	102	13	rather	rather	ADV
fnp-3805	102	14	than	than	ADP
fnp-3805	102	15	duplicated	duplicate	VERB
fnp-3805	102	16	)	)	PUNCT
fnp-3805	102	17	in	in	ADP
fnp-3805	102	18	other	other	ADJ
fnp-3805	102	19	affected	affect	VERB
fnp-3805	102	20	individuals	individual	NOUN
fnp-3805	102	21	,	,	PUNCT
fnp-3805	102	22	suggesting	suggest	VERB
fnp-3805	102	23	that	that	SCONJ
fnp-3805	102	24	it	it	PRON
fnp-3805	102	25	is	be	AUX
fnp-3805	102	26	prone	prone	ADJ
fnp-3805	102	27	to	to	ADP
fnp-3805	102	28	de	de	X
fnp-3805	102	29	novo	novo	NOUN
fnp-3805	102	30	alterations	alteration	NOUN
fnp-3805	102	31	.	.	PUNCT
fnp-3805	103	1	what	what	PRON
fnp-3805	103	2	is	be	AUX
fnp-3805	103	3	the	the	DET
fnp-3805	103	4	clinicopathologic	clinicopathologic	ADJ
fnp-3805	103	5	phenotype	phenotype	NOUN
fnp-3805	103	6	of	of	ADP
fnp-3805	103	7	the	the	DET
fnp-3805	103	8	vwa1	vwa1	NOUN
fnp-3805	103	9	-	-	PUNCT
fnp-3805	103	10	associated	associate	VERB
fnp-3805	103	11	neuromuscular	neuromuscular	ADJ
fnp-3805	103	12	disease	disease	NOUN
fnp-3805	103	13	?	?	PUNCT
fnp-3805	104	1	the	the	DET
fnp-3805	104	2	affected	affect	VERB
fnp-3805	104	3	individuals	individual	NOUN
fnp-3805	104	4	typically	typically	ADV
fnp-3805	104	5	develop	develop	VERB
fnp-3805	104	6	slowly	slowly	ADV
fnp-3805	104	7	progressive	progressive	ADJ
fnp-3805	104	8	non	non	ADJ
fnp-3805	104	9	-	-	ADJ
fnp-3805	104	10	length	length	ADJ
fnp-3805	104	11	dependent	dependent	ADJ
fnp-3805	104	12	axonal	axonal	ADJ
fnp-3805	104	13	motor	motor	NOUN
fnp-3805	104	14	neuropathy	neuropathy	ADJ
fnp-3805	104	15	that	that	SCONJ
fnp-3805	104	16	presents	present	VERB
fnp-3805	104	17	with	with	ADP
fnp-3805	104	18	distal	distal	ADJ
fnp-3805	104	19	weakness	weakness	NOUN
fnp-3805	104	20	and	and	CCONJ
fnp-3805	104	21	foot	foot	NOUN
fnp-3805	104	22	deformities	deformity	NOUN
fnp-3805	104	23	,	,	PUNCT
fnp-3805	104	24	often	often	ADV
fnp-3805	104	25	in	in	ADP
fnp-3805	104	26	early	early	ADJ
fnp-3805	104	27	childhood	childhood	NOUN
fnp-3805	104	28	;	;	PUNCT
fnp-3805	104	29	however	however	ADV
fnp-3805	104	30	,	,	PUNCT
fnp-3805	104	31	proximal	proximal	ADJ
fnp-3805	104	32	weakness	weakness	NOUN
fnp-3805	104	33	with	with	ADP
fnp-3805	104	34	scapular	scapular	ADJ
fnp-3805	104	35	winging	wing	VERB
fnp-3805	104	36	and	and	CCONJ
fnp-3805	104	37	mildly	mildly	ADV
fnp-3805	104	38	elevated	elevated	ADJ
fnp-3805	104	39	ck	ck	ADJ
fnp-3805	104	40	level	level	NOUN
fnp-3805	104	41	is	be	AUX
fnp-3805	104	42	sometimes	sometimes	ADV
fnp-3805	104	43	also	also	ADV
fnp-3805	104	44	present	present	ADJ
fnp-3805	104	45	,	,	PUNCT
fnp-3805	104	46	and	and	CCONJ
fnp-3805	104	47	it	it	PRON
fnp-3805	104	48	is	be	AUX
fnp-3805	104	49	not	not	PART
fnp-3805	104	50	entirely	entirely	ADV
fnp-3805	104	51	clear	clear	ADJ
fnp-3805	104	52	whether	whether	SCONJ
fnp-3805	104	53	this	this	DET
fnp-3805	104	54	myopathic	myopathic	ADJ
fnp-3805	104	55	involvement	involvement	NOUN
fnp-3805	104	56	represents	represent	VERB
fnp-3805	104	57	a	a	DET
fnp-3805	104	58	separate	separate	ADJ
fnp-3805	104	59	phenotype	phenotype	NOUN
fnp-3805	104	60	of	of	ADP
fnp-3805	104	61	vwa1	vwa1	NOUN
fnp-3805	104	62	deficiency	deficiency	NOUN
fnp-3805	104	63	,	,	PUNCT
fnp-3805	104	64	or	or	CCONJ
fnp-3805	104	65	whether	whether	SCONJ
fnp-3805	104	66	myopathic	myopathic	ADJ
fnp-3805	104	67	changes	change	NOUN
fnp-3805	104	68	are	be	AUX
fnp-3805	104	69	secondary	secondary	ADJ
fnp-3805	104	70	to	to	ADP
fnp-3805	104	71	the	the	DET
fnp-3805	104	72	primary	primary	ADJ
fnp-3805	104	73	neuropathic	neuropathic	ADJ
fnp-3805	104	74	process	process	NOUN
fnp-3805	104	75	.	.	PUNCT
fnp-3805	105	1	muscle	muscle	NOUN
fnp-3805	105	2	biopsies	biopsy	NOUN
fnp-3805	105	3	were	be	AUX
fnp-3805	105	4	evaluated	evaluate	VERB
fnp-3805	105	5	for	for	ADP
fnp-3805	105	6	a	a	DET
fnp-3805	105	7	subset	subset	NOUN
fnp-3805	105	8	of	of	ADP
fnp-3805	105	9	cases	case	NOUN
fnp-3805	105	10	(	(	PUNCT
fnp-3805	105	11	7	7	NUM
fnp-3805	105	12	of	of	ADP
fnp-3805	105	13	32	32	NUM
fnp-3805	105	14	patients	patient	NOUN
fnp-3805	105	15	across	across	ADP
fnp-3805	105	16	both	both	DET
fnp-3805	105	17	studies	study	NOUN
fnp-3805	105	18	had	have	AUX
fnp-3805	105	19	biopsies	biopsy	NOUN
fnp-3805	105	20	that	that	PRON
fnp-3805	105	21	were	be	AUX
fnp-3805	105	22	available	available	ADJ
fnp-3805	105	23	for	for	ADP
fnp-3805	105	24	review	review	NOUN
fnp-3805	105	25	)	)	PUNCT
fnp-3805	105	26	,	,	PUNCT
fnp-3805	105	27	showing	show	VERB
fnp-3805	105	28	a	a	DET
fnp-3805	105	29	similarly	similarly	ADV
fnp-3805	105	30	complex	complex	ADJ
fnp-3805	105	31	picture	picture	NOUN
fnp-3805	105	32	:	:	PUNCT
fnp-3805	105	33	well	well	ADV
fnp-3805	105	34	-	-	PUNCT
fnp-3805	105	35	developed	develop	VERB
fnp-3805	105	36	chronic	chronic	ADJ
fnp-3805	105	37	neurogenic	neurogenic	ADJ
fnp-3805	105	38	changes	change	NOUN
fnp-3805	105	39	were	be	AUX
fnp-3805	105	40	accompanied	accompany	VERB
fnp-3805	105	41	by	by	ADP
fnp-3805	105	42	some	some	DET
fnp-3805	105	43	myopathic	myopathic	ADJ
fnp-3805	105	44	features	feature	NOUN
fnp-3805	105	45	(	(	PUNCT
fnp-3805	105	46	including	include	VERB
fnp-3805	105	47	fiber	fiber	NOUN
fnp-3805	105	48	size	size	NOUN
fnp-3805	105	49	variation	variation	NOUN
fnp-3805	105	50	,	,	PUNCT
fnp-3805	105	51	internal	internal	ADJ
fnp-3805	105	52	nucleation	nucleation	NOUN
fnp-3805	105	53	,	,	PUNCT
fnp-3805	105	54	endomysial	endomysial	ADJ
fnp-3805	105	55	fibrosis	fibrosis	NOUN
fnp-3805	105	56	,	,	PUNCT
fnp-3805	105	57	fiber	fiber	NOUN
fnp-3805	105	58	lobulation	lobulation	NOUN
fnp-3805	105	59	and/or	and/or	CCONJ
fnp-3805	105	60	whirling	whirl	VERB
fnp-3805	105	61	,	,	PUNCT
fnp-3805	105	62	and	and	CCONJ
fnp-3805	105	63	mitochondrial	mitochondrial	ADJ
fnp-3805	105	64	alterations	alteration	NOUN
fnp-3805	105	65	)	)	PUNCT
fnp-3805	105	66	but	but	CCONJ
fnp-3805	105	67	no	no	DET
fnp-3805	105	68	basement	basement	NOUN
fnp-3805	105	69	membrane	membrane	NOUN
fnp-3805	105	70	abnormalities	abnormality	NOUN
fnp-3805	105	71	.	.	PUNCT
fnp-3805	106	1	vwa1	vwa1	NOUN
fnp-3805	106	2	is	be	AUX
fnp-3805	106	3	a	a	DET
fnp-3805	106	4	445	445	NUM
fnp-3805	106	5	aa	aa	ADJ
fnp-3805	106	6	extracellular	extracellular	ADJ
fnp-3805	106	7	matrix	matrix	NOUN
fnp-3805	106	8	protein	protein	NOUN
fnp-3805	106	9	that	that	PRON
fnp-3805	106	10	contains	contain	VERB
fnp-3805	106	11	the	the	DET
fnp-3805	106	12	n	n	CCONJ
fnp-3805	106	13	-	-	PUNCT
fnp-3805	106	14	terminal	terminal	ADJ
fnp-3805	106	15	von	von	PROPN
fnp-3805	106	16	willebrand	willebrand	PROPN
fnp-3805	106	17	factor	factor	NOUN
fnp-3805	106	18	a	a	DET
fnp-3805	106	19	domain	domain	NOUN
fnp-3805	106	20	followed	follow	VERB
fnp-3805	106	21	by	by	ADP
fnp-3805	106	22	two	two	NUM
fnp-3805	106	23	fibronectin	fibronectin	NOUN
fnp-3805	106	24	type	type	NOUN
fnp-3805	106	25	iii	iii	NUM
fnp-3805	106	26	repeats	repeat	NOUN
fnp-3805	106	27	;	;	PUNCT
fnp-3805	106	28	it	it	PRON
fnp-3805	106	29	is	be	AUX
fnp-3805	106	30	expressed	express	VERB
fnp-3805	106	31	in	in	ADP
fnp-3805	106	32	the	the	DET
fnp-3805	106	33	cartilage	cartilage	NOUN
fnp-3805	106	34	and	and	CCONJ
fnp-3805	106	35	in	in	ADP
fnp-3805	106	36	the	the	DET
fnp-3805	106	37	basement	basement	NOUN
fnp-3805	106	38	membranes	membrane	NOUN
fnp-3805	106	39	of	of	ADP
fnp-3805	106	40	peripheral	peripheral	ADJ
fnp-3805	106	41	nerves	nerve	NOUN
fnp-3805	106	42	(	(	PUNCT
fnp-3805	106	43	endoneurium	endoneurium	NOUN
fnp-3805	106	44	)	)	PUNCT
fnp-3805	106	45	,	,	PUNCT
fnp-3805	106	46	skeletal	skeletal	ADJ
fnp-3805	106	47	muscle	muscle	NOUN
fnp-3805	106	48	(	(	PUNCT
fnp-3805	106	49	endomysium	endomysium	NOUN
fnp-3805	106	50	)	)	PUNCT
fnp-3805	106	51	,	,	PUNCT
fnp-3805	106	52	and	and	CCONJ
fnp-3805	106	53	the	the	DET
fnp-3805	106	54	cns	cns	NOUN
fnp-3805	106	55	vasculature	vasculature	NOUN
fnp-3805	106	56	,	,	PUNCT
fnp-3805	106	57	where	where	SCONJ
fnp-3805	106	58	it	it	PRON
fnp-3805	106	59	interacts	interact	VERB
fnp-3805	106	60	with	with	ADP
fnp-3805	106	61	collagen	collagen	NOUN
fnp-3805	106	62	vi	vi	NOUN
fnp-3805	106	63	and	and	CCONJ
fnp-3805	106	64	perlecan	perlecan	PROPN
fnp-3805	106	65	(	(	PUNCT
fnp-3805	106	66	two	two	NUM
fnp-3805	106	67	proteins	protein	NOUN
fnp-3805	106	68	that	that	PRON
fnp-3805	106	69	are	be	AUX
fnp-3805	106	70	also	also	ADV
fnp-3805	106	71	associated	associate	VERB
fnp-3805	106	72	with	with	ADP
fnp-3805	106	73	genetic	genetic	ADJ
fnp-3805	106	74	nmd	nmd	NOUN
fnp-3805	106	75	)	)	PUNCT
fnp-3805	106	76	(	(	PUNCT
fnp-3805	106	77	allen	allen	PROPN
fnp-3805	106	78	et	et	PROPN
fnp-3805	106	79	al	al	PROPN
fnp-3805	106	80	.	.	PROPN
fnp-3805	106	81	,	,	PUNCT
fnp-3805	106	82	2009	2009	NUM
fnp-3805	106	83	)	)	PUNCT
fnp-3805	106	84	.	.	PUNCT
fnp-3805	107	1	vwa1	vwa1	NOUN
fnp-3805	107	2	-	-	PUNCT
fnp-3805	107	3	null	null	NOUN
fnp-3805	107	4	mice	mouse	NOUN
fnp-3805	107	5	show	show	VERB
fnp-3805	107	6	a	a	DET
fnp-3805	107	7	delayed	delay	VERB
fnp-3805	107	8	response	response	NOUN
fnp-3805	107	9	to	to	ADP
fnp-3805	107	10	painful	painful	ADJ
fnp-3805	107	11	stimuli	stimulus	NOUN
fnp-3805	107	12	and	and	CCONJ
fnp-3805	107	13	impairment	impairment	NOUN
fnp-3805	107	14	of	of	ADP
fnp-3805	107	15	fine	fine	ADJ
fnp-3805	107	16	motor	motor	NOUN
fnp-3805	107	17	coordination	coordination	NOUN
fnp-3805	107	18	;	;	PUNCT
fnp-3805	107	19	histologically	histologically	ADV
fnp-3805	107	20	,	,	PUNCT
fnp-3805	107	21	their	their	PRON
fnp-3805	107	22	peripheral	peripheral	ADJ
fnp-3805	107	23	nerves	nerve	NOUN
fnp-3805	107	24	show	show	VERB
fnp-3805	107	25	aberrant	aberrant	ADJ
fnp-3805	107	26	fusion	fusion	NOUN
fnp-3805	107	27	of	of	ADP
fnp-3805	107	28	schwann	schwann	PROPN
fnp-3805	107	29	cell	cell	NOUN
fnp-3805	107	30	basement	basement	NOUN
fnp-3805	107	31	membranes	membrane	NOUN
fnp-3805	107	32	,	,	PUNCT
fnp-3805	107	33	while	while	SCONJ
fnp-3805	107	34	their	their	PRON
fnp-3805	107	35	skeletal	skeletal	ADJ
fnp-3805	107	36	muscles	muscle	NOUN
fnp-3805	107	37	and	and	CCONJ
fnp-3805	107	38	other	other	ADJ
fnp-3805	107	39	vwa1	vwa1	NOUN
fnp-3805	107	40	-	-	PUNCT
fnp-3805	107	41	expressing	express	VERB
fnp-3805	107	42	tissues	tissue	NOUN
fnp-3805	107	43	show	show	VERB
fnp-3805	107	44	no	no	DET
fnp-3805	107	45	obvious	obvious	ADJ
fnp-3805	107	46	abnormalities	abnormality	NOUN
fnp-3805	107	47	(	(	PUNCT
fnp-3805	107	48	allen	allen	PROPN
fnp-3805	107	49	et	et	PROPN
fnp-3805	107	50	al	al	PROPN
fnp-3805	107	51	.	.	PROPN
fnp-3805	107	52	,	,	PUNCT
fnp-3805	107	53	2009	2009	NUM
fnp-3805	107	54	)	)	PUNCT
fnp-3805	107	55	.	.	PUNCT
fnp-3805	108	1	knockdown	knockdown	NOUN
fnp-3805	108	2	of	of	ADP
fnp-3805	108	3	zebrafish	zebrafish	ADJ
fnp-3805	108	4	vwa1	vwa1	NOUN
fnp-3805	108	5	gene	gene	NOUN
fnp-3805	108	6	(	(	PUNCT
fnp-3805	108	7	zebrafish	zebrafish	ADJ
fnp-3805	108	8	vwa1	vwa1	NOUN
fnp-3805	108	9	analogue	analogue	NOUN
fnp-3805	108	10	)	)	PUNCT
fnp-3805	108	11	leads	lead	VERB
fnp-3805	108	12	to	to	ADP
fnp-3805	108	13	dose	dose	NOUN
fnp-3805	108	14	-	-	PUNCT
fnp-3805	108	15	dependent	dependent	ADJ
fnp-3805	108	16	abnormalities	abnormality	NOUN
fnp-3805	108	17	of	of	ADP
fnp-3805	108	18	motor	motor	PROPN
fnp-3805	108	19	neuron	neuron	PROPN
fnp-3805	108	20	development	development	PROPN
fnp-3805	108	21	,	,	PUNCT
fnp-3805	108	22	with	with	ADP
fnp-3805	108	23	reduced	reduced	ADJ
fnp-3805	108	24	axon	axon	NOUN
fnp-3805	108	25	branching	branch	VERB
fnp-3805	108	26	of	of	ADP
fnp-3805	108	27	primary	primary	ADJ
fnp-3805	108	28	motor	motor	NOUN
fnp-3805	108	29	neurons	neuron	NOUN
fnp-3805	108	30	,	,	PUNCT
fnp-3805	108	31	axon	axon	NOUN
fnp-3805	108	32	truncation	truncation	NOUN
fnp-3805	108	33	of	of	ADP
fnp-3805	108	34	secondary	secondary	ADJ
fnp-3805	108	35	motor	motor	NOUN
fnp-3805	108	36	neurons	neuron	NOUN
fnp-3805	108	37	,	,	PUNCT
fnp-3805	108	38	and	and	CCONJ
fnp-3805	108	39	reduced	reduced	ADJ
fnp-3805	108	40	number	number	NOUN
fnp-3805	108	41	of	of	ADP
fnp-3805	108	42	neuromuscular	neuromuscular	ADJ
fnp-3805	108	43	junctions	junction	NOUN
fnp-3805	108	44	,	,	PUNCT
fnp-3805	108	45	as	as	ADV
fnp-3805	108	46	well	well	ADV
fnp-3805	108	47	as	as	ADP
fnp-3805	108	48	some	some	DET
fnp-3805	108	49	muscle	muscle	NOUN
fnp-3805	108	50	fiber	fiber	NOUN
fnp-3805	108	51	disorganization	disorganization	NOUN
fnp-3805	108	52	(	(	PUNCT
fnp-3805	108	53	pagnamenta	pagnamenta	NOUN
fnp-3805	108	54	et	et	PROPN
fnp-3805	108	55	al	al	PROPN
fnp-3805	108	56	.	.	PROPN
fnp-3805	108	57	,	,	PUNCT
fnp-3805	108	58	2021	2021	NUM
fnp-3805	108	59	)	)	PUNCT
fnp-3805	108	60	.	.	PUNCT
fnp-3805	109	1	taking	take	VERB
fnp-3805	109	2	together	together	ADV
fnp-3805	109	3	the	the	DET
fnp-3805	109	4	human	human	ADJ
fnp-3805	109	5	and	and	CCONJ
fnp-3805	109	6	animal	animal	NOUN
fnp-3805	109	7	model	model	NOUN
fnp-3805	109	8	data	datum	NOUN
fnp-3805	109	9	,	,	PUNCT
fnp-3805	109	10	it	it	PRON
fnp-3805	109	11	is	be	AUX
fnp-3805	109	12	clear	clear	ADJ
fnp-3805	109	13	that	that	SCONJ
fnp-3805	109	14	vwa1	vwa1	NOUN
fnp-3805	109	15	-	-	PUNCT
fnp-3805	109	16	deficiency	deficiency	NOUN
fnp-3805	109	17	affects	affect	VERB
fnp-3805	109	18	motor	motor	PROPN
fnp-3805	109	19	neuron	neuron	PROPN
fnp-3805	109	20	axons	axon	NOUN
fnp-3805	109	21	and	and	CCONJ
fnp-3805	109	22	leads	lead	VERB
fnp-3805	109	23	to	to	ADP
fnp-3805	109	24	neuropathic	neuropathic	ADJ
fnp-3805	109	25	changes	change	NOUN
fnp-3805	109	26	in	in	ADP
fnp-3805	109	27	the	the	DET
fnp-3805	109	28	affected	affected	ADJ
fnp-3805	109	29	musculature	musculature	NOUN
fnp-3805	109	30	;	;	PUNCT
fnp-3805	109	31	however	however	ADV
fnp-3805	109	32	,	,	PUNCT
fnp-3805	109	33	it	it	PRON
fnp-3805	109	34	remains	remain	VERB
fnp-3805	109	35	to	to	PART
fnp-3805	109	36	be	be	AUX
fnp-3805	109	37	established	establish	VERB
fnp-3805	109	38	whether	whether	SCONJ
fnp-3805	109	39	these	these	DET
fnp-3805	109	40	abnormalities	abnormality	NOUN
fnp-3805	109	41	represent	represent	VERB
fnp-3805	109	42	a	a	DET
fnp-3805	109	43	developmental	developmental	ADJ
fnp-3805	109	44	or	or	CCONJ
fnp-3805	109	45	degenerative	degenerative	ADJ
fnp-3805	109	46	disease	disease	NOUN
fnp-3805	109	47	,	,	PUNCT
fnp-3805	109	48	and	and	CCONJ
fnp-3805	109	49	whether	whether	SCONJ
fnp-3805	109	50	there	there	PRON
fnp-3805	109	51	is	be	VERB
fnp-3805	109	52	a	a	DET
fnp-3805	109	53	separate	separate	ADJ
fnp-3805	109	54	but	but	CCONJ
fnp-3805	109	55	concurrent	concurrent	ADJ
fnp-3805	109	56	myopathic	myopathic	ADJ
fnp-3805	109	57	phenotype	phenotype	NOUN
fnp-3805	109	58	.	.	PUNCT
fnp-3805	110	1	in	in	ADP
fnp-3805	110	2	addition	addition	NOUN
fnp-3805	110	3	,	,	PUNCT
fnp-3805	110	4	it	it	PRON
fnp-3805	110	5	needs	need	VERB
fnp-3805	110	6	to	to	PART
fnp-3805	110	7	be	be	AUX
fnp-3805	110	8	elucidated	elucidate	VERB
fnp-3805	110	9	how	how	SCONJ
fnp-3805	110	10	the	the	DET
fnp-3805	110	11	subtle	subtle	ADJ
fnp-3805	110	12	basement	basement	NOUN
fnp-3805	110	13	membrane	membrane	NOUN
fnp-3805	110	14	abnormalities	abnormality	NOUN
fnp-3805	110	15	lead	lead	VERB
fnp-3805	110	16	to	to	ADP
fnp-3805	110	17	these	these	DET
fnp-3805	110	18	neuromuscular	neuromuscular	ADJ
fnp-3805	110	19	phenotypes	phenotype	NOUN
fnp-3805	110	20	.	.	PUNCT
fnp-3805	111	1	advances	advance	NOUN
fnp-3805	111	2	in	in	ADP
fnp-3805	111	3	understanding	understanding	NOUN
fnp-3805	111	4	of	of	ADP
fnp-3805	111	5	etiology	etiology	NOUN
fnp-3805	111	6	and	and	CCONJ
fnp-3805	111	7	pathogenesis	pathogenesis	NOUN
fnp-3805	111	8	of	of	ADP
fnp-3805	111	9	neuromuscular	neuromuscular	ADJ
fnp-3805	111	10	diseases	disease	NOUN
fnp-3805	111	11	5	5	NUM
fnp-3805	111	12	.	.	PUNCT
fnp-3805	111	13	impaired	impair	VERB
fnp-3805	111	14	repair	repair	NOUN
fnp-3805	111	15	of	of	ADP
fnp-3805	111	16	mitochondrial	mitochondrial	ADJ
fnp-3805	111	17	respiratory	respiratory	ADJ
fnp-3805	111	18	chain	chain	NOUN
fnp-3805	111	19	complex	complex	NOUN
fnp-3805	111	20	1	1	NUM
fnp-3805	111	21	causes	cause	VERB
fnp-3805	111	22	autosomal	autosomal	ADJ
fnp-3805	111	23	recessive	recessive	ADJ
fnp-3805	111	24	variant	variant	NOUN
fnp-3805	111	25	of	of	ADP
fnp-3805	111	26	leber	leber	PROPN
fnp-3805	111	27	’s	’s	PART
fnp-3805	111	28	hereditary	hereditary	ADJ
fnp-3805	111	29	optic	optic	NOUN
fnp-3805	111	30	neuropathy	neuropathy	PROPN
fnp-3805	111	31	leber	leber	PROPN
fnp-3805	111	32	’s	’s	PART
fnp-3805	111	33	hereditary	hereditary	ADJ
fnp-3805	111	34	optic	optic	NOUN
fnp-3805	111	35	neuropathy	neuropathy	ADJ
fnp-3805	111	36	(	(	PUNCT
fnp-3805	111	37	lhon	lhon	NOUN
fnp-3805	111	38	)	)	PUNCT
fnp-3805	111	39	,	,	PUNCT
fnp-3805	111	40	first	first	ADV
fnp-3805	111	41	defined	define	VERB
fnp-3805	111	42	as	as	ADP
fnp-3805	111	43	a	a	DET
fnp-3805	111	44	clinical	clinical	ADJ
fnp-3805	111	45	entity	entity	NOUN
fnp-3805	111	46	in	in	ADP
fnp-3805	111	47	1871	1871	NUM
fnp-3805	111	48	,	,	PUNCT
fnp-3805	111	49	is	be	AUX
fnp-3805	111	50	a	a	DET
fnp-3805	111	51	degenerative	degenerative	ADJ
fnp-3805	111	52	disease	disease	NOUN
fnp-3805	111	53	of	of	ADP
fnp-3805	111	54	retinal	retinal	ADJ
fnp-3805	111	55	ganglion	ganglion	NOUN
fnp-3805	111	56	cells	cell	NOUN
fnp-3805	111	57	and	and	CCONJ
fnp-3805	111	58	their	their	PRON
fnp-3805	111	59	axons	axon	NOUN
fnp-3805	111	60	that	that	PRON
fnp-3805	111	61	presents	present	VERB
fnp-3805	111	62	with	with	ADP
fnp-3805	111	63	subacute	subacute	ADJ
fnp-3805	111	64	bilateral	bilateral	ADJ
fnp-3805	111	65	painless	painless	ADJ
fnp-3805	111	66	loss	loss	NOUN
fnp-3805	111	67	of	of	ADP
fnp-3805	111	68	central	central	ADJ
fnp-3805	111	69	vision	vision	NOUN
fnp-3805	111	70	.	.	PUNCT
fnp-3805	112	1	most	most	ADJ
fnp-3805	112	2	lhon	lhon	ADJ
fnp-3805	112	3	cases	case	NOUN
fnp-3805	112	4	are	be	AUX
fnp-3805	112	5	maternally	maternally	ADV
fnp-3805	112	6	inherited	inherit	VERB
fnp-3805	112	7	;	;	PUNCT
fnp-3805	112	8	three	three	NUM
fnp-3805	112	9	point	point	NOUN
fnp-3805	112	10	mutations	mutation	NOUN
fnp-3805	112	11	in	in	ADP
fnp-3805	112	12	mitochondrial	mitochondrial	ADJ
fnp-3805	112	13	dna	dna	NOUN
fnp-3805	112	14	(	(	PUNCT
fnp-3805	112	15	mtdna	mtdna	NOUN
fnp-3805	112	16	)	)	PUNCT
fnp-3805	112	17	,	,	PUNCT
fnp-3805	112	18	each	each	PRON
fnp-3805	112	19	of	of	ADP
fnp-3805	112	20	which	which	PRON
fnp-3805	112	21	alters	alter	VERB
fnp-3805	112	22	the	the	DET
fnp-3805	112	23	coding	code	VERB
fnp-3805	112	24	sequence	sequence	NOUN
fnp-3805	112	25	of	of	ADP
fnp-3805	112	26	a	a	DET
fnp-3805	112	27	different	different	ADJ
fnp-3805	112	28	subunit	subunit	NOUN
fnp-3805	112	29	of	of	ADP
fnp-3805	112	30	mitochondrial	mitochondrial	ADJ
fnp-3805	112	31	respiratory	respiratory	ADJ
fnp-3805	112	32	chain	chain	NOUN
fnp-3805	112	33	complex	complex	NOUN
fnp-3805	112	34	i	i	PROPN
fnp-3805	112	35	,	,	PUNCT
fnp-3805	112	36	account	account	VERB
fnp-3805	112	37	for	for	ADP
fnp-3805	112	38	~90	~90	NUM
fnp-3805	112	39	%	%	NOUN
fnp-3805	112	40	of	of	ADP
fnp-3805	112	41	the	the	DET
fnp-3805	112	42	maternally	maternally	ADV
fnp-3805	112	43	inherited	inherit	VERB
fnp-3805	112	44	cases	case	NOUN
fnp-3805	112	45	,	,	PUNCT
fnp-3805	112	46	with	with	ADP
fnp-3805	112	47	other	other	ADJ
fnp-3805	112	48	mtdna	mtdna	PROPN
fnp-3805	112	49	mutations	mutation	NOUN
fnp-3805	112	50	accounting	account	VERB
fnp-3805	112	51	for	for	ADP
fnp-3805	112	52	additional	additional	ADJ
fnp-3805	112	53	~5	~5	NOUN
fnp-3805	112	54	%	%	NOUN
fnp-3805	112	55	.	.	PUNCT
fnp-3805	113	1	however	however	ADV
fnp-3805	113	2	,	,	PUNCT
fnp-3805	113	3	approximately	approximately	ADV
fnp-3805	113	4	5	5	NUM
fnp-3805	113	5	%	%	NOUN
fnp-3805	113	6	of	of	ADP
fnp-3805	113	7	lhon	lhon	NOUN
fnp-3805	113	8	patients	patient	NOUN
fnp-3805	113	9	carries	carry	VERB
fnp-3805	113	10	no	no	DET
fnp-3805	113	11	pathogenic	pathogenic	ADJ
fnp-3805	113	12	mtdna	mtdna	NOUN
fnp-3805	113	13	mutations	mutation	NOUN
fnp-3805	113	14	;	;	PUNCT
fnp-3805	113	15	in	in	ADP
fnp-3805	113	16	their	their	PRON
fnp-3805	113	17	groundbreaking	groundbreake	VERB
fnp-3805	113	18	work	work	NOUN
fnp-3805	113	19	published	publish	VERB
fnp-3805	113	20	last	last	ADJ
fnp-3805	113	21	year	year	NOUN
fnp-3805	113	22	,	,	PUNCT
fnp-3805	113	23	stenton	stenton	PROPN
fnp-3805	113	24	et	et	PROPN
fnp-3805	113	25	al	al	PROPN
fnp-3805	113	26	.	.	PROPN
fnp-3805	113	27	showed	show	VERB
fnp-3805	113	28	that	that	SCONJ
fnp-3805	113	29	many	many	ADJ
fnp-3805	113	30	of	of	ADP
fnp-3805	113	31	these	these	DET
fnp-3805	113	32	previously	previously	ADV
fnp-3805	113	33	unresolved	unresolved	ADJ
fnp-3805	113	34	lhon	lhon	ADJ
fnp-3805	113	35	cases	case	NOUN
fnp-3805	113	36	carry	carry	VERB
fnp-3805	113	37	biallelic	biallelic	ADJ
fnp-3805	113	38	missense	missense	NOUN
fnp-3805	113	39	mutations	mutation	NOUN
fnp-3805	113	40	in	in	ADP
fnp-3805	113	41	the	the	DET
fnp-3805	113	42	gene	gene	NOUN
fnp-3805	113	43	encoding	encode	VERB
fnp-3805	113	44	dnajc30	dnajc30	NOUN
fnp-3805	113	45	chaperone	chaperone	NOUN
fnp-3805	113	46	(	(	PUNCT
fnp-3805	113	47	stenton	stenton	NOUN
fnp-3805	113	48	et	et	PROPN
fnp-3805	113	49	al	al	PROPN
fnp-3805	113	50	.	.	PROPN
fnp-3805	113	51	,	,	PUNCT
fnp-3805	113	52	2021	2021	NUM
fnp-3805	113	53	)	)	PUNCT
fnp-3805	113	54	.	.	PUNCT
fnp-3805	114	1	among	among	ADP
fnp-3805	114	2	33	33	NUM
fnp-3805	114	3	individuals	individual	NOUN
fnp-3805	114	4	with	with	ADP
fnp-3805	114	5	dnajc30	dnajc30	NOUN
fnp-3805	114	6	-	-	PUNCT
fnp-3805	114	7	mutated	mutate	VERB
fnp-3805	114	8	,	,	PUNCT
fnp-3805	114	9	autosomal	autosomal	ADJ
fnp-3805	114	10	recessive	recessive	ADJ
fnp-3805	114	11	form	form	NOUN
fnp-3805	114	12	of	of	ADP
fnp-3805	114	13	lhon	lhon	PROPN
fnp-3805	114	14	(	(	PUNCT
fnp-3805	114	15	arlhon	arlhon	PROPN
fnp-3805	114	16	)	)	PUNCT
fnp-3805	114	17	characterized	characterize	VERB
fnp-3805	114	18	by	by	ADP
fnp-3805	114	19	stenton	stenton	NOUN
fnp-3805	114	20	and	and	CCONJ
fnp-3805	114	21	colleagues	colleague	NOUN
fnp-3805	114	22	,	,	PUNCT
fnp-3805	114	23	29	29	NUM
fnp-3805	114	24	carry	carry	VERB
fnp-3805	114	25	the	the	DET
fnp-3805	114	26	same	same	ADJ
fnp-3805	114	27	missense	missense	NOUN
fnp-3805	114	28	mutation	mutation	NOUN
fnp-3805	114	29	(	(	PUNCT
fnp-3805	114	30	nm-032317	nm-032317	PROPN
fnp-3805	114	31	,	,	PUNCT
fnp-3805	114	32	c152a	c152a	PROPN
fnp-3805	114	33	>	>	NOUN
fnp-3805	114	34	g	g	PROPN
fnp-3805	114	35	,	,	PUNCT
fnp-3805	114	36	ptyr51cys	ptyr51cys	PROPN
fnp-3805	114	37	;	;	PUNCT
fnp-3805	114	38	estimated	estimate	VERB
fnp-3805	114	39	to	to	PART
fnp-3805	114	40	have	have	AUX
fnp-3805	114	41	arisen	arise	VERB
fnp-3805	114	42	in	in	ADP
fnp-3805	114	43	eastern	eastern	PROPN
fnp-3805	114	44	europe	europe	PROPN
fnp-3805	114	45	~85	~85	NOUN
fnp-3805	114	46	generations	generation	NOUN
fnp-3805	114	47	/	/	PUNCT
fnp-3805	114	48	~2100	~2100	NUM
fnp-3805	114	49	years	year	NOUN
fnp-3805	114	50	ago	ago	ADV
fnp-3805	114	51	)	)	PUNCT
fnp-3805	114	52	;	;	PUNCT
fnp-3805	114	53	2	2	NUM
fnp-3805	114	54	additional	additional	ADJ
fnp-3805	114	55	missense	missense	NOUN
fnp-3805	114	56	dnajc30	dnajc30	NOUN
fnp-3805	114	57	mutations	mutation	NOUN
fnp-3805	114	58	were	be	AUX
fnp-3805	114	59	identified	identify	VERB
fnp-3805	114	60	in	in	ADP
fnp-3805	114	61	the	the	DET
fnp-3805	114	62	remaining	remain	VERB
fnp-3805	114	63	4	4	NUM
fnp-3805	114	64	patients	patient	NOUN
fnp-3805	114	65	.	.	PUNCT
fnp-3805	115	1	clinically	clinically	ADV
fnp-3805	115	2	,	,	PUNCT
fnp-3805	115	3	arlhon	arlhon	PROPN
fnp-3805	115	4	cases	case	NOUN
fnp-3805	115	5	are	be	AUX
fnp-3805	115	6	indistinguishable	indistinguishable	ADJ
fnp-3805	115	7	from	from	ADP
fnp-3805	115	8	mtlhon	mtlhon	ADJ
fnp-3805	115	9	cases	case	NOUN
fnp-3805	115	10	,	,	PUNCT
fnp-3805	115	11	although	although	SCONJ
fnp-3805	115	12	arlhon	arlhon	PROPN
fnp-3805	115	13	has	have	VERB
fnp-3805	115	14	a	a	DET
fnp-3805	115	15	significantly	significantly	ADV
fnp-3805	115	16	earlier	early	ADJ
fnp-3805	115	17	age	age	NOUN
fnp-3805	115	18	of	of	ADP
fnp-3805	115	19	onset	onset	NOUN
fnp-3805	115	20	(	(	PUNCT
fnp-3805	115	21	19.9+/-7.9	19.9+/-7.9	NUM
fnp-3805	115	22	vs.	vs.	ADP
fnp-3805	115	23	30.7+/-15.0	30.7+/-15.0	NUM
fnp-3805	115	24	years	year	NOUN
fnp-3805	115	25	)	)	PUNCT
fnp-3805	115	26	.	.	PUNCT
fnp-3805	116	1	like	like	INTJ
fnp-3805	116	2	mtlhon	mtlhon	PROPN
fnp-3805	116	3	,	,	PUNCT
fnp-3805	116	4	arlhon	arlhon	PROPN
fnp-3805	116	5	is	be	AUX
fnp-3805	116	6	characterized	characterize	VERB
fnp-3805	116	7	by	by	ADP
fnp-3805	116	8	incomplete	incomplete	ADJ
fnp-3805	116	9	disease	disease	NOUN
fnp-3805	116	10	penetrance	penetrance	NOUN
fnp-3805	116	11	,	,	PUNCT
fnp-3805	116	12	with	with	ADP
fnp-3805	116	13	some	some	DET
fnp-3805	116	14	homozygous	homozygous	ADJ
fnp-3805	116	15	mutation	mutation	NOUN
fnp-3805	116	16	carriers	carrier	NOUN
fnp-3805	116	17	not	not	PART
fnp-3805	116	18	expressing	express	VERB
fnp-3805	116	19	the	the	DET
fnp-3805	116	20	clinical	clinical	ADJ
fnp-3805	116	21	phenotype	phenotype	NOUN
fnp-3805	116	22	.	.	PUNCT
fnp-3805	117	1	interestingly	interestingly	ADV
fnp-3805	117	2	,	,	PUNCT
fnp-3805	117	3	mutation	mutation	NOUN
fnp-3805	117	4	penetrance	penetrance	NOUN
fnp-3805	117	5	is	be	AUX
fnp-3805	117	6	sex	sex	NOUN
fnp-3805	117	7	-	-	PUNCT
fnp-3805	117	8	dependent	dependent	ADJ
fnp-3805	117	9	in	in	ADP
fnp-3805	117	10	both	both	CCONJ
fnp-3805	117	11	mitochondrial	mitochondrial	ADJ
fnp-3805	117	12	and	and	CCONJ
fnp-3805	117	13	autosomal	autosomal	ADJ
fnp-3805	117	14	recessive	recessive	ADJ
fnp-3805	117	15	forms	form	NOUN
fnp-3805	117	16	of	of	ADP
fnp-3805	117	17	lhon	lhon	NOUN
fnp-3805	117	18	,	,	PUNCT
fnp-3805	117	19	with	with	ADP
fnp-3805	117	20	disease	disease	NOUN
fnp-3805	117	21	prevalence	prevalence	NOUN
fnp-3805	117	22	5	5	NUM
fnp-3805	117	23	-	-	SYM
fnp-3805	117	24	10	10	NUM
fnp-3805	117	25	times	time	NOUN
fnp-3805	117	26	higher	high	ADJ
fnp-3805	117	27	in	in	ADP
fnp-3805	117	28	male	male	NOUN
fnp-3805	117	29	compared	compare	VERB
fnp-3805	117	30	to	to	ADP
fnp-3805	117	31	female	female	ADJ
fnp-3805	117	32	mutation	mutation	NOUN
fnp-3805	117	33	carriers	carrier	NOUN
fnp-3805	117	34	;	;	PUNCT
fnp-3805	117	35	both	both	DET
fnp-3805	117	36	incomplete	incomplete	ADJ
fnp-3805	117	37	penetrance	penetrance	NOUN
fnp-3805	117	38	and	and	CCONJ
fnp-3805	117	39	male	male	ADJ
fnp-3805	117	40	predominance	predominance	NOUN
fnp-3805	117	41	are	be	AUX
fnp-3805	117	42	unusual	unusual	ADJ
fnp-3805	117	43	for	for	ADP
fnp-3805	117	44	an	an	DET
fnp-3805	117	45	autosomal	autosomal	ADJ
fnp-3805	117	46	recessive	recessive	ADJ
fnp-3805	117	47	disease	disease	NOUN
fnp-3805	117	48	,	,	PUNCT
fnp-3805	117	49	and	and	CCONJ
fnp-3805	117	50	the	the	DET
fnp-3805	117	51	mechanism(s	mechanism(s	NOUN
fnp-3805	117	52	)	)	PUNCT
fnp-3805	117	53	underlying	underlie	VERB
fnp-3805	117	54	these	these	DET
fnp-3805	117	55	phenomena	phenomenon	NOUN
fnp-3805	117	56	are	be	AUX
fnp-3805	117	57	yet	yet	ADV
fnp-3805	117	58	to	to	PART
fnp-3805	117	59	be	be	AUX
fnp-3805	117	60	elucidated	elucidate	VERB
fnp-3805	117	61	.	.	PUNCT
fnp-3805	118	1	importantly	importantly	ADV
fnp-3805	118	2	,	,	PUNCT
fnp-3805	118	3	arlhon	arlhon	PROPN
fnp-3805	118	4	patients	patient	NOUN
fnp-3805	118	5	have	have	VERB
fnp-3805	118	6	a	a	DET
fnp-3805	118	7	better	well	ADJ
fnp-3805	118	8	response	response	NOUN
fnp-3805	118	9	to	to	ADP
fnp-3805	118	10	treatment	treatment	NOUN
fnp-3805	118	11	with	with	ADP
fnp-3805	118	12	idebenone	idebenone	NOUN
fnp-3805	118	13	[	[	PUNCT
fnp-3805	118	14	a	a	DET
fnp-3805	118	15	coenzyme	coenzyme	PROPN
fnp-3805	118	16	q10	q10	PROPN
fnp-3805	118	17	analogue	analogue	NOUN
fnp-3805	118	18	that	that	PRON
fnp-3805	118	19	bypasses	bypass	VERB
fnp-3805	118	20	complex	complex	ADJ
fnp-3805	118	21	i	i	PRON
fnp-3805	118	22	and	and	CCONJ
fnp-3805	118	23	is	be	AUX
fnp-3805	118	24	currently	currently	ADV
fnp-3805	118	25	approved	approve	VERB
fnp-3805	118	26	for	for	ADP
fnp-3805	118	27	lhon	lhon	ADJ
fnp-3805	118	28	treatment	treatment	NOUN
fnp-3805	118	29	in	in	ADP
fnp-3805	118	30	europe	europe	PROPN
fnp-3805	118	31	(	(	PUNCT
fnp-3805	118	32	amore	amore	PROPN
fnp-3805	118	33	et	et	PROPN
fnp-3805	118	34	al	al	PROPN
fnp-3805	118	35	.	.	PROPN
fnp-3805	118	36	,	,	PUNCT
fnp-3805	118	37	2021	2021	NUM
fnp-3805	118	38	)	)	PUNCT
fnp-3805	118	39	]	]	PUNCT
fnp-3805	118	40	than	than	ADP
fnp-3805	118	41	mtlhon	mtlhon	NOUN
fnp-3805	118	42	patients	patient	NOUN
fnp-3805	118	43	;	;	PUNCT
fnp-3805	118	44	this	this	DET
fnp-3805	118	45	difference	difference	NOUN
fnp-3805	118	46	in	in	ADP
fnp-3805	118	47	the	the	DET
fnp-3805	118	48	treatment	treatment	NOUN
fnp-3805	118	49	response	response	NOUN
fnp-3805	118	50	highlights	highlight	VERB
fnp-3805	118	51	the	the	DET
fnp-3805	118	52	clinical	clinical	ADJ
fnp-3805	118	53	significance	significance	NOUN
fnp-3805	118	54	of	of	ADP
fnp-3805	118	55	early	early	ADJ
fnp-3805	118	56	molecular	molecular	ADJ
fnp-3805	118	57	diagnosis	diagnosis	NOUN
fnp-3805	118	58	of	of	ADP
fnp-3805	118	59	arlhon	arlhon	PROPN
fnp-3805	118	60	cases	case	NOUN
fnp-3805	118	61	.	.	PUNCT
fnp-3805	119	1	notably	notably	ADV
fnp-3805	119	2	,	,	PUNCT
fnp-3805	119	3	these	these	DET
fnp-3805	119	4	genetic	genetic	ADJ
fnp-3805	119	5	and	and	CCONJ
fnp-3805	119	6	clinical	clinical	ADJ
fnp-3805	119	7	findings	finding	NOUN
fnp-3805	119	8	were	be	AUX
fnp-3805	119	9	replicated	replicate	VERB
fnp-3805	119	10	by	by	ADP
fnp-3805	119	11	another	another	DET
fnp-3805	119	12	very	very	ADV
fnp-3805	119	13	recent	recent	ADJ
fnp-3805	119	14	study	study	NOUN
fnp-3805	119	15	(	(	PUNCT
fnp-3805	119	16	kieninger	kieninger	PROPN
fnp-3805	119	17	et	et	PROPN
fnp-3805	119	18	al	al	PROPN
fnp-3805	119	19	.	.	PROPN
fnp-3805	119	20	,	,	PUNCT
fnp-3805	119	21	2022	2022	NUM
fnp-3805	119	22	)	)	PUNCT
fnp-3805	119	23	,	,	PUNCT
fnp-3805	119	24	which	which	PRON
fnp-3805	119	25	also	also	ADV
fnp-3805	119	26	identified	identify	VERB
fnp-3805	119	27	two	two	NUM
fnp-3805	119	28	additional	additional	ADJ
fnp-3805	119	29	dnajc30	dnajc30	NOUN
fnp-3805	119	30	pathogenic	pathogenic	ADJ
fnp-3805	119	31	variants	variant	NOUN
fnp-3805	119	32	.	.	PUNCT
fnp-3805	120	1	how	how	SCONJ
fnp-3805	120	2	do	do	AUX
fnp-3805	120	3	dnajc30	dnajc30	NOUN
fnp-3805	120	4	mutations	mutation	NOUN
fnp-3805	120	5	cause	cause	VERB
fnp-3805	120	6	lhon	lhon	NOUN
fnp-3805	120	7	?	?	PUNCT
fnp-3805	121	1	all	all	DET
fnp-3805	121	2	three	three	NUM
fnp-3805	121	3	initially	initially	ADV
fnp-3805	121	4	identified	identify	VERB
fnp-3805	121	5	variants	variant	NOUN
fnp-3805	121	6	are	be	AUX
fnp-3805	121	7	located	locate	VERB
fnp-3805	121	8	in	in	ADP
fnp-3805	121	9	the	the	DET
fnp-3805	121	10	j	j	PROPN
fnp-3805	121	11	domain	domain	NOUN
fnp-3805	121	12	,	,	PUNCT
fnp-3805	121	13	a	a	DET
fnp-3805	121	14	conserved	conserved	ADJ
fnp-3805	121	15	portion	portion	NOUN
fnp-3805	121	16	of	of	ADP
fnp-3805	121	17	dnajc30	dnajc30	NOUN
fnp-3805	121	18	with	with	ADP
fnp-3805	121	19	homology	homology	NOUN
fnp-3805	121	20	to	to	ADP
fnp-3805	121	21	the	the	DET
fnp-3805	121	22	heat	heat	NOUN
fnp-3805	121	23	shock	shock	NOUN
fnp-3805	121	24	family	family	NOUN
fnp-3805	121	25	of	of	ADP
fnp-3805	121	26	proteins	protein	NOUN
fnp-3805	121	27	.	.	PUNCT
fnp-3805	122	1	muscle	muscle	NOUN
fnp-3805	122	2	biopsies	biopsy	NOUN
fnp-3805	122	3	from	from	ADP
fnp-3805	122	4	arlhon	arlhon	PROPN
fnp-3805	122	5	patients	patient	NOUN
fnp-3805	122	6	showed	show	VERB
fnp-3805	122	7	a	a	DET
fnp-3805	122	8	small	small	ADJ
fnp-3805	122	9	but	but	CCONJ
fnp-3805	122	10	significant	significant	ADJ
fnp-3805	122	11	defect	defect	NOUN
fnp-3805	122	12	in	in	ADP
fnp-3805	122	13	complex	complex	ADJ
fnp-3805	122	14	i	i	PRON
fnp-3805	122	15	activity	activity	NOUN
fnp-3805	122	16	(	(	PUNCT
fnp-3805	122	17	but	but	CCONJ
fnp-3805	122	18	no	no	DET
fnp-3805	122	19	change	change	NOUN
fnp-3805	122	20	in	in	ADP
fnp-3805	122	21	complex	complex	ADJ
fnp-3805	122	22	iv	iv	NUM
fnp-3805	122	23	and	and	CCONJ
fnp-3805	122	24	complex	complex	ADJ
fnp-3805	122	25	v	v	ADJ
fnp-3805	122	26	activities	activity	NOUN
fnp-3805	122	27	)	)	PUNCT
fnp-3805	122	28	,	,	PUNCT
fnp-3805	122	29	and	and	CCONJ
fnp-3805	122	30	this	this	DET
fnp-3805	122	31	complex	complex	ADJ
fnp-3805	122	32	i	i	NOUN
fnp-3805	122	33	-	-	PUNCT
fnp-3805	122	34	specific	specific	ADJ
fnp-3805	122	35	defect	defect	NOUN
fnp-3805	122	36	was	be	AUX
fnp-3805	122	37	recapitulated	recapitulate	VERB
fnp-3805	122	38	in	in	ADP
fnp-3805	122	39	patient	patient	NOUN
fnp-3805	122	40	-	-	PUNCT
fnp-3805	122	41	derived	derive	VERB
fnp-3805	122	42	fibroblast	fibroblast	ADJ
fnp-3805	122	43	cell	cell	NOUN
fnp-3805	122	44	lines	line	NOUN
fnp-3805	122	45	and	and	CCONJ
fnp-3805	122	46	dnajc30	dnajc30	NOUN
fnp-3805	122	47	-	-	PUNCT
fnp-3805	122	48	knockout	knockout	NOUN
fnp-3805	122	49	hek293	hek293	PROPN
fnp-3805	122	50	cells	cell	NOUN
fnp-3805	122	51	.	.	PUNCT
fnp-3805	123	1	interestingly	interestingly	ADV
fnp-3805	123	2	,	,	PUNCT
fnp-3805	123	3	the	the	DET
fnp-3805	123	4	functional	functional	ADJ
fnp-3805	123	5	defect	defect	NOUN
fnp-3805	123	6	of	of	ADP
fnp-3805	123	7	complex	complex	ADJ
fnp-3805	123	8	i	i	PRON
fnp-3805	123	9	was	be	AUX
fnp-3805	123	10	accompanied	accompany	VERB
fnp-3805	123	11	by	by	ADP
fnp-3805	123	12	a	a	DET
fnp-3805	123	13	small	small	ADJ
fnp-3805	123	14	but	but	CCONJ
fnp-3805	123	15	consistent	consistent	ADJ
fnp-3805	123	16	increase	increase	NOUN
fnp-3805	123	17	(	(	PUNCT
fnp-3805	123	18	rather	rather	ADV
fnp-3805	123	19	than	than	ADP
fnp-3805	123	20	decrease	decrease	NOUN
fnp-3805	123	21	)	)	PUNCT
fnp-3805	123	22	in	in	ADP
fnp-3805	123	23	the	the	DET
fnp-3805	123	24	expression	expression	NOUN
fnp-3805	123	25	level	level	NOUN
fnp-3805	123	26	of	of	ADP
fnp-3805	123	27	complex	complex	ADJ
fnp-3805	123	28	i	i	PRON
fnp-3805	123	29	subunits	subunit	NOUN
fnp-3805	123	30	,	,	PUNCT
fnp-3805	123	31	with	with	ADP
fnp-3805	123	32	no	no	DET
fnp-3805	123	33	corresponding	corresponding	ADJ
fnp-3805	123	34	increase	increase	NOUN
fnp-3805	123	35	in	in	ADP
fnp-3805	123	36	the	the	DET
fnp-3805	123	37	level	level	NOUN
fnp-3805	123	38	of	of	ADP
fnp-3805	123	39	mrnas	mrna	NOUN
fnp-3805	123	40	that	that	PRON
fnp-3805	123	41	encode	encode	VERB
fnp-3805	123	42	these	these	DET
fnp-3805	123	43	subunits	subunit	NOUN
fnp-3805	123	44	.	.	PUNCT
fnp-3805	124	1	the	the	DET
fnp-3805	124	2	increase	increase	NOUN
fnp-3805	124	3	in	in	ADP
fnp-3805	124	4	the	the	DET
fnp-3805	124	5	complex	complex	ADJ
fnp-3805	124	6	i	i	PRON
fnp-3805	124	7	subunit	subunit	NOUN
fnp-3805	124	8	expression	expression	NOUN
fnp-3805	124	9	level	level	NOUN
fnp-3805	124	10	was	be	AUX
fnp-3805	124	11	accompanied	accompany	VERB
fnp-3805	124	12	by	by	ADP
fnp-3805	124	13	a	a	DET
fnp-3805	124	14	decrease	decrease	NOUN
fnp-3805	124	15	in	in	ADP
fnp-3805	124	16	the	the	DET
fnp-3805	124	17	turnover	turnover	NOUN
fnp-3805	124	18	of	of	ADP
fnp-3805	124	19	subunits	subunit	NOUN
fnp-3805	124	20	that	that	PRON
fnp-3805	124	21	comprise	comprise	VERB
fnp-3805	124	22	the	the	DET
fnp-3805	124	23	n	n	NOUN
fnp-3805	124	24	-	-	PUNCT
fnp-3805	124	25	module	module	NOUN
fnp-3805	124	26	,	,	PUNCT
fnp-3805	124	27	which	which	PRON
fnp-3805	124	28	normally	normally	ADV
fnp-3805	124	29	have	have	VERB
fnp-3805	124	30	the	the	DET
fnp-3805	124	31	highest	high	ADJ
fnp-3805	124	32	turnover	turnover	NOUN
fnp-3805	124	33	rate	rate	NOUN
fnp-3805	124	34	due	due	ADP
fnp-3805	124	35	to	to	ADP
fnp-3805	124	36	a	a	DET
fnp-3805	124	37	high	high	ADJ
fnp-3805	124	38	degree	degree	NOUN
fnp-3805	124	39	of	of	ADP
fnp-3805	124	40	oxidative	oxidative	ADJ
fnp-3805	124	41	damage	damage	NOUN
fnp-3805	124	42	(	(	PUNCT
fnp-3805	124	43	szczepanowska	szczepanowska	PROPN
fnp-3805	124	44	et	et	PROPN
fnp-3805	124	45	al	al	PROPN
fnp-3805	124	46	.	.	PROPN
fnp-3805	124	47	,	,	PUNCT
fnp-3805	124	48	2020	2020	NUM
fnp-3805	124	49	)	)	PUNCT
fnp-3805	124	50	.	.	PUNCT
fnp-3805	125	1	taken	take	VERB
fnp-3805	125	2	together	together	ADV
fnp-3805	125	3	,	,	PUNCT
fnp-3805	125	4	these	these	DET
fnp-3805	125	5	data	datum	NOUN
fnp-3805	125	6	indicate	indicate	VERB
fnp-3805	125	7	that	that	SCONJ
fnp-3805	125	8	dnajc30	dnajc30	NOUN
fnp-3805	125	9	maintains	maintain	VERB
fnp-3805	125	10	structure	structure	NOUN
fnp-3805	125	11	and	and	CCONJ
fnp-3805	125	12	function	function	NOUN
fnp-3805	125	13	of	of	ADP
fnp-3805	125	14	complex	complex	ADJ
fnp-3805	125	15	i	i	PRON
fnp-3805	125	16	by	by	ADP
fnp-3805	125	17	facilitating	facilitate	VERB
fnp-3805	125	18	exchange	exchange	NOUN
fnp-3805	125	19	of	of	ADP
fnp-3805	125	20	oxidatively	oxidatively	ADV
fnp-3805	125	21	damaged	damage	VERB
fnp-3805	125	22	subunits	subunit	NOUN
fnp-3805	125	23	comprising	comprise	VERB
fnp-3805	125	24	its	its	PRON
fnp-3805	125	25	n	n	CCONJ
fnp-3805	125	26	-	-	PUNCT
fnp-3805	125	27	module	module	NOUN
fnp-3805	125	28	;	;	PUNCT
fnp-3805	125	29	impairment	impairment	NOUN
fnp-3805	125	30	of	of	ADP
fnp-3805	125	31	this	this	DET
fnp-3805	125	32	repair	repair	NOUN
fnp-3805	125	33	mechanism	mechanism	NOUN
fnp-3805	125	34	leads	lead	VERB
fnp-3805	125	35	to	to	ADP
fnp-3805	125	36	accumulation	accumulation	NOUN
fnp-3805	125	37	of	of	ADP
fnp-3805	125	38	damaged	damage	VERB
fnp-3805	125	39	type	type	NOUN
fnp-3805	125	40	i	i	PRON
fnp-3805	125	41	complexes	complexe	VERB
fnp-3805	125	42	,	,	PUNCT
fnp-3805	125	43	functional	functional	ADJ
fnp-3805	125	44	complex	complex	NOUN
fnp-3805	125	45	i	i	PRON
fnp-3805	125	46	defect	defect	VERB
fnp-3805	125	47	,	,	PUNCT
fnp-3805	125	48	and	and	CCONJ
fnp-3805	125	49	lhon	lhon	ADJ
fnp-3805	125	50	clinical	clinical	ADJ
fnp-3805	125	51	phenotype	phenotype	NOUN
fnp-3805	125	52	.	.	PUNCT
fnp-3805	126	1	interestingly	interestingly	ADV
fnp-3805	126	2	,	,	PUNCT
fnp-3805	126	3	dnajc30	dnajc30	NOUN
fnp-3805	126	4	was	be	AUX
fnp-3805	126	5	also	also	ADV
fnp-3805	126	6	shown	show	VERB
fnp-3805	126	7	to	to	PART
fnp-3805	126	8	interact	interact	VERB
fnp-3805	126	9	with	with	ADP
fnp-3805	126	10	several	several	ADJ
fnp-3805	126	11	subunits	subunit	NOUN
fnp-3805	126	12	of	of	ADP
fnp-3805	126	13	complex	complex	ADJ
fnp-3805	126	14	v	v	PROPN
fnp-3805	126	15	/	/	SYM
fnp-3805	126	16	atp	atp	NOUN
fnp-3805	126	17	-	-	PUNCT
fnp-3805	126	18	synthase	synthase	NOUN
fnp-3805	126	19	(	(	PUNCT
fnp-3805	126	20	tebbenkamp	tebbenkamp	PROPN
fnp-3805	126	21	et	et	PROPN
fnp-3805	126	22	al	al	PROPN
fnp-3805	126	23	.	.	PROPN
fnp-3805	126	24	,	,	PUNCT
fnp-3805	126	25	2018	2018	NUM
fnp-3805	126	26	)	)	PUNCT
fnp-3805	126	27	;	;	PUNCT
fnp-3805	126	28	however	however	ADV
fnp-3805	126	29	,	,	PUNCT
fnp-3805	126	30	clinical	clinical	ADJ
fnp-3805	126	31	significance	significance	NOUN
fnp-3805	126	32	of	of	ADP
fnp-3805	126	33	that	that	DET
fnp-3805	126	34	finding	finding	NOUN
fnp-3805	126	35	is	be	AUX
fnp-3805	126	36	unclear	unclear	ADJ
fnp-3805	126	37	given	give	VERB
fnp-3805	126	38	that	that	DET
fnp-3805	126	39	muscle	muscle	NOUN
fnp-3805	126	40	biopsies	biopsy	NOUN
fnp-3805	126	41	from	from	ADP
fnp-3805	126	42	patients	patient	NOUN
fnp-3805	126	43	with	with	ADP
fnp-3805	126	44	dnajc30	dnajc30	NOUN
fnp-3805	126	45	mutations	mutation	NOUN
fnp-3805	126	46	show	show	VERB
fnp-3805	126	47	no	no	DET
fnp-3805	126	48	changes	change	NOUN
fnp-3805	126	49	in	in	ADP
fnp-3805	126	50	complex	complex	ADJ
fnp-3805	126	51	v	v	ADP
fnp-3805	126	52	abundance	abundance	NOUN
fnp-3805	126	53	and	and	CCONJ
fnp-3805	126	54	no	no	DET
fnp-3805	126	55	functional	functional	ADJ
fnp-3805	126	56	complex	complex	NOUN
fnp-3805	126	57	v	v	NUM
fnp-3805	126	58	deficits	deficit	NOUN
fnp-3805	126	59	.	.	PUNCT
fnp-3805	127	1	it	it	PRON
fnp-3805	127	2	is	be	AUX
fnp-3805	127	3	worth	worth	ADJ
fnp-3805	127	4	noting	note	VERB
fnp-3805	127	5	that	that	SCONJ
fnp-3805	127	6	complex	complex	ADJ
fnp-3805	127	7	i	i	PRON
fnp-3805	127	8	dysfunction	dysfunction	NOUN
fnp-3805	127	9	is	be	AUX
fnp-3805	127	10	thought	think	VERB
fnp-3805	127	11	to	to	PART
fnp-3805	127	12	play	play	VERB
fnp-3805	127	13	an	an	DET
fnp-3805	127	14	important	important	ADJ
fnp-3805	127	15	role	role	NOUN
fnp-3805	127	16	in	in	ADP
fnp-3805	127	17	the	the	DET
fnp-3805	127	18	pathogenesis	pathogenesis	NOUN
fnp-3805	127	19	of	of	ADP
fnp-3805	127	20	parkinson	parkinson	NOUN
fnp-3805	127	21	disease	disease	NOUN
fnp-3805	127	22	,	,	PUNCT
fnp-3805	127	23	cancer	cancer	NOUN
fnp-3805	127	24	,	,	PUNCT
fnp-3805	127	25	and	and	CCONJ
fnp-3805	127	26	diabetes	diabete	NOUN
fnp-3805	127	27	;	;	PUNCT
fnp-3805	127	28	a	a	DET
fnp-3805	127	29	long	long	ADJ
fnp-3805	127	30	-	-	PUNCT
fnp-3805	127	31	term	term	NOUN
fnp-3805	127	32	clinical	clinical	ADJ
fnp-3805	127	33	follow	follow	NOUN
fnp-3805	127	34	up	up	ADP
fnp-3805	127	35	of	of	ADP
fnp-3805	127	36	arlhon	arlhon	PROPN
fnp-3805	127	37	patients	patient	NOUN
fnp-3805	127	38	will	will	AUX
fnp-3805	127	39	be	be	AUX
fnp-3805	127	40	necessary	necessary	ADJ
fnp-3805	127	41	to	to	PART
fnp-3805	127	42	determine	determine	VERB
fnp-3805	127	43	whether	whether	SCONJ
fnp-3805	127	44	they	they	PRON
fnp-3805	127	45	are	be	AUX
fnp-3805	127	46	at	at	ADP
fnp-3805	127	47	increased	increase	VERB
fnp-3805	127	48	risk	risk	NOUN
fnp-3805	127	49	for	for	ADP
fnp-3805	127	50	these	these	DET
fnp-3805	127	51	common	common	ADJ
fnp-3805	127	52	age	age	NOUN
fnp-3805	127	53	-	-	PUNCT
fnp-3805	127	54	associated	associate	VERB
fnp-3805	127	55	disorders	disorder	NOUN
fnp-3805	127	56	.	.	PUNCT
fnp-3805	128	1	6	6	X
fnp-3805	128	2	.	.	X
fnp-3805	128	3	autophagy	autophagy	ADJ
fnp-3805	128	4	defects	defect	NOUN
fnp-3805	128	5	in	in	ADP
fnp-3805	128	6	skeletal	skeletal	ADJ
fnp-3805	128	7	myopathies	myopathy	NOUN
fnp-3805	128	8	:	:	PUNCT
fnp-3805	128	9	the	the	DET
fnp-3805	128	10	etiologic	etiologic	ADJ
fnp-3805	128	11	spectrum	spectrum	NOUN
fnp-3805	128	12	widens	widen	VERB
fnp-3805	128	13	degradative	degradative	ADJ
fnp-3805	128	14	macroautophagy	macroautophagy	NOUN
fnp-3805	128	15	(	(	PUNCT
fnp-3805	128	16	hereafter	hereafter	ADV
fnp-3805	128	17	referred	refer	VERB
fnp-3805	128	18	to	to	ADP
fnp-3805	128	19	as	as	ADP
fnp-3805	128	20	autophagy	autophagy	VERB
fnp-3805	128	21	)	)	PUNCT
fnp-3805	128	22	is	be	AUX
fnp-3805	128	23	a	a	DET
fnp-3805	128	24	conserved	conserved	ADJ
fnp-3805	128	25	catabolic	catabolic	ADJ
fnp-3805	128	26	pathway	pathway	NOUN
fnp-3805	128	27	required	require	VERB
fnp-3805	128	28	for	for	ADP
fnp-3805	128	29	cellular	cellular	ADJ
fnp-3805	128	30	adaptation	adaptation	NOUN
fnp-3805	128	31	to	to	PART
fnp-3805	128	32	nutrient	nutrient	VERB
fnp-3805	128	33	deprivation	deprivation	NOUN
fnp-3805	128	34	and	and	CCONJ
fnp-3805	128	35	for	for	ADP
fnp-3805	128	36	degradation	degradation	NOUN
fnp-3805	128	37	of	of	ADP
fnp-3805	128	38	damaged	damage	VERB
fnp-3805	128	39	intracellular	intracellular	ADJ
fnp-3805	128	40	organelles	organelle	NOUN
fnp-3805	128	41	and	and	CCONJ
fnp-3805	128	42	insoluble	insoluble	ADJ
fnp-3805	128	43	protein	protein	NOUN
fnp-3805	128	44	aggregates	aggregate	NOUN
fnp-3805	128	45	.	.	PUNCT
fnp-3805	129	1	autophagy	autophagy	PROPN
fnp-3805	129	2	is	be	AUX
fnp-3805	129	3	a	a	DET
fnp-3805	129	4	highly	highly	ADV
fnp-3805	129	5	regulated	regulate	VERB
fnp-3805	129	6	cellular	cellular	ADJ
fnp-3805	129	7	process	process	NOUN
fnp-3805	129	8	that	that	PRON
fnp-3805	129	9	involves	involve	VERB
fnp-3805	129	10	multiple	multiple	ADJ
fnp-3805	129	11	steps	step	NOUN
fnp-3805	129	12	(	(	PUNCT
fnp-3805	129	13	starting	start	VERB
fnp-3805	129	14	with	with	ADP
fnp-3805	129	15	autophagy	autophagy	ADJ
fnp-3805	129	16	induction	induction	NOUN
fnp-3805	129	17	and	and	CCONJ
fnp-3805	129	18	ending	end	VERB
fnp-3805	129	19	with	with	ADP
fnp-3805	129	20	degradation	degradation	NOUN
fnp-3805	129	21	of	of	ADP
fnp-3805	129	22	sequestered	sequester	VERB
fnp-3805	129	23	cargo	cargo	NOUN
fnp-3805	129	24	by	by	ADP
fnp-3805	129	25	lysosomal	lysosomal	ADJ
fnp-3805	129	26	hydrolases	hydrolase	NOUN
fnp-3805	129	27	)	)	PUNCT
fnp-3805	129	28	,	,	PUNCT
fnp-3805	129	29	disruption	disruption	NOUN
fnp-3805	129	30	of	of	ADP
fnp-3805	129	31	each	each	PRON
fnp-3805	129	32	can	can	AUX
fnp-3805	129	33	lead	lead	VERB
fnp-3805	129	34	to	to	ADP
fnp-3805	129	35	human	human	ADJ
fnp-3805	129	36	disease	disease	NOUN
fnp-3805	129	37	[	[	X
fnp-3805	129	38	reviewed	review	VERB
fnp-3805	129	39	in	in	ADP
fnp-3805	129	40	detail	detail	NOUN
fnp-3805	129	41	in	in	ADP
fnp-3805	129	42	(	(	PUNCT
fnp-3805	129	43	margeta	margeta	NOUN
fnp-3805	129	44	,	,	PUNCT
fnp-3805	129	45	2020a	2020a	NUM
fnp-3805	129	46	)	)	PUNCT
fnp-3805	129	47	]	]	PUNCT
fnp-3805	129	48	.	.	PUNCT
fnp-3805	130	1	from	from	ADP
fnp-3805	130	2	the	the	DET
fnp-3805	130	3	muscle	muscle	NOUN
fnp-3805	130	4	pathology	pathology	NOUN
fnp-3805	130	5	perspective	perspective	NOUN
fnp-3805	130	6	,	,	PUNCT
fnp-3805	130	7	the	the	DET
fnp-3805	130	8	most	most	ADV
fnp-3805	130	9	recognizable	recognizable	ADJ
fnp-3805	130	10	autophagy	autophagy	ADJ
fnp-3805	130	11	defect	defect	NOUN
fnp-3805	130	12	involves	involve	VERB
fnp-3805	130	13	inhibition	inhibition	NOUN
fnp-3805	130	14	of	of	ADP
fnp-3805	130	15	the	the	DET
fnp-3805	130	16	bulk	bulk	ADJ
fnp-3805	130	17	autophagic	autophagic	NOUN
fnp-3805	130	18	flux	flux	NOUN
fnp-3805	130	19	,	,	PUNCT
fnp-3805	130	20	which	which	PRON
fnp-3805	130	21	results	result	VERB
fnp-3805	130	22	in	in	ADP
fnp-3805	130	23	the	the	DET
fnp-3805	130	24	autophagic	autophagic	ADJ
fnp-3805	130	25	vacuolar	vacuolar	ADJ
fnp-3805	130	26	myopathy	myopathy	NOUN
fnp-3805	130	27	(	(	PUNCT
fnp-3805	130	28	avm	avm	PROPN
fnp-3805	130	29	)	)	PUNCT
fnp-3805	130	30	phenotype	phenotype	NOUN
fnp-3805	130	31	;	;	PUNCT
fnp-3805	130	32	however	however	ADV
fnp-3805	130	33	,	,	PUNCT
fnp-3805	130	34	defects	defect	NOUN
fnp-3805	130	35	of	of	ADP
fnp-3805	130	36	autophagy	autophagy	ADJ
fnp-3805	130	37	induction	induction	NOUN
fnp-3805	130	38	and	and	CCONJ
fnp-3805	130	39	cargo	cargo	NOUN
fnp-3805	130	40	sequestration	sequestration	NOUN
fnp-3805	130	41	can	can	AUX
fnp-3805	130	42	also	also	ADV
fnp-3805	130	43	result	result	VERB
fnp-3805	130	44	in	in	ADP
fnp-3805	130	45	muscle	muscle	NOUN
fnp-3805	130	46	disease	disease	NOUN
fnp-3805	130	47	(	(	PUNCT
fnp-3805	130	48	fig	fig	NOUN
fnp-3805	130	49	.	.	PUNCT
fnp-3805	131	1	3	3	NUM
fnp-3805	131	2	)	)	PUNCT
fnp-3805	131	3	.	.	PUNCT
fnp-3805	132	1	several	several	ADJ
fnp-3805	132	2	new	new	ADJ
fnp-3805	132	3	diseases	disease	NOUN
fnp-3805	132	4	with	with	ADP
fnp-3805	132	5	autophagic	autophagic	ADJ
fnp-3805	132	6	impairment	impairment	NOUN
fnp-3805	132	7	were	be	AUX
fnp-3805	132	8	identified	identify	VERB
fnp-3805	132	9	in	in	ADP
fnp-3805	132	10	2021	2021	NUM
fnp-3805	132	11	,	,	PUNCT
fnp-3805	132	12	expanding	expand	VERB
fnp-3805	132	13	the	the	DET
fnp-3805	132	14	spectrum	spectrum	NOUN
fnp-3805	132	15	of	of	ADP
fnp-3805	132	16	etiologies	etiology	NOUN
fnp-3805	132	17	that	that	PRON
fnp-3805	132	18	cause	cause	VERB
fnp-3805	132	19	skeletal	skeletal	ADJ
fnp-3805	132	20	myopathy	myopathy	ADJ
fnp-3805	132	21	through	through	ADP
fnp-3805	132	22	dysregulation	dysregulation	NOUN
fnp-3805	132	23	of	of	ADP
fnp-3805	132	24	autophagy	autophagy	NOUN
fnp-3805	132	25	;	;	PUNCT
fnp-3805	132	26	interestingly	interestingly	ADV
fnp-3805	132	27	,	,	PUNCT
fnp-3805	132	28	however	however	ADV
fnp-3805	132	29	,	,	PUNCT
fnp-3805	132	30	all	all	PRON
fnp-3805	132	31	of	of	ADP
fnp-3805	132	32	them	they	PRON
fnp-3805	132	33	map	map	VERB
fnp-3805	132	34	on	on	ADP
fnp-3805	132	35	one	one	NUM
fnp-3805	132	36	of	of	ADP
fnp-3805	132	37	the	the	DET
fnp-3805	132	38	four	four	NUM
fnp-3805	132	39	previously	previously	ADV
fnp-3805	132	40	identified	identify	VERB
fnp-3805	132	41	pathogenetic	pathogenetic	ADJ
fnp-3805	132	42	pathways	pathway	NOUN
fnp-3805	132	43	illustrated	illustrate	VERB
fnp-3805	132	44	in	in	ADP
fnp-3805	132	45	fig	fig	NOUN
fnp-3805	132	46	.	.	PUNCT
fnp-3805	133	1	3	3	X
fnp-3805	133	2	.	.	X
fnp-3805	133	3	figure	figure	NOUN
fnp-3805	133	4	3	3	NUM
fnp-3805	133	5	.	.	PUNCT
fnp-3805	134	1	the	the	DET
fnp-3805	134	2	role	role	NOUN
fnp-3805	134	3	of	of	ADP
fnp-3805	134	4	autophagic	autophagic	ADJ
fnp-3805	134	5	defects	defect	NOUN
fnp-3805	134	6	in	in	ADP
fnp-3805	134	7	the	the	DET
fnp-3805	134	8	pathogenesis	pathogenesis	NOUN
fnp-3805	134	9	of	of	ADP
fnp-3805	134	10	skeletal	skeletal	ADJ
fnp-3805	134	11	myopathies	myopathy	NOUN
fnp-3805	134	12	.	.	PUNCT
fnp-3805	135	1	in	in	ADP
fnp-3805	135	2	myopathies	myopathy	NOUN
fnp-3805	135	3	with	with	ADP
fnp-3805	135	4	autophagy	autophagy	ADJ
fnp-3805	135	5	induction	induction	NOUN
fnp-3805	135	6	defects	defect	NOUN
fnp-3805	135	7	,	,	PUNCT
fnp-3805	135	8	the	the	DET
fnp-3805	135	9	accumulation	accumulation	NOUN
fnp-3805	135	10	of	of	ADP
fnp-3805	135	11	damaged	damage	VERB
fnp-3805	135	12	cellular	cellular	ADJ
fnp-3805	135	13	organelles	organelle	NOUN
fnp-3805	135	14	activates	activate	VERB
fnp-3805	135	15	signaling	signal	VERB
fnp-3805	135	16	cascades	cascade	NOUN
fnp-3805	135	17	that	that	PRON
fnp-3805	135	18	contribute	contribute	VERB
fnp-3805	135	19	to	to	PART
fnp-3805	135	20	fiber	fiber	VERB
fnp-3805	135	21	atrophy	atrophy	NOUN
fnp-3805	135	22	and	and	CCONJ
fnp-3805	135	23	apoptosis	apoptosis	NOUN
fnp-3805	135	24	;	;	PUNCT
fnp-3805	135	25	however	however	ADV
fnp-3805	135	26	,	,	PUNCT
fnp-3805	135	27	there	there	PRON
fnp-3805	135	28	is	be	VERB
fnp-3805	135	29	no	no	DET
fnp-3805	135	30	accumulation	accumulation	NOUN
fnp-3805	135	31	of	of	ADP
fnp-3805	135	32	autophagosomes	autophagosome	NOUN
fnp-3805	135	33	.	.	PUNCT
fnp-3805	136	1	in	in	ADP
fnp-3805	136	2	contrast	contrast	NOUN
fnp-3805	136	3	,	,	PUNCT
fnp-3805	136	4	autophagic	autophagic	PROPN
fnp-3805	136	5	vacuolar	vacuolar	ADJ
fnp-3805	136	6	myopathies	myopathy	NOUN
fnp-3805	136	7	are	be	AUX
fnp-3805	136	8	caused	cause	VERB
fnp-3805	136	9	by	by	ADP
fnp-3805	136	10	defects	defect	NOUN
fnp-3805	136	11	in	in	ADP
fnp-3805	136	12	the	the	DET
fnp-3805	136	13	general	general	ADJ
fnp-3805	136	14	autophagic	autophagic	NOUN
fnp-3805	136	15	flux	flux	NOUN
fnp-3805	136	16	that	that	PRON
fnp-3805	136	17	lead	lead	VERB
fnp-3805	136	18	to	to	ADP
fnp-3805	136	19	a	a	DET
fnp-3805	136	20	massive	massive	ADJ
fnp-3805	136	21	accumulation	accumulation	NOUN
fnp-3805	136	22	of	of	ADP
fnp-3805	136	23	autophagosomes	autophagosome	NOUN
fnp-3805	136	24	and	and	CCONJ
fnp-3805	136	25	undigested	undigested	ADJ
fnp-3805	136	26	cargo	cargo	NOUN
fnp-3805	136	27	,	,	PUNCT
fnp-3805	136	28	ultimately	ultimately	ADV
fnp-3805	136	29	resulting	result	VERB
fnp-3805	136	30	in	in	ADP
fnp-3805	136	31	a	a	DET
fnp-3805	136	32	reduction	reduction	NOUN
fnp-3805	136	33	of	of	ADP
fnp-3805	136	34	the	the	DET
fnp-3805	136	35	mechanical	mechanical	ADJ
fnp-3805	136	36	force	force	NOUN
fnp-3805	136	37	generated	generate	VERB
fnp-3805	136	38	during	during	ADP
fnp-3805	136	39	muscle	muscle	NOUN
fnp-3805	136	40	contraction	contraction	NOUN
fnp-3805	136	41	(	(	PUNCT
fnp-3805	136	42	i.e.	i.e.	X
fnp-3805	136	43	,	,	PUNCT
fnp-3805	136	44	muscle	muscle	NOUN
fnp-3805	136	45	weakness	weakness	NOUN
fnp-3805	136	46	)	)	PUNCT
fnp-3805	136	47	and	and	CCONJ
fnp-3805	136	48	a	a	DET
fnp-3805	136	49	failure	failure	NOUN
fnp-3805	136	50	of	of	ADP
fnp-3805	136	51	muscle	muscle	NOUN
fnp-3805	136	52	regeneration	regeneration	NOUN
fnp-3805	136	53	.	.	PUNCT
fnp-3805	137	1	finally	finally	ADV
fnp-3805	137	2	,	,	PUNCT
fnp-3805	137	3	cargo	cargo	NOUN
fnp-3805	137	4	recognition	recognition	NOUN
fnp-3805	137	5	defects	defect	NOUN
fnp-3805	137	6	lead	lead	VERB
fnp-3805	137	7	to	to	ADP
fnp-3805	137	8	two	two	NUM
fnp-3805	137	9	different	different	ADJ
fnp-3805	137	10	,	,	PUNCT
fnp-3805	137	11	defect	defect	NOUN
fnp-3805	137	12	-	-	PUNCT
fnp-3805	137	13	specific	specific	ADJ
fnp-3805	137	14	disease	disease	NOUN
fnp-3805	137	15	phenotypes	phenotype	NOUN
fnp-3805	137	16	:	:	PUNCT
fnp-3805	137	17	a	a	DET
fnp-3805	137	18	granulophagy	granulophagy	ADJ
fnp-3805	137	19	defect	defect	NOUN
fnp-3805	137	20	results	result	NOUN
fnp-3805	137	21	in	in	ADP
fnp-3805	137	22	rimmed	rimmed	ADJ
fnp-3805	137	23	vacuole	vacuole	NOUN
fnp-3805	137	24	formation	formation	NOUN
fnp-3805	137	25	and	and	CCONJ
fnp-3805	137	26	inclusion	inclusion	NOUN
fnp-3805	137	27	body	body	NOUN
fnp-3805	137	28	myopathy	myopathy	ADJ
fnp-3805	137	29	,	,	PUNCT
fnp-3805	137	30	while	while	SCONJ
fnp-3805	137	31	a	a	DET
fnp-3805	137	32	casa	casa	PROPN
fnp-3805	137	33	defect	defect	NOUN
fnp-3805	137	34	causes	cause	VERB
fnp-3805	137	35	myofibrillar	myofibrillar	ADJ
fnp-3805	137	36	myopathy	myopathy	ADJ
fnp-3805	137	37	by	by	ADP
fnp-3805	137	38	impairing	impair	VERB
fnp-3805	137	39	z	z	NOUN
fnp-3805	137	40	-	-	PUNCT
fnp-3805	137	41	disc	disc	NOUN
fnp-3805	137	42	stability	stability	NOUN
fnp-3805	137	43	.	.	PUNCT
fnp-3805	138	1	the	the	DET
fnp-3805	138	2	electron	electron	NOUN
fnp-3805	138	3	micrographs	micrograph	NOUN
fnp-3805	138	4	illustrate	illustrate	VERB
fnp-3805	138	5	(	(	PUNCT
fnp-3805	138	6	a	a	PRON
fnp-3805	138	7	)	)	PUNCT
fnp-3805	138	8	subsarcolemmal	subsarcolemmal	ADJ
fnp-3805	138	9	accumulation	accumulation	NOUN
fnp-3805	138	10	of	of	ADP
fnp-3805	138	11	damaged	damage	VERB
fnp-3805	138	12	mitochondria	mitochondria	NOUN
fnp-3805	138	13	that	that	PRON
fnp-3805	138	14	show	show	VERB
fnp-3805	138	15	marked	mark	VERB
fnp-3805	138	16	variation	variation	NOUN
fnp-3805	138	17	in	in	ADP
fnp-3805	138	18	their	their	PRON
fnp-3805	138	19	size	size	NOUN
fnp-3805	138	20	and	and	CCONJ
fnp-3805	138	21	shape	shape	NOUN
fnp-3805	138	22	;	;	PUNCT
fnp-3805	138	23	(	(	PUNCT
fnp-3805	138	24	b	b	X
fnp-3805	138	25	)	)	PUNCT
fnp-3805	138	26	an	an	DET
fnp-3805	138	27	autophagic	autophagic	ADJ
fnp-3805	138	28	vacuole	vacuole	NOUN
fnp-3805	138	29	with	with	ADP
fnp-3805	138	30	an	an	DET
fnp-3805	138	31	accumulation	accumulation	NOUN
fnp-3805	138	32	of	of	ADP
fnp-3805	138	33	undigested	undigested	ADJ
fnp-3805	138	34	,	,	PUNCT
fnp-3805	138	35	electron	electron	NOUN
fnp-3805	138	36	-	-	PUNCT
fnp-3805	138	37	dense	dense	ADJ
fnp-3805	138	38	autophagic	autophagic	ADJ
fnp-3805	138	39	cargo	cargo	NOUN
fnp-3805	138	40	;	;	PUNCT
fnp-3805	138	41	(	(	PUNCT
fnp-3805	138	42	c	c	X
fnp-3805	138	43	)	)	PUNCT
fnp-3805	138	44	a	a	DET
fnp-3805	138	45	rimmed	rimmed	ADJ
fnp-3805	138	46	vacuole	vacuole	NOUN
fnp-3805	138	47	with	with	ADP
fnp-3805	138	48	a	a	DET
fnp-3805	138	49	rim	rim	NOUN
fnp-3805	138	50	of	of	ADP
fnp-3805	138	51	autophagic	autophagic	ADJ
fnp-3805	138	52	material	material	NOUN
fnp-3805	138	53	and	and	CCONJ
fnp-3805	138	54	a	a	DET
fnp-3805	138	55	center	center	NOUN
fnp-3805	138	56	that	that	PRON
fnp-3805	138	57	consists	consist	VERB
fnp-3805	138	58	of	of	ADP
fnp-3805	138	59	aggregated	aggregate	VERB
fnp-3805	138	60	proteins	protein	NOUN
fnp-3805	138	61	;	;	PUNCT
fnp-3805	138	62	and	and	CCONJ
fnp-3805	138	63	(	(	PUNCT
fnp-3805	138	64	d	d	NOUN
fnp-3805	138	65	)	)	PUNCT
fnp-3805	138	66	myofibrillar	myofibrillar	ADJ
fnp-3805	138	67	disorganization	disorganization	NOUN
fnp-3805	138	68	with	with	ADP
fnp-3805	138	69	streaming	streaming	NOUN
fnp-3805	138	70	of	of	ADP
fnp-3805	138	71	the	the	DET
fnp-3805	138	72	z	z	NOUN
fnp-3805	138	73	-	-	PUNCT
fnp-3805	138	74	disc	disc	NOUN
fnp-3805	138	75	material	material	NOUN
fnp-3805	138	76	.	.	PUNCT
fnp-3805	139	1	[	[	X
fnp-3805	139	2	this	this	DET
fnp-3805	139	3	figure	figure	NOUN
fnp-3805	139	4	and	and	CCONJ
fnp-3805	139	5	its	its	PRON
fnp-3805	139	6	legend	legend	NOUN
fnp-3805	139	7	are	be	AUX
fnp-3805	139	8	reproduced	reproduce	VERB
fnp-3805	139	9	from	from	ADP
fnp-3805	139	10	(	(	PUNCT
fnp-3805	139	11	margeta	margeta	NOUN
fnp-3805	139	12	,	,	PUNCT
fnp-3805	139	13	2020a	2020a	NUM
fnp-3805	139	14	)	)	PUNCT
fnp-3805	139	15	with	with	ADP
fnp-3805	139	16	permission	permission	NOUN
fnp-3805	139	17	from	from	ADP
fnp-3805	139	18	the	the	DET
fnp-3805	139	19	annual	annual	ADJ
fnp-3805	139	20	review	review	NOUN
fnp-3805	139	21	of	of	ADP
fnp-3805	139	22	pathology	pathology	NOUN
fnp-3805	139	23	:	:	PUNCT
fnp-3805	139	24	mechanisms	mechanism	NOUN
fnp-3805	139	25	of	of	ADP
fnp-3805	139	26	disease	disease	NOUN
fnp-3805	139	27	,	,	PUNCT
fnp-3805	139	28	volume	volume	NOUN
fnp-3805	139	29	15	15	NUM
fnp-3805	139	30	©	©	PROPN
fnp-3805	139	31	2020	2020	NUM
fnp-3805	139	32	by	by	ADP
fnp-3805	139	33	annual	annual	ADJ
fnp-3805	139	34	reviews	review	NOUN
fnp-3805	139	35	,	,	PUNCT
fnp-3805	139	36	http://www.annualreviews.org/.	http://www.annualreviews.org/.	PROPN
fnp-3805	139	37	]	]	PUNCT
fnp-3805	139	38	when	when	SCONJ
fnp-3805	139	39	there	there	PRON
fnp-3805	139	40	is	be	VERB
fnp-3805	139	41	a	a	DET
fnp-3805	139	42	block	block	NOUN
fnp-3805	139	43	of	of	ADP
fnp-3805	139	44	autophagy	autophagy	ADJ
fnp-3805	139	45	induction	induction	NOUN
fnp-3805	139	46	,	,	PUNCT
fnp-3805	139	47	autophagosomes	autophagosome	NOUN
fnp-3805	139	48	do	do	AUX
fnp-3805	139	49	not	not	PART
fnp-3805	139	50	normally	normally	ADV
fnp-3805	139	51	form	form	VERB
fnp-3805	139	52	and	and	CCONJ
fnp-3805	139	53	therefore	therefore	ADV
fnp-3805	139	54	can	can	AUX
fnp-3805	139	55	not	not	PART
fnp-3805	139	56	significantly	significantly	ADV
fnp-3805	139	57	accumulate	accumulate	VERB
fnp-3805	139	58	;	;	PUNCT
fnp-3805	139	59	however	however	ADV
fnp-3805	139	60	,	,	PUNCT
fnp-3805	139	61	there	there	PRON
fnp-3805	139	62	is	be	VERB
fnp-3805	139	63	accumulation	accumulation	NOUN
fnp-3805	139	64	of	of	ADP
fnp-3805	139	65	damaged	damage	VERB
fnp-3805	139	66	and	and	CCONJ
fnp-3805	139	67	degenerating	degenerate	VERB
fnp-3805	139	68	intracellular	intracellular	ADJ
fnp-3805	139	69	organelles	organelle	NOUN
fnp-3805	139	70	,	,	PUNCT
fnp-3805	139	71	which	which	PRON
fnp-3805	139	72	ultimately	ultimately	ADV
fnp-3805	139	73	leads	lead	VERB
fnp-3805	139	74	to	to	PART
fnp-3805	139	75	fiber	fiber	VERB
fnp-3805	139	76	atrophy	atrophy	NOUN
fnp-3805	139	77	and	and	CCONJ
fnp-3805	139	78	apoptosis	apoptosis	NOUN
fnp-3805	139	79	.	.	PUNCT
fnp-3805	140	1	the	the	DET
fnp-3805	140	2	autophagy	autophagy	ADJ
fnp-3805	140	3	induction	induction	NOUN
fnp-3805	140	4	defect	defect	NOUN
fnp-3805	140	5	plays	play	VERB
fnp-3805	140	6	an	an	DET
fnp-3805	140	7	important	important	ADJ
fnp-3805	140	8	role	role	NOUN
fnp-3805	140	9	in	in	ADP
fnp-3805	140	10	the	the	DET
fnp-3805	140	11	pathogenesis	pathogenesis	NOUN
fnp-3805	140	12	of	of	ADP
fnp-3805	140	13	at	at	ADV
fnp-3805	140	14	least	least	ADJ
fnp-3805	140	15	some	some	PRON
fnp-3805	140	16	muscular	muscular	ADJ
fnp-3805	140	17	dystrophies	dystrophy	NOUN
fnp-3805	140	18	and	and	CCONJ
fnp-3805	140	19	congenital	congenital	ADJ
fnp-3805	140	20	myopathies	myopathy	NOUN
fnp-3805	140	21	;	;	PUNCT
fnp-3805	140	22	however	however	ADV
fnp-3805	140	23	,	,	PUNCT
fnp-3805	140	24	the	the	DET
fnp-3805	140	25	complete	complete	ADJ
fnp-3805	140	26	block	block	NOUN
fnp-3805	140	27	of	of	ADP
fnp-3805	140	28	autophagy	autophagy	ADJ
fnp-3805	140	29	induction	induction	NOUN
fnp-3805	140	30	is	be	AUX
fnp-3805	140	31	embryonically	embryonically	ADV
fnp-3805	140	32	or	or	CCONJ
fnp-3805	140	33	perinatally	perinatally	ADV
fnp-3805	140	34	lethal	lethal	VERB
fnp-3805	140	35	in	in	ADP
fnp-3805	140	36	animal	animal	NOUN
fnp-3805	140	37	models	model	NOUN
fnp-3805	140	38	,	,	PUNCT
fnp-3805	140	39	and	and	CCONJ
fnp-3805	140	40	no	no	DET
fnp-3805	140	41	human	human	ADJ
fnp-3805	140	42	disease	disease	NOUN
fnp-3805	140	43	has	have	AUX
fnp-3805	140	44	previously	previously	ADV
fnp-3805	140	45	been	be	AUX
fnp-3805	140	46	attributed	attribute	VERB
fnp-3805	140	47	to	to	ADP
fnp-3805	140	48	mutations	mutation	NOUN
fnp-3805	140	49	in	in	ADP
fnp-3805	140	50	one	one	NUM
fnp-3805	140	51	of	of	ADP
fnp-3805	140	52	the	the	DET
fnp-3805	140	53	core	core	NOUN
fnp-3805	140	54	autophagy	autophagy	NOUN
fnp-3805	140	55	genes	gene	NOUN
fnp-3805	140	56	(	(	PUNCT
fnp-3805	140	57	margeta	margeta	NOUN
fnp-3805	140	58	,	,	PUNCT
fnp-3805	140	59	2020a	2020a	NUM
fnp-3805	140	60	)	)	PUNCT
fnp-3805	140	61	.	.	PUNCT
fnp-3805	141	1	that	that	PRON
fnp-3805	141	2	changed	change	VERB
fnp-3805	141	3	in	in	ADP
fnp-3805	141	4	2021	2021	NUM
fnp-3805	141	5	,	,	PUNCT
fnp-3805	141	6	when	when	SCONJ
fnp-3805	141	7	collier	collier	PROPN
fnp-3805	141	8	at	at	ADP
fnp-3805	141	9	al	al	PROPN
fnp-3805	141	10	.	.	PROPN
fnp-3805	141	11	identified	identify	VERB
fnp-3805	141	12	five	five	NUM
fnp-3805	141	13	independent	independent	ADJ
fnp-3805	141	14	families	family	NOUN
fnp-3805	141	15	with	with	ADP
fnp-3805	141	16	autosomal	autosomal	ADJ
fnp-3805	141	17	recessive	recessive	ADJ
fnp-3805	141	18	mutations	mutation	NOUN
fnp-3805	141	19	in	in	ADP
fnp-3805	141	20	atg7	atg7	PROPN
fnp-3805	141	21	(	(	PUNCT
fnp-3805	141	22	a	a	DET
fnp-3805	141	23	core	core	NOUN
fnp-3805	141	24	autophagy	autophagy	ADV
fnp-3805	141	25	-	-	PUNCT
fnp-3805	141	26	related	relate	VERB
fnp-3805	141	27	protein	protein	NOUN
fnp-3805	141	28	that	that	PRON
fnp-3805	141	29	is	be	AUX
fnp-3805	141	30	required	require	VERB
fnp-3805	141	31	for	for	ADP
fnp-3805	141	32	lipidation	lipidation	NOUN
fnp-3805	141	33	of	of	ADP
fnp-3805	141	34	lc3	lc3	NOUN
fnp-3805	141	35	,	,	PUNCT
fnp-3805	141	36	the	the	DET
fnp-3805	141	37	key	key	ADJ
fnp-3805	141	38	step	step	NOUN
fnp-3805	141	39	in	in	ADP
fnp-3805	141	40	induction	induction	NOUN
fnp-3805	141	41	of	of	ADP
fnp-3805	141	42	degradative	degradative	ADJ
fnp-3805	141	43	autophagy	autophagy	NOUN
fnp-3805	141	44	)	)	PUNCT
fnp-3805	141	45	;	;	PUNCT
fnp-3805	141	46	the	the	DET
fnp-3805	141	47	affected	affect	VERB
fnp-3805	141	48	individuals	individual	NOUN
fnp-3805	141	49	have	have	VERB
fnp-3805	141	50	a	a	DET
fnp-3805	141	51	complex	complex	ADJ
fnp-3805	141	52	developmental	developmental	ADJ
fnp-3805	141	53	disorder	disorder	NOUN
fnp-3805	141	54	that	that	PRON
fnp-3805	141	55	commonly	commonly	ADV
fnp-3805	141	56	includes	include	VERB
fnp-3805	141	57	cerebellar	cerebellar	ADJ
fnp-3805	141	58	hypoplasia	hypoplasia	NOUN
fnp-3805	141	59	,	,	PUNCT
fnp-3805	141	60	corpus	corpus	NOUN
fnp-3805	141	61	callosum	callosum	NOUN
fnp-3805	141	62	abnormalities	abnormality	NOUN
fnp-3805	141	63	,	,	PUNCT
fnp-3805	141	64	facial	facial	ADJ
fnp-3805	141	65	dysmorphism	dysmorphism	NOUN
fnp-3805	141	66	,	,	PUNCT
fnp-3805	141	67	and	and	CCONJ
fnp-3805	141	68	mild	mild	ADJ
fnp-3805	141	69	proximal	proximal	ADJ
fnp-3805	141	70	myopathy	myopathy	NOUN
fnp-3805	141	71	(	(	PUNCT
fnp-3805	141	72	collier	collier	PROPN
fnp-3805	141	73	et	et	PROPN
fnp-3805	141	74	al	al	PROPN
fnp-3805	141	75	.	.	PROPN
fnp-3805	141	76	,	,	PUNCT
fnp-3805	141	77	2021	2021	NUM
fnp-3805	141	78	)	)	PUNCT
fnp-3805	141	79	.	.	PUNCT
fnp-3805	142	1	muscle	muscle	NOUN
fnp-3805	142	2	biopsies	biopsy	NOUN
fnp-3805	142	3	were	be	AUX
fnp-3805	142	4	performed	perform	VERB
fnp-3805	142	5	on	on	ADP
fnp-3805	142	6	a	a	DET
fnp-3805	142	7	few	few	ADJ
fnp-3805	142	8	affected	affect	VERB
fnp-3805	142	9	individuals	individual	NOUN
fnp-3805	142	10	and	and	CCONJ
fnp-3805	142	11	showed	show	VERB
fnp-3805	142	12	mild	mild	ADJ
fnp-3805	142	13	myopathic	myopathic	ADJ
fnp-3805	142	14	changes	change	NOUN
fnp-3805	142	15	mimicking	mimic	VERB
fnp-3805	142	16	those	those	PRON
fnp-3805	142	17	seen	see	VERB
fnp-3805	142	18	in	in	ADP
fnp-3805	142	19	the	the	DET
fnp-3805	142	20	autophagy	autophagy	ADJ
fnp-3805	142	21	-	-	PUNCT
fnp-3805	142	22	deficient	deficient	ADJ
fnp-3805	142	23	murine	murine	ADJ
fnp-3805	142	24	muscle	muscle	NOUN
fnp-3805	142	25	,	,	PUNCT
fnp-3805	142	26	with	with	ADP
fnp-3805	142	27	moderate	moderate	ADJ
fnp-3805	142	28	mitochondrial	mitochondrial	ADJ
fnp-3805	142	29	abnormalities	abnormality	NOUN
fnp-3805	142	30	,	,	PUNCT
fnp-3805	142	31	lipofuscin	lipofuscin	VERB
fnp-3805	142	32	accumulation	accumulation	NOUN
fnp-3805	142	33	,	,	PUNCT
fnp-3805	142	34	subsarcolemmal	subsarcolemmal	ADJ
fnp-3805	142	35	accumulation	accumulation	NOUN
fnp-3805	142	36	of	of	ADP
fnp-3805	142	37	autophagic	autophagic	ADJ
fnp-3805	142	38	cargo	cargo	NOUN
fnp-3805	142	39	receptor	receptor	NOUN
fnp-3805	142	40	p62	p62	NOUN
fnp-3805	142	41	/	/	SYM
fnp-3805	142	42	sqstm1	sqstm1	NOUN
fnp-3805	142	43	(	(	PUNCT
fnp-3805	142	44	encoded	encode	VERB
fnp-3805	142	45	by	by	ADP
fnp-3805	142	46	sqstm1	sqstm1	NOUN
fnp-3805	142	47	gene	gene	NOUN
fnp-3805	142	48	)	)	PUNCT
fnp-3805	142	49	,	,	PUNCT
fnp-3805	142	50	and	and	CCONJ
fnp-3805	142	51	diminished	diminished	ADJ
fnp-3805	142	52	levels	level	NOUN
fnp-3805	142	53	of	of	ADP
fnp-3805	142	54	lc3	lc3	NOUN
fnp-3805	142	55	-	-	NOUN
fnp-3805	142	56	ii	ii	PROPN
fnp-3805	142	57	(	(	PUNCT
fnp-3805	142	58	the	the	DET
fnp-3805	142	59	lipidated	lipidate	VERB
fnp-3805	142	60	,	,	PUNCT
fnp-3805	142	61	autophagosome	autophagosome	NOUN
fnp-3805	142	62	-	-	PUNCT
fnp-3805	142	63	bound	bind	VERB
fnp-3805	142	64	form	form	NOUN
fnp-3805	142	65	of	of	ADP
fnp-3805	142	66	lc3	lc3	NOUN
fnp-3805	142	67	)	)	PUNCT
fnp-3805	142	68	;	;	PUNCT
fnp-3805	142	69	while	while	SCONJ
fnp-3805	142	70	some	some	DET
fnp-3805	142	71	autophagosomes	autophagosome	NOUN
fnp-3805	142	72	were	be	AUX
fnp-3805	142	73	present	present	ADJ
fnp-3805	142	74	,	,	PUNCT
fnp-3805	142	75	there	there	PRON
fnp-3805	142	76	was	be	VERB
fnp-3805	142	77	no	no	DET
fnp-3805	142	78	accumulation	accumulation	NOUN
fnp-3805	142	79	of	of	ADP
fnp-3805	142	80	autophagic	autophagic	ADJ
fnp-3805	142	81	vacuoles	vacuole	NOUN
fnp-3805	142	82	.	.	PUNCT
fnp-3805	143	1	intriguingly	intriguingly	ADV
fnp-3805	143	2	,	,	PUNCT
fnp-3805	143	3	another	another	DET
fnp-3805	143	4	potential	potential	ADJ
fnp-3805	143	5	myopathy	myopathy	NOUN
fnp-3805	143	6	with	with	ADP
fnp-3805	143	7	impaired	impaired	ADJ
fnp-3805	143	8	autophagy	autophagy	NOUN
fnp-3805	143	9	induction	induction	NOUN
fnp-3805	143	10	was	be	AUX
fnp-3805	143	11	reported	report	VERB
fnp-3805	143	12	last	last	ADJ
fnp-3805	143	13	year	year	NOUN
fnp-3805	143	14	by	by	ADP
fnp-3805	143	15	napolitano	napolitano	PROPN
fnp-3805	143	16	and	and	CCONJ
fnp-3805	143	17	co	co	NOUN
fnp-3805	143	18	-	-	NOUN
fnp-3805	143	19	authors	author	NOUN
fnp-3805	143	20	(	(	PUNCT
fnp-3805	143	21	napolitano	napolitano	PROPN
fnp-3805	143	22	et	et	PROPN
fnp-3805	143	23	al	al	PROPN
fnp-3805	143	24	.	.	PROPN
fnp-3805	143	25	,	,	PUNCT
fnp-3805	143	26	2021	2021	NUM
fnp-3805	143	27	):	):	PUNCT
fnp-3805	143	28	while	while	SCONJ
fnp-3805	143	29	these	these	DET
fnp-3805	143	30	authors	author	NOUN
fnp-3805	143	31	classified	classify	VERB
fnp-3805	143	32	their	their	PRON
fnp-3805	143	33	patient	patient	NOUN
fnp-3805	143	34	6	6	NUM
fnp-3805	143	35	as	as	ADP
fnp-3805	143	36	having	have	VERB
fnp-3805	143	37	an	an	DET
fnp-3805	143	38	avm	avm	NOUN
fnp-3805	143	39	,	,	PUNCT
fnp-3805	143	40	his	his	PRON
fnp-3805	143	41	muscle	muscle	NOUN
fnp-3805	143	42	biopsy	biopsy	NOUN
fnp-3805	143	43	showed	show	VERB
fnp-3805	143	44	high	high	ADJ
fnp-3805	143	45	p62	p62	NOUN
fnp-3805	143	46	and	and	CCONJ
fnp-3805	143	47	low	low	ADJ
fnp-3805	143	48	lc3	lc3	NOUN
fnp-3805	143	49	-	-	NOUN
fnp-3805	143	50	ii	ii	NOUN
fnp-3805	143	51	(	(	PUNCT
fnp-3805	143	52	as	as	SCONJ
fnp-3805	143	53	would	would	AUX
fnp-3805	143	54	be	be	AUX
fnp-3805	143	55	expected	expect	VERB
fnp-3805	143	56	with	with	ADP
fnp-3805	143	57	the	the	DET
fnp-3805	143	58	autophagy	autophagy	ADJ
fnp-3805	143	59	initiation	initiation	NOUN
fnp-3805	143	60	defect	defect	NOUN
fnp-3805	143	61	)	)	PUNCT
fnp-3805	143	62	rather	rather	ADV
fnp-3805	143	63	than	than	ADP
fnp-3805	143	64	high	high	ADJ
fnp-3805	143	65	levels	level	NOUN
fnp-3805	143	66	of	of	ADP
fnp-3805	143	67	both	both	PRON
fnp-3805	143	68	p62	p62	NOUN
fnp-3805	143	69	and	and	CCONJ
fnp-3805	143	70	lc3	lc3	NOUN
fnp-3805	143	71	-	-	NOUN
fnp-3805	143	72	ii	ii	NOUN
fnp-3805	143	73	(	(	PUNCT
fnp-3805	143	74	as	as	SCONJ
fnp-3805	143	75	would	would	AUX
fnp-3805	143	76	be	be	AUX
fnp-3805	143	77	expected	expect	VERB
fnp-3805	143	78	in	in	ADP
fnp-3805	143	79	a	a	DET
fnp-3805	143	80	true	true	ADJ
fnp-3805	143	81	avm	avm	PROPN
fnp-3805	143	82	caused	cause	VERB
fnp-3805	143	83	by	by	ADP
fnp-3805	143	84	the	the	DET
fnp-3805	143	85	autophagic	autophagic	PROPN
fnp-3805	143	86	flux	flux	NOUN
fnp-3805	143	87	defect	defect	NOUN
fnp-3805	143	88	)	)	PUNCT
fnp-3805	143	89	.	.	PUNCT
fnp-3805	144	1	interestingly	interestingly	ADV
fnp-3805	144	2	,	,	PUNCT
fnp-3805	144	3	that	that	DET
fnp-3805	144	4	individual	individual	NOUN
fnp-3805	144	5	was	be	AUX
fnp-3805	144	6	found	find	VERB
fnp-3805	144	7	to	to	PART
fnp-3805	144	8	carry	carry	VERB
fnp-3805	144	9	a	a	DET
fnp-3805	144	10	potentially	potentially	ADV
fnp-3805	144	11	deleterious	deleterious	ADJ
fnp-3805	144	12	variant	variant	NOUN
fnp-3805	144	13	in	in	ADP
fnp-3805	144	14	tbc1d5	tbc1d5	PROPN
fnp-3805	144	15	gene	gene	NOUN
fnp-3805	144	16	,	,	PUNCT
fnp-3805	144	17	which	which	PRON
fnp-3805	144	18	has	have	AUX
fnp-3805	144	19	not	not	PART
fnp-3805	144	20	previously	previously	ADV
fnp-3805	144	21	been	be	AUX
fnp-3805	144	22	associated	associate	VERB
fnp-3805	144	23	with	with	ADP
fnp-3805	144	24	human	human	ADJ
fnp-3805	144	25	disease	disease	NOUN
fnp-3805	144	26	but	but	CCONJ
fnp-3805	144	27	was	be	AUX
fnp-3805	144	28	shown	show	VERB
fnp-3805	144	29	to	to	PART
fnp-3805	144	30	regulate	regulate	VERB
fnp-3805	144	31	autophagy	autophagy	ADJ
fnp-3805	144	32	initiation	initiation	NOUN
fnp-3805	144	33	(	(	PUNCT
fnp-3805	144	34	popovic	popovic	ADJ
fnp-3805	144	35	and	and	CCONJ
fnp-3805	144	36	dikic	dikic	NOUN
fnp-3805	144	37	,	,	PUNCT
fnp-3805	144	38	2014	2014	NUM
fnp-3805	144	39	)	)	PUNCT
fnp-3805	144	40	.	.	PUNCT
fnp-3805	145	1	specific	specific	ADJ
fnp-3805	145	2	classification	classification	NOUN
fnp-3805	145	3	of	of	ADP
fnp-3805	145	4	tbc1d5	tbc1d5	NOUN
fnp-3805	145	5	-	-	PUNCT
fnp-3805	145	6	associated	associate	VERB
fnp-3805	145	7	myopathy	myopathy	NOUN
fnp-3805	145	8	aside	aside	ADV
fnp-3805	145	9	,	,	PUNCT
fnp-3805	145	10	napolitano	napolitano	PROPN
fnp-3805	145	11	et	et	PROPN
fnp-3805	145	12	al	al	PROPN
fnp-3805	145	13	.	.	PROPN
fnp-3805	145	14	showed	show	VERB
fnp-3805	145	15	that	that	SCONJ
fnp-3805	145	16	the	the	DET
fnp-3805	145	17	avm	avm	PROPN
fnp-3805	145	18	pathology	pathology	NOUN
fnp-3805	145	19	mimicking	mimic	VERB
fnp-3805	145	20	late	late	ADJ
fnp-3805	145	21	-	-	PUNCT
fnp-3805	145	22	onset	onset	NOUN
fnp-3805	145	23	pompe	pompe	NOUN
fnp-3805	145	24	disease	disease	NOUN
fnp-3805	145	25	(	(	PUNCT
fnp-3805	145	26	lopd	lopd	NOUN
fnp-3805	145	27	)	)	PUNCT
fnp-3805	145	28	can	can	AUX
fnp-3805	145	29	be	be	AUX
fnp-3805	145	30	associated	associate	VERB
fnp-3805	145	31	with	with	ADP
fnp-3805	145	32	mutations	mutation	NOUN
fnp-3805	145	33	in	in	ADP
fnp-3805	145	34	genes	gene	NOUN
fnp-3805	145	35	not	not	PART
fnp-3805	145	36	previously	previously	ADV
fnp-3805	145	37	associated	associate	VERB
fnp-3805	145	38	with	with	ADP
fnp-3805	145	39	this	this	DET
fnp-3805	145	40	clinicopathologic	clinicopathologic	ADJ
fnp-3805	145	41	phenotype	phenotype	NOUN
fnp-3805	145	42	(	(	PUNCT
fnp-3805	145	43	such	such	ADJ
fnp-3805	145	44	as	as	ADP
fnp-3805	145	45	titin	titin	PROPN
fnp-3805	145	46	,	,	PUNCT
fnp-3805	145	47	dysferlin	dysferlin	PROPN
fnp-3805	145	48	,	,	PUNCT
fnp-3805	145	49	plectin	plectin	NOUN
fnp-3805	145	50	,	,	PUNCT
fnp-3805	145	51	and	and	CCONJ
fnp-3805	145	52	perilipin	perilipin	NOUN
fnp-3805	145	53	3	3	NUM
fnp-3805	145	54	,	,	PUNCT
fnp-3805	145	55	among	among	ADP
fnp-3805	145	56	others	other	NOUN
fnp-3805	145	57	)	)	PUNCT
fnp-3805	145	58	;	;	PUNCT
fnp-3805	145	59	this	this	PRON
fnp-3805	145	60	highlights	highlight	VERB
fnp-3805	145	61	the	the	DET
fnp-3805	145	62	importance	importance	NOUN
fnp-3805	145	63	of	of	ADP
fnp-3805	145	64	genetic	genetic	ADJ
fnp-3805	145	65	diagnosis	diagnosis	NOUN
fnp-3805	145	66	for	for	ADP
fnp-3805	145	67	lopd	lopd	NOUN
fnp-3805	145	68	,	,	PUNCT
fnp-3805	145	69	which	which	PRON
fnp-3805	145	70	can	can	AUX
fnp-3805	145	71	be	be	AUX
fnp-3805	145	72	treated	treat	VERB
fnp-3805	145	73	by	by	ADP
fnp-3805	145	74	enzyme	enzyme	NOUN
fnp-3805	145	75	replacement	replacement	NOUN
fnp-3805	145	76	therapy	therapy	NOUN
fnp-3805	145	77	(	(	PUNCT
fnp-3805	145	78	ert	ert	PROPN
fnp-3805	145	79	;	;	PUNCT
fnp-3805	145	80	further	far	ADV
fnp-3805	145	81	discussed	discuss	VERB
fnp-3805	145	82	in	in	ADP
fnp-3805	145	83	advance	advance	NOUN
fnp-3805	145	84	#	#	SYM
fnp-3805	145	85	10	10	NUM
fnp-3805	145	86	)	)	PUNCT
fnp-3805	145	87	–	–	PUNCT
fnp-3805	145	88	a	a	DET
fnp-3805	145	89	treatment	treatment	NOUN
fnp-3805	145	90	that	that	PRON
fnp-3805	145	91	is	be	AUX
fnp-3805	145	92	unlikely	unlikely	ADJ
fnp-3805	145	93	to	to	PART
fnp-3805	145	94	be	be	AUX
fnp-3805	145	95	effective	effective	ADJ
fnp-3805	145	96	if	if	SCONJ
fnp-3805	145	97	the	the	DET
fnp-3805	145	98	underlying	underlie	VERB
fnp-3805	145	99	molecular	molecular	ADJ
fnp-3805	145	100	defect	defect	NOUN
fnp-3805	145	101	is	be	AUX
fnp-3805	145	102	not	not	PART
fnp-3805	145	103	acid	acid	ADJ
fnp-3805	145	104	α	α	NOUN
fnp-3805	145	105	-	-	NOUN
fnp-3805	145	106	glucosidase	glucosidase	ADJ
fnp-3805	145	107	(	(	PUNCT
fnp-3805	145	108	gaa	gaa	NOUN
fnp-3805	145	109	)	)	PUNCT
fnp-3805	145	110	deficiency	deficiency	NOUN
fnp-3805	145	111	.	.	PUNCT
fnp-3805	146	1	cargo	cargo	NOUN
fnp-3805	146	2	recognition	recognition	NOUN
fnp-3805	146	3	defects	defect	NOUN
fnp-3805	146	4	,	,	PUNCT
fnp-3805	146	5	which	which	PRON
fnp-3805	146	6	result	result	VERB
fnp-3805	146	7	in	in	ADP
fnp-3805	146	8	selective	selective	ADJ
fnp-3805	146	9	(	(	PUNCT
fnp-3805	146	10	rather	rather	ADV
fnp-3805	146	11	than	than	ADP
fnp-3805	146	12	global	global	ADJ
fnp-3805	146	13	)	)	PUNCT
fnp-3805	146	14	autophagy	autophagy	ADJ
fnp-3805	146	15	dysfunction	dysfunction	NOUN
fnp-3805	146	16	,	,	PUNCT
fnp-3805	146	17	can	can	AUX
fnp-3805	146	18	also	also	ADV
fnp-3805	146	19	cause	cause	VERB
fnp-3805	146	20	muscle	muscle	NOUN
fnp-3805	146	21	disease	disease	NOUN
fnp-3805	146	22	:	:	PUNCT
fnp-3805	146	23	impairment	impairment	NOUN
fnp-3805	146	24	of	of	ADP
fnp-3805	146	25	granulophagy	granulophagy	ADJ
fnp-3805	146	26	(	(	PUNCT
fnp-3805	146	27	autophagy	autophagy	NOUN
fnp-3805	146	28	of	of	ADP
fnp-3805	146	29	stress	stress	NOUN
fnp-3805	146	30	granules	granule	NOUN
fnp-3805	146	31	,	,	PUNCT
fnp-3805	146	32	which	which	PRON
fnp-3805	146	33	are	be	AUX
fnp-3805	146	34	ribonucleoprotein	ribonucleoprotein	NOUN
fnp-3805	146	35	foci	focus	NOUN
fnp-3805	146	36	that	that	PRON
fnp-3805	146	37	form	form	VERB
fnp-3805	146	38	under	under	ADP
fnp-3805	146	39	cellular	cellular	ADJ
fnp-3805	146	40	stress	stress	NOUN
fnp-3805	146	41	and	and	CCONJ
fnp-3805	146	42	,	,	PUNCT
fnp-3805	146	43	if	if	SCONJ
fnp-3805	146	44	persistent	persistent	ADJ
fnp-3805	146	45	,	,	PUNCT
fnp-3805	146	46	need	need	VERB
fnp-3805	146	47	to	to	PART
fnp-3805	146	48	be	be	AUX
fnp-3805	146	49	degraded	degrade	VERB
fnp-3805	146	50	via	via	ADP
fnp-3805	146	51	autophagy	autophagy	NOUN
fnp-3805	146	52	)	)	PUNCT
fnp-3805	146	53	leads	lead	VERB
fnp-3805	146	54	to	to	ADP
fnp-3805	146	55	an	an	DET
fnp-3805	146	56	inclusion	inclusion	NOUN
fnp-3805	146	57	body	body	NOUN
fnp-3805	146	58	myopathy	myopathy	ADJ
fnp-3805	146	59	phenotype	phenotype	NOUN
fnp-3805	146	60	,	,	PUNCT
fnp-3805	146	61	while	while	SCONJ
fnp-3805	146	62	impairment	impairment	NOUN
fnp-3805	146	63	of	of	ADP
fnp-3805	146	64	chaperone	chaperone	NOUN
fnp-3805	146	65	-	-	PUNCT
fnp-3805	146	66	assisted	assist	VERB
fnp-3805	146	67	selective	selective	ADJ
fnp-3805	146	68	autophagy	autophagy	NOUN
fnp-3805	146	69	(	(	PUNCT
fnp-3805	146	70	casa	casa	PROPN
fnp-3805	146	71	)	)	PUNCT
fnp-3805	146	72	,	,	PUNCT
fnp-3805	146	73	which	which	PRON
fnp-3805	146	74	is	be	AUX
fnp-3805	146	75	critical	critical	ADJ
fnp-3805	146	76	for	for	ADP
fnp-3805	146	77	the	the	DET
fnp-3805	146	78	z	z	NOUN
fnp-3805	146	79	-	-	PUNCT
fnp-3805	146	80	disc	disc	NOUN
fnp-3805	146	81	maintenance	maintenance	NOUN
fnp-3805	146	82	,	,	PUNCT
fnp-3805	146	83	results	result	NOUN
fnp-3805	146	84	in	in	ADP
fnp-3805	146	85	myofibrillar	myofibrillar	ADJ
fnp-3805	146	86	myopathy	myopathy	ADJ
fnp-3805	146	87	(	(	PUNCT
fnp-3805	146	88	fig	fig	NOUN
fnp-3805	146	89	.	.	PUNCT
fnp-3805	147	1	3	3	NUM
fnp-3805	147	2	)	)	PUNCT
fnp-3805	147	3	.	.	PUNCT
fnp-3805	148	1	each	each	PRON
fnp-3805	148	2	of	of	ADP
fnp-3805	148	3	these	these	DET
fnp-3805	148	4	phenotypes	phenotype	NOUN
fnp-3805	148	5	has	have	AUX
fnp-3805	148	6	been	be	AUX
fnp-3805	148	7	associated	associate	VERB
fnp-3805	148	8	with	with	ADP
fnp-3805	148	9	mutations	mutation	NOUN
fnp-3805	148	10	in	in	ADP
fnp-3805	148	11	many	many	ADJ
fnp-3805	148	12	different	different	ADJ
fnp-3805	148	13	genes	gene	NOUN
fnp-3805	148	14	;	;	PUNCT
fnp-3805	148	15	in	in	ADP
fnp-3805	148	16	2021	2021	NUM
fnp-3805	148	17	,	,	PUNCT
fnp-3805	148	18	two	two	NUM
fnp-3805	148	19	new	new	ADJ
fnp-3805	148	20	genes	gene	NOUN
fnp-3805	148	21	were	be	AUX
fnp-3805	148	22	added	add	VERB
fnp-3805	148	23	to	to	ADP
fnp-3805	148	24	this	this	DET
fnp-3805	148	25	ever	ever	ADV
fnp-3805	148	26	-	-	PUNCT
fnp-3805	148	27	growing	grow	VERB
fnp-3805	148	28	list	list	NOUN
fnp-3805	148	29	.	.	PUNCT
fnp-3805	149	1	in	in	ADP
fnp-3805	149	2	the	the	DET
fnp-3805	149	3	first	first	ADJ
fnp-3805	149	4	study	study	NOUN
fnp-3805	149	5	,	,	PUNCT
fnp-3805	149	6	leoni	leoni	PROPN
fnp-3805	149	7	et	et	PROPN
fnp-3805	149	8	al	al	PROPN
fnp-3805	149	9	.	.	PROPN
fnp-3805	149	10	showed	show	VERB
fnp-3805	149	11	that	that	SCONJ
fnp-3805	149	12	autosomal	autosomal	ADJ
fnp-3805	149	13	dominant	dominant	ADJ
fnp-3805	149	14	missense	missense	NOUN
fnp-3805	149	15	variants	variant	NOUN
fnp-3805	149	16	in	in	ADP
fnp-3805	149	17	annexin	annexin	PROPN
fnp-3805	149	18	a11	a11	PROPN
fnp-3805	149	19	,	,	PUNCT
fnp-3805	149	20	a	a	DET
fnp-3805	149	21	505	505	NUM
fnp-3805	149	22	aa	aa	NOUN
fnp-3805	149	23	calcium	calcium	NOUN
fnp-3805	149	24	-	-	PUNCT
fnp-3805	149	25	dependent	dependent	ADJ
fnp-3805	149	26	phospholipid	phospholipid	NOUN
fnp-3805	149	27	-	-	PUNCT
fnp-3805	149	28	binding	bind	VERB
fnp-3805	149	29	protein	protein	NOUN
fnp-3805	149	30	,	,	PUNCT
fnp-3805	149	31	lead	lead	VERB
fnp-3805	149	32	to	to	ADP
fnp-3805	149	33	hereditary	hereditary	ADJ
fnp-3805	149	34	inclusion	inclusion	NOUN
fnp-3805	149	35	body	body	NOUN
fnp-3805	149	36	myopathy	myopathy	ADJ
fnp-3805	149	37	,	,	PUNCT
fnp-3805	149	38	amyotrophic	amyotrophic	ADJ
fnp-3805	149	39	lateral	lateral	ADJ
fnp-3805	149	40	sclerosis	sclerosis	NOUN
fnp-3805	149	41	,	,	PUNCT
fnp-3805	149	42	and	and	CCONJ
fnp-3805	149	43	frontotemporal	frontotemporal	ADJ
fnp-3805	149	44	lobar	lobar	ADJ
fnp-3805	149	45	degeneration	degeneration	NOUN
fnp-3805	149	46	(	(	PUNCT
fnp-3805	149	47	leoni	leoni	PROPN
fnp-3805	149	48	et	et	PROPN
fnp-3805	149	49	al	al	PROPN
fnp-3805	149	50	.	.	PROPN
fnp-3805	149	51	,	,	PUNCT
fnp-3805	149	52	2021	2021	NUM
fnp-3805	149	53	)	)	PUNCT
fnp-3805	149	54	;	;	PUNCT
fnp-3805	149	55	given	give	VERB
fnp-3805	149	56	that	that	SCONJ
fnp-3805	149	57	other	other	ADJ
fnp-3805	149	58	mutations	mutation	NOUN
fnp-3805	149	59	in	in	ADP
fnp-3805	149	60	anxa11	anxa11	NOUN
fnp-3805	149	61	(	(	PUNCT
fnp-3805	149	62	annexin	annexin	PROPN
fnp-3805	149	63	a11	a11	PROPN
fnp-3805	149	64	-	-	PUNCT
fnp-3805	149	65	encoding	encode	VERB
fnp-3805	149	66	gene	gene	NOUN
fnp-3805	149	67	)	)	PUNCT
fnp-3805	149	68	were	be	AUX
fnp-3805	149	69	previously	previously	ADV
fnp-3805	149	70	shown	show	VERB
fnp-3805	149	71	to	to	PART
fnp-3805	149	72	cause	cause	VERB
fnp-3805	149	73	amyotrophic	amyotrophic	ADJ
fnp-3805	149	74	lateral	lateral	ADJ
fnp-3805	149	75	sclerosis	sclerosis	NOUN
fnp-3805	149	76	and	and	CCONJ
fnp-3805	149	77	frontotemporal	frontotemporal	ADJ
fnp-3805	149	78	degeneration	degeneration	NOUN
fnp-3805	149	79	(	(	PUNCT
fnp-3805	149	80	zhang	zhang	PROPN
fnp-3805	149	81	et	et	PROPN
fnp-3805	149	82	al	al	PROPN
fnp-3805	149	83	.	.	PROPN
fnp-3805	149	84	,	,	PUNCT
fnp-3805	149	85	2018	2018	NUM
fnp-3805	149	86	)	)	PUNCT
fnp-3805	149	87	,	,	PUNCT
fnp-3805	149	88	anxa11	anxa11	NOUN
fnp-3805	149	89	is	be	AUX
fnp-3805	149	90	now	now	ADV
fnp-3805	149	91	the	the	DET
fnp-3805	149	92	sixth	sixth	ADJ
fnp-3805	149	93	gene	gene	NOUN
fnp-3805	149	94	known	know	VERB
fnp-3805	149	95	to	to	PART
fnp-3805	149	96	cause	cause	VERB
fnp-3805	149	97	multiple	multiple	ADJ
fnp-3805	149	98	system	system	NOUN
fnp-3805	149	99	proteinopathy	proteinopathy	ADJ
fnp-3805	149	100	(	(	PUNCT
fnp-3805	149	101	msp	msp	PROPN
fnp-3805	149	102	type	type	NOUN
fnp-3805	149	103	6	6	NUM
fnp-3805	149	104	)	)	PUNCT
fnp-3805	149	105	.	.	PUNCT
fnp-3805	150	1	the	the	DET
fnp-3805	150	2	other	other	ADJ
fnp-3805	150	3	5	5	NUM
fnp-3805	150	4	genes	gene	NOUN
fnp-3805	150	5	associated	associate	VERB
fnp-3805	150	6	with	with	ADP
fnp-3805	150	7	the	the	DET
fnp-3805	150	8	msp	msp	PROPN
fnp-3805	150	9	phenotype	phenotype	NOUN
fnp-3805	150	10	encode	encode	VERB
fnp-3805	150	11	either	either	CCONJ
fnp-3805	150	12	rna	rna	NOUN
fnp-3805	150	13	-	-	PUNCT
fnp-3805	150	14	binding	bind	VERB
fnp-3805	150	15	proteins	protein	NOUN
fnp-3805	150	16	that	that	PRON
fnp-3805	150	17	form	form	VERB
fnp-3805	150	18	stress	stress	NOUN
fnp-3805	150	19	granules	granule	NOUN
fnp-3805	150	20	(	(	PUNCT
fnp-3805	150	21	hnrnpa2b1	hnrnpa2b1	X
fnp-3805	150	22	,	,	PUNCT
fnp-3805	150	23	hnrnpa1	hnrnpa1	ADJ
fnp-3805	150	24	,	,	PUNCT
fnp-3805	150	25	and	and	CCONJ
fnp-3805	150	26	matr3	matr3	NOUN
fnp-3805	150	27	genes	gene	NOUN
fnp-3805	150	28	)	)	PUNCT
fnp-3805	150	29	or	or	CCONJ
fnp-3805	150	30	autophagy	autophagy	ADV
fnp-3805	150	31	-	-	PUNCT
fnp-3805	150	32	associated	associate	VERB
fnp-3805	150	33	regulatory	regulatory	ADJ
fnp-3805	150	34	proteins	protein	NOUN
fnp-3805	150	35	(	(	PUNCT
fnp-3805	150	36	vcp	vcp	NOUN
fnp-3805	150	37	and	and	CCONJ
fnp-3805	150	38	sqstm1	sqstm1	NOUN
fnp-3805	150	39	genes	gene	NOUN
fnp-3805	150	40	)	)	PUNCT
fnp-3805	150	41	;	;	PUNCT
fnp-3805	150	42	while	while	SCONJ
fnp-3805	150	43	the	the	DET
fnp-3805	150	44	precise	precise	ADJ
fnp-3805	150	45	function	function	NOUN
fnp-3805	150	46	of	of	ADP
fnp-3805	150	47	annexin	annexin	NOUN
fnp-3805	150	48	11	11	NUM
fnp-3805	150	49	still	still	ADV
fnp-3805	150	50	needs	need	VERB
fnp-3805	150	51	to	to	PART
fnp-3805	150	52	be	be	AUX
fnp-3805	150	53	elucidated	elucidate	VERB
fnp-3805	150	54	,	,	PUNCT
fnp-3805	150	55	it	it	PRON
fnp-3805	150	56	most	most	ADV
fnp-3805	150	57	likely	likely	ADV
fnp-3805	150	58	falls	fall	VERB
fnp-3805	150	59	in	in	ADP
fnp-3805	150	60	the	the	DET
fnp-3805	150	61	latter	latter	ADJ
fnp-3805	150	62	category	category	NOUN
fnp-3805	150	63	given	give	VERB
fnp-3805	150	64	that	that	SCONJ
fnp-3805	150	65	other	other	ADJ
fnp-3805	150	66	annexin	annexin	NOUN
fnp-3805	150	67	a	a	DET
fnp-3805	150	68	proteins	protein	NOUN
fnp-3805	150	69	play	play	VERB
fnp-3805	150	70	a	a	DET
fnp-3805	150	71	role	role	NOUN
fnp-3805	150	72	in	in	ADP
fnp-3805	150	73	autophagy	autophagy	ADJ
fnp-3805	150	74	regulation	regulation	NOUN
fnp-3805	150	75	(	(	PUNCT
fnp-3805	150	76	xi	xi	X
fnp-3805	150	77	et	et	PROPN
fnp-3805	150	78	al	al	PROPN
fnp-3805	150	79	.	.	PROPN
fnp-3805	150	80	,	,	PUNCT
fnp-3805	150	81	2020	2020	NUM
fnp-3805	150	82	)	)	PUNCT
fnp-3805	150	83	.	.	PUNCT
fnp-3805	151	1	interestingly	interestingly	ADV
fnp-3805	151	2	,	,	PUNCT
fnp-3805	151	3	rimmed	rim	VERB
fnp-3805	151	4	vacuoles	vacuole	NOUN
fnp-3805	151	5	in	in	ADP
fnp-3805	151	6	msp-6	msp-6	PUNCT
fnp-3805	151	7	patients	patient	NOUN
fnp-3805	151	8	are	be	AUX
fnp-3805	151	9	positive	positive	ADJ
fnp-3805	151	10	for	for	ADP
fnp-3805	151	11	annexin	annexin	NOUN
fnp-3805	151	12	11	11	NUM
fnp-3805	151	13	in	in	ADP
fnp-3805	151	14	addition	addition	NOUN
fnp-3805	151	15	to	to	ADP
fnp-3805	151	16	tdp-43	tdp-43	NOUN
fnp-3805	151	17	,	,	PUNCT
fnp-3805	151	18	while	while	SCONJ
fnp-3805	151	19	rimmed	rimmed	ADJ
fnp-3805	151	20	vacuoles	vacuole	NOUN
fnp-3805	151	21	in	in	ADP
fnp-3805	151	22	sporadic	sporadic	ADJ
fnp-3805	151	23	inclusion	inclusion	NOUN
fnp-3805	151	24	body	body	NOUN
fnp-3805	151	25	myositis	myositis	PROPN
fnp-3805	151	26	(	(	PUNCT
fnp-3805	151	27	sibm	sibm	PROPN
fnp-3805	151	28	)	)	PUNCT
fnp-3805	151	29	and	and	CCONJ
fnp-3805	151	30	other	other	ADJ
fnp-3805	151	31	inclusion	inclusion	NOUN
fnp-3805	151	32	body	body	NOUN
fnp-3805	151	33	myopathies	myopathy	NOUN
fnp-3805	151	34	are	be	AUX
fnp-3805	151	35	annexin	annexin	NOUN
fnp-3805	151	36	11	11	NUM
fnp-3805	151	37	-	-	PUNCT
fnp-3805	151	38	negative	negative	ADJ
fnp-3805	151	39	(	(	PUNCT
fnp-3805	151	40	leoni	leoni	PROPN
fnp-3805	151	41	et	et	PROPN
fnp-3805	151	42	al	al	PROPN
fnp-3805	151	43	.	.	PROPN
fnp-3805	151	44	,	,	PUNCT
fnp-3805	151	45	2021	2021	NUM
fnp-3805	151	46	)	)	PUNCT
fnp-3805	151	47	.	.	PUNCT
fnp-3805	152	1	in	in	ADP
fnp-3805	152	2	the	the	DET
fnp-3805	152	3	second	second	ADJ
fnp-3805	152	4	study	study	NOUN
fnp-3805	152	5	,	,	PUNCT
fnp-3805	152	6	johari	johari	PROPN
fnp-3805	152	7	and	and	CCONJ
fnp-3805	152	8	colleagues	colleague	NOUN
fnp-3805	152	9	showed	show	VERB
fnp-3805	152	10	that	that	SCONJ
fnp-3805	152	11	autosomal	autosomal	ADJ
fnp-3805	152	12	dominant	dominant	ADJ
fnp-3805	152	13	missense	missense	NOUN
fnp-3805	152	14	mutations	mutation	NOUN
fnp-3805	152	15	in	in	ADP
fnp-3805	152	16	smpx	smpx	NOUN
fnp-3805	152	17	(	(	PUNCT
fnp-3805	152	18	small	small	ADJ
fnp-3805	152	19	muscle	muscle	NOUN
fnp-3805	152	20	protein	protein	NOUN
fnp-3805	152	21	x	x	VERB
fnp-3805	152	22	-	-	VERB
fnp-3805	152	23	linked	link	VERB
fnp-3805	152	24	)	)	PUNCT
fnp-3805	152	25	cause	cause	VERB
fnp-3805	152	26	distal	distal	ADJ
fnp-3805	152	27	myopathy	myopathy	ADJ
fnp-3805	152	28	with	with	ADP
fnp-3805	152	29	protein	protein	NOUN
fnp-3805	152	30	inclusions	inclusion	NOUN
fnp-3805	152	31	(	(	PUNCT
fnp-3805	152	32	johari	johari	PROPN
fnp-3805	152	33	et	et	PROPN
fnp-3805	152	34	al	al	PROPN
fnp-3805	152	35	.	.	PROPN
fnp-3805	152	36	,	,	PUNCT
fnp-3805	152	37	2021	2021	NUM
fnp-3805	152	38	)	)	PUNCT
fnp-3805	152	39	.	.	PUNCT
fnp-3805	153	1	smpx	smpx	PROPN
fnp-3805	153	2	is	be	AUX
fnp-3805	153	3	a	a	DET
fnp-3805	153	4	small	small	ADJ
fnp-3805	153	5	(	(	PUNCT
fnp-3805	153	6	88	88	NUM
fnp-3805	153	7	aa	aa	NOUN
fnp-3805	153	8	)	)	PUNCT
fnp-3805	153	9	,	,	PUNCT
fnp-3805	153	10	proline	proline	NOUN
fnp-3805	153	11	-	-	PUNCT
fnp-3805	153	12	rich	rich	ADJ
fnp-3805	153	13	protein	protein	NOUN
fnp-3805	153	14	that	that	PRON
fnp-3805	153	15	is	be	AUX
fnp-3805	153	16	highly	highly	ADV
fnp-3805	153	17	expressed	express	VERB
fnp-3805	153	18	in	in	ADP
fnp-3805	153	19	slow	slow	ADJ
fnp-3805	153	20	muscle	muscle	NOUN
fnp-3805	153	21	fibers	fiber	NOUN
fnp-3805	153	22	and	and	CCONJ
fnp-3805	153	23	cardiomyocytes	cardiomyocyte	NOUN
fnp-3805	153	24	,	,	PUNCT
fnp-3805	153	25	where	where	SCONJ
fnp-3805	153	26	it	it	PRON
fnp-3805	153	27	localizes	localize	VERB
fnp-3805	153	28	to	to	ADP
fnp-3805	153	29	costameres	costamere	NOUN
fnp-3805	153	30	and	and	CCONJ
fnp-3805	153	31	intermyofibrillar	intermyofibrillar	ADJ
fnp-3805	153	32	spaces	space	NOUN
fnp-3805	153	33	;	;	PUNCT
fnp-3805	153	34	its	its	PRON
fnp-3805	153	35	function	function	NOUN
fnp-3805	153	36	is	be	AUX
fnp-3805	153	37	currently	currently	ADV
fnp-3805	153	38	unknown	unknown	ADJ
fnp-3805	153	39	,	,	PUNCT
fnp-3805	153	40	but	but	CCONJ
fnp-3805	153	41	loss	loss	NOUN
fnp-3805	153	42	-	-	PUNCT
fnp-3805	153	43	of	of	ADP
fnp-3805	153	44	-	-	PUNCT
fnp-3805	153	45	function	function	NOUN
fnp-3805	153	46	smpx	smpx	NOUN
fnp-3805	153	47	mutations	mutation	NOUN
fnp-3805	153	48	cause	cause	VERB
fnp-3805	153	49	non	non	ADJ
fnp-3805	153	50	-	-	ADJ
fnp-3805	153	51	syndromic	syndromic	ADJ
fnp-3805	153	52	hearing	hearing	NOUN
fnp-3805	153	53	loss	loss	NOUN
fnp-3805	153	54	without	without	ADP
fnp-3805	153	55	muscle	muscle	NOUN
fnp-3805	153	56	weakness	weakness	NOUN
fnp-3805	153	57	.	.	PUNCT
fnp-3805	154	1	muscle	muscle	NOUN
fnp-3805	154	2	biopsies	biopsy	NOUN
fnp-3805	154	3	from	from	ADP
fnp-3805	154	4	patients	patient	NOUN
fnp-3805	154	5	with	with	ADP
fnp-3805	154	6	smpx	smpx	NOUN
fnp-3805	154	7	-	-	PUNCT
fnp-3805	154	8	related	relate	VERB
fnp-3805	154	9	distal	distal	ADJ
fnp-3805	154	10	myopathy	myopathy	ADJ
fnp-3805	154	11	,	,	PUNCT
fnp-3805	154	12	who	who	PRON
fnp-3805	154	13	do	do	AUX
fnp-3805	154	14	not	not	PART
fnp-3805	154	15	have	have	AUX
fnp-3805	154	16	hearing	hear	VERB
fnp-3805	154	17	loss	loss	NOUN
fnp-3805	154	18	,	,	PUNCT
fnp-3805	154	19	showed	show	VERB
fnp-3805	154	20	lc3	lc3	ADJ
fnp-3805	154	21	-	-	ADJ
fnp-3805	154	22	positive	positive	ADJ
fnp-3805	154	23	rimmed	rimmed	ADJ
fnp-3805	154	24	vacuoles	vacuole	NOUN
fnp-3805	154	25	,	,	PUNCT
fnp-3805	154	26	abundant	abundant	ADJ
fnp-3805	154	27	smpx	smpx	NOUN
fnp-3805	154	28	-	-	PUNCT
fnp-3805	154	29	and	and	CCONJ
fnp-3805	154	30	p62	p62	NOUN
fnp-3805	154	31	-	-	PUNCT
fnp-3805	154	32	positive	positive	ADJ
fnp-3805	154	33	sarcoplasmic	sarcoplasmic	NOUN
fnp-3805	154	34	inclusions	inclusion	NOUN
fnp-3805	154	35	,	,	PUNCT
fnp-3805	154	36	as	as	ADV
fnp-3805	154	37	well	well	ADV
fnp-3805	154	38	as	as	ADP
fnp-3805	154	39	smpx	smpx	NOUN
fnp-3805	154	40	-	-	PUNCT
fnp-3805	154	41	negative	negative	ADJ
fnp-3805	154	42	inclusions	inclusion	NOUN
fnp-3805	154	43	that	that	PRON
fnp-3805	154	44	were	be	AUX
fnp-3805	154	45	positive	positive	ADJ
fnp-3805	154	46	for	for	ADP
fnp-3805	154	47	αb	αb	NOUN
fnp-3805	154	48	-	-	PUNCT
fnp-3805	154	49	crystallin	crystallin	NOUN
fnp-3805	154	50	and	and	CCONJ
fnp-3805	154	51	myotilin	myotilin	NOUN
fnp-3805	154	52	in	in	ADP
fnp-3805	154	53	addition	addition	NOUN
fnp-3805	154	54	to	to	ADP
fnp-3805	154	55	casa	casa	PROPN
fnp-3805	154	56	chaperones	chaperones	PROPN
fnp-3805	154	57	bag3	bag3	PROPN
fnp-3805	154	58	and	and	CCONJ
fnp-3805	154	59	hspb8	hspb8	PROPN
fnp-3805	154	60	;	;	PUNCT
fnp-3805	154	61	however	however	ADV
fnp-3805	154	62	,	,	PUNCT
fnp-3805	154	63	there	there	PRON
fnp-3805	154	64	was	be	VERB
fnp-3805	154	65	no	no	DET
fnp-3805	154	66	significant	significant	ADJ
fnp-3805	154	67	myofibrillar	myofibrillar	ADJ
fnp-3805	154	68	disarray	disarray	NOUN
fnp-3805	154	69	on	on	ADP
fnp-3805	154	70	electron	electron	NOUN
fnp-3805	154	71	microscopy	microscopy	NOUN
fnp-3805	154	72	.	.	PUNCT
fnp-3805	155	1	thus	thus	ADV
fnp-3805	155	2	,	,	PUNCT
fnp-3805	155	3	it	it	PRON
fnp-3805	155	4	is	be	AUX
fnp-3805	155	5	not	not	PART
fnp-3805	155	6	yet	yet	ADV
fnp-3805	155	7	clear	clear	ADJ
fnp-3805	155	8	whether	whether	SCONJ
fnp-3805	155	9	this	this	DET
fnp-3805	155	10	new	new	ADJ
fnp-3805	155	11	disease	disease	NOUN
fnp-3805	155	12	should	should	AUX
fnp-3805	155	13	be	be	AUX
fnp-3805	155	14	classified	classify	VERB
fnp-3805	155	15	as	as	ADP
fnp-3805	155	16	a	a	DET
fnp-3805	155	17	rimmed	rimmed	ADJ
fnp-3805	155	18	vacuolar	vacuolar	ADJ
fnp-3805	155	19	(	(	PUNCT
fnp-3805	155	20	inclusion	inclusion	NOUN
fnp-3805	155	21	body	body	NOUN
fnp-3805	155	22	)	)	PUNCT
fnp-3805	155	23	myopathy	myopathy	ADJ
fnp-3805	155	24	or	or	CCONJ
fnp-3805	155	25	as	as	ADP
fnp-3805	155	26	a	a	DET
fnp-3805	155	27	myofibrillar	myofibrillar	ADJ
fnp-3805	155	28	myopathy	myopathy	NOUN
fnp-3805	155	29	;	;	PUNCT
fnp-3805	155	30	while	while	SCONJ
fnp-3805	155	31	a	a	DET
fnp-3805	155	32	lot	lot	NOUN
fnp-3805	155	33	of	of	ADP
fnp-3805	155	34	additional	additional	ADJ
fnp-3805	155	35	work	work	NOUN
fnp-3805	155	36	is	be	AUX
fnp-3805	155	37	needed	need	VERB
fnp-3805	155	38	to	to	PART
fnp-3805	155	39	fully	fully	ADV
fnp-3805	155	40	elucidate	elucidate	VERB
fnp-3805	155	41	its	its	PRON
fnp-3805	155	42	pathogenesis	pathogenesis	NOUN
fnp-3805	155	43	,	,	PUNCT
fnp-3805	155	44	initial	initial	ADJ
fnp-3805	155	45	experiments	experiment	NOUN
fnp-3805	155	46	suggest	suggest	VERB
fnp-3805	155	47	that	that	SCONJ
fnp-3805	155	48	smpx	smpx	NOUN
fnp-3805	155	49	may	may	AUX
fnp-3805	155	50	affect	affect	VERB
fnp-3805	155	51	stress	stress	ADJ
fnp-3805	155	52	granule	granule	NOUN
fnp-3805	155	53	dynamics	dynamic	NOUN
fnp-3805	155	54	(	(	PUNCT
fnp-3805	155	55	johari	johari	PROPN
fnp-3805	155	56	et	et	PROPN
fnp-3805	155	57	al	al	PROPN
fnp-3805	155	58	.	.	PROPN
fnp-3805	155	59	,	,	PUNCT
fnp-3805	155	60	2021	2021	NUM
fnp-3805	155	61	)	)	PUNCT
fnp-3805	155	62	.	.	PUNCT
fnp-3805	156	1	thus	thus	ADV
fnp-3805	156	2	,	,	PUNCT
fnp-3805	156	3	it	it	PRON
fnp-3805	156	4	will	will	AUX
fnp-3805	156	5	be	be	AUX
fnp-3805	156	6	interesting	interesting	ADJ
fnp-3805	156	7	to	to	PART
fnp-3805	156	8	see	see	VERB
fnp-3805	156	9	whether	whether	SCONJ
fnp-3805	156	10	smpx	smpx	VERB
fnp-3805	156	11	mutations	mutation	NOUN
fnp-3805	156	12	can	can	AUX
fnp-3805	156	13	also	also	ADV
fnp-3805	156	14	cause	cause	VERB
fnp-3805	156	15	other	other	ADJ
fnp-3805	156	16	diseases	disease	NOUN
fnp-3805	156	17	in	in	ADP
fnp-3805	156	18	the	the	DET
fnp-3805	156	19	msp	msp	PROPN
fnp-3805	156	20	spectrum	spectrum	NOUN
fnp-3805	156	21	,	,	PUNCT
fnp-3805	156	22	either	either	CCONJ
fnp-3805	156	23	alone	alone	ADJ
fnp-3805	156	24	or	or	CCONJ
fnp-3805	156	25	in	in	ADP
fnp-3805	156	26	combination	combination	NOUN
fnp-3805	156	27	with	with	ADP
fnp-3805	156	28	mutations	mutation	NOUN
fnp-3805	156	29	in	in	ADP
fnp-3805	156	30	other	other	ADJ
fnp-3805	156	31	msp	msp	PROPN
fnp-3805	156	32	-	-	PUNCT
fnp-3805	156	33	associated	associate	VERB
fnp-3805	156	34	genes	gene	NOUN
fnp-3805	156	35	.	.	PUNCT
fnp-3805	157	1	7	7	X
fnp-3805	157	2	.	.	X
fnp-3805	157	3	activation	activation	NOUN
fnp-3805	157	4	of	of	ADP
fnp-3805	157	5	the	the	DET
fnp-3805	157	6	integrated	integrate	VERB
fnp-3805	157	7	stress	stress	NOUN
fnp-3805	157	8	response	response	NOUN
fnp-3805	157	9	plays	play	VERB
fnp-3805	157	10	a	a	DET
fnp-3805	157	11	key	key	ADJ
fnp-3805	157	12	role	role	NOUN
fnp-3805	157	13	in	in	ADP
fnp-3805	157	14	the	the	DET
fnp-3805	157	15	pathogenesis	pathogenesis	NOUN
fnp-3805	157	16	of	of	ADP
fnp-3805	157	17	trna	trna	ADJ
fnp-3805	157	18	synthetase	synthetase	NOUN
fnp-3805	157	19	-	-	PUNCT
fnp-3805	157	20	associated	associate	VERB
fnp-3805	157	21	subtypes	subtype	NOUN
fnp-3805	157	22	of	of	ADP
fnp-3805	157	23	axonal	axonal	ADJ
fnp-3805	157	24	charcot	charcot	PROPN
fnp-3805	157	25	-	-	PUNCT
fnp-3805	157	26	marie	marie	PROPN
fnp-3805	157	27	-	-	PUNCT
fnp-3805	157	28	tooth	tooth	NOUN
fnp-3805	157	29	disease	disease	NOUN
fnp-3805	157	30	non	non	ADJ
fnp-3805	157	31	-	-	ADJ
fnp-3805	157	32	syndromic	syndromic	ADJ
fnp-3805	157	33	inherited	inherit	VERB
fnp-3805	157	34	sensory	sensory	ADJ
fnp-3805	157	35	-	-	PUNCT
fnp-3805	157	36	motor	motor	NOUN
fnp-3805	157	37	peripheral	peripheral	ADJ
fnp-3805	157	38	neuropathies	neuropathy	NOUN
fnp-3805	157	39	,	,	PUNCT
fnp-3805	157	40	also	also	ADV
fnp-3805	157	41	known	know	VERB
fnp-3805	157	42	as	as	ADP
fnp-3805	157	43	charcot	charcot	PROPN
fnp-3805	157	44	-	-	PUNCT
fnp-3805	157	45	marie	marie	PROPN
fnp-3805	157	46	-	-	PUNCT
fnp-3805	157	47	tooth	tooth	NOUN
fnp-3805	157	48	(	(	PUNCT
fnp-3805	157	49	cmt	cmt	PROPN
fnp-3805	157	50	)	)	PUNCT
fnp-3805	157	51	diseases	disease	NOUN
fnp-3805	157	52	,	,	PUNCT
fnp-3805	157	53	are	be	AUX
fnp-3805	157	54	broadly	broadly	ADV
fnp-3805	157	55	classified	classify	VERB
fnp-3805	157	56	into	into	ADP
fnp-3805	157	57	demyelinating	demyelinate	VERB
fnp-3805	157	58	,	,	PUNCT
fnp-3805	157	59	axonal	axonal	ADJ
fnp-3805	157	60	,	,	PUNCT
fnp-3805	157	61	and	and	CCONJ
fnp-3805	157	62	intermediate	intermediate	ADJ
fnp-3805	157	63	subtypes	subtype	NOUN
fnp-3805	157	64	,	,	PUNCT
fnp-3805	157	65	each	each	PRON
fnp-3805	157	66	of	of	ADP
fnp-3805	157	67	which	which	PRON
fnp-3805	157	68	is	be	AUX
fnp-3805	157	69	associated	associate	VERB
fnp-3805	157	70	with	with	ADP
fnp-3805	157	71	a	a	DET
fnp-3805	157	72	large	large	ADJ
fnp-3805	157	73	number	number	NOUN
fnp-3805	157	74	of	of	ADP
fnp-3805	157	75	causative	causative	ADJ
fnp-3805	157	76	genes	gene	NOUN
fnp-3805	157	77	and	and	CCONJ
fnp-3805	157	78	with	with	ADP
fnp-3805	157	79	more	more	ADJ
fnp-3805	157	80	than	than	ADP
fnp-3805	157	81	one	one	NUM
fnp-3805	157	82	mode	mode	NOUN
fnp-3805	157	83	of	of	ADP
fnp-3805	157	84	inheritance	inheritance	NOUN
fnp-3805	157	85	(	(	PUNCT
fnp-3805	157	86	stavrou	stavrou	NOUN
fnp-3805	157	87	et	et	PROPN
fnp-3805	157	88	al	al	PROPN
fnp-3805	157	89	.	.	PROPN
fnp-3805	157	90	,	,	PUNCT
fnp-3805	157	91	2021	2021	NUM
fnp-3805	157	92	;	;	PUNCT
fnp-3805	157	93	zhang	zhang	PROPN
fnp-3805	157	94	et	et	PROPN
fnp-3805	157	95	al	al	PROPN
fnp-3805	157	96	.	.	PROPN
fnp-3805	157	97	,	,	PUNCT
fnp-3805	157	98	2021	2021	NUM
fnp-3805	157	99	)	)	PUNCT
fnp-3805	157	100	.	.	PUNCT
fnp-3805	158	1	within	within	ADP
fnp-3805	158	2	the	the	DET
fnp-3805	158	3	axonal	axonal	ADJ
fnp-3805	158	4	cmt	cmt	PROPN
fnp-3805	158	5	category	category	NOUN
fnp-3805	158	6	,	,	PUNCT
fnp-3805	158	7	an	an	DET
fnp-3805	158	8	interesting	interesting	ADJ
fnp-3805	158	9	and	and	CCONJ
fnp-3805	158	10	relatively	relatively	ADV
fnp-3805	158	11	recently	recently	ADV
fnp-3805	158	12	recognized	recognize	VERB
fnp-3805	158	13	disease	disease	NOUN
fnp-3805	158	14	subset	subset	NOUN
fnp-3805	158	15	is	be	AUX
fnp-3805	158	16	caused	cause	VERB
fnp-3805	158	17	by	by	ADP
fnp-3805	158	18	mutations	mutation	NOUN
fnp-3805	158	19	in	in	ADP
fnp-3805	158	20	aminoacyl	aminoacyl	PROPN
fnp-3805	158	21	-	-	PUNCT
fnp-3805	158	22	trna	trna	NOUN
fnp-3805	158	23	synthetases	synthetase	NOUN
fnp-3805	158	24	(	(	PUNCT
fnp-3805	158	25	arss	arss	ADJ
fnp-3805	158	26	)	)	PUNCT
fnp-3805	158	27	,	,	PUNCT
fnp-3805	158	28	which	which	PRON
fnp-3805	158	29	are	be	AUX
fnp-3805	158	30	ubiquitously	ubiquitously	ADV
fnp-3805	158	31	expressed	express	VERB
fnp-3805	158	32	enzymes	enzyme	NOUN
fnp-3805	158	33	that	that	PRON
fnp-3805	158	34	charge	charge	VERB
fnp-3805	158	35	amino	amino	ADJ
fnp-3805	158	36	acids	acid	NOUN
fnp-3805	158	37	onto	onto	ADP
fnp-3805	158	38	their	their	PRON
fnp-3805	158	39	cognate	cognate	NOUN
fnp-3805	158	40	trnas	trnas	NOUN
fnp-3805	158	41	during	during	ADP
fnp-3805	158	42	protein	protein	NOUN
fnp-3805	158	43	synthesis	synthesis	NOUN
fnp-3805	158	44	.	.	PUNCT
fnp-3805	159	1	of	of	ADP
fnp-3805	159	2	20	20	NUM
fnp-3805	159	3	arss	arss	ADJ
fnp-3805	159	4	,	,	PUNCT
fnp-3805	159	5	5	5	NUM
fnp-3805	159	6	have	have	AUX
fnp-3805	159	7	been	be	AUX
fnp-3805	159	8	associated	associate	VERB
fnp-3805	159	9	with	with	ADP
fnp-3805	159	10	autosomal	autosomal	ADJ
fnp-3805	159	11	dominant	dominant	ADJ
fnp-3805	159	12	forms	form	NOUN
fnp-3805	159	13	of	of	ADP
fnp-3805	159	14	axonal	axonal	ADJ
fnp-3805	159	15	cmt	cmt	PROPN
fnp-3805	159	16	disease	disease	NOUN
fnp-3805	159	17	[	[	X
fnp-3805	159	18	yars	yars	X
fnp-3805	159	19	(	(	PUNCT
fnp-3805	159	20	tyrosyl	tyrosyl	ADJ
fnp-3805	159	21	-	-	PUNCT
fnp-3805	159	22	rs	rs	NOUN
fnp-3805	159	23	;	;	PUNCT
fnp-3805	159	24	cmtdic	cmtdic	ADJ
fnp-3805	159	25	)	)	PUNCT
fnp-3805	159	26	,	,	PUNCT
fnp-3805	159	27	gars	gars	X
fnp-3805	159	28	(	(	PUNCT
fnp-3805	159	29	glycyl	glycyl	NOUN
fnp-3805	159	30	-	-	PUNCT
fnp-3805	159	31	rs	rs	NOUN
fnp-3805	159	32	;	;	PUNCT
fnp-3805	159	33	cmt2d	cmt2d	PROPN
fnp-3805	159	34	)	)	PUNCT
fnp-3805	159	35	,	,	PUNCT
fnp-3805	159	36	aars	aar	NOUN
fnp-3805	159	37	(	(	PUNCT
fnp-3805	159	38	alanyl	alanyl	NOUN
fnp-3805	159	39	-	-	PUNCT
fnp-3805	159	40	rs	rs	ADJ
fnp-3805	159	41	;	;	PUNCT
fnp-3805	159	42	cmt2n	cmt2n	PROPN
fnp-3805	159	43	)	)	PUNCT
fnp-3805	159	44	,	,	PUNCT
fnp-3805	159	45	hars	har	VERB
fnp-3805	159	46	(	(	PUNCT
fnp-3805	159	47	histidyl	histidyl	NOUN
fnp-3805	159	48	-	-	PUNCT
fnp-3805	159	49	rs	rs	NOUN
fnp-3805	159	50	;	;	PUNCT
fnp-3805	159	51	cmt2w	cmt2w	PROPN
fnp-3805	159	52	)	)	PUNCT
fnp-3805	159	53	,	,	PUNCT
fnp-3805	159	54	and	and	CCONJ
fnp-3805	159	55	mars	mar	NOUN
fnp-3805	159	56	(	(	PUNCT
fnp-3805	159	57	methionyl	methionyl	NOUN
fnp-3805	159	58	-	-	PUNCT
fnp-3805	159	59	rs	rs	NOUN
fnp-3805	159	60	;	;	PUNCT
fnp-3805	159	61	cmt2u	cmt2u	NOUN
fnp-3805	159	62	)	)	PUNCT
fnp-3805	159	63	]	]	X
fnp-3805	159	64	,	,	PUNCT
fnp-3805	159	65	while	while	SCONJ
fnp-3805	159	66	two	two	NUM
fnp-3805	159	67	(	(	PUNCT
fnp-3805	159	68	wars	war	NOUN
fnp-3805	159	69	/	/	SYM
fnp-3805	159	70	tryptophanyl	tryptophanyl	NOUN
fnp-3805	159	71	-	-	PUNCT
fnp-3805	159	72	rs	rs	NOUN
fnp-3805	159	73	and	and	CCONJ
fnp-3805	159	74	kars	kars	PROPN
fnp-3805	159	75	/	/	SYM
fnp-3805	159	76	lysyl	lysyl	NOUN
fnp-3805	159	77	-	-	PUNCT
fnp-3805	159	78	rs	rs	NOUN
fnp-3805	159	79	)	)	PUNCT
fnp-3805	159	80	have	have	AUX
fnp-3805	159	81	been	be	AUX
fnp-3805	159	82	associated	associate	VERB
fnp-3805	159	83	with	with	ADP
fnp-3805	159	84	hereditary	hereditary	ADJ
fnp-3805	159	85	motor	motor	NOUN
fnp-3805	159	86	neuropathy	neuropathy	ADJ
fnp-3805	159	87	type	type	NOUN
fnp-3805	159	88	9	9	NUM
fnp-3805	159	89	(	(	PUNCT
fnp-3805	159	90	hmn9	hmn9	PROPN
fnp-3805	159	91	)	)	PUNCT
fnp-3805	159	92	and	and	CCONJ
fnp-3805	159	93	autosomal	autosomal	ADJ
fnp-3805	159	94	recessive	recessive	ADJ
fnp-3805	159	95	intermediate	intermediate	ADJ
fnp-3805	159	96	cmt	cmt	PROPN
fnp-3805	159	97	disease	disease	PROPN
fnp-3805	159	98	cmtrib	cmtrib	PROPN
fnp-3805	159	99	,	,	PUNCT
fnp-3805	159	100	respectively	respectively	ADV
fnp-3805	159	101	.	.	PUNCT
fnp-3805	160	1	(	(	PUNCT
fnp-3805	160	2	of	of	ADP
fnp-3805	160	3	note	note	NOUN
fnp-3805	160	4	,	,	PUNCT
fnp-3805	160	5	gars	gars	PROPN
fnp-3805	160	6	mutations	mutation	NOUN
fnp-3805	160	7	can	can	AUX
fnp-3805	160	8	cause	cause	VERB
fnp-3805	160	9	hmn5a	hmn5a	PRON
fnp-3805	160	10	in	in	ADP
fnp-3805	160	11	addition	addition	NOUN
fnp-3805	160	12	to	to	ADP
fnp-3805	160	13	cmt2d	cmt2d	PROPN
fnp-3805	160	14	,	,	PUNCT
fnp-3805	160	15	while	while	SCONJ
fnp-3805	160	16	hars	hars	ADJ
fnp-3805	160	17	mutations	mutation	NOUN
fnp-3805	160	18	can	can	AUX
fnp-3805	160	19	cause	cause	VERB
fnp-3805	160	20	hmn2	hmn2	VERB
fnp-3805	160	21	in	in	ADP
fnp-3805	160	22	addition	addition	NOUN
fnp-3805	160	23	to	to	ADP
fnp-3805	160	24	cmt2w	cmt2w	PROPN
fnp-3805	160	25	.	.	PUNCT
fnp-3805	160	26	)	)	PUNCT
fnp-3805	161	1	not	not	PART
fnp-3805	161	2	much	much	ADV
fnp-3805	161	3	was	be	AUX
fnp-3805	161	4	known	know	VERB
fnp-3805	161	5	about	about	ADP
fnp-3805	161	6	pathogenesis	pathogenesis	NOUN
fnp-3805	161	7	of	of	ADP
fnp-3805	161	8	ars	ar	NOUN
fnp-3805	161	9	-	-	PUNCT
fnp-3805	161	10	associated	associate	VERB
fnp-3805	161	11	forms	form	NOUN
fnp-3805	161	12	of	of	ADP
fnp-3805	161	13	cmt	cmt	PROPN
fnp-3805	161	14	until	until	ADP
fnp-3805	161	15	last	last	ADJ
fnp-3805	161	16	year	year	NOUN
fnp-3805	161	17	,	,	PUNCT
fnp-3805	161	18	when	when	SCONJ
fnp-3805	161	19	two	two	NUM
fnp-3805	161	20	fascinating	fascinating	ADJ
fnp-3805	161	21	studies	study	NOUN
fnp-3805	161	22	were	be	AUX
fnp-3805	161	23	published	publish	VERB
fnp-3805	161	24	back	back	ADV
fnp-3805	161	25	-	-	PUNCT
fnp-3805	161	26	to	to	AUX
fnp-3805	161	27	-	-	PUNCT
fnp-3805	161	28	back	back	NOUN
fnp-3805	161	29	in	in	ADP
fnp-3805	161	30	science	science	NOUN
fnp-3805	161	31	,	,	PUNCT
fnp-3805	161	32	together	together	ADV
fnp-3805	161	33	providing	provide	VERB
fnp-3805	161	34	important	important	ADJ
fnp-3805	161	35	mechanistic	mechanistic	ADJ
fnp-3805	161	36	insights	insight	NOUN
fnp-3805	161	37	and	and	CCONJ
fnp-3805	161	38	therapeutic	therapeutic	ADJ
fnp-3805	161	39	promise	promise	NOUN
fnp-3805	161	40	for	for	ADP
fnp-3805	161	41	this	this	DET
fnp-3805	161	42	subcategory	subcategory	NOUN
fnp-3805	161	43	of	of	ADP
fnp-3805	161	44	inherited	inherit	VERB
fnp-3805	161	45	neuropathies	neuropathy	NOUN
fnp-3805	161	46	(	(	PUNCT
fnp-3805	161	47	spaulding	spaulde	VERB
fnp-3805	161	48	et	et	PROPN
fnp-3805	161	49	al	al	PROPN
fnp-3805	161	50	.	.	PROPN
fnp-3805	161	51	,	,	PUNCT
fnp-3805	161	52	2021	2021	NUM
fnp-3805	161	53	;	;	PUNCT
fnp-3805	161	54	zuko	zuko	PROPN
fnp-3805	161	55	et	et	PROPN
fnp-3805	161	56	al	al	PROPN
fnp-3805	161	57	.	.	PROPN
fnp-3805	161	58	,	,	PUNCT
fnp-3805	161	59	2021	2021	NUM
fnp-3805	161	60	)	)	PUNCT
fnp-3805	161	61	.	.	PUNCT
fnp-3805	162	1	spaulding	spaulde	VERB
fnp-3805	162	2	et	et	PROPN
fnp-3805	162	3	al	al	PROPN
fnp-3805	162	4	.	.	PROPN
fnp-3805	163	1	used	use	VERB
fnp-3805	163	2	three	three	NUM
fnp-3805	163	3	different	different	ADJ
fnp-3805	163	4	mouse	mouse	NOUN
fnp-3805	163	5	models	model	NOUN
fnp-3805	163	6	of	of	ADP
fnp-3805	163	7	gars	gars	PROPN
fnp-3805	163	8	-	-	PUNCT
fnp-3805	163	9	cmt	cmt	PROPN
fnp-3805	163	10	(	(	PUNCT
fnp-3805	163	11	cmt2d	cmt2d	PROPN
fnp-3805	163	12	)	)	PUNCT
fnp-3805	163	13	and	and	CCONJ
fnp-3805	163	14	one	one	NUM
fnp-3805	163	15	mouse	mouse	NOUN
fnp-3805	163	16	model	model	NOUN
fnp-3805	163	17	of	of	ADP
fnp-3805	163	18	yars	yars	PROPN
fnp-3805	163	19	-	-	PUNCT
fnp-3805	163	20	cmt	cmt	PROPN
fnp-3805	163	21	(	(	PUNCT
fnp-3805	163	22	cmtdic	cmtdic	ADJ
fnp-3805	163	23	)	)	PUNCT
fnp-3805	163	24	to	to	PART
fnp-3805	163	25	investigate	investigate	VERB
fnp-3805	163	26	molecular	molecular	ADJ
fnp-3805	163	27	pathways	pathway	NOUN
fnp-3805	163	28	that	that	PRON
fnp-3805	163	29	are	be	AUX
fnp-3805	163	30	affected	affect	VERB
fnp-3805	163	31	by	by	ADP
fnp-3805	163	32	mutant	mutant	ADJ
fnp-3805	163	33	gene	gene	NOUN
fnp-3805	163	34	expression	expression	NOUN
fnp-3805	163	35	(	(	PUNCT
fnp-3805	163	36	spaulding	spaulde	VERB
fnp-3805	163	37	et	et	PROPN
fnp-3805	163	38	al	al	PROPN
fnp-3805	163	39	.	.	PROPN
fnp-3805	163	40	,	,	PUNCT
fnp-3805	163	41	2021	2021	NUM
fnp-3805	163	42	)	)	PUNCT
fnp-3805	163	43	.	.	PUNCT
fnp-3805	164	1	in	in	ADP
fnp-3805	164	2	all	all	DET
fnp-3805	164	3	four	four	NUM
fnp-3805	164	4	investigated	investigate	VERB
fnp-3805	164	5	mouse	mouse	NOUN
fnp-3805	164	6	models	model	NOUN
fnp-3805	164	7	,	,	PUNCT
fnp-3805	164	8	they	they	PRON
fnp-3805	164	9	found	find	VERB
fnp-3805	164	10	that	that	SCONJ
fnp-3805	164	11	the	the	DET
fnp-3805	164	12	integrated	integrate	VERB
fnp-3805	164	13	stress	stress	NOUN
fnp-3805	164	14	response	response	NOUN
fnp-3805	164	15	(	(	PUNCT
fnp-3805	164	16	isr	isr	NOUN
fnp-3805	164	17	)	)	PUNCT
fnp-3805	164	18	was	be	AUX
fnp-3805	164	19	selectively	selectively	ADV
fnp-3805	164	20	activated	activate	VERB
fnp-3805	164	21	in	in	ADP
fnp-3805	164	22	alpha	alpha	NOUN
fnp-3805	164	23	motor	motor	NOUN
fnp-3805	164	24	neurons	neuron	NOUN
fnp-3805	164	25	and	and	CCONJ
fnp-3805	164	26	a	a	DET
fnp-3805	164	27	subset	subset	NOUN
fnp-3805	164	28	of	of	ADP
fnp-3805	164	29	sensory	sensory	ADJ
fnp-3805	164	30	neurons	neuron	NOUN
fnp-3805	164	31	;	;	PUNCT
fnp-3805	164	32	the	the	DET
fnp-3805	164	33	isr	isr	ADJ
fnp-3805	164	34	activation	activation	NOUN
fnp-3805	164	35	preceded	precede	VERB
fnp-3805	164	36	neurologic	neurologic	ADJ
fnp-3805	164	37	symptom	symptom	NOUN
fnp-3805	164	38	onset	onset	NOUN
fnp-3805	164	39	,	,	PUNCT
fnp-3805	164	40	was	be	AUX
fnp-3805	164	41	associated	associate	VERB
fnp-3805	164	42	with	with	ADP
fnp-3805	164	43	increased	increase	VERB
fnp-3805	164	44	expression	expression	NOUN
fnp-3805	164	45	of	of	ADP
fnp-3805	164	46	genes	gene	NOUN
fnp-3805	164	47	regulated	regulate	VERB
fnp-3805	164	48	by	by	ADP
fnp-3805	164	49	transcription	transcription	NOUN
fnp-3805	164	50	factor	factor	NOUN
fnp-3805	164	51	atf4	atf4	NOUN
fnp-3805	164	52	,	,	PUNCT
fnp-3805	164	53	and	and	CCONJ
fnp-3805	164	54	required	require	VERB
fnp-3805	164	55	sensor	sensor	NOUN
fnp-3805	164	56	kinase	kinase	PROPN
fnp-3805	164	57	gcn2	gcn2	PROPN
fnp-3805	164	58	.	.	PUNCT
fnp-3805	165	1	[	[	X
fnp-3805	165	2	the	the	DET
fnp-3805	165	3	isr	isr	PROPN
fnp-3805	165	4	is	be	AUX
fnp-3805	165	5	a	a	DET
fnp-3805	165	6	conserved	conserved	ADJ
fnp-3805	165	7	cellular	cellular	ADJ
fnp-3805	165	8	signaling	signal	VERB
fnp-3805	165	9	pathway	pathway	NOUN
fnp-3805	165	10	that	that	PRON
fnp-3805	165	11	alters	alter	VERB
fnp-3805	165	12	gene	gene	NOUN
fnp-3805	165	13	expression	expression	NOUN
fnp-3805	165	14	program	program	NOUN
fnp-3805	165	15	in	in	ADP
fnp-3805	165	16	response	response	NOUN
fnp-3805	165	17	to	to	ADP
fnp-3805	165	18	various	various	ADJ
fnp-3805	165	19	cellular	cellular	ADJ
fnp-3805	165	20	stressors	stressor	NOUN
fnp-3805	165	21	,	,	PUNCT
fnp-3805	165	22	including	include	VERB
fnp-3805	165	23	protein	protein	NOUN
fnp-3805	165	24	homeostasis	homeostasis	NOUN
fnp-3805	165	25	defects	defect	NOUN
fnp-3805	165	26	,	,	PUNCT
fnp-3805	165	27	nutrient	nutrient	NOUN
fnp-3805	165	28	deprivation	deprivation	NOUN
fnp-3805	165	29	,	,	PUNCT
fnp-3805	165	30	viral	viral	ADJ
fnp-3805	165	31	infection	infection	NOUN
fnp-3805	165	32	,	,	PUNCT
fnp-3805	165	33	and	and	CCONJ
fnp-3805	165	34	oxidative	oxidative	ADJ
fnp-3805	165	35	stress	stress	NOUN
fnp-3805	165	36	(	(	PUNCT
fnp-3805	165	37	costa	costa	NOUN
fnp-3805	165	38	-	-	PUNCT
fnp-3805	165	39	mattioli	mattioli	PROPN
fnp-3805	165	40	and	and	CCONJ
fnp-3805	165	41	walter	walter	PROPN
fnp-3805	165	42	,	,	PUNCT
fnp-3805	165	43	2020	2020	NUM
fnp-3805	165	44	)	)	PUNCT
fnp-3805	165	45	.	.	PUNCT
fnp-3805	166	1	these	these	DET
fnp-3805	166	2	stresses	stress	NOUN
fnp-3805	166	3	are	be	AUX
fnp-3805	166	4	sensed	sense	VERB
fnp-3805	166	5	by	by	ADP
fnp-3805	166	6	four	four	NUM
fnp-3805	166	7	specialized	specialized	ADJ
fnp-3805	166	8	kinases	kinase	NOUN
fnp-3805	166	9	(	(	PUNCT
fnp-3805	166	10	perk	perk	NOUN
fnp-3805	166	11	,	,	PUNCT
fnp-3805	166	12	gcn2	gcn2	PROPN
fnp-3805	166	13	,	,	PUNCT
fnp-3805	166	14	pkr	pkr	PROPN
fnp-3805	166	15	and	and	CCONJ
fnp-3805	166	16	hri	hri	PROPN
fnp-3805	166	17	)	)	PUNCT
fnp-3805	166	18	,	,	PUNCT
fnp-3805	166	19	activation	activation	NOUN
fnp-3805	166	20	of	of	ADP
fnp-3805	166	21	which	which	PRON
fnp-3805	166	22	ultimately	ultimately	ADV
fnp-3805	166	23	leads	lead	VERB
fnp-3805	166	24	to	to	ADP
fnp-3805	166	25	phosphorylation	phosphorylation	NOUN
fnp-3805	166	26	of	of	ADP
fnp-3805	166	27	the	the	DET
fnp-3805	166	28	eukaryotic	eukaryotic	ADJ
fnp-3805	166	29	translation	translation	NOUN
fnp-3805	166	30	initiation	initiation	NOUN
fnp-3805	166	31	factor	factor	NOUN
fnp-3805	166	32	eif2	eif2	NOUN
fnp-3805	166	33	and	and	CCONJ
fnp-3805	166	34	general	general	ADJ
fnp-3805	166	35	reduction	reduction	NOUN
fnp-3805	166	36	in	in	ADP
fnp-3805	166	37	protein	protein	NOUN
fnp-3805	166	38	synthesis	synthesis	NOUN
fnp-3805	166	39	along	along	ADV
fnp-3805	166	40	with	with	ADP
fnp-3805	166	41	an	an	DET
fnp-3805	166	42	increase	increase	NOUN
fnp-3805	166	43	in	in	ADP
fnp-3805	166	44	translation	translation	NOUN
fnp-3805	166	45	of	of	ADP
fnp-3805	166	46	specific	specific	ADJ
fnp-3805	166	47	mrnas	mrna	NOUN
fnp-3805	166	48	,	,	PUNCT
fnp-3805	166	49	such	such	ADJ
fnp-3805	166	50	as	as	ADP
fnp-3805	166	51	atf4	atf4	NOUN
fnp-3805	166	52	.	.	PUNCT
fnp-3805	167	1	if	if	SCONJ
fnp-3805	167	2	these	these	DET
fnp-3805	167	3	adaptive	adaptive	ADJ
fnp-3805	167	4	responses	response	NOUN
fnp-3805	167	5	fail	fail	VERB
fnp-3805	167	6	to	to	PART
fnp-3805	167	7	mitigate	mitigate	VERB
fnp-3805	167	8	cellular	cellular	ADJ
fnp-3805	167	9	stress	stress	NOUN
fnp-3805	167	10	,	,	PUNCT
fnp-3805	167	11	the	the	DET
fnp-3805	167	12	isr	isr	ADJ
fnp-3805	167	13	triggers	trigger	NOUN
fnp-3805	167	14	programmed	program	VERB
fnp-3805	167	15	cell	cell	NOUN
fnp-3805	167	16	death	death	NOUN
fnp-3805	167	17	.	.	PUNCT
fnp-3805	167	18	]	]	PUNCT
fnp-3805	168	1	genetic	genetic	ADJ
fnp-3805	168	2	deletion	deletion	NOUN
fnp-3805	168	3	of	of	ADP
fnp-3805	168	4	gcn2	gcn2	NOUN
fnp-3805	168	5	completely	completely	ADV
fnp-3805	168	6	rescued	rescue	VERB
fnp-3805	168	7	the	the	DET
fnp-3805	168	8	neuropathy	neuropathy	ADJ
fnp-3805	168	9	phenotype	phenotype	NOUN
fnp-3805	168	10	in	in	ADP
fnp-3805	168	11	the	the	DET
fnp-3805	168	12	gars	gars	PROPN
fnp-3805	168	13	mutant	mutant	ADJ
fnp-3805	168	14	mice	mouse	NOUN
fnp-3805	168	15	,	,	PUNCT
fnp-3805	168	16	with	with	ADP
fnp-3805	168	17	beneficial	beneficial	ADJ
fnp-3805	168	18	effects	effect	NOUN
fnp-3805	168	19	of	of	ADP
fnp-3805	168	20	deletion	deletion	NOUN
fnp-3805	168	21	observed	observe	VERB
fnp-3805	168	22	behaviorally	behaviorally	ADV
fnp-3805	168	23	,	,	PUNCT
fnp-3805	168	24	physiologically	physiologically	ADV
fnp-3805	168	25	(	(	PUNCT
fnp-3805	168	26	as	as	ADP
fnp-3805	168	27	improved	improve	VERB
fnp-3805	168	28	sciatic	sciatic	ADJ
fnp-3805	168	29	nerve	nerve	NOUN
fnp-3805	168	30	conduction	conduction	NOUN
fnp-3805	168	31	velocity	velocity	NOUN
fnp-3805	168	32	)	)	PUNCT
fnp-3805	168	33	,	,	PUNCT
fnp-3805	168	34	and	and	CCONJ
fnp-3805	168	35	pathologically	pathologically	ADV
fnp-3805	168	36	(	(	PUNCT
fnp-3805	168	37	as	as	ADP
fnp-3805	168	38	ameliorated	ameliorate	VERB
fnp-3805	168	39	axon	axon	NOUN
fnp-3805	168	40	loss	loss	NOUN
fnp-3805	168	41	,	,	PUNCT
fnp-3805	168	42	increased	increase	VERB
fnp-3805	168	43	axon	axon	NOUN
fnp-3805	168	44	diameter	diameter	NOUN
fnp-3805	168	45	,	,	PUNCT
fnp-3805	168	46	and	and	CCONJ
fnp-3805	168	47	decreased	decrease	VERB
fnp-3805	168	48	muscle	muscle	NOUN
fnp-3805	168	49	denervation	denervation	NOUN
fnp-3805	168	50	)	)	PUNCT
fnp-3805	168	51	.	.	PUNCT
fnp-3805	169	1	while	while	SCONJ
fnp-3805	169	2	only	only	ADV
fnp-3805	169	3	one	one	NUM
fnp-3805	169	4	of	of	ADP
fnp-3805	169	5	three	three	NUM
fnp-3805	169	6	gars	gars	PROPN
fnp-3805	169	7	-	-	PUNCT
fnp-3805	169	8	cmt	cmt	PROPN
fnp-3805	169	9	mouse	mouse	NOUN
fnp-3805	169	10	models	model	NOUN
fnp-3805	169	11	was	be	AUX
fnp-3805	169	12	tested	test	VERB
fnp-3805	169	13	in	in	ADP
fnp-3805	169	14	these	these	DET
fnp-3805	169	15	genetic	genetic	ADJ
fnp-3805	169	16	studies	study	NOUN
fnp-3805	169	17	,	,	PUNCT
fnp-3805	169	18	similar	similar	ADJ
fnp-3805	169	19	results	result	NOUN
fnp-3805	169	20	were	be	AUX
fnp-3805	169	21	observed	observe	VERB
fnp-3805	169	22	in	in	ADP
fnp-3805	169	23	a	a	DET
fnp-3805	169	24	different	different	ADJ
fnp-3805	169	25	gars	gars	PROPN
fnp-3805	169	26	-	-	PUNCT
fnp-3805	169	27	cmt	cmt	PROPN
fnp-3805	169	28	model	model	NOUN
fnp-3805	169	29	following	follow	VERB
fnp-3805	169	30	pharmacologic	pharmacologic	ADJ
fnp-3805	169	31	inhibition	inhibition	NOUN
fnp-3805	169	32	of	of	ADP
fnp-3805	169	33	gcn2	gcn2	NOUN
fnp-3805	169	34	,	,	PUNCT
fnp-3805	169	35	with	with	ADP
fnp-3805	169	36	treatment	treatment	NOUN
fnp-3805	169	37	that	that	PRON
fnp-3805	169	38	was	be	AUX
fnp-3805	169	39	initiated	initiate	VERB
fnp-3805	169	40	at	at	ADP
fnp-3805	169	41	disease	disease	NOUN
fnp-3805	169	42	onset	onset	NOUN
fnp-3805	169	43	(	(	PUNCT
fnp-3805	169	44	2	2	NUM
fnp-3805	169	45	weeks	week	NOUN
fnp-3805	169	46	of	of	ADP
fnp-3805	169	47	age	age	NOUN
fnp-3805	169	48	)	)	PUNCT
fnp-3805	169	49	;	;	PUNCT
fnp-3805	169	50	interestingly	interestingly	ADV
fnp-3805	169	51	,	,	PUNCT
fnp-3805	169	52	the	the	DET
fnp-3805	169	53	effect	effect	NOUN
fnp-3805	169	54	of	of	ADP
fnp-3805	169	55	pharmacologic	pharmacologic	ADJ
fnp-3805	169	56	gcn2	gcn2	NOUN
fnp-3805	169	57	inhibition	inhibition	NOUN
fnp-3805	169	58	was	be	AUX
fnp-3805	169	59	greater	great	ADJ
fnp-3805	169	60	in	in	ADP
fnp-3805	169	61	male	male	NOUN
fnp-3805	169	62	than	than	ADP
fnp-3805	169	63	female	female	ADJ
fnp-3805	169	64	mice	mouse	NOUN
fnp-3805	169	65	,	,	PUNCT
fnp-3805	169	66	but	but	CCONJ
fnp-3805	169	67	the	the	DET
fnp-3805	169	68	reason	reason	NOUN
fnp-3805	169	69	for	for	ADP
fnp-3805	169	70	this	this	DET
fnp-3805	169	71	sex	sex	NOUN
fnp-3805	169	72	difference	difference	NOUN
fnp-3805	169	73	is	be	AUX
fnp-3805	169	74	currently	currently	ADV
fnp-3805	169	75	unclear	unclear	ADJ
fnp-3805	169	76	.	.	PUNCT
fnp-3805	170	1	in	in	ADP
fnp-3805	170	2	a	a	DET
fnp-3805	170	3	parallel	parallel	ADJ
fnp-3805	170	4	study	study	NOUN
fnp-3805	170	5	,	,	PUNCT
fnp-3805	170	6	zuko	zuko	AUX
fnp-3805	170	7	et	et	PROPN
fnp-3805	170	8	al	al	PROPN
fnp-3805	170	9	.	.	PROPN
fnp-3805	170	10	investigated	investigate	VERB
fnp-3805	170	11	mechanisms	mechanism	NOUN
fnp-3805	170	12	underlying	underlie	VERB
fnp-3805	170	13	inhibition	inhibition	NOUN
fnp-3805	170	14	of	of	ADP
fnp-3805	170	15	global	global	ADJ
fnp-3805	170	16	protein	protein	NOUN
fnp-3805	170	17	synthesis	synthesis	NOUN
fnp-3805	170	18	that	that	PRON
fnp-3805	170	19	was	be	AUX
fnp-3805	170	20	previously	previously	ADV
fnp-3805	170	21	documented	document	VERB
fnp-3805	170	22	in	in	ADP
fnp-3805	170	23	6	6	NUM
fnp-3805	170	24	different	different	ADJ
fnp-3805	170	25	gars	gar	NOUN
fnp-3805	170	26	-	-	PUNCT
fnp-3805	170	27	cmt	cmt	PROPN
fnp-3805	170	28	and	and	CCONJ
fnp-3805	170	29	yars	yars	PROPN
fnp-3805	170	30	-	-	PUNCT
fnp-3805	170	31	cmt	cmt	PROPN
fnp-3805	170	32	mouse	mouse	NOUN
fnp-3805	170	33	lines	line	NOUN
fnp-3805	170	34	and	and	CCONJ
fnp-3805	170	35	could	could	AUX
fnp-3805	170	36	not	not	PART
fnp-3805	170	37	be	be	AUX
fnp-3805	170	38	rescued	rescue	VERB
fnp-3805	170	39	by	by	ADP
fnp-3805	170	40	overexpression	overexpression	NOUN
fnp-3805	170	41	of	of	ADP
fnp-3805	170	42	wt	wt	PROPN
fnp-3805	170	43	gars	gar	NOUN
fnp-3805	170	44	or	or	CCONJ
fnp-3805	170	45	yars	yar	NOUN
fnp-3805	170	46	.	.	PUNCT
fnp-3805	171	1	while	while	SCONJ
fnp-3805	171	2	manipulation	manipulation	NOUN
fnp-3805	171	3	of	of	ADP
fnp-3805	171	4	translation	translation	NOUN
fnp-3805	171	5	initiation	initiation	NOUN
fnp-3805	171	6	and	and	CCONJ
fnp-3805	171	7	upstream	upstream	ADJ
fnp-3805	171	8	regulatory	regulatory	ADJ
fnp-3805	171	9	pathways	pathway	NOUN
fnp-3805	171	10	had	have	VERB
fnp-3805	171	11	no	no	DET
fnp-3805	171	12	significant	significant	ADJ
fnp-3805	171	13	effect	effect	NOUN
fnp-3805	171	14	,	,	PUNCT
fnp-3805	171	15	overexpression	overexpression	NOUN
fnp-3805	171	16	of	of	ADP
fnp-3805	171	17	trnagly	trnagly	ADV
fnp-3805	171	18	rescued	rescue	VERB
fnp-3805	171	19	both	both	CCONJ
fnp-3805	171	20	the	the	DET
fnp-3805	171	21	protein	protein	NOUN
fnp-3805	171	22	synthesis	synthesis	NOUN
fnp-3805	171	23	deficit	deficit	NOUN
fnp-3805	171	24	and	and	CCONJ
fnp-3805	171	25	neuropathy	neuropathy	ADJ
fnp-3805	171	26	phenotype	phenotype	NOUN
fnp-3805	171	27	in	in	ADP
fnp-3805	171	28	two	two	NUM
fnp-3805	171	29	drosophila	drosophila	NOUN
fnp-3805	171	30	models	model	NOUN
fnp-3805	171	31	of	of	ADP
fnp-3805	171	32	gars	gars	PROPN
fnp-3805	171	33	-	-	PUNCT
fnp-3805	171	34	cmt	cmt	PROPN
fnp-3805	171	35	.	.	PUNCT
fnp-3805	172	1	these	these	DET
fnp-3805	172	2	findings	finding	NOUN
fnp-3805	172	3	were	be	AUX
fnp-3805	172	4	replicated	replicate	VERB
fnp-3805	172	5	in	in	ADP
fnp-3805	172	6	two	two	NUM
fnp-3805	172	7	mouse	mouse	NOUN
fnp-3805	172	8	models	model	NOUN
fnp-3805	172	9	of	of	ADP
fnp-3805	172	10	gars	gars	PROPN
fnp-3805	172	11	-	-	PUNCT
fnp-3805	172	12	cmt	cmt	PROPN
fnp-3805	172	13	,	,	PUNCT
fnp-3805	172	14	with	with	ADP
fnp-3805	172	15	trnagly	trnagly	ADV
fnp-3805	172	16	overexpression	overexpression	NOUN
fnp-3805	172	17	resulting	result	VERB
fnp-3805	172	18	in	in	ADP
fnp-3805	172	19	an	an	DET
fnp-3805	172	20	essentially	essentially	ADV
fnp-3805	172	21	complete	complete	ADJ
fnp-3805	172	22	behavioral	behavioral	ADJ
fnp-3805	172	23	,	,	PUNCT
fnp-3805	172	24	physiologic	physiologic	ADJ
fnp-3805	172	25	,	,	PUNCT
fnp-3805	172	26	and	and	CCONJ
fnp-3805	172	27	pathologic	pathologic	ADJ
fnp-3805	172	28	rescue	rescue	NOUN
fnp-3805	172	29	of	of	ADP
fnp-3805	172	30	peripheral	peripheral	ADJ
fnp-3805	172	31	neuropathy	neuropathy	ADJ
fnp-3805	172	32	(	(	PUNCT
fnp-3805	172	33	zuko	zuko	NOUN
fnp-3805	172	34	et	et	PROPN
fnp-3805	172	35	al	al	PROPN
fnp-3805	172	36	.	.	PROPN
fnp-3805	172	37	,	,	PUNCT
fnp-3805	172	38	2021	2021	NUM
fnp-3805	172	39	)	)	PUNCT
fnp-3805	172	40	.	.	PUNCT
fnp-3805	173	1	in	in	ADP
fnp-3805	173	2	addition	addition	NOUN
fnp-3805	173	3	,	,	PUNCT
fnp-3805	173	4	zuko	zuko	PROPN
fnp-3805	173	5	and	and	CCONJ
fnp-3805	173	6	colleagues	colleague	NOUN
fnp-3805	173	7	showed	show	VERB
fnp-3805	173	8	that	that	SCONJ
fnp-3805	173	9	inhibition	inhibition	NOUN
fnp-3805	173	10	of	of	ADP
fnp-3805	173	11	global	global	ADJ
fnp-3805	173	12	protein	protein	NOUN
fnp-3805	173	13	synthesis	synthesis	NOUN
fnp-3805	173	14	in	in	ADP
fnp-3805	173	15	this	this	DET
fnp-3805	173	16	mouse	mouse	NOUN
fnp-3805	173	17	model	model	NOUN
fnp-3805	173	18	was	be	AUX
fnp-3805	173	19	due	due	ADJ
fnp-3805	173	20	to	to	ADP
fnp-3805	173	21	trnagly	trnagly	ADV
fnp-3805	173	22	sequestration	sequestration	NOUN
fnp-3805	173	23	by	by	ADP
fnp-3805	173	24	mutant	mutant	ADJ
fnp-3805	173	25	gars	gar	NOUN
fnp-3805	173	26	,	,	PUNCT
fnp-3805	173	27	which	which	PRON
fnp-3805	173	28	led	lead	VERB
fnp-3805	173	29	to	to	ADP
fnp-3805	173	30	ribosome	ribosome	ADJ
fnp-3805	173	31	stalling	stalling	NOUN
fnp-3805	173	32	at	at	ADP
fnp-3805	173	33	gly	gly	ADJ
fnp-3805	173	34	codons	codon	NOUN
fnp-3805	173	35	;	;	PUNCT
fnp-3805	173	36	as	as	ADP
fnp-3805	173	37	a	a	DET
fnp-3805	173	38	result	result	NOUN
fnp-3805	173	39	,	,	PUNCT
fnp-3805	173	40	the	the	DET
fnp-3805	173	41	neuropathy	neuropathy	ADJ
fnp-3805	173	42	in	in	ADP
fnp-3805	173	43	gars	gars	PROPN
fnp-3805	173	44	-	-	PUNCT
fnp-3805	173	45	cmt	cmt	PROPN
fnp-3805	173	46	mice	mouse	NOUN
fnp-3805	173	47	was	be	AUX
fnp-3805	173	48	worsened	worsen	VERB
fnp-3805	173	49	by	by	ADP
fnp-3805	173	50	concurrent	concurrent	ADJ
fnp-3805	173	51	deletion	deletion	NOUN
fnp-3805	173	52	of	of	ADP
fnp-3805	173	53	the	the	DET
fnp-3805	173	54	ribosome	ribosome	ADJ
fnp-3805	173	55	rescue	rescue	NOUN
fnp-3805	173	56	factor	factor	NOUN
fnp-3805	173	57	gtpbp2	gtpbp2	PROPN
fnp-3805	173	58	,	,	PUNCT
fnp-3805	173	59	which	which	PRON
fnp-3805	173	60	by	by	ADP
fnp-3805	173	61	itself	itself	PRON
fnp-3805	173	62	does	do	AUX
fnp-3805	173	63	not	not	PART
fnp-3805	173	64	lead	lead	VERB
fnp-3805	173	65	to	to	ADP
fnp-3805	173	66	nerve	nerve	NOUN
fnp-3805	173	67	damage	damage	NOUN
fnp-3805	173	68	.	.	PUNCT
fnp-3805	174	1	finally	finally	ADV
fnp-3805	174	2	,	,	PUNCT
fnp-3805	174	3	connecting	connect	VERB
fnp-3805	174	4	the	the	DET
fnp-3805	174	5	dots	dot	NOUN
fnp-3805	174	6	between	between	ADP
fnp-3805	174	7	the	the	DET
fnp-3805	174	8	two	two	NUM
fnp-3805	174	9	studies	study	NOUN
fnp-3805	174	10	,	,	PUNCT
fnp-3805	174	11	zuko	zuko	PROPN
fnp-3805	174	12	et	et	PROPN
fnp-3805	174	13	al	al	PROPN
fnp-3805	174	14	.	.	PROPN
fnp-3805	174	15	showed	show	VERB
fnp-3805	174	16	that	that	SCONJ
fnp-3805	174	17	trnagly	trnagly	ADV
fnp-3805	174	18	overexpression	overexpression	NOUN
fnp-3805	174	19	abrogated	abrogate	VERB
fnp-3805	174	20	activation	activation	NOUN
fnp-3805	174	21	of	of	ADP
fnp-3805	174	22	the	the	DET
fnp-3805	174	23	isr	isr	NOUN
fnp-3805	174	24	in	in	ADP
fnp-3805	174	25	the	the	DET
fnp-3805	174	26	gars	gars	PROPN
fnp-3805	174	27	-	-	PUNCT
fnp-3805	174	28	cmt	cmt	PROPN
fnp-3805	174	29	mouse	mouse	PROPN
fnp-3805	174	30	model	model	NOUN
fnp-3805	174	31	,	,	PUNCT
fnp-3805	174	32	indicating	indicate	VERB
fnp-3805	174	33	that	that	SCONJ
fnp-3805	174	34	depletion	depletion	NOUN
fnp-3805	174	35	of	of	ADP
fnp-3805	174	36	the	the	DET
fnp-3805	174	37	normal	normal	ADJ
fnp-3805	174	38	trnagly	trnagly	ADJ
fnp-3805	174	39	pool	pool	NOUN
fnp-3805	174	40	and	and	CCONJ
fnp-3805	174	41	consequent	consequent	ADJ
fnp-3805	174	42	ribosome	ribosome	NOUN
fnp-3805	174	43	stalling	stalling	NOUN
fnp-3805	174	44	are	be	AUX
fnp-3805	174	45	the	the	DET
fnp-3805	174	46	upstream	upstream	ADJ
fnp-3805	174	47	signals	signal	NOUN
fnp-3805	174	48	that	that	PRON
fnp-3805	174	49	lead	lead	VERB
fnp-3805	174	50	to	to	ADP
fnp-3805	174	51	the	the	DET
fnp-3805	174	52	isr	isr	ADJ
fnp-3805	174	53	activation	activation	NOUN
fnp-3805	174	54	.	.	PUNCT
fnp-3805	175	1	taken	take	VERB
fnp-3805	175	2	together	together	ADV
fnp-3805	175	3	,	,	PUNCT
fnp-3805	175	4	these	these	DET
fnp-3805	175	5	two	two	NUM
fnp-3805	175	6	studies	study	NOUN
fnp-3805	175	7	suggest	suggest	VERB
fnp-3805	175	8	that	that	SCONJ
fnp-3805	175	9	ars	ar	VERB
fnp-3805	175	10	mutations	mutation	NOUN
fnp-3805	175	11	cause	cause	VERB
fnp-3805	175	12	autosomal	autosomal	ADJ
fnp-3805	175	13	dominant	dominant	ADJ
fnp-3805	175	14	axonal	axonal	ADJ
fnp-3805	175	15	cmt	cmt	PROPN
fnp-3805	175	16	disease	disease	NOUN
fnp-3805	175	17	through	through	ADP
fnp-3805	175	18	a	a	DET
fnp-3805	175	19	toxic	toxic	ADJ
fnp-3805	175	20	gain	gain	NOUN
fnp-3805	175	21	-	-	PUNCT
fnp-3805	175	22	of	of	ADP
fnp-3805	175	23	-	-	PUNCT
fnp-3805	175	24	function	function	NOUN
fnp-3805	175	25	mechanism	mechanism	NOUN
fnp-3805	175	26	:	:	PUNCT
fnp-3805	175	27	by	by	ADP
fnp-3805	175	28	binding	bind	VERB
fnp-3805	175	29	more	more	ADV
fnp-3805	175	30	tightly	tightly	ADV
fnp-3805	175	31	to	to	ADP
fnp-3805	175	32	their	their	PRON
fnp-3805	175	33	cognate	cognate	NOUN
fnp-3805	175	34	trnas	trnas	NOUN
fnp-3805	175	35	,	,	PUNCT
fnp-3805	175	36	they	they	PRON
fnp-3805	175	37	deplete	deplete	VERB
fnp-3805	175	38	the	the	DET
fnp-3805	175	39	free	free	ADJ
fnp-3805	175	40	trna	trna	PROPN
fnp-3805	175	41	pool	pool	NOUN
fnp-3805	175	42	,	,	PUNCT
fnp-3805	175	43	ultimately	ultimately	ADV
fnp-3805	175	44	leading	lead	VERB
fnp-3805	175	45	to	to	ADP
fnp-3805	175	46	ribosome	ribosome	ADJ
fnp-3805	175	47	stalling	stalling	NOUN
fnp-3805	175	48	,	,	PUNCT
fnp-3805	175	49	aberrant	aberrant	ADJ
fnp-3805	175	50	isr	isr	ADJ
fnp-3805	175	51	activation	activation	NOUN
fnp-3805	175	52	,	,	PUNCT
fnp-3805	175	53	and	and	CCONJ
fnp-3805	175	54	axonal	axonal	ADJ
fnp-3805	175	55	degeneration	degeneration	NOUN
fnp-3805	175	56	.	.	PUNCT
fnp-3805	176	1	despite	despite	SCONJ
fnp-3805	176	2	the	the	DET
fnp-3805	176	3	very	very	ADV
fnp-3805	176	4	comprehensive	comprehensive	ADJ
fnp-3805	176	5	nature	nature	NOUN
fnp-3805	176	6	of	of	ADP
fnp-3805	176	7	this	this	DET
fnp-3805	176	8	work	work	NOUN
fnp-3805	176	9	,	,	PUNCT
fnp-3805	176	10	additional	additional	ADJ
fnp-3805	176	11	questions	question	NOUN
fnp-3805	176	12	need	need	VERB
fnp-3805	176	13	to	to	PART
fnp-3805	176	14	be	be	AUX
fnp-3805	176	15	answered	answer	VERB
fnp-3805	176	16	.	.	PUNCT
fnp-3805	177	1	for	for	ADP
fnp-3805	177	2	example	example	NOUN
fnp-3805	177	3	,	,	PUNCT
fnp-3805	177	4	it	it	PRON
fnp-3805	177	5	remains	remain	VERB
fnp-3805	177	6	to	to	PART
fnp-3805	177	7	be	be	AUX
fnp-3805	177	8	shown	show	VERB
fnp-3805	177	9	whether	whether	SCONJ
fnp-3805	177	10	the	the	DET
fnp-3805	177	11	same	same	ADJ
fnp-3805	177	12	(	(	PUNCT
fnp-3805	177	13	or	or	CCONJ
fnp-3805	177	14	similar	similar	ADJ
fnp-3805	177	15	)	)	PUNCT
fnp-3805	177	16	molecular	molecular	ADJ
fnp-3805	177	17	mechanism	mechanism	NOUN
fnp-3805	177	18	plays	play	VERB
fnp-3805	177	19	a	a	DET
fnp-3805	177	20	role	role	NOUN
fnp-3805	177	21	in	in	ADP
fnp-3805	177	22	the	the	DET
fnp-3805	177	23	pathogenesis	pathogenesis	NOUN
fnp-3805	177	24	of	of	ADP
fnp-3805	177	25	the	the	DET
fnp-3805	177	26	aars-	aars-	ADJ
fnp-3805	177	27	,	,	PUNCT
fnp-3805	177	28	hars-	hars-	X
fnp-3805	177	29	,	,	PUNCT
fnp-3805	177	30	and	and	CCONJ
fnp-3805	177	31	mars	mar	NOUN
fnp-3805	177	32	-	-	PUNCT
fnp-3805	177	33	associated	associate	VERB
fnp-3805	177	34	cmt	cmt	PROPN
fnp-3805	177	35	,	,	PUNCT
fnp-3805	177	36	and	and	CCONJ
fnp-3805	177	37	in	in	ADP
fnp-3805	177	38	axonal	axonal	ADJ
fnp-3805	177	39	cmt	cmt	PROPN
fnp-3805	177	40	more	more	ADV
fnp-3805	177	41	broadly	broadly	ADV
fnp-3805	177	42	.	.	PUNCT
fnp-3805	178	1	in	in	ADP
fnp-3805	178	2	addition	addition	NOUN
fnp-3805	178	3	,	,	PUNCT
fnp-3805	178	4	it	it	PRON
fnp-3805	178	5	is	be	AUX
fnp-3805	178	6	not	not	PART
fnp-3805	178	7	clear	clear	ADJ
fnp-3805	178	8	which	which	DET
fnp-3805	178	9	downstream	downstream	ADJ
fnp-3805	178	10	effect	effect	NOUN
fnp-3805	178	11	of	of	ADP
fnp-3805	178	12	the	the	DET
fnp-3805	178	13	isr	isr	ADJ
fnp-3805	178	14	activation	activation	NOUN
fnp-3805	178	15	(	(	PUNCT
fnp-3805	178	16	protein	protein	NOUN
fnp-3805	178	17	synthesis	synthesis	NOUN
fnp-3805	178	18	inhibition	inhibition	NOUN
fnp-3805	178	19	or	or	CCONJ
fnp-3805	178	20	the	the	DET
fnp-3805	178	21	atf4	atf4	NOUN
fnp-3805	178	22	pathway	pathway	NOUN
fnp-3805	178	23	activation	activation	NOUN
fnp-3805	178	24	)	)	PUNCT
fnp-3805	178	25	leads	lead	VERB
fnp-3805	178	26	to	to	ADP
fnp-3805	178	27	axonal	axonal	ADJ
fnp-3805	178	28	degeneration	degeneration	NOUN
fnp-3805	178	29	.	.	PUNCT
fnp-3805	179	1	nonetheless	nonetheless	ADV
fnp-3805	179	2	,	,	PUNCT
fnp-3805	179	3	and	and	CCONJ
fnp-3805	179	4	very	very	ADV
fnp-3805	179	5	excitingly	excitingly	ADV
fnp-3805	179	6	,	,	PUNCT
fnp-3805	179	7	this	this	DET
fnp-3805	179	8	work	work	NOUN
fnp-3805	179	9	opens	open	VERB
fnp-3805	179	10	a	a	DET
fnp-3805	179	11	new	new	ADJ
fnp-3805	179	12	direction	direction	NOUN
fnp-3805	179	13	for	for	ADP
fnp-3805	179	14	the	the	DET
fnp-3805	179	15	cmt	cmt	PROPN
fnp-3805	179	16	treatment	treatment	PROPN
fnp-3805	179	17	development	development	NOUN
fnp-3805	179	18	:	:	PUNCT
fnp-3805	179	19	manipulation	manipulation	NOUN
fnp-3805	179	20	of	of	ADP
fnp-3805	179	21	the	the	DET
fnp-3805	179	22	isr	isr	NOUN
fnp-3805	179	23	is	be	AUX
fnp-3805	179	24	emerging	emerge	VERB
fnp-3805	179	25	as	as	ADP
fnp-3805	179	26	a	a	DET
fnp-3805	179	27	promising	promising	ADJ
fnp-3805	179	28	therapeutic	therapeutic	ADJ
fnp-3805	179	29	avenue	avenue	NOUN
fnp-3805	179	30	for	for	ADP
fnp-3805	179	31	several	several	ADJ
fnp-3805	179	32	age	age	NOUN
fnp-3805	179	33	-	-	PUNCT
fnp-3805	179	34	associated	associate	VERB
fnp-3805	179	35	diseases	disease	NOUN
fnp-3805	179	36	,	,	PUNCT
fnp-3805	179	37	including	include	VERB
fnp-3805	179	38	neurodegeneration	neurodegeneration	NOUN
fnp-3805	179	39	and	and	CCONJ
fnp-3805	179	40	cancer	cancer	NOUN
fnp-3805	179	41	(	(	PUNCT
fnp-3805	179	42	costa	costa	PROPN
fnp-3805	179	43	-	-	PUNCT
fnp-3805	179	44	mattioli	mattioli	PROPN
fnp-3805	179	45	and	and	CCONJ
fnp-3805	179	46	walter	walter	PROPN
fnp-3805	179	47	,	,	PUNCT
fnp-3805	179	48	2020	2020	NUM
fnp-3805	179	49	)	)	PUNCT
fnp-3805	179	50	,	,	PUNCT
fnp-3805	179	51	and	and	CCONJ
fnp-3805	179	52	at	at	ADP
fnp-3805	179	53	least	least	ADJ
fnp-3805	179	54	some	some	PRON
fnp-3805	179	55	subtypes	subtype	NOUN
fnp-3805	179	56	of	of	ADP
fnp-3805	179	57	axonal	axonal	ADJ
fnp-3805	179	58	cmt	cmt	PROPN
fnp-3805	179	59	can	can	AUX
fnp-3805	179	60	now	now	ADV
fnp-3805	179	61	be	be	AUX
fnp-3805	179	62	added	add	VERB
fnp-3805	179	63	to	to	ADP
fnp-3805	179	64	that	that	DET
fnp-3805	179	65	list	list	NOUN
fnp-3805	179	66	.	.	PUNCT
fnp-3805	180	1	[	[	X
fnp-3805	180	2	as	as	ADP
fnp-3805	180	3	an	an	DET
fnp-3805	180	4	aside	aside	NOUN
fnp-3805	180	5	,	,	PUNCT
fnp-3805	180	6	ars	ar	VERB
fnp-3805	180	7	enzymes	enzyme	NOUN
fnp-3805	180	8	also	also	ADV
fnp-3805	180	9	play	play	VERB
fnp-3805	180	10	an	an	DET
fnp-3805	180	11	important	important	ADJ
fnp-3805	180	12	role	role	NOUN
fnp-3805	180	13	in	in	ADP
fnp-3805	180	14	anti	anti	ADJ
fnp-3805	180	15	-	-	ADJ
fnp-3805	180	16	synthetase	synthetase	ADJ
fnp-3805	180	17	syndrome	syndrome	NOUN
fnp-3805	180	18	(	(	PUNCT
fnp-3805	180	19	ass	ass	PROPN
fnp-3805	180	20	)	)	PUNCT
fnp-3805	180	21	,	,	PUNCT
fnp-3805	180	22	where	where	SCONJ
fnp-3805	180	23	they	they	PRON
fnp-3805	180	24	are	be	AUX
fnp-3805	180	25	targeted	target	VERB
fnp-3805	180	26	by	by	ADP
fnp-3805	180	27	disease	disease	NOUN
fnp-3805	180	28	-	-	PUNCT
fnp-3805	180	29	causing	cause	VERB
fnp-3805	180	30	autoantibodies	autoantibody	NOUN
fnp-3805	180	31	(	(	PUNCT
fnp-3805	180	32	histidyl	histidyl	NOUN
fnp-3805	180	33	-	-	PUNCT
fnp-3805	180	34	rs	rs	NOUN
fnp-3805	180	35	is	be	AUX
fnp-3805	180	36	targeted	target	VERB
fnp-3805	180	37	by	by	ADP
fnp-3805	180	38	anti	anti	ADJ
fnp-3805	180	39	-	-	ADJ
fnp-3805	180	40	jo-1	jo-1	ADJ
fnp-3805	180	41	antibodies	antibody	NOUN
fnp-3805	180	42	,	,	PUNCT
fnp-3805	180	43	alanyl	alanyl	NOUN
fnp-3805	180	44	-	-	PUNCT
fnp-3805	180	45	rs	rs	NOUN
fnp-3805	180	46	by	by	ADP
fnp-3805	180	47	anti	anti	ADJ
fnp-3805	180	48	-	-	ADJ
fnp-3805	180	49	pl12	pl12	PROPN
fnp-3805	180	50	antibodies	antibodie	VERB
fnp-3805	180	51	,	,	PUNCT
fnp-3805	180	52	glycyl	glycyl	NOUN
fnp-3805	180	53	-	-	PUNCT
fnp-3805	180	54	rs	rs	NOUN
fnp-3805	180	55	by	by	ADP
fnp-3805	180	56	anti	anti	ADJ
fnp-3805	180	57	-	-	ADJ
fnp-3805	180	58	ej	ej	ADJ
fnp-3805	180	59	antibodies	antibodie	VERB
fnp-3805	180	60	,	,	PUNCT
fnp-3805	180	61	lysyl	lysyl	NOUN
fnp-3805	180	62	-	-	PUNCT
fnp-3805	180	63	rs	rs	NOUN
fnp-3805	180	64	by	by	ADP
fnp-3805	180	65	anti	anti	ADJ
fnp-3805	180	66	-	-	ADJ
fnp-3805	180	67	sc	sc	ADJ
fnp-3805	180	68	antibodies	antibodie	VERB
fnp-3805	180	69	,	,	PUNCT
fnp-3805	180	70	and	and	CCONJ
fnp-3805	180	71	tyrosyl	tyrosyl	ADJ
fnp-3805	180	72	-	-	PUNCT
fnp-3805	180	73	rs	rs	NOUN
fnp-3805	180	74	by	by	ADP
fnp-3805	180	75	anti	anti	ADJ
fnp-3805	180	76	-	-	ADJ
fnp-3805	180	77	yrs	yrs	ADJ
fnp-3805	180	78	antibodies	antibodie	VERB
fnp-3805	180	79	;	;	PUNCT
fnp-3805	180	80	witt	witt	PROPN
fnp-3805	180	81	et	et	PROPN
fnp-3805	180	82	al	al	PROPN
fnp-3805	180	83	.	.	PROPN
fnp-3805	180	84	,	,	PUNCT
fnp-3805	180	85	2016	2016	NUM
fnp-3805	180	86	)	)	PUNCT
fnp-3805	180	87	.	.	PUNCT
fnp-3805	181	1	ass	ass	NOUN
fnp-3805	181	2	and	and	CCONJ
fnp-3805	181	3	cmt	cmt	PROPN
fnp-3805	181	4	disease	disease	PROPN
fnp-3805	181	5	have	have	VERB
fnp-3805	181	6	entirely	entirely	ADV
fnp-3805	181	7	different	different	ADJ
fnp-3805	181	8	clinical	clinical	ADJ
fnp-3805	181	9	manifestations	manifestation	NOUN
fnp-3805	181	10	,	,	PUNCT
fnp-3805	181	11	so	so	ADV
fnp-3805	181	12	the	the	DET
fnp-3805	181	13	underlying	underlie	VERB
fnp-3805	181	14	pathogenetic	pathogenetic	ADJ
fnp-3805	181	15	mechanisms	mechanism	NOUN
fnp-3805	181	16	are	be	AUX
fnp-3805	181	17	likely	likely	ADJ
fnp-3805	181	18	also	also	ADV
fnp-3805	181	19	different	different	ADJ
fnp-3805	181	20	despite	despite	SCONJ
fnp-3805	181	21	this	this	DET
fnp-3805	181	22	common	common	ADJ
fnp-3805	181	23	link	link	NOUN
fnp-3805	181	24	;	;	PUNCT
fnp-3805	181	25	while	while	SCONJ
fnp-3805	181	26	there	there	PRON
fnp-3805	181	27	is	be	VERB
fnp-3805	181	28	some	some	DET
fnp-3805	181	29	evidence	evidence	NOUN
fnp-3805	181	30	that	that	SCONJ
fnp-3805	181	31	protein	protein	NOUN
fnp-3805	181	32	translation	translation	NOUN
fnp-3805	181	33	is	be	AUX
fnp-3805	181	34	affected	affect	VERB
fnp-3805	181	35	in	in	ADP
fnp-3805	181	36	ass	ass	NOUN
fnp-3805	181	37	–	–	PUNCT
fnp-3805	181	38	see	see	VERB
fnp-3805	181	39	advance	advance	NOUN
fnp-3805	181	40	#	#	SYM
fnp-3805	181	41	9	9	NUM
fnp-3805	181	42	–	–	PUNCT
fnp-3805	181	43	it	it	PRON
fnp-3805	181	44	remains	remain	VERB
fnp-3805	181	45	to	to	PART
fnp-3805	181	46	be	be	AUX
fnp-3805	181	47	established	establish	VERB
fnp-3805	181	48	whether	whether	SCONJ
fnp-3805	181	49	the	the	DET
fnp-3805	181	50	isr	isr	ADJ
fnp-3805	181	51	activation	activation	NOUN
fnp-3805	181	52	and/or	and/or	CCONJ
fnp-3805	181	53	protein	protein	NOUN
fnp-3805	181	54	synthesis	synthesis	NOUN
fnp-3805	181	55	inhibition	inhibition	NOUN
fnp-3805	181	56	play	play	VERB
fnp-3805	181	57	a	a	DET
fnp-3805	181	58	role	role	NOUN
fnp-3805	181	59	in	in	ADP
fnp-3805	181	60	the	the	DET
fnp-3805	181	61	ass	ass	NOUN
fnp-3805	181	62	pathogenesis	pathogenesis	NOUN
fnp-3805	181	63	.	.	PUNCT
fnp-3805	181	64	]	]	PUNCT
fnp-3805	182	1	advances	advance	VERB
fnp-3805	182	2	in	in	ADP
fnp-3805	182	3	neuromuscular	neuromuscular	ADJ
fnp-3805	182	4	disease	disease	NOUN
fnp-3805	182	5	diagnostics	diagnostic	NOUN
fnp-3805	182	6	8	8	NUM
fnp-3805	182	7	.	.	PUNCT
fnp-3805	183	1	microvascular	microvascular	ADJ
fnp-3805	183	2	pathology	pathology	NOUN
fnp-3805	183	3	in	in	ADP
fnp-3805	183	4	immune	immune	NOUN
fnp-3805	183	5	-	-	PUNCT
fnp-3805	183	6	mediated	mediate	VERB
fnp-3805	183	7	neuromuscular	neuromuscular	ADJ
fnp-3805	183	8	disease	disease	NOUN
fnp-3805	183	9	major	major	ADJ
fnp-3805	183	10	vascular	vascular	ADJ
fnp-3805	183	11	pathology	pathology	NOUN
fnp-3805	183	12	(	(	PUNCT
fnp-3805	183	13	such	such	ADJ
fnp-3805	183	14	as	as	ADP
fnp-3805	183	15	vasculitis	vasculitis	NOUN
fnp-3805	183	16	or	or	CCONJ
fnp-3805	183	17	amyloid	amyloid	NOUN
fnp-3805	183	18	vasculopathy	vasculopathy	NOUN
fnp-3805	183	19	)	)	PUNCT
fnp-3805	183	20	has	have	AUX
fnp-3805	183	21	long	long	ADV
fnp-3805	183	22	been	be	AUX
fnp-3805	183	23	recognized	recognize	VERB
fnp-3805	183	24	as	as	ADP
fnp-3805	183	25	an	an	DET
fnp-3805	183	26	important	important	ADJ
fnp-3805	183	27	cause	cause	NOUN
fnp-3805	183	28	of	of	ADP
fnp-3805	183	29	neuromuscular	neuromuscular	ADJ
fnp-3805	183	30	disease	disease	NOUN
fnp-3805	183	31	,	,	PUNCT
fnp-3805	183	32	and	and	CCONJ
fnp-3805	183	33	vessel	vessel	NOUN
fnp-3805	183	34	evaluation	evaluation	NOUN
fnp-3805	183	35	on	on	ADP
fnp-3805	183	36	routine	routine	ADJ
fnp-3805	183	37	stains	stain	NOUN
fnp-3805	183	38	is	be	AUX
fnp-3805	183	39	a	a	DET
fnp-3805	183	40	standard	standard	ADJ
fnp-3805	183	41	component	component	NOUN
fnp-3805	183	42	of	of	ADP
fnp-3805	183	43	diagnostic	diagnostic	ADJ
fnp-3805	183	44	neuromuscular	neuromuscular	ADJ
fnp-3805	183	45	pathology	pathology	NOUN
fnp-3805	183	46	workup	workup	NOUN
fnp-3805	183	47	.	.	PUNCT
fnp-3805	184	1	the	the	DET
fnp-3805	184	2	role	role	NOUN
fnp-3805	184	3	of	of	ADP
fnp-3805	184	4	microvascular	microvascular	ADJ
fnp-3805	184	5	pathology	pathology	NOUN
fnp-3805	184	6	is	be	AUX
fnp-3805	184	7	less	less	ADV
fnp-3805	184	8	well	well	ADV
fnp-3805	184	9	understood	understand	VERB
fnp-3805	184	10	,	,	PUNCT
fnp-3805	184	11	but	but	CCONJ
fnp-3805	184	12	some	some	DET
fnp-3805	184	13	microvascular	microvascular	ADJ
fnp-3805	184	14	abnormalities	abnormality	NOUN
fnp-3805	184	15	[	[	X
fnp-3805	184	16	such	such	ADJ
fnp-3805	184	17	as	as	ADP
fnp-3805	184	18	deposition	deposition	NOUN
fnp-3805	184	19	of	of	ADP
fnp-3805	184	20	c5b9	c5b9	X
fnp-3805	184	21	(	(	PUNCT
fnp-3805	184	22	complement	complement	VERB
fnp-3805	184	23	membrane	membrane	NOUN
fnp-3805	184	24	attack	attack	NOUN
fnp-3805	184	25	complex	complex	NOUN
fnp-3805	184	26	)	)	PUNCT
fnp-3805	184	27	in	in	ADP
fnp-3805	184	28	the	the	DET
fnp-3805	184	29	endomysial	endomysial	ADJ
fnp-3805	184	30	capillaries	capillary	NOUN
fnp-3805	184	31	]	]	PUNCT
fnp-3805	184	32	are	be	AUX
fnp-3805	184	33	included	include	VERB
fnp-3805	184	34	in	in	ADP
fnp-3805	184	35	the	the	DET
fnp-3805	184	36	diagnostic	diagnostic	ADJ
fnp-3805	184	37	criteria	criterion	NOUN
fnp-3805	184	38	for	for	ADP
fnp-3805	184	39	several	several	ADJ
fnp-3805	184	40	idiopathic	idiopathic	ADJ
fnp-3805	184	41	inflammatory	inflammatory	ADJ
fnp-3805	184	42	myopathies	myopathy	NOUN
fnp-3805	184	43	(	(	PUNCT
fnp-3805	184	44	iims	iim	NOUN
fnp-3805	184	45	)	)	PUNCT
fnp-3805	184	46	including	include	VERB
fnp-3805	184	47	dm	dm	PROPN
fnp-3805	184	48	,	,	PUNCT
fnp-3805	184	49	anti	anti	ADJ
fnp-3805	184	50	-	-	ADJ
fnp-3805	184	51	synthetase	synthetase	ADJ
fnp-3805	184	52	syndrome	syndrome	NOUN
fnp-3805	184	53	-	-	PUNCT
fnp-3805	184	54	associated	associate	VERB
fnp-3805	184	55	myositis	myositis	NOUN
fnp-3805	184	56	(	(	PUNCT
fnp-3805	184	57	assm	assm	PROPN
fnp-3805	184	58	)	)	PUNCT
fnp-3805	184	59	,	,	PUNCT
fnp-3805	184	60	and	and	CCONJ
fnp-3805	184	61	immune	immune	NOUN
fnp-3805	184	62	-	-	PUNCT
fnp-3805	184	63	mediated	mediate	VERB
fnp-3805	184	64	necrotizing	necrotizing	NOUN
fnp-3805	184	65	myopathy	myopathy	NOUN
fnp-3805	184	66	(	(	PUNCT
fnp-3805	184	67	imnm	imnm	PROPN
fnp-3805	184	68	)	)	PUNCT
fnp-3805	184	69	.	.	PUNCT
fnp-3805	185	1	two	two	NUM
fnp-3805	185	2	studies	study	NOUN
fnp-3805	185	3	published	publish	VERB
fnp-3805	185	4	last	last	ADJ
fnp-3805	185	5	year	year	NOUN
fnp-3805	185	6	(	(	PUNCT
fnp-3805	185	7	siegert	siegert	PROPN
fnp-3805	185	8	et	et	PROPN
fnp-3805	185	9	al	al	PROPN
fnp-3805	185	10	.	.	PROPN
fnp-3805	185	11	,	,	PUNCT
fnp-3805	185	12	2021	2021	NUM
fnp-3805	185	13	;	;	PUNCT
fnp-3805	185	14	trikamji	trikamji	ADJ
fnp-3805	185	15	and	and	CCONJ
fnp-3805	185	16	pestronk	pestronk	ADJ
fnp-3805	185	17	,	,	PUNCT
fnp-3805	185	18	2021	2021	NUM
fnp-3805	185	19	)	)	PUNCT
fnp-3805	185	20	expanded	expand	VERB
fnp-3805	185	21	the	the	DET
fnp-3805	185	22	spectrum	spectrum	NOUN
fnp-3805	185	23	of	of	ADP
fnp-3805	185	24	microvascular	microvascular	ADJ
fnp-3805	185	25	abnormalities	abnormality	NOUN
fnp-3805	185	26	seen	see	VERB
fnp-3805	185	27	in	in	ADP
fnp-3805	185	28	immune	immune	NOUN
fnp-3805	185	29	-	-	PUNCT
fnp-3805	185	30	mediated	mediate	VERB
fnp-3805	185	31	neuromuscular	neuromuscular	ADJ
fnp-3805	185	32	disorders	disorder	NOUN
fnp-3805	185	33	,	,	PUNCT
fnp-3805	185	34	highlighting	highlight	VERB
fnp-3805	185	35	that	that	SCONJ
fnp-3805	185	36	careful	careful	ADJ
fnp-3805	185	37	evaluation	evaluation	NOUN
fnp-3805	185	38	of	of	ADP
fnp-3805	185	39	endomysial	endomysial	ADJ
fnp-3805	185	40	and	and	CCONJ
fnp-3805	185	41	endoneurial	endoneurial	ADJ
fnp-3805	185	42	microvessels	microvessel	NOUN
fnp-3805	185	43	(	(	PUNCT
fnp-3805	185	44	arterioles	arteriole	NOUN
fnp-3805	185	45	and	and	CCONJ
fnp-3805	185	46	capillaries	capillary	NOUN
fnp-3805	185	47	)	)	PUNCT
fnp-3805	185	48	can	can	AUX
fnp-3805	185	49	increase	increase	VERB
fnp-3805	185	50	the	the	DET
fnp-3805	185	51	diagnostic	diagnostic	ADJ
fnp-3805	185	52	yield	yield	NOUN
fnp-3805	185	53	of	of	ADP
fnp-3805	185	54	muscle	muscle	NOUN
fnp-3805	185	55	and	and	CCONJ
fnp-3805	185	56	nerve	nerve	NOUN
fnp-3805	185	57	biopsies	biopsy	NOUN
fnp-3805	185	58	.	.	PUNCT
fnp-3805	186	1	systemic	systemic	ADJ
fnp-3805	186	2	sclerosis	sclerosis	NOUN
fnp-3805	186	3	(	(	PUNCT
fnp-3805	186	4	ssc	ssc	NOUN
fnp-3805	186	5	)	)	PUNCT
fnp-3805	186	6	is	be	AUX
fnp-3805	186	7	a	a	DET
fnp-3805	186	8	systemic	systemic	ADJ
fnp-3805	186	9	autoimmune	autoimmune	ADJ
fnp-3805	186	10	disease	disease	NOUN
fnp-3805	186	11	characterized	characterize	VERB
fnp-3805	186	12	by	by	ADP
fnp-3805	186	13	fibrosis	fibrosis	NOUN
fnp-3805	186	14	of	of	ADP
fnp-3805	186	15	skin	skin	NOUN
fnp-3805	186	16	and	and	CCONJ
fnp-3805	186	17	internal	internal	ADJ
fnp-3805	186	18	organs	organ	NOUN
fnp-3805	186	19	,	,	PUNCT
fnp-3805	186	20	vasculopathy	vasculopathy	NOUN
fnp-3805	186	21	,	,	PUNCT
fnp-3805	186	22	and	and	CCONJ
fnp-3805	186	23	evidence	evidence	NOUN
fnp-3805	186	24	of	of	ADP
fnp-3805	186	25	immune	immune	ADJ
fnp-3805	186	26	system	system	NOUN
fnp-3805	186	27	dysregulation	dysregulation	NOUN
fnp-3805	186	28	;	;	PUNCT
fnp-3805	186	29	skeletal	skeletal	ADJ
fnp-3805	186	30	muscle	muscle	NOUN
fnp-3805	186	31	involvement	involvement	NOUN
fnp-3805	186	32	is	be	AUX
fnp-3805	186	33	variable	variable	ADJ
fnp-3805	186	34	,	,	PUNCT
fnp-3805	186	35	with	with	ADP
fnp-3805	186	36	some	some	DET
fnp-3805	186	37	patients	patient	NOUN
fnp-3805	186	38	developing	develop	VERB
fnp-3805	186	39	a	a	DET
fnp-3805	186	40	superimposed	superimpose	VERB
fnp-3805	186	41	specific	specific	ADJ
fnp-3805	186	42	iim	iim	NOUN
fnp-3805	186	43	or	or	CCONJ
fnp-3805	186	44	less	less	ADV
fnp-3805	186	45	specific	specific	ADJ
fnp-3805	186	46	“	"	PUNCT
fnp-3805	186	47	overlap	overlap	NOUN
fnp-3805	186	48	myositis	myositis	NOUN
fnp-3805	186	49	”	"	PUNCT
fnp-3805	186	50	,	,	PUNCT
fnp-3805	186	51	while	while	SCONJ
fnp-3805	186	52	others	other	NOUN
fnp-3805	186	53	(	(	PUNCT
fnp-3805	186	54	~20	~20	ADP
fnp-3805	186	55	%	%	NOUN
fnp-3805	186	56	)	)	PUNCT
fnp-3805	186	57	have	have	VERB
fnp-3805	186	58	a	a	DET
fnp-3805	186	59	poorly	poorly	ADV
fnp-3805	186	60	understood	understand	VERB
fnp-3805	186	61	muscle	muscle	NOUN
fnp-3805	186	62	disease	disease	NOUN
fnp-3805	186	63	specific	specific	ADJ
fnp-3805	186	64	to	to	ADP
fnp-3805	186	65	ssc	ssc	PROPN
fnp-3805	186	66	.	.	PUNCT
fnp-3805	187	1	to	to	PART
fnp-3805	187	2	better	well	ADV
fnp-3805	187	3	define	define	VERB
fnp-3805	187	4	the	the	DET
fnp-3805	187	5	latter	latter	ADJ
fnp-3805	187	6	disease	disease	NOUN
fnp-3805	187	7	entity	entity	NOUN
fnp-3805	187	8	,	,	PUNCT
fnp-3805	187	9	siegert	siegert	PROPN
fnp-3805	187	10	et	et	PROPN
fnp-3805	187	11	al	al	PROPN
fnp-3805	187	12	.	.	PROPN
fnp-3805	187	13	performed	perform	VERB
fnp-3805	187	14	detailed	detailed	ADJ
fnp-3805	187	15	retrospective	retrospective	ADJ
fnp-3805	187	16	evaluation	evaluation	NOUN
fnp-3805	187	17	of	of	ADP
fnp-3805	187	18	muscle	muscle	NOUN
fnp-3805	187	19	biopsies	biopsy	NOUN
fnp-3805	187	20	from	from	ADP
fnp-3805	187	21	18	18	NUM
fnp-3805	187	22	ssc	ssc	NOUN
fnp-3805	187	23	patients	patient	NOUN
fnp-3805	187	24	with	with	ADP
fnp-3805	187	25	muscle	muscle	NOUN
fnp-3805	187	26	symptoms	symptom	NOUN
fnp-3805	187	27	(	(	PUNCT
fnp-3805	187	28	derived	derive	VERB
fnp-3805	187	29	from	from	ADP
fnp-3805	187	30	a	a	DET
fnp-3805	187	31	larger	large	ADJ
fnp-3805	187	32	cohort	cohort	NOUN
fnp-3805	187	33	of	of	ADP
fnp-3805	187	34	367	367	NUM
fnp-3805	187	35	ssc	ssc	NOUN
fnp-3805	187	36	patients	patient	NOUN
fnp-3805	187	37	)	)	PUNCT
fnp-3805	187	38	using	use	VERB
fnp-3805	187	39	routine	routine	ADJ
fnp-3805	187	40	light	light	ADJ
fnp-3805	187	41	microscopy	microscopy	NOUN
fnp-3805	187	42	as	as	ADV
fnp-3805	187	43	well	well	ADV
fnp-3805	187	44	as	as	ADP
fnp-3805	187	45	semi	semi	ADJ
fnp-3805	187	46	-	-	ADJ
fnp-3805	187	47	quantitative	quantitative	ADJ
fnp-3805	187	48	large	large	ADJ
fnp-3805	187	49	scale	scale	NOUN
fnp-3805	187	50	electron	electron	NOUN
fnp-3805	187	51	microscopy	microscopy	NOUN
fnp-3805	187	52	[	[	X
fnp-3805	187	53	described	describe	VERB
fnp-3805	187	54	as	as	ADP
fnp-3805	187	55	advance	advance	NOUN
fnp-3805	187	56	#	#	SYM
fnp-3805	187	57	9	9	NUM
fnp-3805	187	58	in	in	ADP
fnp-3805	187	59	last	last	ADJ
fnp-3805	187	60	year	year	NOUN
fnp-3805	187	61	’s	’s	PART
fnp-3805	187	62	review	review	NOUN
fnp-3805	187	63	(	(	PUNCT
fnp-3805	187	64	margeta	margeta	NOUN
fnp-3805	187	65	,	,	PUNCT
fnp-3805	187	66	2021	2021	NUM
fnp-3805	187	67	)	)	PUNCT
fnp-3805	187	68	]	]	PUNCT
fnp-3805	187	69	.	.	PUNCT
fnp-3805	188	1	two	two	NUM
fnp-3805	188	2	thirds	third	NOUN
fnp-3805	188	3	of	of	ADP
fnp-3805	188	4	evaluated	evaluate	VERB
fnp-3805	188	5	ssc	ssc	NOUN
fnp-3805	188	6	biopsies	biopsy	NOUN
fnp-3805	188	7	(	(	PUNCT
fnp-3805	188	8	12	12	NUM
fnp-3805	188	9	of	of	ADP
fnp-3805	188	10	18	18	NUM
fnp-3805	188	11	)	)	PUNCT
fnp-3805	188	12	showed	show	VERB
fnp-3805	188	13	a	a	DET
fnp-3805	188	14	novel	novel	ADJ
fnp-3805	188	15	morphologic	morphologic	ADJ
fnp-3805	188	16	pattern	pattern	NOUN
fnp-3805	188	17	(	(	PUNCT
fnp-3805	188	18	which	which	PRON
fnp-3805	188	19	the	the	DET
fnp-3805	188	20	authors	author	NOUN
fnp-3805	188	21	termed	term	VERB
fnp-3805	188	22	“	"	PUNCT
fnp-3805	188	23	minimal	minimal	ADJ
fnp-3805	188	24	myositis	myositis	NOUN
fnp-3805	188	25	with	with	ADP
fnp-3805	188	26	capillary	capillary	ADJ
fnp-3805	188	27	pathology	pathology	NOUN
fnp-3805	188	28	”	"	PUNCT
fnp-3805	188	29	;	;	PUNCT
fnp-3805	188	30	mmcp	mmcp	ADJ
fnp-3805	188	31	)	)	PUNCT
fnp-3805	188	32	characterized	characterize	VERB
fnp-3805	188	33	by	by	ADP
fnp-3805	188	34	sparse	sparse	ADJ
fnp-3805	188	35	endomysial	endomysial	ADJ
fnp-3805	188	36	t	t	NOUN
fnp-3805	188	37	cells	cell	NOUN
fnp-3805	188	38	,	,	PUNCT
fnp-3805	188	39	rare	rare	ADJ
fnp-3805	188	40	necrotic	necrotic	ADJ
fnp-3805	188	41	and	and	CCONJ
fnp-3805	188	42	regenerating	regenerate	VERB
fnp-3805	188	43	muscle	muscle	NOUN
fnp-3805	188	44	fibers	fiber	NOUN
fnp-3805	188	45	,	,	PUNCT
fnp-3805	188	46	diffuse	diffuse	PROPN
fnp-3805	188	47	mhc	mhc	PROPN
fnp-3805	188	48	-	-	PUNCT
fnp-3805	188	49	i	i	PROPN
fnp-3805	188	50	and	and	CCONJ
fnp-3805	188	51	focal	focal	ADJ
fnp-3805	188	52	mhc	mhc	PROPN
fnp-3805	188	53	-	-	PUNCT
fnp-3805	188	54	ii	ii	PROPN
fnp-3805	188	55	upregulation	upregulation	NOUN
fnp-3805	188	56	,	,	PUNCT
fnp-3805	188	57	and	and	CCONJ
fnp-3805	188	58	enlarged	enlarge	VERB
fnp-3805	188	59	capillaries	capillary	NOUN
fnp-3805	188	60	with	with	ADP
fnp-3805	188	61	prominent	prominent	ADJ
fnp-3805	188	62	pericytes	pericyte	NOUN
fnp-3805	188	63	but	but	CCONJ
fnp-3805	188	64	no	no	DET
fnp-3805	188	65	capillary	capillary	ADJ
fnp-3805	188	66	c5b9	c5b9	NOUN
fnp-3805	188	67	deposition	deposition	NOUN
fnp-3805	188	68	;	;	PUNCT
fnp-3805	188	69	ultrastructurally	ultrastructurally	ADV
fnp-3805	188	70	,	,	PUNCT
fnp-3805	188	71	mmcp	mmcp	ADJ
fnp-3805	188	72	cases	case	NOUN
fnp-3805	188	73	showed	show	VERB
fnp-3805	188	74	well	well	ADV
fnp-3805	188	75	-	-	PUNCT
fnp-3805	188	76	developed	develop	VERB
fnp-3805	188	77	but	but	CCONJ
fnp-3805	188	78	mild	mild	ADJ
fnp-3805	188	79	capillary	capillary	ADJ
fnp-3805	188	80	pathology	pathology	NOUN
fnp-3805	188	81	,	,	PUNCT
fnp-3805	188	82	including	include	VERB
fnp-3805	188	83	thickening	thickening	NOUN
fnp-3805	188	84	and	and	CCONJ
fnp-3805	188	85	reduplication	reduplication	NOUN
fnp-3805	188	86	of	of	ADP
fnp-3805	188	87	basement	basement	NOUN
fnp-3805	188	88	membranes	membrane	NOUN
fnp-3805	188	89	,	,	PUNCT
fnp-3805	188	90	reactive	reactive	ADJ
fnp-3805	188	91	endothelial	endothelial	ADJ
fnp-3805	188	92	changes	change	NOUN
fnp-3805	188	93	,	,	PUNCT
fnp-3805	188	94	and	and	CCONJ
fnp-3805	188	95	capillary	capillary	ADJ
fnp-3805	188	96	ensheathment	ensheathment	NOUN
fnp-3805	188	97	by	by	ADP
fnp-3805	188	98	pericyte	pericyte	NOUN
fnp-3805	188	99	processes	process	NOUN
fnp-3805	188	100	(	(	PUNCT
fnp-3805	188	101	fig	fig	NOUN
fnp-3805	188	102	.	.	PUNCT
fnp-3805	188	103	4	4	NUM
fnp-3805	188	104	)	)	PUNCT
fnp-3805	188	105	.	.	PUNCT
fnp-3805	189	1	similar	similar	ADJ
fnp-3805	189	2	but	but	CCONJ
fnp-3805	189	3	more	more	ADV
fnp-3805	189	4	severe	severe	ADJ
fnp-3805	189	5	capillary	capillary	ADJ
fnp-3805	189	6	alterations	alteration	NOUN
fnp-3805	189	7	were	be	AUX
fnp-3805	189	8	seen	see	VERB
fnp-3805	189	9	in	in	ADP
fnp-3805	189	10	other	other	ADJ
fnp-3805	189	11	6	6	NUM
fnp-3805	189	12	ssc	ssc	NOUN
fnp-3805	189	13	muscle	muscle	NOUN
fnp-3805	189	14	biopsies	biopsy	NOUN
fnp-3805	189	15	,	,	PUNCT
fnp-3805	189	16	which	which	PRON
fnp-3805	189	17	also	also	ADV
fnp-3805	189	18	showed	show	VERB
fnp-3805	189	19	additional	additional	ADJ
fnp-3805	189	20	capillary	capillary	ADJ
fnp-3805	189	21	abnormalities	abnormality	NOUN
fnp-3805	189	22	(	(	PUNCT
fnp-3805	189	23	such	such	ADJ
fnp-3805	189	24	as	as	ADP
fnp-3805	189	25	tubuloreticular	tubuloreticular	ADJ
fnp-3805	189	26	inclusions	inclusion	NOUN
fnp-3805	189	27	)	)	PUNCT
fnp-3805	189	28	and	and	CCONJ
fnp-3805	189	29	more	more	ADV
fnp-3805	189	30	prominent	prominent	ADJ
fnp-3805	189	31	inflammatory	inflammatory	ADJ
fnp-3805	189	32	changes	change	NOUN
fnp-3805	189	33	;	;	PUNCT
fnp-3805	189	34	therefore	therefore	ADV
fnp-3805	189	35	,	,	PUNCT
fnp-3805	189	36	capillary	capillary	ADJ
fnp-3805	189	37	pathology	pathology	NOUN
fnp-3805	189	38	is	be	AUX
fnp-3805	189	39	a	a	DET
fnp-3805	189	40	uniform	uniform	ADJ
fnp-3805	189	41	feature	feature	NOUN
fnp-3805	189	42	of	of	ADP
fnp-3805	189	43	mmcp	mmcp	ADJ
fnp-3805	189	44	cases	case	NOUN
fnp-3805	189	45	but	but	CCONJ
fnp-3805	189	46	is	be	AUX
fnp-3805	189	47	not	not	PART
fnp-3805	189	48	pathognomonic	pathognomonic	ADJ
fnp-3805	189	49	for	for	ADP
fnp-3805	189	50	this	this	DET
fnp-3805	189	51	condition	condition	NOUN
fnp-3805	189	52	,	,	PUNCT
fnp-3805	189	53	and	and	CCONJ
fnp-3805	189	54	must	must	AUX
fnp-3805	189	55	be	be	AUX
fnp-3805	189	56	interpreted	interpret	VERB
fnp-3805	189	57	in	in	ADP
fnp-3805	189	58	the	the	DET
fnp-3805	189	59	context	context	NOUN
fnp-3805	189	60	of	of	ADP
fnp-3805	189	61	other	other	ADJ
fnp-3805	189	62	muscle	muscle	NOUN
fnp-3805	189	63	biopsy	biopsy	NOUN
fnp-3805	189	64	findings	finding	NOUN
fnp-3805	189	65	.	.	PUNCT
fnp-3805	190	1	interestingly	interestingly	ADV
fnp-3805	190	2	,	,	PUNCT
fnp-3805	190	3	mmcp	mmcp	PROPN
fnp-3805	190	4	ssc	ssc	PROPN
fnp-3805	190	5	cases	case	NOUN
fnp-3805	190	6	were	be	AUX
fnp-3805	190	7	clinically	clinically	ADV
fnp-3805	190	8	less	less	ADV
fnp-3805	190	9	severe	severe	ADJ
fnp-3805	190	10	than	than	ADP
fnp-3805	190	11	non	non	ADJ
fnp-3805	190	12	-	-	ADJ
fnp-3805	190	13	mmcp	mmcp	ADJ
fnp-3805	190	14	ssc	ssc	NOUN
fnp-3805	190	15	cases	case	NOUN
fnp-3805	190	16	,	,	PUNCT
fnp-3805	190	17	with	with	ADP
fnp-3805	190	18	higher	high	ADJ
fnp-3805	190	19	frequency	frequency	NOUN
fnp-3805	190	20	of	of	ADP
fnp-3805	190	21	localized	localized	ADJ
fnp-3805	190	22	(	(	PUNCT
fnp-3805	190	23	versus	versus	ADP
fnp-3805	190	24	diffuse	diffuse	NOUN
fnp-3805	190	25	)	)	PUNCT
fnp-3805	190	26	skin	skin	NOUN
fnp-3805	190	27	sclerosis	sclerosis	NOUN
fnp-3805	190	28	,	,	PUNCT
fnp-3805	190	29	less	less	ADV
fnp-3805	190	30	prominent	prominent	ADJ
fnp-3805	190	31	internal	internal	ADJ
fnp-3805	190	32	organ	organ	NOUN
fnp-3805	190	33	involvement	involvement	NOUN
fnp-3805	190	34	,	,	PUNCT
fnp-3805	190	35	and	and	CCONJ
fnp-3805	190	36	lower	low	ADJ
fnp-3805	190	37	ck	ck	ADJ
fnp-3805	190	38	levels	level	NOUN
fnp-3805	190	39	;	;	PUNCT
fnp-3805	190	40	however	however	ADV
fnp-3805	190	41	,	,	PUNCT
fnp-3805	190	42	these	these	DET
fnp-3805	190	43	muscle	muscle	NOUN
fnp-3805	190	44	abnormalities	abnormality	NOUN
fnp-3805	190	45	developed	develop	VERB
fnp-3805	190	46	early	early	ADV
fnp-3805	190	47	in	in	ADP
fnp-3805	190	48	the	the	DET
fnp-3805	190	49	disease	disease	NOUN
fnp-3805	190	50	course	course	NOUN
fnp-3805	190	51	,	,	PUNCT
fnp-3805	190	52	with	with	ADP
fnp-3805	190	53	mean	mean	ADJ
fnp-3805	190	54	disease	disease	NOUN
fnp-3805	190	55	duration	duration	NOUN
fnp-3805	190	56	of	of	ADP
fnp-3805	190	57	3	3	NUM
fnp-3805	190	58	years	year	NOUN
fnp-3805	190	59	at	at	ADP
fnp-3805	190	60	the	the	DET
fnp-3805	190	61	time	time	NOUN
fnp-3805	190	62	of	of	ADP
fnp-3805	190	63	biopsy	biopsy	NOUN
fnp-3805	190	64	(	(	PUNCT
fnp-3805	190	65	<	<	X
fnp-3805	190	66	1	1	NUM
fnp-3805	190	67	year	year	NOUN
fnp-3805	190	68	in	in	ADP
fnp-3805	190	69	6	6	NUM
fnp-3805	190	70	of	of	ADP
fnp-3805	190	71	12	12	NUM
fnp-3805	190	72	cases	case	NOUN
fnp-3805	190	73	)	)	PUNCT
fnp-3805	190	74	.	.	PUNCT
fnp-3805	191	1	figure	figure	VERB
fnp-3805	191	2	4	4	NUM
fnp-3805	191	3	.	.	PUNCT
fnp-3805	192	1	ultrastructural	ultrastructural	ADJ
fnp-3805	192	2	characterization	characterization	NOUN
fnp-3805	192	3	of	of	ADP
fnp-3805	192	4	skeletal	skeletal	ADJ
fnp-3805	192	5	muscle	muscle	NOUN
fnp-3805	192	6	biopsies	biopsy	NOUN
fnp-3805	192	7	with	with	ADP
fnp-3805	192	8	histological	histological	PROPN
fnp-3805	192	9	minimal	minimal	ADJ
fnp-3805	192	10	myositis	myositis	NOUN
fnp-3805	192	11	with	with	ADP
fnp-3805	192	12	capillary	capillary	ADJ
fnp-3805	192	13	pathology	pathology	NOUN
fnp-3805	192	14	(	(	PUNCT
fnp-3805	192	15	mmcp	mmcp	ADJ
fnp-3805	192	16	)	)	PUNCT
fnp-3805	192	17	phenotype	phenotype	NOUN
fnp-3805	192	18	.	.	PUNCT
fnp-3805	193	1	entire	entire	ADJ
fnp-3805	193	2	ultrathin	ultrathin	ADJ
fnp-3805	193	3	sections	section	NOUN
fnp-3805	193	4	were	be	AUX
fnp-3805	193	5	recorded	record	VERB
fnp-3805	193	6	by	by	ADP
fnp-3805	193	7	large	large	ADJ
fnp-3805	193	8	-	-	PUNCT
fnp-3805	193	9	scale	scale	NOUN
fnp-3805	193	10	digitization	digitization	NOUN
fnp-3805	193	11	at	at	ADP
fnp-3805	193	12	7.3	7.3	NUM
fnp-3805	193	13	nm	nm	PRON
fnp-3805	193	14	pixel	pixel	NOUN
fnp-3805	193	15	size	size	NOUN
fnp-3805	193	16	;	;	PUNCT
fnp-3805	193	17	digitally	digitally	ADV
fnp-3805	193	18	magnified	magnify	VERB
fnp-3805	193	19	regions	region	NOUN
fnp-3805	193	20	of	of	ADP
fnp-3805	193	21	interests	interest	NOUN
fnp-3805	193	22	(	(	PUNCT
fnp-3805	193	23	roi	roi	NOUN
fnp-3805	193	24	)	)	PUNCT
fnp-3805	193	25	of	of	ADP
fnp-3805	193	26	patients	patient	NOUN
fnp-3805	193	27	3	3	NUM
fnp-3805	193	28	(	(	PUNCT
fnp-3805	193	29	a	a	PRON
fnp-3805	193	30	,	,	PUNCT
fnp-3805	193	31	d	d	NOUN
fnp-3805	193	32	,	,	PUNCT
fnp-3805	193	33	g	g	NOUN
fnp-3805	193	34	–	–	PUNCT
fnp-3805	193	35	l	l	NOUN
fnp-3805	193	36	)	)	PUNCT
fnp-3805	193	37	,	,	PUNCT
fnp-3805	193	38	8	8	NUM
fnp-3805	193	39	(	(	PUNCT
fnp-3805	193	40	b	b	NUM
fnp-3805	193	41	,	,	PUNCT
fnp-3805	193	42	m	m	PROPN
fnp-3805	193	43	)	)	PUNCT
fnp-3805	193	44	,	,	PUNCT
fnp-3805	193	45	6	6	NUM
fnp-3805	193	46	(	(	PUNCT
fnp-3805	193	47	e	e	NOUN
fnp-3805	193	48	)	)	PUNCT
fnp-3805	193	49	,	,	PUNCT
fnp-3805	193	50	2	2	NUM
fnp-3805	193	51	(	(	PUNCT
fnp-3805	193	52	f	f	NOUN
fnp-3805	193	53	)	)	PUNCT
fnp-3805	193	54	,	,	PUNCT
fnp-3805	193	55	18	18	NUM
fnp-3805	193	56	(	(	PUNCT
fnp-3805	193	57	n	n	CCONJ
fnp-3805	193	58	;	;	PUNCT
fnp-3805	193	59	severe	severe	ADJ
fnp-3805	193	60	necrotizing	necrotize	VERB
fnp-3805	193	61	myositis	myositis	NOUN
fnp-3805	193	62	with	with	ADP
fnp-3805	193	63	capillary	capillary	ADJ
fnp-3805	193	64	pathology	pathology	NOUN
fnp-3805	193	65	and	and	CCONJ
fnp-3805	193	66	fibrosis	fibrosis	NOUN
fnp-3805	193	67	)	)	PUNCT
fnp-3805	193	68	,	,	PUNCT
fnp-3805	193	69	1	1	NUM
fnp-3805	193	70	(	(	PUNCT
fnp-3805	193	71	o	o	NOUN
fnp-3805	193	72	)	)	PUNCT
fnp-3805	193	73	and	and	CCONJ
fnp-3805	193	74	non	non	ADJ
fnp-3805	193	75	-	-	ADJ
fnp-3805	193	76	diseased	diseased	ADJ
fnp-3805	193	77	control	control	NOUN
fnp-3805	193	78	(	(	PUNCT
fnp-3805	193	79	c	c	NOUN
fnp-3805	193	80	)	)	PUNCT
fnp-3805	193	81	.	.	PUNCT
fnp-3805	194	1	a	a	DET
fnp-3805	194	2	markedly	markedly	ADV
fnp-3805	194	3	thickened	thicken	VERB
fnp-3805	194	4	capillaries	capillary	NOUN
fnp-3805	194	5	can	can	AUX
fnp-3805	194	6	be	be	AUX
fnp-3805	194	7	clearly	clearly	ADV
fnp-3805	194	8	identified	identify	VERB
fnp-3805	194	9	at	at	ADP
fnp-3805	194	10	low	low	ADJ
fnp-3805	194	11	magnification	magnification	NOUN
fnp-3805	194	12	(	(	PUNCT
fnp-3805	194	13	arrows	arrow	NOUN
fnp-3805	194	14	)	)	PUNCT
fnp-3805	194	15	.	.	PUNCT
fnp-3805	195	1	b	b	X
fnp-3805	195	2	capillary	capillary	ADJ
fnp-3805	195	3	with	with	ADP
fnp-3805	195	4	pronounced	pronounce	VERB
fnp-3805	195	5	thickening	thickening	NOUN
fnp-3805	195	6	and	and	CCONJ
fnp-3805	195	7	reduplication	reduplication	NOUN
fnp-3805	195	8	(	(	PUNCT
fnp-3805	195	9	arrow	arrow	NOUN
fnp-3805	195	10	)	)	PUNCT
fnp-3805	195	11	of	of	ADP
fnp-3805	195	12	the	the	DET
fnp-3805	195	13	basement	basement	NOUN
fnp-3805	195	14	membrane	membrane	NOUN
fnp-3805	195	15	(	(	PUNCT
fnp-3805	195	16	bm	bm	PROPN
fnp-3805	195	17	)	)	PUNCT
fnp-3805	195	18	as	as	ADV
fnp-3805	195	19	well	well	ADV
fnp-3805	195	20	as	as	ADP
fnp-3805	195	21	ensheathment	ensheathment	NOUN
fnp-3805	195	22	by	by	ADP
fnp-3805	195	23	pericyte	pericyte	NOUN
fnp-3805	195	24	processes	process	NOUN
fnp-3805	195	25	(	(	PUNCT
fnp-3805	195	26	white	white	ADJ
fnp-3805	195	27	asterisk	asterisk	NOUN
fnp-3805	195	28	)	)	PUNCT
fnp-3805	195	29	,	,	PUNCT
fnp-3805	195	30	mildly	mildly	ADV
fnp-3805	195	31	activated	activate	VERB
fnp-3805	195	32	endothelium	endothelium	NOUN
fnp-3805	195	33	(	(	PUNCT
fnp-3805	195	34	black	black	ADJ
fnp-3805	195	35	asterisk	asterisk	NOUN
fnp-3805	195	36	)	)	PUNCT
fnp-3805	195	37	,	,	PUNCT
fnp-3805	195	38	lumen	luman	NOUN
fnp-3805	195	39	(	(	PUNCT
fnp-3805	195	40	lu	lu	NOUN
fnp-3805	195	41	)	)	PUNCT
fnp-3805	195	42	,	,	PUNCT
fnp-3805	195	43	adjacent	adjacent	ADJ
fnp-3805	195	44	muscle	muscle	NOUN
fnp-3805	195	45	fiber	fiber	NOUN
fnp-3805	195	46	(	(	PUNCT
fnp-3805	195	47	mf	mf	X
fnp-3805	195	48	)	)	PUNCT
fnp-3805	195	49	.	.	PUNCT
fnp-3805	196	1	c	c	PROPN
fnp-3805	196	2	healthy	healthy	ADJ
fnp-3805	196	3	capillary	capillary	ADJ
fnp-3805	196	4	with	with	ADP
fnp-3805	196	5	thin	thin	PROPN
fnp-3805	196	6	bm	bm	PROPN
fnp-3805	196	7	(	(	PUNCT
fnp-3805	196	8	arrow	arrow	NOUN
fnp-3805	196	9	):	):	PUNCT
fnp-3805	196	10	note	note	NOUN
fnp-3805	196	11	that	that	SCONJ
fnp-3805	196	12	no	no	DET
fnp-3805	196	13	reduplication	reduplication	NOUN
fnp-3805	196	14	is	be	AUX
fnp-3805	196	15	apparent	apparent	ADJ
fnp-3805	196	16	,	,	PUNCT
fnp-3805	196	17	endothelium	endothelium	NOUN
fnp-3805	196	18	with	with	ADP
fnp-3805	196	19	no	no	DET
fnp-3805	196	20	signs	sign	NOUN
fnp-3805	196	21	of	of	ADP
fnp-3805	196	22	activation	activation	NOUN
fnp-3805	196	23	(	(	PUNCT
fnp-3805	196	24	asterisk	asterisk	NOUN
fnp-3805	196	25	)	)	PUNCT
fnp-3805	196	26	,	,	PUNCT
fnp-3805	196	27	lumen	luman	NOUN
fnp-3805	196	28	with	with	ADP
fnp-3805	196	29	erythrocyte	erythrocyte	PROPN
fnp-3805	196	30	(	(	PUNCT
fnp-3805	196	31	er	er	INTJ
fnp-3805	196	32	)	)	PUNCT
fnp-3805	196	33	.	.	PUNCT
fnp-3805	197	1	different	different	ADJ
fnp-3805	197	2	types	type	NOUN
fnp-3805	197	3	of	of	ADP
fnp-3805	197	4	bm	bm	PROPN
fnp-3805	197	5	(	(	PUNCT
fnp-3805	197	6	bm	bm	PROPN
fnp-3805	197	7	)	)	PUNCT
fnp-3805	197	8	thickening	thickening	NOUN
fnp-3805	197	9	were	be	AUX
fnp-3805	197	10	detected	detect	VERB
fnp-3805	197	11	(	(	PUNCT
fnp-3805	197	12	d	d	X
fnp-3805	197	13	–	–	PUNCT
fnp-3805	197	14	f	f	NUM
fnp-3805	197	15	):	):	PUNCT
fnp-3805	197	16	distinct	distinct	ADJ
fnp-3805	197	17	reduplication	reduplication	NOUN
fnp-3805	197	18	(	(	PUNCT
fnp-3805	197	19	d	d	NOUN
fnp-3805	197	20	;	;	PUNCT
fnp-3805	197	21	arrows	arrow	NOUN
fnp-3805	197	22	)	)	PUNCT
fnp-3805	197	23	,	,	PUNCT
fnp-3805	197	24	endothelium	endothelium	NOUN
fnp-3805	197	25	(	(	PUNCT
fnp-3805	197	26	asterisk	asterisk	NOUN
fnp-3805	197	27	)	)	PUNCT
fnp-3805	197	28	,	,	PUNCT
fnp-3805	197	29	fibroblast	fibroblast	ADJ
fnp-3805	197	30	(	(	PUNCT
fnp-3805	197	31	fi	fi	NOUN
fnp-3805	197	32	)	)	PUNCT
fnp-3805	197	33	;	;	PUNCT
fnp-3805	197	34	fuzzy	fuzzy	ADJ
fnp-3805	197	35	appearance	appearance	NOUN
fnp-3805	197	36	with	with	ADP
fnp-3805	197	37	less	less	ADV
fnp-3805	197	38	pronounced	pronounced	ADJ
fnp-3805	197	39	reduplication	reduplication	NOUN
fnp-3805	197	40	(	(	PUNCT
fnp-3805	197	41	e	e	NOUN
fnp-3805	197	42	):	):	PUNCT
fnp-3805	197	43	note	note	VERB
fnp-3805	197	44	that	that	SCONJ
fnp-3805	197	45	the	the	DET
fnp-3805	197	46	bm	bm	PROPN
fnp-3805	197	47	(	(	PUNCT
fnp-3805	197	48	arrow	arrow	NOUN
fnp-3805	197	49	)	)	PUNCT
fnp-3805	197	50	directly	directly	ADV
fnp-3805	197	51	underneath	underneath	ADP
fnp-3805	197	52	the	the	DET
fnp-3805	197	53	endothelium	endothelium	NOUN
fnp-3805	197	54	(	(	PUNCT
fnp-3805	197	55	asterisk	asterisk	NOUN
fnp-3805	197	56	)	)	PUNCT
fnp-3805	197	57	is	be	AUX
fnp-3805	197	58	clearly	clearly	ADV
fnp-3805	197	59	visible	visible	ADJ
fnp-3805	197	60	,	,	PUNCT
fnp-3805	197	61	fibrous	fibrous	ADJ
fnp-3805	197	62	long	long	ADJ
fnp-3805	197	63	spacing	space	VERB
fnp-3805	197	64	collagen	collagen	NOUN
fnp-3805	197	65	(	(	PUNCT
fnp-3805	197	66	arrowhead	arrowhead	NOUN
fnp-3805	197	67	)	)	PUNCT
fnp-3805	197	68	;	;	PUNCT
fnp-3805	198	1	homogeneous	homogeneous	ADJ
fnp-3805	198	2	thickened	thicken	VERB
fnp-3805	198	3	bm	bm	PROPN
fnp-3805	198	4	(	(	PUNCT
fnp-3805	198	5	f	f	PROPN
fnp-3805	198	6	)	)	PUNCT
fnp-3805	198	7	,	,	PUNCT
fnp-3805	198	8	capillary	capillary	ADJ
fnp-3805	198	9	lumen	luman	NOUN
fnp-3805	198	10	(	(	PUNCT
fnp-3805	198	11	lu	lu	NOUN
fnp-3805	198	12	)	)	PUNCT
fnp-3805	198	13	,	,	PUNCT
fnp-3805	198	14	neighboring	neighboring	NOUN
fnp-3805	198	15	muscle	muscle	NOUN
fnp-3805	198	16	fiber	fiber	NOUN
fnp-3805	198	17	(	(	PUNCT
fnp-3805	198	18	mf	mf	X
fnp-3805	198	19	)	)	PUNCT
fnp-3805	198	20	with	with	ADP
fnp-3805	198	21	basal	basal	ADJ
fnp-3805	198	22	lamina	lamina	PROPN
fnp-3805	198	23	(	(	PUNCT
fnp-3805	198	24	white	white	ADJ
fnp-3805	198	25	arrow	arrow	NOUN
fnp-3805	198	26	)	)	PUNCT
fnp-3805	198	27	.	.	PUNCT
fnp-3805	199	1	different	different	ADJ
fnp-3805	199	2	types	type	NOUN
fnp-3805	199	3	of	of	ADP
fnp-3805	199	4	endothelial	endothelial	ADJ
fnp-3805	199	5	activation	activation	NOUN
fnp-3805	199	6	(	(	PUNCT
fnp-3805	199	7	g	g	NOUN
fnp-3805	199	8	–	–	PUNCT
fnp-3805	199	9	i	i	PRON
fnp-3805	199	10	):	):	PUNCT
fnp-3805	199	11	increased	increase	VERB
fnp-3805	199	12	size	size	NOUN
fnp-3805	199	13	and	and	CCONJ
fnp-3805	199	14	number	number	NOUN
fnp-3805	199	15	of	of	ADP
fnp-3805	199	16	endothelial	endothelial	ADJ
fnp-3805	199	17	cells	cell	NOUN
fnp-3805	199	18	(	(	PUNCT
fnp-3805	199	19	g	g	NOUN
fnp-3805	199	20	;	;	PUNCT
fnp-3805	199	21	asterisk	asterisk	NOUN
fnp-3805	199	22	,	,	PUNCT
fnp-3805	199	23	lu	lu	PROPN
fnp-3805	199	24	lumen	luman	NOUN
fnp-3805	199	25	)	)	PUNCT
fnp-3805	199	26	,	,	PUNCT
fnp-3805	199	27	note	note	VERB
fnp-3805	199	28	the	the	DET
fnp-3805	199	29	granular	granular	ADJ
fnp-3805	199	30	appearance	appearance	NOUN
fnp-3805	199	31	of	of	ADP
fnp-3805	199	32	the	the	DET
fnp-3805	199	33	cytoplasm	cytoplasm	NOUN
fnp-3805	199	34	,	,	PUNCT
fnp-3805	199	35	probably	probably	ADV
fnp-3805	199	36	mostly	mostly	ADV
fnp-3805	199	37	due	due	ADJ
fnp-3805	199	38	to	to	ADP
fnp-3805	199	39	ribosomes	ribosome	NOUN
fnp-3805	199	40	;	;	PUNCT
fnp-3805	199	41	prominent	prominent	ADJ
fnp-3805	199	42	endothelial	endothelial	ADJ
fnp-3805	199	43	membrane	membrane	NOUN
fnp-3805	199	44	organelles	organelle	NOUN
fnp-3805	199	45	(	(	PUNCT
fnp-3805	199	46	h	h	NOUN
fnp-3805	199	47	;	;	PUNCT
fnp-3805	199	48	black	black	ADJ
fnp-3805	199	49	asterisk	asterisk	NOUN
fnp-3805	199	50	,	,	PUNCT
fnp-3805	199	51	er	er	INTJ
fnp-3805	199	52	erythrocyte	erythrocyte	NOUN
fnp-3805	199	53	in	in	ADP
fnp-3805	199	54	lumen	luman	NOUN
fnp-3805	199	55	)	)	PUNCT
fnp-3805	199	56	,	,	PUNCT
fnp-3805	199	57	note	note	VERB
fnp-3805	199	58	the	the	DET
fnp-3805	199	59	prominent	prominent	ADJ
fnp-3805	199	60	and	and	CCONJ
fnp-3805	199	61	mostly	mostly	ADV
fnp-3805	199	62	small	small	ADJ
fnp-3805	199	63	pericyte	pericyte	NOUN
fnp-3805	199	64	processes	process	NOUN
fnp-3805	199	65	demonstrating	demonstrate	VERB
fnp-3805	199	66	mild	mild	ADJ
fnp-3805	199	67	ensheathment	ensheathment	NOUN
fnp-3805	199	68	(	(	PUNCT
fnp-3805	199	69	white	white	ADJ
fnp-3805	199	70	asterisks	asterisk	NOUN
fnp-3805	199	71	)	)	PUNCT
fnp-3805	199	72	;	;	PUNCT
fnp-3805	199	73	degraded	degraded	ADJ
fnp-3805	199	74	capillary	capillary	ADJ
fnp-3805	199	75	(	(	PUNCT
fnp-3805	199	76	i	i	NOUN
fnp-3805	199	77	)	)	PUNCT
fnp-3805	199	78	,	,	PUNCT
fnp-3805	199	79	showing	show	VERB
fnp-3805	199	80	some	some	DET
fnp-3805	199	81	remaining	remain	VERB
fnp-3805	199	82	membrane	membrane	NOUN
fnp-3805	199	83	structures	structure	NOUN
fnp-3805	199	84	,	,	PUNCT
fnp-3805	199	85	probably	probably	ADV
fnp-3805	199	86	of	of	ADP
fnp-3805	199	87	endothelial	endothelial	NOUN
fnp-3805	199	88	or	or	CCONJ
fnp-3805	199	89	pericyte	pericyte	NOUN
fnp-3805	199	90	origin	origin	NOUN
fnp-3805	199	91	(	(	PUNCT
fnp-3805	199	92	arrowheads	arrowhead	NOUN
fnp-3805	199	93	)	)	PUNCT
fnp-3805	199	94	,	,	PUNCT
fnp-3805	199	95	almost	almost	ADV
fnp-3805	199	96	empty	empty	ADJ
fnp-3805	199	97	bm	bm	NOUN
fnp-3805	199	98	“	"	PUNCT
fnp-3805	199	99	sack	sack	NOUN
fnp-3805	199	100	”	"	PUNCT
fnp-3805	199	101	with	with	ADP
fnp-3805	199	102	mild	mild	ADJ
fnp-3805	199	103	reduplication	reduplication	NOUN
fnp-3805	199	104	(	(	PUNCT
fnp-3805	199	105	arrows	arrow	NOUN
fnp-3805	199	106	)	)	PUNCT
fnp-3805	199	107	.	.	PUNCT
fnp-3805	200	1	[	[	X
fnp-3805	200	2	this	this	DET
fnp-3805	200	3	figure	figure	NOUN
fnp-3805	200	4	and	and	CCONJ
fnp-3805	200	5	its	its	PRON
fnp-3805	200	6	legend	legend	NOUN
fnp-3805	200	7	were	be	AUX
fnp-3805	200	8	adopted	adopt	VERB
fnp-3805	200	9	from	from	ADP
fnp-3805	200	10	figure	figure	NOUN
fnp-3805	200	11	3	3	NUM
fnp-3805	200	12	in	in	ADP
fnp-3805	200	13	(	(	PUNCT
fnp-3805	200	14	siegert	siegert	PROPN
fnp-3805	200	15	et	et	PROPN
fnp-3805	200	16	al	al	PROPN
fnp-3805	200	17	.	.	PROPN
fnp-3805	200	18	,	,	PUNCT
fnp-3805	200	19	2021	2021	NUM
fnp-3805	200	20	)	)	PUNCT
fnp-3805	200	21	;	;	PUNCT
fnp-3805	200	22	this	this	DET
fnp-3805	200	23	use	use	NOUN
fnp-3805	200	24	is	be	AUX
fnp-3805	200	25	permitted	permit	VERB
fnp-3805	200	26	under	under	ADP
fnp-3805	200	27	the	the	DET
fnp-3805	200	28	creative	creative	ADJ
fnp-3805	200	29	commons	common	NOUN
fnp-3805	200	30	attribution	attribution	NOUN
fnp-3805	200	31	4.0	4.0	NUM
fnp-3805	200	32	international	international	ADJ
fnp-3805	200	33	license	license	NOUN
fnp-3805	200	34	.	.	PUNCT
fnp-3805	200	35	]	]	PUNCT
fnp-3805	201	1	while	while	SCONJ
fnp-3805	201	2	at	at	ADV
fnp-3805	201	3	least	least	ADJ
fnp-3805	201	4	some	some	DET
fnp-3805	201	5	aspects	aspect	NOUN
fnp-3805	201	6	of	of	ADP
fnp-3805	201	7	microvascular	microvascular	ADJ
fnp-3805	201	8	pathology	pathology	NOUN
fnp-3805	201	9	are	be	AUX
fnp-3805	201	10	routinely	routinely	ADV
fnp-3805	201	11	evaluated	evaluate	VERB
fnp-3805	201	12	in	in	ADP
fnp-3805	201	13	muscle	muscle	NOUN
fnp-3805	201	14	biopsies	biopsy	NOUN
fnp-3805	201	15	,	,	PUNCT
fnp-3805	201	16	the	the	DET
fnp-3805	201	17	same	same	ADJ
fnp-3805	201	18	is	be	AUX
fnp-3805	201	19	not	not	PART
fnp-3805	201	20	true	true	ADJ
fnp-3805	201	21	for	for	ADP
fnp-3805	201	22	nerve	nerve	NOUN
fnp-3805	201	23	biopsies	biopsy	NOUN
fnp-3805	201	24	;	;	PUNCT
fnp-3805	201	25	the	the	DET
fnp-3805	201	26	2021	2021	NUM
fnp-3805	201	27	study	study	NOUN
fnp-3805	201	28	by	by	ADP
fnp-3805	201	29	trikamji	trikamji	ADJ
fnp-3805	201	30	and	and	CCONJ
fnp-3805	201	31	pestronk	pestronk	PROPN
fnp-3805	201	32	suggests	suggest	VERB
fnp-3805	201	33	that	that	SCONJ
fnp-3805	201	34	this	this	DET
fnp-3805	201	35	approach	approach	NOUN
fnp-3805	201	36	to	to	ADP
fnp-3805	201	37	nerve	nerve	NOUN
fnp-3805	201	38	biopsy	biopsy	NOUN
fnp-3805	201	39	processing	processing	NOUN
fnp-3805	201	40	should	should	AUX
fnp-3805	201	41	probably	probably	ADV
fnp-3805	201	42	change	change	VERB
fnp-3805	201	43	.	.	PUNCT
fnp-3805	202	1	these	these	DET
fnp-3805	202	2	authors	author	NOUN
fnp-3805	202	3	have	have	AUX
fnp-3805	202	4	retrospectively	retrospectively	ADV
fnp-3805	202	5	analyzed	analyze	VERB
fnp-3805	202	6	a	a	DET
fnp-3805	202	7	cohort	cohort	NOUN
fnp-3805	202	8	of	of	ADP
fnp-3805	202	9	16	16	NUM
fnp-3805	202	10	patients	patient	NOUN
fnp-3805	202	11	with	with	ADP
fnp-3805	202	12	a	a	DET
fnp-3805	202	13	motor	motor	NOUN
fnp-3805	202	14	-	-	PUNCT
fnp-3805	202	15	sensory	sensory	ADJ
fnp-3805	202	16	axonal	axonal	ADJ
fnp-3805	202	17	polyneuropathy	polyneuropathy	NOUN
fnp-3805	202	18	and	and	CCONJ
fnp-3805	202	19	complement	complement	VERB
fnp-3805	202	20	deposition	deposition	NOUN
fnp-3805	202	21	in	in	ADP
fnp-3805	202	22	endoneurial	endoneurial	ADJ
fnp-3805	202	23	microvessels	microvessel	NOUN
fnp-3805	202	24	,	,	PUNCT
fnp-3805	202	25	detected	detect	VERB
fnp-3805	202	26	by	by	ADP
fnp-3805	202	27	c5b9	c5b9	X
fnp-3805	202	28	immunohistochemistry	immunohistochemistry	NOUN
fnp-3805	202	29	performed	perform	VERB
fnp-3805	202	30	on	on	ADP
fnp-3805	202	31	nerve	nerve	NOUN
fnp-3805	202	32	cryosections	cryosection	NOUN
fnp-3805	202	33	.	.	PUNCT
fnp-3805	203	1	this	this	DET
fnp-3805	203	2	patient	patient	ADJ
fnp-3805	203	3	cohort	cohort	NOUN
fnp-3805	203	4	showed	show	VERB
fnp-3805	203	5	unique	unique	ADJ
fnp-3805	203	6	clinicopathologic	clinicopathologic	ADJ
fnp-3805	203	7	features	feature	NOUN
fnp-3805	203	8	that	that	PRON
fnp-3805	203	9	could	could	AUX
fnp-3805	203	10	reflect	reflect	VERB
fnp-3805	203	11	a	a	DET
fnp-3805	203	12	new	new	ADJ
fnp-3805	203	13	/	/	SYM
fnp-3805	203	14	previously	previously	ADV
fnp-3805	203	15	unrecognized	unrecognize	VERB
fnp-3805	203	16	autoimmune	autoimmune	ADJ
fnp-3805	203	17	neuropathy	neuropathy	PROPN
fnp-3805	203	18	,	,	PUNCT
fnp-3805	203	19	which	which	PRON
fnp-3805	203	20	the	the	DET
fnp-3805	203	21	authors	author	NOUN
fnp-3805	203	22	termed	term	VERB
fnp-3805	203	23	“	"	PUNCT
fnp-3805	203	24	humoral	humoral	ADJ
fnp-3805	203	25	immune	immune	ADJ
fnp-3805	203	26	endoneurial	endoneurial	ADJ
fnp-3805	203	27	microvasculopathy	microvasculopathy	ADJ
fnp-3805	203	28	”	"	PUNCT
fnp-3805	203	29	(	(	PUNCT
fnp-3805	203	30	hiem	hiem	NOUN
fnp-3805	203	31	)	)	PUNCT
fnp-3805	203	32	.	.	PUNCT
fnp-3805	204	1	clinically	clinically	ADV
fnp-3805	204	2	,	,	PUNCT
fnp-3805	204	3	hiem	hiem	NOUN
fnp-3805	204	4	patients	patient	NOUN
fnp-3805	204	5	showed	show	VERB
fnp-3805	204	6	progressive	progressive	ADJ
fnp-3805	204	7	asymmetric	asymmetric	ADJ
fnp-3805	204	8	distal	distal	ADJ
fnp-3805	204	9	weakness	weakness	NOUN
fnp-3805	204	10	that	that	PRON
fnp-3805	204	11	was	be	AUX
fnp-3805	204	12	more	more	ADV
fnp-3805	204	13	prominent	prominent	ADJ
fnp-3805	204	14	in	in	ADP
fnp-3805	204	15	lower	low	ADJ
fnp-3805	204	16	extremities	extremity	NOUN
fnp-3805	204	17	;	;	PUNCT
fnp-3805	204	18	there	there	PRON
fnp-3805	204	19	was	be	VERB
fnp-3805	204	20	no	no	DET
fnp-3805	204	21	evidence	evidence	NOUN
fnp-3805	204	22	of	of	ADP
fnp-3805	204	23	a	a	DET
fnp-3805	204	24	systemic	systemic	ADJ
fnp-3805	204	25	inflammatory	inflammatory	ADJ
fnp-3805	204	26	process	process	NOUN
fnp-3805	204	27	.	.	PUNCT
fnp-3805	205	1	pathologically	pathologically	ADV
fnp-3805	205	2	,	,	PUNCT
fnp-3805	205	3	there	there	PRON
fnp-3805	205	4	was	be	VERB
fnp-3805	205	5	a	a	DET
fnp-3805	205	6	patchy	patchy	ADJ
fnp-3805	205	7	/	/	SYM
fnp-3805	205	8	asymmetric	asymmetric	ADJ
fnp-3805	205	9	axon	axon	NOUN
fnp-3805	205	10	loss	loss	NOUN
fnp-3805	205	11	that	that	PRON
fnp-3805	205	12	preferentially	preferentially	ADV
fnp-3805	205	13	affected	affect	VERB
fnp-3805	205	14	myelinated	myelinated	ADJ
fnp-3805	205	15	axons	axon	NOUN
fnp-3805	205	16	,	,	PUNCT
fnp-3805	205	17	with	with	ADP
fnp-3805	205	18	rare	rare	ADJ
fnp-3805	205	19	digestion	digestion	NOUN
fnp-3805	205	20	chambers	chamber	NOUN
fnp-3805	205	21	and	and	CCONJ
fnp-3805	205	22	rare	rare	ADJ
fnp-3805	205	23	regenerating	regenerate	VERB
fnp-3805	205	24	axon	axon	NOUN
fnp-3805	205	25	clusters	cluster	NOUN
fnp-3805	205	26	but	but	CCONJ
fnp-3805	205	27	no	no	DET
fnp-3805	205	28	significant	significant	ADJ
fnp-3805	205	29	inflammation	inflammation	NOUN
fnp-3805	205	30	;	;	PUNCT
fnp-3805	205	31	strong	strong	ADJ
fnp-3805	205	32	c5b9	c5b9	PRON
fnp-3805	205	33	staining	stain	VERB
fnp-3805	205	34	was	be	AUX
fnp-3805	205	35	seen	see	VERB
fnp-3805	205	36	surrounding	surround	VERB
fnp-3805	205	37	the	the	DET
fnp-3805	205	38	endothelium	endothelium	NOUN
fnp-3805	205	39	in	in	ADP
fnp-3805	205	40	all	all	DET
fnp-3805	205	41	or	or	CCONJ
fnp-3805	205	42	nearly	nearly	ADV
fnp-3805	205	43	all	all	PRON
fnp-3805	205	44	endoneurial	endoneurial	ADJ
fnp-3805	205	45	microvessels	microvessel	NOUN
fnp-3805	205	46	,	,	PUNCT
fnp-3805	205	47	and	and	CCONJ
fnp-3805	205	48	was	be	AUX
fnp-3805	205	49	also	also	ADV
fnp-3805	205	50	detectable	detectable	ADJ
fnp-3805	205	51	in	in	ADP
fnp-3805	205	52	endomysial	endomysial	ADJ
fnp-3805	205	53	capillaries	capillary	NOUN
fnp-3805	205	54	in	in	ADP
fnp-3805	205	55	the	the	DET
fnp-3805	205	56	majority	majority	NOUN
fnp-3805	205	57	of	of	ADP
fnp-3805	205	58	paired	pair	VERB
fnp-3805	205	59	muscle	muscle	NOUN
fnp-3805	205	60	biopsies	biopsy	NOUN
fnp-3805	205	61	(	(	PUNCT
fnp-3805	205	62	trikamji	trikamji	ADJ
fnp-3805	205	63	and	and	CCONJ
fnp-3805	205	64	pestronk	pestronk	ADJ
fnp-3805	205	65	,	,	PUNCT
fnp-3805	205	66	2021	2021	NUM
fnp-3805	205	67	)	)	PUNCT
fnp-3805	205	68	.	.	PUNCT
fnp-3805	206	1	a	a	DET
fnp-3805	206	2	potentially	potentially	ADV
fnp-3805	206	3	confounding	confound	VERB
fnp-3805	206	4	factor	factor	NOUN
fnp-3805	206	5	is	be	AUX
fnp-3805	206	6	that	that	SCONJ
fnp-3805	206	7	similar	similar	ADJ
fnp-3805	206	8	capillary	capillary	ADJ
fnp-3805	206	9	changes	change	NOUN
fnp-3805	206	10	were	be	AUX
fnp-3805	206	11	previously	previously	ADV
fnp-3805	206	12	documented	document	VERB
fnp-3805	206	13	in	in	ADP
fnp-3805	206	14	nerve	nerve	NOUN
fnp-3805	206	15	and	and	CCONJ
fnp-3805	206	16	muscle	muscle	NOUN
fnp-3805	206	17	biopsies	biopsy	NOUN
fnp-3805	206	18	from	from	ADP
fnp-3805	206	19	diabetic	diabetic	ADJ
fnp-3805	206	20	patients	patient	NOUN
fnp-3805	206	21	(	(	PUNCT
fnp-3805	206	22	yell	yell	VERB
fnp-3805	206	23	et	et	PROPN
fnp-3805	206	24	al	al	PROPN
fnp-3805	206	25	.	.	PROPN
fnp-3805	206	26	,	,	PUNCT
fnp-3805	206	27	2018	2018	NUM
fnp-3805	206	28	)	)	PUNCT
fnp-3805	206	29	;	;	PUNCT
fnp-3805	206	30	56	56	NUM
fnp-3805	206	31	%	%	NOUN
fnp-3805	206	32	of	of	ADP
fnp-3805	206	33	the	the	DET
fnp-3805	206	34	patients	patient	NOUN
fnp-3805	206	35	in	in	ADP
fnp-3805	206	36	the	the	DET
fnp-3805	206	37	hiem	hiem	NOUN
fnp-3805	206	38	cohort	cohort	NOUN
fnp-3805	206	39	also	also	ADV
fnp-3805	206	40	had	have	VERB
fnp-3805	206	41	diabetes	diabetes	NOUN
fnp-3805	206	42	,	,	PUNCT
fnp-3805	206	43	and	and	CCONJ
fnp-3805	206	44	the	the	DET
fnp-3805	206	45	mean	mean	ADJ
fnp-3805	206	46	age	age	NOUN
fnp-3805	206	47	of	of	ADP
fnp-3805	206	48	onset	onset	NOUN
fnp-3805	206	49	was	be	AUX
fnp-3805	206	50	lower	low	ADJ
fnp-3805	206	51	in	in	ADP
fnp-3805	206	52	diabetic	diabetic	NOUN
fnp-3805	206	53	than	than	ADP
fnp-3805	206	54	non	non	ADJ
fnp-3805	206	55	-	-	ADJ
fnp-3805	206	56	diabetic	diabetic	ADJ
fnp-3805	206	57	patients	patient	NOUN
fnp-3805	206	58	.	.	PUNCT
fnp-3805	207	1	however	however	ADV
fnp-3805	207	2	,	,	PUNCT
fnp-3805	207	3	and	and	CCONJ
fnp-3805	207	4	very	very	ADV
fnp-3805	207	5	compellingly	compellingly	ADV
fnp-3805	207	6	,	,	PUNCT
fnp-3805	207	7	15	15	NUM
fnp-3805	207	8	of	of	ADP
fnp-3805	207	9	16	16	NUM
fnp-3805	207	10	hiem	hiem	NOUN
fnp-3805	207	11	patients	patient	NOUN
fnp-3805	207	12	showed	show	VERB
fnp-3805	207	13	a	a	DET
fnp-3805	207	14	measurable	measurable	ADJ
fnp-3805	207	15	strength	strength	NOUN
fnp-3805	207	16	improvement	improvement	NOUN
fnp-3805	207	17	following	follow	VERB
fnp-3805	207	18	a	a	DET
fnp-3805	207	19	short	short	ADJ
fnp-3805	207	20	course	course	NOUN
fnp-3805	207	21	of	of	ADP
fnp-3805	207	22	corticosteroid	corticosteroid	ADJ
fnp-3805	207	23	therapy	therapy	NOUN
fnp-3805	207	24	;	;	PUNCT
fnp-3805	207	25	this	this	PRON
fnp-3805	207	26	would	would	AUX
fnp-3805	207	27	not	not	PART
fnp-3805	207	28	be	be	AUX
fnp-3805	207	29	expected	expect	VERB
fnp-3805	207	30	if	if	SCONJ
fnp-3805	207	31	the	the	DET
fnp-3805	207	32	observed	observed	ADJ
fnp-3805	207	33	nerve	nerve	NOUN
fnp-3805	207	34	pathology	pathology	NOUN
fnp-3805	207	35	was	be	AUX
fnp-3805	207	36	mainly	mainly	ADV
fnp-3805	207	37	due	due	ADJ
fnp-3805	207	38	to	to	ADP
fnp-3805	207	39	chronic	chronic	ADJ
fnp-3805	207	40	(	(	PUNCT
fnp-3805	207	41	and	and	CCONJ
fnp-3805	207	42	likely	likely	ADV
fnp-3805	207	43	irreversible	irreversible	ADJ
fnp-3805	207	44	)	)	PUNCT
fnp-3805	207	45	diabetic	diabetic	NOUN
fnp-3805	207	46	neuropathy	neuropathy	ADJ
fnp-3805	207	47	.	.	PUNCT
fnp-3805	208	1	while	while	SCONJ
fnp-3805	208	2	very	very	ADV
fnp-3805	208	3	intriguing	intriguing	ADJ
fnp-3805	208	4	,	,	PUNCT
fnp-3805	208	5	these	these	DET
fnp-3805	208	6	findings	finding	NOUN
fnp-3805	208	7	need	need	VERB
fnp-3805	208	8	to	to	PART
fnp-3805	208	9	be	be	AUX
fnp-3805	208	10	replicated	replicate	VERB
fnp-3805	208	11	in	in	ADP
fnp-3805	208	12	other	other	ADJ
fnp-3805	208	13	patient	patient	ADJ
fnp-3805	208	14	cohorts	cohort	NOUN
fnp-3805	208	15	,	,	PUNCT
fnp-3805	208	16	with	with	ADP
fnp-3805	208	17	corticosteroid	corticosteroid	ADJ
fnp-3805	208	18	treatment	treatment	NOUN
fnp-3805	208	19	effectiveness	effectiveness	NOUN
fnp-3805	208	20	confirmed	confirm	VERB
fnp-3805	208	21	by	by	ADP
fnp-3805	208	22	double	double	ADJ
fnp-3805	208	23	-	-	PUNCT
fnp-3805	208	24	blind	blind	ADJ
fnp-3805	208	25	clinical	clinical	ADJ
fnp-3805	208	26	trials	trial	NOUN
fnp-3805	208	27	.	.	PUNCT
fnp-3805	209	1	in	in	ADP
fnp-3805	209	2	addition	addition	NOUN
fnp-3805	209	3	,	,	PUNCT
fnp-3805	209	4	both	both	DET
fnp-3805	209	5	nerve	nerve	NOUN
fnp-3805	209	6	and	and	CCONJ
fnp-3805	209	7	muscle	muscle	NOUN
fnp-3805	209	8	biopsies	biopsy	NOUN
fnp-3805	209	9	from	from	ADP
fnp-3805	209	10	hiem	hiem	NOUN
fnp-3805	209	11	patients	patient	NOUN
fnp-3805	209	12	should	should	AUX
fnp-3805	209	13	be	be	AUX
fnp-3805	209	14	evaluated	evaluate	VERB
fnp-3805	209	15	by	by	ADP
fnp-3805	209	16	electron	electron	NOUN
fnp-3805	209	17	microscopy	microscopy	NOUN
fnp-3805	209	18	:	:	PUNCT
fnp-3805	209	19	it	it	PRON
fnp-3805	209	20	is	be	AUX
fnp-3805	209	21	possible	possible	ADJ
fnp-3805	209	22	that	that	SCONJ
fnp-3805	209	23	ultrastructural	ultrastructural	ADJ
fnp-3805	209	24	evaluation	evaluation	NOUN
fnp-3805	209	25	will	will	AUX
fnp-3805	209	26	yield	yield	VERB
fnp-3805	209	27	additional	additional	ADJ
fnp-3805	209	28	useful	useful	ADJ
fnp-3805	209	29	clues	clue	NOUN
fnp-3805	209	30	,	,	PUNCT
fnp-3805	209	31	either	either	CCONJ
fnp-3805	209	32	from	from	ADP
fnp-3805	209	33	pathogenetic	pathogenetic	ADJ
fnp-3805	209	34	or	or	CCONJ
fnp-3805	209	35	diagnostic	diagnostic	ADJ
fnp-3805	209	36	perspective	perspective	NOUN
fnp-3805	209	37	.	.	PUNCT
fnp-3805	210	1	nonetheless	nonetheless	ADV
fnp-3805	210	2	,	,	PUNCT
fnp-3805	210	3	trikamji	trikamji	ADJ
fnp-3805	210	4	and	and	CCONJ
fnp-3805	210	5	pestronk	pestronk	PROPN
fnp-3805	210	6	’s	’s	PART
fnp-3805	210	7	findings	finding	NOUN
fnp-3805	210	8	suggest	suggest	VERB
fnp-3805	210	9	that	that	SCONJ
fnp-3805	210	10	a	a	DET
fnp-3805	210	11	portion	portion	NOUN
fnp-3805	210	12	of	of	ADP
fnp-3805	210	13	each	each	DET
fnp-3805	210	14	nerve	nerve	NOUN
fnp-3805	210	15	biopsy	biopsy	NOUN
fnp-3805	210	16	should	should	AUX
fnp-3805	210	17	be	be	AUX
fnp-3805	210	18	frozen	freeze	VERB
fnp-3805	210	19	for	for	ADP
fnp-3805	210	20	specialized	specialized	ADJ
fnp-3805	210	21	immunohistochemical	immunohistochemical	ADJ
fnp-3805	210	22	studies	study	NOUN
fnp-3805	210	23	,	,	PUNCT
fnp-3805	210	24	which	which	PRON
fnp-3805	210	25	is	be	AUX
fnp-3805	210	26	currently	currently	ADV
fnp-3805	210	27	not	not	PART
fnp-3805	210	28	a	a	DET
fnp-3805	210	29	standard	standard	ADJ
fnp-3805	210	30	operating	operating	NOUN
fnp-3805	210	31	protocol	protocol	NOUN
fnp-3805	210	32	in	in	ADP
fnp-3805	210	33	the	the	DET
fnp-3805	210	34	majority	majority	NOUN
fnp-3805	210	35	of	of	ADP
fnp-3805	210	36	neuromuscular	neuromuscular	ADJ
fnp-3805	210	37	pathology	pathology	NOUN
fnp-3805	210	38	laboratories	laboratory	NOUN
fnp-3805	210	39	:	:	PUNCT
fnp-3805	210	40	in	in	ADP
fnp-3805	210	41	addition	addition	NOUN
fnp-3805	210	42	to	to	ADP
fnp-3805	210	43	enabling	enable	VERB
fnp-3805	210	44	identification	identification	NOUN
fnp-3805	210	45	of	of	ADP
fnp-3805	210	46	potentially	potentially	ADV
fnp-3805	210	47	treatable	treatable	ADJ
fnp-3805	210	48	hiem	hiem	NOUN
fnp-3805	210	49	patients	patient	NOUN
fnp-3805	210	50	,	,	PUNCT
fnp-3805	210	51	such	such	ADJ
fnp-3805	210	52	processing	processing	NOUN
fnp-3805	210	53	would	would	AUX
fnp-3805	210	54	also	also	ADV
fnp-3805	210	55	facilitate	facilitate	VERB
fnp-3805	210	56	detection	detection	NOUN
fnp-3805	210	57	of	of	ADP
fnp-3805	210	58	immunoglobulin	immunoglobulin	NOUN
fnp-3805	210	59	deposits	deposit	NOUN
fnp-3805	210	60	that	that	PRON
fnp-3805	210	61	are	be	AUX
fnp-3805	210	62	important	important	ADJ
fnp-3805	210	63	for	for	ADP
fnp-3805	210	64	accurate	accurate	ADJ
fnp-3805	210	65	classification	classification	NOUN
fnp-3805	210	66	of	of	ADP
fnp-3805	210	67	amyloid	amyloid	NOUN
fnp-3805	210	68	and	and	CCONJ
fnp-3805	210	69	vasculitic	vasculitic	ADJ
fnp-3805	210	70	neuropathies	neuropathy	NOUN
fnp-3805	210	71	.	.	PUNCT
fnp-3805	211	1	9	9	X
fnp-3805	211	2	.	.	X
fnp-3805	211	3	gene	gene	NOUN
fnp-3805	211	4	expression	expression	NOUN
fnp-3805	211	5	profiling	profiling	NOUN
fnp-3805	211	6	in	in	ADP
fnp-3805	211	7	idiopathicinflammatory	idiopathicinflammatory	ADJ
fnp-3805	211	8	myopathies	myopathy	NOUN
fnp-3805	211	9	based	base	VERB
fnp-3805	211	10	on	on	ADP
fnp-3805	211	11	the	the	DET
fnp-3805	211	12	current	current	ADJ
fnp-3805	211	13	clinicoseropathologic	clinicoseropathologic	ADJ
fnp-3805	211	14	criteria	criterion	NOUN
fnp-3805	211	15	,	,	PUNCT
fnp-3805	211	16	iims	iim	NOUN
fnp-3805	211	17	are	be	AUX
fnp-3805	211	18	divided	divide	VERB
fnp-3805	211	19	into	into	ADP
fnp-3805	211	20	four	four	NUM
fnp-3805	211	21	distinct	distinct	ADJ
fnp-3805	211	22	subcategories	subcategorie	NOUN
fnp-3805	211	23	[	[	X
fnp-3805	211	24	dm	dm	X
fnp-3805	211	25	,	,	PUNCT
fnp-3805	211	26	assm	assm	PROPN
fnp-3805	211	27	,	,	PUNCT
fnp-3805	211	28	imnm	imnm	PROPN
fnp-3805	211	29	,	,	PUNCT
fnp-3805	211	30	and	and	CCONJ
fnp-3805	211	31	sibm	sibm	NOUN
fnp-3805	211	32	;	;	PUNCT
fnp-3805	211	33	for	for	ADP
fnp-3805	211	34	a	a	DET
fnp-3805	211	35	brief	brief	ADJ
fnp-3805	211	36	overview	overview	NOUN
fnp-3805	211	37	of	of	ADP
fnp-3805	211	38	the	the	DET
fnp-3805	211	39	diagnostic	diagnostic	ADJ
fnp-3805	211	40	criteria	criterion	NOUN
fnp-3805	211	41	and	and	CCONJ
fnp-3805	211	42	other	other	ADJ
fnp-3805	211	43	recent	recent	ADJ
fnp-3805	211	44	advances	advance	NOUN
fnp-3805	211	45	in	in	ADP
fnp-3805	211	46	the	the	DET
fnp-3805	211	47	iim	iim	NOUN
fnp-3805	211	48	field	field	NOUN
fnp-3805	211	49	,	,	PUNCT
fnp-3805	211	50	see	see	VERB
fnp-3805	211	51	the	the	DET
fnp-3805	211	52	2020	2020	NUM
fnp-3805	211	53	update	update	NOUN
fnp-3805	211	54	in	in	ADP
fnp-3805	211	55	this	this	DET
fnp-3805	211	56	article	article	NOUN
fnp-3805	211	57	series	series	NOUN
fnp-3805	211	58	(	(	PUNCT
fnp-3805	211	59	margeta	margeta	NOUN
fnp-3805	211	60	,	,	PUNCT
fnp-3805	211	61	2020b	2020b	NUM
fnp-3805	211	62	)	)	PUNCT
fnp-3805	211	63	]	]	PUNCT
fnp-3805	211	64	.	.	PUNCT
fnp-3805	212	1	an	an	DET
fnp-3805	212	2	interesting	interesting	ADJ
fnp-3805	212	3	study	study	NOUN
fnp-3805	212	4	published	publish	VERB
fnp-3805	212	5	last	last	ADJ
fnp-3805	212	6	year	year	NOUN
fnp-3805	212	7	(	(	PUNCT
fnp-3805	212	8	amici	amici	PROPN
fnp-3805	212	9	et	et	PROPN
fnp-3805	212	10	al	al	PROPN
fnp-3805	212	11	.	.	PROPN
fnp-3805	212	12	,	,	PUNCT
fnp-3805	212	13	2021	2021	NUM
fnp-3805	212	14	)	)	PUNCT
fnp-3805	212	15	has	have	AUX
fnp-3805	212	16	used	use	VERB
fnp-3805	212	17	a	a	DET
fnp-3805	212	18	gene	gene	NOUN
fnp-3805	212	19	expression	expression	NOUN
fnp-3805	212	20	profiling	profiling	NOUN
fnp-3805	212	21	approach	approach	NOUN
fnp-3805	212	22	to	to	PART
fnp-3805	212	23	take	take	VERB
fnp-3805	212	24	a	a	DET
fnp-3805	212	25	deeper	deep	ADJ
fnp-3805	212	26	look	look	NOUN
fnp-3805	212	27	into	into	ADP
fnp-3805	212	28	these	these	DET
fnp-3805	212	29	disorders	disorder	NOUN
fnp-3805	212	30	;	;	PUNCT
fnp-3805	212	31	while	while	SCONJ
fnp-3805	212	32	the	the	DET
fnp-3805	212	33	current	current	ADJ
fnp-3805	212	34	data	data	NOUN
fnp-3805	212	35	is	be	AUX
fnp-3805	212	36	mainly	mainly	ADV
fnp-3805	212	37	interesting	interesting	ADJ
fnp-3805	212	38	from	from	ADP
fnp-3805	212	39	the	the	DET
fnp-3805	212	40	standpoint	standpoint	NOUN
fnp-3805	212	41	of	of	ADP
fnp-3805	212	42	disease	disease	NOUN
fnp-3805	212	43	pathogenesis	pathogenesis	NOUN
fnp-3805	212	44	,	,	PUNCT
fnp-3805	212	45	this	this	DET
fnp-3805	212	46	study	study	NOUN
fnp-3805	212	47	also	also	ADV
fnp-3805	212	48	provides	provide	VERB
fnp-3805	212	49	a	a	DET
fnp-3805	212	50	glimpse	glimpse	NOUN
fnp-3805	212	51	into	into	ADP
fnp-3805	212	52	the	the	DET
fnp-3805	212	53	use	use	NOUN
fnp-3805	212	54	of	of	ADP
fnp-3805	212	55	transcriptomic	transcriptomic	ADJ
fnp-3805	212	56	profiles	profile	NOUN
fnp-3805	212	57	for	for	ADP
fnp-3805	212	58	disease	disease	NOUN
fnp-3805	212	59	diagnostics	diagnostic	NOUN
fnp-3805	212	60	.	.	PUNCT
fnp-3805	213	1	the	the	DET
fnp-3805	213	2	authors	author	NOUN
fnp-3805	213	3	used	use	VERB
fnp-3805	213	4	rna	rna	NOUN
fnp-3805	213	5	-	-	PUNCT
fnp-3805	213	6	sequencing	sequence	VERB
fnp-3805	213	7	data	datum	NOUN
fnp-3805	213	8	from	from	ADP
fnp-3805	213	9	119	119	NUM
fnp-3805	213	10	iim	iim	NOUN
fnp-3805	213	11	muscle	muscle	NOUN
fnp-3805	213	12	biopsies	biopsy	NOUN
fnp-3805	213	13	[	[	X
fnp-3805	213	14	39	39	NUM
fnp-3805	213	15	dm	dm	PROPN
fnp-3805	213	16	cases	case	NOUN
fnp-3805	213	17	,	,	PUNCT
fnp-3805	213	18	18	18	NUM
fnp-3805	213	19	assm	assm	NOUN
fnp-3805	213	20	cases	case	NOUN
fnp-3805	213	21	,	,	PUNCT
fnp-3805	213	22	49	49	NUM
fnp-3805	213	23	imnm	imnm	PROPN
fnp-3805	213	24	cases	case	NOUN
fnp-3805	213	25	,	,	PUNCT
fnp-3805	213	26	and	and	CCONJ
fnp-3805	213	27	13	13	NUM
fnp-3805	213	28	sibm	sibm	NOUN
fnp-3805	213	29	cases	case	NOUN
fnp-3805	213	30	;	;	PUNCT
fnp-3805	213	31	all	all	DET
fnp-3805	213	32	assm	assm	NOUN
fnp-3805	213	33	cases	case	NOUN
fnp-3805	213	34	were	be	AUX
fnp-3805	213	35	positive	positive	ADJ
fnp-3805	213	36	for	for	ADP
fnp-3805	213	37	anti	anti	ADJ
fnp-3805	213	38	-	-	ADJ
fnp-3805	213	39	jo-1	jo-1	ADJ
fnp-3805	213	40	antibodies	antibodie	VERB
fnp-3805	213	41	,	,	PUNCT
fnp-3805	213	42	while	while	SCONJ
fnp-3805	213	43	the	the	DET
fnp-3805	213	44	dm	dm	NOUN
fnp-3805	213	45	and	and	CCONJ
fnp-3805	213	46	imnm	imnm	PROPN
fnp-3805	213	47	groups	group	NOUN
fnp-3805	213	48	were	be	AUX
fnp-3805	213	49	heterogenous	heterogenous	ADJ
fnp-3805	213	50	with	with	ADP
fnp-3805	213	51	respect	respect	NOUN
fnp-3805	213	52	to	to	ADP
fnp-3805	213	53	the	the	DET
fnp-3805	213	54	patient	patient	NOUN
fnp-3805	213	55	’s	’s	PART
fnp-3805	213	56	serologic	serologic	ADJ
fnp-3805	213	57	status	status	NOUN
fnp-3805	213	58	,	,	PUNCT
fnp-3805	213	59	with	with	ADP
fnp-3805	213	60	5	5	NUM
fnp-3805	213	61	-	-	SYM
fnp-3805	213	62	40	40	NUM
fnp-3805	213	63	cases	case	NOUN
fnp-3805	213	64	per	per	ADP
fnp-3805	213	65	myositis	myositis	NOUN
fnp-3805	213	66	-	-	PUNCT
fnp-3805	213	67	specific	specific	ADJ
fnp-3805	213	68	antibody	antibody	NOUN
fnp-3805	213	69	(	(	PUNCT
fnp-3805	213	70	msa	msa	PROPN
fnp-3805	213	71	)	)	PUNCT
fnp-3805	213	72	subgroup	subgroup	PROPN
fnp-3805	213	73	]	]	PUNCT
fnp-3805	213	74	and	and	CCONJ
fnp-3805	213	75	20	20	NUM
fnp-3805	213	76	normal	normal	ADJ
fnp-3805	213	77	muscle	muscle	NOUN
fnp-3805	213	78	biopsies	biopsy	NOUN
fnp-3805	213	79	to	to	PART
fnp-3805	213	80	generate	generate	VERB
fnp-3805	213	81	transcriptome	transcriptome	ADJ
fnp-3805	213	82	maps	map	NOUN
fnp-3805	213	83	and	and	CCONJ
fnp-3805	213	84	identify	identify	VERB
fnp-3805	213	85	gene	gene	NOUN
fnp-3805	213	86	expression	expression	NOUN
fnp-3805	213	87	modules	module	NOUN
fnp-3805	213	88	that	that	PRON
fnp-3805	213	89	are	be	AUX
fnp-3805	213	90	dynamically	dynamically	ADV
fnp-3805	213	91	regulated	regulate	VERB
fnp-3805	213	92	in	in	ADP
fnp-3805	213	93	iims	iim	NOUN
fnp-3805	213	94	.	.	PUNCT
fnp-3805	214	1	some	some	PRON
fnp-3805	214	2	of	of	ADP
fnp-3805	214	3	the	the	DET
fnp-3805	214	4	results	result	NOUN
fnp-3805	214	5	were	be	AUX
fnp-3805	214	6	not	not	PART
fnp-3805	214	7	surprising	surprising	ADJ
fnp-3805	214	8	;	;	PUNCT
fnp-3805	214	9	for	for	ADP
fnp-3805	214	10	example	example	NOUN
fnp-3805	214	11	,	,	PUNCT
fnp-3805	214	12	dm	dm	PROPN
fnp-3805	214	13	biopsies	biopsy	NOUN
fnp-3805	214	14	showed	show	VERB
fnp-3805	214	15	activation	activation	NOUN
fnp-3805	214	16	of	of	ADP
fnp-3805	214	17	the	the	DET
fnp-3805	214	18	type	type	NOUN
fnp-3805	214	19	1	1	NUM
fnp-3805	214	20	interferon	interferon	ADJ
fnp-3805	214	21	-	-	PUNCT
fnp-3805	214	22	inducible	inducible	ADJ
fnp-3805	214	23	gene	gene	NOUN
fnp-3805	214	24	module	module	NOUN
fnp-3805	214	25	,	,	PUNCT
fnp-3805	214	26	which	which	PRON
fnp-3805	214	27	was	be	AUX
fnp-3805	214	28	not	not	PART
fnp-3805	214	29	significantly	significantly	ADV
fnp-3805	214	30	upregulated	upregulate	VERB
fnp-3805	214	31	in	in	ADP
fnp-3805	214	32	other	other	ADJ
fnp-3805	214	33	iim	iim	NOUN
fnp-3805	214	34	subtypes	subtype	NOUN
fnp-3805	214	35	,	,	PUNCT
fnp-3805	214	36	while	while	SCONJ
fnp-3805	214	37	sibm	sibm	NOUN
fnp-3805	214	38	cases	case	NOUN
fnp-3805	214	39	were	be	AUX
fnp-3805	214	40	unique	unique	ADJ
fnp-3805	214	41	in	in	ADP
fnp-3805	214	42	showing	show	VERB
fnp-3805	214	43	consistent	consistent	ADJ
fnp-3805	214	44	overexpression	overexpression	NOUN
fnp-3805	214	45	of	of	ADP
fnp-3805	214	46	t	t	NOUN
fnp-3805	214	47	cell	cell	NOUN
fnp-3805	214	48	genes	gene	NOUN
fnp-3805	214	49	.	.	PUNCT
fnp-3805	215	1	other	other	ADJ
fnp-3805	215	2	findings	finding	NOUN
fnp-3805	215	3	,	,	PUNCT
fnp-3805	215	4	however	however	ADV
fnp-3805	215	5	,	,	PUNCT
fnp-3805	215	6	were	be	AUX
fnp-3805	215	7	novel	novel	ADJ
fnp-3805	215	8	and	and	CCONJ
fnp-3805	215	9	somewhat	somewhat	ADV
fnp-3805	215	10	surprising	surprising	ADJ
fnp-3805	215	11	.	.	PUNCT
fnp-3805	216	1	for	for	ADP
fnp-3805	216	2	example	example	NOUN
fnp-3805	216	3	,	,	PUNCT
fnp-3805	216	4	two	two	NUM
fnp-3805	216	5	gene	gene	NOUN
fnp-3805	216	6	modules	module	NOUN
fnp-3805	216	7	–	–	PUNCT
fnp-3805	216	8	the	the	DET
fnp-3805	216	9	stress	stress	NOUN
fnp-3805	216	10	response	response	NOUN
fnp-3805	216	11	acute	acute	NOUN
fnp-3805	216	12	phase	phase	NOUN
fnp-3805	216	13	response	response	NOUN
fnp-3805	216	14	module	module	NOUN
fnp-3805	216	15	and	and	CCONJ
fnp-3805	216	16	the	the	DET
fnp-3805	216	17	neutrophil	neutrophil	ADJ
fnp-3805	216	18	degranulation	degranulation	NOUN
fnp-3805	216	19	module	module	NOUN
fnp-3805	216	20	–	–	PUNCT
fnp-3805	216	21	were	be	AUX
fnp-3805	216	22	upregulated	upregulate	VERB
fnp-3805	216	23	across	across	ADP
fnp-3805	216	24	all	all	DET
fnp-3805	216	25	iim	iim	NOUN
fnp-3805	216	26	subtypes	subtype	NOUN
fnp-3805	216	27	(	(	PUNCT
fnp-3805	216	28	including	include	VERB
fnp-3805	216	29	imnm	imnm	PROPN
fnp-3805	216	30	cases	case	NOUN
fnp-3805	216	31	,	,	PUNCT
fnp-3805	216	32	which	which	PRON
fnp-3805	216	33	generally	generally	ADV
fnp-3805	216	34	lack	lack	VERB
fnp-3805	216	35	significant	significant	ADJ
fnp-3805	216	36	inflammation	inflammation	NOUN
fnp-3805	216	37	)	)	PUNCT
fnp-3805	216	38	,	,	PUNCT
fnp-3805	216	39	as	as	SCONJ
fnp-3805	216	40	was	be	AUX
fnp-3805	216	41	the	the	DET
fnp-3805	216	42	cytoskeleton	cytoskeleton	NOUN
fnp-3805	216	43	remodeling	remodeling	NOUN
fnp-3805	216	44	module	module	NOUN
fnp-3805	216	45	,	,	PUNCT
fnp-3805	216	46	which	which	PRON
fnp-3805	216	47	includes	include	VERB
fnp-3805	216	48	tgf	tgf	PROPN
fnp-3805	216	49	-	-	PUNCT
fnp-3805	216	50	β	β	PROPN
fnp-3805	216	51	and	and	CCONJ
fnp-3805	216	52	could	could	AUX
fnp-3805	216	53	be	be	AUX
fnp-3805	216	54	related	relate	VERB
fnp-3805	216	55	to	to	ADP
fnp-3805	216	56	endomysial	endomysial	ADJ
fnp-3805	216	57	fibrosis	fibrosis	NOUN
fnp-3805	216	58	seen	see	VERB
fnp-3805	216	59	in	in	ADP
fnp-3805	216	60	many	many	ADJ
fnp-3805	216	61	long	long	ADV
fnp-3805	216	62	-	-	PUNCT
fnp-3805	216	63	standing	stand	VERB
fnp-3805	216	64	iim	iim	NOUN
fnp-3805	216	65	cases	case	NOUN
fnp-3805	216	66	;	;	PUNCT
fnp-3805	216	67	in	in	ADP
fnp-3805	216	68	contrast	contrast	NOUN
fnp-3805	216	69	,	,	PUNCT
fnp-3805	216	70	the	the	DET
fnp-3805	216	71	large	large	ADJ
fnp-3805	216	72	muscle	muscle	NOUN
fnp-3805	216	73	function	function	NOUN
fnp-3805	216	74	,	,	PUNCT
fnp-3805	216	75	redox	redox	ADJ
fnp-3805	216	76	metabolism	metabolism	NOUN
fnp-3805	216	77	,	,	PUNCT
fnp-3805	216	78	and	and	CCONJ
fnp-3805	216	79	ubiquitination	ubiquitination	NOUN
fnp-3805	216	80	gene	gene	NOUN
fnp-3805	216	81	module	module	NOUN
fnp-3805	216	82	was	be	AUX
fnp-3805	216	83	downregulated	downregulate	VERB
fnp-3805	216	84	across	across	ADP
fnp-3805	216	85	all	all	DET
fnp-3805	216	86	iim	iim	PROPN
fnp-3805	216	87	subtypes	subtype	NOUN
fnp-3805	216	88	.	.	PUNCT
fnp-3805	217	1	expression	expression	NOUN
fnp-3805	217	2	changes	change	NOUN
fnp-3805	217	3	in	in	ADP
fnp-3805	217	4	some	some	DET
fnp-3805	217	5	gene	gene	NOUN
fnp-3805	217	6	modules	module	NOUN
fnp-3805	217	7	were	be	AUX
fnp-3805	217	8	more	more	ADV
fnp-3805	217	9	specific	specific	ADJ
fnp-3805	217	10	and	and	CCONJ
fnp-3805	217	11	characteristic	characteristic	ADJ
fnp-3805	217	12	for	for	ADP
fnp-3805	217	13	individual	individual	ADJ
fnp-3805	217	14	iim	iim	PROPN
fnp-3805	217	15	subtypes	subtype	NOUN
fnp-3805	217	16	:	:	PUNCT
fnp-3805	217	17	for	for	ADP
fnp-3805	217	18	example	example	NOUN
fnp-3805	217	19	,	,	PUNCT
fnp-3805	217	20	the	the	DET
fnp-3805	217	21	previously	previously	ADV
fnp-3805	217	22	mentioned	mention	VERB
fnp-3805	217	23	upregulation	upregulation	NOUN
fnp-3805	217	24	of	of	ADP
fnp-3805	217	25	the	the	DET
fnp-3805	217	26	type	type	NOUN
fnp-3805	217	27	1	1	NUM
fnp-3805	217	28	interferon	interferon	ADJ
fnp-3805	217	29	-	-	PUNCT
fnp-3805	217	30	induced	induce	VERB
fnp-3805	217	31	gene	gene	NOUN
fnp-3805	217	32	module	module	NOUN
fnp-3805	217	33	in	in	ADP
fnp-3805	217	34	dm	dm	PROPN
fnp-3805	217	35	cases	case	NOUN
fnp-3805	217	36	was	be	AUX
fnp-3805	217	37	strongly	strongly	ADV
fnp-3805	217	38	correlated	correlate	VERB
fnp-3805	217	39	with	with	ADP
fnp-3805	217	40	downregulation	downregulation	NOUN
fnp-3805	217	41	of	of	ADP
fnp-3805	217	42	the	the	DET
fnp-3805	217	43	titin	titin	PROPN
fnp-3805	217	44	transcript	transcript	NOUN
fnp-3805	217	45	,	,	PUNCT
fnp-3805	217	46	while	while	SCONJ
fnp-3805	217	47	the	the	DET
fnp-3805	217	48	assm	assm	PROPN
fnp-3805	217	49	cases	case	NOUN
fnp-3805	217	50	showed	show	VERB
fnp-3805	217	51	upregulation	upregulation	NOUN
fnp-3805	217	52	of	of	ADP
fnp-3805	217	53	the	the	DET
fnp-3805	217	54	rna	rna	NOUN
fnp-3805	217	55	binding	binding	NOUN
fnp-3805	217	56	,	,	PUNCT
fnp-3805	217	57	splicing	splicing	NOUN
fnp-3805	217	58	,	,	PUNCT
fnp-3805	217	59	and	and	CCONJ
fnp-3805	217	60	translation	translation	NOUN
fnp-3805	217	61	genes	gene	NOUN
fnp-3805	217	62	.	.	PUNCT
fnp-3805	218	1	in	in	ADP
fnp-3805	218	2	addition	addition	NOUN
fnp-3805	218	3	to	to	ADP
fnp-3805	218	4	studying	study	VERB
fnp-3805	218	5	gene	gene	NOUN
fnp-3805	218	6	expression	expression	NOUN
fnp-3805	218	7	changes	change	NOUN
fnp-3805	218	8	across	across	ADP
fnp-3805	218	9	different	different	ADJ
fnp-3805	218	10	iim	iim	NOUN
fnp-3805	218	11	subtypes	subtype	NOUN
fnp-3805	218	12	,	,	PUNCT
fnp-3805	218	13	the	the	DET
fnp-3805	218	14	authors	author	NOUN
fnp-3805	218	15	of	of	ADP
fnp-3805	218	16	this	this	DET
fnp-3805	218	17	study	study	NOUN
fnp-3805	218	18	converted	convert	VERB
fnp-3805	218	19	individual	individual	ADJ
fnp-3805	218	20	trascriptomic	trascriptomic	ADJ
fnp-3805	218	21	profiles	profile	NOUN
fnp-3805	218	22	into	into	ADP
fnp-3805	218	23	images	image	NOUN
fnp-3805	218	24	suitable	suitable	ADJ
fnp-3805	218	25	for	for	ADP
fnp-3805	218	26	computational	computational	ADJ
fnp-3805	218	27	analysis	analysis	NOUN
fnp-3805	218	28	by	by	ADP
fnp-3805	218	29	a	a	DET
fnp-3805	218	30	convolutional	convolutional	ADJ
fnp-3805	218	31	neural	neural	ADJ
fnp-3805	218	32	network	network	NOUN
fnp-3805	218	33	.	.	PUNCT
fnp-3805	219	1	unsupervised	unsupervised	ADJ
fnp-3805	219	2	hierarchical	hierarchical	ADJ
fnp-3805	219	3	clustering	clustering	NOUN
fnp-3805	219	4	by	by	ADP
fnp-3805	219	5	neural	neural	ADJ
fnp-3805	219	6	network	network	NOUN
fnp-3805	219	7	-	-	PUNCT
fnp-3805	219	8	derived	derive	VERB
fnp-3805	219	9	features	feature	NOUN
fnp-3805	219	10	led	lead	VERB
fnp-3805	219	11	to	to	ADP
fnp-3805	219	12	an	an	DET
fnp-3805	219	13	interesting	interesting	ADJ
fnp-3805	219	14	hierarchy	hierarchy	NOUN
fnp-3805	219	15	of	of	ADP
fnp-3805	219	16	different	different	ADJ
fnp-3805	219	17	patient	patient	NOUN
fnp-3805	219	18	subgroups	subgroup	NOUN
fnp-3805	219	19	,	,	PUNCT
fnp-3805	219	20	with	with	ADP
fnp-3805	219	21	the	the	DET
fnp-3805	219	22	severe	severe	ADJ
fnp-3805	219	23	dm	dm	PROPN
fnp-3805	219	24	cases	case	NOUN
fnp-3805	219	25	clustering	cluster	VERB
fnp-3805	219	26	closer	close	ADV
fnp-3805	219	27	to	to	ADP
fnp-3805	219	28	the	the	DET
fnp-3805	219	29	assm	assm	PROPN
fnp-3805	219	30	cases	case	NOUN
fnp-3805	219	31	and	and	CCONJ
fnp-3805	219	32	severe	severe	ADJ
fnp-3805	219	33	imnm	imnm	NOUN
fnp-3805	219	34	cases	case	NOUN
fnp-3805	219	35	than	than	ADP
fnp-3805	219	36	to	to	ADP
fnp-3805	219	37	the	the	DET
fnp-3805	219	38	mild	mild	ADJ
fnp-3805	219	39	dm	dm	NOUN
fnp-3805	219	40	and	and	CCONJ
fnp-3805	219	41	imnm	imnm	PROPN
fnp-3805	219	42	cases	case	NOUN
fnp-3805	219	43	;	;	PUNCT
fnp-3805	219	44	one	one	NUM
fnp-3805	219	45	severe	severe	ADJ
fnp-3805	219	46	anti	anti	NOUN
fnp-3805	219	47	-	-	NOUN
fnp-3805	219	48	mi-2	mi-2	ADJ
fnp-3805	219	49	dm	dm	NOUN
fnp-3805	219	50	case	case	NOUN
fnp-3805	219	51	was	be	AUX
fnp-3805	219	52	even	even	ADV
fnp-3805	219	53	misclassified	misclassifie	VERB
fnp-3805	219	54	within	within	ADP
fnp-3805	219	55	the	the	DET
fnp-3805	219	56	assm	assm	PROPN
fnp-3805	219	57	group	group	NOUN
fnp-3805	219	58	.	.	PUNCT
fnp-3805	220	1	this	this	DET
fnp-3805	220	2	finding	finding	NOUN
fnp-3805	220	3	is	be	AUX
fnp-3805	220	4	congruent	congruent	ADJ
fnp-3805	220	5	with	with	ADP
fnp-3805	220	6	the	the	DET
fnp-3805	220	7	experience	experience	NOUN
fnp-3805	220	8	on	on	ADP
fnp-3805	220	9	a	a	DET
fnp-3805	220	10	diagnostic	diagnostic	ADJ
fnp-3805	220	11	muscle	muscle	NOUN
fnp-3805	220	12	pathology	pathology	NOUN
fnp-3805	220	13	service	service	NOUN
fnp-3805	220	14	,	,	PUNCT
fnp-3805	220	15	where	where	SCONJ
fnp-3805	220	16	one	one	PRON
fnp-3805	220	17	can	can	AUX
fnp-3805	220	18	occasionally	occasionally	ADV
fnp-3805	220	19	see	see	VERB
fnp-3805	220	20	a	a	DET
fnp-3805	220	21	significant	significant	ADJ
fnp-3805	220	22	histopathologic	histopathologic	ADJ
fnp-3805	220	23	overlap	overlap	NOUN
fnp-3805	220	24	between	between	ADP
fnp-3805	220	25	anti	anti	ADJ
fnp-3805	220	26	-	-	ADJ
fnp-3805	220	27	mi-2	mi-2	ADJ
fnp-3805	220	28	dm	dm	NOUN
fnp-3805	220	29	,	,	PUNCT
fnp-3805	220	30	assm	assm	NOUN
fnp-3805	220	31	,	,	PUNCT
fnp-3805	220	32	and	and	CCONJ
fnp-3805	220	33	severe	severe	ADJ
fnp-3805	220	34	imnm	imnm	NOUN
fnp-3805	220	35	(	(	PUNCT
fnp-3805	220	36	fig	fig	NOUN
fnp-3805	220	37	.	.	PUNCT
fnp-3805	220	38	5	5	NUM
fnp-3805	220	39	)	)	PUNCT
fnp-3805	220	40	.	.	PUNCT
fnp-3805	221	1	interestingly	interestingly	ADV
fnp-3805	221	2	,	,	PUNCT
fnp-3805	221	3	in	in	ADP
fnp-3805	221	4	the	the	DET
fnp-3805	221	5	group	group	NOUN
fnp-3805	221	6	of	of	ADP
fnp-3805	221	7	119	119	NUM
fnp-3805	221	8	iim	iim	NOUN
fnp-3805	221	9	cases	case	NOUN
fnp-3805	221	10	studied	study	VERB
fnp-3805	221	11	by	by	ADP
fnp-3805	221	12	amici	amici	PROPN
fnp-3805	221	13	at	at	ADP
fnp-3805	221	14	al	al	PROPN
fnp-3805	221	15	.	.	PROPN
fnp-3805	221	16	,	,	PUNCT
fnp-3805	221	17	disease	disease	NOUN
fnp-3805	221	18	severity	severity	NOUN
fnp-3805	221	19	did	do	AUX
fnp-3805	221	20	not	not	PART
fnp-3805	221	21	correlate	correlate	VERB
fnp-3805	221	22	with	with	ADP
fnp-3805	221	23	a	a	DET
fnp-3805	221	24	specific	specific	ADJ
fnp-3805	221	25	msa	msa	NOUN
fnp-3805	221	26	subtype	subtype	NOUN
fnp-3805	221	27	;	;	PUNCT
fnp-3805	221	28	instead	instead	ADV
fnp-3805	221	29	,	,	PUNCT
fnp-3805	221	30	both	both	CCONJ
fnp-3805	221	31	mild	mild	ADJ
fnp-3805	221	32	and	and	CCONJ
fnp-3805	221	33	severe	severe	ADJ
fnp-3805	221	34	cases	case	NOUN
fnp-3805	221	35	were	be	AUX
fnp-3805	221	36	seen	see	VERB
fnp-3805	221	37	in	in	ADP
fnp-3805	221	38	each	each	DET
fnp-3805	221	39	msa	msa	PROPN
fnp-3805	221	40	-	-	PUNCT
fnp-3805	221	41	defined	define	VERB
fnp-3805	221	42	subgroup	subgroup	NOUN
fnp-3805	221	43	.	.	PUNCT
fnp-3805	222	1	if	if	SCONJ
fnp-3805	222	2	validated	validate	VERB
fnp-3805	222	3	by	by	ADP
fnp-3805	222	4	future	future	ADJ
fnp-3805	222	5	studies	study	NOUN
fnp-3805	222	6	and	and	CCONJ
fnp-3805	222	7	found	find	VERB
fnp-3805	222	8	to	to	PART
fnp-3805	222	9	correlate	correlate	VERB
fnp-3805	222	10	with	with	ADP
fnp-3805	222	11	the	the	DET
fnp-3805	222	12	response	response	NOUN
fnp-3805	222	13	to	to	ADP
fnp-3805	222	14	therapy	therapy	NOUN
fnp-3805	222	15	and/or	and/or	CCONJ
fnp-3805	222	16	patient	patient	ADJ
fnp-3805	222	17	outcomes	outcome	NOUN
fnp-3805	222	18	,	,	PUNCT
fnp-3805	222	19	this	this	DET
fnp-3805	222	20	finding	finding	NOUN
fnp-3805	222	21	suggests	suggest	VERB
fnp-3805	222	22	that	that	SCONJ
fnp-3805	222	23	transcriptomic	transcriptomic	ADJ
fnp-3805	222	24	analysis	analysis	NOUN
fnp-3805	222	25	might	might	AUX
fnp-3805	222	26	be	be	AUX
fnp-3805	222	27	able	able	ADJ
fnp-3805	222	28	to	to	PART
fnp-3805	222	29	extract	extract	VERB
fnp-3805	222	30	clinically	clinically	ADV
fnp-3805	222	31	useful	useful	ADJ
fnp-3805	222	32	information	information	NOUN
fnp-3805	222	33	not	not	PART
fnp-3805	222	34	captured	capture	VERB
fnp-3805	222	35	by	by	ADP
fnp-3805	222	36	serotype	serotype	ADJ
fnp-3805	222	37	/	/	SYM
fnp-3805	222	38	disease	disease	NOUN
fnp-3805	222	39	subtype	subtype	NOUN
fnp-3805	222	40	,	,	PUNCT
fnp-3805	222	41	and	and	CCONJ
fnp-3805	222	42	that	that	SCONJ
fnp-3805	222	43	gene	gene	NOUN
fnp-3805	222	44	expression	expression	NOUN
fnp-3805	222	45	profiling	profiling	NOUN
fnp-3805	222	46	therefore	therefore	ADV
fnp-3805	222	47	may	may	AUX
fnp-3805	222	48	at	at	ADP
fnp-3805	222	49	some	some	DET
fnp-3805	222	50	point	point	NOUN
fnp-3805	222	51	become	become	VERB
fnp-3805	222	52	a	a	DET
fnp-3805	222	53	routine	routine	ADJ
fnp-3805	222	54	component	component	NOUN
fnp-3805	222	55	of	of	ADP
fnp-3805	222	56	diagnostic	diagnostic	ADJ
fnp-3805	222	57	muscle	muscle	NOUN
fnp-3805	222	58	biopsy	biopsy	NOUN
fnp-3805	222	59	work	work	NOUN
fnp-3805	222	60	-	-	PUNCT
fnp-3805	222	61	up	up	NOUN
fnp-3805	222	62	.	.	PUNCT
fnp-3805	223	1	excitingly	excitingly	ADV
fnp-3805	223	2	,	,	PUNCT
fnp-3805	223	3	the	the	DET
fnp-3805	223	4	authors	author	NOUN
fnp-3805	223	5	of	of	ADP
fnp-3805	223	6	this	this	DET
fnp-3805	223	7	study	study	NOUN
fnp-3805	223	8	have	have	AUX
fnp-3805	223	9	shared	share	VERB
fnp-3805	223	10	the	the	DET
fnp-3805	223	11	source	source	NOUN
fnp-3805	223	12	code	code	NOUN
fnp-3805	223	13	and	and	CCONJ
fnp-3805	223	14	model	model	VERB
fnp-3805	223	15	weights	weight	NOUN
fnp-3805	223	16	on	on	ADP
fnp-3805	223	17	their	their	PRON
fnp-3805	223	18	website	website	NOUN
fnp-3805	223	19	(	(	PUNCT
fnp-3805	223	20	https://github.com/mendillolab	https://github.com/mendillolab	PROPN
fnp-3805	223	21	)	)	PUNCT
fnp-3805	223	22	,	,	PUNCT
fnp-3805	223	23	and	and	CCONJ
fnp-3805	223	24	this	this	DET
fnp-3805	223	25	tool	tool	NOUN
fnp-3805	223	26	can	can	AUX
fnp-3805	223	27	be	be	AUX
fnp-3805	223	28	used	use	VERB
fnp-3805	223	29	by	by	ADP
fnp-3805	223	30	other	other	ADJ
fnp-3805	223	31	researchers	researcher	NOUN
fnp-3805	223	32	who	who	PRON
fnp-3805	223	33	perform	perform	VERB
fnp-3805	223	34	muscle	muscle	NOUN
fnp-3805	223	35	transcriptomics	transcriptomic	NOUN
fnp-3805	223	36	to	to	AUX
fnp-3805	223	37	further	further	ADJ
fnp-3805	223	38	test	test	VERB
fnp-3805	223	39	and	and	CCONJ
fnp-3805	223	40	improve	improve	VERB
fnp-3805	223	41	their	their	PRON
fnp-3805	223	42	algorithm	algorithm	NOUN
fnp-3805	223	43	.	.	PUNCT
fnp-3805	224	1	figure	figure	NOUN
fnp-3805	224	2	5	5	NUM
fnp-3805	224	3	.	.	PUNCT
fnp-3805	225	1	histologic	histologic	ADJ
fnp-3805	225	2	overlap	overlap	NOUN
fnp-3805	225	3	between	between	ADP
fnp-3805	225	4	assm	assm	PROPN
fnp-3805	225	5	(	(	PUNCT
fnp-3805	225	6	a	a	DET
fnp-3805	225	7	-	-	PUNCT
fnp-3805	225	8	c	c	NOUN
fnp-3805	225	9	)	)	PUNCT
fnp-3805	225	10	,	,	PUNCT
fnp-3805	225	11	anti	anti	ADJ
fnp-3805	225	12	-	-	ADJ
fnp-3805	225	13	mi-2	mi-2	ADJ
fnp-3805	225	14	dm	dm	NOUN
fnp-3805	225	15	(	(	PUNCT
fnp-3805	225	16	d	d	PROPN
fnp-3805	225	17	-	-	PUNCT
fnp-3805	225	18	f	f	NOUN
fnp-3805	225	19	)	)	PUNCT
fnp-3805	225	20	,	,	PUNCT
fnp-3805	225	21	and	and	CCONJ
fnp-3805	225	22	a	a	DET
fnp-3805	225	23	severe	severe	ADJ
fnp-3805	225	24	case	case	NOUN
fnp-3805	225	25	of	of	ADP
fnp-3805	225	26	anti	anti	ADJ
fnp-3805	225	27	-	-	ADJ
fnp-3805	225	28	hmgcr	hmgcr	ADJ
fnp-3805	225	29	imnm	imnm	NOUN
fnp-3805	225	30	(	(	PUNCT
fnp-3805	225	31	g	g	PROPN
fnp-3805	225	32	-	-	PUNCT
fnp-3805	225	33	i	i	NOUN
fnp-3805	225	34	)	)	PUNCT
fnp-3805	225	35	.	.	PUNCT
fnp-3805	226	1	a	a	DET
fnp-3805	226	2	typical	typical	ADJ
fnp-3805	226	3	assm	assm	NOUN
fnp-3805	226	4	case	case	NOUN
fnp-3805	226	5	shows	show	VERB
fnp-3805	226	6	perifascicular	perifascicular	ADJ
fnp-3805	226	7	fiber	fiber	NOUN
fnp-3805	226	8	atrophy	atrophy	NOUN
fnp-3805	226	9	and	and	CCONJ
fnp-3805	226	10	necrosis	necrosis	NOUN
fnp-3805	226	11	(	(	PUNCT
fnp-3805	226	12	a	a	NOUN
fnp-3805	226	13	)	)	PUNCT
fnp-3805	226	14	along	along	ADP
fnp-3805	226	15	with	with	ADP
fnp-3805	226	16	marked	mark	VERB
fnp-3805	226	17	perimysial	perimysial	ADJ
fnp-3805	226	18	abnormalities	abnormality	NOUN
fnp-3805	226	19	[	[	X
fnp-3805	226	20	edema	edema	NOUN
fnp-3805	226	21	,	,	PUNCT
fnp-3805	226	22	fragmentation	fragmentation	NOUN
fnp-3805	226	23	,	,	PUNCT
fnp-3805	226	24	macrophage	macrophage	ADJ
fnp-3805	226	25	-	-	PUNCT
fnp-3805	226	26	rich	rich	ADJ
fnp-3805	226	27	inflammation	inflammation	NOUN
fnp-3805	226	28	(	(	PUNCT
fnp-3805	226	29	best	good	ADJ
fnp-3805	226	30	visualized	visualize	VERB
fnp-3805	226	31	on	on	ADP
fnp-3805	226	32	acid	acid	ADJ
fnp-3805	226	33	phosphatase	phosphatase	NOUN
fnp-3805	226	34	stain	stain	NOUN
fnp-3805	226	35	;	;	PUNCT
fnp-3805	226	36	b	b	X
fnp-3805	226	37	)	)	PUNCT
fnp-3805	226	38	and	and	CCONJ
fnp-3805	226	39	a	a	DET
fnp-3805	226	40	linear	linear	ADJ
fnp-3805	226	41	pattern	pattern	NOUN
fnp-3805	226	42	of	of	ADP
fnp-3805	226	43	alkaline	alkaline	ADJ
fnp-3805	226	44	phosphatase	phosphatase	NOUN
fnp-3805	226	45	positivity	positivity	NOUN
fnp-3805	226	46	(	(	PUNCT
fnp-3805	226	47	c	c	NOUN
fnp-3805	226	48	)	)	PUNCT
fnp-3805	226	49	]	]	PUNCT
fnp-3805	226	50	.	.	PUNCT
fnp-3805	227	1	anti	anti	ADJ
fnp-3805	227	2	-	-	ADJ
fnp-3805	227	3	mi-2	mi-2	ADV
fnp-3805	227	4	-	-	PUNCT
fnp-3805	227	5	associated	associate	VERB
fnp-3805	227	6	dm	dm	NOUN
fnp-3805	227	7	often	often	ADV
fnp-3805	227	8	leads	lead	VERB
fnp-3805	227	9	to	to	ADP
fnp-3805	227	10	a	a	DET
fnp-3805	227	11	more	more	ADV
fnp-3805	227	12	severe	severe	ADJ
fnp-3805	227	13	muscle	muscle	NOUN
fnp-3805	227	14	involvement	involvement	NOUN
fnp-3805	227	15	than	than	ADP
fnp-3805	227	16	other	other	ADJ
fnp-3805	227	17	dm	dm	PROPN
fnp-3805	227	18	subtypes	subtype	NOUN
fnp-3805	227	19	and	and	CCONJ
fnp-3805	227	20	can	can	AUX
fnp-3805	227	21	histologically	histologically	ADV
fnp-3805	227	22	mimic	mimic	VERB
fnp-3805	227	23	assm	assm	NOUN
fnp-3805	227	24	;	;	PUNCT
fnp-3805	227	25	in	in	ADP
fnp-3805	227	26	this	this	DET
fnp-3805	227	27	example	example	NOUN
fnp-3805	227	28	(	(	PUNCT
fnp-3805	227	29	d	d	X
fnp-3805	227	30	-	-	PUNCT
fnp-3805	227	31	f	f	NOUN
fnp-3805	227	32	)	)	PUNCT
fnp-3805	227	33	,	,	PUNCT
fnp-3805	227	34	there	there	PRON
fnp-3805	227	35	was	be	VERB
fnp-3805	227	36	a	a	DET
fnp-3805	227	37	prominent	prominent	ADJ
fnp-3805	227	38	perimysial	perimysial	ADJ
fnp-3805	227	39	involvement	involvement	NOUN
fnp-3805	227	40	including	include	VERB
fnp-3805	227	41	macrophage	macrophage	ADJ
fnp-3805	227	42	-	-	PUNCT
fnp-3805	227	43	rich	rich	ADJ
fnp-3805	227	44	inflammation	inflammation	NOUN
fnp-3805	227	45	(	(	PUNCT
fnp-3805	227	46	e	e	NOUN
fnp-3805	227	47	)	)	PUNCT
fnp-3805	227	48	and	and	CCONJ
fnp-3805	227	49	strong	strong	ADJ
fnp-3805	227	50	alkaline	alkaline	NOUN
fnp-3805	227	51	phosphatase	phosphatase	NOUN
fnp-3805	227	52	staining	stain	VERB
fnp-3805	227	53	(	(	PUNCT
fnp-3805	227	54	f	f	NOUN
fnp-3805	227	55	)	)	PUNCT
fnp-3805	227	56	.	.	PUNCT
fnp-3805	228	1	markers	marker	NOUN
fnp-3805	228	2	of	of	ADP
fnp-3805	228	3	type	type	NOUN
fnp-3805	228	4	1	1	NUM
fnp-3805	228	5	interferon	interferon	ADJ
fnp-3805	228	6	response	response	NOUN
fnp-3805	228	7	(	(	PUNCT
fnp-3805	228	8	such	such	ADJ
fnp-3805	228	9	as	as	ADP
fnp-3805	228	10	mxa	mxa	NOUN
fnp-3805	228	11	)	)	PUNCT
fnp-3805	228	12	can	can	AUX
fnp-3805	228	13	help	help	VERB
fnp-3805	228	14	differentiate	differentiate	VERB
fnp-3805	228	15	dm	dm	PROPN
fnp-3805	228	16	from	from	ADP
fnp-3805	228	17	assm	assm	PROPN
fnp-3805	228	18	,	,	PUNCT
fnp-3805	228	19	but	but	CCONJ
fnp-3805	228	20	in	in	ADP
fnp-3805	228	21	the	the	DET
fnp-3805	228	22	ucsf	ucsf	PROPN
fnp-3805	228	23	experience	experience	PROPN
fnp-3805	228	24	mxa	mxa	PROPN
fnp-3805	228	25	upregulation	upregulation	NOUN
fnp-3805	228	26	is	be	AUX
fnp-3805	228	27	often	often	ADV
fnp-3805	228	28	weak	weak	ADJ
fnp-3805	228	29	in	in	ADP
fnp-3805	228	30	anti	anti	ADJ
fnp-3805	228	31	-	-	ADJ
fnp-3805	228	32	mi-2	mi-2	ADJ
fnp-3805	228	33	dm	dm	NOUN
fnp-3805	228	34	cases	case	NOUN
fnp-3805	228	35	.	.	PUNCT
fnp-3805	229	1	typical	typical	ADJ
fnp-3805	229	2	imnm	imnm	PROPN
fnp-3805	229	3	cases	case	NOUN
fnp-3805	229	4	show	show	VERB
fnp-3805	229	5	little	little	ADJ
fnp-3805	229	6	to	to	ADP
fnp-3805	229	7	no	no	DET
fnp-3805	229	8	inflammation	inflammation	NOUN
fnp-3805	229	9	and	and	CCONJ
fnp-3805	229	10	are	be	AUX
fnp-3805	229	11	generally	generally	ADV
fnp-3805	229	12	easily	easily	ADV
fnp-3805	229	13	distinguished	distinguish	VERB
fnp-3805	229	14	from	from	ADP
fnp-3805	229	15	other	other	ADJ
fnp-3805	229	16	autoimmune	autoimmune	ADJ
fnp-3805	229	17	myopathies	myopathy	NOUN
fnp-3805	229	18	;	;	PUNCT
fnp-3805	229	19	however	however	ADV
fnp-3805	229	20	,	,	PUNCT
fnp-3805	229	21	severe	severe	ADJ
fnp-3805	229	22	cases	case	NOUN
fnp-3805	229	23	(	(	PUNCT
fnp-3805	229	24	such	such	ADJ
fnp-3805	229	25	as	as	ADP
fnp-3805	229	26	the	the	DET
fnp-3805	229	27	one	one	NOUN
fnp-3805	229	28	shown	show	VERB
fnp-3805	229	29	in	in	ADP
fnp-3805	229	30	g	g	PROPN
fnp-3805	229	31	-	-	PUNCT
fnp-3805	229	32	i	i	PROPN
fnp-3805	229	33	)	)	PUNCT
fnp-3805	229	34	can	can	AUX
fnp-3805	229	35	be	be	AUX
fnp-3805	229	36	diagnostically	diagnostically	ADV
fnp-3805	229	37	challenging	challenging	ADJ
fnp-3805	229	38	.	.	PUNCT
fnp-3805	230	1	this	this	DET
fnp-3805	230	2	anti	anti	ADJ
fnp-3805	230	3	-	-	ADJ
fnp-3805	230	4	hmgcr	hmgcr	ADJ
fnp-3805	230	5	imnm	imnm	NOUN
fnp-3805	230	6	case	case	NOUN
fnp-3805	230	7	showed	show	VERB
fnp-3805	230	8	abundant	abundant	ADJ
fnp-3805	230	9	macrophage	macrophage	ADJ
fnp-3805	230	10	-	-	PUNCT
fnp-3805	230	11	rich	rich	ADJ
fnp-3805	230	12	inflammatory	inflammatory	ADJ
fnp-3805	230	13	infiltrate	infiltrate	VERB
fnp-3805	230	14	in	in	ADP
fnp-3805	230	15	the	the	DET
fnp-3805	230	16	perimysium	perimysium	NOUN
fnp-3805	230	17	(	(	PUNCT
fnp-3805	230	18	h	h	NOUN
fnp-3805	230	19	)	)	PUNCT
fnp-3805	230	20	along	along	ADP
fnp-3805	230	21	with	with	ADP
fnp-3805	230	22	well	well	ADV
fnp-3805	230	23	-	-	PUNCT
fnp-3805	230	24	developed	develop	VERB
fnp-3805	230	25	perimysial	perimysial	ADJ
fnp-3805	230	26	alkaline	alkaline	NOUN
fnp-3805	230	27	phosphatase	phosphatase	NOUN
fnp-3805	230	28	positivity	positivity	NOUN
fnp-3805	230	29	(	(	PUNCT
fnp-3805	230	30	i	i	NOUN
fnp-3805	230	31	)	)	PUNCT
fnp-3805	230	32	;	;	PUNCT
fnp-3805	230	33	the	the	DET
fnp-3805	230	34	only	only	ADJ
fnp-3805	230	35	clue	clue	NOUN
fnp-3805	230	36	to	to	ADP
fnp-3805	230	37	the	the	DET
fnp-3805	230	38	correct	correct	ADJ
fnp-3805	230	39	diagnosis	diagnosis	NOUN
fnp-3805	230	40	was	be	AUX
fnp-3805	230	41	dense	dense	ADJ
fnp-3805	230	42	punctate	punctate	NOUN
fnp-3805	230	43	p62	p62	NOUN
fnp-3805	230	44	staining	stain	VERB
fnp-3805	230	45	of	of	ADP
fnp-3805	230	46	muscle	muscle	NOUN
fnp-3805	230	47	fibers	fiber	NOUN
fnp-3805	230	48	(	(	PUNCT
fnp-3805	230	49	inset	inset	NOUN
fnp-3805	230	50	in	in	ADP
fnp-3805	230	51	g	g	NOUN
fnp-3805	230	52	)	)	PUNCT
fnp-3805	230	53	,	,	PUNCT
fnp-3805	230	54	which	which	PRON
fnp-3805	230	55	is	be	AUX
fnp-3805	230	56	not	not	PART
fnp-3805	230	57	typically	typically	ADV
fnp-3805	230	58	seen	see	VERB
fnp-3805	230	59	in	in	ADP
fnp-3805	230	60	either	either	PRON
fnp-3805	230	61	dm	dm	PROPN
fnp-3805	230	62	or	or	CCONJ
fnp-3805	230	63	assm	assm	PROPN
fnp-3805	230	64	.	.	PUNCT
fnp-3805	230	65	representative	representative	ADJ
fnp-3805	230	66	cryosection	cryosection	NOUN
fnp-3805	230	67	images	image	NOUN
fnp-3805	230	68	are	be	AUX
fnp-3805	230	69	shown	show	VERB
fnp-3805	230	70	for	for	ADP
fnp-3805	230	71	all	all	DET
fnp-3805	230	72	three	three	NUM
fnp-3805	230	73	cases	case	NOUN
fnp-3805	230	74	;	;	PUNCT
fnp-3805	231	1	scale	scale	NOUN
fnp-3805	231	2	bars	bar	NOUN
fnp-3805	231	3	,	,	PUNCT
fnp-3805	231	4	100	100	NUM
fnp-3805	231	5	μm	μm	NOUN
fnp-3805	231	6	.	.	PUNCT
fnp-3805	232	1	advances	advance	NOUN
fnp-3805	232	2	in	in	ADP
fnp-3805	232	3	neuromuscular	neuromuscular	ADJ
fnp-3805	232	4	disease	disease	NOUN
fnp-3805	232	5	treatment	treatment	NOUN
fnp-3805	232	6	10	10	NUM
fnp-3805	232	7	.	.	PUNCT
fnp-3805	233	1	clinical	clinical	ADJ
fnp-3805	233	2	trials	trial	NOUN
fnp-3805	233	3	:	:	PUNCT
fnp-3805	233	4	late	late	ADJ
fnp-3805	233	5	-	-	PUNCT
fnp-3805	233	6	onset	onset	NOUN
fnp-3805	233	7	pompe	pompe	NOUN
fnp-3805	233	8	disease	disease	NOUN
fnp-3805	233	9	revisited	revisit	VERB
fnp-3805	233	10	pompe	pompe	PROPN
fnp-3805	233	11	disease	disease	NOUN
fnp-3805	233	12	is	be	AUX
fnp-3805	233	13	an	an	DET
fnp-3805	233	14	autosomal	autosomal	ADJ
fnp-3805	233	15	recessive	recessive	ADJ
fnp-3805	233	16	metabolic	metabolic	NOUN
fnp-3805	233	17	disorder	disorder	NOUN
fnp-3805	233	18	caused	cause	VERB
fnp-3805	233	19	by	by	ADP
fnp-3805	233	20	loss	loss	NOUN
fnp-3805	233	21	-	-	PUNCT
fnp-3805	233	22	of	of	ADP
fnp-3805	233	23	-	-	PUNCT
fnp-3805	233	24	function	function	NOUN
fnp-3805	233	25	mutations	mutation	NOUN
fnp-3805	233	26	in	in	ADP
fnp-3805	233	27	gaa	gaa	PROPN
fnp-3805	233	28	,	,	PUNCT
fnp-3805	233	29	the	the	DET
fnp-3805	233	30	lysosomal	lysosomal	ADJ
fnp-3805	233	31	glycogen	glycogen	NOUN
fnp-3805	233	32	-	-	PUNCT
fnp-3805	233	33	catabolizing	catabolizing	NOUN
fnp-3805	233	34	enzyme	enzyme	NOUN
fnp-3805	233	35	;	;	PUNCT
fnp-3805	233	36	depending	depend	VERB
fnp-3805	233	37	on	on	ADP
fnp-3805	233	38	the	the	DET
fnp-3805	233	39	level	level	NOUN
fnp-3805	233	40	of	of	ADP
fnp-3805	233	41	residual	residual	ADJ
fnp-3805	233	42	gaa	gaa	NOUN
fnp-3805	233	43	activity	activity	NOUN
fnp-3805	233	44	,	,	PUNCT
fnp-3805	233	45	the	the	DET
fnp-3805	233	46	disease	disease	NOUN
fnp-3805	233	47	can	can	AUX
fnp-3805	233	48	present	present	VERB
fnp-3805	233	49	in	in	ADP
fnp-3805	233	50	infancy	infancy	NOUN
fnp-3805	233	51	,	,	PUNCT
fnp-3805	233	52	childhood	childhood	NOUN
fnp-3805	233	53	,	,	PUNCT
fnp-3805	233	54	or	or	CCONJ
fnp-3805	233	55	adulthood	adulthood	NOUN
fnp-3805	233	56	.	.	PUNCT
fnp-3805	234	1	while	while	SCONJ
fnp-3805	234	2	early	early	ADJ
fnp-3805	234	3	onset	onset	VERB
fnp-3805	234	4	pompe	pompe	PROPN
fnp-3805	234	5	disease	disease	NOUN
fnp-3805	234	6	is	be	AUX
fnp-3805	234	7	a	a	DET
fnp-3805	234	8	systemic	systemic	ADJ
fnp-3805	234	9	disorder	disorder	NOUN
fnp-3805	234	10	that	that	PRON
fnp-3805	234	11	affects	affect	VERB
fnp-3805	234	12	multiple	multiple	ADJ
fnp-3805	234	13	organs	organ	NOUN
fnp-3805	234	14	systems	system	NOUN
fnp-3805	234	15	,	,	PUNCT
fnp-3805	234	16	lopd	lopd	NOUN
fnp-3805	234	17	primarily	primarily	ADV
fnp-3805	234	18	affects	affect	VERB
fnp-3805	234	19	skeletal	skeletal	ADJ
fnp-3805	234	20	musculature	musculature	NOUN
fnp-3805	234	21	and	and	CCONJ
fnp-3805	234	22	is	be	AUX
fnp-3805	234	23	characterized	characterize	VERB
fnp-3805	234	24	by	by	ADP
fnp-3805	234	25	progressive	progressive	ADJ
fnp-3805	234	26	weakness	weakness	NOUN
fnp-3805	234	27	of	of	ADP
fnp-3805	234	28	the	the	DET
fnp-3805	234	29	axial	axial	ADJ
fnp-3805	234	30	,	,	PUNCT
fnp-3805	234	31	limb	limb	NOUN
fnp-3805	234	32	-	-	PUNCT
fnp-3805	234	33	girdle	girdle	NOUN
fnp-3805	234	34	,	,	PUNCT
fnp-3805	234	35	and	and	CCONJ
fnp-3805	234	36	respiratory	respiratory	ADJ
fnp-3805	234	37	muscles	muscle	NOUN
fnp-3805	234	38	;	;	PUNCT
fnp-3805	234	39	pathologically	pathologically	ADV
fnp-3805	234	40	,	,	PUNCT
fnp-3805	234	41	vacuolated	vacuolate	VERB
fnp-3805	234	42	muscle	muscle	NOUN
fnp-3805	234	43	fibers	fiber	NOUN
fnp-3805	234	44	show	show	VERB
fnp-3805	234	45	an	an	DET
fnp-3805	234	46	accumulation	accumulation	NOUN
fnp-3805	234	47	of	of	ADP
fnp-3805	234	48	membrane	membrane	NOUN
fnp-3805	234	49	-	-	PUNCT
fnp-3805	234	50	bound	bind	VERB
fnp-3805	234	51	as	as	ADV
fnp-3805	234	52	well	well	ADV
fnp-3805	234	53	as	as	ADP
fnp-3805	234	54	free	free	ADJ
fnp-3805	234	55	glycogen	glycogen	NOUN
fnp-3805	234	56	and	and	CCONJ
fnp-3805	234	57	a	a	DET
fnp-3805	234	58	build	build	NOUN
fnp-3805	234	59	-	-	PUNCT
fnp-3805	234	60	up	up	NOUN
fnp-3805	234	61	of	of	ADP
fnp-3805	234	62	autophagic	autophagic	ADJ
fnp-3805	234	63	debris	debris	NOUN
fnp-3805	234	64	(	(	PUNCT
fnp-3805	234	65	fig	fig	NOUN
fnp-3805	234	66	.	.	PUNCT
fnp-3805	235	1	6	6	NUM
fnp-3805	235	2	)	)	PUNCT
fnp-3805	235	3	,	,	PUNCT
fnp-3805	235	4	so	so	CCONJ
fnp-3805	235	5	this	this	DET
fnp-3805	235	6	disease	disease	NOUN
fnp-3805	235	7	is	be	AUX
fnp-3805	235	8	currently	currently	ADV
fnp-3805	235	9	classified	classify	VERB
fnp-3805	235	10	as	as	ADP
fnp-3805	235	11	an	an	DET
fnp-3805	235	12	avm	avm	PROPN
fnp-3805	235	13	(	(	PUNCT
fnp-3805	235	14	fig	fig	NOUN
fnp-3805	235	15	.	.	PUNCT
fnp-3805	236	1	6	6	NUM
fnp-3805	236	2	)	)	PUNCT
fnp-3805	236	3	.	.	PUNCT
fnp-3805	237	1	ert	ert	VERB
fnp-3805	237	2	with	with	ADP
fnp-3805	237	3	alglucosidase	alglucosidase	NOUN
fnp-3805	237	4	alfa	alfa	NOUN
fnp-3805	237	5	,	,	PUNCT
fnp-3805	237	6	recombinant	recombinant	ADJ
fnp-3805	237	7	form	form	NOUN
fnp-3805	237	8	of	of	ADP
fnp-3805	237	9	human	human	PROPN
fnp-3805	237	10	gaa	gaa	PROPN
fnp-3805	237	11	,	,	PUNCT
fnp-3805	237	12	was	be	AUX
fnp-3805	237	13	approved	approve	VERB
fnp-3805	237	14	in	in	ADP
fnp-3805	237	15	2006	2006	NUM
fnp-3805	237	16	,	,	PUNCT
fnp-3805	237	17	constituting	constitute	VERB
fnp-3805	237	18	a	a	DET
fnp-3805	237	19	breakthrough	breakthrough	NOUN
fnp-3805	237	20	in	in	ADP
fnp-3805	237	21	pompe	pompe	PROPN
fnp-3805	237	22	disease	disease	NOUN
fnp-3805	237	23	management	management	NOUN
fnp-3805	237	24	;	;	PUNCT
fnp-3805	237	25	however	however	ADV
fnp-3805	237	26	,	,	PUNCT
fnp-3805	237	27	most	most	ADJ
fnp-3805	237	28	lopd	lopd	NOUN
fnp-3805	237	29	patients	patient	NOUN
fnp-3805	237	30	on	on	ADP
fnp-3805	237	31	this	this	DET
fnp-3805	237	32	therapy	therapy	NOUN
fnp-3805	237	33	experience	experience	VERB
fnp-3805	237	34	a	a	DET
fnp-3805	237	35	short	short	ADJ
fnp-3805	237	36	-	-	PUNCT
fnp-3805	237	37	term	term	NOUN
fnp-3805	237	38	improvement	improvement	NOUN
fnp-3805	237	39	followed	follow	VERB
fnp-3805	237	40	by	by	ADP
fnp-3805	237	41	progressive	progressive	ADJ
fnp-3805	237	42	decline	decline	NOUN
fnp-3805	237	43	.	.	PUNCT
fnp-3805	238	1	the	the	DET
fnp-3805	238	2	failure	failure	NOUN
fnp-3805	238	3	of	of	ADP
fnp-3805	238	4	ert	ert	NOUN
fnp-3805	238	5	in	in	ADP
fnp-3805	238	6	lopd	lopd	NOUN
fnp-3805	238	7	is	be	AUX
fnp-3805	238	8	thought	think	VERB
fnp-3805	238	9	to	to	PART
fnp-3805	238	10	primarily	primarily	ADV
fnp-3805	238	11	reflect	reflect	VERB
fnp-3805	238	12	inefficient	inefficient	ADJ
fnp-3805	238	13	delivery	delivery	NOUN
fnp-3805	238	14	of	of	ADP
fnp-3805	238	15	alglucosidase	alglucosidase	NOUN
fnp-3805	238	16	alfa	alfa	NOUN
fnp-3805	238	17	to	to	ADP
fnp-3805	238	18	skeletal	skeletal	ADJ
fnp-3805	238	19	muscle	muscle	NOUN
fnp-3805	238	20	lysosomes	lysosome	NOUN
fnp-3805	238	21	:	:	PUNCT
fnp-3805	238	22	efficient	efficient	ADJ
fnp-3805	238	23	lysosomal	lysosomal	NOUN
fnp-3805	238	24	targeting	targeting	NOUN
fnp-3805	238	25	is	be	AUX
fnp-3805	238	26	based	base	VERB
fnp-3805	238	27	on	on	ADP
fnp-3805	238	28	binding	bind	VERB
fnp-3805	238	29	of	of	ADP
fnp-3805	238	30	mannose	mannose	NOUN
fnp-3805	238	31	6	6	NUM
fnp-3805	238	32	-	-	PUNCT
fnp-3805	238	33	phosphate	phosphate	NOUN
fnp-3805	238	34	(	(	PUNCT
fnp-3805	238	35	m6p)-glycans	m6p)-glycan	NOUN
fnp-3805	238	36	and	and	CCONJ
fnp-3805	238	37	bis	bi	NOUN
fnp-3805	238	38	-	-	PUNCT
fnp-3805	238	39	m6p	m6p	NOUN
fnp-3805	238	40	-	-	PUNCT
fnp-3805	238	41	glycans	glycan	NOUN
fnp-3805	238	42	within	within	ADP
fnp-3805	238	43	the	the	DET
fnp-3805	238	44	recombinant	recombinant	ADJ
fnp-3805	238	45	protein	protein	NOUN
fnp-3805	238	46	to	to	ADP
fnp-3805	238	47	the	the	DET
fnp-3805	238	48	cation	cation	NOUN
fnp-3805	238	49	-	-	PUNCT
fnp-3805	238	50	independent	independent	ADJ
fnp-3805	238	51	m6p	m6p	NOUN
fnp-3805	238	52	receptor	receptor	NOUN
fnp-3805	238	53	in	in	ADP
fnp-3805	238	54	the	the	DET
fnp-3805	238	55	target	target	NOUN
fnp-3805	238	56	tissue	tissue	NOUN
fnp-3805	238	57	,	,	PUNCT
fnp-3805	238	58	and	and	CCONJ
fnp-3805	238	59	only	only	ADV
fnp-3805	238	60	a	a	DET
fnp-3805	238	61	minor	minor	ADJ
fnp-3805	238	62	fraction	fraction	NOUN
fnp-3805	238	63	of	of	ADP
fnp-3805	238	64	originally	originally	ADV
fnp-3805	238	65	developed	develop	VERB
fnp-3805	238	66	recombinant	recombinant	ADJ
fnp-3805	238	67	gaa	gaa	PROPN
fnp-3805	238	68	contains	contain	VERB
fnp-3805	238	69	bis	bis	ADJ
fnp-3805	238	70	-	-	NOUN
fnp-3805	238	71	m6p	m6p	NOUN
fnp-3805	238	72	ligands	ligand	NOUN
fnp-3805	238	73	.	.	PUNCT
fnp-3805	239	1	figure	figure	NOUN
fnp-3805	239	2	6	6	NUM
fnp-3805	239	3	.	.	PUNCT
fnp-3805	239	4	muscle	muscle	NOUN
fnp-3805	239	5	biopsy	biopsy	NOUN
fnp-3805	239	6	findings	finding	NOUN
fnp-3805	239	7	in	in	ADP
fnp-3805	239	8	lopd	lopd	NOUN
fnp-3805	239	9	.	.	PUNCT
fnp-3805	240	1	a	a	DET
fnp-3805	240	2	representative	representative	ADJ
fnp-3805	240	3	h&e	h&e	NOUN
fnp-3805	240	4	-	-	PUNCT
fnp-3805	240	5	stained	stain	VERB
fnp-3805	240	6	cryosection	cryosection	NOUN
fnp-3805	240	7	(	(	PUNCT
fnp-3805	240	8	a	a	X
fnp-3805	240	9	)	)	PUNCT
fnp-3805	240	10	shows	show	VERB
fnp-3805	240	11	largely	largely	ADV
fnp-3805	240	12	unremarkable	unremarkable	ADJ
fnp-3805	240	13	skeletal	skeletal	ADJ
fnp-3805	240	14	muscle	muscle	NOUN
fnp-3805	240	15	with	with	ADP
fnp-3805	240	16	a	a	DET
fnp-3805	240	17	single	single	ADJ
fnp-3805	240	18	highly	highly	ADV
fnp-3805	240	19	vacuolated	vacuolate	VERB
fnp-3805	240	20	muscle	muscle	NOUN
fnp-3805	240	21	fiber	fiber	NOUN
fnp-3805	240	22	in	in	ADP
fnp-3805	240	23	this	this	DET
fnp-3805	240	24	microscopic	microscopic	ADJ
fnp-3805	240	25	field	field	NOUN
fnp-3805	240	26	(	(	PUNCT
fnp-3805	240	27	black	black	ADJ
fnp-3805	240	28	arrowhead	arrowhead	NOUN
fnp-3805	240	29	)	)	PUNCT
fnp-3805	240	30	.	.	PUNCT
fnp-3805	241	1	the	the	DET
fnp-3805	241	2	same	same	ADJ
fnp-3805	241	3	microscopic	microscopic	ADJ
fnp-3805	241	4	field	field	NOUN
fnp-3805	241	5	from	from	ADP
fnp-3805	241	6	a	a	DET
fnp-3805	241	7	pas	pas	NOUN
fnp-3805	241	8	(	(	PUNCT
fnp-3805	241	9	periodic	periodic	ADJ
fnp-3805	241	10	acid	acid	NOUN
fnp-3805	241	11	-	-	PUNCT
fnp-3805	241	12	schiff)-stained	schiff)-staine	VERB
fnp-3805	241	13	cryosection	cryosection	NOUN
fnp-3805	241	14	(	(	PUNCT
fnp-3805	241	15	b	b	NOUN
fnp-3805	241	16	)	)	PUNCT
fnp-3805	241	17	shows	show	VERB
fnp-3805	241	18	two	two	NUM
fnp-3805	241	19	vacuolated	vacuolate	VERB
fnp-3805	241	20	muscle	muscle	NOUN
fnp-3805	241	21	fibers	fiber	NOUN
fnp-3805	241	22	with	with	ADP
fnp-3805	241	23	mild	mild	ADJ
fnp-3805	241	24	glycogen	glycogen	NOUN
fnp-3805	241	25	accumulation	accumulation	NOUN
fnp-3805	241	26	(	(	PUNCT
fnp-3805	241	27	black	black	ADJ
fnp-3805	241	28	arrowheads	arrowhead	NOUN
fnp-3805	241	29	)	)	PUNCT
fnp-3805	241	30	;	;	PUNCT
fnp-3805	241	31	the	the	DET
fnp-3805	241	32	less	less	ADV
fnp-3805	241	33	vacuolated	vacuolated	ADJ
fnp-3805	241	34	fiber	fiber	NOUN
fnp-3805	241	35	at	at	ADP
fnp-3805	241	36	the	the	DET
fnp-3805	241	37	bottom	bottom	NOUN
fnp-3805	241	38	of	of	ADP
fnp-3805	241	39	the	the	DET
fnp-3805	241	40	image	image	NOUN
fnp-3805	241	41	shows	show	VERB
fnp-3805	241	42	no	no	DET
fnp-3805	241	43	obvious	obvious	ADJ
fnp-3805	241	44	changes	change	NOUN
fnp-3805	241	45	on	on	ADP
fnp-3805	241	46	the	the	DET
fnp-3805	241	47	corresponding	corresponding	ADJ
fnp-3805	241	48	h&e	h&e	PROPN
fnp-3805	241	49	-	-	PUNCT
fnp-3805	241	50	stained	stain	VERB
fnp-3805	241	51	section	section	NOUN
fnp-3805	241	52	(	(	PUNCT
fnp-3805	241	53	a	a	NOUN
fnp-3805	241	54	)	)	PUNCT
fnp-3805	241	55	.	.	PUNCT
fnp-3805	242	1	electron	electron	PROPN
fnp-3805	242	2	microscopy	microscopy	PROPN
fnp-3805	242	3	shows	show	VERB
fnp-3805	242	4	an	an	DET
fnp-3805	242	5	increase	increase	NOUN
fnp-3805	242	6	in	in	ADP
fnp-3805	242	7	the	the	DET
fnp-3805	242	8	lysosomal	lysosomal	NOUN
fnp-3805	242	9	(	(	PUNCT
fnp-3805	242	10	membrane	membrane	NOUN
fnp-3805	242	11	-	-	PUNCT
fnp-3805	242	12	bound	bind	VERB
fnp-3805	242	13	)	)	PUNCT
fnp-3805	242	14	glycogen	glycogen	NOUN
fnp-3805	242	15	(	(	PUNCT
fnp-3805	242	16	white	white	ADJ
fnp-3805	242	17	arrowheads	arrowhead	NOUN
fnp-3805	242	18	in	in	ADP
fnp-3805	242	19	c	c	NOUN
fnp-3805	242	20	)	)	PUNCT
fnp-3805	242	21	as	as	ADV
fnp-3805	242	22	well	well	ADV
fnp-3805	242	23	as	as	ADP
fnp-3805	242	24	accumulation	accumulation	NOUN
fnp-3805	242	25	of	of	ADP
fnp-3805	242	26	free	free	ADJ
fnp-3805	242	27	sarcoplasmic	sarcoplasmic	NOUN
fnp-3805	242	28	glycogen	glycogen	NOUN
fnp-3805	242	29	accompanied	accompany	VERB
fnp-3805	242	30	by	by	ADP
fnp-3805	242	31	electron	electron	NOUN
fnp-3805	242	32	dense	dense	ADJ
fnp-3805	242	33	autophagic	autophagic	ADJ
fnp-3805	242	34	debris	debris	NOUN
fnp-3805	242	35	(	(	PUNCT
fnp-3805	242	36	d	d	NOUN
fnp-3805	242	37	)	)	PUNCT
fnp-3805	242	38	.	.	PUNCT
fnp-3805	243	1	the	the	DET
fnp-3805	243	2	focal	focal	ADJ
fnp-3805	243	3	nature	nature	NOUN
fnp-3805	243	4	of	of	ADP
fnp-3805	243	5	these	these	DET
fnp-3805	243	6	pathologic	pathologic	ADJ
fnp-3805	243	7	findings	finding	NOUN
fnp-3805	243	8	is	be	AUX
fnp-3805	243	9	typical	typical	ADJ
fnp-3805	243	10	for	for	ADP
fnp-3805	243	11	lopd	lopd	NOUN
fnp-3805	243	12	,	,	PUNCT
fnp-3805	243	13	although	although	SCONJ
fnp-3805	243	14	the	the	DET
fnp-3805	243	15	degree	degree	NOUN
fnp-3805	243	16	of	of	ADP
fnp-3805	243	17	muscle	muscle	NOUN
fnp-3805	243	18	fiber	fiber	NOUN
fnp-3805	243	19	involvement	involvement	NOUN
fnp-3805	243	20	varies	vary	VERB
fnp-3805	243	21	from	from	ADP
fnp-3805	243	22	case	case	NOUN
fnp-3805	243	23	to	to	PART
fnp-3805	243	24	case	case	VERB
fnp-3805	243	25	.	.	PUNCT
fnp-3805	244	1	scale	scale	NOUN
fnp-3805	244	2	bars	bar	NOUN
fnp-3805	244	3	:	:	PUNCT
fnp-3805	244	4	a	a	PRON
fnp-3805	244	5	and	and	CCONJ
fnp-3805	244	6	b	b	NOUN
fnp-3805	244	7	,	,	PUNCT
fnp-3805	244	8	60	60	NUM
fnp-3805	244	9	μm	μm	NUM
fnp-3805	244	10	;	;	PUNCT
fnp-3805	244	11	c	c	PROPN
fnp-3805	244	12	and	and	CCONJ
fnp-3805	244	13	d	d	NOUN
fnp-3805	244	14	,	,	PUNCT
fnp-3805	244	15	2	2	NUM
fnp-3805	244	16	μm	μm	NOUN
fnp-3805	244	17	.	.	PUNCT
fnp-3805	245	1	to	to	PART
fnp-3805	245	2	try	try	VERB
fnp-3805	245	3	circumventing	circumvent	VERB
fnp-3805	245	4	this	this	DET
fnp-3805	245	5	problem	problem	NOUN
fnp-3805	245	6	,	,	PUNCT
fnp-3805	245	7	two	two	NUM
fnp-3805	245	8	new	new	ADJ
fnp-3805	245	9	versions	version	NOUN
fnp-3805	245	10	of	of	ADP
fnp-3805	245	11	recombinant	recombinant	ADJ
fnp-3805	245	12	gaa	gaa	PROPN
fnp-3805	245	13	were	be	AUX
fnp-3805	245	14	developed	develop	VERB
fnp-3805	245	15	and	and	CCONJ
fnp-3805	245	16	tested	test	VERB
fnp-3805	245	17	against	against	ADP
fnp-3805	245	18	the	the	DET
fnp-3805	245	19	current	current	ADJ
fnp-3805	245	20	standard	standard	NOUN
fnp-3805	245	21	of	of	ADP
fnp-3805	245	22	care	care	NOUN
fnp-3805	245	23	(	(	PUNCT
fnp-3805	245	24	alglucosidase	alglucosidase	PROPN
fnp-3805	245	25	alfa	alfa	PROPN
fnp-3805	245	26	)	)	PUNCT
fnp-3805	245	27	,	,	PUNCT
fnp-3805	245	28	with	with	ADP
fnp-3805	245	29	the	the	DET
fnp-3805	245	30	results	result	NOUN
fnp-3805	245	31	of	of	ADP
fnp-3805	245	32	both	both	CCONJ
fnp-3805	245	33	clinical	clinical	ADJ
fnp-3805	245	34	trials	trial	NOUN
fnp-3805	245	35	published	publish	VERB
fnp-3805	245	36	last	last	ADJ
fnp-3805	245	37	year	year	NOUN
fnp-3805	245	38	in	in	ADP
fnp-3805	245	39	lancet	lancet	PROPN
fnp-3805	245	40	neurology	neurology	NOUN
fnp-3805	245	41	(	(	PUNCT
fnp-3805	245	42	diaz	diaz	PROPN
fnp-3805	245	43	-	-	PUNCT
fnp-3805	245	44	manera	manera	PROPN
fnp-3805	245	45	et	et	PROPN
fnp-3805	245	46	al	al	PROPN
fnp-3805	245	47	.	.	PROPN
fnp-3805	245	48	,	,	PUNCT
fnp-3805	245	49	2021	2021	NUM
fnp-3805	245	50	;	;	PUNCT
fnp-3805	245	51	schoser	schoser	NOUN
fnp-3805	245	52	et	et	PROPN
fnp-3805	245	53	al	al	PROPN
fnp-3805	245	54	.	.	PROPN
fnp-3805	245	55	,	,	PUNCT
fnp-3805	245	56	2021	2021	NUM
fnp-3805	245	57	)	)	PUNCT
fnp-3805	245	58	.	.	PUNCT
fnp-3805	246	1	to	to	PART
fnp-3805	246	2	generate	generate	VERB
fnp-3805	246	3	the	the	DET
fnp-3805	246	4	first	first	ADJ
fnp-3805	246	5	investigational	investigational	ADJ
fnp-3805	246	6	drug	drug	NOUN
fnp-3805	246	7	,	,	PUNCT
fnp-3805	246	8	avalglucosidase	avalglucosidase	VERB
fnp-3805	246	9	alfa	alfa	PROPN
fnp-3805	246	10	,	,	PUNCT
fnp-3805	246	11	synthetic	synthetic	ADJ
fnp-3805	246	12	bis	bis	ADJ
fnp-3805	246	13	-	-	PUNCT
fnp-3805	246	14	m6p	m6p	NOUN
fnp-3805	246	15	-	-	PUNCT
fnp-3805	246	16	glycane	glycane	NOUN
fnp-3805	246	17	-	-	PUNCT
fnp-3805	246	18	containing	contain	VERB
fnp-3805	246	19	oligosaccharides	oligosaccharide	NOUN
fnp-3805	246	20	were	be	AUX
fnp-3805	246	21	chemically	chemically	ADV
fnp-3805	246	22	conjugated	conjugate	VERB
fnp-3805	246	23	to	to	ADP
fnp-3805	246	24	recombinant	recombinant	ADJ
fnp-3805	246	25	human	human	PROPN
fnp-3805	246	26	gaa	gaa	PROPN
fnp-3805	246	27	;	;	PUNCT
fnp-3805	246	28	the	the	DET
fnp-3805	246	29	safety	safety	NOUN
fnp-3805	246	30	and	and	CCONJ
fnp-3805	246	31	efficacy	efficacy	NOUN
fnp-3805	246	32	of	of	ADP
fnp-3805	246	33	this	this	DET
fnp-3805	246	34	drug	drug	NOUN
fnp-3805	246	35	was	be	AUX
fnp-3805	246	36	evaluated	evaluate	VERB
fnp-3805	246	37	by	by	ADP
fnp-3805	246	38	the	the	DET
fnp-3805	246	39	comet	comet	NOUN
fnp-3805	246	40	study	study	NOUN
fnp-3805	246	41	,	,	PUNCT
fnp-3805	246	42	a	a	DET
fnp-3805	246	43	phase	phase	NOUN
fnp-3805	246	44	3	3	NUM
fnp-3805	246	45	,	,	PUNCT
fnp-3805	246	46	randomized	randomize	VERB
fnp-3805	246	47	,	,	PUNCT
fnp-3805	246	48	double	double	ADJ
fnp-3805	246	49	-	-	PUNCT
fnp-3805	246	50	blind	blind	ADJ
fnp-3805	246	51	clinical	clinical	ADJ
fnp-3805	246	52	trial	trial	NOUN
fnp-3805	246	53	involving	involve	VERB
fnp-3805	246	54	55	55	NUM
fnp-3805	246	55	sites	site	NOUN
fnp-3805	246	56	in	in	ADP
fnp-3805	246	57	20	20	NUM
fnp-3805	246	58	countries	country	NOUN
fnp-3805	246	59	(	(	PUNCT
fnp-3805	246	60	diaz	diaz	PROPN
fnp-3805	246	61	-	-	PUNCT
fnp-3805	246	62	manera	manera	PROPN
fnp-3805	246	63	et	et	PROPN
fnp-3805	246	64	al	al	PROPN
fnp-3805	246	65	.	.	PROPN
fnp-3805	246	66	,	,	PUNCT
fnp-3805	246	67	2021	2021	NUM
fnp-3805	246	68	)	)	PUNCT
fnp-3805	246	69	.	.	PUNCT
fnp-3805	247	1	the	the	DET
fnp-3805	247	2	second	second	ADJ
fnp-3805	247	3	investigational	investigational	ADJ
fnp-3805	247	4	drug	drug	NOUN
fnp-3805	247	5	,	,	PUNCT
fnp-3805	247	6	cipaglucosidase	cipaglucosidase	PROPN
fnp-3805	247	7	alfa	alfa	PROPN
fnp-3805	247	8	,	,	PUNCT
fnp-3805	247	9	is	be	AUX
fnp-3805	247	10	a	a	DET
fnp-3805	247	11	novel	novel	ADJ
fnp-3805	247	12	recombinant	recombinant	ADJ
fnp-3805	247	13	human	human	PROPN
fnp-3805	247	14	gaa	gaa	PROPN
fnp-3805	247	15	with	with	ADP
fnp-3805	247	16	a	a	DET
fnp-3805	247	17	high	high	ADJ
fnp-3805	247	18	bis	bi	NOUN
fnp-3805	247	19	-	-	NOUN
fnp-3805	247	20	m6p	m6p	NOUN
fnp-3805	247	21	glycan	glycan	NOUN
fnp-3805	247	22	content	content	NOUN
fnp-3805	247	23	that	that	PRON
fnp-3805	247	24	is	be	AUX
fnp-3805	247	25	co	co	VERB
fnp-3805	247	26	-	-	VERB
fnp-3805	247	27	administered	administer	VERB
fnp-3805	247	28	with	with	ADP
fnp-3805	247	29	a	a	DET
fnp-3805	247	30	pharmacologic	pharmacologic	ADJ
fnp-3805	247	31	chaperone	chaperone	NOUN
fnp-3805	247	32	(	(	PUNCT
fnp-3805	247	33	miglustat	miglustat	NOUN
fnp-3805	247	34	)	)	PUNCT
fnp-3805	247	35	to	to	PART
fnp-3805	247	36	increase	increase	VERB
fnp-3805	247	37	its	its	PRON
fnp-3805	247	38	bioavailability	bioavailability	NOUN
fnp-3805	247	39	;	;	PUNCT
fnp-3805	247	40	the	the	DET
fnp-3805	247	41	safety	safety	NOUN
fnp-3805	247	42	and	and	CCONJ
fnp-3805	247	43	efficacy	efficacy	NOUN
fnp-3805	247	44	of	of	ADP
fnp-3805	247	45	this	this	DET
fnp-3805	247	46	drug	drug	NOUN
fnp-3805	247	47	combination	combination	NOUN
fnp-3805	247	48	was	be	AUX
fnp-3805	247	49	evaluated	evaluate	VERB
fnp-3805	247	50	by	by	ADP
fnp-3805	247	51	the	the	DET
fnp-3805	247	52	propel	propel	PROPN
fnp-3805	247	53	study	study	NOUN
fnp-3805	247	54	,	,	PUNCT
fnp-3805	247	55	also	also	ADV
fnp-3805	247	56	a	a	DET
fnp-3805	247	57	phase	phase	NOUN
fnp-3805	247	58	3	3	NUM
fnp-3805	247	59	,	,	PUNCT
fnp-3805	247	60	randomized	randomize	VERB
fnp-3805	247	61	,	,	PUNCT
fnp-3805	247	62	double	double	ADJ
fnp-3805	247	63	-	-	PUNCT
fnp-3805	247	64	blind	blind	ADJ
fnp-3805	247	65	clinical	clinical	ADJ
fnp-3805	247	66	trial	trial	NOUN
fnp-3805	247	67	that	that	PRON
fnp-3805	247	68	involved	involve	VERB
fnp-3805	247	69	62	62	NUM
fnp-3805	247	70	sites	site	NOUN
fnp-3805	247	71	in	in	ADP
fnp-3805	247	72	24	24	NUM
fnp-3805	247	73	countries	country	NOUN
fnp-3805	247	74	(	(	PUNCT
fnp-3805	247	75	schoser	schoser	NOUN
fnp-3805	247	76	et	et	PROPN
fnp-3805	247	77	al	al	PROPN
fnp-3805	247	78	.	.	PROPN
fnp-3805	247	79	,	,	PUNCT
fnp-3805	247	80	2021	2021	NUM
fnp-3805	247	81	)	)	PUNCT
fnp-3805	247	82	.	.	PUNCT
fnp-3805	248	1	the	the	DET
fnp-3805	248	2	comet	comet	NOUN
fnp-3805	248	3	trial	trial	NOUN
fnp-3805	248	4	enrolled	enrol	VERB
fnp-3805	248	5	100	100	NUM
fnp-3805	248	6	ert	ert	ADJ
fnp-3805	248	7	-	-	ADJ
fnp-3805	248	8	naïve	naïve	ADJ
fnp-3805	248	9	lopd	lopd	NOUN
fnp-3805	248	10	patients	patient	NOUN
fnp-3805	248	11	who	who	PRON
fnp-3805	248	12	were	be	AUX
fnp-3805	248	13	randomized	randomize	VERB
fnp-3805	248	14	into	into	ADP
fnp-3805	248	15	equally	equally	ADV
fnp-3805	248	16	sized	sized	ADJ
fnp-3805	248	17	avalglucosidase	avalglucosidase	NOUN
fnp-3805	248	18	alfa	alfa	NOUN
fnp-3805	248	19	and	and	CCONJ
fnp-3805	248	20	alglucosidase	alglucosidase	NOUN
fnp-3805	248	21	alfa	alfa	NOUN
fnp-3805	248	22	groups	group	NOUN
fnp-3805	248	23	;	;	PUNCT
fnp-3805	248	24	the	the	DET
fnp-3805	248	25	propel	propel	NOUN
fnp-3805	248	26	trial	trial	NOUN
fnp-3805	248	27	,	,	PUNCT
fnp-3805	248	28	on	on	ADP
fnp-3805	248	29	the	the	DET
fnp-3805	248	30	other	other	ADJ
fnp-3805	248	31	hand	hand	NOUN
fnp-3805	248	32	,	,	PUNCT
fnp-3805	248	33	had	have	VERB
fnp-3805	248	34	a	a	DET
fnp-3805	248	35	parallel	parallel	ADJ
fnp-3805	248	36	group	group	NOUN
fnp-3805	248	37	design	design	NOUN
fnp-3805	248	38	(	(	PUNCT
fnp-3805	248	39	28	28	NUM
fnp-3805	248	40	ert	ert	ADJ
fnp-3805	248	41	-	-	ADJ
fnp-3805	248	42	naïve	naïve	ADJ
fnp-3805	248	43	participants	participant	NOUN
fnp-3805	248	44	and	and	CCONJ
fnp-3805	248	45	95	95	NUM
fnp-3805	248	46	participants	participant	NOUN
fnp-3805	248	47	previously	previously	ADV
fnp-3805	248	48	treated	treat	VERB
fnp-3805	248	49	with	with	ADP
fnp-3805	248	50	alglucosidase	alglucosidase	NOUN
fnp-3805	248	51	alfa	alfa	PROPN
fnp-3805	248	52	)	)	PUNCT
fnp-3805	248	53	,	,	PUNCT
fnp-3805	248	54	with	with	ADP
fnp-3805	248	55	two	two	NUM
fnp-3805	248	56	thirds	third	NOUN
fnp-3805	248	57	of	of	ADP
fnp-3805	248	58	participants	participant	NOUN
fnp-3805	248	59	in	in	ADP
fnp-3805	248	60	each	each	DET
fnp-3805	248	61	subgroup	subgroup	NOUN
fnp-3805	248	62	receiving	receive	VERB
fnp-3805	248	63	cipaglucosidase	cipaglucosidase	NOUN
fnp-3805	248	64	alfa	alfa	NOUN
fnp-3805	248	65	+	+	CCONJ
fnp-3805	248	66	miglustat	miglustat	NOUN
fnp-3805	248	67	and	and	CCONJ
fnp-3805	248	68	one	one	NUM
fnp-3805	248	69	third	third	ADJ
fnp-3805	248	70	receiving	receive	VERB
fnp-3805	248	71	alglucosidase	alglucosidase	NOUN
fnp-3805	248	72	alfa	alfa	NOUN
fnp-3805	248	73	+	+	CCONJ
fnp-3805	248	74	placebo	placebo	NOUN
fnp-3805	248	75	.	.	PUNCT
fnp-3805	249	1	while	while	SCONJ
fnp-3805	249	2	the	the	DET
fnp-3805	249	3	details	detail	NOUN
fnp-3805	249	4	of	of	ADP
fnp-3805	249	5	the	the	DET
fnp-3805	249	6	study	study	NOUN
fnp-3805	249	7	design	design	NOUN
fnp-3805	249	8	differed	differ	VERB
fnp-3805	249	9	slightly	slightly	ADV
fnp-3805	249	10	between	between	ADP
fnp-3805	249	11	the	the	DET
fnp-3805	249	12	two	two	NUM
fnp-3805	249	13	trials	trial	NOUN
fnp-3805	249	14	,	,	PUNCT
fnp-3805	249	15	they	they	PRON
fnp-3805	249	16	had	have	VERB
fnp-3805	249	17	similar	similar	ADJ
fnp-3805	249	18	duration	duration	NOUN
fnp-3805	249	19	(	(	PUNCT
fnp-3805	249	20	49	49	NUM
fnp-3805	249	21	weeks	week	NOUN
fnp-3805	249	22	for	for	ADP
fnp-3805	249	23	comet	comet	NOUN
fnp-3805	249	24	and	and	CCONJ
fnp-3805	249	25	52	52	NUM
fnp-3805	249	26	weeks	week	NOUN
fnp-3805	249	27	for	for	ADP
fnp-3805	249	28	propel	propel	NOUN
fnp-3805	249	29	)	)	PUNCT
fnp-3805	249	30	and	and	CCONJ
fnp-3805	249	31	their	their	PRON
fnp-3805	249	32	outcomes	outcome	NOUN
fnp-3805	249	33	were	be	AUX
fnp-3805	249	34	quite	quite	ADV
fnp-3805	249	35	similar	similar	ADJ
fnp-3805	249	36	:	:	PUNCT
fnp-3805	249	37	(	(	PUNCT
fnp-3805	249	38	1	1	X
fnp-3805	249	39	)	)	PUNCT
fnp-3805	249	40	the	the	DET
fnp-3805	249	41	safety	safety	NOUN
fnp-3805	249	42	of	of	ADP
fnp-3805	249	43	both	both	CCONJ
fnp-3805	249	44	investigational	investigational	ADJ
fnp-3805	249	45	drugs	drug	NOUN
fnp-3805	249	46	was	be	AUX
fnp-3805	249	47	high	high	ADJ
fnp-3805	249	48	,	,	PUNCT
fnp-3805	249	49	with	with	SCONJ
fnp-3805	249	50	no	no	DET
fnp-3805	249	51	new	new	ADJ
fnp-3805	249	52	safety	safety	NOUN
fnp-3805	249	53	signals	signal	NOUN
fnp-3805	249	54	reported	report	VERB
fnp-3805	249	55	;	;	PUNCT
fnp-3805	249	56	(	(	PUNCT
fnp-3805	249	57	2	2	X
fnp-3805	249	58	)	)	PUNCT
fnp-3805	249	59	neither	neither	CCONJ
fnp-3805	249	60	investigational	investigational	ADJ
fnp-3805	249	61	drug	drug	NOUN
fnp-3805	249	62	was	be	AUX
fnp-3805	249	63	inferior	inferior	ADJ
fnp-3805	249	64	to	to	ADP
fnp-3805	249	65	alglucosidase	alglucosidase	PROPN
fnp-3805	249	66	alfa	alfa	PROPN
fnp-3805	249	67	,	,	PUNCT
fnp-3805	249	68	the	the	DET
fnp-3805	249	69	current	current	ADJ
fnp-3805	249	70	standard	standard	NOUN
fnp-3805	249	71	of	of	ADP
fnp-3805	249	72	care	care	NOUN
fnp-3805	249	73	;	;	PUNCT
fnp-3805	249	74	and	and	CCONJ
fnp-3805	249	75	(	(	PUNCT
fnp-3805	249	76	3	3	X
fnp-3805	249	77	)	)	PUNCT
fnp-3805	249	78	while	while	SCONJ
fnp-3805	249	79	there	there	PRON
fnp-3805	249	80	was	be	VERB
fnp-3805	249	81	a	a	DET
fnp-3805	249	82	trend	trend	NOUN
fnp-3805	249	83	toward	toward	ADP
fnp-3805	249	84	increased	increase	VERB
fnp-3805	249	85	efficacy	efficacy	NOUN
fnp-3805	249	86	for	for	ADP
fnp-3805	249	87	both	both	CCONJ
fnp-3805	249	88	investigational	investigational	ADJ
fnp-3805	249	89	drugs	drug	NOUN
fnp-3805	249	90	,	,	PUNCT
fnp-3805	249	91	neither	neither	CCONJ
fnp-3805	249	92	reached	reach	VERB
fnp-3805	249	93	a	a	DET
fnp-3805	249	94	statistically	statistically	ADV
fnp-3805	249	95	significant	significant	ADJ
fnp-3805	249	96	primary	primary	ADJ
fnp-3805	249	97	end	end	NOUN
fnp-3805	249	98	-	-	PUNCT
fnp-3805	249	99	point	point	NOUN
fnp-3805	249	100	.	.	PUNCT
fnp-3805	250	1	given	give	VERB
fnp-3805	250	2	the	the	DET
fnp-3805	250	3	very	very	ADV
fnp-3805	250	4	promising	promising	ADJ
fnp-3805	250	5	results	result	NOUN
fnp-3805	250	6	of	of	ADP
fnp-3805	250	7	prior	prior	ADJ
fnp-3805	250	8	preclinical	preclinical	ADJ
fnp-3805	250	9	(	(	PUNCT
fnp-3805	250	10	mouse	mouse	NOUN
fnp-3805	250	11	model	model	NOUN
fnp-3805	250	12	)	)	PUNCT
fnp-3805	250	13	studies	study	NOUN
fnp-3805	250	14	and	and	CCONJ
fnp-3805	250	15	initial	initial	ADJ
fnp-3805	250	16	phase	phase	NOUN
fnp-3805	250	17	1/2	1/2	NUM
fnp-3805	250	18	trials	trial	NOUN
fnp-3805	250	19	(	(	PUNCT
fnp-3805	250	20	meena	meena	PROPN
fnp-3805	250	21	et	et	PROPN
fnp-3805	250	22	al	al	PROPN
fnp-3805	250	23	.	.	PROPN
fnp-3805	250	24	,	,	PUNCT
fnp-3805	250	25	2020	2020	NUM
fnp-3805	250	26	;	;	PUNCT
fnp-3805	250	27	puertollano	puertollano	NOUN
fnp-3805	250	28	and	and	CCONJ
fnp-3805	250	29	raben	raben	PROPN
fnp-3805	250	30	,	,	PUNCT
fnp-3805	250	31	2021	2021	NUM
fnp-3805	250	32	)	)	PUNCT
fnp-3805	250	33	,	,	PUNCT
fnp-3805	250	34	these	these	DET
fnp-3805	250	35	results	result	NOUN
fnp-3805	250	36	are	be	AUX
fnp-3805	250	37	somewhat	somewhat	ADV
fnp-3805	250	38	disappointing	disappointing	ADJ
fnp-3805	250	39	.	.	PUNCT
fnp-3805	251	1	intriguingly	intriguingly	ADV
fnp-3805	251	2	,	,	PUNCT
fnp-3805	251	3	however	however	ADV
fnp-3805	251	4	,	,	PUNCT
fnp-3805	251	5	the	the	DET
fnp-3805	251	6	cipaglucosidase	cipaglucosidase	NOUN
fnp-3805	251	7	alfa	alfa	NOUN
fnp-3805	251	8	+	+	CCONJ
fnp-3805	251	9	miglustat	miglustat	NOUN
fnp-3805	251	10	treatment	treatment	NOUN
fnp-3805	251	11	was	be	AUX
fnp-3805	251	12	significantly	significantly	ADV
fnp-3805	251	13	more	more	ADV
fnp-3805	251	14	effective	effective	ADJ
fnp-3805	251	15	than	than	ADP
fnp-3805	251	16	the	the	DET
fnp-3805	251	17	alglucosidase	alglucosidase	NOUN
fnp-3805	251	18	alfa	alfa	NOUN
fnp-3805	251	19	+	+	CCONJ
fnp-3805	251	20	placebo	placebo	NOUN
fnp-3805	251	21	treatment	treatment	NOUN
fnp-3805	251	22	in	in	ADP
fnp-3805	251	23	the	the	DET
fnp-3805	251	24	ert	ert	NOUN
fnp-3805	251	25	-	-	PUNCT
fnp-3805	251	26	experienced	experienced	ADJ
fnp-3805	251	27	subgroup	subgroup	NOUN
fnp-3805	251	28	of	of	ADP
fnp-3805	251	29	the	the	DET
fnp-3805	251	30	propel	propel	PROPN
fnp-3805	251	31	study	study	NOUN
fnp-3805	251	32	,	,	PUNCT
fnp-3805	251	33	which	which	PRON
fnp-3805	251	34	is	be	AUX
fnp-3805	251	35	arguably	arguably	ADV
fnp-3805	251	36	most	most	ADV
fnp-3805	251	37	representative	representative	NOUN
fnp-3805	251	38	of	of	ADP
fnp-3805	251	39	the	the	DET
fnp-3805	251	40	segment	segment	NOUN
fnp-3805	251	41	of	of	ADP
fnp-3805	251	42	the	the	DET
fnp-3805	251	43	lopd	lopd	NOUN
fnp-3805	251	44	patient	patient	ADJ
fnp-3805	251	45	population	population	NOUN
fnp-3805	251	46	with	with	ADP
fnp-3805	251	47	the	the	DET
fnp-3805	251	48	greatest	great	ADJ
fnp-3805	251	49	need	need	NOUN
fnp-3805	251	50	for	for	ADP
fnp-3805	251	51	new	new	ADJ
fnp-3805	251	52	and	and	CCONJ
fnp-3805	251	53	more	more	ADV
fnp-3805	251	54	effective	effective	ADJ
fnp-3805	251	55	lopd	lopd	NOUN
fnp-3805	251	56	therapies	therapy	NOUN
fnp-3805	251	57	.	.	PUNCT
fnp-3805	252	1	both	both	DET
fnp-3805	252	2	trials	trial	NOUN
fnp-3805	252	3	have	have	AUX
fnp-3805	252	4	now	now	ADV
fnp-3805	252	5	moved	move	VERB
fnp-3805	252	6	into	into	ADP
fnp-3805	252	7	their	their	PRON
fnp-3805	252	8	last	last	ADJ
fnp-3805	252	9	phase	phase	NOUN
fnp-3805	252	10	(	(	PUNCT
fnp-3805	252	11	open	open	ADJ
fnp-3805	252	12	label	label	NOUN
fnp-3805	252	13	extended	extend	VERB
fnp-3805	252	14	treatment	treatment	NOUN
fnp-3805	252	15	period	period	NOUN
fnp-3805	252	16	)	)	PUNCT
fnp-3805	252	17	,	,	PUNCT
fnp-3805	252	18	the	the	DET
fnp-3805	252	19	aim	aim	NOUN
fnp-3805	252	20	of	of	ADP
fnp-3805	252	21	which	which	PRON
fnp-3805	252	22	is	be	AUX
fnp-3805	252	23	to	to	PART
fnp-3805	252	24	assess	assess	VERB
fnp-3805	252	25	the	the	DET
fnp-3805	252	26	long	long	ADJ
fnp-3805	252	27	-	-	PUNCT
fnp-3805	252	28	term	term	NOUN
fnp-3805	252	29	safety	safety	NOUN
fnp-3805	252	30	and	and	CCONJ
fnp-3805	252	31	efficacy	efficacy	NOUN
fnp-3805	252	32	of	of	ADP
fnp-3805	252	33	these	these	DET
fnp-3805	252	34	new	new	ADJ
fnp-3805	252	35	drugs	drug	NOUN
fnp-3805	252	36	;	;	PUNCT
fnp-3805	252	37	it	it	PRON
fnp-3805	252	38	will	will	AUX
fnp-3805	252	39	be	be	AUX
fnp-3805	252	40	interesting	interesting	ADJ
fnp-3805	252	41	to	to	PART
fnp-3805	252	42	see	see	VERB
fnp-3805	252	43	whether	whether	SCONJ
fnp-3805	252	44	the	the	DET
fnp-3805	252	45	difference	difference	NOUN
fnp-3805	252	46	in	in	ADP
fnp-3805	252	47	the	the	DET
fnp-3805	252	48	efficacy	efficacy	NOUN
fnp-3805	252	49	profile	profile	NOUN
fnp-3805	252	50	between	between	ADP
fnp-3805	252	51	either	either	CCONJ
fnp-3805	252	52	investigational	investigational	ADJ
fnp-3805	252	53	drug	drug	NOUN
fnp-3805	252	54	and	and	CCONJ
fnp-3805	252	55	alglucosidase	alglucosidase	NOUN
fnp-3805	252	56	alfa	alfa	NOUN
fnp-3805	252	57	becomes	become	VERB
fnp-3805	252	58	greater	great	ADJ
fnp-3805	252	59	over	over	ADP
fnp-3805	252	60	time	time	NOUN
fnp-3805	252	61	or	or	CCONJ
fnp-3805	252	62	whether	whether	SCONJ
fnp-3805	252	63	they	they	PRON
fnp-3805	252	64	will	will	AUX
fnp-3805	252	65	show	show	VERB
fnp-3805	252	66	a	a	DET
fnp-3805	252	67	similar	similar	ADJ
fnp-3805	252	68	loss	loss	NOUN
fnp-3805	252	69	of	of	ADP
fnp-3805	252	70	efficacy	efficacy	NOUN
fnp-3805	252	71	over	over	ADP
fnp-3805	252	72	time	time	NOUN
fnp-3805	252	73	.	.	PUNCT
fnp-3805	253	1	in	in	ADP
fnp-3805	253	2	addition	addition	NOUN
fnp-3805	253	3	,	,	PUNCT
fnp-3805	253	4	it	it	PRON
fnp-3805	253	5	will	will	AUX
fnp-3805	253	6	be	be	AUX
fnp-3805	253	7	interesting	interesting	ADJ
fnp-3805	253	8	to	to	PART
fnp-3805	253	9	directly	directly	ADV
fnp-3805	253	10	compare	compare	VERB
fnp-3805	253	11	the	the	DET
fnp-3805	253	12	two	two	NUM
fnp-3805	253	13	new	new	ADJ
fnp-3805	253	14	lopd	lopd	NOUN
fnp-3805	253	15	drugs	drug	NOUN
fnp-3805	253	16	and	and	CCONJ
fnp-3805	253	17	determine	determine	VERB
fnp-3805	253	18	whether	whether	SCONJ
fnp-3805	253	19	one	one	NUM
fnp-3805	253	20	of	of	ADP
fnp-3805	253	21	them	they	PRON
fnp-3805	253	22	is	be	AUX
fnp-3805	253	23	superior	superior	ADJ
fnp-3805	253	24	to	to	ADP
fnp-3805	253	25	the	the	DET
fnp-3805	253	26	other	other	ADJ
fnp-3805	253	27	with	with	ADP
fnp-3805	253	28	respect	respect	NOUN
fnp-3805	253	29	to	to	ADP
fnp-3805	253	30	the	the	DET
fnp-3805	253	31	size	size	NOUN
fnp-3805	253	32	of	of	ADP
fnp-3805	253	33	initial	initial	ADJ
fnp-3805	253	34	improvement	improvement	NOUN
fnp-3805	253	35	,	,	PUNCT
fnp-3805	253	36	effect	effect	NOUN
fnp-3805	253	37	duration	duration	NOUN
fnp-3805	253	38	,	,	PUNCT
fnp-3805	253	39	or	or	CCONJ
fnp-3805	253	40	both	both	PRON
fnp-3805	253	41	.	.	PUNCT
fnp-3805	254	1	most	most	ADV
fnp-3805	254	2	importantly	importantly	ADV
fnp-3805	254	3	,	,	PUNCT
fnp-3805	254	4	however	however	ADV
fnp-3805	254	5	,	,	PUNCT
fnp-3805	254	6	the	the	DET
fnp-3805	254	7	modest	modest	ADJ
fnp-3805	254	8	results	result	NOUN
fnp-3805	254	9	of	of	ADP
fnp-3805	254	10	these	these	DET
fnp-3805	254	11	large	large	ADJ
fnp-3805	254	12	and	and	CCONJ
fnp-3805	254	13	expensive	expensive	ADJ
fnp-3805	254	14	clinical	clinical	ADJ
fnp-3805	254	15	trials	trial	NOUN
fnp-3805	254	16	indicate	indicate	VERB
fnp-3805	254	17	that	that	SCONJ
fnp-3805	254	18	the	the	DET
fnp-3805	254	19	cure	cure	NOUN
fnp-3805	254	20	for	for	ADP
fnp-3805	254	21	lopd	lopd	NOUN
fnp-3805	254	22	remains	remain	VERB
fnp-3805	254	23	elusive	elusive	ADJ
fnp-3805	254	24	and	and	CCONJ
fnp-3805	254	25	highlight	highlight	VERB
fnp-3805	254	26	the	the	DET
fnp-3805	254	27	need	need	NOUN
fnp-3805	254	28	for	for	ADP
fnp-3805	254	29	a	a	DET
fnp-3805	254	30	novel	novel	NOUN
fnp-3805	254	31	,	,	PUNCT
fnp-3805	254	32	ideally	ideally	ADV
fnp-3805	254	33	more	more	ADV
fnp-3805	254	34	effective	effective	ADJ
fnp-3805	254	35	and	and	CCONJ
fnp-3805	254	36	durable	durable	ADJ
fnp-3805	254	37	,	,	PUNCT
fnp-3805	254	38	lopd	lopd	NOUN
fnp-3805	254	39	treatment	treatment	NOUN
fnp-3805	254	40	approach	approach	NOUN
fnp-3805	254	41	going	go	VERB
fnp-3805	254	42	forward	forward	ADV
fnp-3805	254	43	.	.	PUNCT
fnp-3805	255	1	disclosure	disclosure	NOUN
fnp-3805	255	2	statement	statement	NOUN
fnp-3805	255	3	the	the	DET
fnp-3805	255	4	author	author	NOUN
fnp-3805	255	5	receives	receive	VERB
fnp-3805	255	6	research	research	NOUN
fnp-3805	255	7	support	support	NOUN
fnp-3805	255	8	from	from	ADP
fnp-3805	255	9	astellas	astellas	NOUN
fnp-3805	255	10	gene	gene	NOUN
fnp-3805	255	11	therapies	therapy	NOUN
fnp-3805	255	12	(	(	PUNCT
fnp-3805	255	13	formerly	formerly	ADV
fnp-3805	255	14	known	know	VERB
fnp-3805	255	15	as	as	ADP
fnp-3805	255	16	audentes	audente	NOUN
fnp-3805	255	17	therapeutics	therapeutic	NOUN
fnp-3805	255	18	,	,	PUNCT
fnp-3805	255	19	inc	inc	PROPN
fnp-3805	255	20	)	)	PUNCT
fnp-3805	255	21	as	as	ADP
fnp-3805	255	22	a	a	DET
fnp-3805	255	23	member	member	NOUN
fnp-3805	255	24	of	of	ADP
fnp-3805	255	25	the	the	DET
fnp-3805	255	26	muscle	muscle	NOUN
fnp-3805	255	27	biopsy	biopsy	PROPN
fnp-3805	255	28	review	review	PROPN
fnp-3805	255	29	committee	committee	PROPN
fnp-3805	255	30	for	for	ADP
fnp-3805	255	31	the	the	DET
fnp-3805	255	32	aspiro	aspiro	ADJ
fnp-3805	255	33	(	(	PUNCT
fnp-3805	255	34	nct03199469	nct03199469	ADJ
fnp-3805	255	35	)	)	PUNCT
fnp-3805	255	36	and	and	CCONJ
fnp-3805	255	37	fortis	fortis	PROPN
fnp-3805	255	38	(	(	PUNCT
fnp-3805	255	39	nct04174105	nct04174105	NOUN
fnp-3805	255	40	)	)	PUNCT
fnp-3805	255	41	clinical	clinical	ADJ
fnp-3805	255	42	trials	trial	NOUN
fnp-3805	255	43	,	,	PUNCT
fnp-3805	255	44	which	which	PRON
fnp-3805	255	45	are	be	AUX
fnp-3805	255	46	evaluating	evaluate	VERB
fnp-3805	255	47	the	the	DET
fnp-3805	255	48	safety	safety	NOUN
fnp-3805	255	49	and	and	CCONJ
fnp-3805	255	50	efficacy	efficacy	NOUN
fnp-3805	255	51	of	of	ADP
fnp-3805	255	52	gene	gene	NOUN
fnp-3805	255	53	transfer	transfer	NOUN
fnp-3805	255	54	therapy	therapy	NOUN
fnp-3805	255	55	for	for	ADP
fnp-3805	255	56	x	x	ADV
fnp-3805	255	57	-	-	VERB
fnp-3805	255	58	linked	link	VERB
fnp-3805	255	59	myotubular	myotubular	ADJ
fnp-3805	255	60	myopathy	myopathy	ADJ
fnp-3805	255	61	(	(	PUNCT
fnp-3805	255	62	aspiro	aspiro	ADJ
fnp-3805	255	63	)	)	PUNCT
fnp-3805	255	64	and	and	CCONJ
fnp-3805	255	65	lopd	lopd	NOUN
fnp-3805	255	66	(	(	PUNCT
fnp-3805	255	67	fortis	fortis	PROPN
fnp-3805	255	68	)	)	PUNCT
fnp-3805	255	69	.	.	PUNCT
fnp-3805	256	1	acknowledgements	acknowledgement	NOUN
fnp-3805	256	2	i	i	PRON
fnp-3805	256	3	am	be	AUX
fnp-3805	256	4	grateful	grateful	ADJ
fnp-3805	256	5	to	to	PART
fnp-3805	256	6	drs	drs	PROPN
fnp-3805	256	7	.	.	PUNCT
fnp-3805	257	1	nigel	nigel	PROPN
fnp-3805	257	2	g.	g.	PROPN
fnp-3805	257	3	laing	laing	PROPN
fnp-3805	257	4	,	,	PUNCT
fnp-3805	257	5	gina	gina	PROPN
fnp-3805	257	6	ravenscroft	ravenscroft	PROPN
fnp-3805	257	7	,	,	PUNCT
fnp-3805	257	8	and	and	CCONJ
fnp-3805	257	9	benedikt	benedikt	NOUN
fnp-3805	257	10	schoser	schoser	NOUN
fnp-3805	257	11	for	for	ADP
fnp-3805	257	12	helpful	helpful	ADJ
fnp-3805	257	13	input	input	NOUN
fnp-3805	257	14	during	during	ADP
fnp-3805	257	15	the	the	DET
fnp-3805	257	16	conceptualization	conceptualization	NOUN
fnp-3805	257	17	stage	stage	NOUN
fnp-3805	257	18	of	of	ADP
fnp-3805	257	19	this	this	DET
fnp-3805	257	20	review	review	NOUN
fnp-3805	257	21	.	.	PUNCT
fnp-3805	258	1	in	in	ADP
fnp-3805	258	2	addition	addition	NOUN
fnp-3805	258	3	,	,	PUNCT
fnp-3805	258	4	i	i	PRON
fnp-3805	258	5	would	would	AUX
fnp-3805	258	6	like	like	VERB
fnp-3805	258	7	to	to	PART
fnp-3805	258	8	thank	thank	VERB
fnp-3805	258	9	ms	ms	PROPN
fnp-3805	258	10	.	.	PROPN
fnp-3805	258	11	christine	christine	PROPN
fnp-3805	258	12	lin	lin	PROPN
fnp-3805	258	13	for	for	ADP
fnp-3805	258	14	assistance	assistance	NOUN
fnp-3805	258	15	with	with	ADP
fnp-3805	258	16	figure	figure	NOUN
fnp-3805	258	17	preparation	preparation	NOUN
fnp-3805	258	18	.	.	PUNCT
fnp-3805	259	1	references	reference	NOUN
fnp-3805	259	2	ahmady	ahmady	PROPN
fnp-3805	259	3	,	,	PUNCT
fnp-3805	259	4	e.	e.	PROPN
fnp-3805	259	5	,	,	PUNCT
fnp-3805	259	6	deeke	deeke	PROPN
fnp-3805	259	7	,	,	PUNCT
fnp-3805	259	8	s.a	s.a	PROPN
fnp-3805	259	9	.	.	PROPN
fnp-3805	259	10	,	,	PUNCT
fnp-3805	259	11	rabaa	rabaa	PROPN
fnp-3805	259	12	,	,	PUNCT
fnp-3805	259	13	s.	s.	PROPN
fnp-3805	259	14	,	,	PUNCT
fnp-3805	259	15	kouri	kouri	PROPN
fnp-3805	259	16	,	,	PUNCT
fnp-3805	259	17	l.	l.	PROPN
fnp-3805	259	18	,	,	PUNCT
fnp-3805	259	19	kenney	kenney	PROPN
fnp-3805	259	20	,	,	PUNCT
fnp-3805	259	21	l.	l.	PROPN
fnp-3805	259	22	,	,	PUNCT
fnp-3805	259	23	stewart	stewart	PROPN
fnp-3805	259	24	,	,	PUNCT
fnp-3805	259	25	a.f	a.f	PROPN
fnp-3805	259	26	.	.	PROPN
fnp-3805	259	27	,	,	PUNCT
fnp-3805	259	28	and	and	CCONJ
fnp-3805	259	29	burgon	burgon	PROPN
fnp-3805	259	30	,	,	PUNCT
fnp-3805	259	31	p.g	p.g	PROPN
fnp-3805	259	32	.	.	PROPN
fnp-3805	259	33	(	(	PUNCT
fnp-3805	259	34	2011	2011	NUM
fnp-3805	259	35	)	)	PUNCT
fnp-3805	259	36	.	.	PUNCT
fnp-3805	260	1	identification	identification	NOUN
fnp-3805	260	2	of	of	ADP
fnp-3805	260	3	a	a	DET
fnp-3805	260	4	novel	novel	ADJ
fnp-3805	260	5	muscle	muscle	NOUN
fnp-3805	260	6	a	a	DET
fnp-3805	260	7	-	-	PUNCT
fnp-3805	260	8	type	type	NOUN
fnp-3805	260	9	lamin	lamin	NOUN
fnp-3805	260	10	-	-	PUNCT
fnp-3805	260	11	interacting	interact	VERB
fnp-3805	260	12	protein	protein	NOUN
fnp-3805	260	13	(	(	PUNCT
fnp-3805	260	14	mlip	mlip	NOUN
fnp-3805	260	15	)	)	PUNCT
fnp-3805	260	16	.	.	PUNCT
fnp-3805	261	1	j	j	PROPN
fnp-3805	261	2	biol	biol	PROPN
fnp-3805	261	3	chem	chem	NOUN
fnp-3805	261	4	286	286	NUM
fnp-3805	261	5	,	,	PUNCT
fnp-3805	261	6	19702	19702	NUM
fnp-3805	261	7	-	-	SYM
fnp-3805	261	8	19713	19713	NUM
fnp-3805	261	9	.	.	PUNCT
fnp-3805	262	1	allen	allen	PROPN
fnp-3805	262	2	,	,	PUNCT
fnp-3805	262	3	j.m	j.m	PROPN
fnp-3805	262	4	.	.	PROPN
fnp-3805	262	5	,	,	PUNCT
fnp-3805	262	6	zamurs	zamurs	PROPN
fnp-3805	262	7	,	,	PUNCT
fnp-3805	262	8	l.	l.	PROPN
fnp-3805	262	9	,	,	PUNCT
fnp-3805	262	10	brachvogel	brachvogel	PROPN
fnp-3805	262	11	,	,	PUNCT
fnp-3805	262	12	b.	b.	PROPN
fnp-3805	262	13	,	,	PUNCT
fnp-3805	262	14	schlotzer	schlotzer	NOUN
fnp-3805	262	15	-	-	PUNCT
fnp-3805	262	16	schrehardt	schrehardt	NOUN
fnp-3805	262	17	,	,	PUNCT
fnp-3805	262	18	u.	u.	PROPN
fnp-3805	262	19	,	,	PUNCT
fnp-3805	262	20	hansen	hansen	PROPN
fnp-3805	262	21	,	,	PUNCT
fnp-3805	262	22	u.	u.	PROPN
fnp-3805	262	23	,	,	PUNCT
fnp-3805	262	24	lamande	lamande	PROPN
fnp-3805	262	25	,	,	PUNCT
fnp-3805	262	26	s.r	s.r	PROPN
fnp-3805	262	27	.	.	PROPN
fnp-3805	262	28	,	,	PUNCT
fnp-3805	262	29	rowley	rowley	PROPN
fnp-3805	262	30	,	,	PUNCT
fnp-3805	262	31	l.	l.	PROPN
fnp-3805	262	32	,	,	PUNCT
fnp-3805	262	33	fitzgerald	fitzgerald	PROPN
fnp-3805	262	34	,	,	PUNCT
fnp-3805	262	35	j.	j.	PROPN
fnp-3805	262	36	,	,	PUNCT
fnp-3805	262	37	and	and	CCONJ
fnp-3805	262	38	bateman	bateman	PROPN
fnp-3805	262	39	,	,	PUNCT
fnp-3805	262	40	j.f	j.f	PROPN
fnp-3805	262	41	.	.	PROPN
fnp-3805	262	42	(	(	PUNCT
fnp-3805	262	43	2009	2009	NUM
fnp-3805	262	44	)	)	PUNCT
fnp-3805	262	45	.	.	PUNCT
fnp-3805	263	1	mice	mouse	NOUN
fnp-3805	263	2	lacking	lack	VERB
fnp-3805	263	3	the	the	DET
fnp-3805	263	4	extracellular	extracellular	ADJ
fnp-3805	263	5	matrix	matrix	NOUN
fnp-3805	263	6	protein	protein	NOUN
fnp-3805	263	7	warp	warp	NOUN
fnp-3805	263	8	develop	develop	VERB
fnp-3805	263	9	normally	normally	ADV
fnp-3805	263	10	but	but	CCONJ
fnp-3805	263	11	have	have	AUX
fnp-3805	263	12	compromised	compromise	VERB
fnp-3805	263	13	peripheral	peripheral	ADJ
fnp-3805	263	14	nerve	nerve	NOUN
fnp-3805	263	15	structure	structure	NOUN
fnp-3805	263	16	and	and	CCONJ
fnp-3805	263	17	function	function	NOUN
fnp-3805	263	18	.	.	PUNCT
fnp-3805	264	1	j	j	PROPN
fnp-3805	264	2	biol	biol	PROPN
fnp-3805	264	3	chem	chem	NOUN
fnp-3805	264	4	284	284	NUM
fnp-3805	264	5	,	,	PUNCT
fnp-3805	264	6	12020	12020	NUM
fnp-3805	264	7	-	-	SYM
fnp-3805	264	8	12030	12030	NUM
fnp-3805	264	9	.	.	PUNCT
fnp-3805	265	1	amici	amici	PROPN
fnp-3805	265	2	,	,	PUNCT
fnp-3805	265	3	d.r	d.r	PROPN
fnp-3805	265	4	.	.	PROPN
fnp-3805	265	5	,	,	PUNCT
fnp-3805	265	6	pinal	pinal	PROPN
fnp-3805	265	7	-	-	PUNCT
fnp-3805	265	8	fernandez	fernandez	PROPN
fnp-3805	265	9	,	,	PUNCT
fnp-3805	265	10	i.	i.	PROPN
fnp-3805	265	11	,	,	PUNCT
fnp-3805	265	12	christopher	christopher	PROPN
fnp-3805	265	13	-	-	PUNCT
fnp-3805	265	14	stine	stine	PROPN
fnp-3805	265	15	,	,	PUNCT
fnp-3805	265	16	l.	l.	PROPN
fnp-3805	265	17	,	,	PUNCT
fnp-3805	265	18	mammen	mammen	PROPN
fnp-3805	265	19	,	,	PUNCT
fnp-3805	265	20	a.l	a.l	PROPN
fnp-3805	265	21	.	.	PROPN
fnp-3805	265	22	,	,	PUNCT
fnp-3805	265	23	and	and	CCONJ
fnp-3805	265	24	mendillo	mendillo	PROPN
fnp-3805	265	25	,	,	PUNCT
fnp-3805	265	26	m.l	m.l	PROPN
fnp-3805	265	27	.	.	PUNCT
fnp-3805	265	28	(	(	PUNCT
fnp-3805	265	29	2021	2021	NUM
fnp-3805	265	30	)	)	PUNCT
fnp-3805	265	31	.	.	PUNCT
fnp-3805	266	1	a	a	DET
fnp-3805	266	2	network	network	NOUN
fnp-3805	266	3	of	of	ADP
fnp-3805	266	4	core	core	NOUN
fnp-3805	266	5	and	and	CCONJ
fnp-3805	266	6	subtype	subtype	NOUN
fnp-3805	266	7	-	-	PUNCT
fnp-3805	266	8	specific	specific	ADJ
fnp-3805	266	9	gene	gene	NOUN
fnp-3805	266	10	expression	expression	NOUN
fnp-3805	266	11	programs	program	NOUN
fnp-3805	266	12	in	in	ADP
fnp-3805	266	13	myositis	myositis	PROPN
fnp-3805	266	14	.	.	PUNCT
fnp-3805	267	1	acta	acta	PROPN
fnp-3805	267	2	neuropathol	neuropathol	PROPN
fnp-3805	267	3	142	142	NUM
fnp-3805	267	4	,	,	PUNCT
fnp-3805	267	5	887	887	NUM
fnp-3805	267	6	-	-	SYM
fnp-3805	267	7	898	898	NUM
fnp-3805	267	8	.	.	PUNCT
fnp-3805	268	1	amore	amore	PROPN
fnp-3805	268	2	,	,	PUNCT
fnp-3805	268	3	g.	g.	PROPN
fnp-3805	268	4	,	,	PUNCT
fnp-3805	268	5	romagnoli	romagnoli	NOUN
fnp-3805	268	6	,	,	PUNCT
fnp-3805	268	7	m.	m.	NOUN
fnp-3805	268	8	,	,	PUNCT
fnp-3805	268	9	carbonelli	carbonelli	PROPN
fnp-3805	268	10	,	,	PUNCT
fnp-3805	268	11	m.	m.	NOUN
fnp-3805	268	12	,	,	PUNCT
fnp-3805	268	13	barboni	barboni	NOUN
fnp-3805	268	14	,	,	PUNCT
fnp-3805	268	15	p.	p.	PROPN
fnp-3805	268	16	,	,	PUNCT
fnp-3805	268	17	carelli	carelli	PROPN
fnp-3805	268	18	,	,	PUNCT
fnp-3805	268	19	v.	v.	ADV
fnp-3805	268	20	,	,	PUNCT
fnp-3805	268	21	and	and	CCONJ
fnp-3805	268	22	la	la	PRON
fnp-3805	268	23	morgia	morgia	NOUN
fnp-3805	268	24	,	,	PUNCT
fnp-3805	268	25	c.	c.	NOUN
fnp-3805	268	26	(	(	PUNCT
fnp-3805	268	27	2021	2021	NUM
fnp-3805	268	28	)	)	PUNCT
fnp-3805	268	29	.	.	PUNCT
fnp-3805	269	1	therapeutic	therapeutic	ADJ
fnp-3805	269	2	options	option	NOUN
fnp-3805	269	3	in	in	ADP
fnp-3805	269	4	hereditary	hereditary	ADJ
fnp-3805	269	5	optic	optic	NOUN
fnp-3805	269	6	neuropathies	neuropathy	NOUN
fnp-3805	269	7	.	.	PUNCT
fnp-3805	270	1	drugs	drug	NOUN
fnp-3805	270	2	81	81	NUM
fnp-3805	270	3	,	,	PUNCT
fnp-3805	270	4	57	57	NUM
fnp-3805	270	5	-	-	SYM
fnp-3805	270	6	86	86	NUM
fnp-3805	270	7	.	.	PUNCT
fnp-3805	271	1	aschman	aschman	NOUN
fnp-3805	271	2	,	,	PUNCT
fnp-3805	271	3	t.	t.	PROPN
fnp-3805	271	4	,	,	PUNCT
fnp-3805	271	5	schneider	schneider	PROPN
fnp-3805	271	6	,	,	PUNCT
fnp-3805	271	7	j.	j.	PROPN
fnp-3805	271	8	,	,	PUNCT
fnp-3805	271	9	greuel	greuel	NOUN
fnp-3805	271	10	,	,	PUNCT
fnp-3805	271	11	s.	s.	PROPN
fnp-3805	271	12	,	,	PUNCT
fnp-3805	271	13	meinhardt	meinhardt	PROPN
fnp-3805	271	14	,	,	PUNCT
fnp-3805	271	15	j.	j.	PROPN
fnp-3805	271	16	,	,	PUNCT
fnp-3805	271	17	streit	streit	PROPN
fnp-3805	271	18	,	,	PUNCT
fnp-3805	271	19	s.	s.	PROPN
fnp-3805	271	20	,	,	PUNCT
fnp-3805	271	21	goebel	goebel	NOUN
fnp-3805	271	22	,	,	PUNCT
fnp-3805	271	23	h.h	h.h	PROPN
fnp-3805	271	24	.	.	PROPN
fnp-3805	271	25	,	,	PUNCT
fnp-3805	271	26	buttnerova	buttnerova	PROPN
fnp-3805	271	27	,	,	PUNCT
fnp-3805	271	28	i.	i.	NOUN
fnp-3805	271	29	,	,	PUNCT
fnp-3805	271	30	elezkurtaj	elezkurtaj	PROPN
fnp-3805	271	31	,	,	PUNCT
fnp-3805	271	32	s.	s.	PROPN
fnp-3805	271	33	,	,	PUNCT
fnp-3805	271	34	scheibe	scheibe	NOUN
fnp-3805	271	35	,	,	PUNCT
fnp-3805	271	36	f.	f.	PROPN
fnp-3805	271	37	,	,	PUNCT
fnp-3805	271	38	radke	radke	PROPN
fnp-3805	271	39	,	,	PUNCT
fnp-3805	271	40	j.	j.	PROPN
fnp-3805	271	41	,	,	PUNCT
fnp-3805	271	42	et	et	PROPN
fnp-3805	271	43	al	al	PROPN
fnp-3805	271	44	.	.	PROPN
fnp-3805	272	1	(	(	PUNCT
fnp-3805	272	2	2021	2021	NUM
fnp-3805	272	3	)	)	PUNCT
fnp-3805	272	4	.	.	PUNCT
fnp-3805	273	1	association	association	NOUN
fnp-3805	273	2	between	between	ADP
fnp-3805	273	3	sars	sar	NOUN
fnp-3805	273	4	-	-	PUNCT
fnp-3805	273	5	cov-2	cov-2	PART
fnp-3805	273	6	infection	infection	NOUN
fnp-3805	273	7	and	and	CCONJ
fnp-3805	273	8	immune	immune	NOUN
fnp-3805	273	9	-	-	PUNCT
fnp-3805	273	10	mediated	mediate	VERB
fnp-3805	273	11	myopathy	myopathy	ADJ
fnp-3805	273	12	in	in	ADP
fnp-3805	273	13	patients	patient	NOUN
fnp-3805	273	14	who	who	PRON
fnp-3805	273	15	have	have	AUX
fnp-3805	273	16	died	die	VERB
fnp-3805	273	17	.	.	PUNCT
fnp-3805	274	1	jama	jama	PROPN
fnp-3805	274	2	neurol	neurol	PROPN
fnp-3805	274	3	78	78	NUM
fnp-3805	274	4	,	,	PUNCT
fnp-3805	274	5	948	948	NUM
fnp-3805	274	6	-	-	SYM
fnp-3805	274	7	960	960	NUM
fnp-3805	274	8	.	.	PUNCT
fnp-3805	275	1	cattin	cattin	PROPN
fnp-3805	275	2	,	,	PUNCT
fnp-3805	275	3	m.e	m.e	PROPN
fnp-3805	275	4	.	.	PROPN
fnp-3805	275	5	,	,	PUNCT
fnp-3805	275	6	wang	wang	PROPN
fnp-3805	275	7	,	,	PUNCT
fnp-3805	275	8	j.	j.	PROPN
fnp-3805	275	9	,	,	PUNCT
fnp-3805	275	10	weldrick	weldrick	PROPN
fnp-3805	275	11	,	,	PUNCT
fnp-3805	275	12	j.j	j.j	PROPN
fnp-3805	275	13	.	.	PROPN
fnp-3805	275	14	,	,	PUNCT
fnp-3805	275	15	roeske	roeske	ADJ
fnp-3805	275	16	,	,	PUNCT
fnp-3805	275	17	c.l	c.l	PROPN
fnp-3805	275	18	.	.	PROPN
fnp-3805	275	19	,	,	PUNCT
fnp-3805	275	20	mak	mak	PROPN
fnp-3805	275	21	,	,	PUNCT
fnp-3805	275	22	e.	e.	PROPN
fnp-3805	275	23	,	,	PUNCT
fnp-3805	275	24	thorn	thorn	PROPN
fnp-3805	275	25	,	,	PUNCT
fnp-3805	275	26	s.l	s.l	PROPN
fnp-3805	275	27	.	.	PROPN
fnp-3805	275	28	,	,	PUNCT
fnp-3805	275	29	dasilva	dasilva	PROPN
fnp-3805	275	30	,	,	PUNCT
fnp-3805	275	31	j.n	j.n	PROPN
fnp-3805	275	32	.	.	PROPN
fnp-3805	275	33	,	,	PUNCT
fnp-3805	275	34	wang	wang	PROPN
fnp-3805	275	35	,	,	PUNCT
fnp-3805	275	36	y.	y.	PROPN
fnp-3805	275	37	,	,	PUNCT
fnp-3805	275	38	lusis	lusis	PROPN
fnp-3805	275	39	,	,	PUNCT
fnp-3805	275	40	a.j	a.j	PROPN
fnp-3805	275	41	.	.	PROPN
fnp-3805	275	42	,	,	PUNCT
fnp-3805	275	43	and	and	CCONJ
fnp-3805	275	44	burgon	burgon	PROPN
fnp-3805	275	45	,	,	PUNCT
fnp-3805	275	46	p.g	p.g	PROPN
fnp-3805	275	47	.	.	PROPN
fnp-3805	275	48	(	(	PUNCT
fnp-3805	275	49	2015	2015	NUM
fnp-3805	275	50	)	)	PUNCT
fnp-3805	275	51	.	.	PUNCT
fnp-3805	276	1	deletion	deletion	NOUN
fnp-3805	276	2	of	of	ADP
fnp-3805	276	3	mlip	mlip	NOUN
fnp-3805	276	4	(	(	PUNCT
fnp-3805	276	5	muscle	muscle	NOUN
fnp-3805	276	6	-	-	PUNCT
fnp-3805	276	7	enriched	enrich	VERB
fnp-3805	276	8	a	a	DET
fnp-3805	276	9	-	-	PUNCT
fnp-3805	276	10	type	type	NOUN
fnp-3805	276	11	lamin	lamin	NOUN
fnp-3805	276	12	-	-	PUNCT
fnp-3805	276	13	interacting	interact	VERB
fnp-3805	276	14	protein	protein	NOUN
fnp-3805	276	15	)	)	PUNCT
fnp-3805	276	16	leads	lead	VERB
fnp-3805	276	17	to	to	ADP
fnp-3805	276	18	cardiac	cardiac	ADJ
fnp-3805	276	19	hyperactivation	hyperactivation	NOUN
fnp-3805	276	20	of	of	ADP
fnp-3805	276	21	akt	akt	PROPN
fnp-3805	276	22	/	/	SYM
fnp-3805	276	23	mammalian	mammalian	ADJ
fnp-3805	276	24	target	target	NOUN
fnp-3805	276	25	of	of	ADP
fnp-3805	276	26	rapamycin	rapamycin	NOUN
fnp-3805	276	27	(	(	PUNCT
fnp-3805	276	28	mtor	mtor	NOUN
fnp-3805	276	29	)	)	PUNCT
fnp-3805	276	30	and	and	CCONJ
fnp-3805	276	31	impaired	impaired	ADJ
fnp-3805	276	32	cardiac	cardiac	ADJ
fnp-3805	276	33	adaptation	adaptation	NOUN
fnp-3805	276	34	.	.	PUNCT
fnp-3805	277	1	j	j	PROPN
fnp-3805	277	2	biol	biol	PROPN
fnp-3805	277	3	chem	chem	NOUN
fnp-3805	277	4	290	290	NUM
fnp-3805	277	5	,	,	PUNCT
fnp-3805	277	6	26699	26699	NUM
fnp-3805	277	7	-	-	SYM
fnp-3805	277	8	26714	26714	NUM
fnp-3805	277	9	.	.	PUNCT
fnp-3805	278	1	collier	collier	PROPN
fnp-3805	278	2	,	,	PUNCT
fnp-3805	278	3	j.j	j.j	PROPN
fnp-3805	278	4	.	.	PROPN
fnp-3805	278	5	,	,	PUNCT
fnp-3805	278	6	guissart	guissart	PROPN
fnp-3805	278	7	,	,	PUNCT
fnp-3805	278	8	c.	c.	PROPN
fnp-3805	278	9	,	,	PUNCT
fnp-3805	278	10	olahova	olahova	PROPN
fnp-3805	278	11	,	,	PUNCT
fnp-3805	278	12	m.	m.	NOUN
fnp-3805	278	13	,	,	PUNCT
fnp-3805	278	14	sasorith	sasorith	PROPN
fnp-3805	278	15	,	,	PUNCT
fnp-3805	278	16	s.	s.	PROPN
fnp-3805	278	17	,	,	PUNCT
fnp-3805	278	18	piron	piron	NOUN
fnp-3805	278	19	-	-	PUNCT
fnp-3805	278	20	prunier	prunier	NOUN
fnp-3805	278	21	,	,	PUNCT
fnp-3805	278	22	f.	f.	PROPN
fnp-3805	278	23	,	,	PUNCT
fnp-3805	278	24	suomi	suomi	PROPN
fnp-3805	278	25	,	,	PUNCT
fnp-3805	278	26	f.	f.	PROPN
fnp-3805	278	27	,	,	PUNCT
fnp-3805	278	28	zhang	zhang	PROPN
fnp-3805	278	29	,	,	PUNCT
fnp-3805	278	30	d.	d.	PROPN
fnp-3805	278	31	,	,	PUNCT
fnp-3805	278	32	martinez	martinez	PROPN
fnp-3805	278	33	-	-	PUNCT
fnp-3805	278	34	lopez	lopez	NOUN
fnp-3805	278	35	,	,	PUNCT
fnp-3805	278	36	n.	n.	NOUN
fnp-3805	278	37	,	,	PUNCT
fnp-3805	278	38	leboucq	leboucq	PROPN
fnp-3805	278	39	,	,	PUNCT
fnp-3805	278	40	n.	n.	NOUN
fnp-3805	278	41	,	,	PUNCT
fnp-3805	278	42	bahr	bahr	PROPN
fnp-3805	278	43	,	,	PUNCT
fnp-3805	278	44	a.	a.	PROPN
fnp-3805	278	45	,	,	PUNCT
fnp-3805	278	46	et	et	PROPN
fnp-3805	278	47	al	al	PROPN
fnp-3805	278	48	.	.	PROPN
fnp-3805	278	49	(	(	PUNCT
fnp-3805	278	50	2021	2021	NUM
fnp-3805	278	51	)	)	PUNCT
fnp-3805	278	52	.	.	PUNCT
fnp-3805	279	1	developmental	developmental	ADJ
fnp-3805	279	2	consequences	consequence	NOUN
fnp-3805	279	3	of	of	ADP
fnp-3805	279	4	defective	defective	ADJ
fnp-3805	279	5	atg7	atg7	NOUN
fnp-3805	279	6	-	-	PUNCT
fnp-3805	279	7	mediated	mediate	VERB
fnp-3805	279	8	autophagy	autophagy	NOUN
fnp-3805	279	9	in	in	ADP
fnp-3805	279	10	humans	human	NOUN
fnp-3805	279	11	.	.	PUNCT
fnp-3805	280	1	n	n	PRON
fnp-3805	280	2	engl	engl	PROPN
fnp-3805	280	3	j	j	PROPN
fnp-3805	280	4	med	med	PROPN
fnp-3805	280	5	384	384	NUM
fnp-3805	280	6	,	,	PUNCT
fnp-3805	280	7	2406	2406	NUM
fnp-3805	280	8	-	-	SYM
fnp-3805	280	9	2417	2417	NUM
fnp-3805	280	10	.	.	PUNCT
fnp-3805	281	1	costa	costa	PROPN
fnp-3805	281	2	-	-	PUNCT
fnp-3805	281	3	mattioli	mattioli	PROPN
fnp-3805	281	4	,	,	PUNCT
fnp-3805	281	5	m.	m.	NOUN
fnp-3805	281	6	,	,	PUNCT
fnp-3805	281	7	and	and	CCONJ
fnp-3805	281	8	walter	walter	PROPN
fnp-3805	281	9	,	,	PUNCT
fnp-3805	281	10	p.	p.	NOUN
fnp-3805	281	11	(	(	PUNCT
fnp-3805	281	12	2020	2020	NUM
fnp-3805	281	13	)	)	PUNCT
fnp-3805	281	14	.	.	PUNCT
fnp-3805	282	1	the	the	DET
fnp-3805	282	2	integrated	integrate	VERB
fnp-3805	282	3	stress	stress	NOUN
fnp-3805	282	4	response	response	NOUN
fnp-3805	282	5	:	:	PUNCT
fnp-3805	282	6	from	from	ADP
fnp-3805	282	7	mechanism	mechanism	NOUN
fnp-3805	282	8	to	to	PART
fnp-3805	282	9	disease	disease	VERB
fnp-3805	282	10	.	.	PUNCT
fnp-3805	283	1	science	science	NOUN
fnp-3805	283	2	368	368	NUM
fnp-3805	283	3	,	,	PUNCT
fnp-3805	283	4	eaat5314	eaat5314	PROPN
fnp-3805	283	5	.	.	PUNCT
fnp-3805	283	6	deschauer	deschauer	PROPN
fnp-3805	283	7	,	,	PUNCT
fnp-3805	283	8	m.	m.	NOUN
fnp-3805	283	9	,	,	PUNCT
fnp-3805	283	10	hengel	hengel	PROPN
fnp-3805	283	11	,	,	PUNCT
fnp-3805	283	12	h.	h.	PROPN
fnp-3805	283	13	,	,	PUNCT
fnp-3805	283	14	rupprich	rupprich	PROPN
fnp-3805	283	15	,	,	PUNCT
fnp-3805	283	16	k.	k.	PROPN
fnp-3805	283	17	,	,	PUNCT
fnp-3805	283	18	kreiss	kreiss	PROPN
fnp-3805	283	19	,	,	PUNCT
fnp-3805	283	20	m.	m.	NOUN
fnp-3805	283	21	,	,	PUNCT
fnp-3805	283	22	schlotter	schlotter	NOUN
fnp-3805	283	23	-	-	PUNCT
fnp-3805	283	24	weigel	weigel	PROPN
fnp-3805	283	25	,	,	PUNCT
fnp-3805	283	26	b.	b.	PROPN
fnp-3805	283	27	,	,	PUNCT
fnp-3805	283	28	grimmel	grimmel	NOUN
fnp-3805	283	29	,	,	PUNCT
fnp-3805	283	30	m.	m.	NOUN
fnp-3805	283	31	,	,	PUNCT
fnp-3805	283	32	admard	admard	PROPN
fnp-3805	283	33	,	,	PUNCT
fnp-3805	283	34	j.	j.	PROPN
fnp-3805	283	35	,	,	PUNCT
fnp-3805	283	36	schneider	schneider	PROPN
fnp-3805	283	37	,	,	PUNCT
fnp-3805	283	38	i.	i.	PROPN
fnp-3805	283	39	,	,	PUNCT
fnp-3805	283	40	alhaddad	alhaddad	PROPN
fnp-3805	283	41	,	,	PUNCT
fnp-3805	283	42	b.	b.	PROPN
fnp-3805	283	43	,	,	PUNCT
fnp-3805	283	44	gazou	gazou	PROPN
fnp-3805	283	45	,	,	PUNCT
fnp-3805	283	46	a.	a.	NOUN
fnp-3805	283	47	,	,	PUNCT
fnp-3805	283	48	et	et	PROPN
fnp-3805	283	49	al	al	PROPN
fnp-3805	283	50	.	.	PROPN
fnp-3805	284	1	(	(	PUNCT
fnp-3805	284	2	2021	2021	NUM
fnp-3805	284	3	)	)	PUNCT
fnp-3805	284	4	.	.	PUNCT
fnp-3805	285	1	bi	bi	ADJ
fnp-3805	285	2	-	-	ADJ
fnp-3805	285	3	allelic	allelic	ADJ
fnp-3805	285	4	truncating	truncate	VERB
fnp-3805	285	5	mutations	mutation	NOUN
fnp-3805	285	6	in	in	ADP
fnp-3805	285	7	vwa1	vwa1	NOUN
fnp-3805	285	8	cause	cause	VERB
fnp-3805	285	9	neuromyopathy	neuromyopathy	ADJ
fnp-3805	285	10	.	.	PUNCT
fnp-3805	286	1	brain	brain	NOUN
fnp-3805	286	2	144	144	NUM
fnp-3805	286	3	,	,	PUNCT
fnp-3805	286	4	574	574	NUM
fnp-3805	286	5	-	-	SYM
fnp-3805	286	6	583	583	NUM
fnp-3805	286	7	.	.	PUNCT
fnp-3805	287	1	diaz	diaz	PROPN
fnp-3805	287	2	-	-	PUNCT
fnp-3805	287	3	manera	manera	PROPN
fnp-3805	287	4	,	,	PUNCT
fnp-3805	287	5	j.	j.	PROPN
fnp-3805	287	6	,	,	PUNCT
fnp-3805	287	7	kishnani	kishnani	PROPN
fnp-3805	287	8	,	,	PUNCT
fnp-3805	287	9	p.s	p.s	PROPN
fnp-3805	287	10	.	.	PROPN
fnp-3805	287	11	,	,	PUNCT
fnp-3805	287	12	kushlaf	kushlaf	PROPN
fnp-3805	287	13	,	,	PUNCT
fnp-3805	287	14	h.	h.	PROPN
fnp-3805	287	15	,	,	PUNCT
fnp-3805	287	16	ladha	ladha	PROPN
fnp-3805	287	17	,	,	PUNCT
fnp-3805	287	18	s.	s.	PROPN
fnp-3805	287	19	,	,	PUNCT
fnp-3805	287	20	mozaffar	mozaffar	ADV
fnp-3805	287	21	,	,	PUNCT
fnp-3805	287	22	t.	t.	PROPN
fnp-3805	287	23	,	,	PUNCT
fnp-3805	287	24	straub	straub	PROPN
fnp-3805	287	25	,	,	PUNCT
fnp-3805	287	26	v.	v.	PROPN
fnp-3805	287	27	,	,	PUNCT
fnp-3805	287	28	toscano	toscano	PROPN
fnp-3805	287	29	,	,	PUNCT
fnp-3805	287	30	a.	a.	PROPN
fnp-3805	287	31	,	,	PUNCT
fnp-3805	287	32	van	van	PROPN
fnp-3805	287	33	der	der	PROPN
fnp-3805	287	34	ploeg	ploeg	PROPN
fnp-3805	287	35	,	,	PUNCT
fnp-3805	287	36	a.t	a.t	PROPN
fnp-3805	287	37	.	.	PROPN
fnp-3805	287	38	,	,	PUNCT
fnp-3805	287	39	berger	berger	PROPN
fnp-3805	287	40	,	,	PUNCT
fnp-3805	287	41	k.i	k.i	PROPN
fnp-3805	287	42	.	.	PROPN
fnp-3805	287	43	,	,	PUNCT
fnp-3805	287	44	clemens	clemens	PROPN
fnp-3805	287	45	,	,	PUNCT
fnp-3805	287	46	p.r	p.r	PROPN
fnp-3805	287	47	.	.	PROPN
fnp-3805	287	48	,	,	PUNCT
fnp-3805	287	49	et	et	PROPN
fnp-3805	287	50	al	al	PROPN
fnp-3805	287	51	.	.	PROPN
fnp-3805	287	52	(	(	PUNCT
fnp-3805	287	53	2021	2021	NUM
fnp-3805	287	54	)	)	PUNCT
fnp-3805	287	55	.	.	PUNCT
fnp-3805	288	1	safety	safety	NOUN
fnp-3805	288	2	and	and	CCONJ
fnp-3805	288	3	efficacy	efficacy	NOUN
fnp-3805	288	4	of	of	ADP
fnp-3805	288	5	avalglucosidase	avalglucosidase	PROPN
fnp-3805	288	6	alfa	alfa	NOUN
fnp-3805	288	7	versus	versus	ADP
fnp-3805	288	8	alglucosidase	alglucosidase	NOUN
fnp-3805	288	9	alfa	alfa	NOUN
fnp-3805	288	10	in	in	ADP
fnp-3805	288	11	patients	patient	NOUN
fnp-3805	288	12	with	with	ADP
fnp-3805	288	13	late	late	ADJ
fnp-3805	288	14	-	-	PUNCT
fnp-3805	288	15	onset	onset	NOUN
fnp-3805	288	16	pompe	pompe	NOUN
fnp-3805	288	17	disease	disease	NOUN
fnp-3805	288	18	(	(	PUNCT
fnp-3805	288	19	comet	comet	PROPN
fnp-3805	288	20	):	):	PUNCT
fnp-3805	288	21	a	a	DET
fnp-3805	288	22	phase	phase	NOUN
fnp-3805	288	23	3	3	NUM
fnp-3805	288	24	,	,	PUNCT
fnp-3805	288	25	randomised	randomise	VERB
fnp-3805	288	26	,	,	PUNCT
fnp-3805	288	27	multicentre	multicentre	NOUN
fnp-3805	288	28	trial	trial	NOUN
fnp-3805	288	29	.	.	PUNCT
fnp-3805	289	1	lancet	lancet	PROPN
fnp-3805	289	2	neurol	neurol	PROPN
fnp-3805	289	3	20	20	NUM
fnp-3805	289	4	,	,	PUNCT
fnp-3805	289	5	1012	1012	NUM
fnp-3805	289	6	-	-	SYM
fnp-3805	289	7	1026	1026	NUM
fnp-3805	289	8	.	.	PUNCT
fnp-3805	290	1	dodig	dodig	PROPN
fnp-3805	290	2	,	,	PUNCT
fnp-3805	290	3	d.	d.	PROPN
fnp-3805	290	4	,	,	PUNCT
fnp-3805	290	5	tarnopolsky	tarnopolsky	PROPN
fnp-3805	290	6	,	,	PUNCT
fnp-3805	290	7	m.a	m.a	PROPN
fnp-3805	290	8	.	.	PROPN
fnp-3805	290	9	,	,	PUNCT
fnp-3805	290	10	margeta	margeta	NOUN
fnp-3805	290	11	,	,	PUNCT
fnp-3805	290	12	m.	m.	NOUN
fnp-3805	290	13	,	,	PUNCT
fnp-3805	290	14	gordon	gordon	PROPN
fnp-3805	290	15	,	,	PUNCT
fnp-3805	290	16	k.	k.	PROPN
fnp-3805	290	17	,	,	PUNCT
fnp-3805	290	18	fritzler	fritzler	PROPN
fnp-3805	290	19	,	,	PUNCT
fnp-3805	290	20	m.j	m.j	PROPN
fnp-3805	290	21	.	.	PROPN
fnp-3805	290	22	,	,	PUNCT
fnp-3805	290	23	and	and	CCONJ
fnp-3805	290	24	lu	lu	PROPN
fnp-3805	290	25	,	,	PUNCT
fnp-3805	290	26	j.q	j.q	PROPN
fnp-3805	290	27	.	.	PROPN
fnp-3805	290	28	(	(	PUNCT
fnp-3805	290	29	2022	2022	NUM
fnp-3805	290	30	)	)	PUNCT
fnp-3805	290	31	.	.	PUNCT
fnp-3805	291	1	covid-19	covid-19	PROPN
fnp-3805	291	2	-	-	PUNCT
fnp-3805	291	3	associated	associate	VERB
fnp-3805	291	4	critical	critical	ADJ
fnp-3805	291	5	illness	illness	NOUN
fnp-3805	291	6	myopathy	myopathy	ADJ
fnp-3805	291	7	with	with	ADP
fnp-3805	291	8	direct	direct	ADJ
fnp-3805	291	9	viral	viral	ADJ
fnp-3805	291	10	effects	effect	NOUN
fnp-3805	291	11	.	.	PUNCT
fnp-3805	292	1	ann	ann	PROPN
fnp-3805	292	2	neurol	neurol	PROPN
fnp-3805	292	3	,	,	PUNCT
fnp-3805	292	4	epub	epub	NOUN
fnp-3805	292	5	ahead	ahead	ADV
fnp-3805	292	6	of	of	ADP
fnp-3805	292	7	print	print	NOUN
fnp-3805	292	8	.	.	PUNCT
fnp-3805	293	1	esslinger	esslinger	NOUN
fnp-3805	293	2	,	,	PUNCT
fnp-3805	293	3	u.	u.	PROPN
fnp-3805	293	4	,	,	PUNCT
fnp-3805	293	5	garnier	garnier	PROPN
fnp-3805	293	6	,	,	PUNCT
fnp-3805	293	7	s.	s.	PROPN
fnp-3805	293	8	,	,	PUNCT
fnp-3805	293	9	korniat	korniat	PROPN
fnp-3805	293	10	,	,	PUNCT
fnp-3805	293	11	a.	a.	PROPN
fnp-3805	293	12	,	,	PUNCT
fnp-3805	293	13	proust	proust	PROPN
fnp-3805	293	14	,	,	PUNCT
fnp-3805	293	15	c.	c.	PROPN
fnp-3805	293	16	,	,	PUNCT
fnp-3805	293	17	kararigas	kararigas	PROPN
fnp-3805	293	18	,	,	PUNCT
fnp-3805	293	19	g.	g.	PROPN
fnp-3805	293	20	,	,	PUNCT
fnp-3805	293	21	muller	muller	NOUN
fnp-3805	293	22	-	-	PUNCT
fnp-3805	293	23	nurasyid	nurasyid	NOUN
fnp-3805	293	24	,	,	PUNCT
fnp-3805	293	25	m.	m.	NOUN
fnp-3805	293	26	,	,	PUNCT
fnp-3805	293	27	empana	empana	PROPN
fnp-3805	293	28	,	,	PUNCT
fnp-3805	293	29	j.p	j.p	PROPN
fnp-3805	293	30	.	.	PROPN
fnp-3805	293	31	,	,	PUNCT
fnp-3805	293	32	morley	morley	PROPN
fnp-3805	293	33	,	,	PUNCT
fnp-3805	293	34	m.p	m.p	PROPN
fnp-3805	293	35	.	.	PROPN
fnp-3805	293	36	,	,	PUNCT
fnp-3805	293	37	perret	perret	PROPN
fnp-3805	293	38	,	,	PUNCT
fnp-3805	293	39	c.	c.	PROPN
fnp-3805	293	40	,	,	PUNCT
fnp-3805	293	41	stark	stark	PROPN
fnp-3805	293	42	,	,	PUNCT
fnp-3805	293	43	k.	k.	PROPN
fnp-3805	293	44	,	,	PUNCT
fnp-3805	293	45	et	et	PROPN
fnp-3805	293	46	al	al	PROPN
fnp-3805	293	47	.	.	PUNCT
fnp-3805	293	48	(	(	PUNCT
fnp-3805	293	49	2017	2017	NUM
fnp-3805	293	50	)	)	PUNCT
fnp-3805	293	51	.	.	PUNCT
fnp-3805	294	1	exome	exome	NOUN
fnp-3805	294	2	-	-	PUNCT
fnp-3805	294	3	wide	wide	ADJ
fnp-3805	294	4	association	association	NOUN
fnp-3805	294	5	study	study	NOUN
fnp-3805	294	6	reveals	reveal	VERB
fnp-3805	294	7	novel	novel	ADJ
fnp-3805	294	8	susceptibility	susceptibility	NOUN
fnp-3805	294	9	genes	gene	NOUN
fnp-3805	294	10	to	to	ADP
fnp-3805	294	11	sporadic	sporadic	ADJ
fnp-3805	294	12	dilated	dilated	ADJ
fnp-3805	294	13	cardiomyopathy	cardiomyopathy	NOUN
fnp-3805	294	14	.	.	PUNCT
fnp-3805	295	1	plos	plos	PROPN
fnp-3805	295	2	one	one	NUM
fnp-3805	295	3	12	12	NUM
fnp-3805	295	4	,	,	PUNCT
fnp-3805	295	5	e0172995	e0172995	NOUN
fnp-3805	295	6	.	.	PUNCT
fnp-3805	295	7	filosto	filosto	PROPN
fnp-3805	295	8	,	,	PUNCT
fnp-3805	295	9	m.	m.	NOUN
fnp-3805	295	10	,	,	PUNCT
fnp-3805	295	11	cotti	cotti	PROPN
fnp-3805	295	12	piccinelli	piccinelli	PROPN
fnp-3805	295	13	,	,	PUNCT
fnp-3805	295	14	s.	s.	PROPN
fnp-3805	295	15	,	,	PUNCT
fnp-3805	295	16	gazzina	gazzina	PROPN
fnp-3805	295	17	,	,	PUNCT
fnp-3805	295	18	s.	s.	PROPN
fnp-3805	295	19	,	,	PUNCT
fnp-3805	295	20	foresti	foresti	PROPN
fnp-3805	295	21	,	,	PUNCT
fnp-3805	295	22	c.	c.	NOUN
fnp-3805	295	23	,	,	PUNCT
fnp-3805	295	24	frigeni	frigeni	NOUN
fnp-3805	295	25	,	,	PUNCT
fnp-3805	295	26	b.	b.	PROPN
fnp-3805	295	27	,	,	PUNCT
fnp-3805	295	28	servalli	servalli	PROPN
fnp-3805	295	29	,	,	PUNCT
fnp-3805	295	30	m.c	m.c	PROPN
fnp-3805	295	31	.	.	PROPN
fnp-3805	295	32	,	,	PUNCT
fnp-3805	295	33	sessa	sessa	NOUN
fnp-3805	295	34	,	,	PUNCT
fnp-3805	295	35	m.	m.	NOUN
fnp-3805	295	36	,	,	PUNCT
fnp-3805	295	37	cosentino	cosentino	PROPN
fnp-3805	295	38	,	,	PUNCT
fnp-3805	295	39	g.	g.	PROPN
fnp-3805	295	40	,	,	PUNCT
fnp-3805	295	41	marchioni	marchioni	NOUN
fnp-3805	295	42	,	,	PUNCT
fnp-3805	295	43	e.	e.	PROPN
fnp-3805	295	44	,	,	PUNCT
fnp-3805	295	45	ravaglia	ravaglia	PROPN
fnp-3805	295	46	,	,	PUNCT
fnp-3805	295	47	s.	s.	PROPN
fnp-3805	295	48	,	,	PUNCT
fnp-3805	295	49	et	et	PROPN
fnp-3805	295	50	al	al	PROPN
fnp-3805	295	51	.	.	PUNCT
fnp-3805	296	1	(	(	PUNCT
fnp-3805	296	2	2021	2021	NUM
fnp-3805	296	3	)	)	PUNCT
fnp-3805	296	4	.	.	PUNCT
fnp-3805	297	1	guillain	guillain	NOUN
fnp-3805	297	2	-	-	PUNCT
fnp-3805	297	3	barre	barre	NOUN
fnp-3805	297	4	syndrome	syndrome	NOUN
fnp-3805	297	5	and	and	CCONJ
fnp-3805	297	6	covid-19	covid-19	PROPN
fnp-3805	297	7	:	:	PUNCT
fnp-3805	297	8	an	an	DET
fnp-3805	297	9	observational	observational	ADJ
fnp-3805	297	10	multicentre	multicentre	NOUN
fnp-3805	297	11	study	study	NOUN
fnp-3805	297	12	from	from	ADP
fnp-3805	297	13	two	two	NUM
fnp-3805	297	14	italian	italian	ADJ
fnp-3805	297	15	hotspot	hotspot	NOUN
fnp-3805	297	16	regions	region	NOUN
fnp-3805	297	17	.	.	PUNCT
fnp-3805	298	1	j	j	PROPN
fnp-3805	298	2	neurol	neurol	PROPN
fnp-3805	298	3	neurosurg	neurosurg	PROPN
fnp-3805	298	4	psychiatry	psychiatry	PROPN
fnp-3805	298	5	92	92	NUM
fnp-3805	298	6	,	,	PUNCT
fnp-3805	298	7	751	751	NUM
fnp-3805	298	8	-	-	SYM
fnp-3805	298	9	756	756	NUM
fnp-3805	298	10	.	.	PUNCT
fnp-3805	299	1	fragiel	fragiel	PROPN
fnp-3805	299	2	,	,	PUNCT
fnp-3805	299	3	m.	m.	NOUN
fnp-3805	299	4	,	,	PUNCT
fnp-3805	299	5	miro	miro	PROPN
fnp-3805	299	6	,	,	PUNCT
fnp-3805	299	7	o.	o.	PROPN
fnp-3805	299	8	,	,	PUNCT
fnp-3805	299	9	llorens	llorens	PROPN
fnp-3805	299	10	,	,	PUNCT
fnp-3805	299	11	p.	p.	PROPN
fnp-3805	299	12	,	,	PUNCT
fnp-3805	299	13	jimenez	jimenez	PROPN
fnp-3805	299	14	,	,	PUNCT
fnp-3805	299	15	s.	s.	PROPN
fnp-3805	299	16	,	,	PUNCT
fnp-3805	299	17	pinera	pinera	PROPN
fnp-3805	299	18	,	,	PUNCT
fnp-3805	299	19	p.	p.	PROPN
fnp-3805	299	20	,	,	PUNCT
fnp-3805	299	21	burillo	burillo	PROPN
fnp-3805	299	22	,	,	PUNCT
fnp-3805	299	23	g.	g.	PROPN
fnp-3805	299	24	,	,	PUNCT
fnp-3805	299	25	martin	martin	PROPN
fnp-3805	299	26	,	,	PUNCT
fnp-3805	299	27	a.	a.	PROPN
fnp-3805	299	28	,	,	PUNCT
fnp-3805	299	29	martin	martin	PROPN
fnp-3805	299	30	-	-	PUNCT
fnp-3805	299	31	sanchez	sanchez	PROPN
fnp-3805	299	32	,	,	PUNCT
fnp-3805	299	33	f.j	f.j	PROPN
fnp-3805	299	34	.	.	PROPN
fnp-3805	299	35	,	,	PUNCT
fnp-3805	299	36	garcia	garcia	PROPN
fnp-3805	299	37	-	-	PUNCT
fnp-3805	299	38	lamberechts	lamberechts	PROPN
fnp-3805	299	39	,	,	PUNCT
fnp-3805	299	40	e.j	e.j	PROPN
fnp-3805	299	41	.	.	PROPN
fnp-3805	299	42	,	,	PUNCT
fnp-3805	299	43	jacob	jacob	PROPN
fnp-3805	299	44	,	,	PUNCT
fnp-3805	299	45	j.	j.	PROPN
fnp-3805	299	46	,	,	PUNCT
fnp-3805	299	47	et	et	PROPN
fnp-3805	299	48	al	al	PROPN
fnp-3805	299	49	.	.	PROPN
fnp-3805	299	50	(	(	PUNCT
fnp-3805	299	51	2021	2021	NUM
fnp-3805	299	52	)	)	PUNCT
fnp-3805	299	53	.	.	PUNCT
fnp-3805	300	1	incidence	incidence	NOUN
fnp-3805	300	2	,	,	PUNCT
fnp-3805	300	3	clinical	clinical	ADJ
fnp-3805	300	4	,	,	PUNCT
fnp-3805	300	5	risk	risk	NOUN
fnp-3805	300	6	factors	factor	NOUN
fnp-3805	300	7	and	and	CCONJ
fnp-3805	300	8	outcomes	outcome	NOUN
fnp-3805	300	9	of	of	ADP
fnp-3805	300	10	guillain	guillain	NOUN
fnp-3805	300	11	-	-	PUNCT
fnp-3805	300	12	barre	barre	NOUN
fnp-3805	300	13	in	in	ADP
fnp-3805	300	14	covid-19	covid-19	PROPN
fnp-3805	300	15	.	.	PUNCT
fnp-3805	301	1	ann	ann	PROPN
fnp-3805	301	2	neurol	neurol	PROPN
fnp-3805	301	3	89	89	NUM
fnp-3805	301	4	,	,	PUNCT
fnp-3805	301	5	598	598	NUM
fnp-3805	301	6	-	-	SYM
fnp-3805	301	7	603	603	NUM
fnp-3805	301	8	.	.	PUNCT
fnp-3805	302	1	ho	ho	PROPN
fnp-3805	302	2	,	,	PUNCT
fnp-3805	302	3	r.	r.	PROPN
fnp-3805	302	4	,	,	PUNCT
fnp-3805	302	5	and	and	CCONJ
fnp-3805	302	6	hegele	hegele	PROPN
fnp-3805	302	7	,	,	PUNCT
fnp-3805	302	8	r.a	r.a	PROPN
fnp-3805	302	9	.	.	PROPN
fnp-3805	302	10	(	(	PUNCT
fnp-3805	302	11	2019	2019	NUM
fnp-3805	302	12	)	)	PUNCT
fnp-3805	302	13	.	.	PUNCT
fnp-3805	303	1	complex	complex	ADJ
fnp-3805	303	2	effects	effect	NOUN
fnp-3805	303	3	of	of	ADP
fnp-3805	303	4	laminopathy	laminopathy	ADJ
fnp-3805	303	5	mutations	mutation	NOUN
fnp-3805	303	6	on	on	ADP
fnp-3805	303	7	nuclear	nuclear	ADJ
fnp-3805	303	8	structure	structure	NOUN
fnp-3805	303	9	and	and	CCONJ
fnp-3805	303	10	function	function	NOUN
fnp-3805	303	11	.	.	PUNCT
fnp-3805	304	1	clin	clin	PROPN
fnp-3805	304	2	genet	genet	PROPN
fnp-3805	304	3	95	95	NUM
fnp-3805	304	4	,	,	PUNCT
fnp-3805	304	5	199	199	NUM
fnp-3805	304	6	-	-	SYM
fnp-3805	304	7	209	209	NUM
fnp-3805	304	8	.	.	PUNCT
fnp-3805	305	1	huang	huang	PROPN
fnp-3805	305	2	,	,	PUNCT
fnp-3805	305	3	z.p	z.p	PROPN
fnp-3805	305	4	.	.	PROPN
fnp-3805	305	5	,	,	PUNCT
fnp-3805	305	6	kataoka	kataoka	PROPN
fnp-3805	305	7	,	,	PUNCT
fnp-3805	305	8	m.	m.	NOUN
fnp-3805	305	9	,	,	PUNCT
fnp-3805	305	10	chen	chen	PROPN
fnp-3805	305	11	,	,	PUNCT
fnp-3805	305	12	j.	j.	PROPN
fnp-3805	305	13	,	,	PUNCT
fnp-3805	305	14	wu	wu	PROPN
fnp-3805	305	15	,	,	PUNCT
fnp-3805	305	16	g.	g.	PROPN
fnp-3805	305	17	,	,	PUNCT
fnp-3805	305	18	ding	ding	NOUN
fnp-3805	305	19	,	,	PUNCT
fnp-3805	305	20	j.	j.	PROPN
fnp-3805	305	21	,	,	PUNCT
fnp-3805	305	22	nie	nie	PROPN
fnp-3805	305	23	,	,	PUNCT
fnp-3805	305	24	m.	m.	NOUN
fnp-3805	305	25	,	,	PUNCT
fnp-3805	305	26	lin	lin	PROPN
fnp-3805	305	27	,	,	PUNCT
fnp-3805	305	28	z.	z.	PROPN
fnp-3805	305	29	,	,	PUNCT
fnp-3805	305	30	liu	liu	PROPN
fnp-3805	305	31	,	,	PUNCT
fnp-3805	305	32	j.	j.	PROPN
fnp-3805	305	33	,	,	PUNCT
fnp-3805	305	34	hu	hu	PROPN
fnp-3805	305	35	,	,	PUNCT
fnp-3805	305	36	x.	x.	PROPN
fnp-3805	305	37	,	,	PUNCT
fnp-3805	305	38	ma	ma	PROPN
fnp-3805	305	39	,	,	PUNCT
fnp-3805	305	40	l.	l.	PROPN
fnp-3805	305	41	,	,	PUNCT
fnp-3805	305	42	et	et	PROPN
fnp-3805	305	43	al	al	PROPN
fnp-3805	305	44	.	.	PUNCT
fnp-3805	305	45	(	(	PUNCT
fnp-3805	305	46	2015	2015	NUM
fnp-3805	305	47	)	)	PUNCT
fnp-3805	305	48	.	.	PUNCT
fnp-3805	306	1	cardiomyocyte	cardiomyocyte	NOUN
fnp-3805	306	2	-	-	PUNCT
fnp-3805	306	3	enriched	enrich	VERB
fnp-3805	306	4	protein	protein	NOUN
fnp-3805	306	5	cip	cip	NOUN
fnp-3805	306	6	protects	protect	VERB
fnp-3805	306	7	against	against	ADP
fnp-3805	306	8	pathophysiological	pathophysiological	ADJ
fnp-3805	306	9	stresses	stress	NOUN
fnp-3805	306	10	and	and	CCONJ
fnp-3805	306	11	regulates	regulate	VERB
fnp-3805	306	12	cardiac	cardiac	ADJ
fnp-3805	306	13	homeostasis	homeostasis	NOUN
fnp-3805	306	14	.	.	PUNCT
fnp-3805	307	1	j	j	PROPN
fnp-3805	307	2	clin	clin	PROPN
fnp-3805	307	3	invest	invest	VERB
fnp-3805	307	4	125	125	NUM
fnp-3805	307	5	,	,	PUNCT
fnp-3805	307	6	4122	4122	NUM
fnp-3805	307	7	-	-	SYM
fnp-3805	307	8	4134	4134	NUM
fnp-3805	307	9	.	.	PUNCT
fnp-3805	308	1	jha	jha	PROPN
fnp-3805	308	2	,	,	PUNCT
fnp-3805	308	3	m.k	m.k	PROPN
fnp-3805	308	4	.	.	PROPN
fnp-3805	308	5	,	,	PUNCT
fnp-3805	308	6	passero	passero	NOUN
fnp-3805	308	7	,	,	PUNCT
fnp-3805	308	8	j.v	j.v	PROPN
fnp-3805	308	9	.	.	PROPN
fnp-3805	308	10	,	,	PUNCT
fnp-3805	308	11	rawat	rawat	PROPN
fnp-3805	308	12	,	,	PUNCT
fnp-3805	308	13	a.	a.	PROPN
fnp-3805	308	14	,	,	PUNCT
fnp-3805	308	15	ament	ament	PROPN
fnp-3805	308	16	,	,	PUNCT
fnp-3805	308	17	x.h	x.h	PROPN
fnp-3805	308	18	.	.	PROPN
fnp-3805	308	19	,	,	PUNCT
fnp-3805	308	20	yang	yang	PROPN
fnp-3805	308	21	,	,	PUNCT
fnp-3805	308	22	f.	f.	PROPN
fnp-3805	308	23	,	,	PUNCT
fnp-3805	308	24	vidensky	vidensky	NOUN
fnp-3805	308	25	,	,	PUNCT
fnp-3805	308	26	s.	s.	PROPN
fnp-3805	308	27	,	,	PUNCT
fnp-3805	308	28	collins	collins	PROPN
fnp-3805	308	29	,	,	PUNCT
fnp-3805	308	30	s.l	s.l	PROPN
fnp-3805	308	31	.	.	PROPN
fnp-3805	308	32	,	,	PUNCT
fnp-3805	308	33	horton	horton	PROPN
fnp-3805	308	34	,	,	PUNCT
fnp-3805	308	35	m.r	m.r	PROPN
fnp-3805	308	36	.	.	PROPN
fnp-3805	308	37	,	,	PUNCT
fnp-3805	308	38	hoke	hoke	PROPN
fnp-3805	308	39	,	,	PUNCT
fnp-3805	308	40	a.	a.	PROPN
fnp-3805	308	41	,	,	PUNCT
fnp-3805	308	42	rutter	rutter	PROPN
fnp-3805	308	43	,	,	PUNCT
fnp-3805	308	44	g.a	g.a	PROPN
fnp-3805	308	45	.	.	PROPN
fnp-3805	308	46	,	,	PUNCT
fnp-3805	308	47	et	et	PROPN
fnp-3805	308	48	al	al	PROPN
fnp-3805	308	49	.	.	PROPN
fnp-3805	308	50	(	(	PUNCT
fnp-3805	308	51	2021	2021	NUM
fnp-3805	308	52	)	)	PUNCT
fnp-3805	308	53	.	.	PUNCT
fnp-3805	309	1	macrophage	macrophage	ADJ
fnp-3805	309	2	monocarboxylate	monocarboxylate	ADJ
fnp-3805	309	3	transporter	transporter	NOUN
fnp-3805	309	4	1	1	NUM
fnp-3805	309	5	promotes	promote	VERB
fnp-3805	309	6	peripheral	peripheral	ADJ
fnp-3805	309	7	nerve	nerve	NOUN
fnp-3805	309	8	regeneration	regeneration	NOUN
fnp-3805	309	9	after	after	ADP
fnp-3805	309	10	injury	injury	NOUN
fnp-3805	309	11	in	in	ADP
fnp-3805	309	12	mice	mouse	NOUN
fnp-3805	309	13	.	.	PUNCT
fnp-3805	310	1	j	j	PROPN
fnp-3805	310	2	clin	clin	PROPN
fnp-3805	310	3	invest	invest	VERB
fnp-3805	310	4	131	131	NUM
fnp-3805	310	5	,	,	PUNCT
fnp-3805	310	6	e141964	e141964	PROPN
fnp-3805	310	7	.	.	PUNCT
fnp-3805	311	1	johari	johari	PROPN
fnp-3805	311	2	,	,	PUNCT
fnp-3805	311	3	m.	m.	NOUN
fnp-3805	311	4	,	,	PUNCT
fnp-3805	311	5	sarparanta	sarparanta	NOUN
fnp-3805	311	6	,	,	PUNCT
fnp-3805	311	7	j.	j.	PROPN
fnp-3805	311	8	,	,	PUNCT
fnp-3805	311	9	vihola	vihola	PROPN
fnp-3805	311	10	,	,	PUNCT
fnp-3805	311	11	a.	a.	PROPN
fnp-3805	311	12	,	,	PUNCT
fnp-3805	311	13	jonson	jonson	PROPN
fnp-3805	311	14	,	,	PUNCT
fnp-3805	311	15	p.h	p.h	PROPN
fnp-3805	311	16	.	.	PROPN
fnp-3805	311	17	,	,	PUNCT
fnp-3805	311	18	savarese	savarese	ADJ
fnp-3805	311	19	,	,	PUNCT
fnp-3805	311	20	m.	m.	NOUN
fnp-3805	311	21	,	,	PUNCT
fnp-3805	311	22	jokela	jokela	PROPN
fnp-3805	311	23	,	,	PUNCT
fnp-3805	311	24	m.	m.	NOUN
fnp-3805	311	25	,	,	PUNCT
fnp-3805	311	26	torella	torella	PROPN
fnp-3805	311	27	,	,	PUNCT
fnp-3805	311	28	a.	a.	NOUN
fnp-3805	311	29	,	,	PUNCT
fnp-3805	311	30	piluso	piluso	PROPN
fnp-3805	311	31	,	,	PUNCT
fnp-3805	311	32	g.	g.	PROPN
fnp-3805	311	33	,	,	PUNCT
fnp-3805	311	34	said	say	VERB
fnp-3805	311	35	,	,	PUNCT
fnp-3805	311	36	e.	e.	PROPN
fnp-3805	311	37	,	,	PUNCT
fnp-3805	311	38	vella	vella	PROPN
fnp-3805	311	39	,	,	PUNCT
fnp-3805	311	40	n.	n.	PROPN
fnp-3805	311	41	,	,	PUNCT
fnp-3805	311	42	et	et	PROPN
fnp-3805	311	43	al	al	PROPN
fnp-3805	311	44	.	.	PROPN
fnp-3805	312	1	(	(	PUNCT
fnp-3805	312	2	2021	2021	NUM
fnp-3805	312	3	)	)	PUNCT
fnp-3805	312	4	.	.	PUNCT
fnp-3805	313	1	missense	missense	NOUN
fnp-3805	313	2	mutations	mutation	NOUN
fnp-3805	313	3	in	in	ADP
fnp-3805	313	4	small	small	ADJ
fnp-3805	313	5	muscle	muscle	NOUN
fnp-3805	313	6	protein	protein	NOUN
fnp-3805	313	7	x	x	VERB
fnp-3805	313	8	-	-	VERB
fnp-3805	313	9	linked	link	VERB
fnp-3805	313	10	(	(	PUNCT
fnp-3805	313	11	smpx	smpx	NOUN
fnp-3805	313	12	)	)	PUNCT
fnp-3805	313	13	cause	cause	VERB
fnp-3805	313	14	distal	distal	ADJ
fnp-3805	313	15	myopathy	myopathy	ADJ
fnp-3805	313	16	with	with	ADP
fnp-3805	313	17	protein	protein	NOUN
fnp-3805	313	18	inclusions	inclusion	NOUN
fnp-3805	313	19	.	.	PUNCT
fnp-3805	314	1	acta	acta	PROPN
fnp-3805	314	2	neuropathol	neuropathol	PROPN
fnp-3805	314	3	142	142	NUM
fnp-3805	314	4	,	,	PUNCT
fnp-3805	314	5	375	375	NUM
fnp-3805	314	6	-	-	SYM
fnp-3805	314	7	393	393	NUM
fnp-3805	314	8	.	.	PUNCT
fnp-3805	315	1	keddie	keddie	PROPN
fnp-3805	315	2	,	,	PUNCT
fnp-3805	315	3	s.	s.	PROPN
fnp-3805	315	4	,	,	PUNCT
fnp-3805	315	5	pakpoor	pakpoor	PROPN
fnp-3805	315	6	,	,	PUNCT
fnp-3805	315	7	j.	j.	PROPN
fnp-3805	315	8	,	,	PUNCT
fnp-3805	315	9	mousele	mousele	PROPN
fnp-3805	315	10	,	,	PUNCT
fnp-3805	315	11	c.	c.	PROPN
fnp-3805	315	12	,	,	PUNCT
fnp-3805	315	13	pipis	pipis	ADJ
fnp-3805	315	14	,	,	PUNCT
fnp-3805	315	15	m.	m.	NOUN
fnp-3805	315	16	,	,	PUNCT
fnp-3805	315	17	machado	machado	PROPN
fnp-3805	315	18	,	,	PUNCT
fnp-3805	315	19	p.m.	p.m.	NOUN
fnp-3805	315	20	,	,	PUNCT
fnp-3805	315	21	foster	foster	ADJ
fnp-3805	315	22	,	,	PUNCT
fnp-3805	315	23	m.	m.	NOUN
fnp-3805	315	24	,	,	PUNCT
fnp-3805	315	25	record	record	NOUN
fnp-3805	315	26	,	,	PUNCT
fnp-3805	315	27	c.j	c.j	PROPN
fnp-3805	315	28	.	.	PROPN
fnp-3805	315	29	,	,	PUNCT
fnp-3805	315	30	keh	keh	PROPN
fnp-3805	315	31	,	,	PUNCT
fnp-3805	315	32	r.y.s	r.y.s	PROPN
fnp-3805	315	33	.	.	PROPN
fnp-3805	315	34	,	,	PUNCT
fnp-3805	315	35	fehmi	fehmi	PROPN
fnp-3805	315	36	,	,	PUNCT
fnp-3805	315	37	j.	j.	PROPN
fnp-3805	315	38	,	,	PUNCT
fnp-3805	315	39	paterson	paterson	PROPN
fnp-3805	315	40	,	,	PUNCT
fnp-3805	315	41	r.w	r.w	PROPN
fnp-3805	315	42	.	.	PROPN
fnp-3805	315	43	,	,	PUNCT
fnp-3805	315	44	et	et	PROPN
fnp-3805	315	45	al	al	PROPN
fnp-3805	315	46	.	.	PROPN
fnp-3805	315	47	(	(	PUNCT
fnp-3805	315	48	2021	2021	NUM
fnp-3805	315	49	)	)	PUNCT
fnp-3805	315	50	.	.	PUNCT
fnp-3805	316	1	epidemiological	epidemiological	ADJ
fnp-3805	316	2	and	and	CCONJ
fnp-3805	316	3	cohort	cohort	NOUN
fnp-3805	316	4	study	study	NOUN
fnp-3805	316	5	finds	find	VERB
fnp-3805	316	6	no	no	DET
fnp-3805	316	7	association	association	NOUN
fnp-3805	316	8	between	between	ADP
fnp-3805	316	9	covid-19	covid-19	PROPN
fnp-3805	316	10	and	and	CCONJ
fnp-3805	316	11	guillain	guillain	NOUN
fnp-3805	316	12	-	-	PUNCT
fnp-3805	316	13	barre	barre	NOUN
fnp-3805	316	14	syndrome	syndrome	NOUN
fnp-3805	316	15	.	.	PUNCT
fnp-3805	317	1	brain	brain	NOUN
fnp-3805	317	2	144	144	NUM
fnp-3805	317	3	,	,	PUNCT
fnp-3805	317	4	682	682	NUM
fnp-3805	317	5	-	-	SYM
fnp-3805	317	6	693	693	NUM
fnp-3805	317	7	.	.	PUNCT
fnp-3805	318	1	keh	keh	PROPN
fnp-3805	318	2	,	,	PUNCT
fnp-3805	318	3	r.y.s	r.y.s	PROPN
fnp-3805	318	4	.	.	PROPN
fnp-3805	318	5	,	,	PUNCT
fnp-3805	318	6	scanlon	scanlon	PROPN
fnp-3805	318	7	,	,	PUNCT
fnp-3805	318	8	s.	s.	PROPN
fnp-3805	318	9	,	,	PUNCT
fnp-3805	318	10	datta	datta	NOUN
fnp-3805	318	11	-	-	PUNCT
fnp-3805	318	12	nemdharry	nemdharry	PROPN
fnp-3805	318	13	,	,	PUNCT
fnp-3805	318	14	p.	p.	PROPN
fnp-3805	318	15	,	,	PUNCT
fnp-3805	318	16	donegan	donegan	PROPN
fnp-3805	318	17	,	,	PUNCT
fnp-3805	318	18	k.	k.	PROPN
fnp-3805	318	19	,	,	PUNCT
fnp-3805	318	20	cavanagh	cavanagh	PROPN
fnp-3805	318	21	,	,	PUNCT
fnp-3805	318	22	s.	s.	PROPN
fnp-3805	318	23	,	,	PUNCT
fnp-3805	318	24	foster	foster	ADJ
fnp-3805	318	25	,	,	PUNCT
fnp-3805	318	26	m.	m.	NOUN
fnp-3805	318	27	,	,	PUNCT
fnp-3805	318	28	skelland	skelland	PROPN
fnp-3805	318	29	,	,	PUNCT
fnp-3805	318	30	d.	d.	PROPN
fnp-3805	318	31	,	,	PUNCT
fnp-3805	318	32	palmer	palmer	PROPN
fnp-3805	318	33	,	,	PUNCT
fnp-3805	318	34	j.	j.	PROPN
fnp-3805	318	35	,	,	PUNCT
fnp-3805	318	36	machado	machado	PROPN
fnp-3805	318	37	,	,	PUNCT
fnp-3805	318	38	p.m.	p.m.	NOUN
fnp-3805	318	39	,	,	PUNCT
fnp-3805	318	40	keddie	keddie	PROPN
fnp-3805	318	41	,	,	PUNCT
fnp-3805	318	42	s.	s.	PROPN
fnp-3805	318	43	,	,	PUNCT
fnp-3805	318	44	et	et	PROPN
fnp-3805	318	45	al	al	PROPN
fnp-3805	318	46	.	.	PROPN
fnp-3805	318	47	(	(	PUNCT
fnp-3805	318	48	2022	2022	NUM
fnp-3805	318	49	)	)	PUNCT
fnp-3805	318	50	.	.	PUNCT
fnp-3805	319	1	covid-19	covid-19	PROPN
fnp-3805	319	2	vaccination	vaccination	NOUN
fnp-3805	319	3	and	and	CCONJ
fnp-3805	319	4	guillain	guillain	NOUN
fnp-3805	319	5	-	-	PUNCT
fnp-3805	319	6	barré	barré	NOUN
fnp-3805	319	7	syndrome	syndrome	NOUN
fnp-3805	319	8	:	:	PUNCT
fnp-3805	319	9	analyses	analysis	NOUN
fnp-3805	319	10	using	use	VERB
fnp-3805	319	11	the	the	DET
fnp-3805	319	12	national	national	ADJ
fnp-3805	319	13	immunoglobulin	immunoglobulin	NOUN
fnp-3805	319	14	database	database	NOUN
fnp-3805	319	15	.	.	PUNCT
fnp-3805	320	1	medrxiv	medrxiv	PROPN
fnp-3805	320	2	,	,	PUNCT
fnp-3805	320	3	2021.2012.2014.21267418	2021.2012.2014.21267418	PROPN
fnp-3805	320	4	.	.	PUNCT
fnp-3805	321	1	kieninger	kieninger	PROPN
fnp-3805	321	2	,	,	PUNCT
fnp-3805	321	3	s.	s.	PROPN
fnp-3805	321	4	,	,	PUNCT
fnp-3805	321	5	xiao	xiao	PROPN
fnp-3805	321	6	,	,	PUNCT
fnp-3805	321	7	t.	t.	PROPN
fnp-3805	321	8	,	,	PUNCT
fnp-3805	321	9	weisschuh	weisschuh	PROPN
fnp-3805	321	10	,	,	PUNCT
fnp-3805	321	11	n.	n.	NOUN
fnp-3805	321	12	,	,	PUNCT
fnp-3805	321	13	kohl	kohl	NOUN
fnp-3805	321	14	,	,	PUNCT
fnp-3805	321	15	s.	s.	PROPN
fnp-3805	321	16	,	,	PUNCT
fnp-3805	321	17	ruther	ruther	PROPN
fnp-3805	321	18	,	,	PUNCT
fnp-3805	321	19	k.	k.	PROPN
fnp-3805	321	20	,	,	PUNCT
fnp-3805	321	21	kroisel	kroisel	PROPN
fnp-3805	321	22	,	,	PUNCT
fnp-3805	321	23	p.m.	p.m.	NOUN
fnp-3805	321	24	,	,	PUNCT
fnp-3805	321	25	brockmann	brockmann	NOUN
fnp-3805	321	26	,	,	PUNCT
fnp-3805	321	27	t.	t.	PROPN
fnp-3805	321	28	,	,	PUNCT
fnp-3805	321	29	knappe	knappe	PROPN
fnp-3805	321	30	,	,	PUNCT
fnp-3805	321	31	s.	s.	PROPN
fnp-3805	321	32	,	,	PUNCT
fnp-3805	321	33	kellner	kellner	PROPN
fnp-3805	321	34	,	,	PUNCT
fnp-3805	321	35	u.	u.	PROPN
fnp-3805	321	36	,	,	PUNCT
fnp-3805	321	37	lagreze	lagreze	PROPN
fnp-3805	321	38	,	,	PUNCT
fnp-3805	321	39	w.	w.	PROPN
fnp-3805	321	40	,	,	PUNCT
fnp-3805	321	41	et	et	PROPN
fnp-3805	321	42	al	al	PROPN
fnp-3805	321	43	.	.	PROPN
fnp-3805	321	44	(	(	PUNCT
fnp-3805	321	45	2022	2022	NUM
fnp-3805	321	46	)	)	PUNCT
fnp-3805	321	47	.	.	PUNCT
fnp-3805	322	1	dnajc30	dnajc30	NOUN
fnp-3805	322	2	disease	disease	NOUN
fnp-3805	322	3	-	-	PUNCT
fnp-3805	322	4	causing	cause	VERB
fnp-3805	322	5	gene	gene	NOUN
fnp-3805	322	6	variants	variant	NOUN
fnp-3805	322	7	in	in	ADP
fnp-3805	322	8	a	a	DET
fnp-3805	322	9	large	large	ADJ
fnp-3805	322	10	central	central	ADJ
fnp-3805	322	11	european	european	ADJ
fnp-3805	322	12	cohort	cohort	NOUN
fnp-3805	322	13	of	of	ADP
fnp-3805	322	14	patients	patient	NOUN
fnp-3805	322	15	with	with	ADP
fnp-3805	322	16	suspected	suspect	VERB
fnp-3805	322	17	leber	leber	PROPN
fnp-3805	322	18	's	's	PART
fnp-3805	322	19	hereditary	hereditary	ADJ
fnp-3805	322	20	optic	optic	NOUN
fnp-3805	322	21	neuropathy	neuropathy	ADJ
fnp-3805	322	22	and	and	CCONJ
fnp-3805	322	23	optic	optic	ADJ
fnp-3805	322	24	atrophy	atrophy	NOUN
fnp-3805	322	25	.	.	PUNCT
fnp-3805	323	1	j	j	PROPN
fnp-3805	323	2	med	med	PROPN
fnp-3805	323	3	genet	genet	PROPN
fnp-3805	323	4	.	.	PUNCT
fnp-3805	324	1	leoni	leoni	PROPN
fnp-3805	324	2	,	,	PUNCT
fnp-3805	324	3	t.b	t.b	PROPN
fnp-3805	324	4	.	.	PROPN
fnp-3805	324	5	,	,	PUNCT
fnp-3805	324	6	gonzalez	gonzalez	PROPN
fnp-3805	324	7	-	-	PUNCT
fnp-3805	324	8	salazar	salazar	PROPN
fnp-3805	324	9	,	,	PUNCT
fnp-3805	324	10	c.	c.	PROPN
fnp-3805	324	11	,	,	PUNCT
fnp-3805	324	12	rezende	rezende	PROPN
fnp-3805	324	13	,	,	PUNCT
fnp-3805	324	14	t.j.r	t.j.r	PROPN
fnp-3805	324	15	.	.	PROPN
fnp-3805	324	16	,	,	PUNCT
fnp-3805	324	17	hernandez	hernandez	PROPN
fnp-3805	324	18	,	,	PUNCT
fnp-3805	324	19	a.l.c	a.l.c	NOUN
fnp-3805	324	20	.	.	PROPN
fnp-3805	324	21	,	,	PUNCT
fnp-3805	324	22	mattos	mattos	PROPN
fnp-3805	324	23	,	,	PUNCT
fnp-3805	324	24	a.h.b	a.h.b	PROPN
fnp-3805	324	25	.	.	PROPN
fnp-3805	324	26	,	,	PUNCT
fnp-3805	324	27	coimbra	coimbra	PROPN
fnp-3805	324	28	neto	neto	PROPN
fnp-3805	324	29	,	,	PUNCT
fnp-3805	324	30	a.r	a.r	PROPN
fnp-3805	324	31	.	.	PROPN
fnp-3805	324	32	,	,	PUNCT
fnp-3805	324	33	da	da	PROPN
fnp-3805	324	34	graca	graca	PROPN
fnp-3805	324	35	,	,	PUNCT
fnp-3805	324	36	f.f	f.f	PROPN
fnp-3805	324	37	.	.	PROPN
fnp-3805	324	38	,	,	PUNCT
fnp-3805	324	39	goncalves	goncalve	NOUN
fnp-3805	324	40	,	,	PUNCT
fnp-3805	324	41	j.p.n	j.p.n	PROPN
fnp-3805	324	42	.	.	PROPN
fnp-3805	324	43	,	,	PUNCT
fnp-3805	324	44	martinez	martinez	PROPN
fnp-3805	324	45	,	,	PUNCT
fnp-3805	324	46	a.r.m	a.r.m	PROPN
fnp-3805	324	47	.	.	PROPN
fnp-3805	324	48	,	,	PUNCT
fnp-3805	324	49	taniguti	taniguti	NOUN
fnp-3805	324	50	,	,	PUNCT
fnp-3805	324	51	l.	l.	PROPN
fnp-3805	324	52	,	,	PUNCT
fnp-3805	324	53	et	et	PROPN
fnp-3805	324	54	al	al	PROPN
fnp-3805	324	55	.	.	PROPN
fnp-3805	324	56	(	(	PUNCT
fnp-3805	324	57	2021	2021	NUM
fnp-3805	324	58	)	)	PUNCT
fnp-3805	324	59	.	.	PUNCT
fnp-3805	325	1	a	a	DET
fnp-3805	325	2	novel	novel	ADJ
fnp-3805	325	3	multisystem	multisystem	NOUN
fnp-3805	325	4	proteinopathy	proteinopathy	ADJ
fnp-3805	325	5	caused	cause	VERB
fnp-3805	325	6	by	by	ADP
fnp-3805	325	7	a	a	DET
fnp-3805	325	8	missense	missense	NOUN
fnp-3805	325	9	anxa11	anxa11	NOUN
fnp-3805	325	10	variant	variant	NOUN
fnp-3805	325	11	.	.	PUNCT
fnp-3805	326	1	ann	ann	PROPN
fnp-3805	326	2	neurol	neurol	PROPN
fnp-3805	326	3	90	90	NUM
fnp-3805	326	4	,	,	PUNCT
fnp-3805	326	5	239	239	NUM
fnp-3805	326	6	-	-	SYM
fnp-3805	326	7	252	252	NUM
fnp-3805	326	8	.	.	PUNCT
fnp-3805	327	1	liu	liu	PROPN
fnp-3805	327	2	,	,	PUNCT
fnp-3805	327	3	j.	j.	PROPN
fnp-3805	327	4	,	,	PUNCT
fnp-3805	327	5	huang	huang	PROPN
fnp-3805	327	6	,	,	PUNCT
fnp-3805	327	7	z.p	z.p	PROPN
fnp-3805	327	8	.	.	PROPN
fnp-3805	327	9	,	,	PUNCT
fnp-3805	327	10	nie	nie	PROPN
fnp-3805	327	11	,	,	PUNCT
fnp-3805	327	12	m.	m.	NOUN
fnp-3805	327	13	,	,	PUNCT
fnp-3805	327	14	wang	wang	PROPN
fnp-3805	327	15	,	,	PUNCT
fnp-3805	327	16	g.	g.	PROPN
fnp-3805	327	17	,	,	PUNCT
fnp-3805	327	18	silva	silva	PROPN
fnp-3805	327	19	,	,	PUNCT
fnp-3805	327	20	w.j	w.j	PROPN
fnp-3805	327	21	.	.	PROPN
fnp-3805	327	22	,	,	PUNCT
fnp-3805	327	23	yang	yang	PROPN
fnp-3805	327	24	,	,	PUNCT
fnp-3805	327	25	q.	q.	PROPN
fnp-3805	327	26	,	,	PUNCT
fnp-3805	327	27	freire	freire	PROPN
fnp-3805	327	28	,	,	PUNCT
fnp-3805	327	29	p.p	p.p	PROPN
fnp-3805	327	30	.	.	PROPN
fnp-3805	327	31	,	,	PUNCT
fnp-3805	327	32	hu	hu	PROPN
fnp-3805	327	33	,	,	PUNCT
fnp-3805	327	34	x.	x.	PROPN
fnp-3805	327	35	,	,	PUNCT
fnp-3805	327	36	chen	chen	PROPN
fnp-3805	327	37	,	,	PUNCT
fnp-3805	327	38	h.	h.	PROPN
fnp-3805	327	39	,	,	PUNCT
fnp-3805	327	40	deng	deng	PROPN
fnp-3805	327	41	,	,	PUNCT
fnp-3805	327	42	z.	z.	PROPN
fnp-3805	327	43	,	,	PUNCT
fnp-3805	327	44	et	et	PROPN
fnp-3805	327	45	al	al	PROPN
fnp-3805	327	46	.	.	PROPN
fnp-3805	327	47	(	(	PUNCT
fnp-3805	327	48	2020	2020	NUM
fnp-3805	327	49	)	)	PUNCT
fnp-3805	327	50	.	.	PUNCT
fnp-3805	328	1	regulation	regulation	NOUN
fnp-3805	328	2	of	of	ADP
fnp-3805	328	3	myonuclear	myonuclear	NOUN
fnp-3805	328	4	positioning	positioning	NOUN
fnp-3805	328	5	and	and	CCONJ
fnp-3805	328	6	muscle	muscle	NOUN
fnp-3805	328	7	function	function	NOUN
fnp-3805	328	8	by	by	ADP
fnp-3805	328	9	the	the	DET
fnp-3805	328	10	skeletal	skeletal	ADJ
fnp-3805	328	11	muscle	muscle	NOUN
fnp-3805	328	12	-	-	PUNCT
fnp-3805	328	13	specific	specific	ADJ
fnp-3805	328	14	cip	cip	NOUN
fnp-3805	328	15	protein	protein	NOUN
fnp-3805	328	16	.	.	PUNCT
fnp-3805	329	1	proc	proc	PROPN
fnp-3805	329	2	natl	natl	PROPN
fnp-3805	329	3	acad	acad	PROPN
fnp-3805	329	4	sci	sci	PROPN
fnp-3805	329	5	u	u	PROPN
fnp-3805	329	6	s	s	PROPN
fnp-3805	329	7	a	a	DET
fnp-3805	329	8	117	117	NUM
fnp-3805	329	9	,	,	PUNCT
fnp-3805	329	10	19254	19254	NUM
fnp-3805	329	11	-	-	SYM
fnp-3805	329	12	19265	19265	NUM
fnp-3805	329	13	.	.	PUNCT
fnp-3805	330	1	lopes	lopes	PROPN
fnp-3805	330	2	abath	abath	ADP
fnp-3805	330	3	neto	neto	PROPN
fnp-3805	330	4	,	,	PUNCT
fnp-3805	330	5	o.	o.	PROPN
fnp-3805	330	6	,	,	PUNCT
fnp-3805	330	7	medne	medne	PROPN
fnp-3805	330	8	,	,	PUNCT
fnp-3805	330	9	l.	l.	PROPN
fnp-3805	330	10	,	,	PUNCT
fnp-3805	330	11	donkervoort	donkervoort	NOUN
fnp-3805	330	12	,	,	PUNCT
fnp-3805	330	13	s.	s.	PROPN
fnp-3805	330	14	,	,	PUNCT
fnp-3805	330	15	rodriguez	rodriguez	PROPN
fnp-3805	330	16	-	-	PUNCT
fnp-3805	330	17	garcia	garcia	PROPN
fnp-3805	330	18	,	,	PUNCT
fnp-3805	330	19	m.e	m.e	PROPN
fnp-3805	330	20	.	.	PROPN
fnp-3805	330	21	,	,	PUNCT
fnp-3805	330	22	bolduc	bolduc	PROPN
fnp-3805	330	23	,	,	PUNCT
fnp-3805	330	24	v.	v.	PROPN
fnp-3805	330	25	,	,	PUNCT
fnp-3805	330	26	hu	hu	PROPN
fnp-3805	330	27	,	,	PUNCT
fnp-3805	330	28	y.	y.	PROPN
fnp-3805	330	29	,	,	PUNCT
fnp-3805	330	30	guadagnin	guadagnin	PROPN
fnp-3805	330	31	,	,	PUNCT
fnp-3805	330	32	e.	e.	PROPN
fnp-3805	330	33	,	,	PUNCT
fnp-3805	330	34	foley	foley	PROPN
fnp-3805	330	35	,	,	PUNCT
fnp-3805	330	36	a.r	a.r	PROPN
fnp-3805	330	37	.	.	PROPN
fnp-3805	330	38	,	,	PUNCT
fnp-3805	330	39	brandsema	brandsema	PROPN
fnp-3805	330	40	,	,	PUNCT
fnp-3805	330	41	j.f	j.f	PROPN
fnp-3805	330	42	.	.	PROPN
fnp-3805	330	43	,	,	PUNCT
fnp-3805	330	44	glanzman	glanzman	PROPN
fnp-3805	330	45	,	,	PUNCT
fnp-3805	330	46	a.m.	a.m.	ADV
fnp-3805	330	47	,	,	PUNCT
fnp-3805	330	48	et	et	PROPN
fnp-3805	330	49	al	al	PROPN
fnp-3805	330	50	.	.	PROPN
fnp-3805	330	51	(	(	PUNCT
fnp-3805	330	52	2021	2021	NUM
fnp-3805	330	53	)	)	PUNCT
fnp-3805	330	54	.	.	PUNCT
fnp-3805	331	1	mlip	mlip	PROPN
fnp-3805	331	2	causes	cause	VERB
fnp-3805	331	3	recessive	recessive	ADJ
fnp-3805	331	4	myopathy	myopathy	ADJ
fnp-3805	331	5	with	with	ADP
fnp-3805	331	6	rhabdomyolysis	rhabdomyolysis	NOUN
fnp-3805	331	7	,	,	PUNCT
fnp-3805	331	8	myalgia	myalgia	NOUN
fnp-3805	331	9	and	and	CCONJ
fnp-3805	331	10	baseline	baseline	ADJ
fnp-3805	331	11	elevated	elevate	VERB
fnp-3805	331	12	serum	serum	PROPN
fnp-3805	331	13	creatine	creatine	PROPN
fnp-3805	331	14	kinase	kinase	PROPN
fnp-3805	331	15	.	.	PUNCT
fnp-3805	332	1	brain	brain	PROPN
fnp-3805	332	2	144	144	NUM
fnp-3805	332	3	,	,	PUNCT
fnp-3805	332	4	2722	2722	NUM
fnp-3805	332	5	-	-	SYM
fnp-3805	332	6	2731	2731	NUM
fnp-3805	332	7	.	.	PUNCT
fnp-3805	333	1	luijten	luijten	VERB
fnp-3805	333	2	,	,	PUNCT
fnp-3805	333	3	l.w.g	l.w.g	NOUN
fnp-3805	333	4	.	.	PROPN
fnp-3805	333	5	,	,	PUNCT
fnp-3805	333	6	leonhard	leonhard	PROPN
fnp-3805	333	7	,	,	PUNCT
fnp-3805	333	8	s.e	s.e	PROPN
fnp-3805	333	9	.	.	PROPN
fnp-3805	333	10	,	,	PUNCT
fnp-3805	333	11	van	van	PROPN
fnp-3805	333	12	der	der	PROPN
fnp-3805	333	13	eijk	eijk	PROPN
fnp-3805	333	14	,	,	PUNCT
fnp-3805	333	15	a.a	a.a	PROPN
fnp-3805	333	16	.	.	PROPN
fnp-3805	333	17	,	,	PUNCT
fnp-3805	333	18	doets	doet	NOUN
fnp-3805	333	19	,	,	PUNCT
fnp-3805	333	20	a.y	a.y	PROPN
fnp-3805	333	21	.	.	PROPN
fnp-3805	333	22	,	,	PUNCT
fnp-3805	333	23	appeltshauser	appeltshauser	PROPN
fnp-3805	333	24	,	,	PUNCT
fnp-3805	333	25	l.	l.	PROPN
fnp-3805	333	26	,	,	PUNCT
fnp-3805	333	27	arends	arend	NOUN
fnp-3805	333	28	,	,	PUNCT
fnp-3805	333	29	s.	s.	PROPN
fnp-3805	333	30	,	,	PUNCT
fnp-3805	333	31	attarian	attarian	NOUN
fnp-3805	333	32	,	,	PUNCT
fnp-3805	333	33	s.	s.	PROPN
fnp-3805	333	34	,	,	PUNCT
fnp-3805	333	35	benedetti	benedetti	PROPN
fnp-3805	333	36	,	,	PUNCT
fnp-3805	333	37	l.	l.	PROPN
fnp-3805	333	38	,	,	PUNCT
fnp-3805	333	39	briani	briani	PROPN
fnp-3805	333	40	,	,	PUNCT
fnp-3805	333	41	c.	c.	PROPN
fnp-3805	333	42	,	,	PUNCT
fnp-3805	333	43	casasnovas	casasnovas	PROPN
fnp-3805	333	44	,	,	PUNCT
fnp-3805	333	45	c.	c.	PROPN
fnp-3805	333	46	,	,	PUNCT
fnp-3805	333	47	et	et	PROPN
fnp-3805	333	48	al	al	PROPN
fnp-3805	333	49	.	.	PROPN
fnp-3805	334	1	(	(	PUNCT
fnp-3805	334	2	2021	2021	NUM
fnp-3805	334	3	)	)	PUNCT
fnp-3805	334	4	.	.	PUNCT
fnp-3805	335	1	guillain	guillain	NOUN
fnp-3805	335	2	-	-	PUNCT
fnp-3805	335	3	barre	barre	NOUN
fnp-3805	335	4	syndrome	syndrome	NOUN
fnp-3805	335	5	after	after	ADP
fnp-3805	335	6	sars	sar	NOUN
fnp-3805	335	7	-	-	PUNCT
fnp-3805	335	8	cov-2	cov-2	PART
fnp-3805	335	9	infection	infection	NOUN
fnp-3805	335	10	in	in	ADP
fnp-3805	335	11	an	an	DET
fnp-3805	335	12	international	international	ADJ
fnp-3805	335	13	prospective	prospective	ADJ
fnp-3805	335	14	cohort	cohort	NOUN
fnp-3805	335	15	study	study	NOUN
fnp-3805	335	16	.	.	PUNCT
fnp-3805	336	1	brain	brain	NOUN
fnp-3805	336	2	144	144	NUM
fnp-3805	336	3	,	,	PUNCT
fnp-3805	336	4	3392	3392	NUM
fnp-3805	336	5	-	-	SYM
fnp-3805	336	6	3404	3404	NUM
fnp-3805	336	7	.	.	PUNCT
fnp-3805	337	1	lunn	lunn	PROPN
fnp-3805	337	2	,	,	PUNCT
fnp-3805	337	3	m.p	m.p	PROPN
fnp-3805	337	4	.	.	PROPN
fnp-3805	337	5	,	,	PUNCT
fnp-3805	337	6	carr	carr	PROPN
fnp-3805	337	7	,	,	PUNCT
fnp-3805	337	8	a.c	a.c	PROPN
fnp-3805	337	9	.	.	PROPN
fnp-3805	337	10	,	,	PUNCT
fnp-3805	337	11	keddie	keddie	PROPN
fnp-3805	337	12	,	,	PUNCT
fnp-3805	337	13	s.	s.	PROPN
fnp-3805	337	14	,	,	PUNCT
fnp-3805	337	15	pakpoor	pakpoor	PROPN
fnp-3805	337	16	,	,	PUNCT
fnp-3805	337	17	j.	j.	PROPN
fnp-3805	337	18	,	,	PUNCT
fnp-3805	337	19	pipis	pipis	ADJ
fnp-3805	337	20	,	,	PUNCT
fnp-3805	337	21	m.	m.	NOUN
fnp-3805	337	22	,	,	PUNCT
fnp-3805	337	23	and	and	CCONJ
fnp-3805	337	24	willison	willison	PROPN
fnp-3805	337	25	,	,	PUNCT
fnp-3805	337	26	h.j	h.j	PROPN
fnp-3805	337	27	.	.	PROPN
fnp-3805	337	28	(	(	PUNCT
fnp-3805	337	29	2021	2021	NUM
fnp-3805	337	30	)	)	PUNCT
fnp-3805	337	31	.	.	PUNCT
fnp-3805	338	1	reply	reply	NOUN
fnp-3805	338	2	:	:	PUNCT
fnp-3805	338	3	guillain	guillain	NOUN
fnp-3805	338	4	-	-	PUNCT
fnp-3805	338	5	barre	barre	NOUN
fnp-3805	338	6	syndrome	syndrome	NOUN
fnp-3805	338	7	,	,	PUNCT
fnp-3805	338	8	sars	sar	NOUN
fnp-3805	338	9	-	-	PUNCT
fnp-3805	338	10	cov-2	cov-2	X
fnp-3805	338	11	and	and	CCONJ
fnp-3805	338	12	molecular	molecular	ADJ
fnp-3805	338	13	mimicry	mimicry	NOUN
fnp-3805	338	14	and	and	CCONJ
fnp-3805	338	15	ongoing	ongoing	ADJ
fnp-3805	338	16	challenges	challenge	NOUN
fnp-3805	338	17	in	in	ADP
fnp-3805	338	18	unravelling	unravel	VERB
fnp-3805	338	19	the	the	DET
fnp-3805	338	20	association	association	NOUN
fnp-3805	338	21	between	between	ADP
fnp-3805	338	22	covid-19	covid-19	PROPN
fnp-3805	338	23	and	and	CCONJ
fnp-3805	338	24	guillain	guillain	NOUN
fnp-3805	338	25	-	-	PUNCT
fnp-3805	338	26	barre	barre	NOUN
fnp-3805	338	27	syndrome	syndrome	NOUN
fnp-3805	338	28	and	and	CCONJ
fnp-3805	338	29	unclear	unclear	ADJ
fnp-3805	338	30	association	association	NOUN
fnp-3805	338	31	between	between	ADP
fnp-3805	338	32	covid-19	covid-19	PROPN
fnp-3805	338	33	and	and	CCONJ
fnp-3805	338	34	guillain	guillain	NOUN
fnp-3805	338	35	-	-	PUNCT
fnp-3805	338	36	barre	barre	NOUN
fnp-3805	338	37	syndrome	syndrome	NOUN
fnp-3805	338	38	and	and	CCONJ
fnp-3805	338	39	currently	currently	ADV
fnp-3805	338	40	available	available	ADJ
fnp-3805	338	41	data	datum	NOUN
fnp-3805	338	42	regarding	regard	VERB
fnp-3805	338	43	the	the	DET
fnp-3805	338	44	potential	potential	ADJ
fnp-3805	338	45	association	association	NOUN
fnp-3805	338	46	between	between	ADP
fnp-3805	338	47	covid-19	covid-19	PROPN
fnp-3805	338	48	and	and	CCONJ
fnp-3805	338	49	guillain	guillain	NOUN
fnp-3805	338	50	-	-	PUNCT
fnp-3805	338	51	barre	barre	NOUN
fnp-3805	338	52	syndrome	syndrome	NOUN
fnp-3805	338	53	.	.	PUNCT
fnp-3805	339	1	brain	brain	NOUN
fnp-3805	339	2	144	144	NUM
fnp-3805	339	3	,	,	PUNCT
fnp-3805	339	4	e47	e47	PROPN
fnp-3805	339	5	.	.	PROPN
fnp-3805	339	6	margeta	margeta	PROPN
fnp-3805	339	7	,	,	PUNCT
fnp-3805	339	8	m.	m.	NOUN
fnp-3805	339	9	(	(	PUNCT
fnp-3805	339	10	2020a	2020a	NUM
fnp-3805	339	11	)	)	PUNCT
fnp-3805	339	12	.	.	PUNCT
fnp-3805	340	1	autophagy	autophagy	ADJ
fnp-3805	340	2	defects	defect	NOUN
fnp-3805	340	3	in	in	ADP
fnp-3805	340	4	skeletal	skeletal	ADJ
fnp-3805	340	5	myopathies	myopathy	NOUN
fnp-3805	340	6	.	.	PUNCT
fnp-3805	341	1	annu	annu	PROPN
fnp-3805	341	2	rev	rev	PROPN
fnp-3805	341	3	pathol	pathol	PROPN
fnp-3805	341	4	15	15	NUM
fnp-3805	341	5	,	,	PUNCT
fnp-3805	341	6	261	261	NUM
fnp-3805	341	7	-	-	SYM
fnp-3805	341	8	285	285	NUM
fnp-3805	341	9	.	.	PUNCT
fnp-3805	342	1	margeta	margeta	NOUN
fnp-3805	342	2	,	,	PUNCT
fnp-3805	342	3	m.	m.	NOUN
fnp-3805	342	4	(	(	PUNCT
fnp-3805	342	5	2020b	2020b	NUM
fnp-3805	342	6	)	)	PUNCT
fnp-3805	342	7	.	.	PUNCT
fnp-3805	343	1	top	top	ADJ
fnp-3805	343	2	ten	ten	NUM
fnp-3805	343	3	discoveries	discovery	NOUN
fnp-3805	343	4	of	of	ADP
fnp-3805	343	5	the	the	DET
fnp-3805	343	6	year	year	NOUN
fnp-3805	343	7	:	:	PUNCT
fnp-3805	343	8	neuromuscular	neuromuscular	ADJ
fnp-3805	343	9	disease	disease	NOUN
fnp-3805	343	10	.	.	PUNCT
fnp-3805	344	1	free	free	ADJ
fnp-3805	344	2	neuropathol	neuropathol	NOUN
fnp-3805	344	3	1	1	NUM
fnp-3805	344	4	,	,	PUNCT
fnp-3805	344	5	4	4	NUM
fnp-3805	344	6	.	.	X
fnp-3805	344	7	margeta	margeta	NOUN
fnp-3805	344	8	,	,	PUNCT
fnp-3805	344	9	m.	m.	NOUN
fnp-3805	344	10	(	(	PUNCT
fnp-3805	344	11	2021	2021	NUM
fnp-3805	344	12	)	)	PUNCT
fnp-3805	344	13	.	.	PUNCT
fnp-3805	345	1	neuromuscular	neuromuscular	ADJ
fnp-3805	345	2	disease	disease	NOUN
fnp-3805	345	3	:	:	PUNCT
fnp-3805	345	4	2021	2021	NUM
fnp-3805	345	5	update	update	NOUN
fnp-3805	345	6	.	.	PUNCT
fnp-3805	346	1	free	free	ADJ
fnp-3805	346	2	neuropathol	neuropathol	NOUN
fnp-3805	346	3	2	2	NUM
fnp-3805	346	4	,	,	PUNCT
fnp-3805	346	5	3	3	NUM
fnp-3805	346	6	.	.	PUNCT
fnp-3805	346	7	meena	meena	PROPN
fnp-3805	346	8	,	,	PUNCT
fnp-3805	346	9	n.k	n.k	PROPN
fnp-3805	346	10	.	.	PROPN
fnp-3805	346	11	,	,	PUNCT
fnp-3805	346	12	ralston	ralston	PROPN
fnp-3805	346	13	,	,	PUNCT
fnp-3805	346	14	e.	e.	PROPN
fnp-3805	346	15	,	,	PUNCT
fnp-3805	346	16	raben	raben	PROPN
fnp-3805	346	17	,	,	PUNCT
fnp-3805	346	18	n.	n.	NOUN
fnp-3805	346	19	,	,	PUNCT
fnp-3805	346	20	and	and	CCONJ
fnp-3805	346	21	puertollano	puertollano	NOUN
fnp-3805	346	22	,	,	PUNCT
fnp-3805	346	23	r.	r.	PROPN
fnp-3805	346	24	(	(	PUNCT
fnp-3805	346	25	2020	2020	NUM
fnp-3805	346	26	)	)	PUNCT
fnp-3805	346	27	.	.	PUNCT
fnp-3805	347	1	enzyme	enzyme	NOUN
fnp-3805	347	2	replacement	replacement	NOUN
fnp-3805	347	3	therapy	therapy	NOUN
fnp-3805	347	4	can	can	AUX
fnp-3805	347	5	reverse	reverse	VERB
fnp-3805	347	6	pathogenic	pathogenic	ADJ
fnp-3805	347	7	cascade	cascade	NOUN
fnp-3805	347	8	in	in	ADP
fnp-3805	347	9	pompe	pompe	PROPN
fnp-3805	347	10	disease	disease	PROPN
fnp-3805	347	11	.	.	PUNCT
fnp-3805	348	1	mol	mol	ADP
fnp-3805	348	2	ther	ther	PROPN
fnp-3805	348	3	methods	method	NOUN
fnp-3805	348	4	clin	clin	PROPN
fnp-3805	348	5	dev	dev	PROPN
fnp-3805	348	6	18	18	NUM
fnp-3805	348	7	,	,	PUNCT
fnp-3805	348	8	199	199	NUM
fnp-3805	348	9	-	-	SYM
fnp-3805	348	10	214	214	NUM
fnp-3805	348	11	.	.	PUNCT
fnp-3805	349	1	napolitano	napolitano	PROPN
fnp-3805	349	2	,	,	PUNCT
fnp-3805	349	3	f.	f.	PROPN
fnp-3805	349	4	,	,	PUNCT
fnp-3805	349	5	terracciano	terracciano	PROPN
fnp-3805	349	6	,	,	PUNCT
fnp-3805	349	7	c.	c.	PROPN
fnp-3805	349	8	,	,	PUNCT
fnp-3805	349	9	bruno	bruno	PROPN
fnp-3805	349	10	,	,	PUNCT
fnp-3805	349	11	g.	g.	PROPN
fnp-3805	349	12	,	,	PUNCT
fnp-3805	349	13	de	de	X
fnp-3805	349	14	blasiis	blasiis	NOUN
fnp-3805	349	15	,	,	PUNCT
fnp-3805	349	16	p.	p.	NOUN
fnp-3805	349	17	,	,	PUNCT
fnp-3805	349	18	lombardi	lombardi	PROPN
fnp-3805	349	19	,	,	PUNCT
fnp-3805	349	20	l.	l.	PROPN
fnp-3805	349	21	,	,	PUNCT
fnp-3805	349	22	gialluisi	gialluisi	ADJ
fnp-3805	349	23	,	,	PUNCT
fnp-3805	349	24	a.	a.	NOUN
fnp-3805	349	25	,	,	PUNCT
fnp-3805	349	26	gianfrancesco	gianfrancesco	PROPN
fnp-3805	349	27	,	,	PUNCT
fnp-3805	349	28	f.	f.	PROPN
fnp-3805	349	29	,	,	PUNCT
fnp-3805	349	30	de	de	X
fnp-3805	349	31	giovanni	giovanni	PROPN
fnp-3805	349	32	,	,	PUNCT
fnp-3805	349	33	d.	d.	PROPN
fnp-3805	349	34	,	,	PUNCT
fnp-3805	349	35	tummolo	tummolo	ADV
fnp-3805	349	36	,	,	PUNCT
fnp-3805	349	37	a.	a.	NOUN
fnp-3805	349	38	,	,	PUNCT
fnp-3805	349	39	di	di	X
fnp-3805	349	40	iorio	iorio	PROPN
fnp-3805	349	41	,	,	PUNCT
fnp-3805	349	42	g.	g.	PROPN
fnp-3805	349	43	,	,	PUNCT
fnp-3805	349	44	et	et	PROPN
fnp-3805	349	45	al	al	PROPN
fnp-3805	349	46	.	.	PROPN
fnp-3805	349	47	(	(	PUNCT
fnp-3805	349	48	2021	2021	NUM
fnp-3805	349	49	)	)	PUNCT
fnp-3805	349	50	.	.	PUNCT
fnp-3805	350	1	novel	novel	ADJ
fnp-3805	350	2	autophagic	autophagic	ADJ
fnp-3805	350	3	vacuolar	vacuolar	ADJ
fnp-3805	350	4	myopathies	myopathy	NOUN
fnp-3805	350	5	:	:	PUNCT
fnp-3805	350	6	phenotype	phenotype	NOUN
fnp-3805	350	7	and	and	CCONJ
fnp-3805	350	8	genotype	genotype	NOUN
fnp-3805	350	9	features	feature	NOUN
fnp-3805	350	10	.	.	PUNCT
fnp-3805	351	1	neuropathol	neuropathol	NOUN
fnp-3805	351	2	appl	appl	PROPN
fnp-3805	351	3	neurobiol	neurobiol	PROPN
fnp-3805	351	4	47	47	NUM
fnp-3805	351	5	,	,	PUNCT
fnp-3805	351	6	664	664	NUM
fnp-3805	351	7	-	-	SYM
fnp-3805	351	8	678	678	NUM
fnp-3805	351	9	.	.	PUNCT
fnp-3805	352	1	pagnamenta	pagnamenta	NOUN
fnp-3805	352	2	,	,	PUNCT
fnp-3805	352	3	a.t	a.t	PROPN
fnp-3805	352	4	.	.	PROPN
fnp-3805	352	5	,	,	PUNCT
fnp-3805	352	6	kaiyrzhanov	kaiyrzhanov	PROPN
fnp-3805	352	7	,	,	PUNCT
fnp-3805	352	8	r.	r.	PROPN
fnp-3805	352	9	,	,	PUNCT
fnp-3805	352	10	zou	zou	PROPN
fnp-3805	352	11	,	,	PUNCT
fnp-3805	352	12	y.	y.	PROPN
fnp-3805	352	13	,	,	PUNCT
fnp-3805	352	14	da'as	da'as	PROPN
fnp-3805	352	15	,	,	PUNCT
fnp-3805	352	16	s.i	s.i	PROPN
fnp-3805	352	17	.	.	PROPN
fnp-3805	352	18	,	,	PUNCT
fnp-3805	352	19	maroofian	maroofian	PROPN
fnp-3805	352	20	,	,	PUNCT
fnp-3805	352	21	r.	r.	PROPN
fnp-3805	352	22	,	,	PUNCT
fnp-3805	352	23	donkervoort	donkervoort	NOUN
fnp-3805	352	24	,	,	PUNCT
fnp-3805	352	25	s.	s.	PROPN
fnp-3805	352	26	,	,	PUNCT
fnp-3805	352	27	dominik	dominik	PROPN
fnp-3805	352	28	,	,	PUNCT
fnp-3805	352	29	n.	n.	PROPN
fnp-3805	352	30	,	,	PUNCT
fnp-3805	352	31	lauffer	lauffer	PROPN
fnp-3805	352	32	,	,	PUNCT
fnp-3805	352	33	m.	m.	NOUN
fnp-3805	352	34	,	,	PUNCT
fnp-3805	352	35	ferla	ferla	NOUN
fnp-3805	352	36	,	,	PUNCT
fnp-3805	352	37	m.p	m.p	PROPN
fnp-3805	352	38	.	.	PROPN
fnp-3805	352	39	,	,	PUNCT
fnp-3805	352	40	orioli	orioli	PROPN
fnp-3805	352	41	,	,	PUNCT
fnp-3805	352	42	a.	a.	NOUN
fnp-3805	352	43	,	,	PUNCT
fnp-3805	352	44	et	et	PROPN
fnp-3805	352	45	al	al	PROPN
fnp-3805	352	46	.	.	PROPN
fnp-3805	353	1	(	(	PUNCT
fnp-3805	353	2	2021	2021	NUM
fnp-3805	353	3	)	)	PUNCT
fnp-3805	353	4	.	.	PUNCT
fnp-3805	354	1	an	an	DET
fnp-3805	354	2	ancestral	ancestral	ADJ
fnp-3805	354	3	10	10	NUM
fnp-3805	354	4	-	-	PUNCT
fnp-3805	354	5	bp	bp	NOUN
fnp-3805	354	6	repeat	repeat	NOUN
fnp-3805	354	7	expansion	expansion	NOUN
fnp-3805	354	8	in	in	ADP
fnp-3805	354	9	vwa1	vwa1	NOUN
fnp-3805	354	10	causes	cause	VERB
fnp-3805	354	11	recessive	recessive	ADJ
fnp-3805	354	12	hereditary	hereditary	ADJ
fnp-3805	354	13	motor	motor	NOUN
fnp-3805	354	14	neuropathy	neuropathy	ADJ
fnp-3805	354	15	.	.	PUNCT
fnp-3805	355	1	brain	brain	NOUN
fnp-3805	355	2	144	144	NUM
fnp-3805	355	3	,	,	PUNCT
fnp-3805	355	4	584	584	NUM
fnp-3805	355	5	-	-	SYM
fnp-3805	355	6	600	600	NUM
fnp-3805	355	7	.	.	PUNCT
fnp-3805	356	1	patone	patone	NOUN
fnp-3805	356	2	,	,	PUNCT
fnp-3805	356	3	m.	m.	NOUN
fnp-3805	356	4	,	,	PUNCT
fnp-3805	356	5	handunnetthi	handunnetthi	PROPN
fnp-3805	356	6	,	,	PUNCT
fnp-3805	356	7	l.	l.	PROPN
fnp-3805	356	8	,	,	PUNCT
fnp-3805	356	9	saatci	saatci	PROPN
fnp-3805	356	10	,	,	PUNCT
fnp-3805	356	11	d.	d.	PROPN
fnp-3805	356	12	,	,	PUNCT
fnp-3805	356	13	pan	pan	PROPN
fnp-3805	356	14	,	,	PUNCT
fnp-3805	356	15	j.	j.	PROPN
fnp-3805	356	16	,	,	PUNCT
fnp-3805	356	17	katikireddi	katikireddi	PROPN
fnp-3805	356	18	,	,	PUNCT
fnp-3805	356	19	s.v	s.v	PROPN
fnp-3805	356	20	.	.	PROPN
fnp-3805	356	21	,	,	PUNCT
fnp-3805	356	22	razvi	razvi	VERB
fnp-3805	356	23	,	,	PUNCT
fnp-3805	356	24	s.	s.	PROPN
fnp-3805	356	25	,	,	PUNCT
fnp-3805	356	26	hunt	hunt	PROPN
fnp-3805	356	27	,	,	PUNCT
fnp-3805	356	28	d.	d.	PROPN
fnp-3805	356	29	,	,	PUNCT
fnp-3805	356	30	mei	mei	PROPN
fnp-3805	356	31	,	,	PUNCT
fnp-3805	356	32	x.w	x.w	PROPN
fnp-3805	356	33	.	.	PROPN
fnp-3805	356	34	,	,	PUNCT
fnp-3805	356	35	dixon	dixon	PROPN
fnp-3805	356	36	,	,	PUNCT
fnp-3805	356	37	s.	s.	PROPN
fnp-3805	356	38	,	,	PUNCT
fnp-3805	356	39	zaccardi	zaccardi	PROPN
fnp-3805	356	40	,	,	PUNCT
fnp-3805	356	41	f.	f.	PROPN
fnp-3805	356	42	,	,	PUNCT
fnp-3805	356	43	et	et	PROPN
fnp-3805	356	44	al	al	PROPN
fnp-3805	356	45	.	.	PROPN
fnp-3805	357	1	(	(	PUNCT
fnp-3805	357	2	2021	2021	NUM
fnp-3805	357	3	)	)	PUNCT
fnp-3805	357	4	.	.	PUNCT
fnp-3805	358	1	neurological	neurological	ADJ
fnp-3805	358	2	complications	complication	NOUN
fnp-3805	358	3	after	after	ADP
fnp-3805	358	4	first	first	ADV
fnp-3805	358	5	dose	dose	NOUN
fnp-3805	358	6	of	of	ADP
fnp-3805	358	7	covid-19	covid-19	PROPN
fnp-3805	358	8	vaccines	vaccine	NOUN
fnp-3805	358	9	and	and	CCONJ
fnp-3805	358	10	sars	sar	NOUN
fnp-3805	358	11	-	-	PUNCT
fnp-3805	358	12	cov-2	cov-2	NOUN
fnp-3805	358	13	infection	infection	NOUN
fnp-3805	358	14	.	.	PUNCT
fnp-3805	359	1	nat	nat	PROPN
fnp-3805	359	2	med	me	VERB
fnp-3805	359	3	27	27	NUM
fnp-3805	359	4	,	,	PUNCT
fnp-3805	359	5	2144	2144	NUM
fnp-3805	359	6	-	-	SYM
fnp-3805	359	7	2153	2153	NUM
fnp-3805	359	8	.	.	PUNCT
fnp-3805	360	1	popovic	popovic	PROPN
fnp-3805	360	2	,	,	PUNCT
fnp-3805	360	3	d.	d.	PROPN
fnp-3805	360	4	,	,	PUNCT
fnp-3805	360	5	and	and	CCONJ
fnp-3805	360	6	dikic	dikic	PROPN
fnp-3805	360	7	,	,	PUNCT
fnp-3805	360	8	i.	i.	PROPN
fnp-3805	360	9	(	(	PUNCT
fnp-3805	360	10	2014	2014	NUM
fnp-3805	360	11	)	)	PUNCT
fnp-3805	360	12	.	.	PUNCT
fnp-3805	361	1	tbc1d5	tbc1d5	NOUN
fnp-3805	361	2	and	and	CCONJ
fnp-3805	361	3	the	the	DET
fnp-3805	361	4	ap2	ap2	PROPN
fnp-3805	361	5	complex	complex	NOUN
fnp-3805	361	6	regulate	regulate	VERB
fnp-3805	361	7	atg9	atg9	NOUN
fnp-3805	361	8	trafficking	trafficking	NOUN
fnp-3805	361	9	and	and	CCONJ
fnp-3805	361	10	initiation	initiation	NOUN
fnp-3805	361	11	of	of	ADP
fnp-3805	361	12	autophagy	autophagy	NOUN
fnp-3805	361	13	.	.	PUNCT
fnp-3805	362	1	embo	embo	PROPN
fnp-3805	362	2	rep	rep	PROPN
fnp-3805	362	3	15	15	NUM
fnp-3805	362	4	,	,	PUNCT
fnp-3805	362	5	392	392	NUM
fnp-3805	362	6	-	-	SYM
fnp-3805	362	7	401	401	NUM
fnp-3805	362	8	.	.	PUNCT
fnp-3805	363	1	puertollano	puertollano	PROPN
fnp-3805	363	2	,	,	PUNCT
fnp-3805	363	3	r.	r.	PROPN
fnp-3805	363	4	,	,	PUNCT
fnp-3805	363	5	and	and	CCONJ
fnp-3805	363	6	raben	raben	PROPN
fnp-3805	363	7	,	,	PUNCT
fnp-3805	363	8	n.	n.	NOUN
fnp-3805	363	9	(	(	PUNCT
fnp-3805	363	10	2021	2021	NUM
fnp-3805	363	11	)	)	PUNCT
fnp-3805	363	12	.	.	PUNCT
fnp-3805	364	1	new	new	ADJ
fnp-3805	364	2	therapies	therapy	NOUN
fnp-3805	364	3	for	for	ADP
fnp-3805	364	4	pompe	pompe	PROPN
fnp-3805	364	5	disease	disease	PROPN
fnp-3805	364	6	:	:	PUNCT
fnp-3805	364	7	are	be	AUX
fnp-3805	364	8	we	we	PRON
fnp-3805	364	9	closer	close	ADJ
fnp-3805	364	10	to	to	ADP
fnp-3805	364	11	a	a	DET
fnp-3805	364	12	cure	cure	NOUN
fnp-3805	364	13	?	?	PUNCT
fnp-3805	365	1	lancet	lancet	PROPN
fnp-3805	365	2	neurol	neurol	NOUN
fnp-3805	365	3	20	20	NUM
fnp-3805	365	4	,	,	PUNCT
fnp-3805	365	5	973	973	NUM
fnp-3805	365	6	-	-	SYM
fnp-3805	365	7	975	975	NUM
fnp-3805	365	8	.	.	PUNCT
fnp-3805	366	1	quarta	quarta	NOUN
fnp-3805	366	2	,	,	PUNCT
fnp-3805	366	3	m.	m.	NOUN
fnp-3805	366	4	,	,	PUNCT
fnp-3805	366	5	cromie	cromie	VERB
fnp-3805	366	6	,	,	PUNCT
fnp-3805	366	7	m.	m.	NOUN
fnp-3805	366	8	,	,	PUNCT
fnp-3805	366	9	chacon	chacon	PROPN
fnp-3805	366	10	,	,	PUNCT
fnp-3805	366	11	r.	r.	PROPN
fnp-3805	366	12	,	,	PUNCT
fnp-3805	366	13	blonigan	blonigan	PROPN
fnp-3805	366	14	,	,	PUNCT
fnp-3805	366	15	j.	j.	PROPN
fnp-3805	366	16	,	,	PUNCT
fnp-3805	366	17	garcia	garcia	PROPN
fnp-3805	366	18	,	,	PUNCT
fnp-3805	366	19	v.	v.	ADV
fnp-3805	366	20	,	,	PUNCT
fnp-3805	366	21	akimenko	akimenko	ADJ
fnp-3805	366	22	,	,	PUNCT
fnp-3805	366	23	i.	i.	NOUN
fnp-3805	366	24	,	,	PUNCT
fnp-3805	366	25	hamer	hamer	NOUN
fnp-3805	366	26	,	,	PUNCT
fnp-3805	366	27	m.	m.	NOUN
fnp-3805	366	28	,	,	PUNCT
fnp-3805	366	29	paine	paine	NOUN
fnp-3805	366	30	,	,	PUNCT
fnp-3805	366	31	p.	p.	PROPN
fnp-3805	366	32	,	,	PUNCT
fnp-3805	366	33	stok	stok	PROPN
fnp-3805	366	34	,	,	PUNCT
fnp-3805	366	35	m.	m.	NOUN
fnp-3805	366	36	,	,	PUNCT
fnp-3805	366	37	shrager	shrager	NOUN
fnp-3805	366	38	,	,	PUNCT
fnp-3805	366	39	j.b	j.b	PROPN
fnp-3805	366	40	.	.	PROPN
fnp-3805	366	41	,	,	PUNCT
fnp-3805	366	42	et	et	PROPN
fnp-3805	366	43	al	al	PROPN
fnp-3805	366	44	.	.	PUNCT
fnp-3805	366	45	(	(	PUNCT
fnp-3805	366	46	2017	2017	NUM
fnp-3805	366	47	)	)	PUNCT
fnp-3805	366	48	.	.	PUNCT
fnp-3805	367	1	bioengineered	bioengineere	VERB
fnp-3805	367	2	constructs	construct	NOUN
fnp-3805	367	3	combined	combine	VERB
fnp-3805	367	4	with	with	ADP
fnp-3805	367	5	exercise	exercise	NOUN
fnp-3805	367	6	enhance	enhance	NOUN
fnp-3805	367	7	stem	stem	NOUN
fnp-3805	367	8	cell	cell	NOUN
fnp-3805	367	9	-	-	PUNCT
fnp-3805	367	10	mediated	mediate	VERB
fnp-3805	367	11	treatment	treatment	NOUN
fnp-3805	367	12	of	of	ADP
fnp-3805	367	13	volumetric	volumetric	NOUN
fnp-3805	367	14	muscle	muscle	NOUN
fnp-3805	367	15	loss	loss	NOUN
fnp-3805	367	16	.	.	PUNCT
fnp-3805	368	1	nat	nat	PROPN
fnp-3805	368	2	commun	commun	PROPN
fnp-3805	368	3	8	8	NUM
fnp-3805	368	4	,	,	PUNCT
fnp-3805	368	5	15613	15613	NUM
fnp-3805	368	6	.	.	PUNCT
fnp-3805	369	1	ratnayake	ratnayake	NOUN
fnp-3805	369	2	,	,	PUNCT
fnp-3805	369	3	d.	d.	PROPN
fnp-3805	369	4	,	,	PUNCT
fnp-3805	369	5	nguyen	nguyen	PROPN
fnp-3805	369	6	,	,	PUNCT
fnp-3805	369	7	p.d	p.d	PROPN
fnp-3805	369	8	.	.	PROPN
fnp-3805	369	9	,	,	PUNCT
fnp-3805	369	10	rossello	rossello	PROPN
fnp-3805	369	11	,	,	PUNCT
fnp-3805	369	12	f.j	f.j	PROPN
fnp-3805	369	13	.	.	PROPN
fnp-3805	369	14	,	,	PUNCT
fnp-3805	369	15	wimmer	wimmer	PROPN
fnp-3805	369	16	,	,	PUNCT
fnp-3805	369	17	v.c	v.c	PROPN
fnp-3805	369	18	.	.	PROPN
fnp-3805	369	19	,	,	PUNCT
fnp-3805	369	20	tan	tan	PROPN
fnp-3805	369	21	,	,	PUNCT
fnp-3805	369	22	j.l	j.l	PROPN
fnp-3805	369	23	.	.	PROPN
fnp-3805	369	24	,	,	PUNCT
fnp-3805	369	25	galvis	galvis	PROPN
fnp-3805	369	26	,	,	PUNCT
fnp-3805	369	27	l.a	l.a	PROPN
fnp-3805	369	28	.	.	PROPN
fnp-3805	369	29	,	,	PUNCT
fnp-3805	369	30	julier	julier	PROPN
fnp-3805	369	31	,	,	PUNCT
fnp-3805	369	32	z.	z.	PROPN
fnp-3805	369	33	,	,	PUNCT
fnp-3805	369	34	wood	wood	PROPN
fnp-3805	369	35	,	,	PUNCT
fnp-3805	369	36	a.j	a.j	PROPN
fnp-3805	369	37	.	.	PROPN
fnp-3805	369	38	,	,	PUNCT
fnp-3805	369	39	boudier	boudier	NOUN
fnp-3805	369	40	,	,	PUNCT
fnp-3805	369	41	t.	t.	PROPN
fnp-3805	369	42	,	,	PUNCT
fnp-3805	369	43	isiaku	isiaku	NOUN
fnp-3805	369	44	,	,	PUNCT
fnp-3805	369	45	a.i	a.i	PROPN
fnp-3805	369	46	.	.	PROPN
fnp-3805	369	47	,	,	PUNCT
fnp-3805	369	48	et	et	PROPN
fnp-3805	369	49	al	al	PROPN
fnp-3805	369	50	.	.	PROPN
fnp-3805	370	1	(	(	PUNCT
fnp-3805	370	2	2021	2021	NUM
fnp-3805	370	3	)	)	PUNCT
fnp-3805	370	4	.	.	PUNCT
fnp-3805	371	1	macrophages	macrophage	NOUN
fnp-3805	371	2	provide	provide	VERB
fnp-3805	371	3	a	a	DET
fnp-3805	371	4	transient	transient	ADJ
fnp-3805	371	5	muscle	muscle	NOUN
fnp-3805	371	6	stem	stem	NOUN
fnp-3805	371	7	cell	cell	NOUN
fnp-3805	371	8	niche	niche	NOUN
fnp-3805	371	9	via	via	ADP
fnp-3805	371	10	nampt	nampt	ADJ
fnp-3805	371	11	secretion	secretion	NOUN
fnp-3805	371	12	.	.	PUNCT
fnp-3805	372	1	nature	nature	NOUN
fnp-3805	372	2	591	591	NUM
fnp-3805	372	3	,	,	PUNCT
fnp-3805	372	4	281	281	NUM
fnp-3805	372	5	-	-	SYM
fnp-3805	372	6	287	287	NUM
fnp-3805	372	7	.	.	PUNCT
fnp-3805	373	1	salzer	salzer	NOUN
fnp-3805	373	2	-	-	PUNCT
fnp-3805	373	3	sheelo	sheelo	NOUN
fnp-3805	373	4	,	,	PUNCT
fnp-3805	373	5	l.	l.	PROPN
fnp-3805	373	6	,	,	PUNCT
fnp-3805	373	7	fellner	fellner	PROPN
fnp-3805	373	8	,	,	PUNCT
fnp-3805	373	9	a.	a.	NOUN
fnp-3805	373	10	,	,	PUNCT
fnp-3805	373	11	orenstein	orenstein	ADV
fnp-3805	373	12	,	,	PUNCT
fnp-3805	373	13	n.	n.	NOUN
fnp-3805	373	14	,	,	PUNCT
fnp-3805	373	15	bazak	bazak	NOUN
fnp-3805	373	16	,	,	PUNCT
fnp-3805	373	17	l.	l.	PROPN
fnp-3805	373	18	,	,	PUNCT
fnp-3805	373	19	lev	lev	PROPN
fnp-3805	373	20	-	-	PUNCT
fnp-3805	373	21	el	el	PROPN
fnp-3805	373	22	halabi	halabi	PROPN
fnp-3805	373	23	,	,	PUNCT
fnp-3805	373	24	n.	n.	NOUN
fnp-3805	373	25	,	,	PUNCT
fnp-3805	373	26	daue	daue	NOUN
fnp-3805	373	27	,	,	PUNCT
fnp-3805	373	28	m.	m.	NOUN
fnp-3805	373	29	,	,	PUNCT
fnp-3805	373	30	smirin	smirin	NOUN
fnp-3805	373	31	-	-	PUNCT
fnp-3805	373	32	yosef	yosef	PROPN
fnp-3805	373	33	,	,	PUNCT
fnp-3805	373	34	p.	p.	PROPN
fnp-3805	373	35	,	,	PUNCT
fnp-3805	373	36	van	van	PROPN
fnp-3805	373	37	hout	hout	PROPN
fnp-3805	373	38	,	,	PUNCT
fnp-3805	373	39	c.v	c.v	PROPN
fnp-3805	373	40	.	.	PROPN
fnp-3805	373	41	,	,	PUNCT
fnp-3805	373	42	fellig	fellig	PROPN
fnp-3805	373	43	,	,	PUNCT
fnp-3805	373	44	y.	y.	NOUN
fnp-3805	373	45	,	,	PUNCT
fnp-3805	373	46	ruhrman	ruhrman	NOUN
fnp-3805	373	47	-	-	PUNCT
fnp-3805	373	48	shahar	shahar	PROPN
fnp-3805	373	49	,	,	PUNCT
fnp-3805	373	50	n.	n.	PROPN
fnp-3805	373	51	,	,	PUNCT
fnp-3805	373	52	et	et	PROPN
fnp-3805	373	53	al	al	PROPN
fnp-3805	373	54	.	.	PROPN
fnp-3805	374	1	(	(	PUNCT
fnp-3805	374	2	2021	2021	NUM
fnp-3805	374	3	)	)	PUNCT
fnp-3805	374	4	.	.	PUNCT
fnp-3805	375	1	biallelic	biallelic	ADJ
fnp-3805	375	2	truncating	truncate	VERB
fnp-3805	375	3	variants	variant	NOUN
fnp-3805	375	4	in	in	ADP
fnp-3805	375	5	the	the	DET
fnp-3805	375	6	muscular	muscular	ADJ
fnp-3805	375	7	a	a	DET
fnp-3805	375	8	-	-	PUNCT
fnp-3805	375	9	type	type	NOUN
fnp-3805	375	10	lamin	lamin	NOUN
fnp-3805	375	11	-	-	PUNCT
fnp-3805	375	12	interacting	interact	VERB
fnp-3805	375	13	protein	protein	NOUN
fnp-3805	375	14	(	(	PUNCT
fnp-3805	375	15	mlip	mlip	NOUN
fnp-3805	375	16	)	)	PUNCT
fnp-3805	375	17	gene	gene	NOUN
fnp-3805	375	18	cause	cause	NOUN
fnp-3805	375	19	myopathy	myopathy	ADJ
fnp-3805	375	20	with	with	ADP
fnp-3805	375	21	hyperckemia	hyperckemia	NOUN
fnp-3805	375	22	.	.	PUNCT
fnp-3805	376	1	eur	eur	PROPN
fnp-3805	376	2	j	j	PROPN
fnp-3805	376	3	neurol	neurol	PROPN
fnp-3805	376	4	,	,	PUNCT
fnp-3805	376	5	epub	epub	NOUN
fnp-3805	376	6	ahead	ahead	ADV
fnp-3805	376	7	of	of	ADP
fnp-3805	376	8	print	print	NOUN
fnp-3805	376	9	.	.	PUNCT
fnp-3805	377	1	schoser	schoser	NOUN
fnp-3805	377	2	,	,	PUNCT
fnp-3805	377	3	b.	b.	PROPN
fnp-3805	377	4	,	,	PUNCT
fnp-3805	377	5	roberts	roberts	PROPN
fnp-3805	377	6	,	,	PUNCT
fnp-3805	377	7	m.	m.	NOUN
fnp-3805	377	8	,	,	PUNCT
fnp-3805	377	9	byrne	byrne	NOUN
fnp-3805	377	10	,	,	PUNCT
fnp-3805	377	11	b.j	b.j	PROPN
fnp-3805	377	12	.	.	PROPN
fnp-3805	377	13	,	,	PUNCT
fnp-3805	377	14	sitaraman	sitaraman	NOUN
fnp-3805	377	15	,	,	PUNCT
fnp-3805	377	16	s.	s.	PROPN
fnp-3805	377	17	,	,	PUNCT
fnp-3805	377	18	jiang	jiang	PROPN
fnp-3805	377	19	,	,	PUNCT
fnp-3805	377	20	h.	h.	PROPN
fnp-3805	377	21	,	,	PUNCT
fnp-3805	377	22	laforet	laforet	PROPN
fnp-3805	377	23	,	,	PUNCT
fnp-3805	377	24	p.	p.	PROPN
fnp-3805	377	25	,	,	PUNCT
fnp-3805	377	26	toscano	toscano	PROPN
fnp-3805	377	27	,	,	PUNCT
fnp-3805	377	28	a.	a.	PROPN
fnp-3805	377	29	,	,	PUNCT
fnp-3805	377	30	castelli	castelli	PROPN
fnp-3805	377	31	,	,	PUNCT
fnp-3805	377	32	j.	j.	PROPN
fnp-3805	377	33	,	,	PUNCT
fnp-3805	377	34	diaz	diaz	PROPN
fnp-3805	377	35	-	-	PUNCT
fnp-3805	377	36	manera	manera	PROPN
fnp-3805	377	37	,	,	PUNCT
fnp-3805	377	38	j.	j.	PROPN
fnp-3805	377	39	,	,	PUNCT
fnp-3805	377	40	goldman	goldman	PROPN
fnp-3805	377	41	,	,	PUNCT
fnp-3805	377	42	m.	m.	NOUN
fnp-3805	377	43	,	,	PUNCT
fnp-3805	377	44	et	et	PROPN
fnp-3805	377	45	al	al	PROPN
fnp-3805	377	46	.	.	PROPN
fnp-3805	377	47	(	(	PUNCT
fnp-3805	377	48	2021	2021	NUM
fnp-3805	377	49	)	)	PUNCT
fnp-3805	377	50	.	.	PUNCT
fnp-3805	378	1	safety	safety	NOUN
fnp-3805	378	2	and	and	CCONJ
fnp-3805	378	3	efficacy	efficacy	NOUN
fnp-3805	378	4	of	of	ADP
fnp-3805	378	5	cipaglucosidase	cipaglucosidase	PROPN
fnp-3805	378	6	alfa	alfa	NOUN
fnp-3805	378	7	plus	plus	CCONJ
fnp-3805	378	8	miglustat	miglustat	X
fnp-3805	378	9	versus	versus	ADP
fnp-3805	378	10	alglucosidase	alglucosidase	NOUN
fnp-3805	378	11	alfa	alfa	NOUN
fnp-3805	378	12	plus	plus	CCONJ
fnp-3805	378	13	placebo	placebo	NOUN
fnp-3805	378	14	in	in	ADP
fnp-3805	378	15	late	late	ADJ
fnp-3805	378	16	-	-	PUNCT
fnp-3805	378	17	onset	onset	NOUN
fnp-3805	378	18	pompe	pompe	NOUN
fnp-3805	378	19	disease	disease	NOUN
fnp-3805	378	20	(	(	PUNCT
fnp-3805	378	21	propel	propel	NOUN
fnp-3805	378	22	):	):	PUNCT
fnp-3805	378	23	an	an	DET
fnp-3805	378	24	international	international	ADJ
fnp-3805	378	25	,	,	PUNCT
fnp-3805	378	26	randomised	randomise	VERB
fnp-3805	378	27	,	,	PUNCT
fnp-3805	378	28	double	double	ADJ
fnp-3805	378	29	-	-	PUNCT
fnp-3805	378	30	blind	blind	ADJ
fnp-3805	378	31	,	,	PUNCT
fnp-3805	378	32	parallel	parallel	NOUN
fnp-3805	378	33	-	-	PUNCT
fnp-3805	378	34	group	group	NOUN
fnp-3805	378	35	,	,	PUNCT
fnp-3805	378	36	phase	phase	NOUN
fnp-3805	378	37	3	3	NUM
fnp-3805	378	38	trial	trial	NOUN
fnp-3805	378	39	.	.	PUNCT
fnp-3805	379	1	lancet	lancet	PROPN
fnp-3805	379	2	neurol	neurol	PROPN
fnp-3805	379	3	20	20	NUM
fnp-3805	379	4	,	,	PUNCT
fnp-3805	379	5	1027	1027	NUM
fnp-3805	379	6	-	-	SYM
fnp-3805	379	7	1037	1037	NUM
fnp-3805	379	8	.	.	PUNCT
fnp-3805	380	1	sicari	sicari	PROPN
fnp-3805	380	2	,	,	PUNCT
fnp-3805	380	3	b.m	b.m	PROPN
fnp-3805	380	4	.	.	PROPN
fnp-3805	380	5	,	,	PUNCT
fnp-3805	380	6	agrawal	agrawal	PROPN
fnp-3805	380	7	,	,	PUNCT
fnp-3805	380	8	v.	v.	ADP
fnp-3805	380	9	,	,	PUNCT
fnp-3805	380	10	siu	siu	NOUN
fnp-3805	380	11	,	,	PUNCT
fnp-3805	380	12	b.f	b.f	PROPN
fnp-3805	380	13	.	.	PROPN
fnp-3805	380	14	,	,	PUNCT
fnp-3805	380	15	medberry	medberry	NOUN
fnp-3805	380	16	,	,	PUNCT
fnp-3805	380	17	c.j	c.j	PROPN
fnp-3805	380	18	.	.	PROPN
fnp-3805	380	19	,	,	PUNCT
fnp-3805	380	20	dearth	dearth	NOUN
fnp-3805	380	21	,	,	PUNCT
fnp-3805	380	22	c.l	c.l	PROPN
fnp-3805	380	23	.	.	PROPN
fnp-3805	380	24	,	,	PUNCT
fnp-3805	380	25	turner	turner	PROPN
fnp-3805	380	26	,	,	PUNCT
fnp-3805	380	27	n.j	n.j	PROPN
fnp-3805	380	28	.	.	PROPN
fnp-3805	380	29	,	,	PUNCT
fnp-3805	380	30	and	and	CCONJ
fnp-3805	380	31	badylak	badylak	NOUN
fnp-3805	380	32	,	,	PUNCT
fnp-3805	380	33	s.f	s.f	PROPN
fnp-3805	380	34	.	.	PROPN
fnp-3805	380	35	(	(	PUNCT
fnp-3805	380	36	2012	2012	NUM
fnp-3805	380	37	)	)	PUNCT
fnp-3805	380	38	.	.	PUNCT
fnp-3805	381	1	a	a	DET
fnp-3805	381	2	murine	murine	ADJ
fnp-3805	381	3	model	model	NOUN
fnp-3805	381	4	of	of	ADP
fnp-3805	381	5	volumetric	volumetric	NOUN
fnp-3805	381	6	muscle	muscle	NOUN
fnp-3805	381	7	loss	loss	NOUN
fnp-3805	381	8	and	and	CCONJ
fnp-3805	381	9	a	a	DET
fnp-3805	381	10	regenerative	regenerative	ADJ
fnp-3805	381	11	medicine	medicine	NOUN
fnp-3805	381	12	approach	approach	NOUN
fnp-3805	381	13	for	for	ADP
fnp-3805	381	14	tissue	tissue	NOUN
fnp-3805	381	15	replacement	replacement	NOUN
fnp-3805	381	16	.	.	PUNCT
fnp-3805	382	1	tissue	tissue	NOUN
fnp-3805	382	2	eng	eng	PROPN
fnp-3805	382	3	part	part	NOUN
fnp-3805	382	4	a	a	DET
fnp-3805	382	5	18	18	NUM
fnp-3805	382	6	,	,	PUNCT
fnp-3805	382	7	1941	1941	NUM
fnp-3805	382	8	-	-	SYM
fnp-3805	382	9	1948	1948	NUM
fnp-3805	382	10	.	.	PUNCT
fnp-3805	383	1	siegert	siegert	PROPN
fnp-3805	383	2	,	,	PUNCT
fnp-3805	383	3	e.	e.	PROPN
fnp-3805	383	4	,	,	PUNCT
fnp-3805	383	5	uruha	uruha	ADJ
fnp-3805	383	6	,	,	PUNCT
fnp-3805	383	7	a.	a.	NOUN
fnp-3805	383	8	,	,	PUNCT
fnp-3805	383	9	goebel	goebel	NOUN
fnp-3805	383	10	,	,	PUNCT
fnp-3805	383	11	h.h	h.h	PROPN
fnp-3805	383	12	.	.	PROPN
fnp-3805	383	13	,	,	PUNCT
fnp-3805	383	14	preusse	preusse	NOUN
fnp-3805	383	15	,	,	PUNCT
fnp-3805	383	16	c.	c.	PROPN
fnp-3805	383	17	,	,	PUNCT
fnp-3805	383	18	casteleyn	casteleyn	NOUN
fnp-3805	383	19	,	,	PUNCT
fnp-3805	383	20	v.	v.	ADV
fnp-3805	383	21	,	,	PUNCT
fnp-3805	383	22	kleefeld	kleefeld	VERB
fnp-3805	383	23	,	,	PUNCT
fnp-3805	383	24	f.	f.	PROPN
fnp-3805	383	25	,	,	PUNCT
fnp-3805	383	26	alten	alten	PROPN
fnp-3805	383	27	,	,	PUNCT
fnp-3805	383	28	r.	r.	PROPN
fnp-3805	383	29	,	,	PUNCT
fnp-3805	383	30	burmester	burmester	PROPN
fnp-3805	383	31	,	,	PUNCT
fnp-3805	383	32	g.r	g.r	PROPN
fnp-3805	383	33	.	.	PROPN
fnp-3805	383	34	,	,	PUNCT
fnp-3805	383	35	schneider	schneider	PROPN
fnp-3805	383	36	,	,	PUNCT
fnp-3805	383	37	u.	u.	PROPN
fnp-3805	383	38	,	,	PUNCT
fnp-3805	383	39	hoppner	hoppner	NOUN
fnp-3805	383	40	,	,	PUNCT
fnp-3805	383	41	j.	j.	PROPN
fnp-3805	383	42	,	,	PUNCT
fnp-3805	383	43	et	et	PROPN
fnp-3805	383	44	al	al	PROPN
fnp-3805	383	45	.	.	PROPN
fnp-3805	383	46	(	(	PUNCT
fnp-3805	383	47	2021	2021	NUM
fnp-3805	383	48	)	)	PUNCT
fnp-3805	383	49	.	.	PUNCT
fnp-3805	384	1	systemic	systemic	ADJ
fnp-3805	384	2	sclerosis	sclerosis	NOUN
fnp-3805	384	3	-	-	PUNCT
fnp-3805	384	4	associated	associate	VERB
fnp-3805	384	5	myositis	myositis	NOUN
fnp-3805	384	6	features	feature	VERB
fnp-3805	384	7	minimal	minimal	ADJ
fnp-3805	384	8	inflammation	inflammation	NOUN
fnp-3805	384	9	and	and	CCONJ
fnp-3805	384	10	characteristic	characteristic	ADJ
fnp-3805	384	11	capillary	capillary	ADJ
fnp-3805	384	12	pathology	pathology	NOUN
fnp-3805	384	13	.	.	PUNCT
fnp-3805	385	1	acta	acta	PROPN
fnp-3805	385	2	neuropathol	neuropathol	PROPN
fnp-3805	385	3	141	141	NUM
fnp-3805	385	4	,	,	PUNCT
fnp-3805	385	5	917	917	NUM
fnp-3805	385	6	-	-	SYM
fnp-3805	385	7	927	927	NUM
fnp-3805	385	8	.	.	PUNCT
fnp-3805	386	1	spaulding	spaulding	PROPN
fnp-3805	386	2	,	,	PUNCT
fnp-3805	386	3	e.l	e.l	PROPN
fnp-3805	386	4	.	.	PROPN
fnp-3805	386	5	,	,	PUNCT
fnp-3805	386	6	hines	hines	PROPN
fnp-3805	386	7	,	,	PUNCT
fnp-3805	386	8	t.j	t.j	PROPN
fnp-3805	386	9	.	.	PROPN
fnp-3805	386	10	,	,	PUNCT
fnp-3805	386	11	bais	bais	PROPN
fnp-3805	386	12	,	,	PUNCT
fnp-3805	386	13	p.	p.	NOUN
fnp-3805	386	14	,	,	PUNCT
fnp-3805	386	15	tadenev	tadenev	PROPN
fnp-3805	386	16	,	,	PUNCT
fnp-3805	386	17	a.l.d	a.l.d	NOUN
fnp-3805	386	18	.	.	PROPN
fnp-3805	386	19	,	,	PUNCT
fnp-3805	386	20	schneider	schneider	PROPN
fnp-3805	386	21	,	,	PUNCT
fnp-3805	386	22	r.	r.	PROPN
fnp-3805	386	23	,	,	PUNCT
fnp-3805	386	24	jewett	jewett	PROPN
fnp-3805	386	25	,	,	PUNCT
fnp-3805	386	26	d.	d.	PROPN
fnp-3805	386	27	,	,	PUNCT
fnp-3805	386	28	pattavina	pattavina	PROPN
fnp-3805	386	29	,	,	PUNCT
fnp-3805	386	30	b.	b.	PROPN
fnp-3805	386	31	,	,	PUNCT
fnp-3805	386	32	pratt	pratt	PROPN
fnp-3805	386	33	,	,	PUNCT
fnp-3805	386	34	s.l	s.l	PROPN
fnp-3805	386	35	.	.	PROPN
fnp-3805	386	36	,	,	PUNCT
fnp-3805	386	37	morelli	morelli	PROPN
fnp-3805	386	38	,	,	PUNCT
fnp-3805	386	39	k.h	k.h	PROPN
fnp-3805	386	40	.	.	PROPN
fnp-3805	386	41	,	,	PUNCT
fnp-3805	386	42	stum	stum	NOUN
fnp-3805	386	43	,	,	PUNCT
fnp-3805	386	44	m.g	m.g	PROPN
fnp-3805	386	45	.	.	PROPN
fnp-3805	386	46	,	,	PUNCT
fnp-3805	386	47	et	et	PROPN
fnp-3805	386	48	al	al	PROPN
fnp-3805	386	49	.	.	PROPN
fnp-3805	386	50	(	(	PUNCT
fnp-3805	386	51	2021	2021	NUM
fnp-3805	386	52	)	)	PUNCT
fnp-3805	386	53	.	.	PUNCT
fnp-3805	387	1	the	the	DET
fnp-3805	387	2	integrated	integrate	VERB
fnp-3805	387	3	stress	stress	NOUN
fnp-3805	387	4	response	response	NOUN
fnp-3805	387	5	contributes	contribute	VERB
fnp-3805	387	6	to	to	ADP
fnp-3805	387	7	trna	trna	NOUN
fnp-3805	387	8	synthetase	synthetase	NOUN
fnp-3805	387	9	-	-	PUNCT
fnp-3805	387	10	associated	associate	VERB
fnp-3805	387	11	peripheral	peripheral	ADJ
fnp-3805	387	12	neuropathy	neuropathy	ADJ
fnp-3805	387	13	.	.	PUNCT
fnp-3805	388	1	science	science	NOUN
fnp-3805	388	2	373	373	NUM
fnp-3805	388	3	,	,	PUNCT
fnp-3805	388	4	1156	1156	NUM
fnp-3805	388	5	-	-	SYM
fnp-3805	388	6	1161	1161	NUM
fnp-3805	388	7	.	.	PUNCT
fnp-3805	389	1	stavrou	stavrou	NOUN
fnp-3805	389	2	,	,	PUNCT
fnp-3805	389	3	m.	m.	NOUN
fnp-3805	389	4	,	,	PUNCT
fnp-3805	389	5	sargiannidou	sargiannidou	NOUN
fnp-3805	389	6	,	,	PUNCT
fnp-3805	389	7	i.	i.	NOUN
fnp-3805	389	8	,	,	PUNCT
fnp-3805	389	9	christofi	christofi	NOUN
fnp-3805	389	10	,	,	PUNCT
fnp-3805	389	11	t.	t.	PROPN
fnp-3805	389	12	,	,	PUNCT
fnp-3805	389	13	and	and	CCONJ
fnp-3805	389	14	kleopa	kleopa	PROPN
fnp-3805	389	15	,	,	PUNCT
fnp-3805	389	16	k.a	k.a	PROPN
fnp-3805	389	17	.	.	PROPN
fnp-3805	389	18	(	(	PUNCT
fnp-3805	389	19	2021	2021	NUM
fnp-3805	389	20	)	)	PUNCT
fnp-3805	389	21	.	.	PUNCT
fnp-3805	390	1	genetic	genetic	ADJ
fnp-3805	390	2	mechanisms	mechanism	NOUN
fnp-3805	390	3	of	of	ADP
fnp-3805	390	4	peripheral	peripheral	ADJ
fnp-3805	390	5	nerve	nerve	NOUN
fnp-3805	390	6	disease	disease	NOUN
fnp-3805	390	7	.	.	PUNCT
fnp-3805	391	1	neurosci	neurosci	PROPN
fnp-3805	391	2	lett	lett	PROPN
fnp-3805	391	3	742	742	NUM
fnp-3805	391	4	,	,	PUNCT
fnp-3805	391	5	135357	135357	NUM
fnp-3805	391	6	.	.	PUNCT
fnp-3805	392	1	stenton	stenton	PROPN
fnp-3805	392	2	,	,	PUNCT
fnp-3805	392	3	s.l	s.l	PROPN
fnp-3805	392	4	.	.	PROPN
fnp-3805	392	5	,	,	PUNCT
fnp-3805	392	6	sheremet	sheremet	PROPN
fnp-3805	392	7	,	,	PUNCT
fnp-3805	392	8	n.l	n.l	PROPN
fnp-3805	392	9	.	.	PROPN
fnp-3805	392	10	,	,	PUNCT
fnp-3805	392	11	catarino	catarino	PROPN
fnp-3805	392	12	,	,	PUNCT
fnp-3805	392	13	c.b	c.b	PROPN
fnp-3805	392	14	.	.	PROPN
fnp-3805	392	15	,	,	PUNCT
fnp-3805	392	16	andreeva	andreeva	PROPN
fnp-3805	392	17	,	,	PUNCT
fnp-3805	393	1	n.a	n.a	PROPN
fnp-3805	393	2	.	.	PROPN
fnp-3805	393	3	,	,	PUNCT
fnp-3805	393	4	assouline	assouline	PROPN
fnp-3805	393	5	,	,	PUNCT
fnp-3805	393	6	z.	z.	PROPN
fnp-3805	393	7	,	,	PUNCT
fnp-3805	393	8	barboni	barboni	NOUN
fnp-3805	393	9	,	,	PUNCT
fnp-3805	393	10	p.	p.	NOUN
fnp-3805	393	11	,	,	PUNCT
fnp-3805	393	12	barel	barel	PROPN
fnp-3805	393	13	,	,	PUNCT
fnp-3805	393	14	o.	o.	PROPN
fnp-3805	393	15	,	,	PUNCT
fnp-3805	393	16	berutti	berutti	PROPN
fnp-3805	393	17	,	,	PUNCT
fnp-3805	393	18	r.	r.	PROPN
fnp-3805	393	19	,	,	PUNCT
fnp-3805	393	20	bychkov	bychkov	NOUN
fnp-3805	393	21	,	,	PUNCT
fnp-3805	393	22	i.	i.	PROPN
fnp-3805	393	23	,	,	PUNCT
fnp-3805	393	24	caporali	caporali	PROPN
fnp-3805	393	25	,	,	PUNCT
fnp-3805	393	26	l.	l.	PROPN
fnp-3805	393	27	,	,	PUNCT
fnp-3805	393	28	et	et	PROPN
fnp-3805	393	29	al	al	PROPN
fnp-3805	393	30	.	.	PROPN
fnp-3805	393	31	(	(	PUNCT
fnp-3805	393	32	2021	2021	NUM
fnp-3805	393	33	)	)	PUNCT
fnp-3805	393	34	.	.	PUNCT
fnp-3805	394	1	impaired	impaired	ADJ
fnp-3805	394	2	complex	complex	NOUN
fnp-3805	394	3	i	i	PRON
fnp-3805	394	4	repair	repair	VERB
fnp-3805	394	5	causes	cause	VERB
fnp-3805	394	6	recessive	recessive	ADJ
fnp-3805	394	7	leber	leber	PROPN
fnp-3805	394	8	’s	’s	PART
fnp-3805	394	9	hereditary	hereditary	ADJ
fnp-3805	394	10	optic	optic	NOUN
fnp-3805	394	11	neuropathy	neuropathy	ADJ
fnp-3805	394	12	.	.	PUNCT
fnp-3805	395	1	j	j	PROPN
fnp-3805	395	2	clin	clin	PROPN
fnp-3805	395	3	invest	invest	VERB
fnp-3805	395	4	131	131	NUM
fnp-3805	395	5	,	,	PUNCT
fnp-3805	395	6	e138267	e138267	PROPN
fnp-3805	395	7	.	.	PUNCT
fnp-3805	396	1	suh	suh	PROPN
fnp-3805	396	2	,	,	PUNCT
fnp-3805	396	3	j.	j.	PROPN
fnp-3805	396	4	,	,	PUNCT
fnp-3805	396	5	mukerji	mukerji	PROPN
fnp-3805	396	6	,	,	PUNCT
fnp-3805	396	7	s.s	s.s	PROPN
fnp-3805	396	8	.	.	PROPN
fnp-3805	396	9	,	,	PUNCT
fnp-3805	396	10	collens	collens	PROPN
fnp-3805	396	11	,	,	PUNCT
fnp-3805	396	12	s.i	s.i	PROPN
fnp-3805	396	13	.	.	PROPN
fnp-3805	396	14	,	,	PUNCT
fnp-3805	396	15	padera	padera	PROPN
fnp-3805	396	16	,	,	PUNCT
fnp-3805	396	17	r.f	r.f	PROPN
fnp-3805	396	18	.	.	PROPN
fnp-3805	396	19	,	,	PUNCT
fnp-3805	396	20	jr	jr	PROPN
fnp-3805	396	21	.	.	PROPN
fnp-3805	396	22	,	,	PUNCT
fnp-3805	396	23	pinkus	pinku	NOUN
fnp-3805	396	24	,	,	PUNCT
fnp-3805	396	25	g.s	g.s	PROPN
fnp-3805	396	26	.	.	PROPN
fnp-3805	396	27	,	,	PUNCT
fnp-3805	396	28	amato	amato	PROPN
fnp-3805	396	29	,	,	PUNCT
fnp-3805	396	30	a.a	a.a	PROPN
fnp-3805	396	31	.	.	PROPN
fnp-3805	396	32	,	,	PUNCT
fnp-3805	396	33	and	and	CCONJ
fnp-3805	396	34	solomon	solomon	PROPN
fnp-3805	396	35	,	,	PUNCT
fnp-3805	396	36	i.h	i.h	PROPN
fnp-3805	396	37	.	.	PROPN
fnp-3805	396	38	(	(	PUNCT
fnp-3805	396	39	2021	2021	NUM
fnp-3805	396	40	)	)	PUNCT
fnp-3805	396	41	.	.	PUNCT
fnp-3805	397	1	skeletal	skeletal	ADJ
fnp-3805	397	2	muscle	muscle	NOUN
fnp-3805	397	3	and	and	CCONJ
fnp-3805	397	4	peripheral	peripheral	ADJ
fnp-3805	397	5	nerve	nerve	NOUN
fnp-3805	397	6	histopathology	histopathology	NOUN
fnp-3805	397	7	in	in	ADP
fnp-3805	397	8	covid-19	covid-19	PROPN
fnp-3805	397	9	.	.	PROPN
fnp-3805	397	10	neurology	neurology	PROPN
fnp-3805	397	11	97	97	NUM
fnp-3805	397	12	,	,	PUNCT
fnp-3805	397	13	e849	e849	PROPN
fnp-3805	397	14	-	-	PUNCT
fnp-3805	397	15	e858	e858	PROPN
fnp-3805	397	16	.	.	PUNCT
fnp-3805	397	17	szczepanowska	szczepanowska	PROPN
fnp-3805	397	18	,	,	PUNCT
fnp-3805	397	19	k.	k.	PROPN
fnp-3805	397	20	,	,	PUNCT
fnp-3805	397	21	senft	senft	PROPN
fnp-3805	397	22	,	,	PUNCT
fnp-3805	397	23	k.	k.	PROPN
fnp-3805	397	24	,	,	PUNCT
fnp-3805	397	25	heidler	heidler	PROPN
fnp-3805	397	26	,	,	PUNCT
fnp-3805	397	27	j.	j.	PROPN
fnp-3805	397	28	,	,	PUNCT
fnp-3805	397	29	herholz	herholz	PROPN
fnp-3805	397	30	,	,	PUNCT
fnp-3805	397	31	m.	m.	NOUN
fnp-3805	397	32	,	,	PUNCT
fnp-3805	397	33	kukat	kukat	PROPN
fnp-3805	397	34	,	,	PUNCT
fnp-3805	397	35	a.	a.	PROPN
fnp-3805	397	36	,	,	PUNCT
fnp-3805	397	37	hohne	hohne	PROPN
fnp-3805	397	38	,	,	PUNCT
fnp-3805	397	39	m.n	m.n	PROPN
fnp-3805	397	40	.	.	PROPN
fnp-3805	397	41	,	,	PUNCT
fnp-3805	397	42	hofsetz	hofsetz	PROPN
fnp-3805	397	43	,	,	PUNCT
fnp-3805	397	44	e.	e.	PROPN
fnp-3805	397	45	,	,	PUNCT
fnp-3805	397	46	becker	becker	PROPN
fnp-3805	397	47	,	,	PUNCT
fnp-3805	397	48	c.	c.	PROPN
fnp-3805	397	49	,	,	PUNCT
fnp-3805	397	50	kaspar	kaspar	PROPN
fnp-3805	397	51	,	,	PUNCT
fnp-3805	397	52	s.	s.	PROPN
fnp-3805	397	53	,	,	PUNCT
fnp-3805	397	54	giese	giese	PROPN
fnp-3805	397	55	,	,	PUNCT
fnp-3805	397	56	h.	h.	PROPN
fnp-3805	397	57	,	,	PUNCT
fnp-3805	397	58	et	et	PROPN
fnp-3805	397	59	al	al	PROPN
fnp-3805	397	60	.	.	PROPN
fnp-3805	397	61	(	(	PUNCT
fnp-3805	397	62	2020	2020	NUM
fnp-3805	397	63	)	)	PUNCT
fnp-3805	397	64	.	.	PUNCT
fnp-3805	398	1	a	a	DET
fnp-3805	398	2	salvage	salvage	NOUN
fnp-3805	398	3	pathway	pathway	NOUN
fnp-3805	398	4	maintains	maintain	VERB
fnp-3805	398	5	highly	highly	ADV
fnp-3805	398	6	functional	functional	ADJ
fnp-3805	398	7	respiratory	respiratory	ADJ
fnp-3805	398	8	complex	complex	ADJ
fnp-3805	398	9	i.	i.	NOUN
fnp-3805	398	10	nat	nat	PROPN
fnp-3805	398	11	commun	commun	PROPN
fnp-3805	398	12	11	11	NUM
fnp-3805	398	13	,	,	PUNCT
fnp-3805	398	14	1643	1643	NUM
fnp-3805	398	15	.	.	PUNCT
fnp-3805	399	1	tebbenkamp	tebbenkamp	ADJ
fnp-3805	399	2	,	,	PUNCT
fnp-3805	399	3	a.t.n	a.t.n	VERB
fnp-3805	399	4	.	.	PROPN
fnp-3805	399	5	,	,	PUNCT
fnp-3805	399	6	varela	varela	PROPN
fnp-3805	399	7	,	,	PUNCT
fnp-3805	399	8	l.	l.	PROPN
fnp-3805	399	9	,	,	PUNCT
fnp-3805	399	10	choi	choi	PROPN
fnp-3805	399	11	,	,	PUNCT
fnp-3805	399	12	j.	j.	PROPN
fnp-3805	399	13	,	,	PUNCT
fnp-3805	399	14	paredes	paredes	PROPN
fnp-3805	399	15	,	,	PUNCT
fnp-3805	399	16	m.i	m.i	PROPN
fnp-3805	399	17	.	.	PROPN
fnp-3805	399	18	,	,	PUNCT
fnp-3805	399	19	giani	giani	PROPN
fnp-3805	399	20	,	,	PUNCT
fnp-3805	399	21	a.m.	a.m.	ADV
fnp-3805	399	22	,	,	PUNCT
fnp-3805	399	23	song	song	NOUN
fnp-3805	399	24	,	,	PUNCT
fnp-3805	399	25	j.e	j.e	PROPN
fnp-3805	399	26	.	.	PROPN
fnp-3805	399	27	,	,	PUNCT
fnp-3805	399	28	sestan	sestan	PROPN
fnp-3805	399	29	-	-	PUNCT
fnp-3805	399	30	pesa	pesa	NOUN
fnp-3805	399	31	,	,	PUNCT
fnp-3805	399	32	m.	m.	NOUN
fnp-3805	399	33	,	,	PUNCT
fnp-3805	399	34	franjic	franjic	PROPN
fnp-3805	399	35	,	,	PUNCT
fnp-3805	399	36	d.	d.	PROPN
fnp-3805	399	37	,	,	PUNCT
fnp-3805	399	38	sousa	sousa	PROPN
fnp-3805	399	39	,	,	PUNCT
fnp-3805	399	40	a.m.m	a.m.m	PROPN
fnp-3805	399	41	.	.	PROPN
fnp-3805	399	42	,	,	PUNCT
fnp-3805	399	43	liu	liu	PROPN
fnp-3805	399	44	,	,	PUNCT
fnp-3805	399	45	z.w	z.w	PROPN
fnp-3805	399	46	.	.	PROPN
fnp-3805	399	47	,	,	PUNCT
fnp-3805	399	48	et	et	PROPN
fnp-3805	399	49	al	al	PROPN
fnp-3805	399	50	.	.	PUNCT
fnp-3805	400	1	(	(	PUNCT
fnp-3805	400	2	2018	2018	NUM
fnp-3805	400	3	)	)	PUNCT
fnp-3805	400	4	.	.	PUNCT
fnp-3805	401	1	the	the	DET
fnp-3805	401	2	7q11.23	7q11.23	PROPN
fnp-3805	401	3	protein	protein	NOUN
fnp-3805	401	4	dnajc30	dnajc30	NOUN
fnp-3805	401	5	interacts	interact	VERB
fnp-3805	401	6	with	with	ADP
fnp-3805	401	7	atp	atp	NOUN
fnp-3805	401	8	synthase	synthase	NOUN
fnp-3805	401	9	and	and	CCONJ
fnp-3805	401	10	links	link	NOUN
fnp-3805	401	11	mitochondria	mitochondria	VERB
fnp-3805	401	12	to	to	ADP
fnp-3805	401	13	brain	brain	NOUN
fnp-3805	401	14	development	development	NOUN
fnp-3805	401	15	.	.	PUNCT
fnp-3805	402	1	cell	cell	NOUN
fnp-3805	402	2	175	175	NUM
fnp-3805	402	3	,	,	PUNCT
fnp-3805	402	4	1088	1088	NUM
fnp-3805	402	5	-	-	SYM
fnp-3805	402	6	1104	1104	NUM
fnp-3805	402	7	e1023	e1023	PROPN
fnp-3805	402	8	.	.	PUNCT
fnp-3805	403	1	trikamji	trikamji	PROPN
fnp-3805	403	2	,	,	PUNCT
fnp-3805	403	3	b.	b.	PROPN
fnp-3805	403	4	,	,	PUNCT
fnp-3805	403	5	and	and	CCONJ
fnp-3805	403	6	pestronk	pestronk	VERB
fnp-3805	403	7	,	,	PUNCT
fnp-3805	403	8	a.	a.	NOUN
fnp-3805	403	9	(	(	PUNCT
fnp-3805	403	10	2021	2021	NUM
fnp-3805	403	11	)	)	PUNCT
fnp-3805	403	12	.	.	PUNCT
fnp-3805	404	1	treatable	treatable	ADJ
fnp-3805	404	2	,	,	PUNCT
fnp-3805	404	3	motor	motor	NOUN
fnp-3805	404	4	-	-	PUNCT
fnp-3805	404	5	sensory	sensory	ADJ
fnp-3805	404	6	,	,	PUNCT
fnp-3805	404	7	axonal	axonal	ADJ
fnp-3805	404	8	neuropathies	neuropathy	NOUN
fnp-3805	404	9	with	with	ADP
fnp-3805	404	10	c5b-9	c5b-9	PROPN
fnp-3805	404	11	complement	complement	NOUN
fnp-3805	404	12	on	on	ADP
fnp-3805	404	13	endoneurial	endoneurial	ADJ
fnp-3805	404	14	microvessels	microvessel	NOUN
fnp-3805	404	15	.	.	PUNCT
fnp-3805	405	1	muscle	muscle	NOUN
fnp-3805	405	2	nerve	nerve	NOUN
fnp-3805	405	3	63	63	NUM
fnp-3805	405	4	,	,	PUNCT
fnp-3805	405	5	506	506	NUM
fnp-3805	405	6	-	-	SYM
fnp-3805	405	7	515	515	NUM
fnp-3805	405	8	.	.	PUNCT
fnp-3805	406	1	turnbull	turnbull	PROPN
fnp-3805	406	2	,	,	PUNCT
fnp-3805	406	3	c.	c.	PROPN
fnp-3805	406	4	,	,	PUNCT
fnp-3805	406	5	scott	scott	PROPN
fnp-3805	406	6	,	,	PUNCT
fnp-3805	406	7	r.h	r.h	PROPN
fnp-3805	406	8	.	.	PROPN
fnp-3805	406	9	,	,	PUNCT
fnp-3805	406	10	thomas	thomas	PROPN
fnp-3805	406	11	,	,	PUNCT
fnp-3805	406	12	e.	e.	PROPN
fnp-3805	406	13	,	,	PUNCT
fnp-3805	406	14	jones	jones	PROPN
fnp-3805	406	15	,	,	PUNCT
fnp-3805	406	16	l.	l.	PROPN
fnp-3805	406	17	,	,	PUNCT
fnp-3805	406	18	murugaesu	murugaesu	PROPN
fnp-3805	406	19	,	,	PUNCT
fnp-3805	406	20	n.	n.	NOUN
fnp-3805	406	21	,	,	PUNCT
fnp-3805	406	22	pretty	pretty	ADJ
fnp-3805	406	23	,	,	PUNCT
fnp-3805	406	24	f.b	f.b	PROPN
fnp-3805	406	25	.	.	PROPN
fnp-3805	406	26	,	,	PUNCT
fnp-3805	406	27	halai	halai	PROPN
fnp-3805	406	28	,	,	PUNCT
fnp-3805	406	29	d.	d.	PROPN
fnp-3805	406	30	,	,	PUNCT
fnp-3805	406	31	baple	baple	ADV
fnp-3805	406	32	,	,	PUNCT
fnp-3805	406	33	e.	e.	PROPN
fnp-3805	406	34	,	,	PUNCT
fnp-3805	406	35	craig	craig	PROPN
fnp-3805	406	36	,	,	PUNCT
fnp-3805	406	37	c.	c.	PROPN
fnp-3805	406	38	,	,	PUNCT
fnp-3805	406	39	hamblin	hamblin	PROPN
fnp-3805	406	40	,	,	PUNCT
fnp-3805	406	41	a.	a.	PROPN
fnp-3805	406	42	,	,	PUNCT
fnp-3805	406	43	et	et	PROPN
fnp-3805	406	44	al	al	PROPN
fnp-3805	406	45	.	.	PUNCT
fnp-3805	406	46	(	(	PUNCT
fnp-3805	406	47	2018	2018	NUM
fnp-3805	406	48	)	)	PUNCT
fnp-3805	406	49	.	.	PUNCT
fnp-3805	407	1	the	the	DET
fnp-3805	407	2	100	100	NUM
fnp-3805	407	3	000	000	NUM
fnp-3805	407	4	genomes	genome	NOUN
fnp-3805	407	5	project	project	NOUN
fnp-3805	407	6	:	:	PUNCT
fnp-3805	407	7	bringing	bring	VERB
fnp-3805	407	8	whole	whole	ADJ
fnp-3805	407	9	genome	genome	NOUN
fnp-3805	407	10	sequencing	sequence	VERB
fnp-3805	407	11	to	to	ADP
fnp-3805	407	12	the	the	DET
fnp-3805	407	13	nhs	nhs	NOUN
fnp-3805	407	14	.	.	PUNCT
fnp-3805	408	1	bmj	bmj	PROPN
fnp-3805	408	2	361	361	NUM
fnp-3805	408	3	,	,	PUNCT
fnp-3805	409	1	k1687	k1687	NOUN
fnp-3805	409	2	.	.	PUNCT
fnp-3805	409	3	umapathi	umapathi	PROPN
fnp-3805	409	4	,	,	PUNCT
fnp-3805	409	5	t.	t.	PROPN
fnp-3805	409	6	,	,	PUNCT
fnp-3805	409	7	er	er	INTJ
fnp-3805	409	8	,	,	PUNCT
fnp-3805	409	9	b.	b.	PROPN
fnp-3805	409	10	,	,	PUNCT
fnp-3805	409	11	koh	koh	PROPN
fnp-3805	409	12	,	,	PUNCT
fnp-3805	409	13	j.s	j.s	PROPN
fnp-3805	409	14	.	.	PROPN
fnp-3805	409	15	,	,	PUNCT
fnp-3805	409	16	goh	goh	PROPN
fnp-3805	409	17	,	,	PUNCT
fnp-3805	409	18	y.h	y.h	PROPN
fnp-3805	409	19	.	.	PROPN
fnp-3805	409	20	,	,	PUNCT
fnp-3805	409	21	and	and	CCONJ
fnp-3805	409	22	chua	chua	PROPN
fnp-3805	409	23	,	,	PUNCT
fnp-3805	409	24	l.	l.	PROPN
fnp-3805	409	25	(	(	PUNCT
fnp-3805	409	26	2021	2021	NUM
fnp-3805	409	27	)	)	PUNCT
fnp-3805	409	28	.	.	PUNCT
fnp-3805	409	29	guillain	guillain	NOUN
fnp-3805	409	30	-	-	PUNCT
fnp-3805	409	31	barre	barre	NOUN
fnp-3805	409	32	syndrome	syndrome	NOUN
fnp-3805	409	33	decreases	decrease	VERB
fnp-3805	409	34	in	in	ADP
fnp-3805	409	35	singapore	singapore	PROPN
fnp-3805	409	36	during	during	ADP
fnp-3805	409	37	the	the	DET
fnp-3805	409	38	covid-19	covid-19	PROPN
fnp-3805	409	39	pandemic	pandemic	NOUN
fnp-3805	409	40	.	.	PUNCT
fnp-3805	410	1	j	j	PROPN
fnp-3805	410	2	peripher	peripher	PROPN
fnp-3805	410	3	nerv	nerv	PROPN
fnp-3805	410	4	syst	syst	PROPN
fnp-3805	410	5	26	26	NUM
fnp-3805	410	6	,	,	PUNCT
fnp-3805	410	7	235	235	NUM
fnp-3805	410	8	-	-	SYM
fnp-3805	410	9	236	236	NUM
fnp-3805	410	10	.	.	PUNCT
fnp-3805	411	1	witt	witt	PROPN
fnp-3805	411	2	,	,	PUNCT
fnp-3805	411	3	l.j	l.j	PROPN
fnp-3805	411	4	.	.	PROPN
fnp-3805	411	5	,	,	PUNCT
fnp-3805	411	6	curran	curran	PROPN
fnp-3805	411	7	,	,	PUNCT
fnp-3805	411	8	j.j	j.j	PROPN
fnp-3805	411	9	.	.	PROPN
fnp-3805	411	10	,	,	PUNCT
fnp-3805	411	11	and	and	CCONJ
fnp-3805	411	12	strek	strek	PROPN
fnp-3805	411	13	,	,	PUNCT
fnp-3805	411	14	m.e	m.e	PROPN
fnp-3805	411	15	.	.	PROPN
fnp-3805	411	16	(	(	PUNCT
fnp-3805	411	17	2016	2016	NUM
fnp-3805	411	18	)	)	PUNCT
fnp-3805	411	19	.	.	PUNCT
fnp-3805	412	1	the	the	DET
fnp-3805	412	2	diagnosis	diagnosis	NOUN
fnp-3805	412	3	and	and	CCONJ
fnp-3805	412	4	treatment	treatment	NOUN
fnp-3805	412	5	of	of	ADP
fnp-3805	412	6	antisynthetase	antisynthetase	NOUN
fnp-3805	412	7	syndrome	syndrome	PROPN
fnp-3805	412	8	.	.	PUNCT
fnp-3805	413	1	clin	clin	PROPN
fnp-3805	413	2	pulm	pulm	PROPN
fnp-3805	413	3	med	me	VERB
fnp-3805	413	4	23	23	NUM
fnp-3805	413	5	,	,	PUNCT
fnp-3805	413	6	218	218	NUM
fnp-3805	413	7	-	-	SYM
fnp-3805	413	8	226	226	NUM
fnp-3805	413	9	.	.	PUNCT
fnp-3805	414	1	xi	xi	PROPN
fnp-3805	414	2	,	,	PUNCT
fnp-3805	414	3	y.	y.	PROPN
fnp-3805	414	4	,	,	PUNCT
fnp-3805	414	5	ju	ju	PROPN
fnp-3805	414	6	,	,	PUNCT
fnp-3805	414	7	r.	r.	PROPN
fnp-3805	414	8	,	,	PUNCT
fnp-3805	414	9	and	and	CCONJ
fnp-3805	414	10	wang	wang	PROPN
fnp-3805	414	11	,	,	PUNCT
fnp-3805	414	12	y.	y.	PROPN
fnp-3805	414	13	(	(	PUNCT
fnp-3805	414	14	2020	2020	NUM
fnp-3805	414	15	)	)	PUNCT
fnp-3805	414	16	.	.	PUNCT
fnp-3805	415	1	roles	role	NOUN
fnp-3805	415	2	of	of	ADP
fnp-3805	415	3	annexin	annexin	NOUN
fnp-3805	415	4	a	a	DET
fnp-3805	415	5	protein	protein	NOUN
fnp-3805	415	6	family	family	NOUN
fnp-3805	415	7	in	in	ADP
fnp-3805	415	8	autophagy	autophagy	ADJ
fnp-3805	415	9	regulation	regulation	NOUN
fnp-3805	415	10	and	and	CCONJ
fnp-3805	415	11	therapy	therapy	NOUN
fnp-3805	415	12	.	.	PUNCT
fnp-3805	415	13	biomed	biome	VERB
fnp-3805	415	14	pharmacother	pharmacother	ADJ
fnp-3805	415	15	130	130	NUM
fnp-3805	415	16	,	,	PUNCT
fnp-3805	415	17	110591	110591	NUM
fnp-3805	415	18	.	.	PUNCT
fnp-3805	416	1	yell	yell	PROPN
fnp-3805	416	2	,	,	PUNCT
fnp-3805	416	3	p.c	p.c	PROPN
fnp-3805	416	4	.	.	PROPN
fnp-3805	416	5	,	,	PUNCT
fnp-3805	416	6	burns	burn	NOUN
fnp-3805	416	7	,	,	PUNCT
fnp-3805	416	8	d.k	d.k	PROPN
fnp-3805	416	9	.	.	PROPN
fnp-3805	416	10	,	,	PUNCT
fnp-3805	416	11	dittmar	dittmar	NOUN
fnp-3805	416	12	,	,	PUNCT
fnp-3805	416	13	e.g.	e.g.	ADV
fnp-3805	416	14	,	,	PUNCT
fnp-3805	416	15	white	white	ADJ
fnp-3805	416	16	,	,	PUNCT
fnp-3805	416	17	c.l	c.l	PROPN
fnp-3805	416	18	.	.	PROPN
fnp-3805	416	19	,	,	PUNCT
fnp-3805	416	20	3rd	3rd	NOUN
fnp-3805	416	21	,	,	PUNCT
fnp-3805	416	22	and	and	CCONJ
fnp-3805	416	23	cai	cai	PROPN
fnp-3805	416	24	,	,	PUNCT
fnp-3805	416	25	c.	c.	PROPN
fnp-3805	416	26	(	(	PUNCT
fnp-3805	416	27	2018	2018	NUM
fnp-3805	416	28	)	)	PUNCT
fnp-3805	416	29	.	.	PUNCT
fnp-3805	417	1	diffuse	diffuse	VERB
fnp-3805	417	2	microvascular	microvascular	ADJ
fnp-3805	417	3	c5b-9	c5b-9	PROPN
fnp-3805	417	4	deposition	deposition	NOUN
fnp-3805	417	5	is	be	AUX
fnp-3805	417	6	a	a	DET
fnp-3805	417	7	common	common	ADJ
fnp-3805	417	8	feature	feature	NOUN
fnp-3805	417	9	in	in	ADP
fnp-3805	417	10	muscle	muscle	NOUN
fnp-3805	417	11	and	and	CCONJ
fnp-3805	417	12	nerve	nerve	NOUN
fnp-3805	417	13	biopsies	biopsy	NOUN
fnp-3805	417	14	from	from	ADP
fnp-3805	417	15	diabetic	diabetic	ADJ
fnp-3805	417	16	patients	patient	NOUN
fnp-3805	417	17	.	.	PUNCT
fnp-3805	418	1	acta	acta	PROPN
fnp-3805	418	2	neuropathol	neuropathol	PROPN
fnp-3805	418	3	commun	commun	PROPN
fnp-3805	418	4	6	6	NUM
fnp-3805	418	5	,	,	PUNCT
fnp-3805	418	6	11	11	NUM
fnp-3805	418	7	.	.	X
fnp-3805	419	1	zhang	zhang	PROPN
fnp-3805	419	2	,	,	PUNCT
fnp-3805	419	3	h.	h.	PROPN
fnp-3805	419	4	,	,	PUNCT
fnp-3805	419	5	zhou	zhou	PROPN
fnp-3805	419	6	,	,	PUNCT
fnp-3805	419	7	z.w	z.w	PROPN
fnp-3805	419	8	.	.	PROPN
fnp-3805	419	9	,	,	PUNCT
fnp-3805	419	10	and	and	CCONJ
fnp-3805	419	11	sun	sun	NOUN
fnp-3805	419	12	,	,	PUNCT
fnp-3805	419	13	l.	l.	PROPN
fnp-3805	419	14	(	(	PUNCT
fnp-3805	419	15	2021	2021	NUM
fnp-3805	419	16	)	)	PUNCT
fnp-3805	419	17	.	.	PUNCT
fnp-3805	420	1	aminoacyl	aminoacyl	PROPN
fnp-3805	420	2	-	-	PUNCT
fnp-3805	420	3	trna	trna	PROPN
fnp-3805	420	4	synthetases	synthetase	NOUN
fnp-3805	420	5	in	in	ADP
fnp-3805	420	6	charcot	charcot	PROPN
fnp-3805	420	7	-	-	PUNCT
fnp-3805	420	8	marie	marie	PROPN
fnp-3805	420	9	-	-	PUNCT
fnp-3805	420	10	tooth	tooth	NOUN
fnp-3805	420	11	disease	disease	NOUN
fnp-3805	420	12	:	:	PUNCT
fnp-3805	420	13	a	a	DET
fnp-3805	420	14	gain	gain	NOUN
fnp-3805	420	15	or	or	CCONJ
fnp-3805	420	16	a	a	DET
fnp-3805	420	17	loss	loss	NOUN
fnp-3805	420	18	?	?	PUNCT
fnp-3805	421	1	j	j	PROPN
fnp-3805	422	1	neurochem	neurochem	ADV
fnp-3805	422	2	157	157	NUM
fnp-3805	422	3	,	,	PUNCT
fnp-3805	422	4	351	351	NUM
fnp-3805	422	5	-	-	SYM
fnp-3805	422	6	369	369	NUM
fnp-3805	422	7	.	.	PUNCT
fnp-3805	423	1	zhang	zhang	PROPN
fnp-3805	423	2	,	,	PUNCT
fnp-3805	423	3	k.	k.	PROPN
fnp-3805	423	4	,	,	PUNCT
fnp-3805	423	5	liu	liu	PROPN
fnp-3805	423	6	,	,	PUNCT
fnp-3805	423	7	q.	q.	PROPN
fnp-3805	423	8	,	,	PUNCT
fnp-3805	423	9	liu	liu	PROPN
fnp-3805	423	10	,	,	PUNCT
fnp-3805	423	11	k.	k.	PROPN
fnp-3805	423	12	,	,	PUNCT
fnp-3805	423	13	shen	shen	PROPN
fnp-3805	423	14	,	,	PUNCT
fnp-3805	423	15	d.	d.	PROPN
fnp-3805	423	16	,	,	PUNCT
fnp-3805	423	17	tai	tai	PROPN
fnp-3805	423	18	,	,	PUNCT
fnp-3805	423	19	h.	h.	PROPN
fnp-3805	423	20	,	,	PUNCT
fnp-3805	423	21	shu	shu	PROPN
fnp-3805	423	22	,	,	PUNCT
fnp-3805	423	23	s.	s.	PROPN
fnp-3805	423	24	,	,	PUNCT
fnp-3805	423	25	ding	ding	NOUN
fnp-3805	423	26	,	,	PUNCT
fnp-3805	423	27	q.	q.	PROPN
fnp-3805	423	28	,	,	PUNCT
fnp-3805	423	29	fu	fu	PROPN
fnp-3805	423	30	,	,	PUNCT
fnp-3805	423	31	h.	h.	PROPN
fnp-3805	423	32	,	,	PUNCT
fnp-3805	423	33	liu	liu	PROPN
fnp-3805	423	34	,	,	PUNCT
fnp-3805	423	35	s.	s.	PROPN
fnp-3805	423	36	,	,	PUNCT
fnp-3805	423	37	wang	wang	PROPN
fnp-3805	423	38	,	,	PUNCT
fnp-3805	423	39	z.	z.	PROPN
fnp-3805	423	40	,	,	PUNCT
fnp-3805	423	41	et	et	PROPN
fnp-3805	423	42	al	al	PROPN
fnp-3805	423	43	.	.	PUNCT
fnp-3805	423	44	(	(	PUNCT
fnp-3805	423	45	2018	2018	NUM
fnp-3805	423	46	)	)	PUNCT
fnp-3805	423	47	.	.	PUNCT
fnp-3805	424	1	anxa11	anxa11	NOUN
fnp-3805	424	2	mutations	mutation	NOUN
fnp-3805	424	3	prevail	prevail	VERB
fnp-3805	424	4	in	in	ADP
fnp-3805	424	5	chinese	chinese	ADJ
fnp-3805	424	6	als	als	NOUN
fnp-3805	424	7	patients	patient	NOUN
fnp-3805	424	8	with	with	ADP
fnp-3805	424	9	and	and	CCONJ
fnp-3805	424	10	without	without	ADP
fnp-3805	424	11	cognitive	cognitive	ADJ
fnp-3805	424	12	dementia	dementia	NOUN
fnp-3805	424	13	.	.	PUNCT
fnp-3805	425	1	neurol	neurol	PROPN
fnp-3805	425	2	genet	genet	PROPN
fnp-3805	425	3	4	4	NUM
fnp-3805	425	4	,	,	PUNCT
fnp-3805	425	5	e237	e237	PROPN
fnp-3805	425	6	.	.	PUNCT
fnp-3805	426	1	zuko	zuko	PROPN
fnp-3805	426	2	,	,	PUNCT
fnp-3805	426	3	a.	a.	PROPN
fnp-3805	426	4	,	,	PUNCT
fnp-3805	426	5	mallik	mallik	PROPN
fnp-3805	426	6	,	,	PUNCT
fnp-3805	426	7	m.	m.	NOUN
fnp-3805	426	8	,	,	PUNCT
fnp-3805	426	9	thompson	thompson	PROPN
fnp-3805	426	10	,	,	PUNCT
fnp-3805	426	11	r.	r.	PROPN
fnp-3805	426	12	,	,	PUNCT
fnp-3805	426	13	spaulding	spaulding	NOUN
fnp-3805	426	14	,	,	PUNCT
fnp-3805	426	15	e.l	e.l	PROPN
fnp-3805	426	16	.	.	PROPN
fnp-3805	426	17	,	,	PUNCT
fnp-3805	426	18	wienand	wienand	PROPN
fnp-3805	426	19	,	,	PUNCT
fnp-3805	426	20	a.r	a.r	PROPN
fnp-3805	426	21	.	.	PROPN
fnp-3805	426	22	,	,	PUNCT
fnp-3805	426	23	been	be	AUX
fnp-3805	426	24	,	,	PUNCT
fnp-3805	426	25	m.	m.	NOUN
fnp-3805	426	26	,	,	PUNCT
fnp-3805	426	27	tadenev	tadenev	NOUN
fnp-3805	426	28	,	,	PUNCT
fnp-3805	426	29	a.l.d	a.l.d	NOUN
fnp-3805	426	30	.	.	PUNCT
fnp-3805	426	31	,	,	PUNCT
fnp-3805	426	32	van	van	PROPN
fnp-3805	426	33	bakel	bakel	PROPN
fnp-3805	426	34	,	,	PUNCT
fnp-3805	426	35	n.	n.	NOUN
fnp-3805	426	36	,	,	PUNCT
fnp-3805	426	37	sijlmans	sijlman	NOUN
fnp-3805	426	38	,	,	PUNCT
fnp-3805	426	39	c.	c.	PROPN
fnp-3805	426	40	,	,	PUNCT
fnp-3805	426	41	santos	santos	PROPN
fnp-3805	426	42	,	,	PUNCT
fnp-3805	426	43	l.a	l.a	PROPN
fnp-3805	426	44	.	.	PROPN
fnp-3805	426	45	,	,	PUNCT
fnp-3805	426	46	et	et	PROPN
fnp-3805	426	47	al	al	PROPN
fnp-3805	426	48	.	.	PROPN
fnp-3805	427	1	(	(	PUNCT
fnp-3805	427	2	2021	2021	NUM
fnp-3805	427	3	)	)	PUNCT
fnp-3805	427	4	.	.	PUNCT
fnp-3805	428	1	trna	trna	NOUN
fnp-3805	428	2	overexpression	overexpression	NOUN
fnp-3805	428	3	rescues	rescue	NOUN
fnp-3805	428	4	peripheral	peripheral	ADJ
fnp-3805	428	5	neuropathy	neuropathy	ADV
fnp-3805	428	6	caused	cause	VERB
fnp-3805	428	7	by	by	ADP
fnp-3805	428	8	mutations	mutation	NOUN
fnp-3805	428	9	in	in	ADP
fnp-3805	428	10	trna	trna	NOUN
fnp-3805	428	11	synthetase	synthetase	NOUN
fnp-3805	428	12	.	.	PUNCT
fnp-3805	429	1	science	science	NOUN
fnp-3805	429	2	373	373	NUM
fnp-3805	429	3	,	,	PUNCT
fnp-3805	429	4	1161	1161	NUM
fnp-3805	429	5	-	-	SYM
fnp-3805	429	6	1166	1166	NUM
fnp-3805	429	7	.	.	PUNCT
fnp-3805	430	1	copyright	copyright	NOUN
fnp-3805	430	2	:	:	PUNCT
fnp-3805	430	3	©	©	PROPN
fnp-3805	430	4	2022	2022	NUM
fnp-3805	430	5	the	the	DET
fnp-3805	430	6	author(s	author(s	NOUN
fnp-3805	430	7	)	)	PUNCT
fnp-3805	430	8	.	.	PUNCT
fnp-3805	431	1	this	this	PRON
fnp-3805	431	2	is	be	AUX
fnp-3805	431	3	an	an	DET
fnp-3805	431	4	open	open	ADJ
fnp-3805	431	5	access	access	NOUN
fnp-3805	431	6	article	article	NOUN
fnp-3805	431	7	distributed	distribute	VERB
fnp-3805	431	8	under	under	ADP
fnp-3805	431	9	the	the	DET
fnp-3805	431	10	terms	term	NOUN
fnp-3805	431	11	of	of	ADP
fnp-3805	431	12	the	the	DET
fnp-3805	431	13	creative	creative	ADJ
fnp-3805	431	14	commons	common	NOUN
fnp-3805	431	15	attribution	attribution	NOUN
fnp-3805	431	16	4.0	4.0	NUM
fnp-3805	431	17	international	international	ADJ
fnp-3805	431	18	license	license	NOUN
fnp-3805	431	19	(	(	PUNCT
fnp-3805	431	20	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
fnp-3805	431	21	)	)	PUNCT
fnp-3805	431	22	,	,	PUNCT
fnp-3805	431	23	which	which	PRON
fnp-3805	431	24	permits	permit	VERB
fnp-3805	431	25	unrestricted	unrestricted	ADJ
fnp-3805	431	26	use	use	NOUN
fnp-3805	431	27	,	,	PUNCT
fnp-3805	431	28	distribution	distribution	NOUN
fnp-3805	431	29	,	,	PUNCT
fnp-3805	431	30	and	and	CCONJ
fnp-3805	431	31	reproduction	reproduction	NOUN
fnp-3805	431	32	in	in	ADP
fnp-3805	431	33	any	any	DET
fnp-3805	431	34	medium	medium	NOUN
fnp-3805	431	35	,	,	PUNCT
fnp-3805	431	36	provided	provide	VERB
fnp-3805	431	37	the	the	DET
fnp-3805	431	38	original	original	ADJ
fnp-3805	431	39	author	author	NOUN
fnp-3805	431	40	and	and	CCONJ
fnp-3805	431	41	source	source	NOUN
fnp-3805	431	42	are	be	AUX
fnp-3805	431	43	credited	credit	VERB
fnp-3805	431	44	,	,	PUNCT
fnp-3805	431	45	a	a	DET
fnp-3805	431	46	link	link	NOUN
fnp-3805	431	47	to	to	ADP
fnp-3805	431	48	the	the	DET
fnp-3805	431	49	creative	creative	ADJ
fnp-3805	431	50	commons	common	NOUN
fnp-3805	431	51	license	license	NOUN
fnp-3805	431	52	is	be	AUX
fnp-3805	431	53	provided	provide	VERB
fnp-3805	431	54	,	,	PUNCT
fnp-3805	431	55	and	and	CCONJ
fnp-3805	431	56	any	any	DET
fnp-3805	431	57	changes	change	NOUN
fnp-3805	431	58	are	be	AUX
fnp-3805	431	59	indicated	indicate	VERB
fnp-3805	431	60	.	.	PUNCT
fnp-3805	432	1	the	the	DET
fnp-3805	432	2	creative	creative	ADJ
fnp-3805	432	3	commons	common	NOUN
fnp-3805	432	4	public	public	ADJ
fnp-3805	432	5	domain	domain	NOUN
fnp-3805	432	6	dedication	dedication	NOUN
fnp-3805	432	7	waiver	waiver	NOUN
fnp-3805	432	8	(	(	PUNCT
fnp-3805	432	9	https://creativecommons.org/publicdomain/zero/1.0/	https://creativecommons.org/publicdomain/zero/1.0/	PROPN
fnp-3805	432	10	)	)	PUNCT
fnp-3805	432	11	applies	apply	VERB
fnp-3805	432	12	to	to	ADP
fnp-3805	432	13	the	the	DET
fnp-3805	432	14	data	datum	NOUN
fnp-3805	432	15	made	make	VERB
fnp-3805	432	16	available	available	ADJ
fnp-3805	432	17	in	in	ADP
fnp-3805	432	18	this	this	DET
fnp-3805	432	19	article	article	NOUN
fnp-3805	432	20	,	,	PUNCT
fnp-3805	432	21	unless	unless	SCONJ
fnp-3805	432	22	otherwise	otherwise	ADV
fnp-3805	432	23	stated	state	VERB
fnp-3805	432	24	.	.	PUNCT